ComplexName	subunits(UniProt IDs)	subunits(Entrez IDs)	GO description	FunCat description	subunits(Gene name)	Subunits comment	Complex comment	Disease comment
BCL6-HDAC4 complex	P41182;P56524	604;9759	"DNA topological change;negative regulation of transcription, DNA-templated;chromosome organization;B cell differentiation;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;organization of chromosome structure;B-cell;nucleus	BCL6;HDAC4	None	Transcriptional repression by BCL6 is thought to be achieved in part by recruiting a repressor complex containing histone deacetylases.	None
BCL6-HDAC5 complex	P41182;Q9UQL6	604;10014	"DNA topological change;negative regulation of transcription, DNA-templated;chromosome organization;B cell differentiation;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;organization of chromosome structure;B-cell;nucleus	BCL6;HDAC5	None	Transcriptional repression by BCL6 is thought to be achieved in part by recruiting a repressor complex containing histone deacetylases.	None
BCL6-HDAC7 complex	P41182;Q8WUI4	604;51564	"DNA topological change;negative regulation of transcription, DNA-templated;chromosome organization;B cell differentiation;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;organization of chromosome structure;B-cell;nucleus	BCL6;HDAC7	None	Transcriptional repression by BCL6 is thought to be achieved in part by recruiting a repressor complex containing histone deacetylases.	None
Multisubunit ACTR coactivator complex	Q09472;Q92793;Q92831;Q9Y6Q9	2033;1387;8850;8202	"positive regulation of transcription, DNA-templated;signaling;nucleus"	transcription activation;cellular signalling;nucleus	EP300;CREBBP;KAT2B;NCOA3	None	Cofactor ACTR binds directly nuclear receptors and stimulates their transcriptional activities in a hormone-dependent fashion.	None
Condensin I complex	O95347;Q15003;Q15021;Q9BPX3;Q9NTJ3	10592;23397;9918;64151;10051	M phase;mitotic nuclear division;chromosome condensation;chromosome segregation;chromosome organization;chromosome	M phase;chromosome condensation;chromosome segregation/division;organization of chromosome structure;chromosome	SMC2;NCAPH;NCAPD2;NCAPG;SMC4	None	None	None
BLOC-3 (biogenesis of lysosome-related organelles complex 3)	Q92902;Q9NQG7	3257;89781	endosome organization;lysosome organization;vacuole organization	endosome;vacuole or lysosome	HPS1;HPS4	None	The results suggest that HPS1 and HPS4 are components of a protein complex that regulates the intracellular localization of lysosomes and late endosomes and may function in a BLOC-1-dependent pathway for melanosome biogenesis.	"HPS1-7 are involved in Hermansky-Pudlak syndrome (HPS), which  comprises at least seven different autosomal recessive disorders (referred to as HPS-1 through -7) that share the clinical manifestations of oculocutaneous albinism combined with platelet storage pool deficiency and do not present with the severe immunodeficiency and giant intracellular granules characteristic of Chediak-Higashi syndrome (PMID:15030569)."
BLOC-2 (biogenesis of lysosome-related organelles complex 2)	Q86YV9;Q969F9;Q9UPZ3	79803;84343;11234	endosome organization;lysosome organization;vacuole organization	endosome;vacuole or lysosome	HPS6;HPS3;HPS5	None	The results suggest that BLOC-2 is not critical for basal levels of secretion of lysosomal enzymes by fibroblasts.	"HPS1-7 are involved in Hermansky-Pudlak syndrome (HPS), which  comprises at least seven different autosomal recessive disorders (referred to as HPS-1 through -7) that share the clinical manifestations of oculocutaneous albinism combined with platelet storage pool deficiency and do not present with the severe immunodeficiency and giant intracellular granules characteristic of Chediak-Higashi syndrome."
MUS81-CDS1 complex	Q92903;Q96NY9	1040;80198	DNA repair;DNA recombination	DNA repair;DNA recombination	CDS1;MUS81	None	"Human Mus81-associated endonuclease resolves Holliday junctions into linear duplexes by cutting across the junction exclusively on strands of like polarity. In addition, Mus81 protein abundance increases in cells following exposure to agents that block DNA replication. Taken together, these findings suggest a role for Mus81 in resolving Holliday junctions that arise when DNA replication is blocked by damage or by nucleotide depletion. Mus81 is not related by sequence to previously characterized Holliday junction resolving enzymes, and it has distinct enzymatic properties that suggest it uses a novel enzymatic strategy to cleave Holliday junctions. Mus81 interacts with the FHA domain of Cds1."	None
NCOR complex	O15379;O60907;O75376;Q13227;Q92828;Q9BZK7	8841;6907;9611;2874;7464;79718	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	HDAC3;TBL1X;NCOR1;GPS2;CORO2A;TBL1XR1	None	"Corepressors N-CoR and SMRT participate in diverse repression pathways and exist in large protein complexes including HDAC3, TBL1 and TBLR1. The purified N-CoR complex contains 10-12 associated proteins, including previously identified components and a novel actin-binding protein IR10. It is show that TBL1/TBLR1 associates with N-CoR through two independent interactions: the N-terminal region and the C-terminal WD-40 repeats interact with the N-CoR RD1 and RD4 region, respectively. In vitro, TBL1/TBLR1 bind histones H2B and H4, and, importantly, repression by TBL1/TBLR1 correlates with their interaction with histones. By using specific small interference RNAs (siRNAs), the authors demonstrate that HDAC3 is essential, whereas TBL1 and TBLR1 are functionally redundant but essential for repression by unliganded thyroid hormone receptor."	None
BLOC-1 (biogenesis of lysosome-related organelles complex 1)	O95295;P78537;Q6QNY0;Q6QNY1;Q8TDH9;Q96EV8;Q9NUP1;Q9UL45	23557;2647;388552;282991;63915;84062;55330;26258	None	None	SNAPIN;BLOC1S1;BLOC1S3;BLOC1S2;BLOC1S5;DTNBP1;BLOC1S4;BLOC1S6	None	"The authors identified Snapin, BLOS1, BLOS2, and BLOS3 as subunits of BLOC-1 and found that the HPS mouse model strain, reduced pigmentation, carries a nonsense mutation in BLOS3. The genes encoding these proteins may underlie the pathogenesis of novel forms of HPS in patients having no detectable mutation in any of the genes that cause HPS types 1-7."	"PLDN, MUTED, CNO and DTNBP1 are involved in Hermansky-Pudlak syndrome (HPS), a genetic disorder characterized by hypopigmentation and platelet storage pool deficiency."
Arp2/3 protein complex	O15143;O15144;O15145;O15511;P59998;P61158;P61160	10095;10109;10094;10092;10093;10096;10097	None	None	ARPC1B;ARPC2;ARPC3;ARPC5;ARPC4;ACTR3;ACTR2	None	None	"Transcript levels of ARP2/3 complex subunits, and of nucleation promotion factors that regulate the ARP2/3 complex, were significantly lower in DLPFC layer 3 and 5 pyramidal cells in schizophrenia. In contrast, these transcripts were unaltered, or only modestly changed, in parvalbumin interneurons and DLPFC gray matter (PMID:27523502)"
PA28gamma complex	P61289	10197	proteasome-mediated ubiquitin-dependent protein catabolic process;protein binding;peptidase activator activity	proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;protease activator	PSME3	"According to gel filtration chromatography experiments, the protein complex probably consists of seven identical subunits."	None	None
PA28 complex	Q06323;Q9UL46	5720;5721	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;regulation of binding;protein binding;peptidase activator activity;cytoplasm	proteasomal degradation (ubiquitin/proteasomal pathway);regulation by binding / dissociation;protein binding;protease activator;cytoplasm	PSME1;PSME2	None	"PA28 is a regulatory complex of the 20S proteasome. It acts as proteasome activator and stimulates cleavage after basic, acidic, and most hydrophobic residues in many peptides."	None
PA700 complex	O00231;O00232;O00233;O00487;O43242;O75832;P17980;P35998;P43686;P48556;P51665;P55036;P62191;P62195;P62333;Q13200;Q15008;Q16401;Q99460;Q9UNM6	5717;5718;5715;10213;5709;5716;5702;5701;5704;5714;5713;5710;5700;5705;5706;5708;9861;5711;5707;5719	proteasome-mediated ubiquitin-dependent protein catabolic process;protein binding;peptidase activator activity	proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;protease activator	PSMD11;PSMD12;PSMD9;PSMD14;PSMD3;PSMD10;PSMC3;PSMC2;PSMC4;PSMD8;PSMD7;PSMD4;PSMC1;PSMC5;PSMC6;PSMD2;PSMD6;PSMD5;PSMD1;PSMD13	None	"The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degradation of most cellular proteins (for reviews see PMID:8811196 and PMID:10872471). It contains a barrel-shaped proteolytic core complex (the 20S proteasome), and is capped at one or both ends by regulatory complexes like the 19S complex (PMID:11812135), modulator (PMID:8621709), PA28 (PMID:9325261) and PA28gamma (PMID:9325261). Interferon-gamma (IFN-gamma) alters the peptide-degrading specificity of proteasomes and produces an immunoproteasome responsible for accelerated processing of nonself endogenous antigens by inducing the replacement of subunits Psmb5, Psmb6 and Psmb7 by Psmb8, Psmb9 and Psmb10, respectively."	None
Prefoldin complex	O15212;O60925;P61758;Q99471;Q9NQP4;Q9UHV9	10471;5201;7411;5204;5203;5202	cytoskeleton organization;protein folding;protein stabilization;actin cytoskeleton organization	cytoskeleton/structural proteins;protein folding and stabilization;actin cytoskeleton	PFDN6;PFDN1;VBP1;PFDN5;PFDN4;PFDN2	None	None	None
AP1 adaptor complex	O43747;O75843;P56377;P61966;Q10567;Q96PC3;Q9BXS5;Q9Y6Q5	164;8906;8905;1174;162;130340;8907;10053	intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport;membrane budding;vesicle organization;endocytosis;transport vesicle	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.);vesicle formation;endocytosis;intracellular transport vesicles"	AP1G1;AP1G2;AP1S2;AP1S1;AP1B1;AP1S3;AP1M1;AP1M2	None	This adaptor-related complex participates in a transport step different from that of AP-1. It may function at some trafficking step in the complex pathways between the TGN and the cell surface.	None
Mi-2/NuRD-MTA3 complex	O94776;O95983;P41182;Q13547;Q9BTC8	9219;53615;604;3065;57504	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;B cell differentiation;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;B-cell;nucleus"	MTA2;MBD3;BCL6;HDAC1;MTA3	None	"The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. A cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/NuRD, for BCL-6-dependent cell fate determination is reported. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status."	None
"Gamma-secretase complex (APH1A, PSEN1, PSENEN, NCSTN)"	P49768;Q92542;Q96BI3;Q9NZ42	5663;23385;51107;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN1;NCSTN;APH1A;PSENEN	None	"Proteolytic cleavage within the hydrophobic transmembrane domains of Notch and APP are intimately associated with a multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenillin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	Gamma-secretase is causally implicated in Alzheimer's disease.
"Gamma-secretase complex (APH1A, PSEN1, PSENEN, NCSTN)"	P49768;Q92542;Q96BI3;Q9NZ42	5663;23385;51107;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN1;NCSTN;APH1A;PSENEN	None	"Proteolytic cleavage within the hydrophobic transmembrane domains of Notch and APP are intimately associated with a multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenillin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	Gamma-secretase is causally implicated in Alzheimer's disease.
DNMT3B complex	O60264;O95239;O95347;Q13547;Q96ST3;Q9NTJ3;Q9UBC3	8467;24137;10592;3065;25942;10051;1789	DNA methylation;DNA topological change;M phase;mitotic nuclear division;chromosome segregation;chromosome organization;chromosome	DNA methylation;DNA conformation modification (e.g. chromatin);M phase;chromosome segregation/division;organization of chromosome structure;chromosome	SMARCA5;KIF4A;SMC2;HDAC1;SIN3A;SMC4;DNMT3B	None	None	None
RAB5-RABAPTIN5\u2013RABEX5 complex	P20339;Q15276;Q9UJ41	5868;9135;27342	endocytosis	endocytosis	RAB5A;RABEP1;RABGEF1	None	"The Rab5-binding protein, Rabex-5 forms a tight physical complex with Rabaptin-5, and this complex is essential for endocytic membrane fusion. Both Rabaptin-5 and Rabex-5 are recruited by immobilized Rab5."	None
SIN3 complex	O00422;O75446;Q09028;Q13547;Q16576;Q92769;Q96ST3	10284;8819;5928;3065;5931;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP18;SAP30;RBBP4;HDAC1;RBBP7;HDAC2;SIN3A	None	"An important event in gene expression is the covalent modification of histone proteins. Histone deacetylases and SAP18 are components of a human Sin3 complex. SAP18 exists in the same complex with mSin3 and HDAC1, and SAP18 enhances mSin3-HDAC1-mediated transcriptional repression."	None
HDAC4-ERK1 complex	P27361;P56524	5595;9759	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;MAPK cascade;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;MAPKKK cascade;organization of chromosome structure;nucleus	MAPK3;HDAC4	None	"ERK1 activity links the Ras-MAPK signal transduction pathway to a mechanism for chromatin remodeling (i.e., histone deacetylation)."	None
HDAC4-ERK2 complex	P28482;P56524	5594;9759	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;MAPK cascade;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;MAPKKK cascade;organization of chromosome structure;nucleus	MAPK1;HDAC4	None	None	None
SMRT complex	O15379;O60907;Q13227;Q9BZK7;Q9Y618	8841;6907;2874;79718;9612	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	HDAC3;TBL1X;GPS2;TBL1XR1;NCOR2	None	"Corepressors N-CoR and SMRT participate in diverse repression pathways and exist in large protein complexes including HDAC3, TBL1 and TBLR1. IR10, a subunit of the N-CoR complex, does not associate with SMRT (NCOR2)."	None
AP3 adaptor complex	O00203;O14617;P53677;P59780;Q13367;Q92572;Q9Y2T2	8546;8943;10947;10239;8120;1176;26985	intracellular protein transport;protein targeting;protein transport;post-Golgi vesicle-mediated transport;endocytosis;vacuole;lysosome	"protein targeting, sorting and translocation;protein transport;post Golgi transport;endocytosis;vacuole or lysosome"	AP3B1;AP3D1;AP3M2;AP3S2;AP3B2;AP3S1;AP3M1	None	None	None
Interferon-stimulated gene factor 3 transcription complex ISGF3	P42224;P52630;Q00978	6772;6773;10379	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	STAT1;STAT2;IRF9	None	The p48 and Stat1:2 heterodimer do not associate stably in the absence of DNA.	None
Mi2/NuRD complex	O94776;O95983;Q09028;Q13547;Q14839;Q16576;Q92769	9219;53615;5928;3065;1108;5931;3066	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;organization of chromosome structure;nucleus	MTA2;MBD3;RBBP4;HDAC1;CHD4;RBBP7;HDAC2	None	None	"Dermatomyositis, cancer (PMID:9790534)"
MeCP1 complex	O94776;O95983;Q09028;Q13547;Q14839;Q16576;Q92769;Q9UBB5	9219;53615;5928;3065;1108;5931;3066;8932	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	MTA2;MBD3;RBBP4;HDAC1;CHD4;RBBP7;HDAC2;MBD2	None	"MeCP1 protein complex represses transcription through preferential binding, remodeling, and deacetylation of methylated nucleosomes."	CHD4 is involved in dermatomyositis (PMID:9790534).
Cohesin-SA1 complex	O60216;Q14683;Q8WVM7;Q9UQE7	5885;8243;10274;9126	M phase;mitotic nuclear division;chromosome segregation;chromosome organization;chromosome	M phase;chromosome segregation/division;organization of chromosome structure;chromosome	RAD21;SMC1A;STAG1;SMC3	None	The results suggest that vertebrate cohesins are regulated by a novel prophase pathway which is distinct from the APC pathway that controls cohesins in yeast.	None
Cohesin-SA2 complex	O60216;Q14683;Q8N3U4;Q9UQE7	5885;8243;10735;9126	M phase;mitotic nuclear division;chromosome organization;nucleus	M phase;organization of chromosome structure;nucleus	RAD21;SMC1A;STAG2;SMC3	None	None	None
TRAP complex	O60244;O75448;P10827;Q15648;Q93074;Q9NVC6;Q9Y2W1;Q9Y2X0	9282;9862;7067;5469;9968;9440;9967;10025	"positive regulation of transcription, DNA-templated;receptor regulator activity;hormone-mediated signaling pathway;signaling;nucleus"	transcription activation;regulator of receptor activity;hormone mediated signal transduction;cellular signalling;nucleus	MED14;MED24;THRA;MED1;MED12;MED17;THRAP3;MED16	TRAP97 and 93 could not be found in the Uniprot database.	"The human thyroid hormone receptor-associated protein (TRAP) complex is a coactivator for nuclear receptors. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
AP4 adaptor complex	O00189;Q9UPM8;Q9Y587;Q9Y6B7	9179;23431;11154;10717	intracellular protein transport;protein targeting;protein transport;protein binding;post-Golgi vesicle-mediated transport;endocytosis;transport vesicle;Golgi apparatus	"protein targeting, sorting and translocation;protein transport;protein binding;post Golgi transport;endocytosis;intracellular transport vesicles;Golgi"	AP4M1;AP4E1;AP4S1;AP4B1	None	Adaptor protein complexes (APs) function as vesicle coat components in different membrane traffic pathways.	None
BCDX2 complex	O15315;O43502;O43543;O75771	5890;5889;7516;5892	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51B;RAD51C;XRCC2;RAD51D	None	None	None
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	The implication of hMre11/hRad50/p95 protein complex in NBS reveals a direct molecular link between DSB repair and cell cycle checkpoint functions.	Rad50-MRE11-p95 protein complex is involved in Nijmegen breakage syndrome.
R/M complex (RAD50-MRE11 complex)	P49959;Q92878	4361;10111	DNA catabolic process;DNA repair;DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	DNA degradation;DNA repair;DNA binding;DNA damage response;organization of chromosome structure;nucleus	MRE11A;RAD50	None	Mre11 by itself has 3' to 5' exonuclease activity that is increased when Mre11 is in a complex with Rad50.	None
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	"On nonhairpin DNA ends, ATP controls a switch in endonuclease specificity that allows Mre11/Rad50/Nbs1 to cleave a 3'-protruding strand at a double-/single-strand transition."	None
HOMER3-IP3R-TRPC1 complex	P48995;Q14573;Q9NSC5	7220;3710;9454	cation transmembrane transporter activity;cation transport;ion channel activity;signaling;plasma membrane	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;cellular signalling;eukaryotic plasma membrane / membrane attached"	TRPC1;ITPR3;HOMER3	None	"An adaptor protein, termed Homer, facilitates a physical association between TRPC1 and the IP(3)R that is required for the TRP channel to respond to signals. The TRPC1-Homer-IP(3)R complex is dynamic and its disassembly parallels TRPC1 channel activation. Homer's action depends on its ability to crosslink and is blocked by the dominant-negative immediate early gene form, H1a. Since H1a is transcriptionally regulated by cellular activity, this mechanism can affect both short and long-term regulation of TRPC1 function. TRPC1 is present at the plasma membrane."	None
TSC1-TSC2 complex	P49815;Q92574	7249;7248	regulation of translation;regulation of phosphorylation	translational control	TSC2;TSC1	None	"TSC1 and TSC2 form a functional complex and inhibit the phosphorylation of S6K and 4EBP1, two key regulators of translation."	Mutations in either the TSC1 or TSC2 tumor suppressor gene are responsible for Tuberous Sclerosis Complex.
"Ubiquitin E3 ligase (SKP1A, SKP2, CUL1, RBX1)"	P62877;P63208;Q13309;Q13616	9978;6500;6502;8454	None	None	RBX1;SKP1;SKP2;CUL1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on target proteins. The ubiquitin ligase is referred to as an E3 and operates in conjunction with an E1 ubiquitin-activating enzyme and an E2 ubiquitin-conjugating enzyme. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Ubiquitin E3 ligase (SKP1A, FBXW8, CUL7, RBX1)"	P62877;P63208;Q14999;Q8N3Y1	9978;6500;9820;26259	protein ubiquitination;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;SKP1;CUL7;FBXW8	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
NUMAC complex (nucleosomal methylation activator complex)	O14497;P51532;P60709;Q12824;Q86X55;Q8TAQ2;Q92922;Q969G3;Q96GM5;Q96KG9	8289;6597;60;6598;10498;6601;6599;6605;6602;57410	"DNA topological change;positive regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;hormone-mediated signaling pathway;signaling;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription activation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;hormone mediated signal transduction;cellular signalling;organization of chromosome structure;nucleus"	ARID1A;SMARCA4;ACTB;SMARCB1;CARM1;SMARCC2;SMARCC1;SMARCE1;SMARCD1;SCYL1	None	"In the NUMAC complex, the methylase, CARM1, acquires the ability to covalently modify nucleosomal histones."	None
Nup 107-160 subcomplex	P52948;P55735;P57740;Q12769;Q8NFH3;Q8NFH4;Q8WUM0;Q96EE3;Q9BW27	4928;6396;57122;23279;348995;79023;55746;81929;79902	"protein transport;protein transporter activity;transport;nuclear transport;chromosome, centromeric region"	"protein transport;CELLULAR TRANSPORT, TRANSPORT FACILITIES AND TRANSPORT ROUTES;nuclear transport;centromere / kinetochore"	NUP98;SEC13;NUP107;NUP160;NUP43;NUP37;NUP133;SEH1L;NUP85	None	"All trafficking of macromolecules between the cytoplasm and the nucleus occurs through nuclear pore complexes (NPCs), which are supramolecular assemblies at points of fusion between the inner and outer nuclear membranes. NPCs are composed of an eightfold symmetric spoke-ring complex, cytoplasmic fibers, and a nuclear basket."	None
Exocyst Sec6/8 complex	O00471;O60645;Q8IYI6;Q8TAG9;Q96A65;Q96KP1;Q9NV70;Q9UPT5	10640;11336;149371;54536;60412;55770;55763;23265	protein transport;protein transporter activity;exocytosis	protein transport;exocytosis	EXOC5;EXOC3;EXOC8;EXOC6;EXOC4;EXOC2;EXOC1;EXOC7	None	None	None
"FA complex (Fanconi anemia complex), cytoplasmic"	O15287;O15360;Q00597;Q9NPI8	2189;2175;2176;2188	protein ubiquitination;cellular response to DNA damage stimulus;cytoplasm	"modification by ubiquitination, deubiquitination;DNA damage response;cytoplasm"	FANCG;FANCA;FANCC;FANCF	None	None	FA complex is involved in Fanconi anemia (FA) disease.
CD28-transactivation complex	P10747;P19338	940;4691	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription initiation;transcriptional control;nucleus	CD28;NCL	None	None	None
Anaphase-promoting complex	P30260;Q13042;Q9H1A4;Q9UJX2;Q9UJX3;Q9UJX4;Q9UJX5;Q9UJX6	996;8881;64682;8697;51434;51433;29945;29882	mitotic cell cycle;regulation of cell cycle;protein ubiquitination;protein binding;nucleus	"mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by ubiquitination, deubiquitination;protein binding;nucleus"	CDC27;CDC16;ANAPC1;CDC23;ANAPC7;ANAPC5;ANAPC4;ANAPC2	None	The initiation of anaphase and exit from mitosis depend on a multi-subunit ubiquitination complex called the anaphase-promoting complex (APC)1 or cyclosome. The APC ubiquitinates proteins such as Pds1 in budding yeast and Cut2 in fission yeast whose subsequent degradation by the 26 S proteasome is essential for the initiation of sister chromatid separation at the metaphase-anaphase transition. Later in anaphase and telophase the APC promotes the inactivation of the mitotic cyclin-dependent protein kinase 1 by ubiquitinating its activating subunit cyclin B.	None
SNF2H-BAZ1A complex	O60264;Q9NRL2	8467;11177	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;organization of chromosome structure;nucleus	SMARCA5;BAZ1A	None	The hACF complex also possesses ATP-dependent nucleosome remodeling and spacing activities.	None
Ku antigen-NARG1 complex	P12956;P13010;Q9BXJ9	2547;7520;80155	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	XRCC6;XRCC5;NAA15	None	This complex regulates osteocalcin gene expression.	None
Anaphase-promoting complex	P30260;Q13042;Q9H1A4;Q9UJX2;Q9UJX3;Q9UJX4;Q9UJX5;Q9UJX6;Q9UM13	996;8881;64682;8697;51434;51433;29945;29882;10393	mitotic cell cycle;regulation of cell cycle;protein ubiquitination;protein binding;nucleus;ubiquitin-dependent protein catabolic process	"mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by ubiquitination, deubiquitination;protein binding;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	CDC27;CDC16;ANAPC1;CDC23;ANAPC7;ANAPC5;ANAPC4;ANAPC2;ANAPC10	None	The initiation of anaphase and exit from mitosis depend on a multi-subunit ubiquitination complex called the anaphase-promoting complex (APC)1 or cyclosome. The APC ubiquitinates proteins such as Pds1 in budding yeast and Cut2 in fission yeast whose subsequent degradation by the 26 S proteasome is essential for the initiation of sister chromatid separation at the metaphase-anaphase transition. Later in anaphase and telophase the APC promotes the inactivation of the mitotic cyclin-dependent protein kinase 1 by ubiquitinating its activating subunit cyclin B.	None
p300-MDM2-p53 protein complex	P04637;Q00987;Q09472	7157;4193;2033	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;enzyme regulator activity;regulation of catalytic activity;nucleus"	transcriptional control;enzymatic activity regulation / enzyme regulator;nucleus	TP53;MDM2;EP300	None	None	None
hNURF complex	P28370;Q09028;Q12830;Q16576	6594;5928;2186;5931	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;neurogenesis;generation of neurons;chromosome organization;neuron differentiation;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;neurogenesis;organization of chromosome structure;neuron;nucleus	SMARCA1;RBBP4;BPTF;RBBP7	None	NURF is a member of the ISWI-containing chromatin remodeling complexes.	None
RNA polymerase II holoenzyme complex	O15514;P13984;P18074;P19387;P19388;P19447;P20226;P24928;P29083;P29084;P30876;P32780;P35269;P36954;P52434;P52435;P53803;P61218;P62487;P62875;Q00403;Q13888;Q13889;Q92759	5433;2963;2068;5432;5434;2071;6908;5430;2960;2961;5431;2965;2962;5438;5437;5439;5440;5435;5436;5441;2959;2966;2967;2968	"transcription, DNA-templated;DNA binding;nucleus"	TRANSCRIPTION;DNA binding;nucleus	POLR2D;GTF2F2;ERCC2;POLR2C;POLR2E;ERCC3;TBP;POLR2A;GTF2E1;GTF2E2;POLR2B;GTF2H1;GTF2F1;POLR2I;POLR2H;POLR2J;POLR2K;POLR2F;POLR2G;POLR2L;GTF2B;GTF2H2;GTF2H3;GTF2H4	None	None	None
RNA polymerase II core complex	O15514;P19387;P19388;P24928;P30876;P36954;P52434;P52435;P53803;P61218;P62487;P62875	5433;5432;5434;5430;5431;5438;5437;5439;5440;5435;5436;5441	"transcription, DNA-templated;DNA binding;nucleus"	TRANSCRIPTION;DNA binding;nucleus	POLR2D;POLR2C;POLR2E;POLR2A;POLR2B;POLR2I;POLR2H;POLR2J;POLR2K;POLR2F;POLR2G;POLR2L	None	None	None
Polycomb repressive complex 2 (PRC 2)	O75530;Q09028;Q15022;Q15910;Q16576	8726;5928;23512;2146;5931	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	EED;RBBP4;SUZ12;EZH2;RBBP7	None	"Polycomb repressive complexes are required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. They are methylating histones at lysine residues. PRC4 methylates preferentially the histone H1b isoform, whereas PRC2 methylated preferentially the histone H1d isoform. The PRC3 complex exclusively targets methylation of histone H3-K27, and the activity is repressed in the presence of histone H1. PRC2 also methylates histone H3-K27 but in the presence of histone H1, PRC2 methylates both H3-K27 and H1-K26."	"PRC complexes are overexpressed in breast, colon, and prostate cancers."
TFIIH transcription factor complex	P18074;P19447;P32780;P50613;P51946;P51948;Q13888;Q13889;Q92759	2068;2071;2965;1022;902;4331;2966;2967;2968	"DNA repair;cell cycle;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus;ATPase activity;kinase activity;phosphorylation of RNA polymerase II C-terminal domain"	DNA repair;cell cycle;transcriptional control;nucleus	ERCC2;ERCC3;GTF2H1;CDK7;CCNH;MNAT1;GTF2H2;GTF2H3;GTF2H4	None	Transcription factor IIH (TFIIH) is a multisubunit complex required for transcription and for DNA nucleotide excision repair.	None
Prefoldin complex	O15212;O60925;P61758;Q99471;Q9NQP4;Q9UHV9	10471;5201;7411;5204;5203;5202	protein stabilization;protein folding;cytoskeleton organization;actin cytoskeleton organization	protein folding and stabilization;cytoskeleton/structural proteins;actin cytoskeleton	PFDN6;PFDN1;VBP1;PFDN5;PFDN4;PFDN2	None	The biogenesis of the cytoskeletal proteins actin and tubulin involves interaction of nascent chains of each of the two proteins with the oligomeric protein prefoldin(PFD) and their subsequent transfer to the cytosolic chaperonin CCT (chaperonin containing TCP-1). PFD exists as a more complex oligomer assembled from six different proteins.	None
SNAPc (small nuclear RNA-activating protein) complex	O75971;Q13487;Q16533;Q5SXM2;Q92966	10302;6618;6617;6621;6619	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding;DNA binding;nucleus"	transcriptional control;protein binding;DNA binding;nucleus	SNAPC5;SNAPC2;SNAPC1;SNAPC4;SNAPC3	None	Additional information about the constituents of the SNAPc complex is given in PMID:7715707 and PMID:9732265.	None
"Polycomb repressive complex 1 (PRC1, hPRC-H)"	O00257;O60264;P0DMV8;P35226;P78364;Q06587;Q14781;Q8IXK0;Q8NDX5;Q96GD3;Q99496;Q9HC52	8535;8467;3303;648;1911;6015;84733;1912;80012;22955;6045;57332	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	CBX4;SMARCA5;HSPA1A;BMI1;PHC1;RING1;CBX2;PHC2;PHC3;SCMH1;RNF2;CBX8	"Since the authors did not specify HSP70, we used isoform HSPA1A."	"Polycomb repressive complexes are required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones. hPRC-H apparently represents not a single complex but rather a mixture of highly related complexes, here exemplified by the M33F and Bmi1F M2 eluates. The identified beta-tubulin may be a contaminant, it needs more characterization."	None
"Polycomb repressive complex 1 (PRC1, hPRC-H)"	O00257;O60264;P0DMV8;P25490;P35226;P78364;Q06587;Q14781;Q8IXK0;Q8NDX5;Q96GD3;Q99496;Q9HC52	8535;8467;3303;7528;648;1911;6015;84733;1912;80012;22955;6045;57332	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	CBX4;SMARCA5;HSPA1A;YY1;BMI1;PHC1;RING1;CBX2;PHC2;PHC3;SCMH1;RNF2;CBX8	"Since the authors did not specify HSP70, we used isoform HSPA1A"	"Polycomb repressive complexes are required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones. hPRC-H apparently represents not a single complex but rather a mixture of highly related complexes, here exemplified by the Hi-Trap S eluate. The identified beta-tubulin may be a contaminant, it needs more characterization."	None
GPR56-CD81-Galpha(q/11)-Gbeta complex	P29992;P50148;P60033;P62873;Q9Y653	2767;2776;975;2782;9289	None	None	GNA11;GNAQ;CD81;GNB1;ADGRG1	"The Gbeta peptide identified by mass spectrometry is a sequence common to beta subunits 1-4, and the anti-Gbeta antiserum recognizes all four subunits. Since the authors did not specify Gbeta peptide, we used isoform GNB1."	The central role of CD81 (and CD9 when present) suggests possible scaffolding functions for CD81 and CD9 in GPR56 signaling.	None
GPI-GnT activity complex	P37287;Q14442;Q92535;Q9BRB3	5277;5283;5279;9091	phospholipid metabolic process;phospholipid biosynthetic process;phospholipid catabolic process;endoplasmic reticulum	phospholipid metabolism;endoplasmic reticulum	PIGA;PIGH;PIGC;PIGQ	None	This protein complex has GPI-GlcNAc transferase (GPI-GnT) activity in vitro.	None
Lymphotoxin beta receptor complex	P01374;P36941;Q06643	4049;4055;4050	cell surface receptor signaling pathway;apoptotic process	transmembrane signal transduction;apoptosis (type I programmed cell death)	LTA;LTBR;LTB	None	"The binding of heterotrimeric lymphotoxin, LT alpha1 beta2, to the LTbeta receptor (LTbeta R), a member of the tumor necrosis factor receptor (TNFR) superfamily, induces nuclear factor kappaB (NF-kappaB) activation and cell death in HT29 adenocarcinoma cells."	None
Rnase/Mrp complex	O75817;O75818;O95059;O95707;P78345;P78346;Q969H6;Q99575;Q9BUL9;Q9H633	10248;10799;11102;10775;10557;10556;51367;10940;54913;79897	RNA catabolic process;rRNA processing;RNA binding;nucleus	RNA degradation;rRNA processing;RNA binding;nucleus	POP7;RPP40;RPP14;POP4;RPP38;RPP30;POP5;POP1;RPP25;RPP21	None	RNase MRP is involved in the processing of pre-rRNA and the generation of RNA primers for mitochondrial DNA replication.	None
CCT complex (chaperonin containing TCP1 complex)	P17987;P40227;P48643;P49368;P50990;P50991;P78371;Q99832	6950;908;22948;7203;10694;10575;10576;10574	protein stabilization;protein folding;ATP binding;cytoplasm	protein folding and stabilization;ATP binding;cytoplasm	TCP1;CCT6A;CCT5;CCT3;CCT8;CCT4;CCT2;CCT7	None	"The chaperonins are a family of molecular chaperones involved in protein folding, assembly and transport. The chaperonin-containing TCP-1 (CCT) is abundant in eukaryotic cytosol. CCT micro-complexes have mol. wts ranging from 120 to 250 kDa and are present in cells at lower abundance (<5%) as compared with intact CCT."	None
NDC80 kinetochore complex	O14777;Q8NBT2;Q9BZD4;Q9HBM1	10403;147841;83540;57405	"mitotic cell cycle;chromosome segregation;chromosome, centromeric region"	mitotic cell cycle;chromosome segregation/division;centromere / kinetochore	NDC80;SPC24;NUF2;SPC25	None	"Components of the conserved NDC80 complex are required for chromosome congression, and their disruption results in mitotic arrest accompanied by multiple spindle aberrations. hSPC25 is an essential kinetochore component that plays a significant role in proper execution of mitotic events."	None
PIDDsome complex	P42575;P78560;Q9HB75	835;8738;55367	activation of cysteine-type endopeptidase activity involved in apoptotic process;apoptotic process	caspase activation;apoptosis (type I programmed cell death)	CASP2;CRADD;PIDD1	None	None	PIDDsome is involved in caspase-2 dependent TSA-induced cell death in prostate cancer cell lines (PMID:17110788).
Telomere-associated protein complex	P54274;Q15554;Q96AP0;Q9BSI4;Q9NUX5;Q9NYB0	7013;7014;65057;26277;25913;54386	DNA binding;chromosome organization;nucleus;telomere maintenance	DNA binding;organization of chromosome structure;nucleus	TERF1;TERF2;ACD;TINF2;POT1;TERF2IP	None	"TIN2 binds TRF2 directly, thereby tethering TRF2 to the TRF1 complex. This complex is responsible for telomere maintenance."	None
E-box sequence-binding complex	P25791;Q02577;Q86U70;Q9BXY8	4005;4808;8861;None	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;neurogenesis;generation of neurons;nucleus"	transcriptional control;neurogenesis;nucleus	LMO2;NHLH2;LDB1;BEX2	None	This complex may help to understand the molecular mechanisms by which hBex2 plays a role in transcriptional regulation in the brain during neurodevelopment.	None
CD147-gamma-secretase complex	P35613;P49768;Q92542;Q96BI3;Q9NZ42	682;5663;23385;51107;55851	protein processing;signaling;plasma membrane;Golgi apparatus	protein processing (proteolytic);cellular signalling;eukaryotic plasma membrane / membrane attached;Golgi	BSG;PSEN1;NCSTN;APH1A;PSENEN	None	CD147 in gamma-secretase complex down-modulates the production of amyloid beta-peptides.	None
APP-APBB1-LRP1 complex	O00213;P05067;Q07954	322;351;4035	protein processing	protein processing (proteolytic)	APBB1;APP;LRP1	None	None	None
Gamma-BAR-AP1 complex	O43747;O75843;P56377;P61966;Q10567;Q63HQ0;Q96PC3;Q9BXS5;Q9Y6Q5	164;8906;8905;1174;162;55435;130340;8907;10053	intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport;membrane budding;vesicle organization;endocytosis;transport vesicle	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.);vesicle formation;endocytosis;intracellular transport vesicles"	AP1G1;AP1G2;AP1S2;AP1S1;AP1B1;AP1AR;AP1S3;AP1M1;AP1M2	None	The isolation of AP1 adaptor complex was described in PMID:9733768.	None
PBAF complex (Polybromo- and BAF containing complex)	O96019;P51532;P60709;Q12824;Q68CP9;Q86U86;Q8TAQ2;Q92922;Q969G3;Q96GM5	86;6597;60;6598;196528;55193;6601;6599;6605;6602	None	None	ACTL6A;SMARCA4;ACTB;SMARCB1;ARID2;PBRM1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify Actin as well as Actin-like protein 6, we used isoform ACTB and isoform ACTL6A, respectively. At the time of annotation, the additional member BAF240 of the protein complex was not found in the UniProt database."	None	None
TFIIE complex	P29083;P29084	2960;2961	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription initiation;transcriptional control;nucleus	GTF2E1;GTF2E2	None	None	None
TFIIF complex (transcription factor IIF)	P13984;P35269	2963;2962	"DNA-templated transcription, initiation;magnesium ion binding;ATP binding;nucleus"	transcription initiation;magnesium binding;ATP binding;nucleus	GTF2F2;GTF2F1	None	TFIIF facilitates activator-dependent transcription initiation on chromatin templates.	None
TFIID complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15544;Q16594;Q6P1X5	6874;6908;6872;6878;6881;6877;6882;6880;6873	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF11;TAF9;TAF2	None	None	None
Retrotranslocation complex	P57678;Q86TM6;Q9BUN8	50628;84447;79139	protein transport;protein transporter activity	protein transport	GEMIN4;SYVN1;DERL1	None	None	None
Condensin I complex	O95347;Q15003;Q15021;Q9BPX3;Q9NTJ3	10592;23397;9918;64151;10051	mitotic cell cycle;chromosome condensation;chromosome organization;nucleus	mitotic cell cycle;chromosome condensation;organization of chromosome structure;nucleus	SMC2;NCAPH;NCAPD2;NCAPG;SMC4	None	None	None
Condensin I-PARP-1-XRCC1 complex	O95347;P09874;P18887;Q15003;Q15021;Q9BPX3;Q9NTJ3	10592;142;7515;23397;9918;64151;10051	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	SMC2;PARP1;XRCC1;NCAPH;NCAPD2;NCAPG;SMC4	None	The association between PARP-1 and XRCC1 was enhanced in response to DNA damage.	None
Condensin II	O95347;P42695;Q6IBW4;Q86XI2;Q9NTJ3	10592;23310;29781;54892;10051	mitotic cell cycle;chromosome condensation;chromosome organization;nucleus	mitotic cell cycle;chromosome condensation;organization of chromosome structure;nucleus	SMC2;NCAPD3;NCAPH2;NCAPG2;SMC4	None	None	None
COG complex	P83436;Q14746;Q8WTW3;Q96JB2;Q96MW5;Q9H9E3;Q9UP83;Q9Y2V7	91949;22796;9382;83548;84342;25839;10466;57511	protein glycosylation;Golgi organization;Golgi apparatus	"modification with sugar residues (e.g. glycosylation, deglycosylation);Golgi;Golgi"	COG7;COG2;COG1;COG3;COG8;COG4;COG5;COG6	None	None	"Deficiencies in COG1, COG7, COG8 cause a novel group of Cogenital Disorders of Glycosylation II (PMID:17904886)."
Cohesin-SA2 complex	O60216;Q14683;Q8N3U4;Q9UQE7	5885;8243;10735;9126	M phase;mitotic nuclear division;chromosome segregation;DNA binding;chromosome organization;chromosome	M phase;chromosome segregation/division;DNA binding;organization of chromosome structure;chromosome	RAD21;SMC1A;STAG2;SMC3	None	None	None
Cohesin-SA1 complex	O60216;Q14683;Q8WVM7;Q9UQE7	5885;8243;10274;9126	M phase;mitotic nuclear division;chromosome segregation;DNA binding;chromosome organization;chromosome	M phase;chromosome segregation/division;DNA binding;organization of chromosome structure;chromosome	RAD21;SMC1A;STAG1;SMC3	None	"In HeLa cell extracts, the ratio between the hSA1-containing complex (h-cohesin SA1) and the hSA2-containing complex (h-cohesin SA2) is about 1:3."	None
Cohesin-SA1 complex	O60216;Q14683;Q8WVM7;Q9UQE7	5885;8243;10274;9126	M phase;mitotic nuclear division;chromosome segregation;DNA binding;chromosome organization;chromosome	M phase;chromosome segregation/division;DNA binding;organization of chromosome structure;chromosome	RAD21;SMC1A;STAG1;SMC3	None	The cohesin complex binds directly to double-stranded DNA and induces the formation of large protein-DNA aggregates.	None
Cohesin-SA2 complex	O60216;Q14683;Q8N3U4;Q9UQE7	5885;8243;10735;9126	M phase;mitotic nuclear division;chromosome segregation;DNA binding;chromosome organization;chromosome	M phase;chromosome segregation/division;DNA binding;organization of chromosome structure;chromosome	RAD21;SMC1A;STAG2;SMC3	None	The cohesin complex binds directly to double-stranded DNA and induces the formation of large protein-DNA aggregates.	None
Condensin I complex	O95347;Q15003;Q15021;Q9BPX3;Q9NTJ3	10592;23397;9918;64151;10051	mitotic cell cycle;chromosome condensation;chromosome organization;nucleus	mitotic cell cycle;chromosome condensation;organization of chromosome structure;nucleus	SMC2;NCAPH;NCAPD2;NCAPG;SMC4	None	None	None
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	"MRN complex possesses manganese-dependent single-stranded DNA endonuclease and 3' to 5' exonuclease activities, important for recombination, repair, and genomic stability."	Nibrin is mutated in Nijmegen breakage syndrome.
OGT-TRAK1-TRAK2 complex	O15294;O60296;Q9UPV9	8473;66008;22906	protein hydroxylation;protein methylation;gamma-aminobutyric acid signaling pathway	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);gamma-aminobutyric acid signalling pathway"	OGT;TRAK2;TRAK1	None	"O-GlcNAc, OGT, and GRIF-1 could be involved in GABA signaling. GRIF-1 would function as an adaptor/scaffolding protein, bridging OGT to GABAA receptor in this model."	None
"Respiratory chain complex I (holoenzyme), mitochondrial"	O00217;O00483;O14561;O15239;O43181;O43674;O43676;O43677;O43678;O43920;O75251;O75306;O75380;O75438;O75489;O95139;O95167;O95168;O95169;O95178;O95182;O95298;O95299;O96000;P03886;P03891;P03897;P03901;P03915;P03923;P17568;P19404;P28331;P49821;P51970;P56181;P56556;Q16718;Q16795;Q86Y39;Q9NX14;Q9P0J0;Q9UI09;Q9Y6M9	4728;4697;4706;4694;4724;4711;4709;4717;4695;4725;374291;4720;4726;4707;4722;4712;4696;4710;4714;4708;4701;4718;4705;4716;4535;4536;4537;4539;4540;4541;4713;4729;4719;4723;4702;4731;4700;4698;4704;126328;54539;51079;55967;4715	hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS8;NDUFA4;NDUFAB1;NDUFA1;NDUFS4;NDUFB5;NDUFB3;NDUFC1;NDUFA2;NDUFS5;NDUFS7;NDUFS2;NDUFS6;NDUFB1;NDUFS3;NDUFB6;NDUFA3;NDUFB4;NDUFB8;NDUFB2;NDUFA7;NDUFC2;NDUFA10;NDUFB10;MT-ND1;MT-ND2;MT-ND3;MT-ND4L;MT-ND5;MT-ND6;NDUFB7;NDUFV2;NDUFS1;NDUFV1;NDUFA8;NDUFV3;NDUFA6;NDUFA5;NDUFA9;NDUFA11;NDUFB11;NDUFA13;NDUFA12;NDUFB9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
PNUTS-PP1 complex	P62136;Q96QC0	5499;5514	enzyme inhibitor activity	enzyme inhibitor	PPP1CA;PPP1R10	None	None	None
26S proteasome	O14818;P17980;P20618;P25786;P25787;P25788;P25789;P28066;P28070;P28072;P28074;P35998;P43686;P49720;P49721;P55036;P60900;P62191;P62195;P62333;Q99436;Q9UNM6	5688;5702;5689;5682;5683;5684;5685;5686;5692;5694;5693;5701;5704;5691;5690;5710;5687;5700;5705;5706;5695;5719	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding;response to stress;cytoplasm;nucleus	proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;stress response;cytoplasm;nucleus	PSMA7;PSMC3;PSMB1;PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMB4;PSMB6;PSMB5;PSMC2;PSMC4;PSMB3;PSMB2;PSMD4;PSMA6;PSMC1;PSMC5;PSMC6;PSMB7;PSMD13	None	"The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degradation of most cellular proteins (for reviews see PMID:8811196 and PMID:10872471). It contains a barrel-shaped proteolytic core complex (the 20S proteasome), and is capped at one or both ends by regulatory complexes like the 19S complex (PMID:11812135), modulator (PMID:8621709), PA28 (PMID:9325261) and PA28gamma (PMID:9325261). Interferon-gamma (IFN-gamma) alters the peptide-degrading specificity of proteasomes and produces an immunoproteasome responsible for accelerated processing of nonself endogenous antigens by inducing the replacement of subunits Psmb5, Psmb6 and Psmb7 by Psmb8, Psmb9 and Psmb10, respectively."	None
Wave-2 complex	Q7L576;Q8IZP0;Q8WUW1;Q9Y2A7;Q9Y6W5	23191;10006;55845;10787;10163	small GTPase mediated signal transduction;cell migration;actin cytoskeleton organization;actin cytoskeleton	small GTPase mediated signal transduction;cell migration;actin cytoskeleton;actin cytoskeleton	CYFIP1;ABI1;BRK1;NCKAP1;WASF2	None	"Proteins are only present in the complexed form, with the exception of Hspc (C3orf10). The complex is organized around a core of Nap and Abi. Sra is a peripheral subunit recruited on the Nap side, whereas the Wave and Hspc subunits are recruited on the Abi side of the core."	None
BAF complex	O14497;O94805;O96019;P51531;P51532;P60709;P63261;Q12824;Q8NFD5;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;51412;86;6595;6597;60;71;6598;57492;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;nucleus	ARID1A;ACTL6B;ACTL6A;SMARCA2;SMARCA4;ACTB;ACTG1;SMARCB1;ARID1B;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify Actin as well as Actin-like protein 6 and ARID1, we used isoform ACTB, isoform ACTL6A or isoform ARID1A, respectively. At the time of annotation, the additional member BAF110 of the protein complex was not found in the UniProt database."	None	None
Mitotic checkpoint complex (MCC)	O43684;O60566;Q12834;Q13257	9184;701;991;4085	cell cycle checkpoint	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle)"	BUB3;BUB1B;CDC20;MAD2L1	None	"MCC inhibitory activity is 3,000-fold greater than that of recombinant MAD2, MCC is not generated from kinetochores, as it is also present and active in interphase cells."	None
20S proteasome	O14818;P20618;P25786;P25787;P25788;P25789;P28066;P28070;P28072;P28074;P49720;P49721;P60900;Q99436	5688;5689;5682;5683;5684;5685;5686;5692;5694;5693;5691;5690;5687;5695	protein processing;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;response to stress;cytoplasm;nucleus	protein processing (proteolytic);proteasomal degradation (ubiquitin/proteasomal pathway);stress response;cytoplasm;nucleus	PSMA7;PSMB1;PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMB4;PSMB6;PSMB5;PSMB3;PSMB2;PSMA6;PSMB7	None	"The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degradation of most cellular proteins (for reviews see PMID:8811196 and PMID:10872471). It contains a barrel-shaped proteolytic core complex (the 20S proteasome), and is capped at one or both ends by regulatory complexes like the 19S complex (PMID:11812135), modulator (PMID:8621709), PA28 (PMID:9325261) and PA28gamma (PMID:9325261). Interferon-gamma (IFN-gamma) alters the peptide-degrading specificity of proteasomes and produces an immunoproteasome responsible for accelerated processing of nonself endogenous antigens by inducing the replacement of subunits Psmb5, Psmb6 and Psmb7 by Psmb8, Psmb9 and Psmb10, respectively."	None
PA28-20S proteasome	O14818;P20618;P25786;P25787;P25788;P25789;P28066;P28070;P28072;P28074;P49720;P49721;P60900;Q06323;Q99436;Q9UL46	5688;5689;5682;5683;5684;5685;5686;5692;5694;5693;5691;5690;5687;5720;5695;5721	protein processing;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;response to stress;cytoplasm;nucleus	protein processing (proteolytic);proteasomal degradation (ubiquitin/proteasomal pathway);stress response;cytoplasm;nucleus	PSMA7;PSMB1;PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMB4;PSMB6;PSMB5;PSMB3;PSMB2;PSMA6;PSME1;PSMB7;PSME2	None	"The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degradation of most cellular proteins (for reviews see PMID:8811196 and PMID:10872471). It contains a barrel-shaped proteolytic core complex (the 20S proteasome), and is capped at one or both ends by regulatory complexes like the 19S complex (PMID:11812135), modulator (PMID:8621709), PA28 (PMID:9325261) and PA28gamma (PMID:9325261). Interferon-gamma (IFN-gamma) alters the peptide-degrading specificity of proteasomes and produces an immunoproteasome responsible for accelerated processing of nonself endogenous antigens by inducing the replacement of subunits Psmb5, Psmb6 and Psmb7 by Psmb8, Psmb9 and Psmb10, respectively."	None
PA700-20S-PA28 complex	O00231;O00232;O00233;O00487;O14818;O43242;O75832;P17980;P20618;P25786;P25787;P25788;P25789;P28066;P28070;P28072;P28074;P35998;P43686;P48556;P49720;P49721;P51665;P55036;P60900;P62191;P62195;P62333;Q06323;Q13200;Q15008;Q16401;Q99436;Q99460;Q9UL46;Q9UNM6	5717;5718;5715;10213;5688;5709;5716;5702;5689;5682;5683;5684;5685;5686;5692;5694;5693;5701;5704;5714;5691;5690;5713;5710;5687;5700;5705;5706;5720;5708;9861;5711;5695;5707;5721;5719	proteasome-mediated ubiquitin-dependent protein catabolic process;protein binding;peptidase activator activity	proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;protease activator	PSMD11;PSMD12;PSMD9;PSMD14;PSMA7;PSMD3;PSMD10;PSMC3;PSMB1;PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMB4;PSMB6;PSMB5;PSMC2;PSMC4;PSMD8;PSMB3;PSMB2;PSMD7;PSMD4;PSMA6;PSMC1;PSMC5;PSMC6;PSME1;PSMD2;PSMD6;PSMD5;PSMB7;PSMD1;PSME2;PSMD13	None	"The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degradation of most cellular proteins (for reviews see PMID:8811196 and PMID:10872471). It contains a barrel-shaped proteolytic core complex (the 20S proteasome), and is capped at one or both ends by regulatory complexes like the 19S complex (PMID:11812135), modulator (PMID:8621709), PA28 (PMID:9325261) and PA28gamma (PMID:9325261). Interferon-gamma (IFN-gamma) alters the peptide-degrading specificity of proteasomes and produces an immunoproteasome responsible for accelerated processing of nonself endogenous antigens by inducing the replacement of subunits Psmb5, Psmb6 and Psmb7 by Psmb8, Psmb9 and Psmb10, respectively."	None
PA28gamma-20S proteasome	O14818;P20618;P25786;P25787;P25788;P25789;P28066;P28070;P28072;P28074;P49720;P49721;P60900;P61289;Q99436	5688;5689;5682;5683;5684;5685;5686;5692;5694;5693;5691;5690;5687;10197;5695	protein processing;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;response to stress;cytoplasm;nucleus	protein processing (proteolytic);proteasomal degradation (ubiquitin/proteasomal pathway);stress response;cytoplasm;nucleus	PSMA7;PSMB1;PSMA1;PSMA2;PSMA3;PSMA4;PSMA5;PSMB4;PSMB6;PSMB5;PSMB3;PSMB2;PSMA6;PSME3;PSMB7	None	"The proteasome is an essential component of the ATP-dependent proteolytic pathway in eukaryotic cells and is responsible for the degradation of most cellular proteins (for reviews see PMID:8811196 and PMID:10872471). It contains a barrel-shaped proteolytic core complex (the 20S proteasome), and is capped at one or both ends by regulatory complexes like the 19S complex (PMID:11812135), modulator (PMID:8621709), PA28 (PMID:9325261) and PA28gamma (PMID:9325261). Interferon-gamma (IFN-gamma) alters the peptide-degrading specificity of proteasomes and produces an immunoproteasome responsible for accelerated processing of nonself endogenous antigens by inducing the replacement of subunits Psmb5, Psmb6 and Psmb7 by Psmb8, Psmb9 and Psmb10, respectively."	None
HUIC complex	P38398;Q99728	672;580	cell cycle arrest;cell cycle checkpoint;nucleus	"cell cycle arrest;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);nucleus"	BRCA1;BARD1	None	The HUIC complex has been isolated after treating cells with hydroxyurea.	BRCA1 is involved in breast cancer.
BRCA1-RAD50-MRE11-NBS1 complex	O60934;P38398;P49959;Q92878	4683;672;4361;10111	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	NBN;BRCA1;MRE11A;RAD50	None	None	BRCA1 is involved in breast cancer.
"Ubiquitin E3 ligase (VHL, TCEB1, TCEB2, CUL2, RBX1)"	P40337;P62877;Q13617;Q15369;Q15370	7428;9978;8453;6921;6923	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	VHL;RBX1;CUL2;TCEB1;TCEB2	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
DNA ligase IV-XRCC4 complex	P49917;Q13426	3981;7518	DNA repair;mitotic recombination;DNA binding;chromosome	DNA repair;somatic / mitotic recombination;DNA binding;chromosome	LIG4;XRCC4	None	XRCC4 serves as a molecular bridge to target DNA ligase IV to a DNA double-strand break.	None
"Ubiquitin E3 ligase (ASB2, TCEB1, TCEB2, CUL5, RNF7)"	Q15369;Q15370;Q93034;Q96Q27;Q9UBF6	6921;6923;8065;51676;9616	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	TCEB1;TCEB2;CUL5;ASB2;RNF7	The presence of Elongin BC was predicted by the authors but has not been shown experimentally.	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Ubiquitin E3 ligase (ASB1, TCEB1, TCEB2, CUL5, RNF7)"	Q15369;Q15370;Q93034;Q9UBF6;Q9Y576	6921;6923;8065;9616;51665	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	TCEB1;TCEB2;CUL5;RNF7;ASB1	The presence of Elongin BC was predicted by the authors but has not been shown experimentally.	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Ubiquitin E3 ligase (ASB6, TCEB1, TCEB2, CUL5, RNF7)"	Q15369;Q15370;Q93034;Q9NWX5;Q9UBF6	6921;6923;8065;140459;9616	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	TCEB1;TCEB2;CUL5;ASB6;RNF7	The presence of Elongin BC was predicted by the authors but has not been shown experimentally.	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Ubiquitin E3 ligase (ASB7, TCEB1, TCEB2, CUL5, RNF7)"	Q15369;Q15370;Q93034;Q9H672;Q9UBF6	6921;6923;8065;140460;9616	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	TCEB1;TCEB2;CUL5;ASB7;RNF7	The presence of Elongin BC was predicted by the authors but has not been shown experimentally.	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Ubiquitin E3 ligase (ASB12, TCEB1, TCEB2, CUL5, RNF7)"	Q15369;Q15370;Q8WXK4;Q93034;Q9UBF6	6921;6923;142689;8065;9616	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	TCEB1;TCEB2;ASB12;CUL5;RNF7	The presence of Elongin BC was predicted by the authors but has not been shown experimentally.	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
DNA ligase III-XRCC1 complex	P18887;P49916	7515;3980	DNA repair;nucleus	DNA repair;nucleus	XRCC1;LIG3	None	None	None
DNA ligase IV-XRCC1 complex	P18887;P49917	7515;3981	DNA repair;nucleus	DNA repair;nucleus	XRCC1;LIG4	None	None	None
"Ubiquitin E3 ligase (WSB1, TCEB1, TCEB2, CUL5, RBX1)"	P62877;Q15369;Q15370;Q93034;Q9Y6I7	9978;6921;6923;8065;26118	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding;smoothened signaling pathway;endoplasmic reticulum	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;hedgehog-dependent signalling pathway;endoplasmic reticulum"	RBX1;TCEB1;TCEB2;CUL5;WSB1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. WSB-1 is a Hedgehog-inducible ubiquitin ligase that modulates thyroid hormone activation and PTHrP secretion in the developing growth plate.	None
CRSP complex	O43513;O60244;O75448;O95402;Q15648;Q6P2C8;Q9NVC6;Q9ULK4	9443;9282;9862;9441;5469;9442;9440;9439	"positive regulation of transcription, DNA-templated;protein binding;nucleus"	transcription activation;protein binding;nucleus	MED7;MED14;MED24;MED26;MED1;MED27;MED17;MED23	Information about the 85kD component CRSP5 of the protein complex is not available in databases.	"Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
CRSP complex	O43513;O60244;O75448;O95402;Q15648;Q6P2C8;Q9NVC6;Q9ULK4	9443;9282;9862;9441;5469;9442;9440;9439	"positive regulation of transcription, DNA-templated;protein binding;nucleus"	transcription activation;protein binding;nucleus	MED7;MED14;MED24;MED26;MED1;MED27;MED17;MED23	"At the time of annotation, the additional 85kD component CRSP5 of the protein complex was not found in the UniProt database."	"Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
CAND1-CUL1-RBX1 complex	P62877;Q13616;Q86VP6	9978;8454;55832	protein binding;SCF complex assembly;negative regulation of ubiquitin-protein transferase activity	protein binding	RBX1;CUL1;CAND1	None	"Cand1 forms a tight complex with the Cul1-Roc1 SCF catalytic core, inhibiting the assembly of the multisubunit E3 protein-ubiquitin ligase complex.The crystal structure of the Cand1-Cul1-Roc1 ternary complex reveals the detailed mechanisms of how Cand1 participates in regulating the assembly and disassembly of the SCF ubiquitin ligase complex."	None
ARF-Mule complex	P06748;Q7Z6Z7;Q8N726	4869;10075;1029	protein binding;nucleus	protein binding;nucleus	NPM1;HUWE1;CDKN2A	None	ARF is an inhibitor of the ARF-BP1 protein-ubiquitin ligase.	None
CAND1-CUL2-RBX1 complex	P62877;Q13617;Q86VP6	9978;8453;55832	SCF complex assembly;negative regulation of ubiquitin-protein transferase activity	None	RBX1;CUL2;CAND1	None	Binding of Cand1 to cullins inhibits the formation of E3 protein-ubiquitin ligases.	None
CAND1-CUL3-RBX1 complex	P62877;Q13618;Q86VP6	9978;8452;55832	SCF complex assembly;negative regulation of ubiquitin-protein transferase activity	None	RBX1;CUL3;CAND1	None	Binding of Cand1 to cullins inhibits the formation of E3 protein-ubiquitin ligases.	None
CAND1-CUL4A-RBX1 complex	P62877;Q13619;Q86VP6	9978;8451;55832	SCF complex assembly;negative regulation of ubiquitin-protein transferase activity	None	RBX1;CUL4A;CAND1	None	Binding of Cand1 to cullins inhibits the formation of E3 protein-ubiquitin ligases.	None
CAND1-CUL4B-RBX1 complex	P62877;Q13620;Q86VP6	9978;8450;55832	SCF complex assembly;negative regulation of ubiquitin-protein transferase activity	None	RBX1;CUL4B;CAND1	None	Binding of Cand1 to cullins inhibits the formation of E3 protein-ubiquitin ligases.	None
"Ubiquitin E3 ligase (SKP1A, SKP2, CUL1)"	P63208;Q13309;Q13616	6500;6502;8454	protein ubiquitination;protein binding;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;proteasomal degradation (ubiquitin/proteasomal pathway)"	SKP1;SKP2;CUL1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Ubiquitin E3 ligase (SKP1A, BTRC, CUL1)"	P63208;Q13616;Q9Y297	6500;8454;8945	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);protein binding"	SKP1;CUL1;BTRC	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
SMCC complex	O60244;O75448;O75586;P24863;P49336;Q13503;Q15648;Q9Y3C7	9282;9862;10001;892;1024;9412;5469;51003	"positive regulation of transcription, DNA-templated;negative regulation of transcription, DNA-templated;nucleus"	transcription activation;transcription repression;nucleus	MED14;MED24;MED6;CCNC;CDK8;MED21;MED1;MED31	None	"Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
NAT complex	O60244;O75586;P24863;P49336;Q13503;Q9BTT4;Q9ULK4	9282;10001;892;1024;9412;84246;9439	"negative regulation of transcription, DNA-templated;protein binding;nucleus"	transcription repression;protein binding;nucleus	MED14;MED6;CCNC;CDK8;MED21;MED10;MED23	None	"A complex, NAT, that represses activation of transcription by RNAPII has been isolated. The NAT complex is composed of approximately 20 polypeptides and includes a subset of the Srb polypeptides, hSrb7, hSrb10, and hSrb11, as well as hRgr1 and hMed6. The presence of hSrb10, hSrb11, and hRgr1 in a complex that functions to down-regulate transcription is consistent with studies in yeast demonstrating that Srb8-Srb11, as well as Rgr1, function as negative regulators of transcription in vivo. It has been suggested that the NAT complex is a subcomplex of the RNAPII holoenzyme and its function and regulation is through the RNAPII holoenzyme. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
Mediator complex	A0JLT2;O43513;O60244;O75448;O75586;O95402;P24863;P49336;Q13503;Q15528;Q15648;Q6P2C8;Q71F56;Q71SY5;Q93074;Q96G25;Q96HR3;Q96RN5;Q9BTT4;Q9BUE0;Q9BWU1;Q9H204;Q9H944;Q9NPJ6;Q9NVC6;Q9NWA0;Q9NX70;Q9P086;Q9UHV7;Q9ULK4;Q9Y2X0;Q9Y3C7	219541;9443;9282;9862;10001;9441;892;1024;9412;6837;5469;9442;23389;81857;9968;112950;90390;51586;84246;54797;23097;80306;9477;29079;9440;55090;55588;400569;9969;9439;10025;51003	"positive regulation of transcription, DNA-templated;nucleus"	transcription activation;nucleus	MED19;MED7;MED14;MED24;MED6;MED26;CCNC;CDK8;MED21;MED22;MED1;MED27;MED13L;MED25;MED12;MED8;MED30;MED15;MED10;MED18;CDK19;MED28;MED20;MED4;MED17;MED9;MED29;MED11;MED13;MED23;MED16;MED31	None	"Regulation of transcription by RNA polymerase II (Pol II) is controlled by specific combinations of sequence-specific, DNA binding regulatory transcription factors (TFs) bound to a gene's promoter and enhancer regions. These TFs interact with several multiprotein complexes that remodel the chromatin context of the promoter, integrate signals from multiple TFs to control the frequency of transcription initiation, and regulate the efficiency of transcription elongation. One such complex is the Mediator, an ~2-megadalton complex of 20 to 30 subunits that is believed to function as a molecular bridge by simultaneously interacting with both DNA-bound TFs and Pol II. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
ARC complex	O43513;O60244;O75448;O75586;O95402;Q15648;Q71SY5;Q93074;Q96G25;Q96RN5;Q9NPJ6;Q9NVC6;Q9UHV7;Q9UKU7;Q9ULK4	9443;9282;9862;10001;9441;5469;81857;9968;112950;51586;29079;9440;9969;27034;9439	"positive regulation of transcription, DNA-templated;protein binding;intracellular signal transduction;nucleus"	transcription activation;protein binding;cellular signalling;nucleus	MED7;MED14;MED24;MED6;MED26;MED1;MED25;MED12;MED8;MED15;MED4;MED17;MED13;ACAD8;MED23	None	"Experiments show that the transcription coactivator ARC is required for SREBP (sterol regulatory element binding protein) control of cholesterol and lipid homeostasis. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors. According to authors, the ARC complex is probably identical to the DRIP complex."	None
HuCHRAC complex	O60264;Q9NRF9;Q9NRG0;Q9NRL2	8467;54107;54108;11177	DNA topological change;protein binding;DNA binding;ATP binding;nucleus	DNA conformation modification (e.g. chromatin);protein binding;DNA binding;ATP binding;nucleus	SMARCA5;POLE3;CHRAC1;BAZ1A	None	HuCHRAC is a member of the ISWI-containing chromatin remodelling complexes. The polyclonal antibodies against ISWI do not discriminate between hSNF2L and hSNF2H.	None
WICH complex	O60264;Q9UIG0	8467;9031	DNA topological change;protein binding;DNA binding;ATP binding;chromosome	DNA conformation modification (e.g. chromatin);protein binding;DNA binding;ATP binding;chromosome	SMARCA5;BAZ1B	None	WICH is a member of the ISWI-containing chromatin remodelling complexes.	None
SWI-SNF chromatin remodeling-related-BRCA1 complex	O14497;O96019;P38398;P51531;P51532;Q12824;Q8TAQ2;Q92922;Q92925;Q969G3	8289;86;672;6595;6597;6598;6601;6599;6603;6605	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;organization of chromosome structure;nucleus	ARID1A;ACTL6A;BRCA1;SMARCA2;SMARCA4;SMARCB1;SMARCC2;SMARCC1;SMARCD2;SMARCE1	"Since the authors did not specify Actin-like protein 6, we used isoform ACTL6A."	BRCA1 interacts directly with BRG1.	BRCA1 gene is involved in breast and ovarian cancers.
BRCA1-CTIP-ZBRK1 repressor complex	P38398;Q99708;Q9GZX5	672;5932;59348	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	BRCA1;RBBP8;ZNF350	None	None	BRCA1 is involved in breast cancer.
BLOC-3 (biogenesis of lysosome-related organelles complex 3)	Q92902;Q9NQG7	3257;89781	endosome organization;lysosome organization;vacuole organization	endosome;vacuole or lysosome	HPS1;HPS4	None	The results demonstrate that the HPS1 and HPS4 proteins are components of a cytosolic complex that is involved in the biogenesis of lysosomal-related organelles by a mechanism distinct from that operated by AP-3 complex.	"HPS1-7 are involved in Hermansky-Pudlak syndrome (HPS), which  comprises at least seven different autosomal recessive disorders (referred to as HPS-1 through -7) that share the clinical manifestations of oculocutaneous albinism combined with platelet storage pool deficiency and do not present with the severe immunodeficiency and giant intracellular granules characteristic of Chediak-Higashi syndrome (PMID:15030569)."
BRCA1-BACH1 complex	P38398;Q9BX63	672;83990	DNA repair;nucleus	DNA repair;nucleus	BRCA1;BRIP1	None	An intact BRCA1 C-terminal region is necessary for the interaction with BACH1.	BRCA1 is involved in breast cancer.
RalBP1-CDC2-CCNB1 complex	P06493;P14635;Q15311	983;891;10928	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CDK1;CCNB1;RALBP1	None	The complex was only detected in mitotic cell extracts. The authors show that RLIP76 associates with a catalytically active cyclinB\u00b7p34cdc2(cdk1) complex.	None
BRAFT complex	O15287;O15360;P15927;P27694;P35244;P40692;P54132;Q00597;Q13472;Q9H9A7;Q9HB96;Q9NPI8;Q9NW38	2189;2175;6118;6117;6119;4292;641;2176;7156;80010;2178;2188;55120	chromosome organization;DNA repair;cellular response to DNA damage stimulus;nucleus	organization of chromosome structure;DNA repair;DNA damage response;nucleus	FANCG;FANCA;RPA2;RPA1;RPA3;MLH1;BLM;FANCC;TOP3A;RMI1;FANCE;FANCF;FANCL	"The BRAFT complex contains several other proteins of unknown function, called FAAPs or BLAPs. FAAP 43 has been identified as FANCL/PHF9 in a following paper (PMID:12973351)."	None	BRAFT complex is involved in Fanconi Anemia (FA) and Bloom Syndrome (BS).
FA core complex (Fanconi anemia core complex)	O15287;O15360;Q00597;Q0VG06;Q8NB91;Q9H9A7;Q9HB96;Q9NPI8;Q9NW38	2189;2175;2176;80233;2187;80010;2178;2188;55120	protein ubiquitination;protein deubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;FANCC;FAAP100;FANCB;RMI1;FANCE;FANCF;FANCL	FANCB and FANCL have been designated as FAAP90 and FAAP43. RMI1 has been designated as FAAP75.	None	FA complex is involved in Fanconi anemia (FA) disease.
BLM complex III	P40692;P54132;Q13472;Q9H9A7	4292;641;7156;80010	chromosome organization;DNA repair;cellular response to DNA damage stimulus;nucleus	organization of chromosome structure;DNA repair;DNA damage response;nucleus	MLH1;BLM;TOP3A;RMI1	"Another subunit of the complex was found in the analysis, which has not been further characterized: BLAPp100."	None	BLM complex III is involved in Bloom syndrome (BS).
RalBP1-CCNB1-AP2A-NUMB-EPN1 complex	O95782;P14635;P49757;Q15311;Q9Y6I3	160;891;8650;10928;29924	mitotic cell cycle;endocytosis;nucleus	mitotic cell cycle;endocytosis;nucleus	AP2A1;CCNB1;NUMB;RALBP1;EPN1	"Since the authors did not specify AP2A, we used isoform AP2A1."	"RLIP, an effector of the RAL GTPases, is important for the mitotic cdk1 to facilitate the phosphorylation of Epsin."	None
BRAFT complex	O15287;O15360;P15927;P27694;P35244;P54132;Q00597;Q13472;Q9HB96;Q9NPI8;Q9NW38	2189;2175;6118;6117;6119;641;2176;7156;2178;2188;55120	chromosome organization;DNA repair;protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"organization of chromosome structure;DNA repair;modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;RPA2;RPA1;RPA3;BLM;FANCC;TOP3A;FANCE;FANCF;FANCL	FANCL/PHF9 (formerly called FAAP 43) is a newly identified component of the BRAFT complex.	None	None
BCDX2 complex	O15315;O43502;O43543;O75771	5890;5889;7516;5892	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51B;RAD51C;XRCC2;RAD51D	None	BCDX2 binds specifically to nicks in duplex DNA (PMID:11751635).	None
RAD51C-XRCC3 complex	O43502;O43542	5889;7517	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51C;XRCC3	None	None	None
RAD51C-XRCC3 complex	O43502;O43542	5889;7517	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51C;XRCC3	None	The authors postulate that XRCC3 regulates the dissociation and formation of Rad51C-XRCC3 complex through ATP binding and hydrolysis.	None
TBPIP/HOP2-MND1 complex	Q9BWT6;Q9P2W1	84057;29893	reciprocal meiotic recombination;meiotic nuclear division;nuclear division;chromosome segregation;DNA binding;protein binding;nucleus	meiotic recombination;meiosis;nuclear division;chromosome segregation/division;DNA binding;protein binding;nucleus	MND1;PSMC3IP	None	The complex ensures proper pairing between homologous chromosomes.	None
RAD51B-RAD51C complex	O15315;O43502	5890;5889	DNA repair;DNA recombination;DNA binding;ATP binding;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;nucleus	RAD51B;RAD51C	None	None	None
BCDX2 complex	O15315;O43502;O43543;O75771	5890;5889;7516;5892	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51B;RAD51C;XRCC2;RAD51D	None	None	None
RAD51C-XRCC3 complex	O43502;O43542	5889;7517	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51C;XRCC3	None	None	None
RAD51B-RAD51C complex	O15315;O43502	5890;5889	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51B;RAD51C	None	None	None
RAD51B-RAD51C-RAD51D-XRCC2-XRCC3 complex	O15315;O43502;O43542;O43543;O75771	5890;5889;7517;7516;5892	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51B;RAD51C;XRCC3;XRCC2;RAD51D	None	None	None
RAD51L3-XRCC2 complex	O43543;O75771	7516;5892	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	XRCC2;RAD51D	None	None	None
R/M complex (RAD50-MRE11 complex)	P49959;Q92878	4361;10111	DNA catabolic process;DNA repair;DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	DNA degradation;DNA repair;DNA binding;DNA damage response;organization of chromosome structure;nucleus	MRE11A;RAD50	None	R/M consists of two highly flexible intramolecular coiled coils emanating from a central globular DNA binding domain.	None
R/M complex (RAD50-MRE11 complex)	P49959;Q92878	4361;10111	DNA catabolic process;DNA repair;DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	DNA degradation;DNA repair;DNA binding;DNA damage response;organization of chromosome structure;nucleus	MRE11A;RAD50	None	Human Rad50-Mre11 complexes are predominantly heterotetramers.	None
ATR-ATRIP complex	Q13535;Q8WXE1	545;84126	cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	ATR;ATRIP	None	"ATR and ATRIP associate with chromatin in vivo, and they exist as a large molecular weight complex that can bind single-stranded (ss)DNA cellulose in vitro. Neither ATR nor ATRIP are able to bind DNA individually, nor do they bind DNA in a cooperative manner."	None
RAD17-RFC complex	O75943;P35249;P35250;P40937;P40938	5884;5984;5982;5985;5983	cell cycle checkpoint;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;ATP binding;DNA damage response;nucleus"	RAD17;RFC4;RFC2;RFC5;RFC3	None	RFCp38 is necessary for the association of RAD17 with the core complex RFCp36-p37-p40 to form the RAD17-RFC complex. The ATPase activity of RAD17-RFC complex is stimulated by DNA.	None
9-1-1 complex	O60671;O60921;Q99638	5810;3364;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;RAD9A	None	None	None
9-1-1-RAD17-RFC complex	O60671;O60921;O75943;P35249;P35250;P40937;P40938;Q99638	5810;3364;5884;5984;5982;5985;5983;5883	cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;RAD17;RFC4;RFC2;RFC5;RFC3;RAD9A	None	Checkpoint Rad complex has been detected in an in vitro system.	None
RAD17-RFC complex	O75943;P35249;P35250;P40937;P40938	5884;5984;5982;5985;5983	cell cycle checkpoint;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;ATP binding;DNA damage response;nucleus"	RAD17;RFC4;RFC2;RFC5;RFC3	None	RAD17 makes a heteropentameric complex with the four RFC subunits with a deep groove or cleft and is similar to the RFC clamp loader.	None
9-1-1 complex	O60671;O60921;Q99638	5810;3364;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;RAD9A	None	The checkpoint 9-1-1 complex makes a trimeric ring structure reminiscent of the PCNA ring.	None
9-1-1-RAD17-RFC complex	O60671;O60921;O75943;P35249;P35250;P40937;P40938;Q99638	5810;3364;5884;5984;5982;5985;5983;5883	None	None	RAD1;HUS1;RAD17;RFC4;RFC2;RFC5;RFC3;RAD9A	None	"Rad17-RFC complex binds to nicked circular, gapped and primed DNA and recruits the 9-1-1 complex in an ATP-dependent manner. The interaction is mediated mainly by binding of Rad9 to Rad17."	None
9-1-1 complex	O60671;O60921;Q99638	5810;3364;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;RAD9A	None	None	None
9-1-1 complex	O60671;O60921;Q99638	5810;3364;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;RAD9A	None	None	None
RFC complex	P35249;P35250;P35251;P40937;P40938	5984;5982;5981;5985;5983	DNA replication;DNA binding;ATP binding;nucleus	DNA synthesis and replication;DNA binding;ATP binding;nucleus	RFC4;RFC2;RFC1;RFC5;RFC3	None	The subunits of the RFC complex have been reconstituted in an in vitro experiment. The Rfc complex works as a clamp loader.	None
RFC core complex	P35249;P35250;P40937	5984;5982;5985	DNA replication;DNA binding;ATP binding;nucleus	DNA synthesis and replication;DNA binding;ATP binding;nucleus	RFC4;RFC2;RFC5	None	The subunits of the RFC complex have been reconstituted in an in vitro experiment.	None
RFC complex	P35249;P35250;P35251;P40937;P40938	5984;5982;5981;5985;5983	DNA replication;DNA binding;ATP binding;nucleus	DNA synthesis and replication;DNA binding;ATP binding;nucleus	RFC4;RFC2;RFC1;RFC5;RFC3	None	Activator 1 (A1) is a multiprotein complex which is essential for proliferating cell nuclear antigen (PCNA)-dependent DNA polymerase delta (pol delta) activity and efficient in vitro DNA synthesis in the SV40 dipolymerase replication system (PMID:1670772).	None
HMGB1-HMGB2-HSC70-ERP60-GAPDH complex	P04406;P09429;P11142;P26583;P30101	2597;3146;3312;3148;2923	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	GAPDH;HMGB1;HSPA8;HMGB2;PDIA3	None	"The protein/DNA complex was isolated from human leukemia cells deficient in components of the mismatch repair system (Nalm6). This complex detects changes in DNA structure caused by incorporation of nonnatural nucleosides and is a determinant of cell sensitivity to such DNA modifying chemotherapy. The authors show that murine fibroblasts deficient in one component of the complex, Hmgb1, are 10-fold more resistant to thiopurine treatment than their wild-type counterparts."	None
NELF complex (Negative elongation factor complex)	P18615;Q8IXH7;Q8WX92;Q9H3P2	7936;51497;25920;7469	"DNA-templated transcription, elongation;negative regulation of transcription, DNA-templated;RNA binding;protein binding;nucleus"	transcription elongation;transcription repression;RNA binding;protein binding;nucleus	NELFE;NELFCD;NELFB;NELFA	None	NELF cooperates with DSIF and strongly represses POLII elongation.	None
SNF2h-cohesin-NuRD complex	O60216;O60264;O94776;O95983;Q09028;Q12873;Q13330;Q13547;Q14683;Q16576;Q8N3U4;Q8WVM7;Q92769;Q9NRL2;Q9UBB5;Q9UQE7	5885;8467;9219;53615;5928;1107;9112;3065;8243;5931;10735;10274;3066;11177;8932;9126	DNA topological change;DNA binding;chromosome organization;chromosome	DNA conformation modification (e.g. chromatin);DNA binding;organization of chromosome structure;chromosome	RAD21;SMARCA5;MTA2;MBD3;RBBP4;CHD3;MTA1;HDAC1;SMC1A;RBBP7;STAG2;STAG1;HDAC2;BAZ1A;MBD2;SMC3	None	The association of the complex with chromatin can be regulated by the state of DNA methylation.	None
Sin3 complex	O00422;O75446;Q09028;Q13547;Q16576;Q92769;Q96ST3	10284;8819;5928;3065;5931;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;chromosome organization"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure"	SAP18;SAP30;RBBP4;HDAC1;RBBP7;HDAC2;SIN3A	None	None	None
CRSP complex	O43513;O60244;O75448;O75586;O95402;Q13503;Q15648;Q71SY5;Q96RN5;Q9NVC6;Q9ULK4	9443;9282;9862;10001;9441;9412;5469;81857;51586;9440;9439	"positive regulation of transcription, DNA-templated;protein binding;chromosome"	transcription activation;protein binding;chromosome	MED7;MED14;MED24;MED6;MED26;MED21;MED1;MED25;MED15;MED17;MED23	Information about four small protein subunits of the protein complex was not available in the article.	"The activator-recruited cofactor ARC consists of the two distinct multisubunit complexes ARC-L and CRSP. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
PCNA-MLH1-PMS1 complex	P12004;P40692;P54277	5111;4292;5378	DNA replication;DNA repair;nucleus	DNA synthesis and replication;DNA repair;nucleus	PCNA;MLH1;PMS1	None	The authors show that PCNA interacts with MSH2-MSH6 with a higher affinity than with MLH1-PMS1. PCNA acts as a scaffold for consecutive protein-protein interactions.	None
PCNA-MSH2-MSH6 complex	P12004;P43246;P52701	5111;4436;2956	DNA replication;DNA repair;nucleus	DNA synthesis and replication;DNA repair;nucleus	PCNA;MSH2;MSH6	None	The authors show that PCNA interacts with MSH2-MSH6 with a higher affinity than with MLH1-PMS1.	None
ARC-L complex	O43513;O60244;O75448;O75586;P24863;P49336;Q13503;Q15648;Q71SY5;Q93074;Q96RN5;Q9NVC6;Q9UHV7;Q9ULK4	9443;9282;9862;10001;892;1024;9412;5469;81857;9968;51586;9440;9969;9439	protein binding;regulation of sequence-specific DNA binding transcription factor activity;chromosome	protein binding;regulator of transcription factor;chromosome	MED7;MED14;MED24;MED6;CCNC;CDK8;MED21;MED1;MED25;MED12;MED15;MED17;MED13;MED23	None	"Experiemts show that the transcription coactivator ARC is required for SREBP (sterol regulatory element binding protein) control of cholesterol and lipid homeostasis. The activator-recruited cofactor ARC consists of the two distinct multisubunit complexes ARC-L and CRSP; Information about four small components of the protein complex is not available in the article. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
ARC complex	O43513;O60244;O75448;O75586;O95402;P24863;P49336;Q13503;Q15648;Q71SY5;Q93074;Q96RN5;Q9NVC6;Q9UHV7;Q9ULK4	9443;9282;9862;10001;9441;892;1024;9412;5469;81857;9968;51586;9440;9969;9439	"positive regulation of transcription, DNA-templated;regulation of sequence-specific DNA binding transcription factor activity;chromosome"	transcription activation;regulator of transcription factor;chromosome	MED7;MED14;MED24;MED6;MED26;CCNC;CDK8;MED21;MED1;MED25;MED12;MED15;MED17;MED13;MED23	Information about four small components of the protein complex is not available in the article.	"Experiemts show that the transcription coactivator ARC is required for SREBP (sterol regulatory element binding protein) control of cholesterol and lipid homeostasis. The activator-recruited cofactor ARC consists of the two distinct multisubunit complexes ARC-L and CRSP. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
PCNA-MSH2-MSH6 complex	P12004;P43246;P52701	5111;4436;2956	DNA repair;nucleus	DNA repair;nucleus	PCNA;MSH2;MSH6	None	PCNA binds to MSH2-MSH6 complex.	None
MSH2-MLH1-PMS2-PCNA DNA-repair initiation complex	P12004;P40692;P43246;P54278	5111;4292;4436;5395	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	PCNA;MLH1;MSH2;PMS2	None	Formation of the initiation complex is ATP-dependent.	None
MSH2-MLH1-PMS2 DNA-repair initiation complex	P40692;P43246;P54278	4292;4436;5395	DNA repair;DNA binding;nucleus	DNA repair;DNA binding;nucleus	MLH1;MSH2;PMS2	None	Formation of the initiation complex is ATP-dependent.	None
MutL-alpha complex	P40692;P54278	4292;5395	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MLH1;PMS2	None	None	None
PCNA-DNA polymerase delta complex	P12004;P28340;P49005;Q15054;Q9HCU8	5111;5424;5425;10714;57804	DNA replication;DNA repair;nucleus	DNA synthesis and replication;DNA repair;nucleus	PCNA;POLD1;POLD2;POLD3;POLD4	None	PPLD3 stabilizes the polymerase delta complex and increases the affinity of polymerase delta for PCNA.	None
VEGF transcriptional complex	P27695;P40763;Q16665;Q99966	328;6774;3091;4435	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	APEX1;STAT3;HIF1A;CITED1	None	None	This complex regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
IRF3-CBP complex	Q14653;Q99966	3661;4435	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;regulation of sequence-specific DNA binding transcription factor activity"	transcriptional control;regulator of transcription factor	IRF3;CITED1	None	"The crystal structure of IRF-3 in complex with CBP reveals that CBP interacts with a hydrophobic surface on IRF-3, which in latent IRF-3 is covered by its autoinhibitory elements."	None
PC2 complex	O43513;O60244;O75448;O75586;Q13503;Q6P2C8;Q9BTT4;Q9H944;Q9NVC6;Q9Y2W1;Q9Y2X0;Q9Y3C7	9443;9282;9862;10001;9412;9442;84246;9477;9440;9967;10025;51003	"positive regulation of transcription, DNA-templated;protein binding;nucleus"	transcription activation;protein binding;nucleus	MED7;MED14;MED24;MED6;MED21;MED27;MED10;MED20;MED17;THRAP3;MED16;MED31	None	"According to the authors, PC2 is a submodule of TRAP/SMCC. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
SMCC complex	O43513;O60244;O75448;O75586;P24863;P49336;Q13503;Q15648;Q6P2C8;Q93074;Q9BTT4;Q9H944;Q9NVC6;Q9UHV7;Q9Y2W1;Q9Y2X0;Q9Y3C7	9443;9282;9862;10001;892;1024;9412;5469;9442;9968;84246;9477;9440;9969;9967;10025;51003	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding;nucleus"	transcriptional control;protein binding;nucleus	MED7;MED14;MED24;MED6;CCNC;CDK8;MED21;MED1;MED27;MED12;MED10;MED20;MED17;MED13;THRAP3;MED16;MED31	None	"Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
INO80 chromatin remodeling complex	O96019;P15923;Q53TQ3;Q6P4R8;Q6PI98;Q8NBZ0;Q96EZ8;Q9C086;Q9H981;Q9H9F9;Q9ULG1;Q9Y230;Q9Y265	86;6929;54891;4798;125476;283899;10445;83444;93973;79913;54617;10856;8607	DNA topological change;DNA binding;ATP binding;chromosome organization;chromosome	DNA conformation modification (e.g. chromatin);DNA binding;ATP binding;organization of chromosome structure;chromosome	ACTL6A;TCF3;INO80D;NFRKB;INO80C;INO80E;MCRS1;INO80B;ACTR8;ACTR5;INO80;RUVBL2;RUVBL1	None	INO80 complex exhibits DNA- and nucleosome-activated ATPase activity and catalyzes ATP-dependent nucleosome sliding.	None
SRCAP-associated chromatin remodeling complex	O43257;O95619;O96019;P0C0S5;Q15906;Q6ZRS2;Q96CJ1;Q9GZN1;Q9Y230;Q9Y265	10467;8089;86;3015;6944;10847;55840;64431;10856;8607	"DNA topological change;positive regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription activation;organization of chromosome structure;nucleus	ZNHIT1;YEATS4;ACTL6A;H2AFZ;VPS72;SRCAP;EAF2;ACTR6;RUVBL2;RUVBL1	None	None	None
"40S ribosomal subunit, cytoplasmic"	P08708;P08865;P15880;P22090;P23396;P25398;P39019;P42677;P46781;P46782;P46783;P60866;P61247;P62081;P62241;P62244;P62249;P62263;P62266;P62269;P62273;P62277;P62280;P62701;P62753;P62841;P62847;P62851;P62854;P62857;P62861;P62979;P63220	6218;3921;6187;6192;6188;6206;6223;6232;6203;6193;6204;6224;6189;6201;6202;6210;6217;6208;6228;6222;6235;6207;6205;6191;6194;6209;6229;6230;6231;6234;2197;6233;6227	translation;cytoplasm	translation;cytoplasm	RPS17;RPSA;RPS2;RPS4Y1;RPS3;RPS12;RPS19;RPS27;RPS9;RPS5;RPS10;RPS20;RPS3A;RPS7;RPS8;RPS15A;RPS16;RPS14;RPS23;RPS18;RPS29;RPS13;RPS11;RPS4X;RPS6;RPS15;RPS24;RPS25;RPS26;RPS28;FAU;RPS27A;RPS21	"Since the authors did not specify RPS4Y, we used isoform RPS4Y1"	None	None
"Ribosome, cytoplasmic"	P05386;P05387;P05388;P08708;P08865;P15880;P18077;P18124;P18621;P22090;P23396;P25398;P26373;P27635;P30050;P32969;P35268;P36578;P39019;P39023;P40429;P42677;P42766;P46776;P46777;P46778;P46779;P46781;P46782;P46783;P47914;P49207;P50914;P60866;P61247;P61254;P61313;P61353;P61513;P61927;P62081;P62241;P62244;P62249;P62263;P62266;P62269;P62273;P62277;P62280;P62424;P62701;P62750;P62753;P62829;P62841;P62847;P62851;P62854;P62857;P62861;P62888;P62891;P62899;P62906;P62910;P62913;P62917;P62945;P62979;P62987;P63173;P63220;P83731;P83881;P84098;Q02543;Q02878;Q07020;Q9Y3U8	6176;6181;6175;6218;3921;6187;6165;6129;6139;6192;6188;6206;6137;6134;6136;6133;6146;6124;6223;6122;23521;6232;11224;6157;6125;6144;6158;6203;6193;6204;6159;6164;9045;6224;6189;6154;6138;6155;6168;6167;6201;6202;6210;6217;6208;6228;6222;6235;6207;6205;6130;6191;6147;6194;9349;6209;6229;6230;6231;6234;2197;6156;6170;6160;4736;6161;6135;6132;6171;6233;7311;6169;6227;6152;6173;6143;6142;6128;6141;25873	translation;cytoplasm	translation;cytoplasm	RPLP1;RPLP2;RPLP0;RPS17;RPSA;RPS2;RPL35A;RPL7;RPL17;RPS4Y1;RPS3;RPS12;RPL13;RPL10;RPL12;RPL9; RPL9;RPL22;RPL4;RPS19;RPL3;RPL13A;RPS27;RPL35;RPL27A;RPL5;RPL21;RPL28;RPS9;RPS5;RPS10;RPL29;RPL34;RPL14;RPS20;RPS3A;RPL26;RPL15;RPL27;RPL37A;RPL37;RPS7;RPS8;RPS15A;RPS16;RPS14;RPS23;RPS18;RPS29;RPS13;RPS11;RPL7A;RPS4X;RPL23A;RPS6;RPL23;RPS15;RPS24;RPS25;RPS26;RPS28;FAU;RPL30;RPL39;RPL31;RPL10A;RPL32;RPL11;RPL8;RPL41;RPS27A;UBA52;RPL38;RPS21;RPL24;RPL36A;RPL19;RPL18A;RPL6;RPL18;RPL36	"Since the authors did not specify RPS4Y, we used isoform RPS4Y1"	None	None
"60S ribosomal subunit, cytoplasmic"	P05386;P05387;P05388;P18077;P18124;P18621;P26373;P27635;P30050;P32969;P35268;P36578;P39023;P40429;P42766;P46776;P46777;P46778;P46779;P47914;P49207;P50914;P61254;P61313;P61353;P61513;P61927;P62424;P62750;P62829;P62888;P62891;P62899;P62906;P62910;P62913;P62917;P62945;P62987;P63173;P83731;P83881;P84098;Q02543;Q02878;Q07020;Q9Y3U8	6176;6181;6175;6165;6129;6139;6137;6134;6136;6133;6146;6124;6122;23521;11224;6157;6125;6144;6158;6159;6164;9045;6154;6138;6155;6168;6167;6130;6147;9349;6156;6170;6160;4736;6161;6135;6132;6171;7311;6169;6152;6173;6143;6142;6128;6141;25873	translation;cytoplasm	translation;cytoplasm	RPLP1;RPLP2;RPLP0;RPL35A;RPL7;RPL17;RPL13;RPL10;RPL12;RPL9; RPL9;RPL22;RPL4;RPL3;RPL13A;RPL35;RPL27A;RPL5;RPL21;RPL28;RPL29;RPL34;RPL14;RPL26;RPL15;RPL27;RPL37A;RPL37;RPL7A;RPL23A;RPL23;RPL30;RPL39;RPL31;RPL10A;RPL32;RPL11;RPL8;RPL41;UBA52;RPL38;RPL24;RPL36A;RPL19;RPL18A;RPL6;RPL18;RPL36	None	None	None
Cell cycle kinase complex CDC2	O95067;P06493;P12004;P14635;P24385;P38936	9133;983;5111;891;595;1026	mitotic cell cycle	mitotic cell cycle	CCNB2;CDK1;PCNA;CCNB1;CCND1;CDKN1A	None	None	None
Cell cycle kinase complex CDK2	P12004;P24385;P24941;P38936	5111;595;1017;1026	mitotic cell cycle	mitotic cell cycle	PCNA;CCND1;CDK2;CDKN1A	None	None	None
Cell cycle kinase complex CDK4	P11802;P12004;P24385;P38936	1019;5111;595;1026	mitotic cell cycle	mitotic cell cycle	CDK4;PCNA;CCND1;CDKN1A	None	None	None
Cell cycle kinase complex CDK5	P12004;P24385;P30281;P38936;Q00535	5111;595;896;1026;1020	mitotic cell cycle;protein phosphorylation	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation"	PCNA;CCND1;CCND3;CDKN1A;CDK5	None	None	None
PCNA-p21 complex	P12004;P38936	5111;1026	cell cycle checkpoint;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);nucleus"	PCNA;CDKN1A	None	None	None
"28S ribosomal subunit, mitochondrial"	O15235;O60783;P51398;P82650;P82663;P82664;P82673;P82675;P82909;P82912;P82914;P82921;P82930;P82932;P82933;Q92552;Q92665;Q96EL2;Q9BYN8;Q9NP92;Q9NVS2;Q9Y291;Q9Y2Q9;Q9Y2R5;Q9Y2R9;Q9Y399;Q9Y3D3;Q9Y3D5;Q9Y3D9;Q9Y676	6183;63931;7818;56945;64432;55173;None;64969;92259;64963;64960;54460;65993;64968;64965;23107;10240;64951;64949;10884;55168;51650;28957;51373;51081;51116;51021;51023;51649;28973	translation;mitochondrial matrix	translation;mitochondrial matrix	MRPS12;MRPS14;DAP3;MRPS22;MRPS25;MRPS10;MRPS35;MRPS5;MRPS36;MRPS11;MRPS15;MRPS21;MRPS34;MRPS6;MRPS9;MRPS27;MRPS31;MRPS24;MRPS26;MRPS30;MRPS18A;MRPS33;MRPS28;MRPS17;MRPS7;MRPS2;MRPS16;MRPS18C;MRPS23;MRPS18B	None	"With the exception of MRPS12, all proteins of the small ribosomal subunit from ribosomes of Bos taurus were identified in a proteomic approach (PMID:11279123)."	None
"55S ribosome, mitochondrial"	O15235;O60783;O75394;P09001;P49406;P51398;P52815;P82650;P82663;P82664;P82673;P82675;P82909;P82912;P82914;P82921;P82930;P82932;P82933;P83111;Q13084;Q13405;Q16540;Q4U2R6;Q5T653;Q6P161;Q6P1L8;Q7Z2W9;Q7Z7F7;Q7Z7H8;Q86TS9;Q8IXM3;Q8N5N7;Q8N983;Q8TCC3;Q92552;Q92665;Q96A35;Q96DV4;Q96EL2;Q96EL3;Q96GC5;Q9BQ48;Q9BRJ2;Q9BYC8;Q9BYC9;Q9BYD1;Q9BYD2;Q9BYD3;Q9BYD6;Q9BYN8;Q9BZE1;Q9H0U6;Q9H2W6;Q9H9J2;Q9HD33;Q9NP92;Q9NQ50;Q9NRX2;Q9NVS2;Q9NWU5;Q9NX20;Q9NYK5;Q9NZE8;Q9P015;Q9P0J6;Q9P0M9;Q9Y291;Q9Y2Q9;Q9Y2R5;Q9Y2R9;Q9Y399;Q9Y3B7;Q9Y3D3;Q9Y3D5;Q9Y3D9;Q9Y676;Q9Y6G3	6183;63931;9553;11222;9801;7818;6182;56945;64432;55173;None;64969;92259;64963;64960;54460;65993;64968;64965;114294;10573;740;6150;51258;51069;116541;64928;219927;128308;124995;122704;64975;54534;84545;51263;23107;10240;79590;64978;64951;116540;51642;64981;84311;64983;55052;28998;65005;51073;65008;64949;51253;29074;26589;65080;57129;10884;64976;63875;55168;29093;54948;54148;51318;29088;64979;51264;51650;28957;51373;51081;51116;65003;51021;51023;51649;28973;28977	translation;mitochondrial matrix	translation;mitochondrial matrix	MRPS12;MRPS14;MRPL33;MRPL3;MRPL19;DAP3;MRPL12;MRPS22;MRPS25;MRPS10;MRPS35;MRPS5;MRPS36;MRPS11;MRPS15;MRPS21;MRPS34;MRPS6;MRPS9;LACTB;MRPL28;MRPL49;MRPL23;MRPL51;MRPL2;MRPL54;MRPL14;MRPL21;MRPL55;MRPL10;MRPL52;MRPL41;MRPL50;MRPL43;MRPL30;MRPS27;MRPS31;MRPL24;MRPL38;MRPS24;MRPL53;MRPL48;MRPL34;MRPL45;MRPL32;MRPL20;MRPL13;MRPL9;MRPL4;MRPL1;MRPS26;MRPL37;MRPL18;MRPL46;MRPL44;MRPL47;MRPS30;MRPL40;MRPL17;MRPS18A;MRPL22;MRPL16;MRPL39;MRPL35;MRPL15;MRPL36;MRPL27;MRPS33;MRPS28;MRPS17;MRPS7;MRPS2;MRPL11;MRPS16;MRPS18C;MRPS23;MRPS18B;MRPL42	None	None	None
DNA-PK-Ku complex	P12956;P13010;P78527	2547;7520;5591	protein phosphorylation;protein autophosphorylation;DNA binding;nucleus;double-strand break repair via nonhomologous end joining	"modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding;nucleus"	XRCC6;XRCC5;PRKDC	None	For assembly of the DNA-PK-Ku70-Ku80 complex presence of DNA is necessary. DNA-bound Ku directs the recruitment of the catalytic subunit DNA-Pk via a small helical domain at the C-terminus of Ku80.	None
"39S ribosomal subunit, mitochondrial"	O75394;P09001;P49406;P52815;P83111;Q13084;Q13405;Q16540;Q4U2R6;Q5T653;Q6P161;Q6P1L8;Q7Z2W9;Q7Z7F7;Q7Z7H8;Q86TS9;Q8IXM3;Q8N5N7;Q8N983;Q8TCC3;Q96A35;Q96DV4;Q96EL3;Q96GC5;Q9BQ48;Q9BRJ2;Q9BYC8;Q9BYC9;Q9BYD1;Q9BYD2;Q9BYD3;Q9BYD6;Q9BZE1;Q9H0U6;Q9H2W6;Q9H9J2;Q9HD33;Q9NQ50;Q9NRX2;Q9NWU5;Q9NX20;Q9NYK5;Q9NZE8;Q9P015;Q9P0J6;Q9P0M9;Q9Y3B7;Q9Y6G3	9553;11222;9801;6182;114294;10573;740;6150;51258;51069;116541;64928;219927;128308;124995;122704;64975;54534;84545;51263;79590;64978;116540;51642;64981;84311;64983;55052;28998;65005;51073;65008;51253;29074;26589;65080;57129;64976;63875;29093;54948;54148;51318;29088;64979;51264;65003;28977	translation;mitochondrial matrix	translation;mitochondrial matrix	MRPL33;MRPL3;MRPL19;MRPL12;LACTB;MRPL28;MRPL49;MRPL23;MRPL51;MRPL2;MRPL54;MRPL14;MRPL21;MRPL55;MRPL10;MRPL52;MRPL41;MRPL50;MRPL43;MRPL30;MRPL24;MRPL38;MRPL53;MRPL48;MRPL34;MRPL45;MRPL32;MRPL20;MRPL13;MRPL9;MRPL4;MRPL1;MRPL37;MRPL18;MRPL46;MRPL44;MRPL47;MRPL40;MRPL17;MRPL22;MRPL16;MRPL39;MRPL35;MRPL15;MRPL36;MRPL27;MRPL11;MRPL42	"At the time of annotation, about half of the bovine subunits were not found in the UniProt database."	"With the exception of MRPL36 and MRPL42, all proteins of the large ribosomal subunit from ribosomes of Bos taurus were identified in a proteomic approach (PMID:11551941)."	None
Ku antigen complex	P12956;P13010	2547;7520	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	XRCC6;XRCC5	None	In the absence of added DNA Ku70-Ku80 copurify without DNA-PKcs.	None
PSF-p54(nrb) complex	P23246;Q15233	6421;4841	DNA repair;protein binding;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;protein binding;DNA binding;DNA damage response;nucleus	SFPQ;NONO	None	PSF-p54(nrb) complex probably works as a dimeric complex.	None
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	None	None
p54(nrb)-PSF-matrin3 complex	P23246;P43243;Q15233	6421;9782;4841	RNA binding;RNA transport;RNA transmembrane transporter activity;nucleus	RNA binding;RNA transport;nucleus	SFPQ;MATR3;NONO	None	This complex binds specifically to inosine-containing RNAs and anchors hyperedited RNAs to the nuclear matrix.	None
DNA ligase IV-XRCC4-AHNK complex	P49917;Q09666;Q13426	3981;79026;7518	DNA repair;mitotic recombination;DNA binding;nucleus	DNA repair;somatic / mitotic recombination;DNA binding;nucleus	LIG4;AHNAK;XRCC4	None	AHNAK stimulates the double-stranded ligation activity of DNA ligase IV-XRCC4 complex.	None
"40S ribosomal subunit, cytoplasmic"	P08708;P08865;P15880;P23396;P25398;P39019;P46781;P46782;P46783;P60866;P61247;P62081;P62241;P62244;P62249;P62263;P62266;P62269;P62273;P62277;P62280;P62701;P62753;P62841;P62847;P62851;P62854;P62857;P62861;P62979;P63220	6218;3921;6187;6188;6206;6223;6203;6193;6204;6224;6189;6201;6202;6210;6217;6208;6228;6222;6235;6207;6205;6191;6194;6209;6229;6230;6231;6234;2197;6233;6227	translation;cytoplasm	translation;cytoplasm	RPS17;RPSA;RPS2;RPS3;RPS12;RPS19;RPS9;RPS5;RPS10;RPS20;RPS3A;RPS7;RPS8;RPS15A;RPS16;RPS14;RPS23;RPS18;RPS29;RPS13;RPS11;RPS4X;RPS6;RPS15;RPS24;RPS25;RPS26;RPS28;FAU;RPS27A;RPS21	"RPS27 was not detected in this study. RPS4Y1 and RPSY2 could not be detected, since HeLa cells were used, which contain no Y chromosome."	None	None
Sarcoglycan-sarcospan complex SG-SPN	Q13326;Q14714;Q16585;Q16586;Q92629	6445;8082;6443;6442;6444	striated muscle contraction;muscle organ development;plasma membrane	striated muscle contraction;muscle;eukaryotic plasma membrane / membrane attached	SGCG;SSPN;SGCB;SGCA;SGCD	None	The authors demonstrate that assembly of the SG subcomplex is a prerequisite for targeting SPN to the sarcolemma and that the SG- SPN subcomplex functions to stabilize alpha -dystroglycan to the muscle plasma membrane.	"SGCB, SGCG and SGCD are involved in muscular dystrophy and cardiomyopathy (PMID:15117830)."
DNA ligase IV-XRCC4 complex	P49917;Q13426	3981;7518	DNA repair;mitotic recombination;DNA binding;nucleus	DNA repair;somatic / mitotic recombination;DNA binding;nucleus	LIG4;XRCC4	None	None	None
DNA ligase IV-XRCC4 complex	P49917;Q13426	3981;7518	DNA repair;mitotic recombination;DNA binding;chromosome	DNA repair;somatic / mitotic recombination;DNA binding;chromosome	LIG4;XRCC4	None	None	None
DNA ligase IV-XRCC4 complex	P49917;Q13426	3981;7518	DNA repair;mitotic recombination;DNA binding;nucleus	DNA repair;somatic / mitotic recombination;DNA binding;nucleus	LIG4;XRCC4	None	"Cross-linking experiments suggest that an XRCC4\u00b7XRCC4 dimer interface forms the core of the tetramer, and that the DNL IV polypeptides are in contact with XRCC4 but not with one another."	None
DNA ligase IV-XRCC4-PNK complex	P49917;Q13426;Q96T60	3981;7518;11284	DNA repair;chromosome	DNA repair;chromosome	LIG4;XRCC4;PNKP	None	Interaction of PNK with XRCC4 is dependent on the phosphothreonine-binding activity of the FHA domain.	None
Spliceosome	O00425;O00571;O14776;O15042;O15355;O43143;O43172;O43290;O43395;O43447;O43660;O43670;O43719;O43809;O60231;O60306;O60508;O75400;O75533;O75643;O75934;O75937;O75940;O94906;O95232;O95391;O95400;O95926;P08579;P08621;P09012;P09234;P09661;P11940;P14678;P17844;P26368;P38919;P41223;P42285;P49756;P52298;P55081;P55769;P61326;P62304;P62306;P62308;P62310;P62312;P62314;P62316;P62318;P62995;P83876;P84103;Q01081;Q01130;Q05519;Q07955;Q08170;Q08211;Q09161;Q12874;Q13123;Q13242;Q13243;Q13247;Q13356;Q13435;Q13523;Q13573;Q13769;Q13838;Q14011;Q14498;Q14562;Q15007;Q15029;Q15287;Q15393;Q15427;Q15428;Q15459;Q15637;Q16629;Q16630;Q2TAY7;Q4ZG51;Q53GS9;Q69YN4;Q6I9Y2;Q6P2Q9;Q7L014;Q86V81;Q86W42;Q8IYB3;Q8NI27;Q8WUQ7;Q8WVK2;Q8WWY3;Q8WYA6;Q92620;Q92841;Q96BP3;Q96DF8;Q96DI7;Q96FV9;Q96I25;Q96J01;Q96T37;Q96T58;Q99459;Q99633;Q9BQ61;Q9BRD0;Q9BUQ8;Q9BXP5;Q9BZJ0;Q9H2H8;Q9HCE1;Q9HCG8;Q9HCS7;Q9NW64;Q9NYV4;Q9P013;Q9UBB9;Q9UHX1;Q9UJV9;Q9UK45;Q9UKV3;Q9ULR0;Q9UMS4;Q9UNP9;Q9UQ35;Q9Y2W2;Q9Y333;Q9Y3B4;Q9Y3C6;Q9Y4Z0;Q9Y5B6;Q9Y5S9;Q9Y6A4	10643;1654;10915;23350;5496;1665;9128;9092;9129;10465;5356;7756;27336;11051;8449;9716;51362;55660;23451;23020;10286;22826;10285;24148;51747;10569;10421;25949;6629;6625;6626;6631;6627;26986;6628;1655;11338;9775;8896;23517;58517;22916;4236;4809;4116;6635;6636;6637;27258;11157;6632;6633;6634;6434;10907;6428;7307;6427;9295;6426;6429;1660;4686;10946;3550;8683;6430;6431;23759;10992;8899;22938;8563;7919;1153;9584;1659;9589;9343;10921;23450;10262;8175;10291;7536;6432;11052;55234;55660;10713;25962;80145;10594;9879;10189;79228;10250;57187;58509;11017;26121;56259;9785;10521;23398;8220;9410;9984;84991;84321;64783;23013;988;8559;79002;84811;9416;51593;51340;53938;4343;57703;56949;55696;51755;51503;None;22827;51428;51690;22985;57461;27339;10450;23524;51729;57819;51639;51645;25804;94104;9939;29105	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	IGF2BP3;DDX3X;TCERG1;U2SURP;PPM1G;DHX15;PRPF4;SART1;PRPF3;PPIH;PLRG1;ZNF207;HTATSF1;NUDT21;DHX16;AQR;CDC40;PRPF40A;SF3B1;SNRNP200;BCAS2;DNAJC8;SMNDC1;PRPF6;LUC7L3;SLU7;CD2BP2;SYF2;SNRPB2;SNRNP70;SNRPA;SNRPC;SNRPA1;PABPC1;SNRPB;DDX5;U2AF2;EIF4A3;BUD31;MTREX;RBM25;NCBP2;MFAP1;SNU13;MAGOH;SNRPE;SNRPF;SNRPG;LSM3;LSM6;SNRPD1;SNRPD2;SNRPD3;TRA2B;TXNL4A;SRSF3;U2AF1;SRSF2;SRSF11;SRSF1;SRSF4;DHX9;NCBP1;SF3A3;IK;SRSF9;SRSF5;SRSF6;PPIL2;SF3B2;PRPF4B;SNW1;THOC5;DDX39B;CIRBP;RBM39;DHX8;WTAP;EFTUD2;RNPS1;SF3B3;SF3B4;SF3A2;SF3A1;SF1;SRSF7;CPSF6;SMU1;FNBP3;USP39;KIAA1429;THOC7;PRPF8;DDX46;ALYREF;THOC6;SRRM1;THOC2;CACTIN;SNRNP27;PRPF31;CTNNBL1;DHX38;DDX17;PPWD1;DGCR14;SNRNP40;THOC1;RBM17;THOC3;RBM15;SPEN;CDC5L;PRPF18;C19orf43;BUD13;DDX23;SRRT;CRNKL1;PPIL3;MOV10;CWC22;XAB2;RBM22;CDK12;CWC15;TFIP11;PUF60;DDX41;LSM7;ACIN1;ISY1;PRPF19;PPIE;SRRM2;WBP11;LSM2;SF3B6;PPIL1;LSM4;PAXBP1;RBM8A;CFAP20	None	"In eukaryotes, the removal of introns from nascent transcripts is mediated by a highly dynamic, macromolecular machine called the spliceosome."	None
DNA ligase IV-XRCC4 complex	P49917;Q13426	3981;7518	DNA repair;mitotic recombination;DNA binding;chromosome	DNA repair;somatic / mitotic recombination;DNA binding;chromosome	LIG4;XRCC4	None	None	None
DNA ligase IV-condensin complex	O95347;P49917;Q9NTJ3	10592;3981;10051	DNA repair;cell cycle;chromosome	DNA repair;cell cycle;chromosome	SMC2;LIG4;SMC4	None	DNA ligase IV interacts with SMC2L1 protein.	None
DNA ligase IV-XRCC4 complex	P49917;Q13426	3981;7518	DNA repair;mitotic recombination;DNA binding;chromosome	DNA repair;somatic / mitotic recombination;DNA binding;chromosome	LIG4;XRCC4	None	XRCC4 and DNA ligase IV do not colocalize during mitosis.	None
DNA-PK-Ku complex	P12956;P13010;P78527	2547;7520;5591	mRNA transcription;protein phosphorylation;protein autophosphorylation;DNA binding;nucleus	"mRNA synthesis;modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding;nucleus"	XRCC6;XRCC5;PRKDC	None	Ku antigen activates DNA-PK that phosphorylates the C-terminal domain of RNA polymerase II.	None
DNA-PK-Ku complex	P12956;P13010;P78527	2547;7520;5591	mRNA transcription;protein phosphorylation;protein autophosphorylation;DNA binding;nucleus	"mRNA synthesis;modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding;nucleus"	XRCC6;XRCC5;PRKDC	None	DNA-PK is directed to the DNA by interaction with Ku antigen.	None
DNA-PK-Ku complex	P12956;P13010;P78527	2547;7520;5591	mRNA transcription;protein phosphorylation;protein autophosphorylation;DNA binding;nucleus	"mRNA synthesis;modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding;nucleus"	XRCC6;XRCC5;PRKDC	None	Ku antigen activates DNA-PK that phosphorylates the C-terminal domain of RNA polymerase II.	None
DNA ligase IV-XRCC4-XLF complex	P49917;Q13426;Q9H9Q4	3981;7518;79840	DNA repair;nucleus	DNA repair;nucleus	LIG4;XRCC4;NHEJ1	None	None	None
Artemis-DNA-PK complex	P78527;Q96SD1	5591;64421	DNA catabolic process;DNA repair;mitotic recombination;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA degradation;DNA repair;somatic / mitotic recombination;DNA binding;DNA damage response;nucleus	PRKDC;DCLRE1C	None	DNA-PKcs is necessary for the loading of Artemis on damaged chromatin. Ku-mediated assembly of DNA-PK on DNA ends is responsible for a dissociation of the DNA-PKcs\u00b7Artemis complex.	None
Artemis-DNA-PK complex	P78527;Q96SD1	5591;64421	purine nucleotide metabolic process;purine nucleobase metabolic process;DNA repair;mitotic recombination;DNA binding;cellular response to DNA damage stimulus;nucleus	purin nucleotide/nucleoside/nucleobase metabolism;DNA repair;somatic / mitotic recombination;DNA binding;DNA damage response;nucleus	PRKDC;DCLRE1C	None	"Upon complex formation, DNA-PKcs phosphorylates Artemis, and Artemis acquires endonucleolytic activity on 5' and 3' overhangs, as well as hairpins. Finally, the Artemis:DNA-PKcs complex can open hairpins generated by the RAG complex."	None
DNA ligase III-XRCC1-PNK-DNA-pol III multiprotein complex	P06746;P18887;P49916;Q96T60	5423;7515;3980;11284	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	POLB;XRCC1;LIG3;PNKP	None	None	None
DNA ligase III-XRCC1 complex	P18887;P49916	7515;3980	DNA repair;nucleus	DNA repair;nucleus	XRCC1;LIG3	None	None	None
DNA ligase III-XRCC1 complex	P18887;P49916	7515;3980	DNA repair;nucleus	DNA repair;nucleus	XRCC1;LIG3	None	DNA polymerase beta promotes recruitment of the XRCC1-Lig3 complex to sites of base excision repair. However Pol-beta is not stably complexed with the XRCC1-Lig3 heterodimer.	None
ERCC1-ERCC4-MSH2 complex	P07992;P43246;Q92889	2067;4436;2072	DNA catabolic process;DNA repair;cellular response to DNA damage stimulus;nucleus	DNA degradation;DNA repair;DNA damage response;nucleus	ERCC1;MSH2;ERCC4	None	None	ERCC4 is involved in xeroderma pigmentosum group F.
MSH2-MSH6-PMS2-MLH1 complex	P40692;P43246;P52701;P54278	4292;4436;2956;5395	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MLH1;MSH2;MSH6;PMS2	None	The protein complex specifically binds to mismatched DNA. Interactions occur without addition of ATP.	None
MSH2-MSH6-PMS1-MLH1 complex	P40692;P43246;P52701;P54277	4292;4436;2956;5378	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MLH1;MSH2;MSH6;PMS1	None	The protein complex specifically binds to mismatched DNA. Interactions occur without addition of ATP.	None
MSH2-MSH6 complex	P43246;P52701	4436;2956	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MSH2;MSH6	None	None	None
MSH2-MSH3 complex	P20585;P43246	4437;4436	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MSH3;MSH2	None	None	None
PCNA-MutS-alpha-MutL-alpha-DNA complex	P12004;P40692;P43246;P52701;P54278	5111;4292;4436;2956;5395	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	PCNA;MLH1;MSH2;MSH6;PMS2	None	"MutS-alpha, consisting of MSH2 and MSH6 proteins, and PCNA bind to DNA to form an initial complex. MutL-alpha, consisting of MLH1 and PMS2, binds to the complex when the DNA is damaged."	None
PCNA-MSH2-MSH6 complex	P12004;P43246;P52701	5111;4436;2956	DNA repair;DNA binding;nucleus	DNA repair;DNA binding;nucleus	PCNA;MSH2;MSH6	None	"MutS-alpha, consisting of MSH2 and MSH6 proteins, and PCNA bind to DNA to form an initial complex. MutL-alpha, consisting of MLH1 and PMS2, binds to the complex when the DNA is damaged."	None
MSH2-MSH3 complex	P20585;P43246	4437;4436	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MSH3;MSH2	None	None	None
MutL-alpha complex	P40692;P54278	4292;5395	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MLH1;PMS2	None	"Normal levels of hMLH1 protein appear to be important in maintaining normal levels of hPMS1 and hPMS2 proteins, suggesting that PMS proteins are unstable in the absence of hMLH1."	None
MutL-beta complex	P40692;P54277	4292;5378	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	MLH1;PMS1	None	"The results provide evidence for the association of hPMS1 with hMLH1 as a heterodimer in human epithelial cancer cells. Normal levels of hMLH1 protein appear to be important in maintaining normal levels of hPMS1 and hPMS2 proteins, suggesting that PMS proteins are unstable in the absence of hMLH1."	None
"Ubiquitin E3 ligase (UBADC1, RNF123)"	Q5XPI4;Q9BSL1	63891;10422	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding;cytoplasm	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;cytoplasm"	RNF123;UBAC1	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The cyclin-dependent kinase inhibitor p27(Kip1) is degraded at the G0-G1 transition of the cell cycle by the ubiquitin-proteasome pathway. Overexpression of KPC promoted the degradation of p27(Kip1), whereas a dominant-negative mutant of KPC1 delayed p27(Kip1) degradation. The nuclear export of p27(Kip1) by CRM1 seems to be necessary for KPC-mediated proteolysis."	None
MCM complex	P25205;P33991;P33992;P33993;P49736;Q14566	4172;4173;4174;4176;4171;4175	chromosome organization;DNA replication;ATP binding;chromosome	organization of chromosome structure;DNA synthesis and replication;ATP binding;chromosome	MCM3;MCM4;MCM5;MCM7;MCM2;MCM6	None	None	The MCM proteins are highly expressed in malignant human cancer cells and pre-cancerous cells undergoing malignant transformation (PMID:16101384).
ORC complex (origin recognition complex)	O43913;O43929;Q13415;Q13416;Q9UBD5;Q9Y5N6	5001;5000;4998;4999;23595;23594	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;ATP binding;chromosome	ori recognition and priming complex formation;ATP binding;chromosome	ORC5;ORC4;ORC1;ORC2;ORC3;ORC6	None	Orc6 is only weakly associated with the ORC complex.	None
"Ubiquitin E3 ligase (SKP1A, FBXW2, CUL1)"	P63208;Q13616;Q9UKT8	6500;8454;26190	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding;thyroid gland development;cytoplasm	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;thyroid gland;cytoplasm"	SKP1;CUL1;FBXW2	None	The GCM proteins GCMa/1 and GCMb/2 are novel zinc-containing transcription factors critical for glial cell differentiation in fly and for placental as well as parathyroid gland development in mouse. Experiments identify the SCF(hFBW2) E3 complex as the key machinery that targets hGCMa to the ubiquitin-proteasome degradation system.	None
"Ubiquitin E3 ligase (DDB1, CUL4A, RBX1)"	P62877;Q13619;Q16531	9978;8451;1642	protein ubiquitination;protein binding;cellular response to DNA damage stimulus;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein binding;DNA damage response;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;CUL4A;DDB1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"Succinyl-CoA synthetase, GDP-forming"	P53597;Q96I99	8802;8801	purine nucleotide metabolic process;purine nucleobase metabolic process;metabolic process;protein binding;GTP binding;mitochondrion	purin nucleotide/nucleoside/nucleobase metabolism;METABOLISM;protein binding;GTP binding;mitochondrion	SUCLG1;SUCLG2	None	None	"A deletion in SUCLG1, a gene that encodes the alpha subunit of the Krebs-cycle enzyme succinate-coenzyme A ligase (SUCL) causes fatal infantile lactic acidosis(PMID:17668387)."
"Succinyl-CoA synthetase, ADP-forming"	P53597;Q9P2R7	8802;8803	purine nucleotide metabolic process;purine nucleobase metabolic process;metabolic process;protein binding;ATP binding;mitochondrion	purin nucleotide/nucleoside/nucleobase metabolism;METABOLISM;protein binding;ATP binding;mitochondrion	SUCLG1;SUCLA2	None	None	"A deletion in SUCLG1, a gene that encodes the alpha subunit of the Krebs-cycle enzyme succinate-coenzyme A ligase (SUCL) causes fatal infantile lactic acidosis(PMID:17668387)."
"Isocitrate dehydrogenase [NADP], cytoplasmic"	O75874	3417	metabolic process;NADP binding;cytoplasm;peroxisome	METABOLISM;NAD/NADP binding;cytoplasm;peroxisome	IDH1	None	Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to alpha-ketoglutarate. The isocitrate dehydrogenase complex appears as homodimer.	None
"Guanylyl cyclase, soluble (GUCY1A2, GUCY1B3)"	P33402;Q02153	2977;2983	cyclic nucleotide metabolic process;protein binding;cytoplasm	metabolism of cyclic and unusual nucleotides;protein binding;cytoplasm	GUCY1A2;GUCY1B3	None	Two soluble guanylyl cyclase complexes were found in mammals.  The GUCY1A3-GUCY1B3 complex exhibits higher guanylyl cyclase activity than the GUCY1A2-GUCY1B3 complex.	None
"Guanylyl cyclase, soluble (GUCY1A3, GUCY1B3)"	Q02108;Q02153	2982;2983	cyclic nucleotide metabolic process;protein binding;cytoplasm	metabolism of cyclic and unusual nucleotides;protein binding;cytoplasm	GUCY1A3;GUCY1B3	None	Two soluble guanylyl cyclase complexes were found in mammals.  The GUCY1A3-GUCY1B3 complex exhibits higher guanylyl cyclase activity than the GUCY1A2-GUCY1B3 complex.	None
EXO1-MLH1-PMS2 complex	P40692;P54278;Q9UQ84	4292;5395;9156	DNA catabolic process;RNA catabolic process;DNA repair;cellular response to DNA damage stimulus;nucleus	DNA degradation;RNA degradation;DNA repair;DNA damage response;nucleus	MLH1;PMS2;EXO1	None	The authors propose  the involvement of hExoI as a downstream effector in MMR (DNA mismatch repair) and/or DNA recombination.	None
Farnesyltransferase	P49354;P49356	2339;2342	protein lipidation;protein binding	"modification with fatty acids (e.g. myristylation, palmitylation, farnesylation);protein binding"	FNTA;FNTB	None	None	None
Beta-dystroglycan-caveolin-3 complex	P56539;Q14118	859;1605	protein complex assembly;plasma membrane	assembly of protein complexes;eukaryotic plasma membrane / membrane attached	CAV3;DAG1	None	Caveolin-3 can effectively block the interaction of dystrophin with beta -dystroglycan.	DAG1 is involved in muscular dystrophy and cardiomyopathy (PMID:15117830).
EXO1-MLH1-PMS2 complex	P40692;P54278;Q9UQ84	4292;5395;9156	DNA catabolic process;RNA catabolic process;DNA repair;cellular response to DNA damage stimulus;nucleus	DNA degradation;RNA degradation;DNA repair;DNA damage response;nucleus	MLH1;PMS2;EXO1	None	EXO1 plays a role in events at the replication sites as well as a functional role in the DNA mismatch repair and/or recombination processes.	None
EXO1-MLH1-PCNA complex	P12004;P40692;Q9UQ84	5111;4292;9156	DNA catabolic process;RNA catabolic process;DNA repair;cellular response to DNA damage stimulus;nucleus	DNA degradation;RNA degradation;DNA repair;DNA damage response;nucleus	PCNA;MLH1;EXO1	None	EXO1 plays a role in events at the replication sites as well as a functional role in the DNA mismatch repair and/or recombination processes.	None
MSH4-MSH5-GPS2 complex	O15457;O43196;Q13227	4438;4439;2874	DNA repair;reciprocal meiotic recombination;cellular response to DNA damage stimulus	DNA repair;meiotic recombination;DNA damage response	MSH4;MSH5;GPS2	None	The association with GPS2 is mediated through the interface of hMSH4-hMSH5 complex and the N-terminal region of GPS2.	None
Meprin A	Q16819;Q16820	4224;4225	cellular protein catabolic process;protein binding;plasma membrane	cytoplasmic and nuclear protein degradation;protein binding;eukaryotic plasma membrane / membrane attached	MEP1A;MEP1B	None	None	None
Molybdopterin synthase	O96007;O96033	4338;4338	prosthetic group biosynthetic process;vitamin biosynthetic process;cofactor biosynthetic process;protein binding	"biosynthesis of vitamins, cofactors, and prosthetic groups;protein binding"	MOCS2;MOCS2	None	"Molybdenum cofactor (Moco)1 biosynthesis is an ancient, ubiquitous, and highly conserved pathway leading to the biochemical activation of molybdenum. Moco is essential for the activity of sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase in humans. MOCS2A and MOCS2B are encoded on a single bicistronic mRNA."	Human Moco deficiency leads to the pleiotropic loss of all three of these molybdoenzymes and usually progresses to death at an early age.
"Phosphatidylinositol 3-kinase complex (PIK3C3, PIK3R4)"	Q8NEB9;Q99570	5289;30849	protein targeting;protein binding;enzyme linked receptor protein signaling pathway;plasma membrane;phosphatidylinositol phosphorylation;Golgi to lysosome transport	"protein targeting, sorting and translocation;protein binding;receptor enzyme mediated signalling;eukaryotic plasma membrane / membrane attached"	PIK3C3;PIK3R4	None	"The homologous Vps34p-Vps15p complex in yeast mediates protein trafficking. Both human Ptdlns 3-kinase (VPS34) and  yeast Vps34p have identical restricted specificities, using only Ptdlns and not PtdIns4P or PtdIns(4,5P)2 as substrate."	None
18S U11/U12 snRNP	O43143;O75533;P14678;P62304;P62306;P62308;P62314;P62316;P62318;P67809;Q13435;Q15393;Q15427;Q15696;Q16560;Q6IEG0;Q6P2Q9;Q8N8D1;Q8TBF4;Q96LT9;Q9BV90;Q9BWJ5;Q9UDW3;Q9Y3B4	1665;23451;6628;6635;6636;6637;6632;6633;6634;4904;10992;23450;10262;8233;11066;154007;10594;10081;85437;55599;79622;83443;55954;51639	"mRNA splicing, via spliceosome;mRNA processing;nucleus"	"mRNA processing (splicing, 5'-, 3'-end processing);nucleus"	DHX15;SF3B1;SNRPB;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3;YBX1;SF3B2;SF3B3;SF3B4;ZRSR2;SNRNP35;SNRNP48;PRPF8;PDCD7;ZCRB1;RNPC3;SNRNP25;SF3B5;ZMAT5;SF3B6	None	"U12-type spliceosomes excise U12-type introns, which comprise less than 1% of all human introns."	None
MSH2-MSH6-PMS2-MLH1 complex	P40692;P43246;P52701;P54278	4292;4436;2956;5395	DNA repair;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;ATP binding;DNA damage response;nucleus	MLH1;MSH2;MSH6;PMS2	None	MutS-alpha-MutL-alpha-heteroduplex complex requires DNA mismatch and ATP hydrolysis.	None
N-NOS-CHIP-HSP70-1 complex	P0DMV8;P29475;Q9UNE7	3303;4842;10273	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cytoplasm	proteasomal degradation (ubiquitin/proteasomal pathway);cytoplasm	HSPA1A;NOS1;STUB1	None	"Cells for analysis were treated with lactacystin, a selective inhibitor of the proteasome. The authors found that CHIP acts to ubiquitylate nNOS and that hsp70 and hsp40 can facilitate this conjugation reaction."	None
BASC complex (BRCA1-associated genome surveillance complex)	O60934;P35249;P35250;P35251;P38398;P40692;P43246;P49959;P52701;P54132;Q13315;Q92878	4683;5984;5982;5981;672;4292;4436;4361;2956;641;472;10111	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	NBN;RFC4;RFC2;RFC1;BRCA1;MLH1;MSH2;MRE11A;MSH6;BLM;ATM;RAD50	None	The BASC complex may serve as a sensor for DNA damage.	BRCA1 is involved in breast cancer.
BASC (Ab 80) complex (BRCA1-associated genome surveillance complex)	P35249;P35250;P35251;P38398;P40692;P43246;P52701;P54132	5984;5982;5981;672;4292;4436;2956;641	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	RFC4;RFC2;RFC1;BRCA1;MLH1;MSH2;MSH6;BLM	None	"For isolation of the BASC complex (Ab 80), polyclonal antibodies against GST-BRCA1 1021-1552 were used."	BRCA1 is involved in breast cancer.
BASC (Ab 81) complex (BRCA1-associated genome surveillance complex)	P35249;P35250;P35251;P38398;P40692;Q13315	5984;5982;5981;672;4292;472	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	RFC4;RFC2;RFC1;BRCA1;MLH1;ATM	None	"For isolation of the BASC complex (Ab 81), polyclonal antibodies against GST-BRCA1 1501-1861 were used."	BRCA1 is involved in breast cancer.
BASC (Ab C-20) complex (BRCA1-associated genome surveillance complex)	P38398;P52701;Q92878	672;2956;10111	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	BRCA1;MSH6;RAD50	None	"For isolation of the BASC complex (Ab C-20), polyclonal antibodies against the carboxy-terminal epitope of BRCA1 were used."	BRCA1 is involved in breast cancer.
GCN5-TRRAP histone acetyltransferase complex	O75486;O75528;O75529;P38398;P43246;P52701;Q12962;Q16594;Q92830;Q9Y4A5	8464;10474;27097;672;4436;2956;6881;6880;2648;8295	"DNA repair;DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;chromosome organization"	DNA repair;DNA conformation modification (e.g. chromatin);transcriptional control;DNA damage response;organization of chromosome structure	SUPT3H;TADA3;TAF5L;BRCA1;MSH2;MSH6;TAF10;TAF9;KAT2A;TRRAP	None	hGCN5/TRRAP HAT complex subclass is required for the multiple functions of BRCA1 (PMID:16260778).	None
TFTC-type histone acetyl transferase complex	O60244;O75448;P03372;Q15648;Q92830;Q93074;Q9NVC6;Q9UHV7;Q9ULK4;Q9Y2X0;Q9Y4A5	9282;9862;2099;5469;2648;9968;9440;9969;9439;10025;8295	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signaling;chromosome organization;nucleus;receptor binding;histone acetylation"	DNA conformation modification (e.g. chromatin);transcriptional control;cellular signalling;organization of chromosome structure;nucleus;receptor binding	MED14;MED24;ESR1;MED1;KAT2A;MED12;MED17;MED13;MED23;MED16;TRRAP	None	This complex is a coactivator of estrogen receptor alpha (ERalpha).	None
BP-SMAD complex	O14867;O15198;O95452;P17980;P19447;P50539;Q13118;Q15582	571;4093;10804;5702;2071;4601;7071;7045	"positive regulation of transcription, DNA-templated;nucleus"	transcription activation;nucleus	BACH1;SMAD9;GJB6;PSMC3;ERCC3;MXI1;KLF10;TGFBI	None	"Homozygous knockout mice for the homeobox protein Msx1 (Hox7) die at birth exhibiting severe abnormalities limited to the craniofacial region, including a complete cleft of the secondary palate. Results suggest that the BP-SMAD complex is required for transcriptional activation of the mouse Msx1 gene."	None
TFTC complex (TATA-binding protein-free TAF-II-containing complex)	O00268;O15265;O75486;O75528;O75529;P49848;Q12962;Q15393;Q15542;Q15545;Q16514;Q16594;Q6P1X5;Q92830;Q9Y4A5;Q9Y6J9	6874;6314;8464;10474;27097;6878;6881;23450;6877;6879;6883;6880;6873;2648;8295;10629	"DNA topological change;DNA-templated transcription, initiation;positive regulation of transcription, DNA-templated;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription initiation;transcription activation;organization of chromosome structure;nucleus	TAF4;ATXN7;SUPT3H;TADA3;TAF5L;TAF6;TAF10;SF3B3;TAF5;TAF7;TAF12;TAF9;TAF2;KAT2A;TRRAP;TAF6L	"Three other subunits of the complex were found in the analysis, which have not been further characterized. In following publications these proteins were identified as ataxin-7, splicing factor 3B subunit 3 and PAF65A."	None	None
TFTC complex (TATA-binding protein-free TAF-II-containing complex)	O00268;O15265;O75486;O75528;O75529;P49848;Q12962;Q15393;Q15542;Q15545;Q16514;Q16594;Q6P1X5;Q92830;Q9Y4A5;Q9Y6J9	6874;6314;8464;10474;27097;6878;6881;23450;6877;6879;6883;6880;6873;2648;8295;10629	"DNA topological change;DNA-templated transcription, initiation;positive regulation of transcription, DNA-templated;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription initiation;transcription activation;organization of chromosome structure;nucleus	TAF4;ATXN7;SUPT3H;TADA3;TAF5L;TAF6;TAF10;SF3B3;TAF5;TAF7;TAF12;TAF9;TAF2;KAT2A;TRRAP;TAF6L	"TAF-II-30, TAF-II-55 and ADA3 were not identified as TFTC subunits in this study."	None	None
TFTC complex (TATA-binding protein-free TAF-II-containing complex)	O00268;O15265;O75486;O75528;O75529;P49848;Q12962;Q15393;Q15542;Q15545;Q16514;Q16594;Q6P1X5;Q92830;Q9Y4A5;Q9Y6J9	6874;6314;8464;10474;27097;6878;6881;23450;6877;6879;6883;6880;6873;2648;8295;10629	"DNA topological change;DNA-templated transcription, initiation;positive regulation of transcription, DNA-templated;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription initiation;transcription activation;organization of chromosome structure;nucleus	TAF4;ATXN7;SUPT3H;TADA3;TAF5L;TAF6;TAF10;SF3B3;TAF5;TAF7;TAF12;TAF9;TAF2;KAT2A;TRRAP;TAF6L	None	None	None
CRB1-MPP5-INADL complex	P82279;Q8N3R9;Q8NI35	23418;64398;10207	anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	CRB1;MPP5;PATJ	None	This complex  appears to be evolutionarily conserved and likely plays an important role in protein targeting and cell polarity.	None
MPP4-MPP5-CRB1 complex	P82279;Q8N3R9;Q96JB8	23418;64398;58538	detection of light stimulus;response to light stimulus	photoperception and response	CRB1;MPP5;MPP4	None	This complex is localized in outer limiting membrane.	None
TFTC complex (TATA-binding protein-free TAF-II-containing complex)	O00268;O15265;O75486;O75528;O75529;P49848;Q12962;Q15393;Q15542;Q15545;Q16514;Q16594;Q6P1X5;Q92830;Q9Y4A5;Q9Y6J9	6874;6314;8464;10474;27097;6878;6881;23450;6877;6879;6883;6880;6873;2648;8295;10629	"DNA topological change;DNA-templated transcription, initiation;positive regulation of transcription, DNA-templated;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription initiation;transcription activation;organization of chromosome structure;nucleus	TAF4;ATXN7;SUPT3H;TADA3;TAF5L;TAF6;TAF10;SF3B3;TAF5;TAF7;TAF12;TAF9;TAF2;KAT2A;TRRAP;TAF6L	None	"TFTC complex can replace TFIID in vitro, indicating that multiple preinitiation complexes may play an important role in regulating gene expression."	None
TFIID complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594	6874;6908;6872;6878;6881;6877;6884;6882;6879;6883;6880	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9	None	None	None
"Gamma-secretase complex (APH1A, PSEN1, PSENEN, NCSTN)"	P49768;Q92542;Q96BI3;Q9NZ42	5663;23385;51107;55851	protein processing;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN1;NCSTN;APH1A;PSENEN	None	"Proteolytic cleavage within the hydrophobic transmembrane domains of Notch and APP are intimately associated with a multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenillin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	None
"Gamma-secretase complex (APH1B, PSEN2, PSENEN, NCSTN)"	P49810;Q8WW43;Q92542;Q9NZ42	5664;83464;23385;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;signaling;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;cellular signalling;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN2;APH1B;NCSTN;PSENEN	None	"Proteolytic cleavage within the hydrophobic transmembrane domains of Notch and APP are intimately associated with a multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenilin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	None
"Gamma-secretase complex (APH1A, PSEN2, PSENEN, NCSTN)"	P49810;Q92542;Q96BI3;Q9NZ42	5664;23385;51107;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;signaling;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;cellular signalling;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN2;NCSTN;APH1A;PSENEN	None	"Proteolytic cleavage within the hydrophobic transmembrane domains of Notch and APP are intimately associated with a multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenillin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	None
TFIID-beta complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594;Q6P1X5	6874;6908;6872;6878;6881;6877;6884;6882;6879;6883;6880;6873	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription initiation;transcriptional control;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9;TAF2	None	None	None
TFTC complex (TATA-binding protein-free TAF-II-containing complex)	O00268;O15265;O75486;O75528;O75529;P49848;Q12962;Q15393;Q15542;Q15543;Q15545;Q16514;Q16594;Q6P1X5;Q92830;Q9Y4A5;Q9Y6J9	6874;6314;8464;10474;27097;6878;6881;23450;6877;6884;6879;6883;6880;6873;2648;8295;10629	"DNA topological change;DNA-templated transcription, initiation;positive regulation of transcription, DNA-templated;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription initiation;transcription activation;organization of chromosome structure;nucleus	TAF4;ATXN7;SUPT3H;TADA3;TAF5L;TAF6;TAF10;SF3B3;TAF5;TAF13;TAF7;TAF12;TAF9;TAF2;KAT2A;TRRAP;TAF6L	"Three other subunits of the complex were found in the analysis, which have not been further characterized. In following publications these proteins were identified as ataxin-7, splicing factor 3B subunit 3 and PAF65A."	None	None
PCAF complex	O75478;O75486;O75528;O75529;Q12962;Q16514;Q16594;Q92831;Q9Y4A5;Q9Y6J9	6871;8464;10474;27097;6881;6883;6880;8850;8295;10629	"DNA topological change;transcription, DNA-templated;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);TRANSCRIPTION;transcriptional control;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	TADA2A;SUPT3H;TADA3;TAF5L;TAF10;TAF12;TAF9;KAT2B;TRRAP;TAF6L	PCAF is a complex consisting of more than 20 different proteins. Several proteins have not been characterized in this study.	None	None
Prolyl 4-hydroxylase (alpha(I)-type)	P07237;P13674	5034;5033	protein hydroxylation;protein methylation;protein binding;cofactor binding;endoplasmic reticulum	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);protein binding;complex cofactor/cosubstrate/vitamine binding;endoplasmic reticulum"	P4HB;P4HA1	None	Prolyl 4-hydroxylase (EC 1.14.11.2) catalyzes the formation of 4-hydroxyproline in collagens and related proteins.	None
Prolyl 4-hydroxylase (alpha(III)-type)	P07237;Q7Z4N8	5034;283208	protein hydroxylation;protein methylation;protein binding;cofactor binding;endoplasmic reticulum	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);protein binding;complex cofactor/cosubstrate/vitamine binding;endoplasmic reticulum"	P4HB;P4HA3	None	Prolyl 4-hydroxylase (EC 1.14.11.2) catalyzes the formation of 4-hydroxyproline in collagens and related proteins.	None
STAGA complex	O75486;O75528;O75529;O94864;Q12962;Q15393;Q16514;Q16594;Q92830;Q96BN2;Q9Y4A5;Q9Y6J9	8464;10474;27097;9913;6881;23450;6883;6880;2648;117143;8295;10629	"DNA topological change;positive regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription activation;DNA damage response;organization of chromosome structure;nucleus	SUPT3H;TADA3;TAF5L;SUPT7L;TAF10;SF3B3;TAF12;TAF9;KAT2A;TADA1;TRRAP;TAF6L	"Three other subunits of the complex were found in the analysis, which have not been further characterized: STAF60, STAF55, STAF46."	None	None
STAGA complex	O15265;O75486;O75528;O75529;O94864;Q12962;Q15393;Q16514;Q16594;Q92830;Q96BN2;Q9Y4A5;Q9Y6J9	6314;8464;10474;27097;9913;6881;23450;6883;6880;2648;117143;8295;10629	"DNA topological change;positive regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription activation;DNA damage response;organization of chromosome structure;nucleus	ATXN7;SUPT3H;TADA3;TAF5L;SUPT7L;TAF10;SF3B3;TAF12;TAF9;KAT2A;TADA1;TRRAP;TAF6L	None	This complex is a coactivator required for transcription of a subset of RNA polymerase II-dependent genes.	None
PCAF complex	O75478;O75486;O75528;O75529;Q12962;Q16514;Q16594;Q92831;Q9Y4A5;Q9Y6J9	6871;8464;10474;27097;6881;6883;6880;8850;8295;10629	"DNA topological change;transcription, DNA-templated;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);TRANSCRIPTION;transcriptional control;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	TADA2A;SUPT3H;TADA3;TAF5L;TAF10;TAF12;TAF9;KAT2B;TRRAP;TAF6L	PCAF is a complex consisting of more than 20 different proteins. Several proteins have not been characterized in this study.	None	None
STAGA core complex	O75486;Q16594;Q92830	8464;6880;2648	"DNA topological change;positive regulation of transcription, DNA-templated;chromosome organization;nucleus;histone acetylation"	DNA conformation modification (e.g. chromatin);transcription activation;organization of chromosome structure;nucleus	SUPT3H;TAF9;KAT2A	None	None	None
TFIID complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594	6874;6908;6872;6878;6881;6877;6884;6882;6879;6883;6880	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9	None	None	None
"TFIID complex, B-cell specific"	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594;Q92750	6874;6908;6872;6878;6881;6877;6884;6882;6879;6883;6880;6875	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9;TAF4B	None	TAF-II-105 (TAF4B) is a cell-type specific subunit of TFIID complex. Up to now TAF-II-105 is only found in differentiated B cells.Isolation of TBP and TAF9-TAF13 was not shown in this paper.	None
WIP-WASp-actin-myosin-IIa complex	O43516;P19105;P35579;P42768;P60660;P62736	7456;10627;4627;7454;4637;59	response to stimulus;actin cytoskeleton organization;cytoskeleton	animal specific systemic sensing and response;actin cytoskeleton;cytoskeleton	WIPF1;MYL12A;MYH9;WAS;MYL6;ACTA2	None	The multiprotein complex is important for NK cell function. Killer cell immunoglobulin-like receptor inhibitory signaling affects proteins involved in cytoskeletal rearrangements. WIP plays a central role in the formation of the complex and in the regulation of NK cell activity.	None
TFIIA complex	P52655;P52657	2957;2958	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription initiation;transcriptional control;nucleus	GTF2A1;GTF2A2	GTF2A1 encodes both the alpha and beta subunits.	"TFIIA is a heterotrimer of an alpha (p35), a beta (p19) and a gamma subunit (p12)."	None
TFIIA complex	P52655;P52657	2957;2958	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription initiation;transcriptional control;nucleus	GTF2A1;GTF2A2	GTF2A1 encodes both the alpha and beta subunits.	"TFIIA is a heterotrimer of an alpha (p35), a beta (p19) and a gamma subunit (p12)."	None
DA complex	O00268;P20226;P21675;P49848;P52655;P52657;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594;Q5VWG9;Q6P1X5	6874;6908;6872;6878;2957;2958;6881;6877;6884;6882;6879;6883;6880;83860;6873	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;GTF2A1;GTF2A2;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9;TAF3;TAF2	None	DA is a multiprotein complex consisting of TFIID complex and TFIIA complex.	None
DAB complex	O00268;P20226;P21675;P49848;P52655;P52657;Q00403;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594;Q5VWG9;Q6P1X5	6874;6908;6872;6878;2957;2958;2959;6881;6877;6884;6882;6879;6883;6880;83860;6873	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;GTF2A1;GTF2A2;GTF2B;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9;TAF3;TAF2	None	"DAB is a multiprotein complex consisting of TFIID complex, TFIIA complex and TFIIB."	None
TAF4-TAF12 subcomplex of TFIID complex	O00268;Q16514	6874;6883	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding;nucleus"	transcription initiation;transcriptional control;protein binding;nucleus	TAF4;TAF12	None	"TAF12 forms a histone-like heterodimer with TAF4, rather than homodimerizing as suggested earlier (PMID:8598932)."	None
TFIID complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15544;Q15545;Q16514;Q16594	6874;6908;6872;6878;6881;6877;6882;6879;6883;6880	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF11;TAF7;TAF12;TAF9	None	None	None
TFIID complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594;Q92804	6874;6908;6872;6878;6881;6877;6884;6882;6879;6883;6880;8148	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9;TAF15	None	None	None
TFTC complex (TATA-binding protein-free TAF-II-containing complex)	O00268;O15265;O75486;O75528;O75529;P49848;Q12962;Q15393;Q15542;Q15545;Q16514;Q16594;Q6P1X5;Q92830;Q9HBM6;Q9Y4A5;Q9Y6J9	6874;6314;8464;10474;27097;6878;6881;23450;6877;6879;6883;6880;6873;2648;51616;8295;10629	"DNA topological change;DNA-templated transcription, initiation;positive regulation of transcription, DNA-templated;protein acetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription initiation;transcription activation;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	TAF4;ATXN7;SUPT3H;TADA3;TAF5L;TAF6;TAF10;SF3B3;TAF5;TAF7;TAF12;TAF9;TAF2;KAT2A;TAF9B;TRRAP;TAF6L	None	Gene expression profiling revealed that Taf9 and Taf9b control the expression of different sets of genes.	None
TFIID-beta complex	O00268;P20226;P21675;P49848;Q12962;Q15542;Q15543;Q15544;Q15545;Q16514;Q16594;Q9HBM6	6874;6908;6872;6878;6881;6877;6884;6882;6879;6883;6880;51616	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF10;TAF5;TAF13;TAF11;TAF7;TAF12;TAF9;TAF9B	None	Gene expression profiling revealed that Taf9 and Taf9b control the expression of different sets of genes.	None
AKAP5-PRKAR2A-PPP3CA complex	P13861;P24588;Q08209	5576;9495;5530	protein targeting;protein transport;protein phosphorylation;protein dephosphorylation;plasma membrane;cytoskeleton;regulation of synaptic plasticity;calcium-mediated signaling	"protein targeting, sorting and translocation;protein transport;modification by phosphorylation, dephosphorylation, autophosphorylation;eukaryotic plasma membrane / membrane attached;cytoskeleton;Ca2+ mediated signal transduction"	PRKAR2A;AKAP5;PPP3CA	None	None	None
AKAP250-PKA-PDE4D complex	P17612;Q02952;Q08499	5566;9590;5144	intracellular protein transport;protein targeting;protein transport;protein localization;enzyme regulator activity;regulation of catalytic activity;cAMP-mediated signaling;plasma membrane	"protein targeting, sorting and translocation;protein transport;regulation by localization;enzymatic activity regulation / enzyme regulator;cAMP/cGMP mediated signal transduction;eukaryotic plasma membrane / membrane attached"	PRKACA;AKAP12;PDE4D	"Since the authors did not specify PKA catalytic subunit, we used PRKACA."	PDE4D protein isoforms were specified as PDE4D5 and PDE4D3. The authors identified gravin as the AKAP responsible for the localized regulation of cAMP levels by PKA and PDE4 activity.	None
AMY-1-S-AKAP84-RII-beta complex	P31323;Q92667;Q99417	5577;8165;26292	cAMP-mediated signaling;gamete generation;mitochondrion	cAMP/cGMP mediated signal transduction;gametogenesis;mitochondrion	PRKAR2B;AKAP1;MYCBP	None	None	None
KCNQ1 macromolecular complex	P13861;P17612;P51787;P62136;Q99996	5576;5566;3784;5499;10142	ion channel activity;cAMP-mediated signaling;response to stimulus	ion channels;cAMP/cGMP mediated signal transduction;animal specific systemic sensing and response	PRKAR2A;PRKACA;KCNQ1;PPP1CA;AKAP9	None	This complex is required for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.	None
Polycystin-1-E-cadherin-beta-catenin complex	P12830;P35222;P98161	999;1499;5310	cell-cell junction organization;cell-cell junction assembly;epithelial cell differentiation;morphogenesis of an epithelium;kidney development;plasma membrane;cytoplasm	intercellular junction (gap junction/adherens junction);epithelium;kidney;eukaryotic plasma membrane / membrane attached;cytoplasm	CDH1;CTNNB1;PKD1	None	Complex is disrupted in ADPKD cells.	"Polycystin-1-E-cadherin-beta-catenin complex is involved in autosomal dominant polycystic kidney disease (ADPKD). The authors suggest that the expression of mutant polycystin-1 in ADPKD cells, which fails to be cell surface-expressed and assemble into multiprotein complexes with E-cadherin, results in altered cell-cell adhesion and polycystin-1 signaling, thereby triggering dedifferentiation."
Polycystin-1-E-cadherin-beta-catenin-Flotillin-2 complex	P12830;P35222;P98161;Q14254	999;1499;5310;2319	None	None	CDH1;CTNNB1;PKD1;FLOT2	None	"The authors conclude that even though the large multiprotein complex formed by polycystin-1, E-cadherin, beta-catenin and flotillin-2 is not associated with typical lipid rafts, it contains cholesterol molecules that mediate interactions between complexed proteins and may represent a specific membrane domain organization."	PKD1 is involved in ADPKD (autosomal dominant polycystic kidney disease).
TIP60 histone acetylase complex	O96019;Q92993;Q9Y230;Q9Y265;Q9Y4A5	86;10524;10856;8607;8295	None	None	ACTL6A;KAT5;RUVBL2;RUVBL1;TRRAP	"Additional unknown members of the TIP60 complex (p160, p150, p100, p70, p57, p40, p31, p29) have been isolated."	The TIP60 histone acetylase complex plays a role in DNA repair and apoptosis.	None
"TRPC3-TRPC4 channel complex, redox-sensitive"	Q13507;Q9UBN4	7222;7223	cation transmembrane transporter activity;cation transport;ion channel activity;response to reactive oxygen species;response to oxidative stress;plasma membrane	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;oxidative stress response;eukaryotic plasma membrane / membrane attached"	TRPC3;TRPC4	None	Complex analysed in the HEK293 expression system. The authors propose TRPC3 and TRPC4 as subunits of native endothelial cation channels that are governed by the cellular redox state.	None
NuA4/Tip60-HAT complex	O95619;O96019;Q15014;Q92993;Q96L91;Q9H0E9;Q9H2F5;Q9HAF1;Q9NPF5;Q9NV56;Q9NXR8;Q9UBU8;Q9Y230;Q9Y265;Q9Y4A5	8089;86;9643;10524;57634;10902;80314;64769;55929;55257;54556;10933;10856;8607;8295	chromosome organization;DNA repair;DNA topological change;DNA binding;nucleus;histone acetylation	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);DNA binding;nucleus	YEATS4;ACTL6A;MORF4L2;KAT5;EP400;BRD8;EPC1;MEAF6;DMAP1;MRGBP;ING3;MORF4L1;RUVBL2;RUVBL1;TRRAP	None	"The NuA4 histone acetyltransferase (HAT) multisubunit complex is responsible for acetylation of histone H4 and H2A N-terminal tails in yeast. The NuA4/Tip60 HAT complex is highly conserved in eukaryotes playing primary roles in transcription, cellular response to DNA damage, and cell cycle control."	None
NuA4/Tip60-HAT complex	O95619;O96019;Q15014;Q15906;Q92993;Q96L91;Q9H0E9;Q9H2F5;Q9HAF1;Q9NPF5;Q9NV56;Q9NXR8;Q9UBU8;Q9Y230;Q9Y265;Q9Y4A5	8089;86;9643;6944;10524;57634;10902;80314;64769;55929;55257;54556;10933;10856;8607;8295	chromosome organization;DNA repair;DNA topological change;DNA binding;nucleus;histone acetylation	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);DNA binding;nucleus	YEATS4;ACTL6A;MORF4L2;VPS72;KAT5;EP400;BRD8;EPC1;MEAF6;DMAP1;MRGBP;ING3;MORF4L1;RUVBL2;RUVBL1;TRRAP	None	"The NuA4 histone acetyltransferase (HAT) multisubunit complex is responsible for acetylation of histone H4 and H2A N-terminal tails in yeast. The NuA4/Tip60 HAT complex is highly conserved in eukaryotes playing primary roles in transcription, cellular response to DNA damage, and cell cycle control."	None
XPA-ERCC1-ERCC4 complex	P07992;P23025;Q92889	2067;7507;2072	DNA repair;response to stress;nucleus	DNA repair;stress response;nucleus	ERCC1;XPA;ERCC4	None	None	ERCC4 is involved in Xeroderma pigmentosum group F.
IMP3-IMP4-MPP10 complex	O00566;Q96G21;Q9NV31	10199;92856;55272	protein complex assembly;protein binding;RNA binding;nucleus	assembly of protein complexes;protein binding;RNA binding;nucleus	MPHOSPH10;IMP4;IMP3	None	The formation of the hImp3-hMpp10-hImp4 complex correlates with the nucleolar localization of these proteins.	None
TRAP complex	O60244;O75448;O75586;P10827;P24863;Q13503;Q15648;Q6P2C8;Q93074;Q9BTT4;Q9NPJ6;Q9NVC6;Q9UHV7;Q9Y2W1;Q9Y2X0;Q9Y3C7	9282;9862;10001;7067;892;9412;5469;9442;9968;84246;29079;9440;9969;9967;10025;51003	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;regulation of sequence-specific DNA binding transcription factor activity;hormone-mediated signaling pathway;signaling;nucleus"	transcriptional control;regulator of transcription factor;hormone mediated signal transduction;cellular signalling;nucleus	MED14;MED24;MED6;THRA;CCNC;MED21;MED1;MED27;MED12;MED10;MED4;MED17;MED13;THRAP3;MED16;MED31	"Two, up to now uncharacterized members of the complex have been additionally isolated: TRAP97 and TRAP93."	"The human thyroid hormone receptor-associated protein (TRAP) complex is a coactivator for nuclear receptors.  Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
TRPC1-TRPC3-TRPC7 complex	P48995;Q13507;Q9HCX4	7220;7222;57113	cation transmembrane transporter activity;cation transport;channel activity;cellular metal ion homeostasis;plasma membrane	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);channel / pore class transport;homeostasis of metal ions (Na, K, Ca etc.);eukaryotic plasma membrane / membrane attached"	TRPC1;TRPC3;TRPC7	None	"The results indicate that endogenous TRPC1, TRPC3, and TRPC7 participate in forming heteromeric store-operated channels, whereas TRPC3 and TRPC7 can also participate in forming heteromeric receptor-operated channels."	None
IGF1-IGFBP3-ALS complex	P05019;P17936;P35858	3479;3486;3483	response to stimulus	animal specific systemic sensing and response	IGF1;IGFBP3;IGFALS	None	"Circulating levels of IGF-I, IGFBP-3 and ALS, and their degree of association in the ternary complex in the fetus increased with gestational age."	IGF1 is implicated in the pathophysiology of pre-eclampsia.
SMCC complex	O60244;O75448;O75586;P24863;P49336;Q13503;Q15648;Q6P2C8;Q93074;Q9NPJ6;Q9NVC6;Q9UHV7;Q9Y2W1;Q9Y2X0	9282;9862;10001;892;1024;9412;5469;9442;9968;29079;9440;9969;9967;10025	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcriptional control;protein binding;regulator of transcription factor;nucleus	MED14;MED24;MED6;CCNC;CDK8;MED21;MED1;MED27;MED12;MED4;MED17;MED13;THRAP3;MED16	"In SMCC two, up to now uncharacterized members of the complex have been additionally isolated: TRAP97 and TRAP93."	"Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
DRIP complex	O43513;O60244;O75448;O75586;O95402;P11473;P28702;Q15648;Q93074;Q9NPJ6;Q9NVC6;Q9UHV7;Q9ULK4;Q9Y2X0	9443;9282;9862;10001;9441;7421;6257;5469;9968;29079;9440;9969;9439;10025	"positive regulation of transcription, DNA-templated;regulation of sequence-specific DNA binding transcription factor activity;hormone-mediated signaling pathway;signaling;nucleus;histone acetylation"	transcription activation;regulator of transcription factor;hormone mediated signal transduction;cellular signalling;nucleus	MED7;MED14;MED24;MED6;MED26;VDR;RXRB;MED1;MED12;MED4;MED17;MED13;MED23;MED16	None	"Nuclear receptors such as the steroid and thyroid hormone and vitamins A and D receptors, are known to regulate transcription by binding their cognate lipophilic ligands and subsequently undergoing a conformational change that alters their ability to interact with coregulatory proteins. These coregulatory proteins typically consist of complexes like DRIP that either repress (corepressors) or activate (coactivators) transcription. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
DRIP complex	O43513;O60244;O75448;O75586;O95402;P11473;P28702;Q15648;Q93074;Q9NPJ6;Q9NVC6;Q9UHV7;Q9ULK4;Q9Y2X0	9443;9282;9862;10001;9441;7421;6257;5469;9968;29079;9440;9969;9439;10025	"positive regulation of transcription, DNA-templated;protein acetylation;protein binding;regulation of sequence-specific DNA binding transcription factor activity;hormone-mediated signaling pathway;signaling;nucleus"	"transcription activation;modification by acetylation, deacetylation;protein binding;regulator of transcription factor;hormone mediated signal transduction;cellular signalling;nucleus"	MED7;MED14;MED24;MED6;MED26;VDR;RXRB;MED1;MED12;MED4;MED17;MED13;MED23;MED16	None	"Nuclear receptors such as the steroid and thyroid hormone and vitamins A and D receptors, are known to regulate transcription by binding their cognate lipophilic ligands and subsequently undergoing a conformational change that alters their ability to interact with coregulatory proteins. These coregulatory proteins typically consist of complexes like DRIP that either repress (corepressors) or activate (coactivators) transcription. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
NOS3-CAV1-NOSTRIN complex	P29474;Q03135;Q8IVI9	4846;857;115677	intracellular protein transport;protein targeting;protein transport;plasma membrane	"protein targeting, sorting and translocation;protein transport;eukaryotic plasma membrane / membrane attached"	NOS3;CAV1;NOSTRIN	None	Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN.	None
core-histone (H2A/H2B/H3/H4)-TDIF2-TDT complex	P04053;P62805;P68431;Q16777;Q16778;Q5QJE6	1791;None;None;8338;8349;30836	nucleus;chromatin remodeling;DNA binding	nucleus;DNA binding	DNTT;HIST1H4A;;HIST1H3A;;HIST2H2AC;HIST2H2BE;DNTTIP2	None	The authors propose a dual function for TdIF2 in the N region synthesis. One is the function as an inhibitor of TdT. The other is that of a chromatin remodeling protein.	None
IFNAR1-IFNAR2-IFNB1 complex	P01574;P17181;P48551	3456;3454;3455	None	None	IFNB1;IFNAR1;IFNAR2	None	None	None
RHOA-IP3R-TRPC1 complex	P48995;P61586;Q14643	7220;387;3708	cation transmembrane transporter activity;cation transport;ion channel activity;cellular metal ion homeostasis;plasma membrane	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;homeostasis of metal ions (Na, K, Ca etc.);eukaryotic plasma membrane / membrane attached"	TRPC1;RHOA;ITPR1	None	"Cells were stimulated with thrombin. The authors showed that thrombin stimulation of endothelial cells induced translocation of Rho, and subsequent co-localization of Rho with TRPC1 and IP3R at the plasmalemma."	None
PBAF complex (Polybromo- and BAF containing complex)	O96019;P51532;Q12824;Q68CP9;Q86U86;Q8TAQ2;Q92922;Q92925;Q969G3;Q96GM5	86;6597;6598;196528;55193;6601;6599;6603;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;hormone-mediated signaling pathway;signaling;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;hormone mediated signal transduction;cellular signalling;organization of chromosome structure;chromosome	ACTL6A;SMARCA4;SMARCB1;ARID2;PBRM1;SMARCC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1	None	The chromatin-remodeling complex PBAF facilitates gene activation by assisting transcription machinery to gain access to targets on the chromosome. As additional members of the complex the authors mentioned actin and beta-tubulin.	None
BAF complex	O14497;O96019;P51532;Q12824;Q8TAQ2;Q92922;Q92925;Q969G3;Q96GM5	8289;86;6597;6598;6601;6599;6603;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;chromosome	ARID1A;ACTL6A;SMARCA4;SMARCB1;SMARCC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1	None	None	None
PBAF complex (Polybromo- and BAF containing complex)	O96019;P51532;Q12824;Q68CP9;Q86U86;Q8TAQ2;Q92922;Q969G3;Q96GM5	86;6597;6598;196528;55193;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;hormone-mediated signaling pathway;signaling;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;hormone mediated signal transduction;cellular signalling;organization of chromosome structure;chromosome	ACTL6A;SMARCA4;SMARCB1;ARID2;PBRM1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	None	The chromatin-remodeling complex PBAF facilitates gene activation by assisting transcription machinery to gain access to targets on the chromosome.	None
TRP1-G alpha-11-IP3R3-CAV1 signaling complex	P29992;P48995;Q03135;Q14573	2767;7220;857;3710	cation transmembrane transporter activity;cation transport;ion channel activity;cellular metal ion homeostasis;plasma membrane	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;homeostasis of metal ions (Na, K, Ca etc.);eukaryotic plasma membrane / membrane attached"	GNA11;TRPC1;CAV1;ITPR3	None	The results demonstrate that caveolar microdomains provide a scaffold for  assembly of key Ca(2+) signaling proteins into a complex and  coordination of the molecular interactions leading to the activation of SOC (store-operated Ca(2+) influx).	None
Channel complex TRPM6-TRPM7	Q96QT4;Q9BX84	54822;140803	cation transmembrane transporter activity;cation transport;ion channel activity;plasma membrane	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;eukaryotic plasma membrane / membrane attached"	TRPM7;TRPM6	None	None	None
Decapping complex	P26196;Q6P2E9;Q8IU60;Q96F86;Q9NPI6	1656;23644;167227;80153;55802	regulation of mRNA stability;cytoplasm	control of mRNA stability;cytoplasm	DDX6;EDC4;DCP2;EDC3;DCP1A	None	"Decapping is a key step in mRNA turnover. The decapping complex was found to be localized in cytoplasmic processing bodies (PBs), which are thought to be the sites of mRNA decay."	None
LSm1-7 complex	O15116;P62310;P62312;Q9UK45;Q9Y333;Q9Y4Y9;Q9Y4Z0	27257;27258;11157;51690;57819;23658;25804	regulation of mRNA stability;RNA binding;cytoplasm	control of mRNA stability;RNA binding;cytoplasm	LSM1;LSM3;LSM6;LSM7;LSM2;LSM5;LSM4	None	"The cytoplasmic LSm1-7 complex is involved in mRNA decay. The complex has been shown to accumulate in processing bodies (PBs). The LSm2-8 complex which differs in only one subunit from the LSm1-7 complex is involved in RNA splicing. In contrast to the LSM1-7 complex, recombinant LSm2-8 binds to U6 snRNA in vitro."	None
LSm2-8 complex	O95777;P62310;P62312;Q9UK45;Q9Y333;Q9Y4Y9;Q9Y4Z0	51691;27258;11157;51690;57819;23658;25804	RNA splicing;RNA binding;cytoplasm;nucleus	splicing;RNA binding;cytoplasm;nucleus	LSM8;LSM3;LSM6;LSM7;LSM2;LSM5;LSM4	None	"The LSm2-8 complex which differs in only one subunit from the LSm1-7 complex is involved in RNA splicing. In contrast to the LSM1-7 complex, recombinant LSm2-8 binds to U6 snRNA in vitro."	None
"F1F0-ATP synthase, mitochondrial"	O75947;O75964;P00846;P03928;P05496;P06576;P18859;P24539;P25705;P30049;P36542;P48047;P56134;P56381;P56385;Q9UII2	10476;10632;4508;4509;516;506;522;515;498;513;509;539;9551;514;521;93974	aerobic respiration;respiratory electron transport chain;mitochondrial inner membrane;ATP biosynthetic process;mitochondrial ATP synthesis coupled proton transport	aerobic respiration;regulation of electron transport and membrane-associated energy conservation;electron transport;mitochondrial inner membrane	ATP5H;ATP5L;MT-ATP6;MT-ATP8;ATP5G1;ATP5B;ATP5J;ATP5F1;ATP5A1;ATP5D;ATP5C1;ATP5O;ATP5J2;ATP5E;ATP5I;ATPIF1	None	"F1F0 ATPase is the fifth complex in the respiratory chain.The mammalian complex V consists of 16 different subunits withalpha(3), beta(3), gamma, delta and epsilon comprising the F1 part and a, b, c, d, e, f, g, A6L,OSCP, and coupling factor 6 providing the F0 and stator. Also associated in the complex under some conditions is anintrinsic inhibitor protein IF1."	None
BAF complex	O14497;O96019;P51531;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;86;6595;6598;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;nucleus	ARID1A;ACTL6A;SMARCA2;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify SMARCD and SMARCA, we used isoform SMARCD1 and SMARCA2. At the time of annotation, the additional member BAF110 of the protein complex was not found in the UniProt database."	None	None
PBAF complex (Polybromo- and BAF containing complex)	O96019;P51532;Q12824;Q68CP9;Q86U86;Q8TAQ2;Q92922;Q969G3;Q96GM5	86;6597;6598;196528;55193;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;hormone-mediated signaling pathway;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;hormone mediated signal transduction;organization of chromosome structure;chromosome	ACTL6A;SMARCA4;SMARCB1;ARID2;PBRM1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify SMARCD, we used isoform SMARCD1. At the time of annotation, the additional member BAF110 of the protein complex was not found in the UniProt database."	The chromatin-remodeling complex PBAF facilitates gene activation by assisting transcription machinery to gain access to targets on the chromosome.	None
BAF complex	O14497;O96019;P51532;P60709;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;86;6597;60;6598;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;nucleus	ARID1A;ACTL6A;SMARCA4;ACTB;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify SMARCD, we used isoform SMARCD1."	Beta-actin and BAF53 directly interact with BRG1 in the BAF complex. The actin subunit is required for optimal ATPase activity of BRG1.	None
p300-CBP-p270-SWI/SNF complex	O14497;P51532;Q09472;Q12824;Q8TAQ2;Q92793;Q92922	8289;6597;2033;6598;6601;1387;6599	"DNA topological change;positive regulation of transcription, DNA-templated;protein acetylation;DNA binding;chromosome organization;chromosome"	"DNA conformation modification (e.g. chromatin);transcription activation;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;chromosome"	ARID1A;SMARCA4;EP300;SMARCB1;SMARCC2;CREBBP;SMARCC1	"Several other, not further characterized members of the complex have been isolated: p75,p71,p64,p59 and p50."	None	None
p300-CBP-p270 complex	O14497;Q09472;Q92793	8289;2033;1387	"positive regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription activation;DNA binding;nucleus	ARID1A;EP300;CREBBP	None	None	None
ABIN2-NFKB1-MAP3K8 complex	P19838;P41279;Q8NFZ5	4790;1326;79155	protein stabilization;protein folding;protein binding;intracellular signal transduction	protein folding and stabilization;protein binding;cellular signalling	NFKB1;MAP3K8;TNIP2	None	"The optimal TPL-2 stability in vivo requires interaction with ABIN-2 as well as p105. Together, these data raise the possibility that ABIN-2 functions in the TLR4 signaling pathway which regulates TPL-2 activation."	None
FHL2-p53-HIPK2 complex	P04637;Q14192;Q9H2X6	7157;2274;28996	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	TP53;FHL2;HIPK2	None	None	None
Mi2/NuRD-BCL6-MTA3 complex	O95983;P41182;Q13547;Q14839;Q9BTC8	53615;604;3065;1108;57504	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;B cell differentiation;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;B-cell;nucleus"	MBD3;BCL6;HDAC1;CHD4;MTA3	None	None	None
NuRD.1 complex	O95983;Q09028;Q13330;Q14839;Q16576;Q6IT96;Q92769;Q9BTC8	53615;5928;9112;1108;5931;3065;3066;57504	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;hormone-mediated signaling pathway;signaling;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;hormone mediated signal transduction;cellular signalling;organization of chromosome structure;nucleus"	MBD3;RBBP4;MTA1;CHD4;RBBP7;HDAC1;HDAC2;MTA3	"Several other subunits of the complex were found in the analysis, which have not been further characterized: N190, N170, N160, N140, N135, N130, N85, N75, N68, N66, N38."	None	None
SAP complex (Sin3-associated protein complex)	O75446;Q09028;Q13547;Q16576;Q4LE39;Q92769;Q96ST3;Q9H0E3	8819;5928;3065;5931;51742;3066;25942;79595	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP30;RBBP4;HDAC1;RBBP7;ARID4B;HDAC2;SIN3A;SAP130	"In PMID:12724404, SAP45 has been identified as an additional member of the complex."	None	None
SAP complex (Sin3-associated protein complex)	O75446;Q09028;Q13547;Q16576;Q4LE39;Q92769;Q96ST3;Q9H0E3;Q9H7L9	8819;5928;3065;5931;51742;3066;25942;79595;64426	"DNA topological change;negative regulation of transcription, DNA-templated;chromosome organization;nucleus;protein deacetylation"	"DNA conformation modification (e.g. chromatin);transcription repression;organization of chromosome structure;nucleus;modification by acetylation, deacetylation"	SAP30;RBBP4;HDAC1;RBBP7;ARID4B;HDAC2;SIN3A;SAP130;SUDS3	"SAP45 has been newly identified as a member of the SAP complex. Two other subunits of the complex were found in the analysis, which have not been further characterized: SAP38, SAP28."	None	None
Kv4.2-DPP10 channel complex	Q8N608;Q9NZV8	57628;3751	protein targeting;protein transport;cation transport;ion channel activity;action potential;neuronal action potential propagation;neuronal action potential;plasma membrane	"protein targeting, sorting and translocation;protein transport;cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;regulation, generation and propagation of action potential;eukaryotic plasma membrane / membrane attached"	DPP10;KCND2	None	"This study shows that, similar to DPP6, DPP10 may play a critical part in the assembly of the Kv4 macromolecular complex in the brain and modulate its function."	None
SIN3-HDAC-SAP30-ARID4 complex	O75446;Q09028;Q13547;Q16576;Q4LE39;Q92769;Q96ST3	8819;5928;3065;5931;51742;3066;25942	"DNA topological change;cell cycle arrest;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);cell cycle arrest;transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP30;RBBP4;HDAC1;RBBP7;ARID4B;HDAC2;SIN3A	"Two other subunits of the complex were found in the analysis, which have not been further characterized: SAP38, SAP28."	RBP1 associates with mSIN3-HDAC complex.	None
"TIM (TIM17A, TIM17B, TIM23, TIM44) complex, mitochondrial"	O14925;O43615;O60830;Q99595	100287932;10469;10245;10440	intracellular protein transport;protein targeting;protein transport;mitochondrial inner membrane	"protein targeting, sorting and translocation;protein transport;mitochondrial inner membrane"	TIMM23;TIMM44;TIMM17B;TIMM17A	None	Translocation of nuclear-encoded mitochondrial preproteins is mediated by translocases in the outer (TOM) and inner (TIM)  membranes.	None
MSL complex	Q7Z3B3;Q8N5Y2;Q9H7Z6;Q9HCI7	284058;10943;84148;55167	DNA topological change;protein acetylation;protein deacetylation;nucleus	"DNA conformation modification (e.g. chromatin);modification by acetylation, deacetylation;nucleus"	KANSL1;MSL3;KAT8;MSL2	None	The authors found that reduction in the levels of hMSLs and acetylation of H4 at lysine 16 are correlated with reduced transcription of some genes and with a G2/M cell cycle arrest.	None
CTF18-CTF8-DCC1 complex	P0CG13;Q8WVB6;Q9BVC3	54921;63922;79075	cell cycle;chromosome segregation;nucleus	cell cycle;chromosome segregation/division;nucleus	CHTF8;CHTF18;DSCC1	None	This complex is required for sister chromatid cohesion and loads proliferating cell nuclear antigen onto DNA (PMID:12930902).	None
CTF18-CTF8-DCC1-RFC3 complex	P0CG13;P40938;Q8WVB6;Q9BVC3	54921;5983;63922;79075	protein binding;nucleus	protein binding;nucleus	CHTF8;RFC3;CHTF18;DSCC1	None	None	None
NRD complex (Nucleosome remodeling and deacetylation complex)	O60341;Q09028;Q12873;Q13330;Q13547;Q14839;Q92769	23028;5928;1107;9112;3065;1108;3066	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	KDM1A;RBBP4;CHD3;MTA1;HDAC1;CHD4;HDAC2	None	None	None
"Ubiquitin E3 ligase (SKP1A, SKP2, CUL1)"	P63208;Q13309;Q13616	6500;6502;8454	G1/S transition of mitotic cell cycle;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;nucleus	"G1/S transition of mitotic cell cycle;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);nucleus"	SKP1;SKP2;CUL1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.	None
CASK-LIN7C-APBA1 complex	O14936;Q02410;Q9NUP9	8573;320;55327	intracellular protein transport;protein targeting;protein transport;protein lipidation	"protein targeting, sorting and translocation;protein transport;modification with fatty acids (e.g. myristylation, palmitylation, farnesylation)"	CASK;APBA1;LIN7C	None	This complex may play an important role in the trafficking and processing of APP in neurons.	None
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	"The MRN complex functions as an essential guardian of genome integrity by directing the proper processing of DNA ends, including DNA breaks."	None
MRE11A-RAD50-NBN-TRF2 complex	O60934;P49959;Q15554;Q92878	4683;4361;7014;10111	cell cycle checkpoint;DNA binding;chromosome organization;chromosome	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;organization of chromosome structure;chromosome"	NBN;MRE11A;TERF2;RAD50	None	"Several experiments indicate that TRF2 is not involved in DSB repair. RAD50-MRE11-NBS1 complex functions at telomeres, possibly by modulating t-loop formation."	None
CoREST-HDAC complex	O60341;O75362;Q13547;Q92769;Q96BD5;Q9P0W2;Q9UKL0	23028;7764;3065;3066;51317;10362;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	KDM1A;ZNF217;HDAC1;HDAC2;PHF21A;HMG20B;RCOR1	"RbAp46 and RbAp48 were not identified in this complex, although these proteins have been observed in all previously identified complexes and are thought to be part of an HDAC1/2 core."	None	None
"Ubiquitin E3 ligase (VHL, TCEB1, TCEB2, CUL2)"	P40337;Q13617;Q15369;Q15370	7428;8453;6921;6923	protein ubiquitination;protein catabolic process;cytoplasm;nucleus;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;protein/peptide degradation;cytoplasm;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	VHL;CUL2;TCEB1;TCEB2	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome.	None
"TIM (TIM9, TIM10) complex, mitochondrial"	P62072;Q9Y5J7	26519;26520	intracellular protein transport;protein targeting;protein transport;mitochondrial inner membrane	"protein targeting, sorting and translocation;protein transport;mitochondrial inner membrane"	TIMM10;TIMM9	None	Translocation of nuclear-encoded mitochondrial preproteins is mediated by translocases in the outer (TOM) and inner (TIM) membranes.	None
LSD1-CoREST complex	O60341;Q9UKL0	23028;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	KDM1A;RCOR1	None	CoREST endows LSD1 with the ability to demethylate nucleosomal substrates and protects LSD1 from proteasomal degradation in vivo.	None
LSD1 complex	O60341;O75362;P0DMV8;P0DMV9;Q13363;Q13547;Q92766;Q96BD5;Q96EK2;Q9NP66;Q9P0W2;Q9P2K3;Q9UBW7;Q9UKL0	23028;7764;3303;3304;1487;3065;6239;51317;112885;10363;10362;55758;7750;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	KDM1A;ZNF217;HSPA1A;HSPA1B;CTBP1;HDAC1;RREB1;PHF21A;PHF21B;HMG20A;HMG20B;RCOR3;ZMYM2;RCOR1	"Another subunit of the complex was found in the analysis, which has not been further characterized: Y182."	"CoREST positively regulates LSD1 function, while BHC80 inhibits CoREST/LSD1-mediated demethylation in vitro. These findings suggest that LSD1-mediated histone demethylation is regulated dynamically in vivo."	None
MRN-TRRAP complex (MRE11A-RAD50-NBN-TRRAP complex)	O60934;P49959;Q92878;Q9Y4A5	4683;4361;10111;8295	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50;TRRAP	None	"TRRAP-depleted extracts show a reduced nonhomologous DNA end-joining activity in vitro. TRRAP may function as a molecular link between DSB signaling, repair, and chromatin remodeling."	None
BLM-TRF2 complex	P54132;P62380	641;9519	chromosome organization;cell aging	organization of chromosome structure;cell aging	BLM;TBPL1	The results identify BLM as the first protein found to affect telomeric DNA synthesis specifically in human ALT immortalized cell lines.	None	BLM is involved in Bloom syndrome (BS).
Tacc1-chTOG-AuroraA  complex	O14965;O75410;Q14008	6790;6867;9793	"spindle assembly;centrosome cycle;regulation of translation;chromosome, centromeric region"	spindle pole body/centrosome and microtubule cycle;translational control;centromere / kinetochore	AURKA;TACC1;CKAP5	None	"This complex could be involved in the regulation of mRNA translation, cell division in conjunction and microtubule organization."	This complex may be affected during mammary gland oncogenesis.
Anti-HDAC2 complex	O60341;O94776;P78347;Q09028;Q12873;Q13330;Q13547;Q14202;Q14687;Q14839;Q16576;Q92769;Q96BD5;Q96ST3;Q9P0W2;Q9UBW7;Q9UKL0	23028;9219;2969;5928;1107;9112;3065;9203;23199;1108;5931;3066;51317;25942;10362;7750;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	KDM1A;MTA2;GTF2I;RBBP4;CHD3;MTA1;HDAC1;ZMYM3;GSE1;CHD4;RBBP7;HDAC2;PHF21A;SIN3A;HMG20B;ZMYM2;RCOR1	"Since the authors did not specify SIN3, we used isoform SIN3A."	None	XFIM (ZMYM3) is involved in X-linked mental retardation.
anti-BHC110 complex	O60341;O75362;P78347;Q13547;Q14202;Q14687;Q92769;Q96BD5;Q9P0W2;Q9UBW7;Q9UKL0	23028;7764;2969;3065;9203;23199;3066;51317;10362;7750;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	KDM1A;ZNF217;GTF2I;HDAC1;ZMYM3;GSE1;HDAC2;PHF21A;HMG20B;ZMYM2;RCOR1	None	None	XFIM (ZMYM3) is involved in X-linked mental retardation.
XFIM complex	O60341;P78347;Q13547;Q14202;Q92769	23028;2969;3065;9203;3066	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	KDM1A;GTF2I;HDAC1;ZMYM3;HDAC2	None	None	XFIM (ZMYM3) is involved in X-linked mental retardation.
AGPS-GNPAT complex	O00116;O15228	8540;8443	isoprenoid metabolic process;fatty acid biosynthetic process;isoprenoid biosynthetic process;fatty acid catabolic process;lipid catabolic process;isoprenoid catabolic process;lipid metabolic process;fatty acid metabolic process;lipid biosynthetic process;peroxisome	"lipid, fatty acid and isoprenoid metabolism;fatty acid metabolism;isoprenoid metabolism;peroxisome"	AGPS;GNPAT	None	None	None
BHC complex	O60341;Q13547;Q92769;Q96BD5;Q9P0W2;Q9UKL0	23028;3065;3066;51317;10362;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;neuron differentiation;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;neuron;nucleus"	KDM1A;HDAC1;HDAC2;PHF21A;HMG20B;RCOR1	None	The BHC complex mediates repression of neuron-specific genes.	None
RANBPM-Muskelin-TWA1-HSMpp8 complex	Q96S59;Q99549;Q9NWU2;Q9UL63	10048;54737;54994;4289	protein binding;microtubule cytoskeleton organization;cytoplasm	protein binding;microtubule cytoskeleton;cytoplasm	RANBP9;MPHOSPH8;GID8;MKLN1	None	This complex might play a role  in RanGTPase cycle.	None
RANBPM-SMP1 complex	O95807;Q96S59	23585;10048	gamete generation;cytoplasm	gametogenesis;cytoplasm	TMEM50A;RANBP9	None	This complex may be involved in the process of male germ cell differentiation.	None
CtBP complex	O00257;O60315;O60341;O75362;P37275;P56545;Q13363;Q13547;Q92618;Q92766;Q92769;Q96JN0;Q96KQ7;Q9H9B1;Q9P2K3;Q9UKL0;Q9Y232	8535;9839;23028;7764;6935;1488;1487;3065;9658;6239;3066;84458;10919;79813;55758;23186;9425	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	CBX4;ZEB2;KDM1A;ZNF217;ZEB1;CTBP2;CTBP1;HDAC1;ZNF516;RREB1;HDAC2;LCOR;EHMT2;EHMT1;RCOR3;RCOR1;CDYL	None	None	CtBP is implicated in tumorigenesis.
CtBP core complex	O60341;P37275;P56545;Q13363;Q13547;Q92769;Q96KQ7;Q9H9B1;Q9UKL0	23028;6935;1488;1487;3065;3066;10919;79813;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	KDM1A;ZEB1;CTBP2;CTBP1;HDAC1;HDAC2;EHMT2;EHMT1;RCOR1	None	None	CtBP is implicated in tumorigenesis.
ASPP1-SAM68 complex	Q07666;Q96KQ4	10657;23368	RNA splicing;nucleus	splicing;nucleus	KHDRBS1;PPP1R13B	None	The authors suggest that the interaction of ASPP1 with nuclear SAM68 is spatially restricted to human spermatogenesis.	None
HDAC1-associated protein complex	O60341;O94776;O95983;Q09028;Q12873;Q13547;Q16576;Q9UBB5;Q9UKL0	23028;9219;53615;5928;1107;3065;5931;8932;23186	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	KDM1A;MTA2;MBD3;RBBP4;CHD3;HDAC1;RBBP7;MBD2;RCOR1	None	None	None
HDAC1-associated core complex cI	O60341;Q13547;Q9UKL0	23028;3065;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	KDM1A;HDAC1;RCOR1	"Another subunit of the complex was found in the analysis, which has not been further characterized: p37."	None	None
HDAC1-associated core complex cII	O94776;O95983;Q09028;Q12873;Q13547;Q16576;Q86YP4;Q9UBB5;Q9UKL0	9219;53615;5928;1107;3065;5931;54815;8932;23186	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	MTA2;MBD3;RBBP4;CHD3;HDAC1;RBBP7;GATAD2A;MBD2;RCOR1	"Since the authors did not specify GATAD2, we used isoform GATAD2A."	None	None
HDAC2-asscociated core complex	O94776;O95983;Q09028;Q12873;Q16576;Q86YP4;Q92769	9219;53615;5928;1107;5931;54815;3066	"DNA topological change;negative regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus;histone deacetylation"	"DNA conformation modification (e.g. chromatin);transcription repression;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	MTA2;MBD3;RBBP4;CHD3;RBBP7;GATAD2A;HDAC2	"Since the authors did not specify GATAD2, we used isoform GATAD2A."	None	None
AP3-BLOC1 complex	O00203;O14617;O95295;P53677;P59780;P78537;Q13367;Q6QNY0;Q6QNY1;Q8TDH9;Q92572;Q96EV8;Q9NUP1;Q9UL45;Q9Y2T2	8546;8943;23557;10947;10239;2647;8120;388552;282991;63915;1176;84062;55330;26258;26985	None	None	AP3B1;AP3D1;SNAPIN;AP3M2;AP3S2;BLOC1S1;AP3B2;BLOC1S3;BLOC1S2;BLOC1S5;AP3S1;DTNBP1;BLOC1S4;BLOC1S6;AP3M1	None	BLOC-1 interacts physically and functionally with AP-3 to facilitate the trafficking of a known AP-3 cargo.	None
BLOC1-BLOC2 complex	O95295;P78537;Q6QNY0;Q6QNY1;Q86YV9;Q8TDH9;Q969F9;Q96EV8;Q9NUP1;Q9UL45;Q9UPZ3	23557;2647;388552;282991;79803;63915;84343;84062;55330;26258;11234	intracellular protein transport;protein targeting;protein transport;endosome	"protein targeting, sorting and translocation;protein transport;endosome"	SNAPIN;BLOC1S1;BLOC1S3;BLOC1S2;HPS6;BLOC1S5;HPS3;DTNBP1;BLOC1S4;BLOC1S6;HPS5	None	BLOC-1 interacts with BLOC-2 to facilitate Tyrp1 trafficking by a mechanism apparently independent of AP-3 function.	None
HSF1-HSF2 complex	Q00613;Q03933	3297;3298	protein binding	protein binding	HSF1;HSF2	None	None	None
VPS35-VPS29-VPS26A complex	O75436;Q96QK1;Q9UBQ0	9559;55737;51699	intracellular protein transport;protein targeting;protein transport	"protein targeting, sorting and translocation;protein transport"	VPS26A;VPS35;VPS29	None	None	None
"Retromer complex (SNX1, SNX2, VPS35, VPS29, VPS26A)"	O60749;O75436;Q13596;Q96QK1;Q9UBQ0	6643;9559;6642;55737;51699	"intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport;synaptic vesicle recycling;retrograde transport, vesicle recycling within Golgi"	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.);vesicle recycling;retrograde transport"	SNX2;VPS26A;SNX1;VPS35;VPS29	None	None	None
MeCP1 complex	O94776;O95983;Q09028;Q13547;Q14839;Q16576;Q8WXI9;Q92769;Q9UBB5	9219;53615;5928;3065;1108;5931;57459;3066;8932	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	MTA2;MBD3;RBBP4;HDAC1;CHD4;RBBP7;GATAD2B;HDAC2;MBD2	None	"MeCP1 protein complex represses transcription through preferential binding, remodeling, and deacetylation of methylated nucleosomes."	CHD4 is involved in dermatomyositis (PMID:9790534).
BKCA-beta2AR-AKAP79 signaling complex	P07550;P24588;Q12791	154;9495;3778	cation transmembrane transporter activity;cation transport;ion channel activity;G-protein coupled receptor signaling pathway;response to stimulus;smooth muscle contraction	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;G-protein coupled receptor signalling pathway;animal specific systemic sensing and response;smooth muscle contraction"	ADRB2;AKAP5;KCNMA1	None	"BKCa is preferentially regulated by beta2AR within the channel macromolecular complex. Only expression of all three components of the complex reconstituted full-beta2 agonist modulation of the channel.  The ability of beta2AR to form a complex with BKCa, and concomitantly bind phosphorylation-modulatory components (AKAP79/150) enables specific and local regulation of BKCa channels and defines a signal transduction pathway governing cellular excitability in diverse tissues."	None
BKCA-beta2AR complex	P07550;Q12791	154;3778	cation transmembrane transporter activity;cation transport;ion channel activity;G-protein coupled receptor signaling pathway;response to stimulus	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;G-protein coupled receptor signalling pathway;animal specific systemic sensing and response"	ADRB2;KCNMA1	None	None	None
GINS complex	Q14691;Q9BRT9;Q9BRX5;Q9Y248	9837;84296;64785;51659	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;nucleus	ori recognition and priming complex formation;nucleus	GINS1;GINS4;GINS3;GINS2	None	This complex stimulates DNA polymerase alpha-primase.	None
RANBMP-CD39 complex	P43487;P49961	5902;953	enzyme regulator activity;regulation of catalytic activity;plasma membrane	enzymatic activity regulation / enzyme regulator;eukaryotic plasma membrane / membrane attached	RANBP1;ENTPD1	None	"NTPDase activity of recombinant CD39, but not of N-terminus-deleted-CD39 mutant, is substantially diminished by RanBPM co-expression in COS-7 cells.CD39 associations with RanBPM have the potential to regulate NTPDase catalytic activity."	None
C-CFTR-NHERF-ezrin complex	O14745;P13569;P15311	9368;1080;7430	chloride transport;ion channel activity;plasma membrane;cytoskeleton	chloride transport;ion channels;eukaryotic plasma membrane / membrane attached;cytoskeleton	SLC9A3R1;CFTR;EZR	Gel filtration experiments show that the fraction eluted at 11.3 ml is a ternary complex with C-CFTR bound to the first PDZ domain of the binary NHERF\u00b7ezFERM complex.	"There are two types of 1:1:1 ternary complexes formed between C-CFTR and NHERF\u00b7ezFERM. Ezrin is a regulator that can positively control the cooperative binding of NHERF with the cytoplasmic domains of CFTR, thus modulating the stoichiometry of C-CFTR to NHERF interaction. The regulation of NHERF by ezrin may be employed as a general mechanism to assemble channels and receptors in the membrane cytoskeleton."	CFTR is involved in cystic fibrosis (PMID:10811849).
PAX9-MSX1 complex	P28360;P55771	4487;5083	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;odontogenesis"	transcriptional control;odontogenesis	MSX1;PAX9	None	None	PAX9 is involved  in tooth agenesis. The results indicate a functional relationship between Pax9 and Msx1 during tooth development.
MeCP1 complex	O94776;O95983;Q09028;Q13547;Q14839;Q16576;Q8WXI9;Q92769;Q9UBB5	9219;53615;5928;3065;1108;5931;57459;3066;8932	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	MTA2;MBD3;RBBP4;HDAC1;CHD4;RBBP7;GATAD2B;HDAC2;MBD2	None	"MeCP1 protein complex represses transcription through preferential binding, remodeling, and deacetylation of methylated nucleosomes."	CHD4 is involved in dermatomyositis (PMID:9790534).
CFTR-NHERF-beta(2)AR signaling complex	O14745;P07550;P13569	9368;154;1080	chloride transport;ion channel activity;signaling;plasma membrane	chloride transport;ion channels;cellular signalling;eukaryotic plasma membrane / membrane attached	SLC9A3R1;ADRB2;CFTR	None	The results indicate that PDZ-based interactions with ezrin/radixin/moesin-binding phosphoprotein 50 (EBP50) govern both physical and functional regulation of CFTR by beta (2) AR. Assembly of the complex is regulated by PKA-dependent phosphorylation.	CFTR is involved in cystic fibrosis (PMID:10811849).
SIN3-SAP25 complex	O00422;O75446;Q09028;Q13547;Q16576;Q4LE39;Q8TEE9;Q92769;Q96ST3;Q9H0E3;Q9H7L9	10284;8819;5928;3065;5931;51742;100316904;3066;25942;79595;64426	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP18;SAP30;RBBP4;HDAC1;RBBP7;ARID4B;SAP25;HDAC2;SIN3A;SAP130;SUDS3	None	None	None
SIN3-HDAC-SAP30-ARID4 complex	O75446;Q09028;Q13547;Q16576;Q4LE39;Q92769;Q96ST3	8819;5928;3065;5931;51742;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;protein binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;protein binding;organization of chromosome structure;nucleus"	SAP30;RBBP4;HDAC1;RBBP7;ARID4B;HDAC2;SIN3A	"Another subunit of the complex was found in the analysis, which has not been further characterized: SAP250."	None	None
BRMS1-SIN3-HDAC complex	O75182;O75446;Q09028;Q13547;Q16576;Q92769;Q96ST3;Q9HCU9	23309;8819;5928;3065;5931;3066;25942;25855	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SIN3B;SAP30;RBBP4;HDAC1;RBBP7;HDAC2;SIN3A;BRMS1	None	BRMS1 may participate in transcriptional regulation via interaction with the Sin3-HDAC complex and suggest a novel mechanism by which BRMS1 might suppress cancer metastasis.	None
BRMS1-RBP1 complex	Q4LE39;Q9HCU9	51742;25855	"negative regulation of transcription, DNA-templated;nucleus"	transcription repression;nucleus	ARID4B;BRMS1	None	BRMS1 may participate in transcriptional regulation via interaction with the mSin3.HDAC complex and suggest a novel mechanism by which BRMS1 might suppress cancer metastasis.	None
SIN3-HDAC-SAP30-ARID4 complex	O75446;Q09028;Q13547;Q16576;Q4LE39;Q92769;Q96ST3	8819;5928;3065;5931;51742;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP30;RBBP4;HDAC1;RBBP7;ARID4B;HDAC2;SIN3A	None	SAP30 is involved in the functional recruitment of the mSin3-histone deacetylase complex to a specific subset of N-CoR corepressor complexes.	None
ARD1-NATH complex	P36406;Q9BXJ9	373;80155	regulation of translation;protein binding;nucleus	translational control;protein binding;nucleus	TRIM23;NAA15	None	None	None
"SNARE complex (RINT1, ZW10, p31)"	O43264;P48556;Q6NUQ1	9183;5714;60561	mitotic cell cycle;regulation of cell cycle;ER to Golgi vesicle-mediated transport;vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis;endoplasmic reticulum	mitotic cell cycle;mitotic cell cycle and cell cycle control;ER to Golgi transport;vesicle fusion;synaptic vesicle exocytosis;endoplasmic reticulum	ZW10;PSMD8;RINT1	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway. ZW10 is known to participate directly in turning off the spindle checkpoint.  The present results display an unexpected role  in membrane trafficking between ER and Golgi during interphase.	None
"SNARE complex (HGS, SNAP25, STX13)"	O14964;P60880;Q86Y82	9146;6616;23673	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis;endosome	vesicle fusion;synaptic vesicle exocytosis;endosome	HGS;SNAP25;STX12	"STX12 and STX13 are identical (see GeneID:23673): ""STX12 syntaxin 12 (Homo sapiens) Also known as STX13; STX14; MGC51957""."	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP2, SNAP25, STX13)"	P60880;P63027;Q86Y82	6616;6844;23673	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP25;VAMP2;STX12	"STX12 and STX13 are identical (see GeneID:23673): ""STX12 syntaxin 12 (Homo sapiens) Also known as STX13; STX14; MGC51957""."	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
Brg1-associated complex I	O14497;O14744;O96019;P51532;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;10419;86;6597;6598;6601;6599;6605;6602	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;DNA binding;organization of chromosome structure;nucleus	ARID1A;PRMT5;ACTL6A;SMARCA4;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"In a following paper (PMID:14559996) p66 has been identified as PRMT5. Since the authors did not specify SMARCD, we used isoform SMARCD1."	None	None
Brm-associated complex	O14497;O14744;O96019;P51531;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;10419;86;6595;6598;6601;6599;6605;6602	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	ARID1A;PRMT5;ACTL6A;SMARCA2;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"In a following paper (PMID:14559996) p66 has been identified as PRMT5. Since the authors did not specify SMARCD, we used isoform SMARCD1."	None	None
BRG1-SIN3A complex	O14497;O14744;O96019;P51532;Q09028;Q12824;Q6STE5;Q8TAQ2;Q92769;Q92922;Q92925;Q969G3;Q96GM5;Q96ST3	8289;10419;86;6597;5928;6598;6604;6601;3066;6599;6603;6605;6602;25942	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	ARID1A;PRMT5;ACTL6A;SMARCA4;RBBP4;SMARCB1;SMARCD3;SMARCC2;HDAC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1;SIN3A	None	"Components of the Sin3 complex cofractionate with BRG1-associated complex I, but not with BRG1-associated complex II."	None
BRM-SIN3A complex	O14497;O14744;O96019;P51531;Q09028;Q12824;Q13547;Q6STE5;Q8TAQ2;Q92769;Q92922;Q92925;Q969G3;Q96GM5;Q96ST3	8289;10419;86;6595;5928;6598;3065;6604;6601;3066;6599;6603;6605;6602;25942	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	ARID1A;PRMT5;ACTL6A;SMARCA2;RBBP4;SMARCB1;HDAC1;SMARCD3;SMARCC2;HDAC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1;SIN3A	None	Components of the Sin3 complex cofractionate with BRM-associated complex.	None
PU.1-SIN3A-HDAC complex	P17947;Q13547;Q96ST3	6688;3065;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;nucleus"	SPI1;HDAC1;SIN3A	None	None	None
PU.1-TBP complex	P17947;P20226	6688;6908	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	SPI1;TBP	None	None	None
MRG15-PAM14-RB complex	P06400;Q9UBU8;Q9Y605	5925;10933;93621	"positive regulation of transcription, DNA-templated;cell aging;nucleus"	transcription activation;cell aging;nucleus	RB1;MORF4L1;MRFAP1	None	"MRG15 blocks the RB-induced repression of this promotor, leading to transcription activation."	None
MRG15-PAM14-RB complex	P06400;Q9UBU8;Q9Y605	5925;10933;93621	"positive regulation of transcription, DNA-templated;cell aging;nucleus"	transcription activation;cell aging;nucleus	RB1;MORF4L1;MRFAP1	None	None	None
MAF2 complex	Q9H7Z6;Q9UBU8	84148;10933	"positive regulation of transcription, DNA-templated;protein acetylation;cell aging;nucleus"	"transcription activation;modification by acetylation, deacetylation;cell aging;nucleus"	KAT8;MORF4L1	None	None	None
P2X7 receptor signalling complex	O43707;O95425;P05107;P08238;P0DMV8;P11142;P23467;P42356;P60709;Q13368;Q16787;Q99572	81;6840;3689;3326;3303;3312;5787;5297;60;4356;3909;5027	ion transport;ion channel activity;cell surface receptor signaling pathway;cytoskeleton organization;plasma membrane	ion transport;ion channels;transmembrane signal transduction;cytoskeleton/structural proteins;eukaryotic plasma membrane / membrane attached	ACTN4;SVIL;ITGB2;HSP90AB1;HSPA1A;HSPA8;PTPRB;PI4KA;ACTB;MPP3;LAMA3;P2RX7	"Since the authors did not specify HSP70, we used isoform HSPA1A."	None	None
DDB2 complex	P61201;P62877;Q13098;Q13619;Q16531;Q7L5N1;Q92466;Q92905;Q99627;Q9BT78;Q9UBW8;Q9UNS2	9318;9978;2873;8451;1642;10980;1643;10987;10920;51138;50813;8533	DNA repair;protein ubiquitination;DNA binding;cellular response to DNA damage stimulus;nucleus;ubiquitin-dependent protein catabolic process	"DNA repair;modification by ubiquitination, deubiquitination;DNA binding;DNA damage response;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	COPS2;RBX1;GPS1;CUL4A;DDB1;COPS6;DDB2;COPS5;COPS8;COPS4;COPS7A;COPS3	"Since the authors did not specify COPS7, we used isoform COPS7A."	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Results suggest that the distinct UV response of the DDB2 and CSA complexes is involved in diverse mechanisms of nucleotide excision repair (NER). The DDB2 complex binds to DNA after UV irradiation.	None
CSA complex	P61201;P62877;Q13098;Q13216;Q13619;Q16531;Q7L5N1;Q92905;Q99627;Q9BT78;Q9UBW8;Q9UNS2	9318;9978;2873;1161;8451;1642;10980;10987;10920;51138;50813;8533	DNA repair;protein ubiquitination;protein binding;cellular response to DNA damage stimulus;nucleus;ubiquitin-dependent protein catabolic process	"DNA repair;modification by ubiquitination, deubiquitination;protein binding;DNA damage response;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	COPS2;RBX1;GPS1;ERCC8;CUL4A;DDB1;COPS6;COPS5;COPS8;COPS4;COPS7A;COPS3	"Since the authors did not specify COPS7, we used isoform COPS7A."	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Results suggest that the distinct UV response of the DDB2 and CSA complexes is involved in diverse mechanisms of nucleotide excision repair (NER). The CSA complex does not bind to DNA, regardless of UV damage."	None
CSA-POLIIa complex	P24928;P61201;P62877;Q13098;Q13216;Q13619;Q16531;Q7L5N1;Q92905;Q99627;Q9BT78;Q9UBW8;Q9UNS2	5430;9318;9978;2873;1161;8451;1642;10980;10987;10920;51138;50813;8533	DNA repair;mRNA transcription;protein ubiquitination;cellular response to DNA damage stimulus;nucleus;ubiquitin-dependent protein catabolic process	"DNA repair;mRNA synthesis;modification by ubiquitination, deubiquitination;DNA damage response;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	POLR2A;COPS2;RBX1;GPS1;ERCC8;CUL4A;DDB1;COPS6;COPS5;COPS8;COPS4;COPS7A;COPS3	"Since the authors did not specify COPS7, we used isoform COPS7A."	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. This complex has been purified from UV-irradiated cells. Results suggest that the distinct UV response of the DDB2 and CSA complexes is involved in diverse mechanisms of nucleotide excision repair (NER).	None
"Ubiquitin E3 ligase (FBXO31, SKP1A, CUL1, RBX1)"	P62877;P63208;Q13616;Q5XUX0	9978;6500;8454;79791	mitotic cell cycle;protein ubiquitination;protein catabolic process;cell aging;ubiquitin-dependent protein catabolic process	"mitotic cell cycle;modification by ubiquitination, deubiquitination;protein/peptide degradation;cell aging;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;SKP1;CUL1;FBXO31	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex."	None
"SNARE complex (STX4, SNAP23, VAMP1)"	O00161;P23763;Q12846	8773;6843;6810	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP23;VAMP1;STX4	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (STX4, SNAP23, VAMP2)"	O00161;P63027;Q12846	8773;6844;6810	vesicle fusion;exocytosis	vesicle fusion;exocytosis	SNAP23;VAMP2;STX4	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
SIN3 complex	O00422;O75446;Q09028;Q13547;Q16576;Q92769;Q96ST3	10284;8819;5928;3065;5931;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;nucleus"	SAP18;SAP30;RBBP4;HDAC1;RBBP7;HDAC2;SIN3A	None	None	None
"SNARE complex (STX4, VAMP1, VAMP7)"	P23763;P51809;Q12846	6843;6845;6810	vesicle fusion;exocytosis	vesicle fusion;exocytosis	VAMP1;VAMP7;STX4	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
SIN3-ING1b complex I	O00422;O75446;Q09028;Q13547;Q16576;Q4LE39;Q92769;Q96ST3;Q9UK53	10284;8819;5928;3065;5931;51742;3066;25942;3621	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP18;SAP30;RBBP4;HDAC1;RBBP7;ARID4B;HDAC2;SIN3A;ING1	None	SAP30 is a specific component of Sin3 complexes since it is absent in other HDAC1/2-containing complexes such as NuRD.	None
SIN3-ING1b complex II	O00422;O14497;O75446;O96019;P51532;Q09028;Q12824;Q13547;Q16576;Q4LE39;Q8TAQ2;Q92769;Q92922;Q96GM5;Q96ST3;Q9UK53	10284;8289;8819;86;6597;5928;6598;3065;5931;51742;6601;3066;6599;6602;25942;3621	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;regulation of sequence-specific DNA binding transcription factor activity;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;regulator of transcription factor;organization of chromosome structure;nucleus"	SAP18;ARID1A;SAP30;ACTL6A;SMARCA4;RBBP4;SMARCB1;HDAC1;RBBP7;ARID4B;SMARCC2;HDAC2;SMARCC1;SMARCD1;SIN3A;ING1	None	SAP30 is a specific component of Sin3 complexes since it is absent in other HDAC1/2-containing complexes such as NuRD.	None
"Exon junction complex (EIF4A3, MLN51, MAGOH, Y14)"	O15234;P38919;P61326;Q9Y5S9	22794;9775;4116;9939	regulation of mRNA stability;regulation of translation;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	control of mRNA stability;translational control;RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	CASC3;EIF4A3;MAGOH;RBM8A	None	This protein complex remains stably bound to the mRNA through different cellular environments. Magoh and Y14 form a tight heterodimer. The authors propose a that eIF4AIII interacts with Y14:Magoh to enforce a compact arrangement of eIF4AIII's two domains and allow MLN51 to interact with both eIF4AIII and the RNA.	None
NCOR-HDAC3 complex	O15379;O60907;O75376;Q13227;Q9BZK7	8841;6907;9611;2874;79718	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein deacetylation;JNK cascade;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;modification by acetylation, deacetylation;JNK cascade;organization of chromosome structure;nucleus"	HDAC3;TBL1X;NCOR1;GPS2;TBL1XR1	None	N-CoR-HDAC3 complex inhibits JNK activation through the associated GPS2 subunit and thus could potentially provide an alternative mechanism for hormone-mediated antagonism of AP-1 function.	None
"eIF3 complex (EIF3S6, EIF3S5, EIF3S4, EIF3S3, EIF3S6IP, EIF3S2, EIF3S9, EIF3S12,  EIF3S10, EIF3S8,  EIF3S1, EIF3S7)"	O00303;O15371;O15372;O75821;O75822;P55884;P60228;Q13347;Q14152;Q99613;Q9UBQ5;Q9Y262	8665;8664;8667;8666;8669;8662;3646;8668;8661;8663;27335;51386	translational initiation	translation initiation	EIF3F;EIF3D;EIF3H;EIF3G;EIF3J;EIF3B;EIF3E;EIF3I;EIF3A;EIF3C;EIF3K;EIF3L	None	None	None
SIN3-SAP25 complex	O00422;O75446;Q09028;Q13547;Q16576;Q1EHW4;Q4LE39;Q92769;Q96ST3;Q9H0E3;Q9H7L9	10284;8819;5928;3065;5931;751865;51742;3066;25942;79595;64426	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	SAP18;SAP30;RBBP4;HDAC1;RBBP7;Sap25;ARID4B;HDAC2;SIN3A;SAP130;SUDS3	"Since human SAP25 was not available in the UniProt database at the time of annotation, the orthologous protein from mouse was used."	SAP25 binds to the PAH1 domain of SIN3A.	None
"Exon junction complex (EIF4A3, MLN51, MAGOH, Y14)"	O15234;P38919;P61326;Q9Y5S9	22794;9775;4116;9939	regulation of mRNA stability;regulation of translation;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	control of mRNA stability;translational control;RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	CASC3;EIF4A3;MAGOH;RBM8A	None	"The experiments demonstrate that eIF4AIII, MLN51, and Magoh:Y14 are able to form a stable tetrameric complex when co-expressed in vivo. Both eIF4AIII and MLN51 are required for the stable association of either with the Magoh:Y14 heterodimer."	None
NCOR-SIN3-RPD3 complex	O75182;Q92769;Q96ST3;Q9Y618	23309;3066;25942;9612	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein deacetylation;hormone-mediated signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;modification by acetylation, deacetylation;hormone mediated signal transduction;organization of chromosome structure;nucleus"	SIN3B;HDAC2;SIN3A;NCOR2	None	The authors predict that the ligand-induced switch of heterodimeric nuclear receptors from repressor to activator functions involves the exchange of complexes containing histone deacetylases with those that have histone acetylase activity.	None
C/EBPalpha-HNF6 complex	P49715;Q9UBC0	1050;3175	"positive regulation of transcription, DNA-templated;nucleus"	transcription activation;nucleus	CEBPA;ONECUT1	None	Formation of the C/EBPalpha-HNF6 protein complex required the HNF6 cut domain and the C/EBPalpha activation domain (AD) 1/AD2 sequences. The C/EBPalpha-HNF6 protein complex stimulates recruitment of the CBP coactivator protein for expression of Foxa2.	None
NCOR-SIN3-HDAC1 complex	Q13547;Q96ST3;Q9Y618	3065;25942;9612	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein deacetylation;hormone-mediated signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;modification by acetylation, deacetylation;hormone mediated signal transduction;organization of chromosome structure;nucleus"	HDAC1;SIN3A;NCOR2	None	N-CoR directly interact with mSin3A.	None
TRAF6-TAK1 complex	O43318;Q9Y4K3	6885;7189	transmembrane receptor protein serine/threonine kinase signaling pathway	transmembrane receptor protein serine/threonine kinase signalling pathways	MAP3K7;TRAF6	None	"During IL-1 signaling cascade a complex consisting of TRAF6, TAK1, TAB1, TAB2, and the two ubiquitin ligases Uev1A and Ubc13 is formed, phosphorylating TRAF6 and subsequently TAK1. TAK1 activation leads to activation of both NF{kappa}B and the MAPKs, followed by gene transcription. SOCS-3 (suppressor of cytokine signaling-3) inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."	None
MeCP2-SIN3A-HDAC complex	P51608;Q13547;Q92769;Q96ST3	4204;3065;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;embryo development ending in birth or egg hatching;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;early embryogenesis;organization of chromosome structure;nucleus"	MECP2;HDAC1;HDAC2;SIN3A	None	"MeCp binds specifically to methylated DNA, thus linking two global mechanisms of gene regulation, DNA methylation and histone deacetylation."	None
SMRT core complex	O15379;O60907;Q9Y618	8841;6907;9612	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;hormone-mediated signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;hormone mediated signal transduction;organization of chromosome structure;nucleus"	HDAC3;TBL1X;NCOR2	"Another subunit of the complex was found in the analysis, which has not been further characterized: SMRT-p37."	None	TBL1 is involved in deafness.
UTM-SGCE-DAG1-CAV1-NOS3 complex	O43556;P29474;P46939;Q03135;Q14118	8910;4846;7402;857;1605	enzyme regulator activity;regulation of catalytic activity;establishment of endothelial barrier	enzymatic activity regulation / enzyme regulator	SGCE;NOS3;UTRN;CAV1;DAG1	None	The authors propose that this utrophin associated protein complex (UAPC) in human umbilical vein endothelial cells (HUVECs) may play an important role in the regulation of vascular tone.	None
"Exon junction complex (EIF4A3, MLN51, UPF3B, MAGOH, Y14)"	O15234;P38919;P61326;Q0VAK7;Q9Y5S9	22794;9775;4116;65109;9939	regulation of mRNA stability;regulation of translation;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	control of mRNA stability;translational control;RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	CASC3;EIF4A3;MAGOH;UPF3B;RBM8A	None	None	None
"Exon junction complex (EIF4A3, MLN51, UPF3B, MAGOH, Y14, PYM)"	O15234;P38919;P61326;Q0VAK7;Q9BRP8;Q9Y5S9	22794;9775;4116;65109;84305;9939	regulation of mRNA stability;regulation of translation;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	control of mRNA stability;translational control;RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	CASC3;EIF4A3;MAGOH;UPF3B;PYM1;RBM8A	None	None	None
Prune-Gelsolin complex	P06396;Q86TP1	2934;58497	cell migration	cell migration	GSN;PRUNE	None	None	None
Prune-GSK3beta complex	P49841;Q86TP1	2932;58497	cell migration	cell migration	GSK3B;PRUNE	None	None	None
Prune/Nm23-H1 complex	P15531;Q86TP1	4830;58497	movement of cell or subcellular component	cell motility	NME1;PRUNE	None	None	None
"Apoptosis- and splicing-associated protein complex (ASAP-L), SAP18, RNPS1, Acinus-L"	O00422;Q15287;Q9UKV3	10284;10921;22985	"mRNA splicing, via spliceosome;mRNA processing;apoptotic process;nucleus"	"mRNA processing (splicing, 5'-, 3'-end processing);apoptosis (type I programmed cell death);nucleus"	SAP18;RNPS1;ACIN1	None	In vitro splicing assays suggest that the ASAP complexes function to repress splicing in vitro and that the ability of RNPS1 (and possibly Acinus-L) to activate splicing is overcome both when it is a component of ASAP and in the presence of the intact complex. In vitro assays using an apoptotic extract strongly indicate that ASAP complexes disassemble during apoptosis.	None
Y14-Magoh complex	P61326;Q9Y5S9	4116;9939	"mRNA splicing, via spliceosome;mRNA processing;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus"	"mRNA processing (splicing, 5'-, 3'-end processing);RNA transport;nuclear transport;cytoplasm;nucleus"	MAGOH;RBM8A	None	Y14 and Magoh form an extremely stable heterodimer. Magoh binds with high affinity to the RNP motif RNA binding domain (RBD) of Y14 and completely masks its RNA binding surface.	None
Dysferlin-affixin complex	O75923;Q9HBI1	8291;29780	plasma membrane organization;skeletal muscle tissue development;striated muscle tissue development	eukaryotic plasma membrane;myogenesis;striated muscle	DYSF;PARVB	None	The results suggest that affixin may participate in membrane repair with dysferlin.	DYSF is involved in Miyoshi myopathy (MM) and limb girdle muscular dystrophy type 2B (LGMD2B).
"Exon junction complex (EIF4A3, MLN51, MAGOH, Y14)"	O15234;P38919;P61326;Q9Y5S9	22794;9775;4116;9939	regulation of mRNA stability;regulation of translation;RNA binding;ATP binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	control of mRNA stability;translational control;RNA binding;ATP binding;RNA transport;nuclear transport;cytoplasm;nucleus	CASC3;EIF4A3;MAGOH;RBM8A	None	"The DEAD-box protein eIF4AIII encloses an ATP molecule and provides the binding sites for six ribonucleotides. Btz wraps around eIF4AIII and stacks against the 5' nucleotide. An intertwined network of interactions anchors Mago-Y14 and Btz at the interface between the two domains of eIF4AIII, effectively stabilizing the ATP bound state."	None
TREX complex	Q13769;Q13838;Q6I9Y2;Q86V81;Q86W42;Q8NI27;Q96FV9;Q96J01	8563;7919;80145;10189;79228;57187;9984;84321	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nuclear matrix;nuclear speck	RNA binding;RNA transport;nuclear transport;nuclear matrix;nuclear speckles	THOC5;DDX39B;THOC7;ALYREF;THOC6;THOC2;THOC1;THOC3	None	The TREX complex is recruited by the CBC complex to the 5-prime end of spliced RNAs and is involved in RNA export from the nucleus into the cytoplasm. The TREX complex contains the THO transcription elongation complex.	None
NDPKA-AMPKalpha1 complex	P15531;Q13131	4830;5562	protein binding;cytoplasm	protein binding;cytoplasm	NME1;PRKAA1	None	None	None
EIF4A3-MLN51 complex	O15234;P38919	22794;9775	regulation of mRNA stability	control of mRNA stability	CASC3;EIF4A3	None	"The 3.0 Angstroem resolution structure of the eIF4AIII-Btz subcomplex reveals a dramatic conformational change of the helicase domains as compared to EJC bound eIF4AIII. More generally, the authors propose that similarly to what observed for protein kinases, members of the DEAD-box family of proteins are likely to adopt a similar structure in their 'on' state (when bound to ATP and RNA) despite having different conformations in their 'off' states."	None
Y14-Magoh complex	P61326;Q9Y5S9	4116;9939	"mRNA splicing, via spliceosome;mRNA processing;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus"	"mRNA processing (splicing, 5'-, 3'-end processing);RNA transport;nuclear transport;cytoplasm;nucleus"	MAGOH;RBM8A	None	Y14 and Magoh form an extremely stable heterodimer. Magoh binds with high affinity to the RNP motif RNA binding domain (RBD) of Y14 and completely masks its RNA binding surface.	None
THO complex	Q13769;Q6I9Y2;Q86W42;Q8NI27;Q96FV9	8563;80145;79228;57187;9984	RNA binding;nuclear speck	RNA binding;nuclear speckles	THOC5;THOC7;THOC6;THOC2;THOC1	None	"The human THO complex associates with spliced mRNA, but not with unspliced pre-mRNA in vitro. Transcription is not required for this recruitment. It was also shown that the human THO complex colocalizes with splicing factors in nuclear speckle domains in vivo. The TREX complex contains the THO transcription elongation complex."	None
CBC complex (cap binding complex)	P52298;Q09161	22916;4686	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	RNA binding;RNA transport;nuclear transport;nucleus	NCBP2;NCBP1	None	The heterodimeric nuclear cap binding complex (CBC) binds to 5'-capped polymerase II transcripts. It enhances the efficiency of several mRNA maturation steps and is essential for U snRNA nuclear export in multicellular eukaryotes.	None
Exon junction complex	Q15287;Q86V81;Q8IYB3;Q9BZI7;Q9HAU5;Q9UBU9;Q9Y5S9	10921;10189;10250;65109;26019;10482;9939	RNA catabolic process;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	RNA degradation;RNA binding;RNA transport;nuclear transport;nucleus	RNPS1;ALYREF;SRRM1;UPF3B;UPF2;NXF1;RBM8A	None	"The exon junction complex (EJC) is a protein complex that assembles near exon-exon junctions of mRNAs as a result of splicing. EJC proteins play important roles in postsplicing events including mRNA export, cytoplasmic localization, and nonsense-mediated decay."	None
LARC complex (LCR-associated remodeling complex)	O14497;O94776;O95983;O96019;P07910;P51532;P60709;Q09028;Q12824;Q13547;Q14839;Q8TAQ2;Q8WXI9;Q92769;Q92785;Q92922;Q92925;Q969G3;Q9UBB5	8289;9219;53615;86;3183;6597;60;5928;6598;3065;1108;6601;57459;3066;5977;6599;6603;6605;8932	DNA topological change;DNA binding;chromosome organization;nucleus	DNA conformation modification (e.g. chromatin);DNA binding;organization of chromosome structure;nucleus	ARID1A;MTA2;MBD3;ACTL6A;HNRNPC;SMARCA4;ACTB;RBBP4;SMARCB1;HDAC1;CHD4;SMARCC2;GATAD2B;HDAC2;DPF2;SMARCC1;SMARCD2;SMARCE1;MBD2	None	LARC binds to the hypersensitive 2 (HS2)-Maf recognition element (MARE) DNA in a sequence-specific manner and remodels nucleosomes.	None
URI complex (Unconventional prefoldin RPB5 Interactor)	O94763;P19388;P63208;Q13309;Q13616;Q9UHV9;Q9ULZ2;Q9Y230;Q9Y265	8725;5434;6500;6502;8454;5202;26228;10856;8607	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to starvation;phosphatidylinositol-mediated signaling"	transcriptional control;nutrient starvation response	URI1;POLR2E;SKP1;SKP2;CUL1;PFDN2;STAP1;RUVBL2;RUVBL1	"Three other subunits of the complex were found in the analysis, which have not been further characterized: p42, p40, p10.At the time of annotation, the additional member PFD4-related protein of the protein complex was not found in the UniProt database."	"The URI complex participates in the regulation of nutrient-sensitive, TOR-dependent transcription programs."	None
ITCH-USP9X complex	Q93008;Q96J02	8239;83737	protein deubiquitination;protein binding	"modification by ubiquitination, deubiquitination;protein binding"	USP9X;ITCH	None	Interaction between Itch and FAM (USP9X) reverses Itch auto-ubiquitylation and protects the ligase from proteasomal degradation.	None
SMG-1-UPF-ERF1-ERF3 complex (SURF)	P15170;P62495;Q92900;Q96Q15	2935;2107;5976;23049	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay"	None	GSPT1;ETF1;UPF1;SMG1	None	"The SURF complex accumulated greatly when Upf2 or Y14 was depleted or the Upf2-binding region of Upf1 is mutated. SMG-1 forms a complex with Upf1, eRF1, and eRF3in a Upf2- and Y14-independent manner"	None
Exon junction complex	P38919;P61326;Q13838;Q15287;Q86V81;Q8IYB3;Q9BZI7;Q9Y5S9	9775;4116;7919;10921;10189;10250;65109;9939	RNA catabolic process;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	RNA degradation;RNA binding;RNA transport;nuclear transport;nucleus	EIF4A3;MAGOH;DDX39B;RNPS1;ALYREF;SRRM1;UPF3B;RBM8A	None	"The exon junction complex (EJC) is a protein complex that assembles near exon-exon junctions of mRNAs as a result of splicing. EJC proteins play important roles in postsplicing events including mRNA export, cytoplasmic localization, and nonsense-mediated decay."	None
MR-UBC9-SRC1 complex	P08235;Q08209;Q15788	4306;5530;8648	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	NR3C2;PPP3CA;NCOA1	None	None	None
NuA4/Tip60-HAT complex B	O96019;Q92993;Q9H2F5;Q9NPF5;Q9UBU8;Q9Y230;Q9Y265;Q9Y4A5	86;10524;80314;55929;10933;10856;8607;8295	chromosome organization;DNA repair;DNA topological change;DNA binding;cellular response to DNA damage stimulus;nucleus;histone acetylation	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);DNA binding;DNA damage response;nucleus	ACTL6A;KAT5;EPC1;DMAP1;MORF4L1;RUVBL2;RUVBL1;TRRAP	None	"The NuA4 histone acetyltransferase (HAT) multisubunit complex is responsible for acetylation of histone H4 and H2A N-terminal tails in yeast. The NuA4/Tip60 HAT complex is highly conserved in eukaryotes playing primary roles in transcription, cellular response to DNA damage, and cell cycle control."	None
Exosome	Q06265;Q13868;Q15024;Q5RKV6;Q96B26;Q9NPD3;Q9NQT4;Q9NQT5;Q9Y2L1;Q9Y3B2	5393;23404;23016;118460;11340;54512;56915;51010;22894;51013	RNA catabolic process;RNA binding;cytoplasm;nucleus	RNA degradation;RNA binding;cytoplasm;nucleus	EXOSC9;EXOSC2;EXOSC7;EXOSC6;EXOSC8;EXOSC4;EXOSC5;EXOSC3;DIS3;EXOSC1	None	"Inherently unstable mammalian mRNAs contain AU-rich elements (AREs) within their 3' untranslated regions. The mammalian exosome is required for rapid 3'-to-5' degradation of ARE-containing RNAs but not for poly(A) shortening. ARE recognition requires certain ARE binding proteins that can interact with the exosome and recruit it to unstable RNAs, thereby promoting their rapid degradation."	None
Exosome	Q01780;Q06265;Q13868;Q15024;Q5RKV6;Q96B26;Q9NPD3;Q9NQT4;Q9NQT5;Q9Y2L1;Q9Y3B2	5394;5393;23404;23016;118460;11340;54512;56915;51010;22894;51013	RNA catabolic process;RNA binding;nucleus	RNA degradation;RNA binding;nucleus	EXOSC10;EXOSC9;EXOSC2;EXOSC7;EXOSC6;EXOSC8;EXOSC4;EXOSC5;EXOSC3;DIS3;EXOSC1	None	"Inherently unstable mammalian mRNAs contain AU-rich elements (AREs) within their 3' untranslated regions. The mammalian exosome is required for rapid 3'-to-5' degradation of ARE-containing RNAs but not for poly(A) shortening. ARE recognition requires certain ARE binding proteins that can interact with the exosome and recruit it to unstable RNAs, thereby promoting their rapid degradation. The exosome complex containing PMSCL was only found in the nuclear complex."	None
DDB complex	Q16531;Q92466	1642;1643	DNA repair;DNA binding;cellular response to DNA damage stimulus	DNA repair;DNA binding;DNA damage response	DDB1;DDB2	None	None	None
"SNARE complex (VAMP2, SNAP25, STX1a, CPLX1)"	O14810;P60880;P63027;Q16623	10815;6616;6844;6804	receptor regulator activity;vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis;receptor binding	regulator of receptor activity;vesicle fusion;synaptic vesicle exocytosis;receptor binding	CPLX1;SNAP25;VAMP2;STX1A	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP2, SNAP25, STX1a, CPLX2)"	P60880;P63027;Q16623;Q6PUV4	6616;6844;6804;10814	receptor regulator activity;vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis;receptor binding	regulator of receptor activity;vesicle fusion;synaptic vesicle exocytosis;receptor binding	SNAP25;VAMP2;STX1A;CPLX2	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (STX11, VAMP2, SNAP23)"	O00161;O75558;P63027	8773;8676;6844	protein transport;protein transporter activity;vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis;endosome	protein transport;vesicle fusion;synaptic vesicle exocytosis;endosome	SNAP23;STX11;VAMP2	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
NuA4/Tip60-HAT complex A	O95619;O96019;Q52LR7;Q92993;Q96L91;Q9H0E9;Q9H2F5;Q9HAF1;Q9NPF5;Q9NV56;Q9NXR8;Q9UBU8;Q9Y230;Q9Y265;Q9Y4A5	8089;86;26122;10524;57634;10902;80314;64769;55929;55257;54556;10933;10856;8607;8295	chromosome organization;DNA repair;DNA topological change;DNA binding;cellular response to DNA damage stimulus;nucleus;histone acetylation	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);DNA binding;DNA damage response;nucleus	YEATS4;ACTL6A;EPC2;KAT5;EP400;BRD8;EPC1;MEAF6;DMAP1;MRGBP;ING3;MORF4L1;RUVBL2;RUVBL1;TRRAP	None	"The NuA4 histone acetyltransferase (HAT) multisubunit complex is responsible for acetylation of histone H4 and H2A N-terminal tails in yeast. The NuA4/Tip60 HAT complex is highly conserved in eukaryotes playing primary roles in transcription, cellular response to DNA damage, and cell cycle control."	None
DMAP1-associated complex	O96019;Q15906;Q6ZRS2;Q96L91;Q9H0E9;Q9H2F5;Q9NPF5;Q9Y230;Q9Y265;Q9Y4A5	86;6944;10847;57634;10902;80314;55929;10856;8607;8295	chromosome organization;DNA repair;DNA topological change;nucleus	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);nucleus	ACTL6A;VPS72;SRCAP;EP400;BRD8;EPC1;DMAP1;RUVBL2;RUVBL1;TRRAP	None	None	None
"SNARE complex (STX2, SNAP23)"	O00161;P32856	8773;2054	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP23;STX2	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
BRG1-SIN3A-HDAC containing SWI/SNF remodeling complex I	O14497;O14744;O96019;P51532;Q12824;Q8TAQ2;Q92769;Q92922;Q969G3;Q96GM5;Q96ST3	8289;10419;86;6597;6598;6601;3066;6599;6605;6602;25942	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	ARID1A;PRMT5;ACTL6A;SMARCA4;SMARCB1;SMARCC2;HDAC2;SMARCC1;SMARCE1;SMARCD1;SIN3A	None	"The authors provide evidence, that PRMT5, mSin3A/HDAC2, and the Brg1-based hSWI/SNF complex are involved in cad transcriptional repression."	None
"SNARE complex (STX4, SNAP23)"	O00161;Q12846	8773;6810	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP23;STX4	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
BRM-SIN3A-HDAC complex	O14497;O14744;O96019;P51531;Q12824;Q8TAQ2;Q92769;Q92922;Q92925;Q969G3;Q96GM5;Q96ST3	8289;10419;86;6595;6598;6601;3066;6599;6603;6605;6602;25942	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	ARID1A;PRMT5;ACTL6A;SMARCA2;SMARCB1;SMARCC2;HDAC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1;SIN3A	None	None	None
BRG1-associated complex	O14497;O14744;O96019;P51532;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;10419;86;6597;6598;6601;6599;6605;6602	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	ARID1A;PRMT5;ACTL6A;SMARCA4;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	None	None	None
BRM-associated complex	O14497;O14744;O96019;P51531;Q12824;Q8TAQ2;Q92922;Q92925;Q969G3;Q96GM5	8289;10419;86;6595;6598;6601;6599;6603;6605;6602	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	ARID1A;PRMT5;ACTL6A;SMARCA2;SMARCB1;SMARCC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1	None	None	None
eRF1-eRF3-GTP-Mg(2+) complex	P15170;P62495	2935;2107	translational termination;magnesium ion binding;GTP binding;small GTPase mediated signal transduction;cytoplasm	translation termination;magnesium binding;GTP binding;small GTPase mediated signal transduction;cytoplasm	GSPT1;ETF1	"Since the authors did not specify ERF3 , we used isoform ERF3A."	eRF3 binds GDP independently of the presence or absence of eRF1 whereas GTP binds only to the eRF1-eRF3 complex. The authors suggest that the quaternary eRF1-eRF3-GTP-Mg2+ complex binds to the ribosomal pretermination complex.	None
FCP1-associated protein complex	O14744;P30876;P35269;P84090;Q15208;Q9BQA1;Q9Y5B0	10419;5431;2962;2079;11329;79084;9150	"DNA-templated transcription, elongation;protein hydroxylation;protein methylation;nucleus"	"transcription elongation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	PRMT5;POLR2B;GTF2F1;ERH;STK38;WDR77;CTDP1	None	FCP1-associated PRMT5 can methylate histones H4 in vitro.	None
FCP1-associated protein complex	O14744;P30876;P35269;P84090;Q15208;Q9BQA1;Q9Y5B0	10419;5431;2962;2079;11329;79084;9150	"DNA-templated transcription, elongation;protein hydroxylation;protein methylation;nucleus"	"transcription elongation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	PRMT5;POLR2B;GTF2F1;ERH;STK38;WDR77;CTDP1	None	The authors suggest a putative role of FCP1 CTD-phosphatase in linking the transcription elongation with the splicing process.	None
"Upf complex (UPF1, UPF2, UPF3a)"	Q92900;Q9H1J1;Q9HAU5	5976;65110;26019	RNA catabolic process;RNA binding;cytoplasm;nuclear matrix	RNA degradation;RNA binding;cytoplasm;nuclear matrix	UPF1;UPF3A;UPF2	None	"Human Upf proteins target mRNA for nonsense-mediated decay when bound downstream of a termination codon. Nonsense-mediated decay (NMD) rids eukaryotic cells of aberrant mRNAs containing premature termination codons. These are discriminated from true termination codons by downstream cis-elements, such as exon-exon junctions."	None
"Upf complex (UPF1, UPF2, UPF3b)"	Q92900;Q9BZI7;Q9HAU5	5976;65109;26019	RNA catabolic process;RNA binding;cytoplasm;nuclear matrix	RNA degradation;RNA binding;cytoplasm;nuclear matrix	UPF1;UPF3B;UPF2	None	"Human Upf proteins target mRNA for nonsense-mediated decay when bound downstream of a termination codon. Nonsense-mediated decay (NMD) rids eukaryotic cells of aberrant mRNAs containing premature termination codons. These are discriminated from true termination codons by downstream cis-elements, such as exon-exon junctions."	None
Postsplicing complex	Q15287;Q92900;Q9BZI7;Q9H1J1;Q9HAU5;Q9UBU9;Q9Y5S9	10921;5976;65109;65110;26019;10482;9939	RNA catabolic process;RNA binding;nuclear matrix	RNA degradation;RNA binding;nuclear matrix	RNPS1;UPF1;UPF3B;UPF3A;UPF2;NXF1;RBM8A	None	"A final quality-control step in mRNA maturation is mRNA surveillance. This process detects mRNAs with truncated open reading frames and subjects them to nonsense-mediated mRNA decay (NMD). The protein RNPS1, a component of the postsplicing complex that is deposited 5' to exon-exon junctions, interacts with the evolutionarily conserved human Upf complex, a central component of NMD."	None
MRIP-MBS-RHOA complex	O14974;P61586;Q6WCQ1	4659;387;23164	protein complex assembly;protein binding;enzyme regulator activity;regulation of catalytic activity	assembly of protein complexes;protein binding;enzymatic activity regulation / enzyme regulator	PPP1R12A;RHOA;MPRIP	None	None	None
MRIP-RHOA complex	P61586;Q6WCQ1	387;23164	protein binding	protein binding	RHOA;MPRIP	None	None	None
MRIP-MBS complex	O14974;Q6WCQ1	4659;23164	protein binding	protein binding	PPP1R12A;MPRIP	None	None	None
20S methylosome-SmD complex	O14744;P54105;P62314;P62318	10419;1207;6632;6634	protein hydroxylation;protein methylation;protein complex assembly;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);assembly of protein complexes;cytoplasm"	PRMT5;CLNS1A;SNRPD1;SNRPD3	None	PRMT5 and pICln bind only to unmethylated SMD1 and SMD3.	None
"SNARE complex (STX6, SNAP23)"	O00161;O43752	8773;10228	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP23;STX6	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"mRNA decay complex (UPF1, UPF2, UPF3B, DCP2, XRN1, XRN2, EXOSC2, EXOSC4, EXOSC10, PARN)"	O95453;Q01780;Q13868;Q8IU60;Q8IZH2;Q92900;Q9BZI7;Q9H0D6;Q9HAU5;Q9NPD3	5073;5394;23404;167227;54464;5976;65109;22803;26019;54512	RNA catabolic process;RNA binding;cytoplasm;nucleus	RNA degradation;RNA binding;cytoplasm;nucleus	PARN;EXOSC10;EXOSC2;DCP2;XRN1;UPF1;UPF3B;XRN2;UPF2;EXOSC4	None	"From experiments, it is concluded that nonsense-mediated mRNA decay (NMD) in mammalian cells degrades mRNAs from both 5' and 3' ends by recruiting decapping and 5'-->3' exonuclease activities as well as deadenylating and 3'-->5' exonuclease activities. All these activities are present within the mRNA decay complex."	None
Anti-SMN protein complex	O14893;P14678;P57678;Q16637;Q9UHI6	8487;6628;50628;None;11218	RNA splicing;protein complex assembly;cytoplasm	splicing;assembly of protein complexes;cytoplasm	GEMIN2;SNRPB;GEMIN4;SMN1; SMN2;DDX20	None	None	None
JBP1-pICln complex	O14744;P14678;P54105	10419;6628;1207	protein hydroxylation;protein methylation;protein complex assembly;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);assembly of protein complexes;cytoplasm"	PRMT5;SNRPB;CLNS1A	None	None	None
PAR-3-VE-cadherin-beta-catenin complex	P33151;P35222;Q8TEW0	1003;1499;56288	anisotropic cell growth;cell-cell junction assembly;cell junction	directional cell growth (morphogenesis);intercellular junction (gap junction/adherens junction);cell junction	CDH5;CTNNB1;PARD3	None	None	None
TROY-NGR-LINGO1 complex	Q96FE5;Q9BZR6;Q9NS68	84894;65078;55504	None	None	LINGO1;RTN4R;TNFRSF19	None	None	None
TRPC1-STIM1-ORAI1 complex	P48995;Q96D31;Q9UQB3	7220;84876;1501	ion channel activity;plasma membrane;store-operated calcium entry;calcium ion transport;response to calcium ion	ion channels;eukaryotic plasma membrane / membrane attached	TRPC1;ORAI1;CTNND2	None	The results show that all three proteins are essential for generation of TRPC1-SOC channels (store-operated calcium channels). The dynamic assembly of a TRPC1-STIM1-Orai1 complex is involved in activation of Ca2+ entry.	None
"PAR-6-VE-cadherin complex, endothelial"	P33151;Q9NPB6	1003;50855	anisotropic cell growth;cell-cell junction assembly	directional cell growth (morphogenesis);intercellular junction (gap junction/adherens junction)	CDH5;PARD6A	None	None	None
"PAR-6-PAR-3-VE-cadherin complex, endothelial"	P33151;Q8TEW0;Q9NPB6	1003;56288;50855	anisotropic cell growth;cell-cell junction assembly	directional cell growth (morphogenesis);intercellular junction (gap junction/adherens junction)	CDH5;PARD3;PARD6A	None	PAR-3 and PAR-6 are recruited independently to cell-cell contacts and the localization of PAR-6 at cell junctions requires fully matured cell-cell contacts.	None
Anti-Sm protein complex	O14744;O14893;P14678;P54105;P57678;Q16637;Q9UHI6	10419;8487;6628;1207;50628;None;11218	protein hydroxylation;protein methylation;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);cytoplasm"	PRMT5;GEMIN2;SNRPB;CLNS1A;GEMIN4;SMN1; SMN2;DDX20	None	None	None
6S methyltransferase complex	P54105;P62314;P62318	1207;6632;6634	protein complex assembly;protein binding;cytoplasm	assembly of protein complexes;protein binding;cytoplasm	CLNS1A;SNRPD1;SNRPD3	None	None	None
20S methylosome and RG-containing Sm protein complex	O14744;P14678;P54105;P62314;P62316;P62318	10419;6628;1207;6632;6633;6634	RNA splicing;protein hydroxylation;protein methylation;cytoplasm	"splicing;posttranslational modification of amino acids (e.g. hydroxylation, methylation);cytoplasm"	PRMT5;SNRPB;CLNS1A;SNRPD1;SNRPD2;SNRPD3	None	None	None
6S methyltransferase and RG-containing Sm proteins complex	P14678;P54105;P62304;P62306;P62308;P62314;P62316;P62318	6628;1207;6635;6636;6637;6632;6633;6634	RNA splicing;cytoplasm	splicing;cytoplasm	SNRPB;CLNS1A;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3	None	"snRNPs, integral components of the pre-mRNA splicing machinery, consist of seven Sm proteins which assemble in the cytoplasm as a ring structure on the snRNAs U1, U2, U4, and U5. The survival motor neuron (SMN) protein, the spinal muscular atrophy disease gene product, is crucial for snRNP core particle assembly in vivo. Results indicate that methylation of Sm proteins by the methylosome directs Sm proteins to the SMN complex for assembly into snRNP core particles and suggest that the methylosome can regulate snRNP assembly."	None
20S methyltransferase core complex	O14744;P54105	10419;1207	protein hydroxylation;protein methylation;protein complex assembly;protein binding;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);assembly of protein complexes;protein binding;cytoplasm"	PRMT5;CLNS1A	None	The  methylation of Sm proteins by the methylosome directs Sm proteins to the SMN complex for assembly into snRNP core particles and thus the methylosome can regulate snRNP assembly.	None
MEP50-PRMT5-ICLN complex	O14744;P54105;Q9BQA1	10419;1207;79084	protein hydroxylation;protein methylation;protein complex assembly;protein binding;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);assembly of protein complexes;protein binding;cytoplasm"	PRMT5;CLNS1A;WDR77	None	None	None
LIN9-BMYB complex	P10244;Q5TKA1	4605;286826	mitotic cell cycle;regulation of cell cycle	mitotic cell cycle;mitotic cell cycle and cell cycle control	MYBL2;LIN9	None	None	None
PCI-PSA-SCG2 complex	P05154;P07288;P13521	5104;354;7857	cellular protein catabolic process	cytoplasmic and nuclear protein degradation	SERPINA5;KLK3;SCG2	None	"The complex formation among PCI, PSA, and Sg is modulated by several factors in seminal plasma."	None
"RICH1/AMOT polarity complex, Flag-Rich1 precipitated"	P47756;P52907;Q4VCS5;Q68EM7;Q8N3R9;Q8NI35;Q96B97;Q9Y5K6	832;829;154796;55114;64398;10207;30011;23607	protein localization;GTPase activator activity;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	regulation by localization;GTPase activator (GAP);G-protein coupled receptor signalling pathway;directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	CAPZB;CAPZA1;AMOT;ARHGAP17;MPP5;PATJ;SH3KBP1;CD2AP	"Since the authors did not specify F-actin-capping protein subunit alpha , we used isoform CAPZA1 ."	In an additional immunoblot the authors show that Par-3 and aPKC likely associate with Rich1 at lower levels than Pals1 and Patj since they were not identified by MS. The authors propose that Rich1 and Amot maintain TJ integrity by the coordinate regulation of Cdc42 and by linking specific components of the TJ to intracellular protein trafficking.	None
RICH1-PAR3-aPKC polarity complex	P41743;Q68EM7;Q8TEW0	5584;55114;56288	protein localization;GTPase activator activity;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;anisotropic cell growth;cell-cell junction assembly;cell junction	regulation by localization;GTPase activator (GAP);G-protein coupled receptor signalling pathway;directional cell growth (morphogenesis);intercellular junction (gap junction/adherens junction);cell junction	PRKCI;ARHGAP17;PARD3	None	"Immunoblotting revealed aPKC and the 100 kDa isoform of Par-3, but not Par-6, in Rich1 immunoprecipitates. Par-3 and aPKC likely associate with Rich1 at lower levels than Pals1 and Patj since they were not identified by MS (see complex 846)."	None
"RICH1/AMOT polarity complex, Flag-Amot precipitated"	O75970;Q4VCS5;Q5T2T1;Q68EM7;Q8IY63;Q8N3R9;Q8NI35;Q9Y2J4	8777;154796;143098;55114;154810;64398;10207;51421	protein localization;GTPase activator activity;positive regulation of GTPase activity;G-protein coupled receptor signaling pathway;anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	regulation by localization;GTPase activator (GAP);G-protein coupled receptor signalling pathway;directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	MPDZ;AMOT;MPP7;ARHGAP17;AMOTL1;MPP5;PATJ;AMOTL2	None	"The authors suggest that Amot is a component of at least two complexes, only one of which contains Rich1."	None
DNMT1-EHMT2-PCNA complex	P12004;P26358;Q96KQ7	5111;1786;10919	DNA replication;DNA methylation;chromosome organization;nucleus;histone H3-K9 methylation	DNA synthesis and replication;DNA methylation;organization of chromosome structure;nucleus	PCNA;DNMT1;EHMT2	None	DNMT1 and G9a are loaded onto the chromatin simultaneously in a ternary complex with loading factor PCNA during chromatin replication. Direct cooperation between DNMT1 and G9a provides a mechanism of coordinated DNA and H3K9 methylation during cell division.	None
DNMT1-EHMT2 complex	P26358;Q96KQ7	1786;10919	DNA replication;DNA methylation;mitotic S phase;chromosome organization;nucleus;histone H3-K9 methylation	DNA synthesis and replication;DNA methylation;S phase of mitotic cell cycle;organization of chromosome structure;nucleus	DNMT1;EHMT2	None	Direct cooperation between DNMT1 and G9a provides a mechanism of coordinated DNA and H3K9 methylation during cell division. The complex of DNMT1 and G9a led to enhanced DNA and histone methylation of in vitro assembled chromatin substrates.	None
TRAP-SMCC mediator complex	A0JLT2;Q15528;Q15648;Q71SY5;Q96G25;Q9BUE0;Q9NPJ6;Q9NVC6;Q9NX70;Q9P086	219541;6837;5469;81857;112950;54797;29079;9440;55588;400569	"positive regulation of transcription, DNA-templated;protein binding;nucleus"	transcription activation;protein binding;nucleus	MED19;MED22;MED1;MED25;MED8;MED18;MED4;MED17;MED29;MED11	None	"Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
BRAF53-BRCA2 complex	O60341;P51587;Q13547;Q92769;Q96BD5;Q9P0W2;Q9UKL0	23028;675;3065;3066;51317;10362;23186	"DNA repair;DNA topological change;mitotic cell cycle;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;chromosome organization;neuron differentiation;nucleus"	"DNA repair;DNA conformation modification (e.g. chromatin);mitotic cell cycle;transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;neuron;nucleus"	KDM1A;BRCA2;HDAC1;HDAC2;PHF21A;HMG20B;RCOR1	None	Antibody microinjection experiments suggest a role for BRCA2/BRAF35 complex in modulation of cell cycle progression.	BRCA2 confers susceptibility to in breast cancer.
"SNARE complex (STX1A, SNAP29)"	O95721;Q16623	9342;6804	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP29;STX1A	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP3, VAMP4, VAMP8, STX6)"	O43752;O75379;Q15836;Q9BV40	10228;8674;9341;8673	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	STX6;VAMP4;VAMP3;VAMP8	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP3, VAMP4, STX16)"	O14662;O75379;Q15836	8675;8674;9341	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	STX16;VAMP4;VAMP3	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP3, STX6, VTI1A)"	O43752;Q15836;Q96AJ9	10228;9341;143187	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	STX6;VAMP3;VTI1A	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP4, STX6, STX16, VTI1a, VTI1b)"	O14662;O43752;O75379;Q96AJ9;Q9UEU0	8675;10228;8674;143187;10490	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	STX16;STX6;VAMP4;VTI1A;VTI1B	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
PKA (RII-alpha and RII-beta)-AKAP5-ADRB1 complex	P08588;P13861;P24588;P31323	153;5576;9495;5577	G-protein coupled receptor signaling pathway;receptor recycling;protein kinase A signaling	G-protein coupled receptor signalling pathway	ADRB1;PRKAR2A;AKAP5;PRKAR2B	None	AKAP79 provides PKA to phosphorylate the beta(1)-AR and thereby dictate the recycling and resensitization itineraries of the beta(1)-AR.	ADRB1 is involved in hypertension and heart failure.
MTA1 complex	O95983;Q09028;Q13330;Q16576;Q6IT96;Q92769	53615;5928;9112;5931;3065;3066	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;hormone-mediated signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;hormone mediated signal transduction;organization of chromosome structure;nucleus"	MBD3;RBBP4;MTA1;RBBP7;HDAC1;HDAC2	"Several other subunits of the complex were found in the analysis, which have not been further characterized: p68, p66 and three so-called MTA1-associated proteins."	None	MTA1 is involved in metastasis or cancer formation.
MTA2 complex	O94776;O95983;Q09028;Q13547;Q14839;Q16576;Q92769;Q96ST3	9219;53615;5928;3065;1108;5931;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;chromosome organization;nucleus;histone deacetylation"	DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;organization of chromosome structure;nucleus	MTA2;MBD3;RBBP4;HDAC1;CHD4;RBBP7;HDAC2;SIN3A	"Since the authors did not specify SIN3, we used SIN3A."	"Since MTA2 is not involved in metastasis or cancer formation, the authors suggest a housekeeping role of the MTA2 complex."	None
MTA1-HDAC core complex	Q09028;Q13330;Q16576;Q6IT96;Q92769	5928;9112;5931;3065;3066	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;hormone-mediated signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;hormone mediated signal transduction;organization of chromosome structure;nucleus"	RBBP4;MTA1;RBBP7;HDAC1;HDAC2	None	None	MTA1 is involved in metastasis or cancer formation.
"hMediator complex (MED23, CDK8, CCNC, MED7)"	O43513;P24863;P49336;Q9ULK4	9443;892;1024;9439	"positive regulation of transcription, DNA-templated;protein binding;nucleus"	transcription activation;protein binding;nucleus	MED7;CCNC;CDK8;MED23	None	"The high-molecular-mass mammalian Mediator complexes have many subunits in common. However, their reported subunit compositions are not identical (PMID:10838567)."	None
"hMediator complex (MED23, CDK8, CCNC)"	P24863;P49336;Q9ULK4	892;1024;9439	"positive regulation of transcription, DNA-templated;protein binding;nucleus"	transcription activation;protein binding;nucleus	CCNC;CDK8;MED23	None	"The high-molecular-mass mammalian Mediator complexes have many subunits in common. However, their reported subunit compositions are not identical (PMID:10838567)."	None
CDK8-CyclinC-Mediator complex	P24863;P49336	892;1024	"negative regulation of transcription, DNA-templated;protein phosphorylation;cellular protein modification process;nucleus"	"transcription repression;modification by phosphorylation, dephosphorylation, autophosphorylation;protein modification;nucleus"	CCNC;CDK8	None	"It has been shown hat CDK8 phosphorylates the cyclin H subunit of TFIIH and inhibits its function in transcription (PMID:10993082). This explains, why the CDK8-CyclinC-Mediator complex inhibits basal and activated transcription."	None
Mediator complex 1	O60244;O75586;P24863;P49336;Q9ULK4	9282;10001;892;1024;9439	"positive regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription activation;protein binding;regulator of transcription factor;nucleus	MED14;MED6;CCNC;CDK8;MED23	None	"Regulation of transcription by RNA polymerase II (Pol II) is controlled by specific combinations of sequence-specific, DNA binding regulatory transcription factors (TFs) bound to a gene's promoter and enhancer regions. These TFs interact with several multiprotein complexes that remodel the chromatin context of the promoter, integrate signals from multiple TFs to control the frequency of transcription initiation, and regulate the efficiency of transcription elongation. One such complex is the Mediator, an ~2-megadalton complex of 20 to 30 subunits that is believed to function as a molecular bridge by simultaneously interacting with both DNA-bound TFs and Pol II. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
Mediator complex 2	O60244;O75586;Q9ULK4	9282;10001;9439	"positive regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription activation;protein binding;regulator of transcription factor;nucleus	MED14;MED6;MED23	None	"Regulation of transcription by RNA polymerase II (Pol II) is controlled by specific combinations of sequence-specific, DNA binding regulatory transcription factors (TFs) bound to a gene's promoter and enhancer regions. These TFs interact with several multiprotein complexes that remodel the chromatin context of the promoter, integrate signals from multiple TFs to control the frequency of transcription initiation, and regulate the efficiency of transcription elongation. One such complex is the Mediator, an ~2-megadalton complex of 20 to 30 subunits that is believed to function as a molecular bridge by simultaneously interacting with both DNA-bound TFs and Pol II. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
RET-Rai complex	P07949;Q92529	5979;53358	cell surface receptor signaling pathway	transmembrane signal transduction	RET;SHC3	None	RAI protein forms complexes with two variants of RET oncoprotein: MEN2A and PTC.	None
SHC3-GAB1 complex	Q13480;Q92529	2549;53358	cell surface receptor signaling pathway	transmembrane signal transduction	GAB1;SHC3	None	RAI protein forms complexes with two variants of RET oncoprotein: MEN2A and PTC.	None
KIF3A/B-PAR-3-aPKC-PAR-6 complex	O15066;P41743;Q8TEW0;Q9NPB6;Q9Y496	9371;5584;56288;50855;11127	neurogenesis;generation of neurons;neuron differentiation;establishment of cell polarity	neurogenesis;neuron	KIF3B;PRKCI;PARD3;PARD6A;KIF3A	None	The results indicate that PAR-3 interacts with KIF3 in vivo and that aPKC associates with KIF3 through its interaction with PAR-3.	None
ARC92-Mediator complex	O43513;O60244;O75586;O95402;P49336;Q15648;Q71SY5;Q93074;Q96RN5;Q9NVC6;Q9UHV7;Q9ULK4;Q9Y2X0	9443;9282;10001;9441;1024;5469;81857;9968;51586;9440;9969;9439;10025	"positive regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription activation;protein binding;regulator of transcription factor;nucleus	MED7;MED14;MED6;MED26;CDK8;MED1;MED25;MED12;MED15;MED17;MED13;MED23;MED16	None	"Experiemts show that the transcription coactivator ARC is required for SREBP (sterol regulatory element binding protein) control of cholesterol and lipid homeostasis. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
CRSP-Mediator 2 complex	O43513;O60244;O75448;O75586;Q96RN5;Q9BUE0;Q9NPJ6;Q9NVC6;Q9ULK4;Q9Y2X0	9443;9282;9862;10001;51586;54797;29079;9440;9439;10025	"positive regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription activation;protein binding;regulator of transcription factor;nucleus	MED7;MED14;MED24;MED6;MED15;MED18;MED4;MED17;MED23;MED16	"Two other subunits of the complex were found in the analysis, which have not been further characterized: p97 and p26."	"The CRSP-Med 2 complex is a promotor-selective coactivator. It cannot activate transcription from a VDR-responsive promoter, which needs coactivator recruitment by Med220. Several identical subunits appear in protein complexes like DRIP/ARC, CRSP, NAT, PC2, SMCC and Mediator, indicating that unique classes of transcription activators may share common sets or subsets of cofactors."	None
FGFR1-KAL11 complex	P11362;P23352	2260;3730	regulation of fibroblast growth factor receptor signaling pathway	None	FGFR1;ANOS1	"Anosmin-1 directly binds to FGFR1 with high affinity. This interaction involves domains in the N terminus of anosmin-1 (cysteine-rich region, whey acidic protein-like domain and the first fibronectin type III domain) and the D2-D3 extracellular domains of FGFR1."	None	"Loss-of-function mutations of anosmin-1 and FGFR1 are associated with Kallmann syndrome (KS), underlying X-linked, and autosomal dominant/recessive inheritance mode, respectively  (PMID:19696444)."
"SNARE complex (SNAP23, STX1A)"	O00161;Q16623	8773;6804	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis;regulation of chloride transport	vesicle fusion;synaptic vesicle exocytosis	SNAP23;STX1A	None	"SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.SNAP-23 physically associates with CFTR by binding to its amino-terminal tail, a region that modulates channel gating."	None
CERF complex (CECR2-containing remodeling factor complex)	P28370;Q9BXF3	6594;27443	DNA topological change;neurogenesis;generation of neurons;chromosome organization;nucleus	DNA conformation modification (e.g. chromatin);neurogenesis;organization of chromosome structure;nucleus	SMARCA1;CECR2	None	CERF displays an ATP hydrolyzing activity that is stimulated by nucleosomes. CERF plays a critical role in neurolation.	None
PAR3-PAR6-PALS1 complex	Q8N3R9;Q8TEW0;Q9NPB6	64398;56288;50855	anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	MPP5;PARD3;PARD6A	None	"HEK 293 cells transiently expressed with Mys-PALS1 and HA-Par6 or HA-Par3 showed that Par6, but not Par3, coimmunoprecipitated with PALS1. However, when all three proteins were expressed together, the authors detected a complex of PALS1 with both Par6 and Par3."	None
hNURF complex	P28370;Q09028;Q12830;Q16576	6594;5928;2186;5931	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;neurogenesis;generation of neurons;chromosome organization;neuron differentiation;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;neurogenesis;organization of chromosome structure;neuron;nucleus	SMARCA1;RBBP4;BPTF;RBBP7	None	hNURF possesses ATP-dependent chromatin remodeling activity and regulates engrailed-1 (en-1) and engrailed-2 (en-2) expression.	None
Remodeling and spacing factor (RSF) complex	O60264;Q96T23	8467;51773	"nucleotide metabolic process;DNA topological change;DNA-templated transcription, initiation;chromosome organization;nucleus"	nucleotide/nucleoside/nucleobase metabolism;DNA conformation modification (e.g. chromatin);transcription initiation;organization of chromosome structure;nucleus	SMARCA5;RSF1	None	RSF facilitates transcription initiation by remodeling nucleosomes in the promoter region to allow the formation of preinitiation complexes.	None
SNF2L-RSF1 complex	P28370;Q96T23	6594;51773	DNA topological change;chromosome organization;nucleus	DNA conformation modification (e.g. chromatin);organization of chromosome structure;nucleus	SMARCA1;RSF1	None	None	None
Toposome	P07910;P11388;Q08211;Q08945;Q6P2Q9;Q96SB4;Q9NR30	3183;7153;1660;6749;10594;6732;9188	chromosome organization;mitotic cell cycle;regulation of cell cycle;DNA binding;nucleus	organization of chromosome structure;mitotic cell cycle;mitotic cell cycle and cell cycle control;DNA binding;nucleus	HNRNPC;TOP2A;DHX9;SSRP1;PRPF8;SRPK1;DDX21	None	"During chromosome segregation, the toposome complex separates entangled circular chromatin DNA about fourfold more efficiently than topoisomerase IIalpha alone."	None
SNF2H-BAZ1A complex	O60264;Q9NRL2	8467;11177	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;organization of chromosome structure;nucleus	SMARCA5;BAZ1A	None	ATPase activity of WCRF complex is stimulated by nucleososmal DNA.	None
SCRIB-LGL2 complex	Q14160;Q6P1M3	23513;3993	anisotropic cell growth;axis specification;plasma membrane;cytoplasm	directional cell growth (morphogenesis);asymmetries and axis determination;eukaryotic plasma membrane / membrane attached;cytoplasm	SCRIB;LLGL2	None	Analyses done to localize the association of the proteins showed that exogenously expressed Scrib and Lgl2 can interact in either location (at the membrane and in the cytosol).	None
CENP-A NAC complex	Q03188;Q71F23;Q96BT3;Q96H22;Q9H3R5;Q9NSP4	1060;79682;80152;55839;64946;79019	None	None	CENPC;CENPU;CENPT;CENPN;CENPH;CENPM	None	"Assembly of CENP-A NAC complex at centromeres is dependent on CENP-M, CENP-N and CENP-T."	None
SCRIB-VANGL2 complex	Q14160;Q9ULK5	23513;57216	axis specification;plasma membrane	asymmetries and axis determination;eukaryotic plasma membrane / membrane attached	SCRIB;VANGL2	None	"When human EGFP-hVangl2  fusion proteins expressed in transfected MDCK cells were quantitatively immunoprecipitated with anti-GFP, a small (2%) but reproducible amount of total endo Scrib was found in the full-length hVangl2 immunoprecipitate. Further analyses done in HEK293A cell extracts."	None
CEN complex	O60264;P07199;P11021;P11142;P22087;P35226;P49450;Q02241;Q03188;Q06587;Q08945;Q13185;Q13619;Q15007;Q16531;Q53SF7;Q5T200;Q69YN4;Q6T4P5;Q71F23;Q8N0S6;Q8N1F7;Q8NEM2;Q92620;Q92674;Q96JP5;Q96T23;Q99496;Q9BS16;Q9BU64;Q9BXP5;Q9BZH6;Q9H0H5;Q9H3R5;Q9HC52;Q9NSP4;Q9Y5B9	8467;1059;3309;3312;2091;648;1058;9493;1060;6015;6749;11335;8451;9589;1642;22837;23091;25962;79948;79682;91687;9688;79801;9785;2491;80829;51773;6045;64105;79172;51593;55717;29127;64946;57332;79019;11198	mitotic cell cycle;kinetochore assembly;spindle assembly;centrosome cycle;chromosome	mitotic cell cycle;centromere/kinetochore complex maturation;spindle pole body/centrosome and microtubule cycle;chromosome	SMARCA5;CENPB;HSPA5;HSPA8;FBL;BMI1;CENPA;KIF23;CENPC;RING1;SSRP1;CBX3;CUL4A;WTAP;DDB1;COBLL1;ZC3H13;KIAA1429;PLPPR3;CENPU;CENPL;NUP93;SHCBP1;DHX38;CENPI;ZFP91;RSF1;RNF2;CENPK;CENPO;SRRT;WDR11;RACGAP1;CENPH;CBX8;CENPM;SUPT16H	"Two other subunits of the complex were found in the analysis, which have not been further characterized: unknown protein (40kD) and a protein similar to Riken cDNA 2610510J17."	None	None
SCRIB-GIT1-ARHGEF7 complex	Q14155;Q14160;Q9Y2X7	8874;23513;28964	exocytosis;plasma membrane;synaptic transmission;establishment or maintenance of epithelial cell apical/basal polarity	exocytosis;eukaryotic plasma membrane / membrane attached;synaptic transmission	ARHGEF7;SCRIB;GIT1	None	"Yeast two-hybrid analysis showed that beta-PIX directly interacts with hScrib and hScrib PDZ domains. GIT1 had no affinity for Scrib but, as expected, directly bound to beta-PIX. The data highlight the important role of hScrib in the retention of beta-PIX at the plasma membrane upon membrane depolarization."	None
SCRIB-APC complex	P25054;Q14160	324;23513	anisotropic cell growth;axis specification;cell-cell junction assembly;neuron differentiation;epithelial cell differentiation;morphogenesis of an epithelium;synapse assembly	directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);neuron;epithelium;synaptogenesis	APC;SCRIB	None	"The in vitro translated APC bound to the PDZ domains 1 and 4 of hScrib. Mutational analysis provided the evidence that APC interacts with hScrib through its C terminal class 1 PDZ domain-binding sequence Threonine-X-Valine, which is shared by the C terminal sequences of the high-risk HPV E6 proteins."	None
FACT-NEK9 complex	Q08945;Q8TD19;Q9Y5B9	6749;91754;11198	"DNA topological change;G1/S transition of mitotic cell cycle;DNA-templated transcription, elongation;protein phosphorylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);G1/S transition of mitotic cell cycle;transcription elongation;modification by phosphorylation, dephosphorylation, autophosphorylation;organization of chromosome structure;nucleus"	SSRP1;NEK9;SUPT16H	None	"Nek9 forms a stable, approximately 600-kDa complex with FACT in the interphase nuclei."	None
FACT complex	Q08945;Q9Y5B9	6749;11198	"DNA topological change;DNA-templated transcription, elongation;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription elongation;organization of chromosome structure;nucleus	SSRP1;SUPT16H	None	FACT (for facilitates chromatin transcription) is a chromatin-specific elongation factor required for transcription of chromatin templates in vitro.	None
"FACT complex, UV-activated"	P19784;P67870;P68400;Q08945;Q9Y5B9	1459;1460;1457;6749;11198	protein phosphorylation;cellular response to DNA damage stimulus;response to radiation;nucleus	"modification by phosphorylation, dephosphorylation, autophosphorylation;DNA damage response;electromagnetic waves stress response (e.g. UV, X-ray);nucleus"	CSNK2A2;CSNK2B;CSNK2A1;SSRP1;SUPT16H	None	In vitro studies show that FACT alters the specificity of CK2 in the complex such that it selectively phosphorylates p53. Phosphorylation by the kinase complex enhances p53 activity.	None
"Class C Vps complex (VPS11, VPS18, STX7)"	O15400;Q9H270;Q9P253	8417;55823;57617	vesicle-mediated transport;endosome;vacuole;lysosome	"vesicular transport (Golgi network, etc.);endosome;vacuole or lysosome"	STX7;VPS11;VPS18	None	Mammalian Class C Vps proteins are predominantly associated with late endosomes/lysosomes and mediate vesicle trafficking steps in the endosome/lysosome pathway.	None
"Class C Vps complex (VPS11, VPS18, VPS16)"	Q9H269;Q9H270;Q9P253	64601;55823;57617	vesicle-mediated transport;endosome;vacuole;lysosome	"vesicular transport (Golgi network, etc.);endosome;vacuole or lysosome"	VPS16;VPS11;VPS18	None	"Mammalian Class C Vps proteins are predominantly associated with late endosomes/lysosomes, mediate vesicle trafficking steps in the endosome/lysosome pathway and are suggested to play a role in SNARE complex assembly."	None
CDC7-DBF7 complex	O00311;Q9UBU7	8317;10926	DNA replication;regulation of DNA metabolic process	DNA synthesis and replication;regulation of DNA processing	CDC7;DBF4	None	None	None
LLGL2-PAR-6B-PRKCI complex	P41743;Q6P1M3;Q9BYG5	5584;3993;84612	anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	PRKCI;LLGL2;PARD6B	None	Mammalian Lgl-2 competes with PAR-3 for its incorporation to the PAR-6B/aPKC lambda complex in cDNA-transfected 293T cells  and support the presence of two independent protein complexes containing PAR-6B/aPKC lambda. Further results indicate that mLgl-2 interacts with the PDZ domain of PAR-6B and with the kinase domain of aPKC lambda and forms a protein complex independently of the one containing PAR-3. It was suggested that phosphorylation of mLgl-1/2 by aPKC lambda occurs during the cell-cell contact-induced cell polarization and that this is accompanied by dissociation of the interaction between mLgl-2 and the PAR-6B/aPKC lambda complex.	None
PAR-3-PAR-6B-PRKCI complex	P41743;Q8TEW0;Q9BYG5	5584;56288;84612	anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	PRKCI;PARD3;PARD6B	None	Mammalian Lgl-2 competes with PAR-3 for its incorporation to the PAR-6B/aPKC lambda complex in cDNA-transfected 293T cells  and support the presence of two independent protein complexes containing PAR-6B/aPKC lambda.	None
LLGL1-PAR-6B-PRKCI complex	P41743;Q15334;Q9BYG5	5584;3996;84612	anisotropic cell growth;axis specification;cell-cell junction assembly;cell junction	directional cell growth (morphogenesis);asymmetries and axis determination;intercellular junction (gap junction/adherens junction);cell junction	PRKCI;LLGL1;PARD6B	None	"Experiments done in lysates of MDCK, MTD-1A, or Caco 2 cells. The results indicate that PAR-6/aPKC selectively interacts with either mLgl or PAR-3 under the control of aPKC activity to regulate epithelial cell polarity."	None
BRCA1-RAD50-MRE11-NBS1 complex	O60934;P38398;P49959;Q92878	4683;672;4361;10111	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	NBN;BRCA1;MRE11A;RAD50	None	None	BRCA1 is involved in breast cancer.
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	The implication of hMre11/hRad50/p95 protein complex in NBS reveals a direct molecular link between DSB repair and cell cycle checkpoint functions.	Rad50-MRE11-p95 protein complex is involved in Nijmegen breakage syndrome.
EED-EZH2 complex	O75530;Q09028;Q15022;Q15910;Q6ZN18	8726;5928;23512;2146;121536	DNA topological change;RNA biosynthetic process;protein hydroxylation;protein methylation;chromosome organization;nucleus	"DNA conformation modification (e.g. chromatin);RNA synthesis;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	EED;RBBP4;SUZ12;EZH2;AEBP2	None	The results support a model in which ESC-E(Z)-mediated H3-K27 methylation serves as a signal for the recruitment of the PRC1 complex by facilitating PC binding.	None
GAA1-GPI8-PIGT-PIG-PIGS complex	O43292;Q92643;Q969N2;Q96S52;Q9H490	8733;10026;51604;94005;128869	phospholipid metabolic process;phospholipid biosynthetic process;phospholipid catabolic process;plasma membrane	phospholipid metabolism;eukaryotic plasma membrane / membrane attached	GPAA1;PIGK;PIGT;PIGS;PIGU	None	None	None
KIN17-PCNA-RPA70 complex	O60870;P12004;P27694	22944;5111;6117	DNA replication;cell cycle checkpoint;DNA binding;nuclear matrix	"DNA synthesis and replication;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;nuclear matrix"	KIN;PCNA;RPA1	None	This complex associates with DNA polymerase alpha.	None
p23 protein complex	P22626;Q15185;Q86W51	3181;10728;10016	protein binding;regulation of programmed cell death	protein binding;regulation of apoptosis	HNRNPA2B1;PTGES3;PDCD6	None	None	The expression of p23 is increased  after rat focal cerebral ischemia. DHNRPA2B1 is clinical marker of early lung cancer detection (PMID:10632338).
TorsinA-TorsinB complex	O14656;O14657	1861;27348	blood circulation	circulation (e.g. blood pressure)	TOR1A;TOR1B	None	None	None
RC complex (Replication competent complex)	P09884;P20248;P24941;P35249;P35250;P35251;P40937;P40938;Q14181	5422;890;1017;5984;5982;5981;5985;5983;23649	DNA replication;cell cycle checkpoint;DNA binding;chromosome	"DNA synthesis and replication;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;chromosome"	POLA1;CCNA2;CDK2;RFC4;RFC2;RFC1;RFC5;RFC3;POLA2	None	RC complex might be regulated by specific cyclin/Cdk complexes (PMID:12006500).	None
RC complex during S-phase of cell cycle	P09874;P09884;P11387;P15927;P18858;P20248;P24941;P27694;P28340;P35244;P35250;P35251;Q07864	142;5422;7150;6118;3978;890;1017;6117;5424;6119;5982;5981;5426	DNA replication;cell cycle checkpoint;DNA binding;chromosome	"DNA synthesis and replication;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;chromosome"	PARP1;POLA1;TOP1;RPA2;LIG1;CCNA2;CDK2;RPA1;POLD1;RPA3;RFC2;RFC1;POLE	None	"CDK2 associates with the RC complex only during the S-phase of the cell cycle, but disappeares in the G2-phase."	None
RC complex during G2/M-phase of cell cycle	P06493;P09874;P09884;P11387;P14635;P15927;P20248;P27694;P28340;P35244;P35250;P35251;Q07864	983;142;5422;7150;891;6118;890;6117;5424;6119;5982;5981;5426	DNA replication;cell cycle checkpoint;DNA binding;chromosome	"DNA synthesis and replication;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;chromosome"	CDK1;PARP1;POLA1;TOP1;CCNB1;RPA2;CCNA2;RPA1;POLD1;RPA3;RFC2;RFC1;POLE	None	CDK1 and cyclin B1 associate with RC complex only during G2/M-phase of cell cycle. DNA ligase I is not found in the RC complex during G2/M-phase.	None
CAK core complex (Cdk-activating kinase core complex)	P50613;P51946	1022;902	cell cycle;mRNA transcription;cellular protein modification process;regulation of sequence-specific DNA binding transcription factor activity;nucleus;phosphorylation of RNA polymerase II C-terminal domain	cell cycle;mRNA synthesis;protein modification;regulator of transcription factor;nucleus	CDK7;CCNH	None	CAK complex phosphorylates the carboxy-terminal domain of the largest subunit of RNA polymerase II.	None
CAK complex (Cdk-activating kinase complex)	P50613;P51946;P51948	1022;902;4331	cell cycle;kinase activator activity;regulation of sequence-specific DNA binding transcription factor activity;nucleus	cell cycle;kinase activator;regulator of transcription factor;nucleus	CDK7;CCNH;MNAT1	None	MAT1 is required for stabilization and assembly of the active CAK complex.	None
TFIIH transcription factor complex	P18074;P19447;P32780;P50613;P51946;P51948;Q13888;Q13889;Q6ZYL4;Q92759	2068;2071;2965;1022;902;4331;2966;2967;404672;2968	"DNA repair;cell cycle;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;cellular protein modification process;regulation of catalytic activity;nucleus"	DNA repair;cell cycle;transcriptional control;protein modification;enzymatic activity regulation / enzyme regulator;nucleus	ERCC2;ERCC3;GTF2H1;CDK7;CCNH;MNAT1;GTF2H2;GTF2H3;GTF2H5;GTF2H4	None	Transcription factor IIH (TFIIH) is a multisubunit complex required for transcription and for DNA nucleotide excision repair.The GTF2H5 gene product has a role in regulating the level of TFIIH.	None
CAK complex (Cdk-activating kinase complex)	P50613;P51946;P51948	1022;902;4331	cell cycle;kinase activator activity;regulation of sequence-specific DNA binding transcription factor activity;nucleus;phosphorylation of RNA polymerase II C-terminal domain	cell cycle;kinase activator;regulator of transcription factor;nucleus	CDK7;CCNH;MNAT1	None	MAT1 is required for stabilization and assembly of the active CAK complex.	None
HNF4A-SUB1 complex	P41235;P53999	3172;10923	"positive regulation of transcription, DNA-templated"	transcription activation	HNF4A;SUB1	None	"The hepatocellular inflammatory-redox (IR) state enhances PC4-HNF4 binding to upregulate transcription of target hepatocyte genes, such as iNOS."	None
TFIIH transcription factor complex	P18074;P19447;P32780;P50613;P51946;P51948;Q13888;Q13889;Q6ZYL4;Q92759	2068;2071;2965;1022;902;4331;2966;2967;404672;2968	"DNA repair;cell cycle;regulation of transcription, DNA-templated;nucleus;regulation of RNA biosynthetic process;kinase activity;ATPase activity;phosphorylation of RNA polymerase II C-terminal domain;DNA helicase activity"	DNA repair;cell cycle;transcriptional control;nucleus	ERCC2;ERCC3;GTF2H1;CDK7;CCNH;MNAT1;GTF2H2;GTF2H3;GTF2H5;GTF2H4	None	Transcription factor IIH (TFIIH) is a multisubunit complex required for transcription and for DNA nucleotide excision repair.	None
CAK-ERCC2 complex	P18074;P50613;P51946;P51948	2068;1022;902;4331	cell cycle;mRNA transcription;cellular protein modification process;kinase activator activity;regulation of sequence-specific DNA binding transcription factor activity;nucleus	cell cycle;mRNA synthesis;protein modification;kinase activator;regulator of transcription factor;nucleus	ERCC2;CDK7;CCNH;MNAT1	None	CAK-ERCC2 can efficiently associate with core-TFIIH to reconstitute holo-TFIIH transcription activity.	None
ORC complex (origin recognition complex)	O43913;O43929;Q13415;Q13416;Q9UBD5;Q9Y5N6	5001;5000;4998;4999;23595;23594	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;ATP binding;chromosome	ori recognition and priming complex formation;ATP binding;chromosome	ORC5;ORC4;ORC1;ORC2;ORC3;ORC6	None	"HsOrc2, HsOrc3, and HsOrc4 form a core upon which the ordered assembly of HsOrc5 and HsOrc1 takes place. HsOrc6 appears to be the most weakly bound subunit in the complex."	None
ORC 2-4 complex (origin recognition 2-4 complex)	O43929;Q13416;Q9UBD5	5000;4999;23595	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;ATP binding;chromosome	ori recognition and priming complex formation;ATP binding;chromosome	ORC4;ORC2;ORC3	None	"HsOrc2, HsOrc3, and HsOrc4 form a core upon which the ordered assembly of HsOrc5 and HsOrc1 takes place."	None
ORC complex (origin recognition complex)	O43913;O43929;Q13415;Q13416;Q9UBD5;Q9Y5N6	5001;5000;4998;4999;23595;23594	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;ATP binding;chromosome	ori recognition and priming complex formation;ATP binding;chromosome	ORC5;ORC4;ORC1;ORC2;ORC3;ORC6	None	"Only a small fraction of human ORC1 and ORC6 is associated with a subcomplex of ORC2, 3, 4, and 5."	None
ORC 2-5 complex (origin recognition 2-5 complex)	O43913;O43929;Q13416;Q9UBD5	5001;5000;4999;23595	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;ATP binding;chromosome	ori recognition and priming complex formation;ATP binding;chromosome	ORC5;ORC4;ORC2;ORC3	None	"Only a small fraction of human ORC1 and ORC6 is likely to be associated with a subcomplex of ORC2, 3, 4, and 5."	None
TFIIH transcription factor complex	P18074;P19447;P32780;P50613;P51946;P51948;Q13888;Q13889;Q92759	2068;2071;2965;1022;902;4331;2966;2967;2968	"DNA repair;cell cycle;regulation of transcription, DNA-templated;nucleus;ATPase activity;kinase activity;phosphorylation of RNA polymerase II C-terminal domain;regulation of RNA biosynthetic process"	DNA repair;cell cycle;transcriptional control;nucleus	ERCC2;ERCC3;GTF2H1;CDK7;CCNH;MNAT1;GTF2H2;GTF2H3;GTF2H4	None	Transcription factor IIH (TFIIH) is a multisubunit complex required for transcription and for DNA nucleotide excision repair.	"TFIIH is implicated in DNA repair/transcription deficiency disorders such as the rare autosomal recessive disease xeroderma pigmentosum, Cockayne syndrome, a neuro-developmental disease,  and the brittle hair disease trichothiodystrophy (PMID:9118947)."
TFIIH transcription factor core complex	P19447;P32780;Q13888;Q13889;Q92759	2071;2965;2966;2967;2968	"DNA repair;cell cycle;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;regulation of catalytic activity;nucleus"	DNA repair;cell cycle;transcriptional control;enzymatic activity regulation / enzyme regulator;nucleus	ERCC3;GTF2H1;GTF2H2;GTF2H3;GTF2H4	None	None	None
ORC 1-5 complex (origin recognition 1-5 complex)	O43913;O43929;Q13415;Q13416;Q9UBD5	5001;5000;4998;4999;23595	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;ATP binding;chromosome	ori recognition and priming complex formation;ATP binding;chromosome	ORC5;ORC4;ORC1;ORC2;ORC3	None	"ATP-binding motifs of Orc1, Orc4, Orc5 are all essential for the replication activity of the ORC complex."	None
PCNA-PAF complex	P12004;Q15004	5111;9768	DNA repair;cell cycle;apoptotic process;nucleus;mitochondrion	DNA repair;cell cycle;apoptosis (type I programmed cell death);nucleus;mitochondrion	PCNA;KIAA0101	None	None	None
p33ING1b-PCNA complex	Q15004;Q9UK53	9768;3621	DNA repair;cell cycle;apoptotic process;nucleus;mitochondrion	DNA repair;cell cycle;apoptosis (type I programmed cell death);nucleus;mitochondrion	KIAA0101;ING1	None	"p15(PAF) forms part of a larger protein complex potentially involved in the regulation of DNA repair, apoptosis and cell cycle progression."	None
Alpha-dystrobrevin-ZO-1-actin complex	P60709;Q07157;Q9Y4J8	60;7082;1837	cell-cell junction assembly;cell junction	intercellular junction (gap junction/adherens junction);cell junction	ACTB;TJP1;DTNA	"Since the authors did not actin, we used isoform ACTB."	The TJ- protein ZO-1 and actin were demonstrated in immunoprecipitates of alpha-DB from MDCK I and HT 29 cell lines. These findings suggest that alpha-DB is specifically associated with the reorganizing TJ.	None
SRA-SRC-1 ribonucleoprotein complex	Q15788;Q9HD15	8648;10011	"positive regulation of transcription, DNA-templated;signaling;nucleus"	transcription activation;cellular signalling;nucleus	NCOA1;SRA1	None	The authors conclude that SRA exists in a ribonucleoprotein complex containing SRC-1 and that this complex is recruited by a steroid receptor.	None
Snurportin-CRM1-RanGTP complex	O14980;O95149;P62826	7514;10073;5901	protein transport;protein transporter activity;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	protein transport;RNA transport;nuclear transport;cytoplasm;nucleus	XPO1;SNUPN;RAN	None	The complex is exported from the nucleus to the cytoplasm where  RanGTP is removed from CRM1 through the action of RanBP1 and RanGAP.	None
"Ubiquitin E3 ligase (SKP1A, SKP2, CUL1, RBX1)"	P62877;P63208;Q13309;Q13616	9978;6500;6502;8454	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cytoplasm	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cytoplasm"	RBX1;SKP1;SKP2;CUL1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha.	None
"Ubiquitin E3 ligase (FBXW11, SKP1A, CUL1, RBX1)"	P62877;P63208;Q13616;Q9UKB1	9978;6500;8454;23291	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;SKP1;CUL1;FBXW11	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. This complex catalyzes the phosphorylation-dependent ubiquitination of NF-kappa-B inhibitor alpha.	None
ESR1-RELA-BCL3-NCOA3 complex	P03372;P20749;Q04206;Q9Y6Q9	2099;602;5970;8202	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signaling"	transcriptional control;cellular signalling	ESR1;BCL3;RELA;NCOA3	None	None	None
ZNF198-PML complex	P29590;Q9UBW7	5371;7750	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	PML;ZMYM2	None	The authors show by coimmunoprecipitation that PML and sumoylated ZNF198 are in a protein complex in the cell.	ZMYM2 is involved in myeloproliferative disorder.
ZNF198-SUMO1 complex	P63165;Q9UBW7	7341;7750	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	SUMO1;ZMYM2	None	The results show that ZNF198 is covalently modified by SUMO-1.	ZMYM2 is involved in myeloproliferative disorder.
DIPA-MCRS1 complex	Q15834;Q96EZ8	11007;10445	"negative regulation of transcription, DNA-templated;chromosome"	transcription repression;chromosome	CCDC85B;MCRS1	None	None	None
"SNX complex (SNX1, SNX6)"	Q13596;Q9UNH7	6642;58533	"retrograde transport, vesicle recycling within Golgi;endosome"	retrograde transport;endosome	SNX1;SNX6	None	"SNX1 and SNX6 exist in a stable, endosomally associated complex that is required for retromer-mediated retrieval of the cation-independent mannose-6-phosphate receptor."	None
"Retromer complex (SNX1, SNX2, VPS35, VPS29, VPS26A)"	O60749;O75436;Q13596;Q96QK1;Q9UBQ0	6643;9559;6642;55737;51699	"retrograde transport, vesicle recycling within Golgi"	retrograde transport	SNX2;VPS26A;SNX1;VPS35;VPS29	None	None	None
"Retromer complex (SNX1, SNX2, VPS35, VPS29, VPS26B)"	O60749;Q13596;Q4G0F5;Q96QK1;Q9UBQ0	6643;6642;112936;55737;51699	"retrograde transport, vesicle recycling within Golgi"	retrograde transport	SNX2;SNX1;VPS26B;VPS35;VPS29	None	None	None
BAR-BCL2-CASP8 complex	P10415;Q14790;Q9NZS9	596;841;51283	apoptotic process	apoptosis (type I programmed cell death)	BCL2;CASP8;BFAR	None	BAR can bridge procaspase-8 and Bcl-2 into a protein complex. The BAR protein is anchored in intracellular membranes where Bcl-2 resides. BAR therefore may represent a scaffold protein capable of bridging two major apoptosis pathways (intrinsic and extrinsic).	None
GRASP-GRP1 complex	O43739;Q7Z6J2	9265;160622	small GTPase mediated signal transduction;plasma membrane	small GTPase mediated signal transduction;eukaryotic plasma membrane / membrane attached	CYTH3;GRASP	None	The authors propose that GRASP may aid in the localization of GRP1 to discrete signaling networks and facilitate stimulation of ARF-mediated events at the plasma membrane.	None
IFP35-NMI complex	P80217;Q13287	3430;9111	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	IFI35;NMI	None	"The authors show that IFP 35 is degraded in a proteasome-mediated process, and that a novel function of Nmi is to prevent IFP 35 degradation."	None
CD8A-LCK complex	P01732;P06239	925;3932	transmembrane receptor protein tyrosine kinase signaling pathway;immune response;plasma membrane	transmembrane receptor protein tyrosine kinase signalling pathways;immune response;eukaryotic plasma membrane / membrane attached	CD8A;LCK	None	The authors found that newly synthesized p56lck binds rapidly to CD8-alpha throughout the exocytic pathway and about 50% of complexed p56lck reaches the cell surface.	None
12S U11 snRNP	P14678;P62304;P62306;P62308;P62314;P62316;P62318;P67809;Q16560;Q16629;Q6IEG0;Q8N8D1;Q96GM8;Q9BV90;Q9H875	6628;6635;6636;6637;6632;6633;6634;4904;11066;6432;154007;10081;114034;79622;79706	"mRNA splicing, via spliceosome;mRNA processing;nucleus"	"mRNA processing (splicing, 5'-, 3'-end processing);nucleus"	SNRPB;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3;YBX1;SNRNP35;SRSF7;SNRNP48;PDCD7;TOE1;SNRNP25;PRKRIP1	None	"U12-type spliceosomes excise U12-type introns, which comprise less than 1% of all human introns."	None
FIF-FGR2 complex	P09038;Q9BZZ5	2247;8539	protein binding	protein binding	FGF2;API5	None	None	None
"SNX complex (SNX1, SNX1a, SNX2, SNX4)"	O60749;O95219;Q13596	6643;8723;6642	protein transport;protein transporter activity;cellular protein catabolic process	protein transport;cytoplasmic and nuclear protein degradation	SNX2;SNX4;SNX1	SNX1A is a splice variant isoform of SNX1.	"Sorting nexin 1 (SNX1) is a protein that binds to the epidermal growth factor (EGF) receptor and is proposed to play a role in directing EGF receptors to lysosomes for degradation. When expressed in COS7 cells, epitope-tagged sorting nexins SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated with receptor tyrosine kinases for EGF, platelet-derived growth factor, and insulin. SNX2 forms heteromeric complexes with SNX1, SNX1A, and SNX4 but not with SNX3."	None
PKD2-FPC complex	P08F94;Q13563	5314;5311	cation transport;ion channel activity;cellular metal ion homeostasis	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;homeostasis of metal ions (Na, K, Ca etc.)"	PKHD1;PKD2	None	"The study shows that fibrocystin is another partner of PC2, which functionally up-regulates its channel function through KIF3B. Interestingly, although KIF3B directly binds PC2, it has no significant effect on PC2 channel function, indicating that it primarily serves as a linker protein."	PKD2-FPC complex is involved in polycystic kidney disease (PKD).
"SNX complex (SNX2), oligomeric"	O60749	6643	epidermal growth factor receptor binding;insulin receptor binding;leptin receptor binding;protein homodimerization activity;platelet-derived growth factor binding	None	SNX2	SNX2 is able to oligomerize with itself.The exact number of components is not mentioned in paper.	"SNX2 forms heteromeric complexes with SNX1, SNX1A, and SNX4 but not with SNX3. SNX2 was also able to oligomerize with itself."	None
MSH2-MSH6 complex	P43246;P52701	4436;2956	DNA repair;DNA binding;nucleotide binding;nucleus	DNA repair;DNA binding;nucleotide/nucleoside/nucleobase binding;nucleus	MSH2;MSH6	None	The MSH2-MSH6 complex binds to mismatched nucleotides only in the ADP-bound form.	None
P-TEFb.1 complex	O60563;P50750	904;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNT1;CDK9	None	Cyclin T activates CDK9 in the P-TEFb complex. P-TEFb works as a protein kinase that phosphorylates the C-terminal domain of the RNAPII largest subunit.	None
P-TEFb.2 complex	O60583;P50750	905;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNT2;CDK9	None	Cyclin T activates CDK9 in the P-TEFb complex. P-TEFb works as a protein kinase that phosphorylates the C-terminal domain of the RNAPII largest subunit.	None
MRN complex (MRE11-RAD50-NBN complex)	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50	None	"After irradiation, the MRN complex rapidly migrates to sites of double strand breaks, forming foci which remain until DSB repair is complete. Mre11 and Rad50 play direct roles in DSB repair, while Nbs1 appears to be involved in damage signaling. Heat shock, alone or in combination with ionizing radiation, induces a reversible translocation of each of these proteins from the nucleus to the cytoplasm."	None
P-TEFb.1 complex	O60563;P50750	904;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNT1;CDK9	None	Cyclin T activates CDK9 in the P-TEFb complex. P-TEFb works as a protein kinase that phosphorylates the C-terminal domain of the RNAPII largest subunit.	None
P-TEFb.4 complex	O75909;P50750	8812;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNK;CDK9	None	Cyclin K functions as regulatory subunit of CDK9.	None
DNA repair complex NEIL2-PNK-Pol(beta)-LigIII(alpha)-XRCC1	O00764;P06746;P18887;P49916;Q969S2	8566;5423;7515;3980;252969	DNA repair;DNA binding;nucleus	DNA repair;DNA binding;nucleus	PDXK;POLB;XRCC1;LIG3;NEIL2	None	None	None
DNA repair complex NEIL1-PNK-Pol(beta)-LigIII(alpha)-XRCC1	O00764;P06746;P18887;P49916;Q96FI4	8566;5423;7515;3980;79661	DNA repair;DNA binding;nucleus	DNA repair;DNA binding;nucleus	PDXK;POLB;XRCC1;LIG3;NEIL1	None	None	None
BIRC5-AURKB-INCENP-EVI5 complex	O15392;O60447;Q96GD4;Q9NQS7	332;7813;9212;3619	cytokinesis;barrier septum assembly	cytokinesis (cell division) /septum formation and hydrolysis	BIRC5;EVI5;AURKB;INCENP	None	None	None
PRNP-ApolopoproteinE3 complex	P04156;Q13791	5621;348	protein binding	protein binding	PRNP;	None	None	None
VAM1-VELI1 complex	O14910;Q9NZW5	8825;51678	protein complex assembly	assembly of protein complexes	LIN7A;MPP6	None	VAM-1 may function by promoting the assembly of a Veli-1 containing protein complex in neuronal as well as epithelial cells (PMID:11311936).	None
APLG1-Rababtin5 complex	O43747;Q15276	164;9135	vesicle-mediated transport	"vesicular transport (Golgi network, etc.)"	AP1G1;RABEP1	None	The gamma1-adaptin-Rabaptin-5 complex may play a role in membrane trafficking between the TGN and endosomes.	None
"SNX complex (SNX1, SNX1a, SNX2, SNX4, LEPR)"	O60749;O95219;P48357;Q13596	6643;8723;3953;6642	enzyme linked receptor protein signaling pathway;cellular protein catabolic process;leptin receptor activity	receptor enzyme mediated signalling;cytoplasmic and nuclear protein degradation	SNX2;SNX4;LEPR;SNX1	SNX1A is a splice variant isoform of SNX1.	"Sorting nexin 1 (SNX1) is a protein that binds to the epidermal growth factor (EGF) receptor and is proposed to play a role in directing EGF receptors to lysosomes for degradation. When expressed in COS7 cells, epitope-tagged sorting nexins SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated with receptor tyrosine kinases for EGF, platelet-derived growth factor, and insulin. SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated also with the long form hLR303 of the leptin receptor."	None
PCNA-KU antigen complex	P12004;P12956;P13010	5111;2547;7520	DNA repair;DNA binding;ATP binding;cellular response to DNA damage stimulus	DNA repair;DNA binding;ATP binding;DNA damage response	PCNA;XRCC6;XRCC5	None	Interaction of PCNA with Ku70 and Ku80 heterodimer increases after DNA damage.	None
"SNX complex (SNX1, SNX1a, SNX2, SNX4, INSR)"	O60749;O95219;P06213;Q13596	6643;8723;3643;6642	protein transporter activity;insulin receptor signaling pathway;insulin receptor binding	protein transport;insulin receptor signalling pathway	SNX2;SNX4;INSR;SNX1	SNX1A is a splice variant isoform of SNX1.	"Sorting nexin 1 (SNX1) is a protein that binds to the epidermal growth factor (EGF) receptor and is proposed to play a role in directing EGF receptors to lysosomes for degradation. When expressed in COS7 cells, epitope-tagged sorting nexins SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated with receptor tyrosine kinases for EGF, platelet-derived growth factor, and insulin."	None
Frataxin complex	O75964;P10809;P31040;P38646;Q16595;Q9HD34;Q9Y4W6	10632;3329;6389;3313;2395;57128;10939	protein binding;mitochondrion	protein binding;mitochondrion	ATP5L;HSPD1;SDHA;HSPA9;FXN;LYRM4;AFG3L2	None	None	None
"SNX complex (SNX1, SNX1a, SNX2, SNX4, EGFR)"	O60749;O95219;P00533;Q13596	6643;8723;1956;6642	protein transporter activity;epidermal growth factor receptor signaling pathway;epidermal growth factor receptor binding	protein transport;EGF-receptor signalling pathway	SNX2;SNX4;EGFR;SNX1	SNX1A is a splice variant isoform of SNX1.	"Sorting nexin 1 (SNX1) is a protein that binds to the epidermal growth factor (EGF) receptor and is proposed to play a role in directing EGF receptors to lysosomes for degradation. When expressed in COS7 cells, epitope-tagged sorting nexins SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated with receptor tyrosine kinases for EGF, platelet-derived growth factor, and insulin. SNX1 and SNX1A were readily detected in EGF receptor immunoprecipitates. SNX2 and SNX4 were detected, but to a lesser degree, and SNX3 was undetectable."	None
"SNX complex (SNX1, SNX1a, SNX2, SNX4, PDGFRA)"	O60749;O95219;P16234;Q13596	6643;8723;5156;6642	enzyme linked receptor protein signaling pathway;platelet-derived growth factor receptor binding	receptor enzyme mediated signalling	SNX2;SNX4;PDGFRA;SNX1	SNX1A is a splice variant isoform of SNX1.	"Sorting nexin 1 (SNX1) is a protein that binds to the epidermal growth factor (EGF) receptor and is proposed to play a role in directing EGF receptors to lysosomes for degradation. When expressed in COS7 cells, epitope-tagged sorting nexins SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated with receptor tyrosine kinases for EGF, platelet-derived growth factor, and insulin."	None
"eIF3 complex (EIF3S6, EIF3S5, EIF3S4, EIF3S3, EIF3S6IP, EIF3S2, EIF3S9, EIF3S12,  EIF3S10, EIF3S8,  EIF3S1, EIF3S7, PCID1)"	O00303;O15371;O15372;O75821;O75822;P55884;P60228;Q13347;Q14152;Q7L2H7;Q99613;Q9UBQ5;Q9Y262	8665;8664;8667;8666;8669;8662;3646;8668;8661;10480;8663;27335;51386	translational initiation	translation initiation	EIF3F;EIF3D;EIF3H;EIF3G;EIF3J;EIF3B;EIF3E;EIF3I;EIF3A;EIF3M;EIF3C;EIF3K;EIF3L	Each of 13 subunits of this complex present in stoichiometric amounts (PMID:17322308).	"Four eIF3 subunits (h, i, k, and m) were found to dissociate preferentially and are therefore likely to be on the periphery of the complex (PMID:17322308)."	None
DNA synthesome complex (13 subunits)	P09884;P11387;P11388;P12004;P27694;P28340;P35251;P49005;P49642;P49643;Q14181;Q15054;Q9HCU8	5422;7150;7153;5111;6117;5424;5981;5425;5557;5558;23649;10714;57804	DNA replication;nucleus	DNA synthesis and replication;nucleus	POLA1;TOP1;TOP2A;PCNA;RPA1;POLD1;RFC1;POLD2;PRIM1;PRIM2;POLA2;POLD3;POLD4	"Since the authors did not specify TOP2, we used TOP2A."	None	None
DNA synthesome complex (17 subunits)	P09884;P11387;P11388;P12004;P27694;P28340;P35251;P49005;P49642;P49643;P56282;Q07864;Q14181;Q15054;Q9HCU8;Q9NR33;Q9NRF9	5422;7150;7153;5111;6117;5424;5981;5425;5557;5558;5427;5426;23649;10714;57804;56655;54107	DNA replication;nucleus	DNA synthesis and replication;nucleus	POLA1;TOP1;TOP2A;PCNA;RPA1;POLD1;RFC1;POLD2;PRIM1;PRIM2;POLE2;POLE;POLA2;POLD3;POLD4;POLE4;POLE3	"Since the authors did not specify TOP2, we used TOP2A."	None	None
DNA polymerase alpha-primase complex	P09884;P49642;P49643;Q14181	5422;5557;5558;23649	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;nucleus	ori recognition and priming complex formation;nucleus	POLA1;PRIM1;PRIM2;POLA2	None	DNA polymerase alpha-primase can initiate DNA synthesis de novo.	None
transcription factor IIIC multisubunit complex	Q12789;Q8WUA4;Q9UKN8;Q9Y5Q8;Q9Y5Q9	2975;2976;9329;9328;9330	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	GTF3C1;GTF3C2;GTF3C4;GTF3C5;GTF3C3	None	None	None
"SNX complex (SNX1, SNX1a, TFRC)"	P02786;Q13596	7037;6642	protein transporter activity;transferrin receptor activity;transferrin receptor binding	protein transport	TFRC;SNX1	SNX1A is a splice variant isoform of SNX1.	"Sorting nexin 1 (SNX1) is a protein that binds to the epidermal growth factor (EGF) receptor and is proposed to play a role in directing EGF receptors to lysosomes for degradation. When expressed in COS7 cells, epitope-tagged sorting nexins SNX1, SNX1A, SNX2, and SNX4 coimmunoprecipitated with receptor tyrosine kinases for EGF, platelet-derived growth factor, and insulin. Only SNX1 and SNX1A coimmunoprecipitated with endogenous transferrin receptors. Association between endogenous transferrin receptors and SNX2, SNX3, or SNX4 were not detected."	None
transcription factor IIIC multisubunit complex	Q12789;Q8WUA4;Q9UKN8;Q9Y5Q8;Q9Y5Q9	2975;2976;9329;9328;9330	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	GTF3C1;GTF3C2;GTF3C4;GTF3C5;GTF3C3	"At the time of annotation, the additional members of subcomplex TFIIIC1, 70 kDa, 50 kDa, 45kDa and 40 kDa protein were unidentified."	"The authors differentiate two forms of the isolated complexes, the sucrose gradient centrifugation isolated complex and the immunopurified complex of Hela S3 cell line (C alpha 12), which is called holo TFIIIC. Only the holo TFIIIC shows the further additional components topo I and PC4."	None
TFIIIC containing-TOP1-SUB1 complex	P11387;P53999;Q12789;Q8WUA4;Q9UKN8;Q9Y5Q8;Q9Y5Q9	7150;10923;2975;2976;9329;9328;9330	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	TOP1;SUB1;GTF3C1;GTF3C2;GTF3C4;GTF3C5;GTF3C3	"At the time of annotation, the additional members of subcomplex TFIIIC1, 70 kDa, 50 kDa, 45kDa -and 40 kDa protein were unidentified."	"The authors differentiate two forms of the isolated complexes, the sucrose gradient centrifugation isolated complex and the immunopurified complex of Hela S3 cell line (C alpha 12), which is called holo TFIIIC. Only the holo TFIIIC shows the further additional components topo I and PC4."	None
DNA synthesome core complex	P09884;P12004;P28340;P35251;P49005;P49642;P49643;Q14181;Q15054;Q9HCU8	5422;5111;5424;5981;5425;5557;5558;23649;10714;57804	DNA replication;nucleus	DNA synthesis and replication;nucleus	POLA1;PCNA;POLD1;RFC1;POLD2;PRIM1;PRIM2;POLA2;POLD3;POLD4	None	None	None
DNA synthesome complex (15 subunits)	P09884;P12004;P18858;P28340;P35251;P49005;P49642;P49643;P56282;Q07864;Q14181;Q15054;Q9HCU8;Q9NR33;Q9NRF9	5422;5111;3978;5424;5981;5425;5557;5558;5427;5426;23649;10714;57804;56655;54107	DNA replication;nucleus	DNA synthesis and replication;nucleus	POLA1;PCNA;LIG1;POLD1;RFC1;POLD2;PRIM1;PRIM2;POLE2;POLE;POLA2;POLD3;POLD4;POLE4;POLE3	None	None	None
DNA synthesome complex (17 subunits)	P09884;P11387;P11388;P12004;P27694;P28340;P35251;P49005;P49642;P49643;P56282;Q07864;Q14181;Q15054;Q9HCU8;Q9NR33;Q9NRF9	5422;7150;7153;5111;6117;5424;5981;5425;5557;5558;5427;5426;23649;10714;57804;56655;54107	DNA replication;nucleus	DNA synthesis and replication;nucleus	POLA1;TOP1;TOP2A;PCNA;RPA1;POLD1;RFC1;POLD2;PRIM1;PRIM2;POLE2;POLE;POLA2;POLD3;POLD4;POLE4;POLE3	"Since the authors did not specify TOP2, we used TOP2A."	This complex associates also with a not further characterized DNA helicase.	None
5S-DNA-TFIIIA-TFIIIC2 subcomplex	Q12789;Q8WUA4;Q92664;Q9UKN8;Q9Y5Q8;Q9Y5Q9	2975;2976;2971;9329;9328;9330	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	GTF3C1;GTF3C2;GTF3A;GTF3C4;GTF3C5;GTF3C3	None	"This complex could be complemented with TFIIIB beta, TFIIIC1 and RNA polymerase III (pol III) for transcriptional activity."	None
5S-DNA-TFIIIA-TFIIIC2-TFIIIB subcomplex	A6H8Y1;P20226;Q12789;Q8WUA4;Q92664;Q92994;Q9UKN8;Q9Y5Q8;Q9Y5Q9	55814;6908;2975;2976;2971;2972;9329;9328;9330	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	BDP1;TBP;GTF3C1;GTF3C2;GTF3A;BRF1;GTF3C4;GTF3C5;GTF3C3	None	"This complex has to be complemented with TFIIIC1 and RNA polymerase III (pol III) for full transcriptional activity. Adding pol III to an isolated quaternary 5S-DNA-TFIIIA-TFIIIC2-TFIIIB-beta complex does not suffice for transcription, but the further addition of TFIIIC1 is absolutely required."	None
CRM1-Survivin-AuroraB mitotic complex	O14980;O15392;Q96GD4	7514;332;9212	"mitotic cell cycle;nuclear transport;chromosome, centromeric region"	mitotic cell cycle;nuclear transport;centromere / kinetochore	XPO1;BIRC5;AURKB	None	"Crm1 could be recovered in a complex with endogenous Survivin-Aurora-B from mitotic cells, whereas complex formation was abolished on pretreatment with LMB (leptomycin B)."	None
CRM1-Survivin mitotic complex	O14980;O15392	7514;332	"mitotic cell cycle;nuclear transport;chromosome, centromeric region"	mitotic cell cycle;nuclear transport;centromere / kinetochore	XPO1;BIRC5	None	The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.	None
"Chromosomal passenger complex CPC (INCENP, CDCA8, BIRC5, AURKB)"	O15392;Q53HL2;Q96GD4;Q9NQS7	332;55143;9212;3619	"mitotic cell cycle;chromosome segregation;chromosome, centromeric region"	mitotic cell cycle;chromosome segregation/division;centromere / kinetochore	BIRC5;CDCA8;AURKB;INCENP	None	"Borealin forms a complex with Survivin, which can bind to Aurora-B kinase and is incorporated into the CP-holocomplex by interacting with INCENP (PMID:16571674). The NES in Survivin mediates the recruitment of Crm1-Ran-GTP, which seems to be involved in guiding the CPC to the centromeres in early prophase by an unknown mechanism."	None
"Chromosomal passenger complex CPC (INCENP, CDCA8, BIRC5, AURKB)"	O15392;Q53HL2;Q96GD4;Q9NQS7	332;55143;9212;3619	"mitotic cell cycle;chromosome segregation;chromosome, centromeric region;spindle assembly"	mitotic cell cycle;chromosome segregation/division;centromere / kinetochore;spindle pole body/centrosome and microtubule cycle	BIRC5;CDCA8;AURKB;INCENP	None	"Yeast two hybrid analysis pointed out that Aurora B associates with the C terminus of INCENP via the IN-box, Survivin and Borealin interact with the N-terminal 58 amino acids of INCENP and bind to each other."	None
"Chromosomal passenger complex CPC (INCENP, CDCA8, BIRC5)"	O15392;Q53HL2;Q9NQS7	332;55143;3619	"mitotic cell cycle;chromosome segregation;chromosome, centromeric region;spindle assembly"	mitotic cell cycle;chromosome segregation/division;centromere / kinetochore;spindle pole body/centrosome and microtubule cycle	BIRC5;CDCA8;INCENP	None	"Yeast two hybrid analysis pointed out that Survivin and Borealin interact with the N-terminal 58 amino acids of INCENP and bind to each other. The authors showed that a ternary complex between Borealin, Survivin, and the first 58 amino acids of INCENP (INCENP1-58) exists in vivo. This subcomplex was found to be essential and sufficient for targeting to the centromere. Notably, AuroraB kinase, the enzymatic core of the CPC, was not required for centromere localization of the subcomplex."	None
WNK1-OSR1 complex	O95747;Q9H4A3	9943;65125	protein binding;response to osmotic stress;excretion;water homeostasis;detection of osmotic stimulus	protein binding;osmosensing  and response;water homeostasis	OXSR1;WNK1	None	"WNK1 and OSR1 regulate NKCC activity (sodium, potassium, two chloride cotransporter) (PMID:16832045)."	WNK1 is mutated in Gordon's hypertension syndrome.
WNK1-SPAK complex	Q9H4A3;Q9UEW8	65125;27347	response to osmotic stress;excretion;water homeostasis;detection of osmotic stimulus	osmosensing  and response;water homeostasis	WNK1;STK39	None	None	WNK1 is mutated in Gordon's hypertension syndrome.
Hip1R-cortactin complex	O75146;Q14247	9026;2017	structural molecule activity;actin filament-based movement;cytoplasm	structural protein binding;actin dependent transport;cytoplasm	HIP1R;CTTN	None	The Hip1R-cortactin complex negatively regulates actin assembly associated with endocytosis.	None
RFC2-RIalpha complex	P30153;P35250	5518;5982	protein binding	protein binding	PPP2R1A;RFC2	None	None	None
RFC2-RIalpha complex	P30153;P35249	5518;5984	protein binding	protein binding	PPP2R1A;RFC4	None	None	None
ATR-HDAC2 complex	Q13535;Q92769	545;3066	DNA topological change;protein acetylation;protein deacetylation;chromosome organization	"DNA conformation modification (e.g. chromatin);modification by acetylation, deacetylation;organization of chromosome structure"	ATR;HDAC2	None	The ATR-HDAC2 complex is a robust biochemical entity that withstands ammonium sulfate precipitation and anion exchange chromatography.	None
ATR-HDAC2-CHD4 complex	Q13535;Q14839;Q92769	545;1108;3066	DNA topological change;cell cycle checkpoint;protein acetylation;protein deacetylation;cellular response to DNA damage stimulus;chromosome organization;nucleus	"DNA conformation modification (e.g. chromatin);cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);modification by acetylation, deacetylation;DNA damage response;organization of chromosome structure;nucleus"	ATR;CHD4;HDAC2	None	"Other members of the NRD complex HDAC1, MTA-1, and MTA-2 are also detectable in ATR immunoprecipitates."	None
"SNARE complex (VAMP2, SNAP25, STX1a, CPLX1, CPLX3)"	O14810;P60880;P63027;Q16623;Q8WVH0	10815;6616;6844;6804;594855	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	CPLX1;SNAP25;VAMP2;STX1A;CPLX3	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
"SNARE complex (VAMP2, SNAP25, STX1a, CPLX3, CPLX4)"	P60880;P63027;Q16623;Q7Z7G2;Q8WVH0	6616;6844;6804;339302;594855	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP25;VAMP2;STX1A;CPLX4;CPLX3	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway. The interaction between the SNARE complex and CPX4 indicates a lower binding affinity.	None
"SNARE complex (VAMP2, SNAP25, STX1a, STX3, CPLX1, CPLX3, CPLX4)"	O14810;P60880;P63027;Q13277;Q16623;Q7Z7G2;Q8WVH0	10815;6616;6844;6809;6804;339302;594855	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	CPLX1;SNAP25;VAMP2;STX3;STX1A;CPLX4;CPLX3	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway. The interaction between the SNARE complex and CPX4 indicates a lower binding affinity.	None
"Complexin complex (STX3, CPLX1, CPLX3)"	O14810;Q13277;Q8WVH0	10815;6809;594855	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	CPLX1;STX3;CPLX3	None	None	None
CF IIAm complex (Cleavage factor IIAm complex)	O43809;O60231;O94913;P19447;P23246;P26368;P26599;P49959;Q01081;Q07157;Q14444;Q16630;Q8N684;Q92759;Q92989;Q9UKF6	11051;8449;51585;2071;6421;11338;5725;4361;7307;7082;4076;11052;79869;2968;10978;51692	RNA 3'-end processing;mRNA 3'-end processing;nucleus	3'-end processing;nucleus	NUDT21;DHX16;PCF11;ERCC3;SFPQ;U2AF2;PTBP1;MRE11A;U2AF1;TJP1;CAPRIN1;CPSF6;CPSF7;GTF2H4;CLP1;CPSF3	None	"Eukaryotic mRNA precursors (pre-mRNAs) undergo a number of processing steps before they are exported to the cytoplasm. Six different protein factors are required in vitro for 3' end formation of mammalian pre-mRNAs by endonucleolytic cleavage and polyadenylation. One of these factors is cleavage factor IIm (CF IIm). During purification of CF IIm, the activity separated into an essential fraction (CF IIAm) and an apparently non-essential, but stimulatory component (CF IIBm)."	None
SMN complex	O14893;P14678;P62304;P62306;P62308;P62314;P62316;P62318;Q16637;Q9UHI6	8487;6628;6635;6636;6637;6632;6633;6634;None;11218	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN2;SNRPB;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3;SMN1; SMN2;DDX20	"Several other subunits of the complex were found in the analysis, which have not been further characterized:  p175, p95, p60, p50 using anti-SMN (2B1) or p175, p115, p95, p50 using anti-Gemin3 (11G9)."	"Assembly of the Sm-class of U-rich small nuclear ribonucleoprotein particles (U snRNPs) is a process facilitated by the macromolecular survival of motor neuron (SMN) complex. Spinal muscular atrophy (SMA) is the most common genetic cause of infant mortality. Deletions or mutations in the survival of motor neurons (SMN1) gene, the SMA-causing gene, are detected in over 95% of SMA patients. The SMN complex is found both in the cytoplasm and in the nucleus, where it is concentrated in gems, nuclear bodies similar in size and number to Cajal (coiled) bodies and often associated with them."	Spinal muscular atrophy (SMA)
SMN complex	O14893;P14678;P57678;P62304;P62306;P62308;P62314;P62316;P62318;Q16637;Q8TEQ6;Q8WXD5;Q9H840;Q9NWZ8;Q9UHI6;Q9Y3F4	8487;6628;50628;6635;6636;6637;6632;6633;6634;None;25929;79833;79760;54960;11218;11171	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN2;SNRPB;GEMIN4;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3;SMN1; SMN2;GEMIN5;GEMIN6;GEMIN7;GEMIN8;DDX20;STRAP	None	"Assembly of the Sm-class of U-rich small nuclear ribonucleoprotein particles (U snRNPs) is a process facilitated by the macromolecular survival of motor neuron (SMN) complex.  Spinal muscular atrophy (SMA) is the most common genetic cause of infant mortality. Deletions or mutations in the survival of motor neurons (SMN1) gene, the SMA-causing gene, are detected in over 95% of SMA patients. The SMN complex is found both in the cytoplasm and in the nucleus, where it is concentrated in gems, nuclear bodies similar in size and number to Cajal (coiled) bodies and often associated with them. Nine factors, including the SMN protein, the product of the spinal muscular atrophy (SMA) disease gene, Gemins 2-8  and unrip have been identified as the major components of the SMN complex. Interaction studies in the present article revealed a framework of the SMN complex with SMN, Gemin7, and Gemin8 as its backbone."	Spinal muscular atrophy (SMA)
Cleavage and polyadenylation factor (CPSF)	O95639;Q10570;Q6UN15;Q9P2I0;Q9UKF6	10898;29894;None;53981;51692	mRNA 3'-end processing;RNA binding;protein binding;nucleus;regulation of mRNA polyadenylation	3'-end processing;RNA binding;protein binding;nucleus	CPSF4;CPSF1;FIP1L1;CPSF2;CPSF3	None	"In mammals, polyadenylation of mRNA precursors (pre-mRNAs) by poly(A) polymerase (PAP) depends on cleavage and polyadenylation specificity factor (CPSF). CPSF is a multisubunit complex that binds to the canonical AAUAAA hexamer and to U-rich upstream sequence elements on the pre-mRNA, thereby stimulating the otherwise weakly active and nonspecific polymerase to elongate efficiently RNAs containing a poly(A) signal."	None
Cleavage stimulation factor	P33240;Q05048;Q12996	1478;1477;1479	RNA 3'-end processing;mRNA 3'-end processing;RNA binding;nucleus	3'-end processing;RNA binding;nucleus	CSTF2;CSTF1;CSTF3	None	"Polyadenylation of mRNA precursors is a two-step reaction requiring multiple protein factors. Cleavage stimulation factor (CstF) is a heterotrimer necessary for the first step, endonucleolytic cleavage, and it plays an important role in determining the efficiency of polyadenylation. The cleavage and polyadenylation specificity factor (CPSF) recognizes the highly conserved hexanucleotide AAUAAA, whereas CstF binds to GU- or U-rich elements downstream of the poly(A) site."	None
"Polyadenylation complex (CSTF1, CSTF2, CSTF3, SYMPK CPSF1, CPSF2, CPSF3)"	P33240;Q05048;Q10570;Q12996;Q92797;Q9P2I0;Q9UKF6	1478;1477;29894;1479;8189;53981;51692	mRNA 3'-end processing;RNA binding;nucleus;mRNA polyadenylation	3'-end processing;RNA binding;nucleus	CSTF2;CSTF1;CPSF1;CSTF3;SYMPK;CPSF2;CPSF3	None	"Polyadenylation of mRNA precursors is a two-step reaction requiring multiple protein factors. The polyadenylation complex (containing Cstf1, Cstf2, Cstf3, Sympk, Cpsf1, Cpsf2 and Cpsf3), which contains the cleavage stimulation factor (CstF) and subunits of the cleavage and polyadenylation specificity factor (CPSF) might consist of more protein components."	None
snRNP-free U1A (SF-A) complex	P09012;P17844;P23246;Q15233	6626;1655;6421;4841	RNA 3'-end processing;mRNA 3'-end processing;RNA binding;nucleus	3'-end processing;RNA binding;nucleus	SNRPA;DDX5;SFPQ;NONO	None	"The formation of mRNAs in the nuclei of eukaryotic cells involves several co- and post-transcriptional processing events, including 5' end capping, RNA splicing, and 3' end formation. The SF-A complex was found to be involved in cleavage of the mRNA precursor, an essential step of the 3' end formation process."	None
Histone H3.1 complex	O14929;P49321;P62805;P68431;Q09028;Q13111;Q13112;Q8TEX9;Q9NVP2;Q9Y294	8520;4678;None;None;5928;10036;8208;79711;55723;25842	protein complex assembly;nucleus	assembly of protein complexes;nucleus	HAT1;NASP;HIST1H4A;;HIST1H3A;;RBBP4;CHAF1A;CHAF1B;IPO4;ASF1B;ASF1A	None	"The H3.1 and H3.3 complexes contain distinct histone chaperones, CAF-1 and HIRA, that were shown to be necessary to mediate DNA-synthesis-dependent and -independent nucleosome assembly, respectively."	None
Histone H3.3 complex	O14929;P49321;P54198;P62805;P84243;Q09028;Q8TEX9;Q9NVP2;Q9Y294	8520;4678;7290;None;None;5928;79711;55723;25842	protein complex assembly;nucleus	assembly of protein complexes;nucleus	HAT1;NASP;HIRA;HIST1H4A;;H3F3A; H3F;RBBP4;IPO4;ASF1B;ASF1A	None	"The H3.1 and H3.3 complexes contain distinct histone chaperones, CAF-1 and HIRA, that were shown to be necessary to mediate DNA-synthesis-dependent and -independent nucleosome assembly, respectively."	None
FA complex (Fanconi anemia complex)	O15287;O15360;Q00597;Q8IYD8;Q8NB91;Q9HB96;Q9NPI8;Q9NW38	2189;2175;2176;57697;2187;2178;2188;55120	protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;FANCC;FANCM;FANCB;FANCE;FANCF;FANCL	None	"The Fanconi complex normally promotes a cascade of changes in a biochemical pathway that ultimately leads to the repair of cellular DNA damage. But if any of the proteins within the complex are mutated, the enzyme FancL is disabled and the DNA repair pathway is disrupted."	FA complex is involved in Fanconi anemia (FA) disease.
Integrator complex	Q5TA45;Q68E01;Q6P9B9;Q75QN2;Q8N201;Q96CB8;Q96HW7;Q9H0H0;Q9NV88;Q9NVH2;Q9NVR2;Q9UL03	54973;65123;80789;55656;26173;57117;92105;57508;55756;25896;55174;26512	RNA processing;nucleus	RNA processing;nucleus	CPSF3L;INTS3;INTS5;INTS8;INTS1;INTS12;INTS4;INTS2;INTS9;INTS7;INTS10;INTS6	None	The Intergrator complex is involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3' box-dependent processing. The Integrator complex is recruited to the U1 and U2 snRNA genes and mediates the snRNAs 3' cleavage.	None
DSS1 complex	A6NKF1;P51587;P60896;Q5TA45;Q6P9B9;Q75QN2;Q96HW7;Q96PV6;Q9H0H0;Q9NV88;Q9NVH2;Q9NVR2;Q9UL03	None;675;7979;54973;80789;55656;92105;114823;57508;55756;25896;55174;26512	nucleus	nucleus	SAC3D1;BRCA2;SHFM1;CPSF3L;INTS5;INTS8;INTS4;LENG8;INTS2;INTS9;INTS7;INTS10;INTS6	None	None	None
Integrator-RNAPII complex	P24928;P30876;Q5TA45;Q68E01;Q6P9B9;Q75QN2;Q8N201;Q96CB8;Q96HW7;Q9H0H0;Q9NV88;Q9NVH2;Q9NVR2;Q9UL03	5430;5431;54973;65123;80789;55656;26173;57117;92105;57508;55756;25896;55174;26512	"transcription, DNA-templated;RNA processing;nucleus"	TRANSCRIPTION;RNA processing;nucleus	POLR2A;POLR2B;CPSF3L;INTS3;INTS5;INTS8;INTS1;INTS12;INTS4;INTS2;INTS9;INTS7;INTS10;INTS6	None	The integrator complex interacts with the C-terminal domain of the RNA Polymerase II. The integrator-RNAPII complex mediates RNAPII-dependent transcription of at least U1 and U2 snRNA genes.	None
p33ING1b-p300 complex	Q09472;Q9UK53	2033;3621	DNA topological change;mitotic cell cycle;regulation of cell cycle;protein acetylation;chromosome organization;chromosome	"DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by acetylation, deacetylation;organization of chromosome structure;chromosome"	EP300;ING1	None	"Anti-p300 immunoprecipitates contained p33ING1b, but not p47ING1a."	None
p33ING1b-HDAC1 complex	Q13547;Q9UK53	3065;3621	DNA topological change;mitotic cell cycle;regulation of cell cycle;protein deacetylation;chromosome organization;chromosome	"DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by acetylation, deacetylation;organization of chromosome structure;chromosome"	HDAC1;ING1	None	HDAC1 interacts as well with p33ING1b as with p47ING1a.	None
ING1-p300-PCNA complex	P12004;Q09472;Q9UK53	5111;2033;3621	DNA repair;DNA topological change;mitotic cell cycle;regulation of cell cycle;protein acetylation;chromosome organization;chromosome	"DNA repair;DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by acetylation, deacetylation;organization of chromosome structure;chromosome"	PCNA;EP300;ING1	None	p33ING1b affects the degree of physical association between proliferating cell nuclear antigen (PCNA) and p300.	None
"Ubiquitin E3 ligase (DDB1, DDB2, CUL4A, CUL4B, RBX1)"	P62877;Q13619;Q13620;Q16531;Q92466	9978;8451;8450;1642;1643	protein ubiquitination;cellular response to DNA damage stimulus;response to radiation;ubiquitin-dependent protein catabolic process;nucleosome	"modification by ubiquitination, deubiquitination;DNA damage response;electromagnetic waves stress response (e.g. UV, X-ray);proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;CUL4A;CUL4B;DDB1;DDB2	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The CUL4-DDB-ROC1 complex is a ubiquitin E3 ligase for histones H3 and H4. CUL4-DDB-ROC1-mediated H3 and H4 ubiquitylation was shown to facilitate cellular response to UV damage by affecting nucleosome stability.	None
ING1-PCNA complex	P12004;Q9UK53	5111;3621	cellular response to DNA damage stimulus;response to radiation;cell death;chromosome	"DNA damage response;electromagnetic waves stress response (e.g. UV, X-ray);cell death;chromosome"	PCNA;ING1	None	"UV rapidly induces p33ING1b, but not p47ING1a isoform, to bind PCNA."	None
RNF20-RNF40-UbE2E1 complex	O75150;P51965;Q5VTR2	9810;7324;56254	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein ubiquitination;nucleus;ubiquitin-dependent protein catabolic process"	"transcriptional control;modification by ubiquitination, deubiquitination;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	RNF40;UBE2E1;RNF20	None	"In humans, the 600 kDa RNF20/40 complex is the E3 ligase and UbcH6 is the ubiquitin E2-conjugating enzyme for H2B-Lys120 monoubiquitination."	None
p400-associated complex	O96019;P60709;Q96L91;Q9Y230;Q9Y265;Q9Y4A5	86;60;57634;10856;8607;8295	chromosome organization;DNA topological change;protein binding;nucleus	organization of chromosome structure;DNA conformation modification (e.g. chromatin);protein binding;nucleus	ACTL6A;ACTB;EP400;RUVBL2;RUVBL1;TRRAP	"Since the authors did not specify ACTL6, we used ACTL6A."	None	None
Paf complex	Q6P1J9;Q6PD62;Q8N7H5;Q8WVC0;Q9GZS3	79577;9646;54623;123169;80349	"transcription, DNA-templated;nucleus"	TRANSCRIPTION;nucleus	CDC73;CTR9;PAF1;LEO1;WDR61	None	"hPAF participates in histone H2B monoubiquitiation. In addition, hPAF coordinates events during transcription (initiation, promoter clearance, and elongation) and also events in RNA quality control. The hPAF complex interacts with the hSKI complex."	None
SKI complex	Q15477;Q6PGP7;Q9GZS3	6499;9652;80349	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;cytoplasm;nucleus;regulation of mRNA stability"	transcriptional control;cytoplasm;nucleus;control of mRNA stability	SKIV2L;TTC37;WDR61	None	hSKI complex is present at transcriptionally active genes with recruitment dependent on hPAF complex.	None
"SNARE complex (STX4, VAMP8, VAMP3, SNAP23)"	O00161;Q12846;Q15836;Q9BV40	8773;6810;9341;8673	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP23;STX4;VAMP3;VAMP8	None	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.VAMP-3 and VAMP-8 form SNARE complexes with platelet syntaxin 4 and are required for platelet granule secretion.	None
c-MYC-ATPase-helicase complex	O96019;P01106;Q9Y230;Q9Y265;Q9Y4A5	86;4609;10856;8607;8295	"chromosome organization;DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;DNA binding;nucleus"	"organization of chromosome structure;DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;DNA binding;nucleus"	ACTL6A;MYC;RUVBL2;RUVBL1;TRRAP	BAF53 and beta-actin have been described in this paper as p45 and p41. Both subunits were identified in the succeeding paper PMID:11839798.	"TIP49 and TIP48 are complexed with c-Myc in vivo, and binding is dependent on a c-Myc domain essential for oncogenic activity. TIP49 protein is an essential mediator of c-Myc oncogenic transformation."	None
c-MYC-ATPase-helicase complex	O96019;P01106;Q9Y230;Q9Y265;Q9Y4A5	86;4609;10856;8607;8295	"chromosome organization;DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;DNA binding;nucleus"	"organization of chromosome structure;DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;DNA binding;nucleus"	ACTL6A;MYC;RUVBL2;RUVBL1;TRRAP	None	None	None
CBC complex (cap binding complex)	P52298;Q09161	22916;4686	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	RNA binding;RNA transport;nuclear transport;nucleus	NCBP2;NCBP1	None	The heterodimeric nuclear cap binding complex (CBC) binds to 5'-capped polymerase II transcripts. It enhances the efficiency of several mRNA maturation steps and is essential for U snRNA nuclear export in multicellular eukaryotes.	None
TIP49-TIP48-BAF53 complex	O96019;Q9Y230;Q9Y265	86;10856;8607	chromosome organization;nucleus	organization of chromosome structure;nucleus	ACTL6A;RUVBL2;RUVBL1	None	None	None
PHAX-CBC complex (cap binding complex)	P52298;Q09161;Q9H814	22916;4686;51808	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	NCBP2;NCBP1;PHAX	None	"In metazoa, assembly of spliceosomal U snRNPs requires nuclear export of U snRNA precursors. Export depends upon the RNA cap structure, nuclear cap-binding complex (CBC), the export receptor CRM1/Xpo1, and RanGTP. PHAX (phosphorylated adaptor for RNA export) is an additional factor required for U snRNA export complex assembly in vitro. In vivo, PHAX is required for U snRNA export but not for CRM1-mediated export in general. PHAX is phosphorylated in the nucleus and then exported with RNA to the cytoplasm, where it is dephosphorylated. PHAX phosphorylation is essential for export complex assembly while its dephosphorylation causes export complex disassembly. The compartmentalized PHAX phosphorylation cycle can contribute to the directionality of export. PHAX binding to CBC is greatly increased by the presence of capped RNA."	None
TRRAP-BAF53-HAT complex	O96019;Q9Y4A5	86;8295	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	ACTL6A;TRRAP	None	"TRRAP and BAF53 associate with an up to now not identified histone acetyltransferase activity which does not contain TIP60, TIP49 or TIP48."	None
CRM1-RAN-PHAX-CBC complex (cap binding complex)	O14980;P52298;P62826;Q09161;Q9H814	7514;22916;5901;4686;51808	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	XPO1;NCBP2;RAN;NCBP1;PHAX	None	"In metazoa, assembly of spliceosomal U snRNPs requires nuclear export of U snRNA precursors. Export depends upon the RNA cap structure, nuclear cap-binding complex (CBC), the export receptor CRM1/Xpo1, and RanGTP. PHAX (phosphorylated adaptor for RNA export) is an additional factor required for U snRNA export complex assembly in vitro. PHAX binding to CBC is greatly increased by the presence of capped RNA. Phosphorylated PHAX can bind to RanGTP/Xpo1 but does so more strongly in the presence of CBC and even more in the presence of both CBC and RNA. Thus, every step in U snRNA export complex formation involves some degree of cooperativity."	None
Polycomb repressive complex 4	O75530;Q15910;Q96EB6	8726;2146;23411	"DNA topological change;chromosome organization;nucleus;negative regulation of transcription, DNA-templated"	DNA conformation modification (e.g. chromatin);organization of chromosome structure;nucleus;transcription repression	EED;EZH2;SIRT1	None	"Polycomb repressive complexes are required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. They are methylating histones at lysine residues. PRC4 methylates preferentially the histone H1b isoform, whereas PRC2 methylated preferentially the histone H1d isoform. The PRC3 complex exclusively targets methylation of histone H3-K27, and the activity is repressed in the presence of histone H1. PRC2 also methylates histone H3-K27 but in the presence of histone H1, PRC2 methylates both H3-K27 and H1-K26."	"PRC complexes are overexpressed in breast, colon, and prostate cancers."
BCOR complex	P11142;P63208;Q06587;Q6W2J9;Q8N488;Q8NHM5;Q99496;Q9BSM1	3312;6500;6015;54880;23429;84678;6045;84759	"protein ubiquitination;nucleus;ubiquitin-dependent protein catabolic process;covalent chromatin modification;transcription, DNA-templated;histone demethylation"	"modification by ubiquitination, deubiquitination;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway);TRANSCRIPTION"	HSPA8;SKP1;RING1;BCOR;RYBP;KDM2B;RNF2;PCGF1	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The BCOR complex contains E3 ligase activity for histone H2A. Monoubiquitylated H2A is present together with the BCOR complex at BCL6 target genes in B cells. This strongly suggests a role of BCOR as regulator of BCL6, a sequence-specific transcriptional repressor, that probably plays an important role in lymphomagenesis."	None
CENP-A NAC-CAD complex	Q03188;Q13352;Q6IPU0;Q71F23;Q7L2Z9;Q8N0S6;Q8N2Z9;Q96BT3;Q96H22;Q9BS16;Q9BU64;Q9H3R5;Q9NSP4	1060;23421;401541;79682;55166;91687;None;80152;55839;64105;79172;64946;79019	"regulation of gene expression by genetic imprinting;kinetochore assembly;chromosome segregation;spindle assembly;centrosome cycle;chromosome, centromeric region"	DNA imprinting and other epigenetic effects;centromere/kinetochore complex maturation;chromosome segregation/division;spindle pole body/centrosome and microtubule cycle;centromere / kinetochore	CENPC;ITGB3BP;CENPP;CENPU;CENPQ;CENPL;APITD1;CENPT;CENPN;CENPK;CENPO;CENPH;CENPM	None	"Assembly of CENP-A NAC complex at centromeres is dependent on CENP-M, CENP-N and CENP-T."	None
C complex spliceosome	O43290;O43390;O43660;O60306;O60506;O60508;O75533;O75643;O94906;O95391;O95926;P07910;P08579;P09651;P09661;P11940;P14678;P17844;P22626;P31943;P38159;P38919;P42285;P51991;P52272;P52597;P61326;P61978;P62304;P62306;P62308;P62310;P62314;P62316;P62318;Q00839;Q01081;Q07955;Q12874;Q13435;Q13523;Q13573;Q14331;Q14562;Q15029;Q15393;Q15428;Q15459;Q6NZY4;Q6P2Q9;Q6UX04;Q86V81;Q8IYB3;Q8WUQ7;Q92620;Q96BP3;Q96DF8;Q96DI7;Q99459;Q9BRR8;Q9BRX9;Q9BUQ8;Q9BZJ0;Q9H2H8;Q9H307;Q9H5Z1;Q9HCG8;Q9HCS7;Q9NW64;Q9P013;Q9UBB9;Q9UJV9;Q9UKM9;Q9ULR0;Q9UMS4;Q9UNP9;Q9UQ35;Q9Y333;Q9Y3C6;Q9Y5S9	9092;10236;5356;9716;10492;51362;23451;23020;24148;10569;25949;3183;6629;3178;6627;26986;6628;1655;3181;3187;27316;9775;23517;220988;4670;3185;4116;3190;6635;6636;6637;27258;6632;6633;6634;3192;7307;6426;10946;10992;8899;22938;2483;1659;9343;23450;8175;10291;55596;10594;10283;10189;10250;58509;9785;23398;8220;9410;988;55094;84292;9416;51340;53938;5411;60625;57703;56949;55696;51503;None;51428;22913;57461;27339;10450;23524;57819;51645;9939	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	SART1;HNRNPR;PLRG1;AQR;SYNCRIP;CDC40;SF3B1;SNRNP200;PRPF6;SLU7;SYF2;HNRNPC;SNRPB2;HNRNPA1;SNRPA1;PABPC1;SNRPB;DDX5;HNRNPA2B1;HNRNPH1;RBMX;EIF4A3;MTREX;HNRNPA3;HNRNPM;HNRNPF;MAGOH;HNRNPK;SNRPE;SNRPF;SNRPG;LSM3;SNRPD1;SNRPD2;SNRPD3;HNRNPU;U2AF1;SRSF1;SF3A3;SF3B2;PRPF4B;SNW1;FRG1;DHX8;EFTUD2;SF3B3;SF3A2;SF3A1;ZCCHC8;PRPF8;CWC27;ALYREF;SRRM1;CACTIN;DHX38;PPWD1;DGCR14;SNRNP40;CDC5L;GPATCH1;WDR83;DDX23;CRNKL1;PPIL3;PNN;DHX35;CWC22;XAB2;RBM22;CWC15;TFIP11;DDX41;RALY;ISY1;PRPF19;PPIE;SRRM2;LSM2;PPIL1;RBM8A	None	"In eukaryotes, the removal of introns from nascent transcripts is mediated by a highly dynamic, macromolecular machine called the spliceosome."	None
CDC5L core complex	O43660;O75934;P11142;Q92616;Q99459;Q9UMS4	5356;10286;3312;10985;988;27339	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	PLRG1;BCAS2;HSPA8;GCN1;CDC5L;PRPF19	None	The CDC5L complex incorporates into the spliceosome in an ATP-dependent step. This complex is required for the second catalytic step of pre-mRNA splicing. Immunodepletion of the CDC5L complex from HeLa nuclear extract inhibits the formation of pre-mRNA splicing products in vitro but does not prevent spliceosome assembly. Experiments indicate that there exists a CDC5L core complex in HeLa nuclear extract containing at least six proteins that interact with each other and with other splicing factors and enzymes.	None
CDC5L complex	A8K8P3;O15297;O43660;O75533;O75934;P09012;P09661;P11142;P11388;P15884;P23246;P38159;P62136;P62314;P62316;P62318;P78527;Q01130;Q07955;Q12905;Q13435;Q14204;Q15427;Q7L1Q6;Q8IYB3;Q92616;Q99459;Q9P013;Q9UMS4;Q9UPN6	9814;8493;5356;23451;10286;6626;6627;3312;7153;6925;6421;27316;5499;6632;6633;6634;5591;6427;6426;3608;10992;1778;10262;9689;10250;10985;988;51503;27339;22828	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	SFI1;PPM1D;PLRG1;SF3B1;BCAS2;SNRPA;SNRPA1;HSPA8;TOP2A;TCF4;SFPQ;RBMX;PPP1CA;SNRPD1;SNRPD2;SNRPD3;PRKDC;SRSF2;SRSF1;ILF2;SF3B2;DYNC1H1;SF3B4;BZW1;SRRM1;GCN1;CDC5L;CWC15;PRPF19;SCAF8	None	The CDC5L complex incorporates into the spliceosome in an ATP-dependent step. This complex is required for the second catalytic step of pre-mRNA splicing. Immunodepletion of the CDC5L complex from HeLa nuclear extract inhibits the formation of pre-mRNA splicing products in vitro but does not prevent spliceosome assembly.	None
EGFR-containing signaling complex	O00443;O00750;P00533;P04626	5286;5287;1956;2064	epidermal growth factor receptor signaling pathway	EGF-receptor signalling pathway	PIK3C2A;PIK3C2B;EGFR;ERBB2	None	"EGF stimulation recruits both PI3K-C2alpha  and PI3K-C2beta  to the EGFR-containing signaling complex, together with ErbB-2."	None
ESCRT-III complex	O43633;Q7LBR1;Q96CF2;Q96FZ7;Q9BY43;Q9H444;Q9HD42;Q9NZZ3;Q9UQN3;Q9Y3E7	27243;57132;92421;79643;29082;128866;5119;51510;25978;51652	intracellular protein transport;protein targeting;protein transport;protein transporter activity;vesicle-mediated transport;cytoplasm	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.);cytoplasm"	CHMP2A;CHMP1B;CHMP4C;CHMP6;CHMP4A;CHMP4B;CHMP1A;CHMP5;CHMP2B;CHMP3	None	"The ESCRT-III complex is required for multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-III complex is probably involved in the concentration of MVB cargo. In the ESCRT-III complex, it probably serves as an acceptor for ESCRT-II complex on endosomal membranes. In case of infection, the HIV-1 virus takes advantage of the ESCRT-III complex for budding and exocytic cargos of viral proteins."	None
ESCRT-II complex	Q86VN1;Q96H20;Q9BRG1	51028;11267;84313	intracellular protein transport;protein targeting;protein transport;protein transporter activity;vesicle-mediated transport;cytoplasm	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.);cytoplasm"	VPS36;SNF8;VPS25	None	The ESCRT-II complex is required for multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. The MVB pathway mediates delivery of transmembrane proteins into the lumen of the lysosome for degradation. The ESCRT-II complex is probably involved in the recruitment of the ESCRT-III complex.	None
SMRT core complex	O15379;O60907;Q9Y618	8841;6907;9612	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;hormone-mediated signaling pathway;signaling;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;hormone mediated signal transduction;cellular signalling;organization of chromosome structure;nucleus"	HDAC3;TBL1X;NCOR2	None	"HDAC3 did not interact directly with TBL1. However, addition of SMRT to the mixture of HDAC3 and TBL1 allowed formation of a stable TBL1-SMRT-HDAC3 complex in vitro, suggesting that SMRT mediates the association of TBL1 and HDAC3 in a single complex in vivo."	TBL1 is involved in deafness.
DNA double-strand break end-joining complex	O60934;P12956;P13010;P49917;P49959;Q13426;Q92878	4683;2547;7520;3981;4361;7518;10111	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	NBN;XRCC6;XRCC5;LIG4;MRE11A;XRCC4;RAD50	None	None	None
NCBP-NIP1 complex	Q09161;Q96P71	4686;63941	nucleus;RNA cap binding	nucleus	NCBP1;NECAB3	None	None	None
RNA pol II containing coactivator complex Tat-SF	O00267;O43719;P19338;P24928;P50750	6829;27336;4691;5430;1025	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	SUPT5H;HTATSF1;NCL;POLR2A;CDK9	None	All fractions with Tat stimulatory activity contained these components as well as CDK9.	None
ESCRT-I complex	A5D8V6;Q99816;Q9UK41	55048;7251;51160	intracellular protein transport;protein targeting;protein transport;protein transporter activity;vesicle-mediated transport;cytoplasm;endoplasmic reticulum	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.);cytoplasm;endoplasmic reticulum"	VPS37C;TSG101;VPS28	None	ESCRT-I is one of three defined protein complexes in the class E vacuolar protein sorting (VPS) pathway required for the sorting of ubiquitinated transmembrane proteins into internal vesicles of multivesicular bodies.	None
Rap1 complex	P09874;P12956;P13010;P49959;Q15554;Q92878;Q9NYB0	142;2547;7520;4361;7014;10111;54386	DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	DNA binding;DNA damage response;organization of chromosome structure;nucleus	PARP1;XRCC6;XRCC5;MRE11A;TERF2;RAD50;TERF2IP	None	"This complex is responsible for proper maintenance of telomere length and structure. Rad50, Mre11 and Ku86 are recruited to Rap1 independent of TRF2. PARP1, however, most likely interacts with Rap1 through TRF2."	None
E2F-6 complex	O75461;O75712;P61244;Q06587;Q14186;Q8IWI9;Q8IY57;Q969R5;Q96KQ7;Q99496;Q9BYE7;Q9H9B1	1876;2707;4149;6015;7027;23269;10138;83746;10919;6045;84108;79813	"negative regulation of transcription, DNA-templated;DNA binding;nucleus;histone H3-K9 methylation"	transcription repression;DNA binding;nucleus	E2F6;GJB3;MAX;RING1;TFDP1;MGA;YAF2;L3MBTL2;EHMT2;RNF2;PCGF6;EHMT1	None	The E2F-6 complex occupies target promoters like E2F binding elements and contains chromatin modifiers such as histone methyltransferases. Data suggest that these chromatin modifiers contribute to silencing of E2F- and Myc-responsive genes in quiescent cells.	None
Exon junction complex (mRNA splicing-dependent)	Q6P2Q9;Q8IYB3	10594;10250	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	PRPF8;SRRM1	"At the time of annotation, the additional members p50 and p20 of the protein complex remained unidentified."	"The results indicate that splicing alters the complement of proteins associated with exon-exon junctions regardless of the nature of the photoreactive group, the position of this group relative to the exon-exon junction, or the exact sequence of the 5' exon, even though changing the position or the nature of the photoreactive group can affect exactly which proteins are detected by this method."	None
RAD51C-XRCC3 complex	O43502;O43542	5889;7517	DNA repair;DNA recombination;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA recombination;DNA binding;ATP binding;DNA damage response;nucleus	RAD51C;XRCC3	None	"Rad51C protein alone catalyzes homologous pairing, suggesting that Rad51C is the catalytic subunit of the complex. The DNA-binding activity of Rad51C-Xrcc3 complex drastically decreases in the absence of Xrcc3, indicating that Xrcc3 is important for the DNA binding activity of the complex."	None
Telomere-associated protein complex	P54274;Q15554;Q96AP0;Q9BSI4;Q9NUX5;Q9NYB0	7013;7014;65057;26277;25913;54386	DNA binding;chromosome organization;nucleus;telomere maintenance	DNA binding;organization of chromosome structure;nucleus	TERF1;TERF2;ACD;TINF2;POT1;TERF2IP	None	PTOP binds to the carboxyl terminus of POT1 and recruits it to telomeres.	"OMIM:Melanoma, cutaneous malignantThis complex gained particular interest in melanoma genetics as germline variants were found in 3 shelterin genes in melanoma prone families: POT1, ACD and TERF2IP (PMID:15181449)."
TIN2 complex	Q15554;Q96AP0;Q9BSI4;Q9NUX5	7014;65057;26277;25913	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	TERF2;ACD;TINF2;POT1	None	This complex regulates telomere length. PTOP binds to the carboxyl terminus of POT1 and recruits it to telomeres.	None
Oligosaccharyltransferase complex (Stt3A variant)	P04843;P04844;P39656;P46977;P61803;Q9H0U3	6184;6185;1650;3703;1603;84061	protein N-linked glycosylation;endoplasmic reticulum	"N-directed glycosylation, deglycosylation;endoplasmic reticulum"	RPN1;RPN2;DDOST;STT3A;DAD1;MAGT1	None	Oligosaccharyltransferase (OST) is an integral membrane protein that catalyzes N-linked glycosylation of nascent proteins in the lumen of the endoplasmic reticulum. Genomes of most multicellular eukaryotes encode two homologs of Stt3p and mammals express two homologs of Ost3p. Tissue and cell type-specific differences in expression of the Stt3p homologs suggest that the enzymatic properties of oligosaccharyltransferase are regulated in eukaryotes to respond to alterations in glycoprotein flux through the secretory pathway and may contribute to tissue-specific glycan heterogeneity.  Iag2 appears to be weakly associated with the OST complex and dissociates from the other subunits at various stages during enzyme purification.	None
Oligosaccharyltransferase complex (Stt3B variant)	P04843;P04844;P39656;P61803;Q13454;Q8TCJ2;Q9H0U3	6184;6185;1650;1603;7991;201595;84061	protein N-linked glycosylation;endoplasmic reticulum	"N-directed glycosylation, deglycosylation;endoplasmic reticulum"	RPN1;RPN2;DDOST;DAD1;TUSC3;STT3B;MAGT1	None	Oligosaccharyltransferase (OST) is an integral membrane protein that catalyzes N-linked glycosylation of nascent proteins in the lumen of the endoplasmic reticulum. Genomes of most multicellular eukaryotes encode two homologs of Stt3p and mammals express two homologs of Ost3p. Tissue and cell type-specific differences in expression of the Stt3p homologs suggest that the enzymatic properties of oligosaccharyltransferase are regulated in eukaryotes to respond to alterations in glycoprotein flux through the secretory pathway and may contribute to tissue-specific glycan heterogeneity.  Tusc3 and Iag2 appear to be weakly associated with the OST complex and dissociate from the other subunits at various stages during enzyme purification.	None
TRF1-TIN2 complex	P54274;Q96AP0;Q9BSI4;Q9NUX5	7013;65057;26277;25913	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	TERF1;ACD;TINF2;POT1	None	This complex regulates telomere length.	None
TRF1 telomere length regulation complex	O95271;P54274;Q9BSI4	8658;7013;26277	chromosome organization;nucleus	organization of chromosome structure;nucleus	TNKS;TERF1;TINF2	None	Inhibition of TRF1 by tankyrase 1 is controlled by TIN2.	None
Rap1 complex	P54274;Q15554;Q92878;Q96AP0;Q9BSI4;Q9NUX5;Q9NYB0	7013;7014;10111;65057;26277;25913;54386	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	TERF1;TERF2;RAD50;ACD;TINF2;POT1;TERF2IP	None	"TIN2 was found to bind TRF1 and TRF2 simultaneously, showing that TIN2 can link these telomeric proteins. This connection appeared to stabilize TRF2 on the telomeres as the treatment of cells with TIN2 small interfering RNA resulted in a decreased presence of TRF2 and hRap1 at chromosome ends. Only 5-10% of the endogenous TRF1 could be recovered in association with the hRap1 complex."	None
TRF2-Rap1 complex III	Q15554;Q9NYB0	7014;54386	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	TERF2;TERF2IP	None	The TRF2 complex is primarily involved in telomere protection and contains the TRF2 interacting partner human (h)Rap1 as well as several factors involved in the DNA damage response.	None
"TRF-Rap1 complex I, 2MD"	O95271;P54274;Q15554;Q9BSI4;Q9NUX5;Q9NYB0	8658;7013;7014;26277;25913;54386	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	TNKS;TERF1;TERF2;TINF2;POT1;TERF2IP	None	None	None
TRF2-Rap1 complex II	Q15554;Q9BSI4;Q9NUX5;Q9NYB0	7014;26277;25913;54386	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	TERF2;TINF2;POT1;TERF2IP	None	None	None
"Ubiquitin E3 ligase (AHR, ARNT, DDB1, TBL3, CUL4B, RBX1)"	P27540;P35869;P62877;Q12788;Q13620;Q16531	405;196;9978;10607;8450;1642	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;signaling;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cellular signalling;nucleus"	ARNT;AHR;RBX1;TBL3;CUL4B;DDB1	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. In the CUL4B(AhR) ubiquitin E3 ligase complex, ligand-activated dioxin receptor AhR acts as a substrate-specific adaptor component that targets sex steroid receptors for degradation. Thus, experiments uncover a function for AhR as an atypical component of the ubiquitin ligase complex and demonstrate a non-genomic signalling pathway in which fat-soluble ligands regulate target-protein-selective degradation through a ubiquitin ligase complex."	None
"Ubiquitin E3 ligase (DET1, DDB1, CUL4A, RBX1, COP1)"	P62877;Q13619;Q16531;Q7L5Y6;Q8NHY2	9978;8451;1642;55070;64326	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;signaling;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cellular signalling;nucleus"	RBX1;CUL4A;DDB1;DET1;RFWD2	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Human DET1 (hDET1) promotes ubiquitination and degradation of the proto-oncogenic transcription factor c-Jun by assembling a multisubunit ubiquitin E3 ligase. Ablation of any subunit by RNA interference stabilized c-Jun and increased c-Jun-activated transcription.	None
"Ubiquitin E3 ligase (FBXW7, CUL1, SKP1A, RBX1)"	P62877;P63208;Q13616;Q969H0	9978;6500;8454;55294	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;Notch signaling pathway;signaling	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);Notch-receptor signalling pathway;cellular signalling"	RBX1;SKP1;CUL1;FBXW7	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. FBXW7 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation.	None
WRN-TRF2 complex	Q14191;Q15554	7486;7014	chromosome organization;cell aging	organization of chromosome structure;cell aging	WRN;TERF2	None	TRF2 interaction with WRN results in a stimulation of WRN-helicase activity.	None
BLM-TRF2 complex	P54132;Q15554	641;7014	chromosome organization;cell aging	organization of chromosome structure;cell aging	BLM;TERF2	None	None	BLM is involved in Bloom syndrome (BS) (PMID:12444098).
Tankyrin 1-tankyrin 2-TRF1 complex	O95271;P54274;Q9H2K2	8658;7013;80351	chromosome organization;nucleus	organization of chromosome structure;nucleus	TNKS;TERF1;TNKS2	None	TRF1 binding allows tankyrase to regulate telomere dynamics. Mouse TRF1 lacks the binding motif for tankyrase.	None
TRF2-Ku complex	P12956;P13010;Q15554	2547;7520;7014	DNA binding;chromosome organization;nucleus	DNA binding;organization of chromosome structure;nucleus	XRCC6;XRCC5;TERF2	None	None	None
TFIIA-TRF2 complex	P52655;P52657;Q15554	2957;2958;7014	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	GTF2A1;GTF2A2;TERF2	None	TRF2-TFIIA complex is able to replace TBP or TFIID in basal or activated transcription from various RNA polymerase II promoters.	None
"H2AX complex, isolated from cells without IR exposure"	O43390;P05455;P06748;P11021;P11940;P16104;P27797;P62158;P62805;Q08945;Q8N257;Q9Y262;Q9Y5B9	10236;6741;4869;3309;26986;3014;811;None;None;6749;128312;51386;11198	"DNA topological change;cell cycle checkpoint;DNA-templated transcription, elongation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);transcription elongation;organization of chromosome structure;nucleus"	HNRNPR;SSB;NPM1;HSPA5;PABPC1;H2AFX;CALR;CALM1; CAL;HIST1H4A;;SSRP1;HIST3H2BB;EIF3L;SUPT16H	None	None	None
"Ubiquitin E3 ligase (BMI1, SPOP, CUL3)"	O43791;P35226;Q13618	8405;648;8452	dosage compensation by inactivation of X chromosome;protein ubiquitination;nucleus;ubiquitin-dependent protein catabolic process	"chromosome inactivation;modification by ubiquitination, deubiquitination;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	SPOP;BMI1;CUL3	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. X inactivation involves the stable silencing of one of the two X chromosomes in XX female mammals. Initiation of this process occurs during early development and involves Xist (X-inactive-specific transcript) RNA coating and the recruitment of Polycomb repressive complex (PRC) 2 and PRC1 proteins. This recruitment results in an inactive state that is initially labile but is further locked in by epigenetic marks such as DNA methylation, histone hypoacetylation, and MACROH2A deposition. The ubiquitin E3 ligase consisting of SPOP and CULLIN3 is able to ubiquitinate the Polycomb group protein BMI1 and the variant histone H2AFY."	None
"Ubiquitin E3 ligase (H2AFY, SPOP, CUL3)"	O43791;O75367;Q13618	8405;9555;8452	dosage compensation by inactivation of X chromosome;protein ubiquitination;nucleus;ubiquitin-dependent protein catabolic process	"chromosome inactivation;modification by ubiquitination, deubiquitination;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	SPOP;H2AFY;CUL3	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. X inactivation involves the stable silencing of one of the two X chromosomes in XX female mammals. Initiation of this process occurs during early development and involves Xist (X-inactive-specific transcript) RNA coating and the recruitment of Polycomb repressive complex (PRC) 2 and PRC1 proteins. This recruitment results in an inactive state that is initially labile but is further locked in by epigenetic marks such as DNA methylation, histone hypoacetylation, and MACROH2A deposition. The ubiquitin E3 ligase consisting of SPOP and CULLIN3 is able to ubiquitinate the Polycomb group protein BMI1 and the variant histone H2AFY."	None
H2AX complex I	P06748;P09874;P11021;P16104;P27797;Q7L2E3;Q8N257	4869;142;3309;3014;811;22907;128312	"DNA repair;DNA topological change;cell cycle checkpoint;DNA-templated transcription, elongation;cellular response to DNA damage stimulus;chromosome organization;nucleus"	"DNA repair;DNA conformation modification (e.g. chromatin);cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);transcription elongation;DNA damage response;organization of chromosome structure;nucleus"	NPM1;PARP1;HSPA5;H2AFX;CALR;DHX30;HIST3H2BB	None	This complex has been isolated from cells after IR exposure and recovery for 30 minutes.	None
H2AX complex II	P06748;P11021;P16104;P16989;P27797;P33778;P62805;Q8N257;Q96EY7;Q99879	4869;3309;3014;8531;811;3018;None;128312;55037;8342	"DNA repair;DNA topological change;cell cycle checkpoint;DNA-templated transcription, elongation;cellular response to DNA damage stimulus;chromosome organization;nucleus"	"DNA repair;DNA conformation modification (e.g. chromatin);cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);transcription elongation;DNA damage response;organization of chromosome structure;nucleus"	NPM1;HSPA5;H2AFX;YBX3;CALR;HIST1H2BB;HIST1H4A;;HIST3H2BB;PTCD3;HIST1H2BM	None	This complex has been isolated from cells after IR exposure and recovery for 2.5h.	None
WINAC complex	O14497;O96019;P11473;P51531;P51532;Q02880;Q12824;Q13111;Q8TAQ2;Q92922;Q969G3;Q96GM5;Q9UIG0;Q9Y5B9	8289;86;7421;6595;6597;7155;6598;10036;6601;6599;6605;6602;9031;11198	"DNA replication;DNA topological change;mitotic S phase;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus;receptor binding"	DNA synthesis and replication;DNA conformation modification (e.g. chromatin);S phase of mitotic cell cycle;transcriptional control;organization of chromosome structure;nucleus;receptor binding	ARID1A;ACTL6A;VDR;SMARCA2;SMARCA4;TOP2B;SMARCB1;CHAF1A;SMARCC2;SMARCC1;SMARCE1;SMARCD1;BAZ1B;SUPT16H	None	"WINAC mediates the recruitment of unliganded VDR to VDR target sites in promoters, while subsequent binding of coregulators requires ligand binding."	None
FIB-associated protein complex	O14744;P22087;Q07021;Q71U36;Q99873;Q9H4B7	10419;2091;708;7846;3276;81027	rRNA processing;rRNA modification;ribosome biogenesis;nucleus	rRNA processing;rRNA modification;ribosome biogenesis;nucleus	PRMT5;FBL;C1QBP;TUBA1A;PRMT1;TUBB1	None	"FIB-associated protein complexes contain a number of ribosomal proteins and potential trans-acting factors involved in ribosome biogenesis, and the complexes are dependent on RNA integrity."	None
REST-CoREST-mSIN3A complex	Q13127;Q96ST3;Q9UKL0	5978;25942;23186	"negative regulation of transcription, DNA-templated;neurogenesis;generation of neurons;neuron differentiation;nervous system development;nucleus"	transcription repression;neurogenesis;neuron;nervous system;nucleus	REST;SIN3A;RCOR1	None	"The REST-mSin3A association involves the NH(2)-terminal repressor domain of REST and the paired amphipathic helix 2 domain of mSin3A. REST forms complexes with endogenous mSin3A in mammalian cells, and both mSin3A and CoREST interact with REST in intact mammalian cells."	None
CoREST-HDAC2 complex	Q92769;Q9UKL0	3066;23186	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	HDAC2;RCOR1	None	"In the presence of REST, the CoREST/HDAC2 complex represses transcription of the Nav1.2 sodium channel gene."	None
BAF complex	O14497;O96019;P51531;P51532;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;86;6595;6597;6598;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;nucleus	ARID1A;ACTL6A;SMARCA2;SMARCA4;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Another subunit of the complex was found in the analysis, which has not been further characterized: BAF110."	BAF250 confers specificity to the human BAF complex and may recruit the complex to its targets through either protein-DNA or protein-protein interactions.	None
PBAF complex (Polybromo- and BAF containing complex)	O96019;P51532;Q12824;Q68CP9;Q86U86;Q8TAQ2;Q92922;Q969G3;Q96GM5	86;6597;6598;196528;55193;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;hormone-mediated signaling pathway;signaling;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;hormone mediated signal transduction;cellular signalling;organization of chromosome structure;chromosome	ACTL6A;SMARCA4;SMARCB1;ARID2;PBRM1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Two other subunits of the complex were found in the analysis, which have not been further characterized: BAF110 and BAF240."	The chromatin-remodeling complex PBAF facilitates gene activation by assisting transcription machinery to gain access to targets on the chromosome.	None
EBAFb complex	O96019;P51532;Q03111;Q12824;Q8NFD5;Q8TAQ2;Q92922;Q92925;Q969G3;Q96GM5	86;6597;4298;6598;57492;6601;6599;6603;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;chromosome	ACTL6A;SMARCA4;MLLT1;SMARCB1;ARID1B;SMARCC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1	"Three other subunits of the complex were found in the analysis, which have not been further characterized: EBAF140, EBAF100 and EBAF70."	"ENL associates and cooperates with SWI/SNF complexes to activate transcription of the promoter of HoxA7, a downstream target essential for oncogenic activity of ENL."	None
"Ubiquitin E3 ligase (SPOP, DAXX, CUL3)"	O43791;Q13618;Q9UER7	8405;8452;1616	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;regulation of programmed cell death;nucleus"	"transcriptional control;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);regulation of apoptosis;nucleus"	SPOP;CUL3;DAXX	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. SPOP serves as an adaptor of Daxx for the ubiquitination by Cul3-based ubiquitin ligase and subsequent degradation by the proteasome. Experiments suggest that SPOP/Cul3-ubiquitin ligase plays an essential role in the control of Daxx level and, thus, in the regulation of Daxx-mediated cellular processes, including transcriptional regulation and apoptosis."	None
Protein phosphatase 4 complex	P60510;Q9NY27	5531;151987	protein dephosphorylation;centrosome;microtubule cytoskeleton organization	"modification by phosphorylation, dephosphorylation, autophosphorylation;centrosome;microtubule cytoskeleton"	PPP4C;PPP4R2	None	Protein phosphatase 4 (PPP4) is a protein serine/threonine phosphatase that has been implicated in microtubule organization at centrosomes.	None
Apoptosome	O14727;P99999	317;54205	apoptotic process;cytoplasm	apoptosis (type I programmed cell death);cytoplasm	APAF1;CYCS	None	"The apoptosome is a multiprotein complex mediating the mitochondrial pathway of cell death. Oligomeric Apaf-1 mediates the cytochrome c-dependent autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the activation of caspase-3 and apoptosis. In the absence of an apoptotic signal, Apaf-1 exists in a monomeric form."	None
RB-E2F1 complex	P06400;Q01094	5925;1869	cell cycle arrest;cellular response to DNA damage stimulus;nucleus	cell cycle arrest;DNA damage response;nucleus	RB1;E2F1	None	"The phosphorylation of pRB at Ser612 is induced by ATM-Chk1/2 kinase after DNA damage, leading to enhancement of the formation of a complex between pRB and E2F-1. It is proposed, that in asynchronously growing cells, pRB exists in a predominantly phosphorylated state, which is dissociated from E2F, allowing E2F-dependent transcription. DNA damage induces dephosphorylation of pRB at Cdk phosphorylation sites, leading to the complex pRB-E2F-1 being formed. DNA damage also activates ATM kinase and transduces signals to the checkpoint kinases Chk1 and Chk2. Activated Chk1 and Chk2 phosphorylate Ser612 of pRB and this phosphorylation enhances the formation of a complex between pRB and E2F-1, leading to repression of the transcriptional activity of E2F-1. Consequently, pRB-dependent cell cycle arrest and repression of apoptosis occur."	None
BAF complex	O14497;O96019;P51531;Q12824;Q8TAQ2;Q92922;Q969G3;Q96GM5	8289;86;6595;6598;6601;6599;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;chromosome	ARID1A;ACTL6A;SMARCA2;SMARCB1;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify SMARCA, we used SMARCA2."	BAF complex belongs to chromatin remodeling complexes.	None
EBAFa complex	O14497;O96019;P51532;Q03111;Q12824;Q8TAQ2;Q92922;Q92925;Q969G3;Q96GM5	8289;86;6597;4298;6598;6601;6599;6603;6605;6602	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;chromosome"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;chromosome	ARID1A;ACTL6A;SMARCA4;MLLT1;SMARCB1;SMARCC2;SMARCC1;SMARCD2;SMARCE1;SMARCD1	"Three other subunits of the complex were found in the analysis, which have not been further characterized: EBAF140, EBAF100 and EBAF70."	"ENL associates and cooperates with SWI/SNF complexes to activate transcription of the promoter of HoxA7, a downstream target essential for oncogenic activity of ENL."	None
"Ubiquitin E3 ligase (FBXW7, CUL1, SKP1A, RBX1)"	P62877;P63208;Q13616;Q969H0	9978;6500;8454;55294	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;Notch signaling pathway;signaling	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);Notch-receptor signalling pathway;cellular signalling"	RBX1;SKP1;CUL1;FBXW7	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. FBXW7 targets cyclin E, one of the activators of the cyclin-dependent kinase Cdk2 for proteolysis and is mutated in a breast cancer cell line."	None
Menin-associated histone methyltransferase complex	O00255;P30876;P61964;Q15291;Q9C005;Q9UBL3;Q9UMN6	4221;5431;11091;5929;84661;9070;None	"DNA topological change;regulation of gene expression by genetic imprinting;positive regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;chromosome organization;cell differentiation;nucleus"	"DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;transcription activation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;cell differentiation;nucleus"	MEN1;POLR2B;WDR5;KDM6B;DPY30;ASH2L;KMT2B	None	"The menin-associated complex methylates histone H3 on lysine 4, suggesting menin activates the transcription of differentiation-regulating genes by covalent histone modification, and that this activity is related to tumor suppression by MEN1."	MEN1 gene is mutated in familial multiple endocrine neoplasia type 1.
"Ubiquitin E3 ligase (SIAH1, SIP, SKP1A, TBL1X)"	O60907;P63208;Q8IUQ4;Q9HB71	6907;6500;6477;27101	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;signaling	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cellular signalling"	TBL1X;SKP1;SIAH1;CACYBP	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Conditional degradation of beta-catenin represents a central event in the Wnt signaling pathways controlling cell fate and proliferation. A network of protein interactions in which Siah, SIP (a novel Siah-interacting protein), Skp1, and Ebi collaborate in a pathway controlling beta-catenin levels, affecting activity of beta-catenin-dependent Tcf/LEF transcription factors."	None
MLL-HCF complex	O00255;P05546;P51610;P61964;Q03164;Q15291;Q9UBL3	4221;3053;3054;11091;4297;5929;9070	"DNA topological change;regulation of gene expression by genetic imprinting;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;transcriptional control;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	MEN1;SERPIND1;HCFC1;WDR5;KMT2A;KDM6B;ASH2L	None	This complex links the menin tumor suppressor protein to the MLL histone methyltransferase machinery.	None
ALL-1 supercomplex	O00422;O60264;O60341;O75446;O94776;O95983;P20226;P21675;P49848;P51531;P61964;P62826;Q03164;Q09028;Q12824;Q12873;Q13547;Q15029;Q15291;Q16514;Q16576;Q16594;Q8TAQ2;Q92769;Q92797;Q92922;Q96ST3;Q9P2I0	10284;8467;23028;8819;9219;53615;6908;6872;6878;6595;11091;5901;4297;5928;6598;1107;3065;9343;5929;6883;5931;6880;6601;3066;8189;6599;25942;53981	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein deacetylation;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	SAP18;SMARCA5;KDM1A;SAP30;MTA2;MBD3;TBP;TAF1;TAF6;SMARCA2;WDR5;RAN;KMT2A;RBBP4;SMARCB1;CHD3;HDAC1;EFTUD2;KDM6B;TAF12;RBBP7;TAF9;SMARCC2;HDAC2;SYMPK;SMARCC1;SIN3A;CPSF2	None	"The proteins associated with ALL-1 can be classified into eight groups. (1) BRM, BAF170, BAF155, and INI1, the core components of the ATP-dependent SWI/SNF nucleosome remodeling complex, (2) Mi2, MTA1-L1, HDAC1, HDAC2, RbAp46, RbAp48, MBD3, and KIAA0601, all components of the NuRD complex, (3) Sin3A, SAP30, SAP18, HDAC1, HDAC2, RbAp48, and RbAp46, components of the histone deacetylase Sin3A complex, (4) hSNF2H, homolog of ISWI, an ATP-dependent nucleosome remodeling and assembly factor, (5) TAFII250, TAFII80, TAFII31, TAFII20, and TBP, components of the TFIID complex, (6) RbBP5  and WDRP5, components of the yeast Set1 complex,  which methylates H3-K4. (7) Proteins involved in RNA processing, CPSF, Symplekin and EFTUD2. (8) Ran, which functions in nucleocytoplasmic transport and in spindle assembly during mitosis."	None
"Ubiquitin E3 ligase (GLMN, FBXW8, SKP1A, RBX1)"	P62877;P63208;Q8N3Y1;Q92990	9978;6500;26259;11146	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;vasculogenesis	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);vascular organs"	RBX1;SKP1;FBXW8;GLMN	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Experiments suggest that ubiquitin E3 ligase (containing GLMN, FBXW8, SKP1A and RBX1) plays an important role in vascular morphogenesis."	None
Chromatin assembly complex (CAF-1 complex)	Q09028;Q13111;Q13112	5928;10036;8208	DNA replication;DNA topological change;mitotic S phase;chromosome organization;nucleus	DNA synthesis and replication;DNA conformation modification (e.g. chromatin);S phase of mitotic cell cycle;organization of chromosome structure;nucleus	RBBP4;CHAF1A;CHAF1B	None	Caf-1 complex assembles nucleosomes in a replication-dependent manner.	None
"Neddylin ligase (FBXO11, SKP1, CUL1, RBX1)"	P62877;P63208;Q13616;Q86XK2	9978;6500;8454;80204	protein deneddylation;protein sumoylation;protein desumoylation;protein neddylation;Smt3-protein conjugation;cellular protein modification process;regulation of sequence-specific DNA binding transcription factor activity;nucleus	modification by ubiquitin-related proteins;protein modification;regulator of transcription factor;nucleus	RBX1;SKP1;CUL1;FBXO11	None	FBXO11 promotes the neddylation of p53 and inhibits its transcriptional activity.	None
SRm160/300 complex	P08621;P09661;P62995;Q8IYB3;Q9UQ35	6625;6627;6434;10250;23524	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	SNRNP70;SNRPA1;TRA2B;SRRM1;SRRM2	None	"Exonic splicing enhancer (ESE) sequences are important for the recognition of splice sites in pre-mRNA. These sequences are bound by specific serine-arginine (SR) repeat proteins that promote the assembly of splicing complexes at adjacent splice sites. In a study, it was shown that SRm160/300 is required for a purine-rich ESE to promote the splicing of a pre-mRNA derived from the Drosophila doublesex gene. Results suggest a model for ESE function in which the SRm160/300 splicing coactivator promotes critical interactions between ESE-bound ""activators"" and the snRNP machinery of the spliceosome."	None
HNRPF-HNRPH1 complex	P31943;P52597	3187;3185	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	HNRNPH1;HNRNPF	None	The complex is involved in alternative splicing.	None
"DCS complex (PTBP1, PTBP2, HNRPH1, HNRPF)"	P26599;P31943;P52597;Q9UKA9	5725;3187;3185;58155	"regulation of RNA splicing;regulation of mRNA splicing, via spliceosome;RNA binding;nucleus"	regulation of splicing;RNA binding;nucleus	PTBP1;HNRNPH1;HNRNPF;PTBP2	None	None	None
IPO13-RBM8A-MAGOH complex	O94829;P61326;Q9Y5S9	9670;4116;9939	RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	RNA transport;nuclear transport;nucleus	IPO13;MAGOH;RBM8A	None	None	None
DCP1A-DCP2 Decapping complex	Q8IU60;Q9NPI6	167227;55802	RNA catabolic process;cytoplasm	RNA degradation;cytoplasm	DCP2;DCP1A	None	Although the authors suggest the existence of a protein complex containing DCP proteins and UPF proteins they also state that there is currently no direct evidence for the significance of a strong interaction between hUpf1 and hDcp proteins.	None
MKK4-ARRB2-ASK1 complex	P32121;P45985;Q99683	409;6416;4217	JNK cascade;MAPK cascade	JNK cascade;MAPKKK cascade	ARRB2;MAP2K4;MAP3K5	None	"The data suggest that ASK1 binds directly to beta -arrestin 2, and MKK4 interacts indirectly with beta -arrestin 2 via ASK1 or JNK3, thus forming a complete MAPK module."	None
MKK4-ARRB2-JNK3 complex	P32121;P45985;P53779	409;6416;5602	JNK cascade;MAPK cascade	JNK cascade;MAPKKK cascade	ARRB2;MAP2K4;MAPK10	None	"The data suggest that ASK1 binds directly to beta -arrestin 2, and MKK4 interacts indirectly with beta -arrestin 2 via ASK1 or JNK3, thus forming a complete MAPK module."	None
POSH-MLK3 complex	Q16584;Q7Z6J0	4296;57630	JNK cascade	JNK cascade	MAP3K11;SH3RF1	None	A POSH mutant unable to bind to Akt2 exhibits increased binding to MLK3. This increased binding of MLK3 to POSH is accompanied by increased activation of the JNK signaling pathway.	None
CRLR-RAMP1 complex	O60894;Q16602	10267;10203	G-protein coupled receptor signaling pathway;plasma membrane	G-protein coupled receptor signalling pathway;eukaryotic plasma membrane / membrane attached	RAMP1;CALCRL	None	"The results demonstrate that RAMP2 and RAMP3 and not only RAMP1 can promote the full maturation of CRLR, leading to its terminal glycosylation, and only the fully processed receptors were found to bind AM (adrenomedullin) and CGRP (calcitonin gene-related peptide)."	None
CRLR-RAMP1 complex	O60894;Q16602	10267;10203	G-protein coupled receptor signaling pathway;plasma membrane	G-protein coupled receptor signalling pathway;eukaryotic plasma membrane / membrane attached	RAMP1;CALCRL	None	"When RAMP1 is expressed with CRLR, it is targeted to the cell surface as a heterodimer. CGRP (calcitonin gene-related peptide) binding and receptor activation lead to the phosphorylation of CRLR and the internalization of the receptor as a stable complex."	None
PIN1-AUF1 complex	Q13526;Q14103	5300;3184	cytokine activity;cytoplasm	"cytokines (interleukines, colony stimulating factors, etc.);cytoplasm"	PIN1;HNRNPD	None	"Immunoprecipitation of eosinophil cytoplasmic lysates demonstrated an interaction between Pin1 and all four AUF1 isoforms.Pin1 regulated the association of the AU-rich element\u2013binding proteins AUF1 and hnRNP C with GM-CSF mRNA, accelerating or slowing decay, respectively.The authors propose that moderately serine-phosphorylated p40 and p45 AUF1, in physical association with serine-phosphorylated Pin1 and unphosphorylated p42 and p37 AUF1, form a ribonucleoprotein complex with GM-CSF mRNA in resting eosinophils."	None
Multiprotein complex (mRNA turnover)	O60506;O75534;P11940;Q14103;Q9H074	10492;7812;26986;3184;10605	RNA catabolic process;cytoplasm	RNA degradation;cytoplasm	SYNCRIP;CSDE1;PABPC1;HNRNPD;PAIP1	None	None	None
PABPC1-HSPA8-HNRPD-EIF4G1 complex	P11142;P11940;Q04637;Q14103;Q59EJ3	3312;26986;1981;3184;3303	RNA catabolic process	RNA degradation	HSPA8;PABPC1;EIF4G1;HNRNPD;	None	"Cytokine and proto-oncogene messenger RNAs (mRNAs) are rapidly degraded through AU-rich elements in the 39 untranslated region. Rapid decay involves AU-rich binding protein AUF1, which complexes with heat shock proteins hsc70-hsp70, translation initiation factor eIF4G, and poly(A) binding protein."	None
ATF7-TAF12 complex	P17544;Q16514	11016;6883	"positive regulation of transcription, DNA-templated"	transcription activation	ATF7;TAF12	None	"The overexpression of hsTAF12 potentiates ATF7-induced transcriptional activation through direct interaction with ATF7, suggesting that TAF12 is a functional partner of ATF7. Although both TAF12 isoforms (TAF12-1 and -2, formerly TAF(II)20 and TAF(II)15) interact with the ATF7 activation region through their histone-fold domain, only the largest, hsTAF12-1, mediates transcriptional activation through its N-terminal region."	None
"Transcription initiation factor complex (TAF1, TAF5, TAF11, TAF12, TBP)"	P20226;P21675;Q15542;Q15544;Q16514	6908;6872;6877;6882;6883	"DNA-templated transcription, initiation"	transcription initiation	TBP;TAF1;TAF5;TAF11;TAF12	None	"Human transcription initiation factor TFIID contains the TATA-binding protein (TBP) and several TBP-associated factors (TAFs). The authors suggest that hTAFII100 may help stabilize interactions of the histonelike TAFs, perhaps within an octamer structure."	None
"Transcription initiation factor complex (TAF5, TAF6, TAF9, TAF11, TBP)"	P20226;P49848;Q15542;Q15544;Q16594	6908;6878;6877;6882;6880	"DNA-templated transcription, initiation"	transcription initiation	TBP;TAF6;TAF5;TAF11;TAF9	None	"Human transcription initiation factor TFIID contains the TATA-binding protein (TBP) and several TBP-associated factors (TAFs). The authors suggest that hTAFII100 may help stabilize interactions of the histonelike TAFs, perhaps within an octamer structure."	None
Large Drosha complex	O00571;O14979;O43143;P17844;P31943;P35637;P52272;Q00839;Q01844;Q12905;Q12906;Q13148;Q8WYQ5;Q92499;Q92804;Q92841;Q96SB4;Q9BUJ2;Q9NRR4;Q9UKM9	1654;9987;1665;1655;3187;2521;4670;3192;2130;3608;3609;23435;54487;1653;8148;10521;6732;11100;29102;22913	RNA processing;RNA binding;nucleus	RNA processing;RNA binding;nucleus	DDX3X;HNRNPDL;DHX15;DDX5;HNRNPH1;FUS;HNRNPM;HNRNPU;EWSR1;ILF2;ILF3;TARDBP;DGCR8;DDX1;TAF15;DDX17;SRPK1;HNRNPUL1;DROSHA;RALY	None	The large Drosha complex shows only weak pri-miRNA processing activity. It might be involved in pri-ribosomal RNA processing.	DGCR8 is deleted in DiGeorge syndrome. EWS is involved in Ewing's sarcoma disease.
SNW1 complex	O75643;O95071;P07437;P11021;P17858;P23246;P26641;P43243;P43246;P68104;Q00839;Q13573;Q15029;Q16531;Q6P2Q9;Q99459;Q9BUQ8;Q9UG63	23020;51366;203068;3309;5211;6421;1937;9782;4436;1915;3192;22938;9343;1642;10594;988;9416;10061	"positive regulation of transcription, DNA-templated;RNA splicing;nucleus"	transcription activation;splicing;nucleus	SNRNP200;UBR5;TUBB;HSPA5;PFKL;SFPQ;EEF1G;MATR3;MSH2;EEF1A1;HNRNPU;SNW1;EFTUD2;DDB1;PRPF8;CDC5L;DDX23;ABCF2	None	Identified subunits of the SNW1 complex represent components of the spliceosome as well as other nuclear matrix-associated proteins. Evidence was found that the complex couples vitamin D receptor-mediated transcription and RNA splicing.	None
"FOXO3-PCAF complex, oxidative stress stimulated"	O43524;Q92831	2309;8850	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress;nucleus"	transcriptional control;oxidative stress response;nucleus	FOXO3;KAT2B	None	None	None
Septin complex	Q15019;Q16181;Q92599;Q9NVA2;Q9UHD8	4735;989;23176;55752;10801	actin filament reorganization involved in cell cycle;cell budding	"cell cycle dependent actin filament reorganization;budding, cell polarity and filament formation"	SEPT2;SEPT7;SEPT8;SEPT11;SEPT9	None	"Septins are members of a conserved family of cytoskeletal GTPases, filament-forming and cell division cycle regulatory proteins."	None
"NPC subcomplex (NUP98, NUP107, NUP133, NUP160)"	P52948;P57740;Q12769;Q8WUM0	4928;57122;23279;55746	"mitotic cell cycle;protein transport;protein transporter activity;transport;nuclear transport;chromosome, centromeric region"	"mitotic cell cycle;protein transport;CELLULAR TRANSPORT, TRANSPORT FACILITIES AND TRANSPORT ROUTES;nuclear transport;centromere / kinetochore"	NUP98;NUP107;NUP160;NUP133	None	"All trafficking of macromolecules between the cytoplasm and the nucleus occurs through nuclear pore complexes (NPCs), which are supramolecular assemblies at points of fusion between the inner and outer nuclear membranes. NPCs are composed of an eightfold symmetric spoke-ring complex, cytoplasmic fibers, and a nuclear basket. NUP133 and NUP107 are localized on both sides of the NPC to which they are stably associated at interphase and remain associated as part of a NPC subcomplex during mitosis.They are targeted at early stages to the reforming nuclear envelope."	None
GLE1-NUPL2-NUP155 complex	O15504;O75694;Q53GS7	11097;9631;2733	intracellular protein transport;protein targeting;protein transport	"protein targeting, sorting and translocation;protein transport"	NUPL2;NUP155;GLE1	None	None	None
"ING4 complex (ING4, JADE1, KAT7, MEAF6)"	O95251;Q6IE81;Q9HAF1;Q9UNL4	11143;79960;64769;51147	mitotic cell cycle;regulation of cell cycle;angiogenesis	mitotic cell cycle;mitotic cell cycle and cell cycle control;angiogenesis	KAT7;JADE1;MEAF6;ING4	None	ING4 associates with the HBO1 HAT required for normal progression through S phase and the majority of histone H4 acetylation in vivo. ING subunits are probably crucial for acetylation of chromatin substrates.	None
Rb-tal-1-E2A-Lmo2-Ldb1 complex	P06400;P15923;P17542;P25791;Q86U70	5925;6929;6886;4005;8861	"negative regulation of transcription, DNA-templated;erythrocyte differentiation;nucleus"	transcription repression;blood cell;nucleus	RB1;TCF3;TAL1;LMO2;LDB1	None	"Data indicate that this pentameric complex assembled in maturing erythroblasts plays an important regulatory role in c-kit downmodulation; hypothetically, the complex may regulate the expression of other critical erythroid genes."	None
hASC-1 complex	Q15650;Q8N3C0;Q8N9N2;Q9H1I8	9325;10973;51008;84164	"positive regulation of transcription, DNA-templated;signaling;nucleus"	transcription activation;cellular signalling;nucleus	TRIP4;ASCC3;ASCC1;ASCC2	None	"Endogenous hASC-1 complex appears to play an essential role in AP-1, SRF, and NF-kappaB transactivation and to mediate the transrepression between nuclear receptors and either AP-1 or NF-kappaB in vivo."	None
GALNS-lysosomal hydrolase 1.27 MDa complex	P10619;P16278;P34059;Q99519	5476;2720;2588;4758	polysaccharide metabolic process;polysaccharide biosynthetic process;polysaccharide catabolic process;vacuole;lysosome	polysaccharide metabolism;vacuole or lysosome	CTSA;GLB1;GALNS;NEU1	None	The 1.27-MDa complex of lysosomal hydrolases is essential for keratan sulfate catabolism. Disruption of this complex may be responsible for the KS accumulation in beta-galactosidosis and galactosialidosis patients. Association of GALNS with the three other lysosomal hydrolases protects GALNS in lysosomes.	None
Elongator holo complex	O95163;Q6IA86;Q96EB1;Q9H9T3	8518;55250;26610;55140	"DNA-templated transcription, elongation;protein acetylation;protein deacetylation;nucleus"	"transcription elongation;modification by acetylation, deacetylation;nucleus"	IKBKAP;ELP2;ELP4;ELP3	"Two other subunits of the complex were found in the analysis, which have not been further characterized: p38, p30."	The holo-Elongator complex has histone acetyltransferase activity directed against histone H3 and H4. Holo-Elongator interacts with RNA polymerase II.	None
DICER1-NCOA6-AGO2 complex	Q14686;Q9UKV8;Q9UPY3	23054;27161;23405	RNA biosynthetic process;RNA processing;cytoplasm	RNA synthesis;RNA processing;cytoplasm	NCOA6;AGO2;DICER1	None	Results support a role of the Dicer-TRBP complex not only in miRNA processing but also as a platform for RISC assembly.	None
TTP-AGO4 complex	P26651;Q9HCK5	7538;192670	mRNA catabolic process;mRNA destabilization	None	ZFP36;AGO4	None	In analogy to the TTP-AGO2 complex the TTP-AGO4 complex is presumably involved in the miRNA-mediated degradation of RNAs containing AU-rich elements (AREs).	None
TTP-AGO2 complex	P26651;Q9UKV8	7538;27161	mRNA catabolic process;mRNA destabilization	None	ZFP36;AGO2	None	The TTP-AGO2 complex is involved in the miRNA-mediated degradation of RNAs containing AU-rich elements (AREs).	None
WDR5-ASH2L-RBBP5-MLL2 complex	O14686;P61964;Q15291;Q9UBL3	8085;11091;5929;9070	"positive regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;nucleus"	"transcription activation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	KMT2D;WDR5;KDM6B;ASH2L	None	"The WDR5-ASH2L-RBBP5-MLL2 complex performs methylation of lysine 4 (K4) of histone H3. Knockdown of xWDR5 during Xenopus development leads to somitic, gut, and hematopoetic defects."	None
ASCOM complex	O14686;P07437;P68366;Q14686;Q15291;Q8NEZ4;Q9UBL3	8085;203068;7277;23054;5929;58508;9070	"DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;organization of chromosome structure;nucleus	KMT2D;TUBB;TUBA4A;NCOA6;KDM6B;KMT2C;ASH2L	None	"ASCOM exhibit very weak but specific H3-lysine 4 methylation activities in vitro, and transactivation by retinoic acid receptor appears to involve ligand-dependent recruitment of ASCOM and subsequent transient H3-lysine 4 methylation of the promoter region in vivo. Thus, ASCOM may represent a distinct coactivator complex of nuclear receptors. MALDI-TOF mass spectrometry analyses identified also ALR-2, the splicing isoform of ALR-1."	None
MOF complex	O14686;O15047;P21675;P49848;P61964;Q03164;Q15291;Q16594;Q99496;Q9H7Z6	8085;9739;6872;6878;11091;4297;5929;6880;6045;84148	nucleus	nucleus	KMT2D;SETD1A;TAF1;TAF6;WDR5;KMT2A;KDM6B;TAF9;RNF2;KAT8	Immunoprecipitation of the three step purified complex by anti-MOF antibodies. The complex was not functionally characterized.	None	None
NCOR1 complex	O15379;O75376;P51532;Q12824;Q13263;Q15393;Q15459;Q6ZRS2;Q8TAQ2;Q92922	8841;9611;6597;6598;10155;23450;10291;10847;6601;6599	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	HDAC3;NCOR1;SMARCA4;SMARCB1;TRIM28;SF3B3;SF3A1;SRCAP;SMARCC2;SMARCC1	None	"Transcriptional silencing by many transcription factors is mediated by the nuclear receptor corepressor (N-CoR). The mechanism by which N-CoR represses basal transcription involves the direct or indirect recruitment of histone deacetylases (HDACs). Two multiprotein N-CoR complexes have been isolated, designated N-CoR-1 and N-CoR-2, which possess histone deacetylase activity that is mediated by distinct HDACs. Results suggest that N-CoR is found in distinct multiprotein complexes, which are involved in multiple pathways of transcriptional repression."	None
PTGS2 homodimer complex	P35354	5743	isoprenoid metabolic process;fatty acid biosynthetic process;isoprenoid biosynthetic process;fatty acid catabolic process;lipid catabolic process;isoprenoid catabolic process;lipid metabolic process;fatty acid metabolic process;lipid biosynthetic process	"lipid, fatty acid and isoprenoid metabolism;fatty acid metabolism;isoprenoid metabolism"	PTGS2	None	None	None
LIN2-LIN7-SAP97 complex	O14910;O14936;Q12959	8825;8573;1739	intracellular protein transport;protein targeting;protein transport;anisotropic cell growth;axis specification;epithelial cell differentiation;morphogenesis of an epithelium	"protein targeting, sorting and translocation;protein transport;directional cell growth (morphogenesis);asymmetries and axis determination;epithelium"	LIN7A;CASK;DLG1	None	None	None
MCM2-MCM6-MCM7 complex	P33993;P49736;Q14566	4176;4171;4175	DNA replication;nucleus	DNA synthesis and replication;nucleus	MCM7;MCM2;MCM6	None	None	None
AFF1-MLLT1-CBX8 complex	P51825;Q03111;Q9HC52	4299;4298;57332	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nuclear speck"	transcriptional control;nuclear speckles	AFF1;MLLT1;CBX8	None	None	None
SNF2h-HDAC12 complex	O60264;Q92769	8467;3066	regulation of DNA metabolic process;protein acetylation;protein deacetylation;chromosome organization	"regulation of DNA processing;modification by acetylation, deacetylation;organization of chromosome structure"	SMARCA5;HDAC2	None	SNF2h-HDAC1/2 complex coordinates G1-specific chromatin remodeling and histone deacetylation with the DNA replication initiation process at OriP.	None
hPRC1L complex	P35226;Q06587;Q8IXK0;Q99496	648;6015;1912;6045	DNA modification;DNA restriction-modification system;RNA biosynthetic process;protein ubiquitination;nucleus	"DNA restriction or modification;RNA synthesis;modification by ubiquitination, deubiquitination;nucleus"	BMI1;RING1;PHC2;RNF2	None	The hPRC1L complex silences transcription by ubiquinating histone H2A at Lys 119.	None
Mis12 centromere complex	O95229;P45973;Q6P1K2;Q96IY1;Q9H081;Q9H410	11130;23468;11243;25936;79003;79980	"chromosome segregation;chromosome, centromeric region"	chromosome segregation/division;centromere / kinetochore	ZWINT;CBX5;PMF1;NSL1;MIS12;DSN1	None	None	None
"pRb2/p130-multimolecular complex (RB2, E2F5, HDAC1, SUV39H1, P300)"	O43463;Q08999;Q09472;Q13547;Q15329	6839;5934;2033;3065;1875	"transcription, DNA-templated"	TRANSCRIPTION	SUV39H1;RBL2;EP300;HDAC1;E2F5	None	None	None
E2F5-RB2-DP1 complex	Q08999;Q14186;Q15329	5934;7027;1875	"transcription, DNA-templated"	TRANSCRIPTION	RBL2;TFDP1;E2F5	None	None	None
SMAD3/4-E2F4/5-p107-DP1 complex	P28749;P84022;Q13485;Q14186;Q15329;Q16254	5933;4088;4089;7027;1875;1874	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	RBL1;SMAD3;SMAD4;TFDP1;E2F5;E2F4	None	E2F4/5 and p107 act as signal cotransducers that enable a SMAD complex to recognize and repress c-Myc transcription.	None
DNMT1-RB1-HDAC1-E2F1 complex	P06400;P26358;Q01094;Q13547	5925;1786;1869;3065	"negative regulation of transcription, DNA-templated"	transcription repression	RB1;DNMT1;E2F1;HDAC1	None	None	None
DAXX-DNMT1-DMAP1 complex	P26358;Q9NPF5;Q9UER7	1786;55929;1616	"negative regulation of transcription, DNA-templated"	transcription repression	DNMT1;DMAP1;DAXX	None	None	None
RGS6-DNMT1-DMAP1 complex	P26358;P49758;Q9NPF5	1786;9628;55929	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	DNMT1;RGS6;DMAP1	None	This complex inhibits DMAP1 transcriptional repressor activity.	None
BHC110 complex	O60341;O75362;Q13547;Q14687;Q92618;Q92769;Q96BD5;Q9P0W2;Q9UBW7;Q9UKL0	23028;7764;3065;23199;9658;3066;51317;10362;7750;23186	DNA topological change;protein acetylation;protein deacetylation;protein hydroxylation;protein methylation;nucleus	"DNA conformation modification (e.g. chromatin);modification by acetylation, deacetylation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	KDM1A;ZNF217;HDAC1;GSE1;ZNF516;HDAC2;PHF21A;HMG20B;ZMYM2;RCOR1	None	"The BHC110 complex performs demethylation of histone H3 lysine 4 (H3K4). The related BHC complex (CORUM ID 636) is recruited by a neuronal silencer, REST (RE1-silencing transcription factor), and mediates the repression of REST-responsive genes. Depletion of the CoREST (RCOR1) subunit of the BHC110 complex and the BHC complex results in de-repression of REST-responsive gene expression and increased methylation of H3K4."	None
PID complex	O94776;O95983;Q09028;Q13547;Q14839	9219;53615;5928;3065;1108	protein acetylation;protein deacetylation;cellular protein modification process;regulation of sequence-specific DNA binding transcription factor activity;nucleus	"modification by acetylation, deacetylation;protein modification;regulator of transcription factor;nucleus"	MTA2;MBD3;RBBP4;HDAC1;CHD4	None	"PID complex-mediated repression of p53 transactivation functions acts, in part, through deacetylation of p53 at the C terminus. Experiments  show that PID is involved in the regulation of p53-mediated growth arrest and apoptosis."	None
NCOR2 complex	O15379;O75376;O75446;Q13547;Q92769;Q96ST3;Q9Y618	8841;9611;8819;3065;3066;25942;9612	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	HDAC3;NCOR1;SAP30;HDAC1;HDAC2;SIN3A;NCOR2	None	"Transcriptional silencing by many transcription factors is mediated by the nuclear receptor corepressor (N-CoR). The mechanism by which N-CoR represses basal transcription involves the direct or indirect recruitment of histone deacetylases (HDACs). Two multiprotein N-CoR complexes have been isolated, designated N-CoR-1 and N-CoR-2, which possess histone deacetylase activity that is mediated by distinct HDACs. Results suggest that N-CoR is found in distinct multiprotein complexes, which are involved in multiple pathways of transcriptional repression. Only weak amounts of HDAC3 could be detected in the N-CoR-2 complex."	None
BCL6-ZBTB17 complex	P41182;Q13105	604;None	"negative regulation of transcription, DNA-templated"	transcription repression	BCL6;ZBTB17	None	"BCL6 interacted with the transcriptional activator Miz-1 and, via Miz-1, bound to the promoter and suppressed transcription of the cell cycle arrest gene CDKN1A."	None
IL4-IL4R complex	P05112;P24394	3565;3566	protein binding;signaling	protein binding;cellular signalling	IL4;IL4R	None	None	None
IL4-IL4R-IL2RG complex	P05112;P24394;P31785	3565;3566;3561	signaling	cellular signalling	IL4;IL4R;IL2RG	None	None	None
IL6ST-PRKCD-STAT3 complex	P40189;P40763;Q05655	3572;6774;5580	regulation of interleukin-6-mediated signaling pathway	None	IL6ST;STAT3;PRKCD	None	"PKCdelta  is recruited to the receptor gp130 via Stat3, which not only stabilizes the Stat3 and gp130 receptor interaction, but may also phosphorylate gp130."	None
STAT3-NLK-MAP3K7 complex	O43318;P40763;Q9UBE8	6885;6774;None	signal transduction;nucleus	CELLULAR COMMUNICATION/SIGNAL TRANSDUCTION MECHANISM;nucleus	MAP3K7;STAT3;NLK	None	The complex is involved in the TAK1-Nemo-like kinase (NLK) pathway.	None
p300-SMAD1-STAT3 complex	P40763;Q09472;Q15797	6774;2033;4086	"positive regulation of transcription, DNA-templated;enzyme linked receptor protein signaling pathway;astrocyte differentiation"	transcription activation;receptor enzyme mediated signalling	STAT3;EP300;SMAD1	None	P300 acts as an adaptor linking SMAD1 and STAT3.	None
STAT3 homodimer complex	P40763	6774	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	STAT3	None	"Lys685 acetylation was critical for Stat3 to form stable dimers required for cytokine-stimulated DNA binding and transcriptional regulation, to enhance transcription of cell growth-related genes, and to promote cell cycle progression in response to treatment with oncostatin M."	None
Girdin homo-oligomer complex	Q3V6T2	55704	movement of cell or subcellular component;actin cytoskeleton organization	cell motility;actin cytoskeleton	CCDC88A	Oligomer	Girdin is essential for the integrity of the actin cytoskeleton and cell migration.	None
"G protein complex (GNG2, GNB2L1, RAF1)"	P04049;P59768;P63244	5894;54331;10399	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	RAF1;GNG2;RACK1	None	Raf-1 is a serine-threonine protein kinasecritically positioned in a cascade linkingactivated growth factor receptorswith the nucleus and ultimatively regulatingthe mitogenic response.	None
PPP2CA-PPP2R1A complex	P30153;P67775	5518;5515	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	PPP2R1A;PPP2CA	None	None	None
PPP2CA-PPP2R1A-PPP2R3A complex	P30153;P67775;Q06190	5518;5515;5523	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	PPP2R1A;PPP2CA;PPP2R3A	None	None	None
IPO13-RAN-EIF1AX complex	O94829;P47813;P62826	9670;1964;5901	protein transport;protein transporter activity;nuclear transport;cytoplasm;nucleus	protein transport;nuclear transport;cytoplasm;nucleus	IPO13;EIF1AX;RAN	None	"Imp13 operates differently from typical exportins in that the binding of eIF1A to Imp13 is only regulated indirectly by RanGTP, and the cytoplasmic release of eIF1A from Imp13 is triggered by the loading of import substrates onto Imp13 (PMID:11447110)."	None
TNPO2-RAN-NXF1 complex	O14787;P62826;Q9UBU9	30000;5901;10482	RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	RNA binding;RNA transport;nuclear transport;cytoplasm;nucleus	TNPO2;RAN;NXF1	None	"Kap beta2B participates directly in the export of a large proportion of cellular mRNAs, and TAP connects Kap beta2B to the mRNAs to be exported (PMID:12384575)."	None
RANBP1-RAN-KPNB1 complex	P43487;P62826;Q14974	5902;5901;3837	protein transport;protein transporter activity;nuclear transport	protein transport;nuclear transport	RANBP1;RAN;KPNB1	None	"This complex is exported as a complex from the nucleus to the cytoplasm in living cells. The binding of RanBP1 to the Ran-importin beta  complex is required for the dissociation of the complex in the cytoplasm and that the released Ran is recycled to the nucleus, which is essential for the nuclear protein transport (PMID:10037787)."	None
NMI-POLR1B-RRN3 complex	Q13287;Q9H9Y6;Q9NYV6	9111;84172;54700	rRNA transcription	rRNA synthesis	NMI;POLR1B;RRN3	None	None	None
POLR1B-RRN3 complex	Q9H9Y6;Q9NYV6	84172;54700	rRNA transcription	rRNA synthesis	POLR1B;RRN3	None	None	None
NMI-RRN3 complex	Q13287;Q9NYV6	9111;54700	rRNA transcription	rRNA synthesis	NMI;RRN3	None	None	None
NMI homodimer complex	Q13287	9111	protein complex assembly	assembly of protein complexes	NMI	None	Homodimerization of Nmi enhanced its association with BRCA1.	None
Vigilin-DNA-PK-Ku antigen complex	P12956;P13010;P78527;Q00341	2547;7520;5591;3069	chromosome segregation;protein phosphorylation;RNA binding;chromosome	"chromosome segregation/division;modification by phosphorylation, dephosphorylation, autophosphorylation;RNA binding;chromosome"	XRCC6;XRCC5;PRKDC;HDLBP	None	"The authors describe, that in the presence of RNA, the Vigilin complex recruits the DNA-PKcs enzyme, which appears to phosphorylate a discrete set of targets, some or all of which are known to participate in chromatin silencing."	None
GNAS-GNB1-GNG2 complex	P59768;P62873;P63092	54331;2782;2778	signaling	cellular signalling	GNG2;GNB1;GNAS	None	"Guanine nucleotide-binding proteins (G proteins) are composed of 3 units, alpha, beta and gamma and are involved in various transmembrane signaling systems."	None
"G protein complex (MCF2, GNB1, GNG2)"	P10911;P59768;P62873	4168;54331;2782	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	MCF2;GNG2;GNB1	None	None	None
"G protein complex (BTK, GNG1, GNG2)"	P59768;P62873;Q06187	54331;2782;695	G-protein coupled receptor signaling pathway;cell differentiation	G-protein coupled receptor signalling pathway;cell differentiation	GNG2;GNB1;BTK	None	None	Deficient expression or function of Bruton tyrosine kinase (Btk) causes human X chromosome-linked agammaglobulinemia (XLA) or murine X chromosome-linked immunodeficiency (XID).
"G protein complex (CACNA1A, GNB1, GNG2)"	O00555;P59768;P62873	773;54331;2782	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	CACNA1A;GNG2;GNB1	None	"The direct interaction of the G proteins(beta, gamma) with the Ca-channel alpha 1 subunit is responsible for the channel inhibition by G protein-coupled receptors."	None
"G protein complex (PTHR1, GNB1, GNG2)"	P59768;P62873;Q03431	54331;2782;5745	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	GNG2;GNB1;PTH1R	None	The G protein-coupled receptor for PTH-related protein (PTH1R) signals via many intracellular pathways.	None
"G protein complex (HDAC5, GNB1, GNG2)"	P59768;P62873;Q9UQL6	54331;2782;10014	"negative regulation of transcription, DNA-templated;G-protein coupled receptor signaling pathway"	transcription repression;G-protein coupled receptor signalling pathway	GNG2;GNB1;HDAC5	None	The class II HDAC5 binds to GNB1/GNG2 via itsC-terminal domain. The transcriptional co-repressionactivity is then inhibited.	None
"G protein complex (HDAC4, GNB1, GNG2)"	P56524;P59768;P62873	9759;54331;2782	"negative regulation of transcription, DNA-templated;G-protein coupled receptor signaling pathway"	transcription repression;G-protein coupled receptor signalling pathway	HDAC4;GNG2;GNB1	None	The class II HDAC4 binds to GNB1/GNG2 via itsC-terminal domain. The transcriptional co-repressionactivity is then inhibited.	None
FA core complex 1 (Fanconi anemia core complex 1)	O15287;O15360;Q00597;Q9HB96;Q9NPI8	2189;2175;2176;2178;2188	protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;FANCC;FANCE;FANCF	None	FANCE functions to target cytoplasmic FANCC to the nucleus.	FA complex is involved in Fanconi anemia (FA) disease.
FA core complex (Fanconi anemia core complex)	O15287;O15360;Q00597;Q0VG06;Q8IYD8;Q8NB91;Q9HB96;Q9NPI8;Q9NW38	2189;2175;2176;80233;57697;2187;2178;2188;55120	protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;FANCC;FAAP100;FANCM;FANCB;FANCE;FANCF;FANCL	None	None	FA complex is involved in Fanconi anemia (FA) disease.
FA core complex (Fanconi anemia core complex)	O15287;O15360;Q00597;Q8IYD8;Q8NB91;Q9HB96;Q9NPI8	2189;2175;2176;57697;2187;2178;2188	protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;FANCC;FANCM;FANCB;FANCE;FANCF	None	None	FA complex is involved in Fanconi anemia (FA) disease.
CyclinD1-CDK4-CDK6 complex	P11802;P24385;Q00534	1019;595;1021	mitotic cell cycle;G1/S transition of mitotic cell cycle;intracellular signal transduction;skeletal muscle tissue development	mitotic cell cycle;G1/S transition of mitotic cell cycle;cellular signalling;myogenesis	CDK4;CCND1;CDK6	None	Upon myocyte differentiation subunit composition of the CDK4/6 complex is altered. Interaction with cyclinD1 is reduced but interaction with cyclinD3 and p21 is enhanced thus inhibiting the kinase activity of CDK4/6.	None
CyclinD1-CDK4-p21 complex	P11802;P24385;P38936	1019;595;1026	cell cycle arrest;intracellular signal transduction	cell cycle arrest;cellular signalling	CDK4;CCND1;CDKN1A	"Since CCND1, CDKN1A and CDK4 from hamster were not available in the Uniprot database at the time of annotation, the orthologous human proteins were used."	None	None
p16-cyclin D2-CDK4 complex	P11802;P30279;P42771	1019;894;1029	mitotic cell cycle;regulation of cell cycle;intracellular signal transduction	mitotic cell cycle;mitotic cell cycle and cell cycle control;cellular signalling	CDK4;CCND2;CDKN2A	None	"p16 binds to preassembled cyclinD-CDK complex in vitro and inhibits their activity without replacing Cyclin D. However, affinity for p16 to the uncomplexed CDK4 is higher."	None
p27-cyclinE-CDK2 complex	P24864;P24941;P46527	898;1017;1027	G1/S transition of mitotic cell cycle;nucleus	G1/S transition of mitotic cell cycle;nucleus	CCNE1;CDK2;CDKN1B	None	"p27, an important cell cycle regulator, blocks the G1/S transition in cells by binding and inhibiting Cdk2/cyclin A and Cdk2/cyclin E complexes. Ubiquitination and subsequent degradation play a critical role in regulating the levels of p27 during cell cycle progression."	"Overexpression of p27 in certain cancer cells prevents DNA replication and tumor formation in nude mice, whereas the loss of p27 has been reported in many human cancers and predicts a poor prognosis in breast, prostate, colon, gastric, lung, and esophageal cancers."
E2F4-p107-cyclinA complex	P20248;P28749;Q16254	890;5933;1874	G1/S transition of mitotic cell cycle;nucleus	G1/S transition of mitotic cell cycle;nucleus	CCNA2;RBL1;E2F4	None	In proliferating MCF-7 cells the complex contains mostly cyclin A. After overexpression of cyclin E most of the complexes contain cyclin E.	None
SCAMP1-SCAMP2 complex	O15126;O15127	9522;10066	protein transport;protein transporter activity;post-Golgi vesicle-mediated transport	protein transport;post Golgi transport	SCAMP1;SCAMP2	None	None	None
ABL2-HRAS-RIN1 complex	P01112;P42684;Q13671	3265;27;9610	intracellular signal transduction	cellular signalling	HRAS;ABL2;RIN1	None	The formation of this stable complex is consistent with a pathway connecting RAS proteins with the cytoplasmic functions of ABL-family tyrosine kinases through RIN1.	None
IGHM-VPREB1-IGLL1 complex	P01871;P12018;P15814	3507;7441;3543	B cell differentiation	B-cell	IGHM;VPREB1;IGLL1	None	None	None
IL2-IL2RA-IL2RB complex	P01589;P14784;P60568	3559;3560;3558	signaling	cellular signalling	IL2RA;IL2RB;IL2	None	None	None
TICAM1-TICAM2-TLR4 complex	O00206;Q86XR7;Q8IUC6	7099;None;148022	cytokine activity	"cytokines (interleukines, colony stimulating factors, etc.)"	TLR4;TICAM2;TICAM1	None	"TICAM-2 physically bridges TLR4 and TICAM-1 and functionally transmits LPS-TLR4 signaling to TICAM-1, which in turn activates IRF-3."	None
CTCF-nucleophosmin-PARP-HIS-KPNA-LMNA-TOP complex	O00505;P02545;P06748;P09874;P0C0S5;P11388;P49711;P52294;Q6FI13	None;4000;4869;142;3015;7153;10664;3836;None	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	KPNA3;LMNA;NPM1;PARP1;H2AFZ;TOP2A;CTCF;KPNA1;HIST2H2AA3	None	Nucleophosmin is the most prominent binding partner of CTCF.	None
TLE1 corepressor complex (MASH1 promoter-corepressor complex)	P06748;P09874;P19338;P34932;P35580;P60709;Q02880;Q04724;Q15233;Q92878	4869;142;4691;3308;4628;60;7155;7088;4841;10111	"negative regulation of transcription, DNA-templated;protein binding;DNA binding;regulation of sequence-specific DNA binding transcription factor activity;neuron differentiation;nucleus"	transcription repression;protein binding;DNA binding;regulator of transcription factor;neuron;nucleus	NPM1;PARP1;NCL;HSPA4;MYH10;ACTB;TOP2B;TLE1;NONO;RAD50	None	"The TLE1 complex is required for HES1-mediated transcription repression. PARP1 is inactive in the TLE1 complex. After Ca(2+) induction, kinase CaMKII-delta activates PARP1 leading to dismissal of the TLE1 corepresspor complex from HES1."	None
PRMT1 complex	Q99873	3276	protein hydroxylation;protein methylation;nucleus	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	PRMT1	None	"PRMT1 (protein-arginine methyltransferase) formes distinct homo-oligomeric complexes, including a dimer and tetramer."	None
SF3A1-SF3A2-SF3A3 complex	Q12874;Q15428;Q15459	10946;8175;10291	RNA splicing;nucleus	splicing;nucleus	SF3A3;SF3A2;SF3A1	None	All SF3A subunits are essential for the formation of the mature 17S U2 snRNP and the prespliceosome.	None
SF3b complex	O75533;Q13435;Q15393;Q15427;Q7RTV0;Q86XP3;Q9BWJ5;Q9Y3B4	23451;10992;23450;10262;84844;11325;83443;51639	RNA splicing;nucleus	splicing;nucleus	SF3B1;SF3B2;SF3B3;SF3B4;PHF5A;DDX42;SF3B5;SF3B6	None	The splicing factor SF3b is a multiprotein complex essential for the accurate excision of introns from pre-messenger RNA (PMID:12738865).	None
(E.F.G) complex	P62304;P62306;P62308	6635;6636;6637	nucleus;spliceosomal snRNP assembly	nucleus	SNRPE;SNRPF;SNRPG	None	"All four spliceosomal small nuclear ribonucleoproteins (snRNPs) U1, U2, U4/U6 and U5 contain a common structural element called the snRNP core. This core is assembled from the common snRNP proteins and the small nuclear RNA (snRNA). The RNA-free (E.F.G) complex contains the smallest U1 and U5 snRNP core proteins, i.e. E, F and G."	None
SMN complex	O14893;P09012;P14678;P57678;P62304;P62306;P62308;P62314;P62316;P62318;P63162;Q8TEQ6;Q8WXD5;Q9H840;Q9UHI6	8487;6626;6628;50628;6635;6636;6637;6632;6633;6634;6638;25929;79833;79760;11218	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN2;SNRPA;SNRPB;GEMIN4;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3;SNRPN;GEMIN5;GEMIN6;GEMIN7;DDX20	None	"Assembly of the Sm-class of U-rich small nuclear ribonucleoprotein particles (U snRNPs) is a process facilitated by the macromolecular survival of motor neuron (SMN) complex. The SMN complex is found both in the cytoplasm and in the nucleus, where it is concentrated in gems, nuclear bodies similar in size and number to Cajal (coiled) bodies and often associated with them."	"Spinal muscular atrophy (SMA) is the most common genetic cause of infant mortality. Deletions or mutations in the survival of motor neurons (SMN1) gene, the SMA-causing gene, are detected in over 95% of SMA patients."
SMN containing complex	O14893;P09382;P17931;P57678;P62314;P62316;P62318;Q16637	8487;3956;3958;50628;6632;6633;6634;None	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;nucleus	GEMIN2;LGALS1;LGALS3;GEMIN4;SNRPD1;SNRPD2;SNRPD3;SMN1; SMN2	None	Evidence suggests a role for SMN containing complex in spliceosome assembly.	"Spinal muscular atrophy (SMA), (PMID:10601333)"
PRMT5 complex	O14744	10419	protein hydroxylation;protein methylation;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);cytoplasm"	PRMT5	None	"PRMT5 (protein-arginine methyltransferase) formes distinct homo-oligomeric complexes, including a dimer and tetramer. Recombinant PRMT5 protein methylates myelin basic protein, histone, and the amino terminus of fibrillarin."	None
SMN-PolII-RHA complex	O14893;P08579;P14678;P20226;P24928;P57678;P63162;Q00403;Q08211;Q9UHI6	8487;6629;6628;6908;5430;50628;6638;2959;1660;11218	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN2;SNRPB2;SNRPB;TBP;POLR2A;GEMIN4;SNRPN;GTF2B;DHX9;DDX20	None	"Physical association between the Survival Motor Neuron (SMN) complex, RNA polymerase II (pol II), snRNPs and RNA helicase A (RHA) suggest a role for the SMN complex in the assembly of the pol II transcription/processing machinery. SMN localizes both in the cytoplasm and in gems, nuclear bodies similar in size and number to coiled bodies (Cajal bodies) and often associated with them."	Spinal muscular atrophy (SMA)
PPP4C-PPP4R2-Gemin3-Gemin4 complex	P57678;P60510;Q9NY27;Q9UHI6	50628;5531;151987;11218	protein dephosphorylation;nucleus	"modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	GEMIN4;PPP4C;PPP4R2;DDX20	None	"PPP4c is a member of the PPP family of protein phosphatases. PPP4 exists as high molecular mass complex of 450-600 kDa, and two putative regulatory subunits have been identified, R1 and R2. Protein phosphatase 4 interacts also with the Survival of Motor Neurons (SMN) complex and enhances the temporal localisation of snRNPs."	None
SMN complex	O14893;P09012;P14678;P57678;Q16637;Q8TEQ6;Q8WXD5;Q9H840;Q9UHI6;Q9Y3F4	8487;6626;6628;50628;None;25929;79833;79760;11218;11171	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;ion transport;RNA transport;RNA transmembrane transporter activity;nuclear transport;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;ion transport;RNA transport;nuclear transport;cytoplasm;nucleus	GEMIN2;SNRPA;SNRPB;GEMIN4;SMN1; SMN2;GEMIN5;GEMIN6;GEMIN7;DDX20;STRAP	None	"Survival of motor neurons (SMN) protein import depends on the presence of Sm snRNPs. Conversely, import of labeled U1 snRNPs was SMN complex dependent. Thus, import of SMN and U snRNPs are coupled in spinal muscular atrophy (SMA)."	Spinal muscular atrophy (SMA)
SMN complex	O14893;P57678;Q16637;Q8TEQ6;Q8WXD5;Q9H840;Q9UHI6	8487;50628;None;25929;79833;79760;11218	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN2;GEMIN4;SMN1; SMN2;GEMIN5;GEMIN6;GEMIN7;DDX20	None	"The survival of motor neurons (SMN) protein is the product of the gene mutated or deleted in the neurodegenerative disease, spinal muscular atrophy. SMN is part of a large macromolecular complex that also contains Gemin2, Gemin3, Gemin4, Gemin5, and Gemin6. The SMN complex functions in the assembly of spliceosomal small nuclear ribonucleoproteins and probably other ribonucleoprotein particles. The SMN complex is found both in the cytoplasm and in the nucleus where it is concentrated in gems, nuclear bodies similar in size and number to Cajal bodies (coiled bodies (CBs) and often associated with them."	Spinal muscular atrophy (SMA)
TOP1-PSF-P54 complex	P11387;P23246;Q15233	7150;6421;4841	RNA splicing;nucleus	splicing;nucleus	TOP1;SFPQ;NONO	None	None	None
CPSF6-ITCH-NUDT21-POLR2A-UBAP2L complex	O43809;P24928;Q14157;Q16630;Q96J02	11051;5430;9898;11052;83737	None	None	NUDT21;POLR2A;UBAP2L;CPSF6;ITCH	None	None	None
CPSF6-EWSR1-ITCH-NUDT21-POLR2A-UBAP2L complex	O43809;P24928;Q01844;Q14157;Q16630;Q96J02	11051;5430;2130;9898;11052;83737	None	None	NUDT21;POLR2A;EWSR1;UBAP2L;CPSF6;ITCH	None	None	None
CPSF6-ITCH-NUDT21-POLR2A complex	O43809;P24928;Q16630;Q96J02	11051;5430;11052;83737	None	None	NUDT21;POLR2A;CPSF6;ITCH	None	None	None
MICB-KLRK1-HCST complex	P26718;Q29980;Q9UBK5	22914;4277;10870	immune response	immune response	KLRK1;MICB;HCST	None	The ULBPs and the MICs share the property of binding to the NKG2D/DAP10 receptor and provide a positive signal for NK cell activation and cytotoxicity that can override the negative signal mediated by MHC class I/KIR engagement.	None
ULBP3-KLRK1-HCST complex	P26718;Q9BZM4;Q9UBK5	22914;79465;10870	immune response	immune response	KLRK1;ULBP3;HCST	None	The ULBPs and the MICs share the property of binding to the NKG2D/DAP10 receptor and provide a positive signal for NK cell activation and cytotoxicity that can override the negative signal mediated by MHC class I/KIR engagement.	None
MICA-KLRK1-HCST complex	P26718;Q29983;Q9UBK5	22914;100507436;10870	immune response	immune response	KLRK1;MICA;HCST	None	None	None
ULBP2-KLRK1-HCST complex	P26718;Q9BZM5;Q9UBK5	22914;80328;10870	immune response	immune response	KLRK1;ULBP2;HCST	None	The ULBPs and the MICs share the property of binding to the NKG2D/DAP10 receptor and provide a positive signal for NK cell activation and cytotoxicity that can override the negative signal mediated by MHC class I/KIR engagement.	None
"Ubiquitin E3 ligase (SMURF2, SMAD7) - TGF(beta)"	O15105;P36897;P37173;Q9HAU4	4092;7046;7048;64750	transforming growth factor beta receptor signaling pathway;cytoplasm;protein ubiquitination;ubiquitin-dependent protein catabolic process	"TGF-beta-receptor signalling pathway;cytoplasm;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	SMAD7;TGFBR1;TGFBR2;SMURF2	None	SMAD7 mediates the interaction of SMURF2 with TGF-beta-receptor complex.	None
TGF-beta-receptor-PAR6 complex	P36897;P37173;Q9NPB6	7046;7048;50855	transforming growth factor beta receptor signaling pathway;cell-cell junction assembly;cell junction	TGF-beta-receptor signalling pathway;intercellular junction (gap junction/adherens junction);cell junction	TGFBR1;TGFBR2;PARD6A	None	PAR6 interacts directly with TGFBR1.	None
"Ubiquitin E3 ligase (SMAD7, SMURF1) - TGFBR1"	O15105;P36897;Q9HCE7	4092;7046;57154	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;cytoplasm	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);TGF-beta-receptor signalling pathway;cytoplasm"	SMAD7;TGFBR1;SMURF1	None	"SMAD7 associates with SMURF1 in the nucleus and is exported to the cytoplasm. Thus SMAD7 recruits SMURF1 to TGF-betaRI, resulting in the degradation of Tgf-betaRI."	None
RNF11-SMURF2-STAMBP complex	O95630;Q9HAU4;Q9Y3C5	10617;64750;26994	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	STAMBP;SMURF2;RNF11	None	None	None
Nogo-potassium channel complex	P16389;P78357;Q09470;Q9NQC3	3737;8506;3736;57142	cation transmembrane transporter activity;cation transport;ion channel activity;neurogenesis;generation of neurons;central nervous system development	"cation transport (H+, Na+, K+, Ca2+ , NH4+, etc.);ion channels;neurogenesis;central nervous system"	KCNA2;CNTNAP1;KCNA1;RTN4	None	Nogo-A is mainly localized at thegaps between Na+ and K+ channels along axons and its immunoreactivity is clearly located at sites where glialloops make contact with the axonal membrane surface inadult CNS. Nogo-A is a paranodal glial component.	None
LINGO1-RTN4R-NGFR complex	P08138;Q96FE5;Q9BZR6	4804;84894;65078	neurogenesis;generation of neurons;neuron projection development	neurogenesis	NGFR;LINGO1;RTN4R	None	"Triply transfected cells responded to OMgp by activating RhoA, but no activation occurred when binary pairs of NgR1/p75, LINGO-1/p75 or NgR1/LINGO-1 were tested.The binding of LINGO-1 to NgR1, p75 or to both together during CNS development or in response to injury, may modulate RhoA activation status in neurons, and thus control axon growth and extension."	None
SORT1-NGFR complex	P08138;Q99523	4804;6272	protein binding;cytoplasm	protein binding;cytoplasm	NGFR;SORT1	None	None	None
SORT1-NGFR-NGFB complex	P01138;P08138;Q99523	4803;4804;6272	apoptotic process	apoptosis (type I programmed cell death)	NGF;NGFR;SORT1	None	None	None
ITGA4-PXN-GIT1 complex	P13612;P49023;Q9Y2X7	3676;5829;28964	cell migration	cell migration	ITGA4;PXN;GIT1	None	None	None
AXIN-MEKK4-CCD1 complex	O15169;Q155Q3;Q9Y6R4	8312;85458;4216	JNK cascade	JNK cascade	AXIN1;DIXDC1;MAP3K4	None	"The authors analyzed that Ccd1 uses its coiled-coil domain to interact with MEKK4 and the DIX domain to interact with Axin, forming a ternary complex."	None
MAD1L1 homodimer complex	Q9Y6D9	8379	cell cycle checkpoint;centrosome	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);centrosome"	MAD1L1	None	None	None
MAD1L1-MAD2L1 complex	Q13257;Q9Y6D9	4085;8379	cell cycle checkpoint	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle)"	MAD2L1;MAD1L1	None	The closed Mad2 bound to Mad1 represents a template for the conversion of open Mad2 into closed Mad2 bound to Cdc20.	None
JUN-TCF4-CTNNB1 complex	P05412;P15884;P35222	3725;6925;1499	Wnt signaling pathway;signaling	Wnt signalling pathway;cellular signalling	JUN;TCF4;CTNNB1	None	None	None
SMAD3-HEF1-APC10-CDH1 complex	P12830;P84022;Q14511;Q9UM13	999;4088;4739;10393	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;cytoplasm	proteasomal degradation (ubiquitin/proteasomal pathway);TGF-beta-receptor signalling pathway;cytoplasm	CDH1;SMAD3;NEDD9;ANAPC10	None	SMAD3 regulates the proteosomal degradation of its interacting proteins via recruiting the cell-cycle linked E3 ligase APC. SMAD3 interaction with APC10 is regulated by TGF-beta type I receptor activation.	None
PML-SMAD2/3-SARA complex	O95405;P29590;P84022;Q15796	9372;5371;4088;4087	transforming growth factor beta receptor signaling pathway;cytoplasm	TGF-beta-receptor signalling pathway;cytoplasm	ZFYVE9;PML;SMAD3;SMAD2	None	PML is essential for the formation of a stable and functional SARA-SMAD2/3complex. PML may function as a bridging factor between SARA and SMAD2/3.	Promyelocytic leukaemia
TGF-beta receptor I-Axin-SMAD3 complex	O15169;P36897;P84022	8312;7046;4088	transforming growth factor beta receptor signaling pathway;cytoplasm	TGF-beta-receptor signalling pathway;cytoplasm	AXIN1;TGFBR1;SMAD3	None	"Phosphorylation of SMAD3 by TGF-betaRI is faciliated in the presence of Axin. In the absence of ligand stimulation, Axin was colocalized with Smad3 in the cytoplasm in vivo. Upon receptor activation, Smad3 was strongly phosphorylated by TGF-beta type I receptor (TGF-betaRI) in the presence of Axin, and dissociated from TGF-betaRI and Axin."	None
PIAS3-SMAD3-P300 complex	P84022;Q09472;Q9Y6X2	4088;2033;10401	"DNA topological change;positive regulation of transcription, DNA-templated;protein acetylation;DNA binding;transforming growth factor beta receptor signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription activation;modification by acetylation, deacetylation;DNA binding;TGF-beta-receptor signalling pathway;organization of chromosome structure;nucleus"	SMAD3;EP300;PIAS3	None	TGF-beta treatment increases the complex formation.	None
ITGAE-ITGB7-CDH1 complex	P12830;P26010;P38570	999;3695;3682	protein complex assembly	assembly of protein complexes	CDH1;ITGB7;ITGAE	None	None	None
APC-IQGAP1 complex	P25054;P46940	324;8826	cell migration;cytoskeleton organization;cytoskeleton	cell migration;cytoskeleton/structural proteins;cytoskeleton	APC;IQGAP1	None	"The authors demonstrate that the amount of IQGAP1 is about 20 times more than that of APC, and that the armadillo repeats of APC are responsible for the interaction with IQGAP1."	None
APC-IQGAP1-CLIP-170 complex	P25054;P30622;P46940	324;6249;8826	cell migration;cytoskeleton organization;cytoskeleton	cell migration;cytoskeleton/structural proteins;cytoskeleton	APC;CLIP1;IQGAP1	None	None	None
BUB1-BUB3 complex	O43683;O43684	699;9184	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	BUB1;BUB3	None	"Bub1-Bub3 phosphorylated Cdc20. Bub1 alone also efficiently phosphorylatedCdc20, indicating that Bub3 is not required for this process."	None
Sororin-cohesin complex	O60216;Q14683;Q29RF7;Q96FF9;Q9NTI5;Q9UQE7	5885;8243;23244;113130;23047;9126	mitotic cell cycle;chromosome segregation;nucleus	mitotic cell cycle;chromosome segregation/division;nucleus	RAD21;SMC1A;PDS5A;CDCA5;PDS5B;SMC3	None	None	None
TSG101-VPS37B-VPS28 complex	Q99816;Q9H9H4;Q9UK41	7251;79720;51160	intracellular protein transport;protein targeting;protein transport	"protein targeting, sorting and translocation;protein transport"	TSG101;VPS37B;VPS28	None	None	None
"SNARE complex (SNAP25, VAMP3, VAMP2, NAPB, STX13)"	P60880;P63027;Q15836;Q86Y82;Q9H115	6616;6844;9341;23673;63908	vesicle fusion;synaptic vesicle transport;synaptic vesicle exocytosis	vesicle fusion;synaptic vesicle exocytosis	SNAP25;VAMP2;VAMP3;STX12;NAPB	Entrez Gene says that stx12 is synonym to stx13.	SNARE (N-ethylmaleimide-sensitive factor attachment protein receptor) complexes are responsible for membrane fusion in the secretory pathway.	None
ELK1-SRF-ELK4 complex	P11831;P19419;P28324	6722;2002;2005	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	SRF;ELK1;ELK4	None	None	None
"mTOR complex (MTOR, RICTOR, MLST8)"	P42345;Q6R327;Q9BVC4	2475;253260;64223	cell morphogenesis;cell growth;actin cytoskeleton organization	cell growth / morphogenesis;actin cytoskeleton	MTOR;RICTOR;MLST8	None	The authors found that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C alpha (PKCalpha) and the actin cytoskeleton. The rictor-mTOR complex is insensitive to rapamycin.	None
"mTOR complex (MTOR, RICTOR, MLST8)"	P42345;Q6R327;Q9BVC4	2475;253260;64223	protein phosphorylation;regulation of protein kinase B signaling	"modification by phosphorylation, dephosphorylation, autophosphorylation"	MTOR;RICTOR;MLST8	None	"Rictor-TOR has essential roles in Akt/PKB hydrophobic motif site phosphorylation in Drosophila and human cells and in vitro phosphorylates full-length, wild-type Akt/PKB in a serum-sensitive fashion.Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN."	None
"mTOR complex (MTOR, RAPTOR, MLST8)"	P42345;Q8N122;Q9BVC4	2475;57521;64223	regulation of protein serine/threonine kinase activity	None	MTOR;RPTOR;MLST8	None	None	None
NTF4 homodimer complex	P34130	4909	neuron differentiation	neuron	NTF4	None	The structures of the neurotrophin homodimers reveals common features that may be important in the binding between the neurotrophins and their receptors.	None
APC-DLG4 complex	P25054;P78352	324;1742	cell migration;cell morphogenesis;cell growth	cell migration;cell growth / morphogenesis	APC;DLG4	None	None	None
PKD2-PACS1 complex	Q13563;Q6VY07	5311;55690	ion channel activity	ion channels	PKD2;PACS1	None	None	"Mutations of PKD2, a member of the TRP family of cation channels, cause autosomal dominant polycystic kidney disease."
NEK2-NEK11 complex	P51955;Q8NG66	4751;79858	cell cycle arrest	cell cycle arrest	NEK2;NEK11	None	None	None
IRAK1-IRAK2 complex	O43187;P51617	3656;3654	innate immune response	innate immune response (invertebrates and vertebrates)	IRAK2;IRAK1	None	None	None
IRAK1-IRAK3 complex	P51617;Q9Y616	3654;11213	innate immune response	innate immune response (invertebrates and vertebrates)	IRAK1;IRAK3	None	None	None
DAP12 signaling homodimer complex	O43914	7305	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	TYROBP	None	None	None
BMP4-TWSG1 complex	P12644;Q9GZX9	652;57045	transmembrane receptor protein serine/threonine kinase signaling pathway	transmembrane receptor protein serine/threonine kinase signalling pathways	BMP4;TWSG1	None	None	None
BMP4-BGN complex	P12644;P21810	652;633	signaling	cellular signalling	BMP4;BGN	None	None	None
MTNR1A homodimer complex	P48039	4543	None	None	MTNR1A	None	None	None
MTNR1B homodimer complex	P49286	4544	None	None	MTNR1B	None	None	None
MTNR1A-MTNR1B complex	P48039;P49286	4543;4544	None	None	MTNR1A;MTNR1B	None	"This heterodimers contain two functional ligand binding sites that maintain their respective selectivity for MT(1) and MT(2) ligands. Occupation of either binding site is sufficient to induce a conformational change within the heterodimer. Taken together, these results show that the probability of GPCR heterodimer formation may be equal to or even higher than that of the corresponding homodimers and that specific properties of heterodimers can be revealed using a BRET-based ligand/receptor interaction assay."	None
CACY homodimer  complex	P06703	6277	calcium ion binding;zinc ion binding	calcium binding	S100A6	None	None	None
PEX14 homodimer complex	O75381	5195	protein complex assembly;peroxisome organization;peroxisome	assembly of protein complexes;peroxisome;peroxisome	PEX14	None	None	None
AIRE homodimer complex	O43918	326	"positive regulation of transcription, DNA-templated"	transcription activation	AIRE	None	None	Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy is caused by mutations in the autoimmune regulator (AIRE) gene.
Endoglin homodimer complex	P17813	2022	signaling	cellular signalling	ENG	None	None	None
MYOM1 homodimer complex	P52179	8736	muscle organ development	muscle	MYOM1	None	None	None
BANF1 homodimer protein	O75531	8815	DNA binding;response to biotic stimulus	DNA binding;response to biotic stimulus	BANF1	None	None	None
PGRMC1-SCAP complex	O00264;Q12770	10857;22937	cholesterol homeostasis;endoplasmic reticulum	cholesterol homeostasis;endoplasmic reticulum	PGRMC1;SCAP	None	None	None
PRMT2 homodimer complex	P55345	3275	receptor regulator activity	regulator of receptor activity	PRMT2	None	None	None
LEPR homodimer complex	P48357	3953	cytokine activity	"cytokines (interleukines, colony stimulating factors, etc.)"	LEPR	None	None	None
SLC1A2 homotrimer complex	P43004	6506	amino acid transmembrane transporter activity;amino acid transport	amino acid/amino acid derivatives transport	SLC1A2	None	None	None
BAX homo-oligomer complex	Q07812	581	apoptotic signaling pathway	induction of apoptosis by extracellular signals	BAX	Oligomer	Arsenic trioxide  As(2)O(3) treatment triggered Bax conformational change and subsequent translocation from cytosol to mitochondria to form various multimeric homo-oligomers in IM-9 cells.	None
NOD1 homodimer complex	Q9Y239	10392	I-kappaB kinase/NF-kappaB signaling;inflammatory response	NIK-I-kappaB/NF-kappaB cascade;inflammatory response	NOD1	None	None	None
COX1 homodimer complex	P23219	5742	membrane lipid metabolic process;cytoplasm	membrane lipid metabolism;cytoplasm	PTGS1	None	None	None
C1D homodimer protein	Q13901	10438	protein complex assembly	assembly of protein complexes	C1D	None	Only the dimeric but not the monomeric form of C1D can interact with TRAX protein. The finding that the SDS-resistant homodimers of C1D and TRAX interact only after gamma-irradiation may indicate that a post-translational modification is required for the interaction.	None
PTPRA homodimer complex	P18433	5786	enzyme linked receptor protein signaling pathway	receptor enzyme mediated signalling	PTPRA	None	"RPTPalpha dimerized constitutively in living cells, which may be mediated by the transmembrane domain, providing strong support for the model that dimerization is involved in regulation of RPTPs."	None
PRNP homo-oligomer complex	P04156	5621	neuron differentiation	neuron	PRNP	Oligomer	"The non-fibrillar particles, with masses equivalent to 14-28 PrP molecules, are the most efficient initiators of TSE disease."	None
AXL homodimer complex	P30530	558	transmembrane receptor protein tyrosine kinase signaling pathway;plasma membrane	transmembrane receptor protein tyrosine kinase signalling pathways;eukaryotic plasma membrane / membrane attached	AXL	None	None	None
STAT5B homodimer complex	P51692	6777	"positive regulation of transcription, DNA-templated"	transcription activation	STAT5B	None	None	None
IL12A homodimer complex	P29459	3592	T cell differentiation	T-cell	IL12A	None	None	None
IL12A-IL12B complex	P29459;P29460	3592;3593	None	None	IL12A;IL12B	None	None	None
IL12A-IL12B-IL12RB1 complex	P29459;P29460;P42701	3592;3593;3594	signaling	cellular signalling	IL12A;IL12B;IL12RB1	None	None	None
IL12B-IL12RB1-IL12RB2 complex	P29460;P42701;Q99665	3593;3594;3595	T cell differentiation	T-cell	IL12B;IL12RB1;IL12RB2	None	"IL12B (p40) homodimer  was capable of competing with IL-12 heterodimer in binding to the IL12R on T cells but was unable to cause cellular proliferation. Furthermore, p40 homodimer inhibited IL-12-induced T cell proliferation."	None
IL12A-IL12B-IL12RB2 complex	P29459;P29460;Q99665	3592;3593;3595	signaling	cellular signalling	IL12A;IL12B;IL12RB2	None	None	None
STAT5A homodimer complex	P42229	6776	"positive regulation of transcription, DNA-templated"	transcription activation	STAT5A	None	None	None
IL12RB1-IL12RB2 complex	P42701;Q99665	3594;3595	signaling;plasma membrane	cellular signalling;eukaryotic plasma membrane / membrane attached	IL12RB1;IL12RB2	None	None	None
JAK2-IL12RB2 complex	O60674;Q99665	3717;3595	signaling	cellular signalling	JAK2;IL12RB2	None	None	None
BNIP2-ARHGAP8 complex	P85298;Q12982	23779;663	GTPase activator activity;positive regulation of GTPase activity	GTPase activator (GAP)	ARHGAP8;BNIP2	None	None	None
MALT1 homo-oligomer complex	Q9UDY8	10892	positive regulation of catalytic activity;enzyme activator activity	enzyme activator	MALT1	None	"TRAF6 ubiquitin ligase and TAK1 protein kinase mediate IKK activation by MALT1 and BCL10 in lymphocytes. Only oligomers of MALT1 and BCL10 can activate IKK in vitro. MALT1 oligomers bind to TRAF6, induce TRAF6 oligomerization, and activate the ligase activity of TRAF6 to polyubiquinate NEMO. These results reveal an oligomerization-ubiquination-phosphorylation cascade that culminates in NF-kappaB activation in T lymphocytes."	None
BCL10 homo-oligomer complex	O95999	8915	positive regulation of catalytic activity;enzyme activator activity	enzyme activator	BCL10	None	TRAF6 ubiquitin ligase and TAK1 protein kinase mediate IKK activation by MALT1 and BCL10 in lymphocytes. Only oligomers of MALT1 and BCL10 can activate IKK in vitro.	None
BCL10-MALT1 complex	O95999;Q9UDY8	8915;10892	positive regulation of catalytic activity;enzyme activator activity	enzyme activator	BCL10;MALT1	None	BCL10 binds to the Ig domains of MALT1 and promotes MALT1 oligomerization.	None
CASP8-FADD-MALT1-BCL10 complex	O95999;Q13158;Q14790;Q9UDY8	8915;8772;841;10892	regulation of I-kappaB kinase/NF-kappaB signaling	None	BCL10;FADD;CASP8;MALT1	None	The adapter protein FADD associated with caspase-8 and Bcl10-MALT1 at an earlier time (5 min) but disappeared before the recruitment of IKK to form the holocomplex.	None
CASP8-CHUK-IKBKB-MALT1-BCL10 complex	O14920;O15111;O95999;Q14790;Q9UDY8	3551;1147;8915;841;10892	regulation of I-kappaB kinase/NF-kappaB signaling	None	IKBKB;CHUK;BCL10;CASP8;MALT1	None	TCR (T cell receptor) stimulation induced caspase-8 to associate with the Bcl10-MALT1 complex followed by recruitment of IKK. Caspase-8 emerges both as a pivotal molecule for death-receptor signaling and as a selective signal transducer for NF-kappaB during the early genetic response to an antigen.	None
TNFRSF11A-TRAF6-SRC complex	P12931;Q9Y4K3;Q9Y6Q6	6714;7189;8792	signaling	cellular signalling	SRC;TRAF6;TNFRSF11A	None	None	None
TRAF6 homo-oligomer complex	Q9Y4K3	7189	positive regulation of catalytic activity;enzyme activator activity	enzyme activator	TRAF6	None	"MALT1 oligomers bind to TRAF6, induce TRAF6 oligomerization, and activate the ligase activity of TRAF6 to polyubiquinate NEMO. These results reveal an oligomerization-ubiquination-phosphorylation cascade that culminates in NF-kappaB activation in T lymphocytes."	None
B-raf-MAP3K11 complex	Q16584;Q9NY11	4296;6635	signaling	cellular signalling	MAP3K11;B-raf	None	MLK3 and B-Raf form a complex in vivo.	None
NFKB1-NFKB2-REL-RELA-RELB complex	P19838;Q00653;Q01201;Q04206;Q04864	4790;4791;5971;5970;5966	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	NFKB1;NFKB2;RELB;RELA;REL	None	None	None
NFKB1-NFKB2-RELA-RELB complex	P19838;Q00653;Q01201;Q04206	4790;4791;5971;5970	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	NFKB1;NFKB2;RELB;RELA	None	None	None
CHUK-IKBKB-MAP3K14 complex	O14920;O15111;Q99558	3551;1147;9020	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	IKBKB;CHUK;MAP3K14	None	None	None
IKKA-IKKB complex	O14920;O15111	3551;1147	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	IKBKB;CHUK	None	None	None
IKKB-NIK complex	O14920;Q99558	3551;9020	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	IKBKB;MAP3K14	None	None	None
"IkappaB kinase complex (IKBKB, CHUK, IKBKAP, NFKBIA, RELA, MAP3K14)"	O14920;O15111;O95163;P25963;Q04206;Q99558	3551;1147;8518;4792;5970;9020	I-kappaB kinase/NF-kappaB signaling;signaling	NIK-I-kappaB/NF-kappaB cascade;cellular signalling	IKBKB;CHUK;IKBKAP;NFKBIA;RELA;MAP3K14	None	None	None
CDC37-HSP90AA1-HSP90AB1-MAP3K11 complex	P07900;P08238;Q16543;Q16584	3320;3326;11140;4296	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	HSP90AA1;HSP90AB1;CDC37;MAP3K11	None	MLK3 associates with Hsp90/p50(cdc37) through its catalytic domain in an activity-independent manner.	None
CHUK-ERC1-IKBKB-IKBKG	O14920;O15111;Q8IUD2;Q9Y6K9	3551;1147;23085;8517	None	None	IKBKB;CHUK;ERC1;IKBKG	None	"ELKS may contribute an important oligomerization interface to members of the IKK complex as well as to other upstream or downstream regulators of NF-kappaB transcriptional activity, such as I(kappa)B(alpha)."	None
I-kappa-B kinase complex	O14920;O15111;Q9Y6K9	3551;1147;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKB;CHUK;IKBKG	None	None	None
IKBKG homodimer complex	Q9Y6K9	8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKG	None	KK-gamma forms homodimer and homotrimer both in vitro and in yeast or mammalian cells through a C-terminal domain comprising amino acids 251-419.	None
IKK-alpha--ER-alpha-AIB1 complex	O15111;P03372;Q9Y6Q9	1147;2099;8202	"regulation of transcription, DNA-templated;protein phosphorylation;DNA binding;cellular response to estrogen stimulus;intracellular estrogen receptor signaling pathway"	"transcriptional control;modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding"	CHUK;ESR1;NCOA3	None	"The authors showed that in estradiol-stimulated MCF7 cells, the association of both ER-alpha and AIB1/SRC-3 with IKK-alpha bound to the cyclin D1 promoter was markedly increased in an estrogen-dependent manner. Further siRNA experiments showed that IKK-alpha contributes to the estrogen-mediated phosphorylation of both ER-alpha and AIB1/SRC-3."	None
DNAJB2-HSPA8-PSMA3 complex	P11142;P25686;P25788	3312;3300;5684	intracellular protein transport;protein targeting;protein transport;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"protein targeting, sorting and translocation;protein transport;proteasomal degradation (ubiquitin/proteasomal pathway)"	HSPA8;DNAJB2;PSMA3	None	None	None
MAP2K5-PRKCI-SQSTM1 complex	P41743;Q13163;Q13501	5584;5607;8878	intracellular signal transduction;signaling	cellular signalling	PRKCI;MAP2K5;SQSTM1	None	None	None
HSF1-YWHAE complex	P62258;Q00613	7531;3297	response to heat	heat shock response	YWHAE;HSF1	None	None	None
ARNT-HLF complex	P27540;Q16534	405;3131	"positive regulation of transcription, DNA-templated"	transcription activation	ARNT;HLF	None	None	None
ITGAM-ITGB2-CD11 complex	P05107;P08962;P11215	3689;967;3684	signaling;cell adhesion	cellular signalling;cell adhesion	ITGB2;CD63;ITGAM	None	None	None
YBX1-AKT1 complex	P31749;P67809	207;4904	regulation of cell size;nucleus	growth regulators / regulation of cell size;nucleus	AKT1;YBX1	None	None	Akt and YB-1 work together to promote the growth and possibly the development of breast tumors.
AR-AKT-APPL complex	P10275;P31749;Q9UKG1	367;207;26060	signaling	cellular signalling	AR;AKT1;APPL1	None	"The authors  suggest that APPL, Akt, and AR may exist in a complex and Akt may serve as an important bridge factor for the association of APPL with AR. They demonstrated that the APPL\u00b7AR complex was not clearly seen, and that the addition of Akt markedly enhanced APPL\u00b7AR complex formation."	None
AOF2-AR complex	O60341;P10275	23028;367	"positive regulation of transcription, DNA-templated"	transcription activation	KDM1A;AR	None	The androgen receptor and LSD1 form chromatin-associated complexes in a ligand-dependent manner. LSD1 co-localizes with the androgen receptor in normal human prostate and prostate tumour.	None
APPBP1-UBA3 complex	Q13564;Q8TBC4	8883;9039	protein ubiquitination	"modification by ubiquitination, deubiquitination"	NAE1;UBA3	None	"The APPBP1-UBA3 complex initiates NEDD8 conjugation by first catalyzing adenylation of the C terminus of NEDD8 and ultimately catalyzing transfer of NEDD8 to the downstream enzyme in the pathway, Ubc12 (PMID:16275315)."	None
"Ubiquitin E3 ligase (CDC34, CUL1, RBX1)"	P49427;P62877;Q13616	997;9978;8454	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	CDC34;RBX1;CUL1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The conjugation of Nedd8 to the ROC1-CUL1 complex selectively stimulates Cdc34-catalyzed Lys48-linked multiubiquitin chain assembly.	None
"Ubiquitin E3 ligase (CHEK1, CUL4A)"	O14757;Q13619	1111;8451	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);DNA damage response;nucleus"	CHEK1;CUL4A	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The Chk1 kinase is a major effector of S phase checkpoint signaling during the cellular response to genotoxic stress. Replicative stress induces the polyubiquitination and degradation of Chk1 in human cells.	None
"Ubiquitin E3 ligase (CDT1, DDB1, CUL4A, RBX1)"	P62877;Q13619;Q16531;Q9H211	9978;8451;1642;81620	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);DNA damage response"	RBX1;CUL4A;DDB1;CDT1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The CDT1-DDB1-CUL4A complex was observed in an investigation of targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage.	None
COP9 signalosome complex	P61201;Q13098;Q7L5N1;Q92905;Q99627;Q9BT78;Q9UBW8;Q9UNS2	9318;2873;10980;10987;10920;51138;50813;8533	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signal transduction;detection of light stimulus;response to light stimulus"	transcriptional control;CELLULAR COMMUNICATION/SIGNAL TRANSDUCTION MECHANISM;photoperception and response	COPS2;GPS1;COPS6;COPS5;COPS8;COPS4;COPS7A;COPS3	"Since the authors did not specify COP7, we used isoform COPS7A."	"The purified complex is very similar, if not identical, to the plant COP9 complex involved in light-mediated signal transduction. A regulating transcriptional activity is discussed."	None
CNS-P53 complex	P04637;P61201;Q13098;Q7L5N1;Q92905;Q99627;Q9BT78;Q9UBW8;Q9UNS2	7157;9318;2873;10980;10987;10920;51138;50813;8533	intracellular protein transport;protein targeting;protein transport	"protein targeting, sorting and translocation;protein transport"	TP53;COPS2;GPS1;COPS6;COPS5;COPS8;COPS4;COPS7A;COPS3	None	None	None
Kaiso-NCOR complex	O15379;O60907;O75164;O75376;P52732;Q13227;Q86T24;Q92828;Q9BZK7;Q9UPN9	8841;6907;9682;9611;3832;2874;10009;7464;79718;51592	"DNA topological change;negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;nucleus"	HDAC3;TBL1X;KDM4A;NCOR1;KIF11;GPS2;ZBTB33;CORO2A;TBL1XR1;TRIM33	None	Kaiso targets the N-CoR complex to the MTA2 gene promoter in a methylation-dependent manner.The authors postulate that deacetylation of chromatin stabilizes the association of Kaiso-N-CoR with chromatin.	None
"Ubiquitin E3 ligase (CDC34, NEDD8, BTRC, CUL1, SKP1A, RBX1)"	P62877;P63208;Q13616;Q15843;Q9Y297	9978;6500;8454;4738;8945	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cytoplasm	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cytoplasm"	RBX1;SKP1;CUL1;NEDD8;BTRC	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Regulation of NF-kappaB occurs through phosphorylation-dependent ubiquitination of IkappaBalpha, which is degraded by the 26S proteasome. Recent studies have shown that ubiquitination of IkappaBalpha is carried out by ubiquitin E3 ligase complexes. Nedd8 modification of the Cul-1 component of ubiquitin E3 ligases is important for ubiquitination of IkappaBalpha."	None
"Ubiquitin E3 ligase (SMAD3, BTRC, CUL1, SKP1A, RBX1)"	P62877;P63208;P84022;Q13616;Q9Y297	9978;6500;4088;8454;8945	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;signaling;cytoplasm;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cellular signalling;cytoplasm;nucleus"	RBX1;SKP1;SMAD3;CUL1;BTRC	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Ubiquitin E3 ligase complex ROC1-SCFFbw1a interacts with activated Smad3 through its MH2 domain and induces the ubiquitination and proteasomal degradation of the transcriptional modulator Smad3.	None
"Ubiquitin E3 ligase (FBXO18, SKP1A, CUL1, RBX1)"	P62877;P63208;Q13616;Q8NFZ0	9978;6500;8454;84893	ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;SKP1;CUL1;FBXO18	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. hFBH1 is the first F-box protein implicated in nucleic acid metabolism.	None
"Ubiquitin E3 ligase (NIPA, SKP1A, CUL1, RBX1)"	P62877;P63208;Q13616;Q86WB0	9978;6500;8454;51530	mitotic cell cycle;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;nucleus	"mitotic cell cycle;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);nucleus"	RBX1;SKP1;CUL1;ZC3HC1	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Activity of ubiquitin E3 ligase (containing NIPA, SKP1A, CUL1 and RBX1) oscillates throughout the cell cycle, and cell-cycle-regulated phosphorylation of NIPA constitutes the responsible timing circuit. Nuclear cyclin B1 was identified to be a critical substrate of the complex in interphase. According to the oscillating activity of ubiquitin E3 ligase (containing NIPA, SKP1A, CUL1 and RBX1), this targeting process is terminated at G2/M to allow for nuclear cyclin B1 accumulation, which is necessary for mitotic entry."	None
9-1-1-LIG1 complex	O60671;O60921;P18858;Q99638	5810;3364;3978;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;LIG1;RAD9A	None	The 9-1-1 complex can stimulate DNA ligase I.	None
9-1-1-FEN1 complex	O60671;O60921;P39748;Q99638	5810;3364;2237;5883	DNA catabolic process;RNA catabolic process;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA degradation;RNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;FEN1;RAD9A	None	The 9-1-1 complex stimulates FEN1 activity.	None
9-1-1-POLB complex	O60671;O60921;P06746;Q99638	5810;3364;5423;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;POLB;RAD9A	None	The 9-1-1 complex directly interacts with and stimulates POLB activity thus recruiting POLB to DNA damage sites.	None
CHTF18-RFC2-5 complex	P35249;P35250;P40937;P40938;Q8WVB6	5984;5982;5985;5983;63922	DNA replication;chromosome segregation;chromosome organization;nucleus;DNA binding;ATPase activity	DNA synthesis and replication;chromosome segregation/division;organization of chromosome structure;nucleus;DNA binding	RFC4;RFC2;RFC5;RFC3;CHTF18	None	CTF18 interacts with RFC5.	None
RFC2-5 subcomplex	P35249;P35250;P40937;P40938	5984;5982;5985;5983	DNA replication;DNA binding;nucleus;ATPase activity	DNA synthesis and replication;DNA binding;nucleus	RFC4;RFC2;RFC5;RFC3	None	"Reconstitution experiments have revealed that a minimum of three subunits (the 40-, 37-, and 36-kDa subunits) are required for DNA-dependent ATPase activity in vitro."	None
PCNA-RFC2-5 complex	P12004;P35249;P35250;P40937;P40938	5111;5984;5982;5985;5983	DNA replication;nucleus	DNA synthesis and replication;nucleus	PCNA;RFC4;RFC2;RFC5;RFC3	None	None	None
CHTF18-RFC2-5 complex	P35249;P35250;P40937;P40938;Q8WVB6	5984;5982;5985;5983;63922	DNA replication;nucleus	DNA synthesis and replication;nucleus	RFC4;RFC2;RFC5;RFC3;CHTF18	None	None	None
BRD4-RFC complex	O60885;P35249;P35250;P35251;P40937;P40938	23476;5984;5982;5981;5985;5983	mitotic cell cycle;regulation of cell cycle;G1/S transition of mitotic cell cycle;nucleus	mitotic cell cycle;mitotic cell cycle and cell cycle control;G1/S transition of mitotic cell cycle;nucleus	BRD4;RFC4;RFC2;RFC1;RFC5;RFC3	None	BRD4 regulates cell cycle progression from G1 to S phase by interacting with RFC1.	None
MCM8-ORC2-CDC6 complex	Q13416;Q99741;Q9UJA3	4999;990;84515	DNA replication;G1/S transition of mitotic cell cycle;nucleus	DNA synthesis and replication;G1/S transition of mitotic cell cycle;nucleus	ORC2;CDC6;MCM8	None	Down-regulation of MCM8 impairs the G1-to-S transition.	None
ORC5-ORC1 complex	O43913;Q13415	5001;4998	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;nucleus	ori recognition and priming complex formation;nucleus	ORC5;ORC1	None	None	None
BRCA1-IRIS-pre-replication complex	O75496;Q13415;Q5YLB2;Q99741	51053;4998;672;990	DNA replication;nucleus	DNA synthesis and replication;nucleus	GMNN;ORC1;BRCA1;CDC6	None	BRCA1-IRIS is a BRCA1 gene product encoded by an uninterrupted open reading frame that extends from codon 1 of the known BRCA1 open reading frame to a termination point 34 triplets into intron 11. BRCA1-IRIS localizes to the nucleus and fails to interact with BARD1.	None
BARD1-BRCA1-CSTF complex	P33240;P38398;Q05048;Q12996;Q99728	1478;672;1477;1479;580	RNA 3'-end processing;mRNA 3'-end processing;RNA binding;nucleus	3'-end processing;RNA binding;nucleus	CSTF2;BRCA1;CSTF1;CSTF3;BARD1	None	Interaction of BARD1 with CstF inhibits RNA polyadenylation and ensures that at DNA damage sites nascent RNAs are not erroneously polyadenylated.	BRCA1 is involved in breast cancer.
BRCA1-BARD1-POLR2A complex	P24928;P38398;Q99728	5430;672;580	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein ubiquitination;nucleus"	"transcriptional control;modification by ubiquitination, deubiquitination;nucleus"	POLR2A;BRCA1;BARD1	None	BRCA1 and BARD1 heterodimer ubiquitinates a hyperphosphorylated form of POLR2A.	BRCA1 is involved in breast cancer.
LMO4-BRCA1-CTIP-LDB1 complex	P38398;P61968;Q86U70;Q99708	672;8543;8861;5932	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	BRCA1;LMO4;LDB1;RBBP8	None	None	BRCA1 is involved in breast cancer.
BRCA1-LMO4-CTIP complex	P38398;P61968;Q99708	672;8543;5932	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	BRCA1;LMO4;RBBP8	None	LMO4 functions as a repressor of BRCA1 activity in breast tissue.	BRCA1 is involved in breast cancer.
MDC1-MRN-ATM-FANCD2 complex	O60934;P49959;Q13315;Q14676;Q92878;Q9BXW9	4683;4361;472;9656;10111;2177	DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;ATM;MDC1;RAD50;FANCD2	None	Prior exposure of cells to irradiation appears to reduce the interaction of MDC1 with ATM and FANCD2.	None
MDC1-MRE11-RAD50-NBS1 complex	O60934;P49959;Q14676;Q92878	4683;4361;9656;10111	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	NBN;MRE11A;MDC1;RAD50	None	"In response to ionizing radiation, MDC1 is hyperphosphorylated and rapidly relocalizes to nuclear foci that also contain the MRE11 complex. MDC1-mediated focus formation by the MRE11 complex at sites of DNA damage is crucial for the efficient activation of the intra-S-phase checkpoint."	None
TERF1 homodimer complex	P54274	7013	mitotic cell cycle;regulation of cell cycle;DNA binding;chromosome organization	mitotic cell cycle;mitotic cell cycle and cell cycle control;DNA binding;organization of chromosome structure	TERF1	None	TERF1 is shown to be important in regulating telomere length. It may connect mitotic control to the telomere regulatory machinery.	None
RAD52-ERCC4-ERCC1 complex	P07992;P43351;Q92889	2067;5893;2072	DNA catabolic process;DNA recombination;DNA repair;nucleus	DNA degradation;DNA recombination;DNA repair;nucleus	ERCC1;RAD52;ERCC4	None	Rad52-XPF-ERCC1 complex processes recombination intermediates generated during the repair of DNA double strand breaks.	ERCC4 is involved in xeroderma pigmentosum group F.
BLM complex II	P15927;P27694;P35244;P54132;Q13472;Q9H9A7	6118;6117;6119;641;7156;80010	chromosome organization;DNA repair;cellular response to DNA damage stimulus;nucleus	organization of chromosome structure;DNA repair;DNA damage response;nucleus	RPA2;RPA1;RPA3;BLM;TOP3A;RMI1	None	BLAP75 is an integral component of BLM complexes and is essential for their stability.	None
BLM-TOP3A complex	P54132;Q13472	641;7156	chromosome organization;nucleus	organization of chromosome structure;nucleus	BLM;TOP3A	None	None	BLM is involved in Bloom syndrome (BS).
MSH2/6-BLM-p53-RAD51 complex	P04637;P43246;P52701;P54132;Q06609	7157;4436;2956;641;5888	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	TP53;MSH2;MSH6;BLM;RAD51	None	"MSH2/6 protein complex stimulates the ability of the Bloom's syndrome gene product, BLM, to process Holliday junctions in vitro, an activity that could also be regulated by p53. MSH6 colocalizes with BLM and p53 in hydroxyurea-induced RAD51 nuclear foci."	BLM is involved in Bloom's syndrome.
MutS-alpha-PK-zeta complex	P43246;P52701;Q05513	4436;2956;5590	DNA repair;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	DNA repair;proteasomal degradation (ubiquitin/proteasomal pathway)	MSH2;MSH6;PRKCZ	None	PKC zeta protects MutS-alpha protein complex from degradation. PKC zeta interacts with hMSH2 and hMSH6 proteins and phosphorylates both.	None
BLM-RAD51L3-XRCC2 complex	O43543;O75771;P54132	7516;5892;641	DNA repair;nucleus	DNA repair;nucleus	XRCC2;RAD51D;BLM	None	Interaction between BLM and RAD51L3 is mediated through the N-terminal domain of BLM. RAD51L3-XRCC2 complex stimulates ability of BLM to disrupt Holliday junction structures.	BLM is involved in Bloom's syndrome (BS).
PCNA homotrimer complex	P12004	5111	DNA replication;nucleus	DNA synthesis and replication;nucleus	PCNA	None	PCNA exists mainly as homotrimer whose expression increases in the late G1- to S-phase of cell cycle.	PCNA is a target for autoimmunity in systemic lupus erythematosus.
Replication-coupled CAF-1-MBD1-ETDB1 complex	Q13111;Q15047;Q9UIS9	10036;9869;4152	DNA replication;DNA topological change;regulation of gene expression by genetic imprinting;mitotic S phase;protein hydroxylation;protein methylation;chromosome organization;nucleus	"DNA synthesis and replication;DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;S phase of mitotic cell cycle;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	CHAF1A;SETDB1;MBD1	None	Formation of CAF-1-MBD1-SETDB1 complex occurs during S phase of cell cycle. This complex facilitates methylation of H3-K9 during replication-coupled chromatin assembly.	None
Chromatin assembly complex (CAF-1 complex)	Q09028;Q13111;Q13112	5928;10036;8208	DNA replication;DNA topological change;mitotic S phase;chromosome organization;nucleus	DNA synthesis and replication;DNA conformation modification (e.g. chromatin);S phase of mitotic cell cycle;organization of chromosome structure;nucleus	RBBP4;CHAF1A;CHAF1B	None	Caf-1 complex assembles nucleosomes in a replication-dependent manner.	None
ASF1-interacting protein complex	P54198;P68431;Q13111;Q13112;Q9NVP2;Q9Y294	7290;None;10036;8208;55723;25842	DNA replication;DNA topological change;chromosome organization	DNA synthesis and replication;DNA conformation modification (e.g. chromatin);organization of chromosome structure	HIRA;HIST1H3A;;CHAF1A;CHAF1B;ASF1B;ASF1A	None	"Asf1 provides the cells with a buffering system for histone excess generated in response to stalled replication and explains how mammalian cells maintain a critical ""active"" histone pool available for deposition during recovery from replication stresses."	None
ASF1-histone containing complex	O96017;P49321;P50502;P68431;Q13112;Q9NVP2;Q9Y294	11200;4678;6767;None;8208;55723;25842	DNA replication;DNA topological change;chromosome organization	DNA synthesis and replication;DNA conformation modification (e.g. chromatin);organization of chromosome structure	CHEK2;NASP;ST13;HIST1H3A;;CHAF1B;ASF1B;ASF1A	None	"Asf1 provides the cells with a buffering system for histone excess generated in response to stalled replication and explains how mammalian cells maintain a critical ""active"" histone pool available for deposition during recovery from replication stresses."	None
SP1-MCAF2 complex	P08047;Q5U623	6667;80063	"DNA topological change;regulation of gene expression by genetic imprinting;negative regulation of transcription, DNA-templated;RNA biosynthetic process;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;transcription repression;RNA synthesis;organization of chromosome structure;nucleus	SP1;ATF7IP2	None	"MCAF2 also binds to SETDB1, but more efficiently to SP1."	None
MBD1-MCAF1-SETDB1 complex	Q15047;Q6VMQ6;Q9UIS9	9869;55729;4152	"DNA topological change;regulation of gene expression by genetic imprinting;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;transcription repression;RNA synthesis;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	SETDB1;ATF7IP;MBD1	None	MCAF1 enhances transcriptional repression by MBD1 together with SETDB1.	None
HD-RAB8A-OPTN complex	P42858;P61006;Q96CV9	3064;4218;10133	vesicle-mediated transport	"vesicular transport (Golgi network, etc.)"	HTT;RAB8A;OPTN	None	This complex probably involved in membrane trafficking and cellular morphogenesis.	None
TGM2-HD-CALM1 complex	P21980;P42858;P62158	7052;3064;None	protein complex assembly	assembly of protein complexes	TGM2;HTT;CALM1; CAL	None	Inhibiting the interaction of calmodulin with transglutaminase and huntingtin protein could decrease cross-linking and diminish huntingtin aggregate formation in the HD brain.	None
TGM2-HD complex	P21980;P42858	7052;3064	protein complex assembly	assembly of protein complexes	TGM2;HTT	None	None	None
CTGF/Hcs24-actin(beta/gamma) complex	P29279;P60709;P63261	1490;60;71	actin filament reorganization involved in cell cycle;actin cytoskeleton organization;cartilage development;cytoplasm	cell cycle dependent actin filament reorganization;actin cytoskeleton;cartilage;cytoplasm	CTGF;ACTB;ACTG1	None	The authors suggest that binding of CTGF/Hcs24 to actin in chondrocytes may play some important roles in the regulation of cytoskeletal organization and of the cell cycle.	None
Cofilin-actin-CAP1 complex	P23528;P60709;Q01518	1072;60;10487	movement of cell or subcellular component;actin cytoskeleton organization;actin cytoskeleton	cell motility;actin cytoskeleton;actin cytoskeleton	CFL1;ACTB;CAP1	None	"As well as full-length CAP1, both CAP1-NT and CAP1-CT enhanced cofilin-induced acceleration of F-actin turnover, whereas their effect was only marginally visible in the absence of cofilin. Localization experiments in fibroblasts demonstrated that CAP1-NT is primarily responsible for accumulating CAP1 with cofilin and actin in dynamic peripheral regions of spreading cells."	None
RIAM-Rap1-GTP complex	P62834;Q7Z5R6	5906;54518	cell adhesion;actin cytoskeleton organization;plasma membrane	cell adhesion;actin cytoskeleton;eukaryotic plasma membrane / membrane attached	RAP1A;APBB1IP	None	RIAM preferentially interacted with Rap1-GTP compared to Ras-GTP. The results indicate that RIAM is required for localization of Rap1-GTP at the plasma membrane.	None
VILIP-1-AChR-alpha-4-AChR-beta-2 complex	P17787;P43681;P62760	1141;1137;7447	calcium ion binding;synaptic transmission;response to calcium ion;regulation of acetylcholine-gated cation channel activity	calcium binding;synaptic transmission	CHRNB2;CHRNA4;VSNL1	None	The results suggest a rule for VILIP-1 as an AChR-associated protein that modulates the surface expression levels and functional properties of alpha 4beta 2 AChRs in response to changes in the intracellular levels of calcium.	None
PPP3CA-PPP3CA-RCAN1 complex	P16298;P53805;Q08209	5532;1827;5530	calcium-mediated signaling	Ca2+ mediated signal transduction	PPP3CB;RCAN1;PPP3CA	None	None	None
PICK1-GRIP1-GLUR2 complex	P42262;Q9NRD5;Q9Y3R0	2891;9463;23426	intracellular protein transport;protein targeting;protein transport;endocytosis;plasma membrane	"protein targeting, sorting and translocation;protein transport;endocytosis;eukaryotic plasma membrane / membrane attached"	GRIA2;PICK1;GRIP1	None	Complex analysed both in vitro and in vivo. This triple complex may function in the presentation of PKC-PICK1 complexes to the ABP/GRIP-GluR2 complex.	None
ABI1-WASF2 complex	Q8IZP0;Q9Y6W5	10006;10163	actin cytoskeleton organization	actin cytoskeleton	ABI1;WASF2	None	None	None
ABI1-WASL complex	O00401;Q8IZP0	8976;10006	actin cytoskeleton organization	actin cytoskeleton	WASL;ABI1	None	None	Neural Wiskott-Aldrich syndrome
Profilin 2 complex	O75116;P11142;P17600;P35080;P60709;Q05193;Q7L576;Q92777;Q9Y2A7	9475;3312;6853;5217;60;1759;23191;6854;10787	protein complex assembly;endocytosis;actin cytoskeleton organization	assembly of protein complexes;endocytosis;actin cytoskeleton	ROCK2;HSPA8;SYN1;PFN2;ACTB;DNM1;CYFIP1;SYN2;NCKAP1	None	None	None
AP3D1-AP3S2 complex	O14617;P59780	8943;10239	intracellular protein transport;protein targeting;protein transport	"protein targeting, sorting and translocation;protein transport"	AP3D1;AP3S2	None	None	None
AP3D1-AP3S1 complex	O14617;Q92572	8943;1176	intracellular protein transport;protein targeting;protein transport	"protein targeting, sorting and translocation;protein transport"	AP3D1;AP3S1	None	None	None
ITGA6-ITGB4-Laminin10/12 complex	O15230;P07942;P11047;P16144;P23229	3911;3912;3915;3691;3655	cell adhesion	cell adhesion	LAMA5;LAMB1;LAMC1;ITGB4;ITGA6	None	None	None
ITGA6-ITGB4-Laminin10/12 complex	O15230;P11047;P16144;P23229;P55268	3911;3915;3691;3655;3913	cell adhesion	cell adhesion	LAMA5;LAMC1;ITGB4;ITGA6;LAMB2	None	None	None
ITGA6-ITGB4-CD151 complex	P16144;P23229;P48509	3691;3655;977	protein binding;cell-matrix adhesion	protein binding;cell-matrix adhesion	ITGB4;ITGA6;CD151	None	The recruitment of Cd151 into hemidesmosomes is regulated by the integrin alpha6beta4.	None
ITGA6-ITGB4-FYN complex	P06241;P16144;P23229	2534;3691;3655	protein binding;cellular component disassembly involved in execution phase of apoptosis	protein binding;disassembly of cell structures	FYN;ITGB4;ITGA6	None	"EGF-R with  ITGA6-ITGB4 and, through the tyrosine kinase Fyn, induces phosphorylation of the beta4 tail (ITGB4) and disruption of hemidesmosomes."	None
ITGA6-ITGB4-LAMA5 complex	O15230;P16144;P23229	3911;3691;3655	cell adhesion	cell adhesion	LAMA5;ITGB4;ITGA6	None	None	None
ITGA6-ITGB4 complex	P16144;P23229	3691;3655	signaling;movement of cell or subcellular component	cellular signalling;cell motility	ITGB4;ITGA6	None	None	None
ITGAV-ITGB8-MMP14-TGFB1 complex	P01137;P06756;P26012;P50281	7040;3685;3696;4323	cell growth;regulation of transforming growth factor beta1 activation	cell growth / morphogenesis	TGFB1;ITGAV;ITGB8;MMP14	None	"SLC binds to alphav-beta8, an integrin expressed by normal epithelial and neuronal cells in vivo. This binding results in the membrane type 1 (MT1)-MMP-dependent release of active TGF-beta, which leads to autocrine and paracrine effects on cell growth and matrix production."	None
ITGAV-ITGB5-PLAUR complex	P06756;P18084;Q03405	3685;3693;5329	cell migration	cell migration	ITGAV;ITGB5;PLAUR	None	uPAR association with alpha(v)beta5 leads to a functional interaction of these receptors and suggests that uPAR directs cytoskeletal rearrangements and cell migration by altering alpha(v)beta5 signaling specificity.	None
ITGAV-ITGB5-ICAM4 complex	P06756;P18084;Q14773	3685;3693;3386	protein binding;cell adhesion	protein binding;cell adhesion	ITGAV;ITGB5;ICAM4	None	None	None
ITGAV-ITGB5-ADAM9 complex	P06756;P18084;Q13443	3685;3693;8754	protein binding;cell adhesion	protein binding;cell adhesion	ITGAV;ITGB5;ADAM9	None	MDC-9 interacts with alpha(v)beta(5) in an RGD-independent manner.	None
ITGAV-ITGB5-SPP1 complex	P06756;P10451;P18084	3685;6696;3693	protein binding;cell adhesion	protein binding;cell adhesion	ITGAV;SPP1;ITGB5	None	None	None
ITGAV-ITGB5-CYR61 complex	O00622;P06756;P18084	3491;3685;3693	cell migration;cell adhesion;fibroblast migration	cell migration;cell adhesion	CYR61;ITGAV;ITGB5	None	CYR61-dependent chemotaxis is mediated through integrin alpha(v)beta5.	None
ITGAV-ITGB5 complex	P06756;P18084	3685;3693	protein binding;cell adhesion	protein binding;cell adhesion	ITGAV;ITGB5	None	None	None
ITGB6-FYN-FN1 complex	P02751;P06241;P18564	2335;2534;3694	intracellular signal transduction;integrin-mediated signaling pathway	cellular signalling;integrin receptor signalling pathway	FN1;FYN;ITGB6	None	Integrin beta6 signaling activates Fyn and thus promotes oral cancer progression.	None
ITGAV-ITGB6-SPP1 complex	P06756;P10451;P18564	3685;6696;3694	protein binding;cell adhesion	protein binding;cell adhesion	ITGAV;SPP1;ITGB6	None	None	None
ITGAV-ITGB6-TGFB3 complex	P06756;P10600;P18564	3685;7043;3694	transforming growth factor beta3 activation	None	ITGAV;TGFB3;ITGB6	None	None	None
ITGAV-ITGB6 complex	P06756;P18564	3685;3694	protein binding	protein binding	ITGAV;ITGB6	None	"Cells expressing alpha(v)beta6 attach, but less avidly, do not spread, and completely fail to proliferate."	None
ITGAV-ITGB3-CD47-FCER2 complex	P05106;P06734;P06756;Q08722	3690;2208;3685;961	protein binding;inflammatory response	protein binding;inflammatory response	ITGB3;FCER2;ITGAV;CD47	None	Alpha(v)beta3-CD47 mediates proinflammatory cytokine synthesis via interaction with CD23.	None
ITGB3-ITGAV-CD47 complex	P05106;P06756;Q08722	3690;3685;961	protein binding;cell adhesion;plasma membrane	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached	ITGB3;ITGAV;CD47	None	"CD47 interactions with alpha(v)beta3 were found to promote both integrin activation induced by RGD peptide, and alpha(v)beta3 avidity in binding immobilized substrates by enhancing integrin clustering (PMID:14966135)."	None
ITGAV-ITGB3-SPP1 complex	P05106;P06756;P10451	3690;3685;6696	cell migration;cell morphogenesis;cell growth	cell migration;cell growth / morphogenesis	ITGB3;ITGAV;SPP1	None	"The interaction of OPN with alpha(v)beta3 integrin, expressed on CASMCs (coronary artery smooth muscle cells), causes migration, extracellular matrix invasion, and proliferation."	None
ITGAV-ITGB3-ADAM15 complex	P05106;P06756;Q13444	3690;3685;8751	protein binding;cell adhesion;plasma membrane;extracellular matrix	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached;extracellular matrix component	ITGB3;ITGAV;ADAM15	None	ADAM15/alpha(v)beta3 interactions may be important in the adhesion of tumour cells to endothelium (PMID:9914169).	None
ITAGV-ITGB3-F11R complex	P05106;P06756;Q9Y624	3690;3685;50848	blood vessel development;vasculature development	vessels	ITGB3;ITGAV;F11R	None	JAM-1/A and alpha(v)beta3 form a complex in the absence of bFGF.	None
ITGAV-ITGB3-PXN-PTK2b complex	P05106;P06756;P49023;Q14289	3690;3685;5829;2185	protein binding;cell adhesion	protein binding;cell adhesion	ITGB3;ITGAV;PXN;PTK2B	None	This complex could play key role in the regulation of cell adhesion-triggered cytoskeletal organization and signal transduction in podosome-containing cells derived from monocytic lineage.	None
ITGAV-ITGB3-ADAM23 complex	O75077;P05106;P06756	8745;3690;3685	protein binding;cell adhesion	protein binding;cell adhesion	ADAM23;ITGB3;ITGAV	None	"ADAM 23, through its disintegrin-like domain, may function as an adhesion molecule involved in alpha(v)beta3-mediated cell interactions occurring in normal and pathological processes, including progression of malignant tumors from neural origin."	None
ITGAV-ITGB3-COL4A3 complex	P05106;P06756;Q01955	3690;3685;1285	regulation of translation	translational control	ITGB3;ITGAV;COL4A3	None	Tumstatin binding to alpha(v)beta3 integrin leads to the inhibition of Cap-dependent translation (protein synthesis) mediated by focal adhesion kinase/phosphatidylinositol 3-kinase/Akt/mTOR/4E-BP1 pathway.	None
ITGAV-ITGB3-PPAP2b complex	O14495;P05106;P06756	8613;3690;3685	cell adhesion;blood vessel development;vasculature development;plasma membrane	cell adhesion;vessels;eukaryotic plasma membrane / membrane attached	PLPP3;ITGB3;ITGAV	None	None	None
ITGAV-ITGB3-EGFR complex	P00533;P05106;P06756	1956;3690;3685	protein binding;epidermal growth factor receptor signaling pathway;integrin-mediated signaling pathway	protein binding;EGF-receptor signalling pathway;integrin receptor signalling pathway	EGFR;ITGB3;ITGAV	None	"The coordination between EGFR and alpha(v)beta3 is essential for the early events of HCMV infection, including viral entry."	None
ITGA2B-ITGB3-CD9 complex	P05106;P08514;P21926	3690;3674;928	cell adhesion;plasma membrane	cell adhesion;eukaryotic plasma membrane / membrane attached	ITGB3;ITGA2B;CD9	None	"CD9 is part of a protein complex that co-precipitates with aIIb3 under native conditions and provides evidence of CD9 and aIIbb3 associating in resting, inactive platelets (PMID:9355765)."	None
ITGAV-ITGB3-SPP1 complex	P05106;P06756;P10451	3690;3685;6696	cell migration	cell migration	ITGB3;ITGAV;SPP1	None	None	None
ITGAV-ITGB3-LAMA4 complex	P05106;P06756;Q16363	3690;3685;3910	protein binding;cell adhesion;extracellular matrix	protein binding;cell adhesion;extracellular matrix component	ITGB3;ITGAV;LAMA4	None	The alpha4 laminin subunit mediates endothelial cell-adhesion through alpha(v)beta3 integrin and that the key site is G1121-1139.	The G1121-1139 peptide promotes angiogenesis in vivo.
FN1-TGM2 complex	P02751;P21980	2335;7052	protein binding;cell adhesion	protein binding;cell adhesion	FN1;TGM2	None	"Overexpression of tTG increases the amount of Fn on the cell surface, enhances adhesion and spreading of fibronectin."	None
ITGA2B-ITGB3-FN1-TGM2 complex	P02751;P05106;P08514;P21980	2335;3690;3674;7052	protein binding;cell adhesion;plasma membrane	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached	FN1;ITGB3;ITGA2B;TGM2	None	"The tissue transglutaminase mediates the interaction of integrins with fibronectin, thereby acting as an integrin-associated coreceptor to promote cell adhesion and spreading."	None
ITGA2b-ITGB3-CD47-SRC complex	P05106;P08514;P12931;Q08722	3690;3674;6714;961	protein binding;plasma membrane	protein binding;eukaryotic plasma membrane / membrane attached	ITGB3;ITGA2B;SRC;CD47	None	At least five members of the Src-type kinase family are expressed in megakaryocytes and platelets (PMID:7545532) but only c-Src could be detected in the alpha IIb-beta 3-IAP complex.	None
ITGA2b-ITGB3-TLN1 complex	P05106;P08514;Q9Y490	3690;3674;7094	protein binding	protein binding	ITGB3;ITGA2B;TLN1	None	The purified talin binds to the cytoplasmic sequences of both alpha  and beta  subunits of this integrin. The regulated binding of talin to integrin beta tails is a final common element of cellular signaling cascades that control integrin activation (PMID:14526080).	Disrupting the beta3 integrin-talin interaction blocks {alpha}IIb-beta3 activation and has a dramatic antithrombotic effect (PMID:17627302).
ITGA2B-ITGB3-CIB1 complex	P05106;P08514;Q99828	3690;3674;10519	calcium ion binding;cell adhesion	calcium binding;cell adhesion	ITGB3;ITGA2B;CIB1	None	"CIB does not regulate alpha-IIb-beta3 inside-out signaling, but rather is involved in an alpha-IIb-beta3 post-receptor occupancy event."	None
ITGA2B-ITGB3 complex	P05106;P08514	3690;3674	None	None	ITGB3;ITGA2B	None	None	None
ITGA2B-ITGB3-F11R complex	P05106;P08514;Q9Y624	3690;3674;50848	cell adhesion	cell adhesion	ITGB3;ITGA2B;F11R	None	None	None
ITGA5-ITGB1-FN1-TGM2 complex	P02751;P05556;P08648;P21980	2335;3688;3678;7052	protein binding;cell adhesion;plasma membrane	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached	FN1;ITGB1;ITGA5;TGM2	None	"The tissue transglutaminase mediates the interaction of integrins with fibronectin, thereby acting as an integrin-associated coreceptor to promote cell adhesion and spreading."	None
ITGA5-ITGB1-ADAM15 complex	P05556;P08648;Q13444	3688;3678;8751	protein binding;cell adhesion	protein binding;cell adhesion	ITGB1;ITGA5;ADAM15	None	None	None
ITGA5-ITGB4 complex	P05556;P08648	3688;3678	cell adhesion	cell adhesion	ITGB1;ITGA5	None	None	None
CD98-LAT2-ITGB1 complex	P05556;P08195;Q9UHI5	3688;6520;23428	single organismal cell-cell adhesion	cell-cell adhesion	ITGB1;SLC3A2;SLC7A8	None	The specific molecular ratio between the heterodimer CD98/LAT-2 and beta 1 integrin may be required for the polarity of epithelial cells.	None
ITGA7-ITGB1-CD151 complex	P05556;P48509;Q13683	3688;977;3679	protein binding;cell adhesion	protein binding;cell adhesion	ITGB1;CD151;ITGA7	None	The expression of alpha7-beta1 in K562 cells results in increased levels of CD151 at its surface.	None
ITGA7-ITGB1-CD9 complex	P05556;P21926;Q13683	3688;928;3679	skeletal muscle tissue development	myogenesis	ITGB1;CD9;ITGA7	None	None	None
ITGA7-ITGB1-ITGB1BP3 complex	P05556;Q13683;Q9NPI5	3688;3679;27231	cell adhesion	cell adhesion	ITGB1;ITGA7;NMRK2	None	None	None
ITGA3-ITGB1-BSG complex	P05556;P26006;P35613	3688;3675;682	cell-matrix adhesion;regulation of matrix metallopeptidase secretion	cell-matrix adhesion	ITGB1;ITGA3;BSG	None	The physical association between EMMPRIN (Basigin) and alpha3-beta1 may play a role in adhesion-induced matrix metalloproteinase production.	None
ITGA3-ITGB1-CD63 complex	P05556;P08962;P26006	3688;967;3675	movement of cell or subcellular component;cell adhesion	cell motility;cell adhesion	ITGB1;CD63;ITGA3	None	None	None
ITGA3-ITGB1-CD151 complex	P05556;P26006;P48509	3688;3675;977	peptide binding;cell-matrix adhesion;plasma membrane	peptide binding;cell-matrix adhesion;eukaryotic plasma membrane / membrane attached	ITGB1;ITGA3;CD151	None	CD151 is colocalized with alpha3-beta1 in pre-hemidesmosomal structures together with laminin-5.	None
ITGA3-ITGB1-THBS1 complex	P05556;P07996;P26006	3688;7057;3675	cell adhesion	cell adhesion	ITGB1;THBS1;ITGA3	None	None	None
ITGA3-ITGB1 complex	P05556;P26006	3688;3675	cell adhesion	cell adhesion	ITGB1;ITGA3	None	None	None
ITGA6-ITGB1-CD151 complex	P05556;P23229;P48509	3688;3655;977	cell migration	cell migration	ITGB1;ITGA6;CD151	None	The YXXphi motif-mediated internalization of CD151 promotes integrin-dependent cell migration by modulating the endocytosis and/or vesicular trafficking of its associated integrins (PMID:17716972).	None
ITGA6-ITGB1 complex	P05556;P23229	3688;3655	cell adhesion	cell adhesion	ITGB1;ITGA6	None	None	None
ITGB1-RAP1A-PKD1 complex	P05556;P62834;P98161	3688;5906;5310	regulation of integrin activation	None	ITGB1;RAP1A;PKD1	None	"The authors propose a novel adaptor protein function for PKD1 in regulating integrin functional activity in T cells that involves rapid, transient membrane translocation of both PKD1 and Rap1 to beta-1 integrins."	None
ITGA4-ITGB1-EMILIN1 complex	P05556;P13612;Q9Y6C2	3688;3676;11117	movement of cell or subcellular component;cell adhesion	cell motility;cell adhesion	ITGB1;ITGA4;EMILIN1	None	None	None
ITGA4-ITGB1 complex	P05556;P13612	3688;3676	cell adhesion	cell adhesion	ITGB1;ITGA4	None	None	None
ITGA4-ITGB1-CD81 complex	P05556;P13612;P60033	3688;3676;975	cell adhesion	cell adhesion	ITGB1;ITGA4;CD81	None	None	None
ITGA4-ITGB1-CD53 complex	P05556;P13612;P19397	3688;3676;963	protein binding	protein binding	ITGB1;ITGA4;CD53	None	None	None
ITGA4-ITGB1-VCAM1 complex	P05556;P13612;P19320	3688;3676;7412	cell adhesion	cell adhesion	ITGB1;ITGA4;VCAM1	None	None	None
ITGA4-ITGB1-JAM2 complex	P05556;P13612;P57087	3688;3676;58494	cell adhesion	cell adhesion	ITGB1;ITGA4;JAM2	None	None	None
ITGA4-ITGB1-CD47 complex	P05556;P13612;Q08722	3688;3676;961	cell adhesion	cell adhesion	ITGB1;ITGA4;CD47	None	None	None
ITGA4-ITGB1-CD63 complex	P05556;P08962;P13612	3688;967;3676	protein binding	protein binding	ITGB1;CD63;ITGA4	None	None	None
ITGA4-ITGB1-THBS1 complex	P05556;P07996;P13612	3688;7057;3676	cell adhesion	cell adhesion	ITGB1;THBS1;ITGA4	None	None	None
ITGA4-ITGB1-THBS2 complex	P05556;P13612;P35442	3688;3676;7058	cell adhesion	cell adhesion	ITGB1;ITGA4;THBS2	None	None	None
ITGA2-ITGB1-CD47 complex	P05556;P17301;Q08722	3688;3673;961	chemotaxis	chemotaxis	ITGB1;ITGA2;CD47	None	"Integrin-associated protein (IAP/CD47) augments the function of alpha2-beta1 integrin in smooth muscle cells (SMC), resulting in enhanced chemotaxis toward soluble collagen."	None
ITGA2-ITGB1-CHAD complex	O15335;P05556;P17301	1101;3688;3673	cell adhesion	cell adhesion	CHAD;ITGB1;ITGA2	None	None	None
ITGA2-ITGB1-COL6A3 complex	P05556;P12111;P17301	3688;1293;3673	protein binding;cell adhesion;plasma membrane;extracellular matrix	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached;extracellular matrix component	ITGB1;COL6A3;ITGA2	None	None	None
ITGA2-ITGB1 complex	P05556;P17301	3688;3673	cell adhesion	cell adhesion	ITGB1;ITGA2	None	None	None
ITGA1-ITGB1-COL6A3 complex	P05556;P12111;P56199	3688;1293;3672	protein binding;cell adhesion;plasma membrane;extracellular matrix	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached;extracellular matrix component	ITGB1;COL6A3;ITGA1	None	None	None
ITGA1-ITGB1-PTPN2 complex	P05556;P17706;P56199	3688;5771;3672	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	ITGB1;PTPN2;ITGA1	None	The cytoplasmic tail of alpha(1) integrin selectively interacts with a ubiquitously expressed TCPTP and activates it after cell adhesion to collagen.	None
ITGAV-ITGB1 complex	P05556;P06756	3688;3685	protein binding;cell adhesion	protein binding;cell adhesion	ITGB1;ITGAV	None	The cell surface expression level of alphaV-beta1 is dependent on the number of alphaV subunits available after the formation of other alphaV-containing heterodimers (PMID:11997396).	None
ITGA6-ITGB1-CYR61 complex	O00622;P05556;P23229	3491;3688;3655	cell adhesion;blood vessel development;vasculature development	cell adhesion;vessels	CYR61;ITGB1;ITGA6	None	The T1 sequence in CCN1 is a novel binding motif for integrin alpha6-beta1.	None
ITGA8-ITGB1 complex	P05556;P53708	3688;8516	protein binding;cell adhesion	protein binding;cell adhesion	ITGB1;ITGA8	None	"This integrin is receptor for tenascin, fibronectin, and vitronectin."	None
ITGA9-ITGB1-ADAM9 complex	P05556;Q13443;Q13797	3688;8754;3680	protein binding	protein binding	ITGB1;ADAM9;ITGA9	None	"Alpha9-eta1-ADAM interactions may have a broad significance in many biological and pathological processes such as fertilization, development, and tissue remodeling."	None
ITGA9-ITGB1-VCAM1 complex	P05556;P19320;Q13797	3688;7412;3680	cell migration;cell adhesion;neutrophil extravasation	cell migration;cell adhesion	ITGB1;VCAM1;ITGA9	None	None	None
ITGA9-ITGB1-TNC complex	P05556;P24821;Q13797	3688;3371;3680	protein binding	protein binding	ITGB1;TNC;ITGA9	None	None	None
ITGB1-ITGA9 complex	P05556;Q13797	3688;3680	protein binding;cell adhesion;cell growth	protein binding;cell adhesion;cell growth / morphogenesis	ITGB1;ITGA9	None	"Cells expressing alpha9-beta1 attach and spread equally well, and also proliferate, but significantly less than do cells expressing alpha(v)beta3."	None
ITGA9-ITGB1-ADAM15 complex	P05556;Q13444;Q13797	3688;8751;3680	protein binding;single organismal cell-cell adhesion	protein binding;cell-cell adhesion	ITGB1;ADAM15;ITGA9	None	"Alpha9-beta 1-ADAM interactions may have a broad significance in many biological and pathological processes such as fertilization, development, and tissue remodeling."	None
ITGA9-ITGB1-FIGF complex	O43915;P05556;Q13797	2277;3688;3680	cell migration;cell adhesion;cell differentiation	cell migration;cell adhesion;cell differentiation	VEGFD;ITGB1;ITGA9	None	Alpha9-beta1 directly binds to VEGF-C and -D and contributes to lymphangiogenesis.	None
ITGA9-ITGB1-ADAM12 complex	O43184;P05556;Q13797	8038;3688;3680	single organismal cell-cell adhesion;plasma membrane	cell-cell adhesion;eukaryotic plasma membrane / membrane attached	ADAM12;ITGB1;ITGA9	None	None	None
Multiprotein complex (monoubiquitination)	P00533;Q13191;Q5U5U6;Q96B97	1956;868;7314;30011	protein ubiquitination	"modification by ubiquitination, deubiquitination"	EGFR;CBLB;UBB;SH3KBP1	None	"The authors show that the adaptor protein CIN85 and its homologue CMS are monoubiquitinated by Cbl/Cbl-b after epidermal growth factor (EGF) stimulation.CIN85  has a dual role in controlling EGFR down-regulation, because it both promotes receptor internalization and participates in endosomal sorting and subsequent degradation of activated receptors."	None
"CIN85-CBL-SH3GL2-EGFR complex, EGF stimulated"	P00533;P22681;Q3V639;Q96B97	1956;867;6456;30011	membrane budding;vesicle organization;endocytosis;epidermal growth factor receptor signaling pathway	vesicle formation;endocytosis;EGF-receptor signalling pathway	EGFR;CBL;SH3GL2;SH3KBP1	None	"Cbl rapidly recruits CIN85 and endophilins to form a complex with activated EGF receptors, thus controlling receptor internalization."	None
CIN85-SH3GL2 complex	Q96B97;Q99962	30011;6456	membrane budding;vesicle organization;endocytosis	vesicle formation;endocytosis	SH3KBP1;SH3GL2	None	None	None
"MET-CIN85-SH3GL3-CBL complex, HGF stimulated"	P08581;P22681;Q96B97;Q99963	4233;867;30011;6457	membrane budding;vesicle organization;endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway	vesicle formation;endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways	MET;CBL;SH3KBP1;SH3GL3	None	"The authors propose the following model: upon ligand activation, HGF receptor becomes tyrosine phosphorylated, binds and phosphorylates Cbl, which in turn targets the receptor to clathrin-coated pits by recruiting the CIN85\u2013endophilin complex."	None
CIN85-SH3GL3 complex	Q96B97;Q99963	30011;6457	membrane budding;vesicle organization;endocytosis	vesicle formation;endocytosis	SH3KBP1;SH3GL3	None	None	None
Caveolin-1 homodimer complex	Q03135	857	None	None	CAV1	None	None	None
p130Cas-ER-alpha-cSrc-kinase- PI3-kinase p85-subunit complex	P03372;P12931;P27986;P56945	2099;6714;5295;9564	"protein phosphorylation;cellular response to estrogen stimulus;intracellular estrogen receptor signaling pathway;regulation of transcription, DNA-templated;regulation of ERK1 and ERK2 cascade"	"modification by phosphorylation, dephosphorylation, autophosphorylation;transcriptional control"	ESR1;SRC;PIK3R1;BCAR1	None	"The authors suggest that estradiol triggers association of ER-alpha, c-Src, the p85 subunit of PI 3-kinase (PI3K) and p130Cas in a macromolecular complex and activates the c-Src kinase leading to p130Cas-dependent Erk1/2 phosphorylation."	None
SRC-PRKCD-CDCP1 complex	P12931;Q05655;Q9H5V8	6714;5580;64866	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	SRC;PRKCD;CDCP1	None	"The tyrosine phosphorylation of CDCP1 by Src appears to promote the formation of a complex between CDCP1, Src, and PKC-delta."	None
CRKL-PDGFRA-CRK-RAPGEF1 complex	P16234;P46108;P46109;Q13905	5156;1398;1399;2889	intracellular signal transduction	cellular signalling	PDGFRA;CRK;CRKL;RAPGEF1	"CrkI and CrkII are splice variants of the Crk gene, only variant CrkII has been identified as component of the complex."	None	None
"CIN85 complex (CIN85, CRK, BCAR1, CBL, PIK3R1, GRB2, SOS1)"	P22681;P27986;P46108;P56945;P62993;Q07889;Q96B97	867;5295;1398;9564;2885;6654;30011	cell-cell signaling	None	CBL;PIK3R1;CRK;BCAR1;GRB2;SOS1;SH3KBP1	None	"The authors propose that CIN85 acts as a mediator to couple the c-Cbl signaling pathway with other pathways through its multiple protein complexes, thereby leading to their interplay."	None
GIPC1-LHCGR complex	O14908;P22888	10755;3973	intracellular protein transport;protein targeting;protein transport;endocytosis	"protein targeting, sorting and translocation;protein transport;endocytosis"	GIPC1;LHCGR	None	This protein is involved in the post-endocytotic trafficking of the internalized hCG and in maintaining the levels of cell surface hLHR during endocytosis of the bound hormone.	None
GIPC1-NTRK1-RGS19 complex	O14908;P04629;P49795	10755;4914;10287	"retrograde transport, vesicle recycling within Golgi"	retrograde transport	GIPC1;NTRK1;RGS19	None	GIPC forms a complex with GAIP and the TrkA receptor and colocalizes with phosphoryated TrkA in retrograde transport vesicles.	None
NCR3-CD247 complex	O14931;P20963	259197;919	apoptotic process	apoptosis (type I programmed cell death)	NCR3;CD247	None	"NKp30, similar to other NK triggering receptors including CD16 (34) (35) and NKp46 (23), can transduce activating signals via association with the ITAM-containing CD3{zeta} polypeptides (PMID: 10562324)."	None
ZAP70-CRKL-WIPF1-WAS complex	O43516;P42768;P43403;P46109	7456;7454;7535;1399	intracellular signal transduction	cellular signalling	WIPF1;WAS;ZAP70;CRKL	None	None	None
CRKL-WIPF1-WAS complex	O43516;P42768;P46109	7456;7454;1399	intracellular signal transduction	cellular signalling	WIPF1;WAS;CRKL	None	None	None
N-WASp homomer complex	O00401	8976	actin cytoskeleton organization	actin cytoskeleton	WASL	None	N-WASp undergoes self-association upon increasing concentration and the monomeric form activates actin polymerization and is favored by Grb2 binding.	None
ERBB2-MEMO-SHC complex	P04626;P29353;Q9Y316	2064;6464;51072	movement of cell or subcellular component;microtubule cytoskeleton organization	cell motility;microtubule cytoskeleton	ERBB2;SHC1;MEMO1	None	The results suggest that the Shc adaptor protein mediates binding of Memo to the phospho-YD (Tyr 1227) residue of ErbB2.	None
"LAT-PLC-gamma-1-p85-GRB2-CBL-VAV-SLP-76 signaling complex, C305 activated"	O43561;P15498;P19174;P22681;P27986;P62993;Q13094	27040;7409;5335;867;5295;2885;3937	transmembrane receptor protein tyrosine kinase signaling pathway;response to stimulus;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;animal specific systemic sensing and response	LAT;VAV1;PLCG1;CBL;PIK3R1;GRB2;LCP2	None	"The authors show that upon tyrosine phosphorylation, LAT binds Grb2, PLC-gamma1, the p85 subunit of PI3K, and other critical signaling molecules. They provide evidence that LAT plays an important role in linking the TCR to cellular activation."	None
"Cbl-SLP-76-Grb2 complex, Fc receptor gamma-R1 stimulated"	P22681;P62993;Q13094	867;2885;3937	transmembrane receptor protein tyrosine kinase signaling pathway;immune response	transmembrane receptor protein tyrosine kinase signalling pathways;immune response	CBL;GRB2;LCP2	None	"The authors demonstrate that the kinetics of SLP-76 phosphorylation parallels the kinetics of Cbl phosphorylation, suggesting a link between these two adapter proteins in the Fc gamma RI-signaling cascade."	None
"SLP-76-Cbl-Grb2-Shc complex, Fc receptor gamma-R1 stimulated"	P22681;P29353;P62993;Q13094	867;6464;2885;3937	transmembrane receptor protein tyrosine kinase signaling pathway;immune response	transmembrane receptor protein tyrosine kinase signalling pathways;immune response	CBL;SHC1;GRB2;LCP2	None	"The authors propose that the association of Grb2 and Shc with SLP-76 and Cbl may serve as a repository for Grb2 and Shc, regulating their association with Sos and subsequent activation of Ras."	None
PLC-gamma-2-SLP-76-Lyn-Grb2 complex	P07948;P16885;P62993;Q13094	4067;5336;2885;3937	transmembrane receptor protein tyrosine kinase signaling pathway;blood coagulation;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;blood coagulation	LYN;PLCG2;GRB2;LCP2	None	Analyses done with different GST-PLC-gamma-2 fusion proteins from resting and CRP (collagen-related peptide) stimulated platelets.	None
"PKC-alpha-PLD1-PLC-gamma-2 signaling complex, lacritin stimulated"	P16885;P17252;Q13393	5336;5578;5337	calcium-mediated signaling;epithelial cell differentiation;morphogenesis of an epithelium;Golgi apparatus;phosphatidylinositol-mediated signaling	Ca2+ mediated signal transduction;epithelium;Golgi	PLCG2;PRKCA;PLD1	None	"Lacritin is described as mitogenic for a small subset of epithelial cell lines derived mainly from the nongermative epithelia that normally contact lacritin during its outward glandular flow. The authors propose that lacritin signaling  stimulates the formation of a transient perinuclear Golgi complex of PKC-alpha, PLD1, and PLC-gamma-2. This activates PLD1 of the mTOR pathway. Some PLC-gamma-2 activation and considerable IP3 generation were detected. Ca(2+) mobilization may then be a consequence."	None
BCR-ABL (p210 fusion protein)-GRB2 complex	A1Z199;P62993	None;2885	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	BCR/ABL fu;GRB2	None	It was shown that Grb2 binds to the Tyr177 autophosphorylation site on Bcr-Abl.	Chimeric bcr-abl oncogene is involved in Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL).
HGF-Met complex	P08581;P14210	4233;3082	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	MET;HGF	None	"HGF interacts with the extracellular domain of Met, resulting in the activation of Met and subsequent downstream functions. The authors demonstrate that that copper(II) inhibits HGF/Met interaction."	None
EGFR-CBL-GRB2 complex	P00533;P22681;P62993	1956;867;2885	intracellular signal transduction;endosome	cellular signalling;endosome	EGFR;CBL;GRB2	None	"The energy transfer analysis results prompted the authors to support the previously proposed model that although Cbl is capable of direct binding to EGFR, it preferentially binds receptors indirectly through Grb2."	None
PLC-gamma-1-SLP-76-SOS1-LAT complex	O43561;P19174;Q07889;Q13094	27040;5335;6654;3937	transmembrane receptor protein tyrosine kinase signaling pathway;response to stimulus;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;animal specific systemic sensing and response	LAT;PLCG1;SOS1;LCP2	None	"In a supplementary figure the authors show that PLC-gamma-1, SLP-76 and Sos1 are effectively recruited to LAT in the absence of Dyn2. The results show further that when Dyn2 was present, several tyrosine-phosphorylated proteins coimmunoprecipitated with Lat, including SLP76, PLC-gamma1 and several other unidentified proteins. PLC-gamma-1 total tyrosine phosphorylation was diminished in the absence of Dyn2."	None
"PDGFRA-PLC-gamma-1-PI3K-SHP-2 complex, PDGF stimulated"	P16234;P19174;P27986;Q06124	5156;5335;5295;5781	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	PDGFRA;PLCG1;PIK3R1;PTPN11	None	"Mutational analysis shows that Y720 of PDGFRA is required for binding of SHP-2 to the PDGFRA but not for the association of PLCg, the p85 subunit of PI3K, or Src. The data strongly suggest that SHP-2 must bind to the PDGFRA to be efficiently tyrosine phosphorylated."	None
p56(LCK)-CAML complex	P06239;P49069	3932;819	transmembrane receptor protein tyrosine kinase signaling pathway;T cell differentiation	transmembrane receptor protein tyrosine kinase signalling pathways;T-cell	LCK;CAMLG	None	"The results of the authors suggest that CAML interacts with p56Lck to regulate its subcellular localization and timely activation of the kinase in response to TCR induction. They propose that CAML functions to maintain the proper storage of p56Lck to prevent excessive activation and to ensure carefully measured release of the kinase in response to TCR stimulation, thereby facilitating productive T cell activation with less cell death."	None
FGFR2-c-Cbl-Lyn-Fyn complex	P06241;P07948;P21802;P22681	2534;4067;2263;867	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;signaling;fibroblast growth factor receptor signaling pathway;osteoblast differentiation	"proteasomal degradation (ubiquitin/proteasomal pathway);cellular signalling;FGF-receptor signalling pathway;structural cell of tissue (fibroblast, osteoblast, etc.)"	FYN;LYN;FGFR2;CBL	None	"The results indicate that FGFR2 interacts with Lyn and Fyn and with c-Cbl, which can then mediate proteasome degradation of these three molecules in osteoblasts. The authors propose a mechanism by which constitutive FGFR2 activation in osteoblasts induces c-Cbl-dependent recruitment of FGFR2, Lyn, and Fyn, leading to their proteasome degradation, decreased kinase activity, and hence increased osteoblast differentiation."	None
"p21(ras)GAP-Fyn-Lyn-Yes complex, thrombin stimulated"	P06241;P07947;P07948;P20936	2534;7525;4067;5921	signaling;blood coagulation	cellular signalling;blood coagulation	FYN;YES1;LYN;RASA1	None	"The authors showed that Fyn, Lyn,and Yes are associated with GAP in thrombin-stimulatedplatelets. They could not distinguish whether this complex is preformed in restingplatelets or whether the kinases associate with GAP followingactivation with thrombin."	None
"CD20-LCK-LYN-FYN-p75/80 complex, (Raji human B cell line)"	P06239;P06241;P07948;P11836	3932;2534;4067;931	signaling	cellular signalling	LCK;FYN;LYN;MS4A1	"At the time of annotation, the identity of the additional member p75/80 of the protein complex was not known."	Lyn accounted for most of the PTK activity in the CD20 complex.	None
RAB5-EEA1 complex	P20339;Q15075	5868;8411	endocytosis;endosome	endocytosis;endosome	RAB5A;EEA1	None	None	None
Class C VPS/HOPS complex	P20339;Q15075;Q96JC1;Q9H269;Q9H270;Q9P253	5868;8411;23339;64601;55823;57617	endocytosis;endosome organization;endosome	endocytosis;endosome;endosome	RAB5A;EEA1;VPS39;VPS16;VPS11;VPS18	None	"The class C VPS/HOPS complex, an established GEF for Rab7, interacts with Rab5 and is required for Rab5-to-Rab7 conversion."	None
CD19-VAV1-PIK3R1 complex	P15391;P15498;P27986	930;7409;5295	B cell differentiation;phosphatidylinositol-mediated signaling;regulation of immune response	B-cell	CD19;VAV1;PIK3R1	None	The authors show that cross-linking of CD19 on surface Ig-negative B cell precursors and surface Ig-positive immature B cells results in the rapid tyrosine phosphorylation of Vav and a concomitant physical association of Vav with CD19 and PI 3-kinase.	None
Sam68-p85 P13K-IRS-1-IR signaling complex	P06213;P27986;P35568;Q07666	3643;5295;3667;10657	insulin receptor signaling pathway;cytoplasm	insulin receptor signalling pathway;cytoplasm	INSR;PIK3R1;IRS1;KHDRBS1	None	The authors found that Sam68 is tyrosine phosphorylated and associates with p85 PI3K after insulin stimulation in a complex that also contains IRS-1 and the IR itself. Further they demonstrated that Sam68 relocalizes after insulin stimulation from the nucleus to the cytoplasm. Regarding the association of Sam68 with p120GAP it is concluded that Sam68 is linking p120GAP to P13K signaling pathway.	None
Sam68-p120GAP complex	P20936;Q07666	5921;10657	insulin receptor signaling pathway;cytoplasm	insulin receptor signalling pathway;cytoplasm	RASA1;KHDRBS1	None	The authors suggest that Sam68 is associated with p120GAP after insulin stimulation and in this way it links GAP to the PI3K pathway. Further they demonstrated that Sam68 relocalizes after insulin stimulation from the nucleus to the cytoplasm.	None
"Chromosomal passenger complex CPC (INCENP, BIRC5, AURKB)"	O15392;Q96GD4;Q9NQS7	332;9212;3619	"mitotic cell cycle;spindle assembly;chromosome segregation;chromosome, centromeric region"	mitotic cell cycle;spindle pole body/centrosome and microtubule cycle;chromosome segregation/division;centromere / kinetochore	BIRC5;AURKB;INCENP	None	"All three proteins showed very similar changes in cell cycle progression, low in G1/S, increased during G2 and M. The studies revealed an evolutionarily conserved mechanism for Aurora B activation by INCENP binding and phosphorylation."	None
Survivin homodimer complex	O15392	332	M phase;mitotic nuclear division;spindle assembly;centrosome cycle;negative regulation of apoptotic process;microtubule cytoskeleton organization;microtubule cytoskeleton	M phase;spindle pole body/centrosome and microtubule cycle;anti-apoptosis;microtubule cytoskeleton;microtubule cytoskeleton	BIRC5	None	Survivin temporally and spatially localizes to microtubule organizing centers (MTOC) during mitosis (PMID:9859993).	None
RasGAP-AURKA-survivin complex	O14965;O15392;P20936	6790;332;5921	mitotic cell cycle;regulation of cell cycle;G-protein coupled receptor signaling pathway	mitotic cell cycle;mitotic cell cycle and cell cycle control;G-protein coupled receptor signalling pathway	AURKA;BIRC5;RASA1	None	The authors define this ternary complex by several protein-protein interactions. RasGAP binds to the kinase domain of Aurora and this interaction inhibits the kinase activity of AURKA and AURKB.	None
"Chromosomal passenger complex CPC (CDCA8, AURKB, BIRC5)"	O15392;Q53HL2;Q96GD4	332;55143;9212	"mitotic cell cycle;spindle assembly;chromosome, centromeric region;chromosome segregation"	mitotic cell cycle;spindle pole body/centrosome and microtubule cycle;centromere / kinetochore;chromosome segregation/division	BIRC5;CDCA8;AURKB	None	"The authors propose that Dasra B may act to regulate the stability of Survivin, which, together with Incenp, serves to target Aurora B to chromosomal arms and centromeres."	None
PGC-1-SRp40-SRp55-SRp75 complex	Q08170;Q13243;Q13247;Q9UBK2	6429;6430;6431;10891	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;mRNA splicing, via spliceosome;mRNA processing;nucleic acid binding;nucleus"	"transcriptional control;mRNA processing (splicing, 5'-, 3'-end processing);nucleic acid binding;nucleus"	SRSF4;SRSF5;SRSF6;PPARGC1A	None	"PGC-1 is part of both the preinitiation and elongation Pol II complexes, and association with the elongation form of Pol II depends on the C-terminal domain of PGC-1."	None
FOXO1-FHL2-SIRT1 complex	Q12778;Q14192;Q96EB6	2308;2274;23411	"negative regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;nucleus"	"transcription repression;modification by acetylation, deacetylation;nucleus"	FOXO1;FHL2;SIRT1	None	"The authors came to the following results: 1. FHL2 colocalizes and interacts with FOXO1 in prostate cancer cells. 2. FHL2 inhibits the activation of an IRS-driven reporter gene by FOXO1 in the presence but not in the absence of SIRT1 activity. 3. SIRT1 binds FOXO1, decreases its acetylation, and inhibits its transcriptional activity. 4. FHL2 interacts with SIRT1 and promotes its interaction with FOXO1. They suggest a model  that FHL2 negates the transcriptional activity of FOXO1 by promoting its deacetylation by SIRT1."	None
SIRT1 homotrimer complex	Q96EB6	23411	protein deacetylation;nucleus;chromatin silencing	"modification by acetylation, deacetylation;nucleus"	SIRT1	None	SirT1 exists as a trimer and interacts with histone H1.	None
"FOXO3-SIRT1 complex, oxidative stress stimulated"	O43524;Q96EB6	2309;23411	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress;negative regulation of apoptotic process;nucleus"	transcriptional control;oxidative stress response;anti-apoptosis;nucleus	FOXO3;SIRT1	None	"SIRT1 and  transcription factor FOXO3 formed a complex in cells in response to oxidative stress, and SIRT1 deacetylated FOXO3 in vitro and within cells. SIRT1 increased FOXO3's ability to induce cell cycle arrest and resistance to oxidative stress but inhibited FOXO3's ability to induce cell death."	None
NELF complex (Negative elongation factor complex)	P18615;Q8IXH7;Q8WX92;Q9H3P2	7936;51497;25920;7469	"DNA-templated transcription, elongation;negative regulation of transcription, DNA-templated;RNA binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription elongation;transcription repression;RNA binding;regulator of transcription factor;nucleus	NELFE;NELFCD;NELFB;NELFA	None	NELF cooperates with DSIF and represses DRB-sensitive RNA-Polymerase II.	None
POLR2A-CCNT1-CDK9-NCL-LEM6-CPSF2 complex	O60563;P19338;P24928;P50750;Q9P2I0;Q9UBK2	904;4691;5430;1025;53981;10891	"regulation of transcription, DNA-templated;mRNA splicing, via spliceosome;mRNA processing;protein phosphorylation;nucleic acid binding;nucleus"	"transcriptional control;mRNA processing (splicing, 5'-, 3'-end processing);modification by phosphorylation, dephosphorylation, autophosphorylation;nucleic acid binding;nucleus"	CCNT1;NCL;POLR2A;CDK9;CPSF2;PPARGC1A	None	"The authors demonstrate that PGC-1 is part of both the preinitiation and elongation Pol II complexes, and association with the elongation form of Pol II depends on the C-terminal domain of PGC-1."	None
BRD4 complex	O60244;O60563;O60885;O75448;P50750;Q15648;Q93074;Q9NVC6	9282;904;23476;9862;1025;5469;9968;9440	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	MED14;CCNT1;BRD4;MED24;CDK9;MED1;MED12;MED17	None	None	None
P-TEFb-BRD4-TRAP220 complex	O60563;O60885;P50750;Q15648	904;23476;1025;5469	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNT1;BRD4;CDK9;MED1	None	Brd4 is necessary to mediate the interaction between P-TEFb and Mediator complex.	None
P-TEFb-7SKRNA-HEXIM1 complex	O60563;O94992;P50750	904;10614;1025	"DNA-templated transcription, elongation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription elongation;transcriptional control;nucleus	CCNT1;HEXIM1;CDK9	None	"7SK RNA is required for HEXIM1 to associate with P-TEFb complex. This allowes HEXIM1 to inhibit transcription. P-TEFb dissociates from HEXIM1 and 7SK in cells undergoing stress response, increasing the level of active P-TEFb for stress-induced transcription."	None
"Transcription elongation factor complex (SUPT5H, CDK9, CCNT1)"	O00267;O60563;P50750	6829;904;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;protein phosphorylation;phosphorylation of RNA polymerase II C-terminal domain"	"transcription elongation;transcription activation;nucleus;modification by phosphorylation, dephosphorylation, autophosphorylation"	SUPT5H;CCNT1;CDK9	None	P-TEFb preferentially phosphorylates hSPT5 as compared with the carboxyl-terminal domain of RNA Pol II in vitro.	None
P-TEFb-SKP2 complex	O60563;P50750;Q13309	904;1025;6502	"DNA-templated transcription, elongation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;nucleus"	transcription elongation;transcriptional control;proteasomal degradation (ubiquitin/proteasomal pathway);nucleus	CCNT1;CDK9;SKP2	None	Binding of SKP2 to P-TEFb requires PEST domain of cyclin T1. CDK9 is ubiquitinated and degraded by the proteasome whereas cyclin T1 is stable.	None
CCNT1- CDK9-GRN complex	O60563;P28799;P50750	904;2896;1025	"negative regulation of transcription, DNA-templated"	transcription repression	CCNT1;GRN;CDK9	None	Granulin is a cellular proteinthat interacts with cyclin T1 to inhibit transcription.	None
CDK8-MED6-PARP1 complex	O75586;P09874;P49336	10001;142;1024	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	MED6;PARP1;CDK8	None	None	None
CCNC-CDK8-MED1-MED6-MED7 xcomplex	O43513;O75586;P24863;P49336;Q15648	9443;10001;892;1024;5469	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	MED7;MED6;CCNC;CDK8;MED1	None	None	None
CCNC-CDK3 complex	P24863;Q00526	892;1018	cell cycle	cell cycle	CCNC;CDK3	None	"A non-cdk8-associated cellular pool of cyclin C combines with cdk3 to stimulate pRb phosphorylation at S807/811 during the G0/G1 transition, and that this phosphorylation is required for cells to exit G0 efficiently."	None
BETA2-Cyclin D1 complex	P24385;Q13562	595;4760	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	CCND1;NEUROD1	None	None	None
HES1 promoter corepressor complex	P24928;P50613;Q06330;Q09472;Q7KZ85;Q92793	5430;1022;3516;2033;6830;1387	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	POLR2A;CDK7;RBPJ;EP300;SUPT6H;CREBBP	None	This complex has been studied on the HES1 promoter (a Notch target gene) in cells without Notch signaling.	None
HES1 promoter-Notch enhancer complex	O60563;P24928;P46531;P49336;P50613;P50750;Q06330;Q09472;Q15648;Q7KZ85;Q92585;Q9BT40;Q9Y5B9	904;5430;4851;1024;1022;1025;3516;2033;5469;6830;9794;51763;11198	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;nucleus	CCNT1;POLR2A;NOTCH1;CDK8;CDK7;CDK9;RBPJ;EP300;MED1;SUPT6H;MAML1;INPP5K;SUPT16H	None	"After Notch signaling endogenous CDK8 is recruited to the HES1 promoter (a Notch target gene) together with Notch and MAM. Signaling also induces binding of SKIP, as well as two transcription elongation factors, P-TEFb and FACT."	None
CREBBP-KAT2B-MYOD1 complex	P15172;Q92793;Q92831	4654;1387;8850	"skeletal muscle tissue development;transcription, DNA-templated"	myogenesis;TRANSCRIPTION	MYOD1;CREBBP;KAT2B	"The transcriptional coactivators p300 and CBP are considered as functional homologs, the authors refer to them as p300/CBP. We used CBP."	None	None
SMAD1-P300 complex	Q09472;Q15797	2033;4086	"DNA topological change;positive regulation of transcription, DNA-templated;protein acetylation;transforming growth factor beta receptor signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription activation;modification by acetylation, deacetylation;TGF-beta-receptor signalling pathway;organization of chromosome structure;nucleus"	EP300;SMAD1	None	SMAD1 stimulates transcription cooperatively with P300.	None
MYC-DNMT3A-ZBTB17 complex	P01106;Q13105;Q9Y6K1	4609;None;1788	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	MYC;ZBTB17;DNMT3A	None	This complex is involved in a transcriptional silencing of  p21Cip1 promoter.	None
DNMT3B-DNMT3L complex	Q9UBC3;Q9UJW3	1789;29947	DNA methylation	DNA methylation	DNMT3B;DNMT3L	None	None	None
DNMT3L-DNMT3A complex	Q9UJW3;Q9Y6K1	29947;1788	DNA methylation	DNA methylation	DNMT3L;DNMT3A	None	None	None
MYC-MAX-KAT2A-TRRAP complex	P01106;P61244;Q92830;Q9Y4A5	4609;4149;2648;8295	"histone acetylation;chromatin remodeling;transcription, DNA-templated"	TRANSCRIPTION	MYC;MAX;KAT2A;TRRAP	None	None	None
MYC-MAX complex	P01106;P61244	4609;4149	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	MYC;MAX	None	None	None
ESR1-CDK7-CCNH-MNAT1-MTA1-HDAC2 complex	P03372;P50613;P51946;P51948;Q13330;Q92769	2099;1022;902;4331;9112;3066	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein phosphorylation;nucleus;regulation of intracellular estrogen receptor signaling pathway"	"transcriptional control;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	ESR1;CDK7;CCNH;MNAT1;MTA1;HDAC2	None	The authors identified MAT1 as a target of corepressor MTA1 and provided new evidence to suggest that the transactivation functions of ER are influenced by the regulatory interactions between CAK and MTA1.	MTA1 is involved in metastasis or cancer formation.
CAK-ERCC2 complex	P18074;P50613;P51946;P51948	2068;1022;902;4331	DNA repair	DNA repair	ERCC2;CDK7;CCNH;MNAT1	None	TFIIH* and ERCC2/CAK interact to form the TFIIH holoenzyme capable of efficiently assembling the pol II transcription initiation complex and directly participating in excision repair reactions.	None
Er-alpha-p53-hdm2 complex	P03372;P04637;Q00987	2099;7157;4193	enzyme regulator activity;regulation of catalytic activity	enzymatic activity regulation / enzyme regulator	ESR1;TP53;MDM2	None	The authors demonstrated that ER-alpha protects p53 from being deactivated by hdm2 in a Luc reporter assay.	None
"FOXO3-TP53 complex, oxidative stress stimulated"	O43524;P04637	2309;7157	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress;nucleus"	transcriptional control;oxidative stress response;nucleus	FOXO3;TP53	None	None	None
p53-SP1 complex	P04637;P08047	7157;6667	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	TP53;SP1	None	"The authors provide evidence that p53 repressed the RECQ4 promoter by forming a complex with the transcription factor, SP1, and by regulating promoter occupancy of both itself and SP1 in concert with histone deacetylase 1 (HDAC1). The formation of this complex is camptothecin-dependent."	None
p53 homotetramer complex	P04637	7157	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	TP53	None	"The results demonstrate that Ref-1 (redox factor 1) modulates p53 DNA binding not only as a redox regulator but also as a factor, which facilitates the formation of p53 tetramers from higher oligomeric forms as well as from dimers. Ref-1 mediates de-stacking of higher oligomeric forms into individual tetramers, as well as the assembly of dimers into tetramers. Redox-dependent and redox-independent activation of p53 seem to require different amounts of Ref-1."	None
RNA polymerase II (RNAPII)	O15514;P13984;P19387;P19388;P24928;P30876;P35269;P36954;P52434;P52435;P53803;P61218;P62487;P62875;Q00403;Q9BWH6;Q9Y5B0	5433;2963;5432;5434;5430;5431;2962;5438;5437;5439;5440;5435;5436;5441;2959;26015;9150	"transcription, DNA-templated;DNA binding;nucleus"	TRANSCRIPTION;DNA binding;nucleus	POLR2D;GTF2F2;POLR2C;POLR2E;POLR2A;POLR2B;GTF2F1;POLR2I;POLR2H;POLR2J;POLR2K;POLR2F;POLR2G;POLR2L;GTF2B;RPAP1;CTDP1	None	The authors demonstrate the purification of a functionally active human RNAPII by the use of doubly tagged subunits expressed in mammalian cells.	None
BRCA1-core RNA polymerase II complex	O15514;P19387;P19388;P24928;P30876;P36954;P38398;P52434;P52435;P53803;P61218;P62487;P62875	5433;5432;5434;5430;5431;5438;672;5437;5439;5440;5435;5436;5441	"transcription, DNA-templated;DNA binding;nucleus"	TRANSCRIPTION;DNA binding;nucleus	POLR2D;POLR2C;POLR2E;POLR2A;POLR2B;POLR2I;BRCA1;POLR2H;POLR2J;POLR2K;POLR2F;POLR2G;POLR2L	None	The transcriptional coactivator BRCA1 interacts directly with the core Pol II complex in vitro.	None
MMP14-CLDN1 complex	O95832;P50281	9076;4323	positive regulation of metallopeptidase activity;cell-cell junction organization	intercellular junction (gap junction/adherens junction)	CLDN1;MMP14	None	Claudin-5 was identified to promote the activation of pro-MMP-2 mediated by MT1-MMP in 293T cells.	None
SMAD3-SMAD4-cJun-cFos complex	P01100;P05412;P84022;Q13485	2353;3725;4088;4089	"positive regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription activation;DNA binding;TGF-beta-receptor signalling pathway;nucleus	FOS;JUN;SMAD3;SMAD4	None	None	None
NFAT-JUN-FOS DNA-protein complex	P01100;P05412;Q13469	2353;3725;4773	"positive regulation of transcription, DNA-templated;DNA binding;immune response"	transcription activation;DNA binding;immune response	FOS;JUN;NFATC2	None	NFAT and heterodimer Fos-Jun cooperatively bind a composite DNA site and synergistically activate the expression of many immune-response genes.	None
ERG-JUN-FOS DNA-protein complex	P01100;P05412;P11308	2353;3725;2078	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	FOS;JUN;ERG	None	"The authors demonstrated that amino acids Arg(367) and Tyr(371) of the ETS domain, but not Asp374, play an important role in the recruitment of the Jun/Fos heterodimer by Erg. The authors propose that interdependent protein-protein and protein-DNA contacts regulate Erg-Jun/Fos-DNA complex assembly."	None
ETS2-FOS-JUN complex	P01100;P05412;P15036	2353;3725;2114	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	FOS;JUN;ETS2	None	"The results suggest that stromelysin-1 promoter DNA can enhance the ETS2/Fos/Jun interaction, perhaps by stabilizing protein contacts."	None
ESR1-JUN-GRIP1 complex	P03372;P05412;Q9Y3R0	2099;3725;23426	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signaling"	transcriptional control;cellular signalling	ESR1;JUN;GRIP1	None	"The authors showed that ERalpha , c-Jun, and the p160 coactivator GRIP1 can form a multiprotein complex in vitro and in intact cells and that the ERalpha - c-Jun interaction could be crucial for the stability of this complex."	None
ESR1-JUN complex	P03372;P05412	2099;3725	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;signaling"	transcriptional control;DNA binding;cellular signalling	ESR1;JUN	None	All experiments demonstrated that ER-alpha and c-Jun could interact in mammalian cells in a ligand-dependent manner.	None
Ectodermin-SMAD4 complex	Q13485;Q9UPN9	4089;51592	protein ubiquitination;transforming growth factor beta receptor signaling pathway;nucleus	"modification by ubiquitination, deubiquitination;TGF-beta-receptor signalling pathway;nucleus"	SMAD4;TRIM33	None	None	None
SMAD3-SMAD4-CTCF protein-DNA complex	P49711;P84022;Q13485	10664;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	CTCF;SMAD3;SMAD4	None	"The authors demonstrated that TGF-beta increases APP gene transcription in NHAs (normal human astrocytes) through activation of the proximal APP promoter domain, (-488) base pairs (bp) relative to the transcription start site (+1). In the presence of TGF-beta stimulation, Smads 3 and 4 specifically associated with the CTCF-APBbeta complex, likely enhancing APP gene transcription."	None
SMAD3-SMAD4-SP1 complex	P08047;P84022;Q13485	6667;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SP1;SMAD3;SMAD4	None	"The authors demonstrated that Sp1 and Smad3/Smad4 are able to bind the endoglin promoter at positions -50/-29 forming a multiprotein complex, and suggest their cooperation in the transcriptional activity of endoglin."	None
SMAD3-SMAD4-FOXO3-FOXG1 complex	O43524;P55316;P84022;Q13485	2309;2290;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	FOXO3;FOXG1;SMAD3;SMAD4	None	The results suggest that FoxG1 is a direct inhibitor of the FoxO-Smad transcriptional complex and a blocker of p21Cip1 induction by TGF-beta signals in neuroepithelial cells.	None
SMAD3-SMAD4-cJUN complex	P05412;P84022;Q13485	3725;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;TGF-beta-receptor signalling pathway;nucleus	JUN;SMAD3;SMAD4	None	"On TGF-beta  treatment, Smad3 and Smad4 heteromerize and enter the nucleus, where they can associate with TGF-beta-responsive promoters by binding a discreet DNA sequence and/or AP-1 members bound to AP-1 sites on the same promoter."	None
MMP-9-TIMP-1-LRP complex	P01033;P14780;Q07954	7076;4318;4035	enzyme regulator activity;regulation of catalytic activity;receptor-mediated endocytosis;extracellular matrix organization	enzymatic activity regulation / enzyme regulator;receptor-mediated endocytosis;extracellular matrix	TIMP1;MMP9;LRP1	None	"The binding to LRP was blocked when excess RAP (39-kDa receptor-associated protein) was incubated along with MMP-9. Further results indicated that MMP-9 directly binds to LRP even in the absence of TIMP-1 and that reduction of MMP-9 abolishes its ability to bind LRP. The authors summarize that LRP is a functional receptor for MMP-9 and confirm that LRP is capable of mediating the cellular uptake of at least three MMPs (MMP-2, MMP-13, and MMP-9)."	None
LRP-1-Alpha-2-M-annexin VI complex	P01023;P08133;Q07954	2;309;4035	receptor-mediated endocytosis	receptor-mediated endocytosis	A2M;ANXA6;LRP1	None	Cell surface annexin VI is involved in the binding of 125I-alpha-2M(activated) to LRP-1 at neutral pH and forms ternary complexes with 125I-alpha-2M(activated) and LRP-1 at neutral pH.	None
Amyloid beta protein homo-oligomer complex	P05067	351	negative regulation of long-term synaptic potentiation;regulation of long-term neuronal synaptic plasticity	None	APP	None	"Size fractionation showed that Abeta oligomers, not monomers or fibrils, were responsible for inhibiting long-term potentiation (LTP), and an Abeta antibody again prevented such inhibition."	None
"Ubiquitin E3 ligase (CHEK1, CUL1)"	O14757;Q13616	1111;8454	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);DNA damage response;nucleus"	CHEK1;CUL1	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The Chk1 kinase is a major effector of S phase checkpoint signaling during the cellular response to genotoxic stress. Replicative stress induces the polyubiquitination and degradation of Chk1 in human cells.	None
"Ubiquitin E3 ligase (CSN1, CSN8, HRT1, SKP1, SKP2, CUL1, CUL2, CUL3)"	P62877;P63208;Q13098;Q13309;Q13616;Q13617;Q13618;Q99627	9978;6500;2873;6502;8454;8453;8452;10920	ubiquitin-dependent protein catabolic process;cullin-RING ubiquitin ligase complex	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;SKP1;GPS1;SKP2;CUL1;CUL2;CUL3;COPS8	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. SCF ubiquitin ligases consist of at least four subunits: CUL1 and HRT1 (=ROC1, RBX1), which  harbor a core ubiquitin ligase activity; a variable F-box protein that serves as a substrate receptor; and SKP1, which links the two modules together. Because CSN binds all cullins, it might be a global signal integrator that radiates its output onto various associated ubiquitin ligases to modulate their activity."	None
Elongator core complex	O95163;Q6IA86;Q9H9T3	8518;55250;55140	"DNA-templated transcription, elongation;nucleus"	transcription elongation;nucleus	IKBKAP;ELP2;ELP3	None	The core-Elongator complex does not have histone acetyltransferase activity despite containing the catalytic Elp3 subunit.	None
"Ubiquitin E3 ligase (TRIM25, DDX58)"	O95786;Q14258	23586;7706	protein ubiquitination;intracellular signal transduction;response to stimulus;cytoplasm;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;cellular signalling;animal specific systemic sensing and response;cytoplasm;proteasomal degradation (ubiquitin/proteasomal pathway)"	DDX58;TRIM25	None	"TRIM25 E3 ubiquitin ligase induces the Lys 63-linked ubiquitination of RIG-I, which is crucial for the cytosolic RIG-I signalling pathway to elicit host antiviral innate immunity."	None
MAD2-CDC20 complex	Q12834;Q13257	991;4085	cell cycle arrest;mitotic spindle assembly checkpoint;anaphase-promoting complex-dependent catabolic process	cell cycle arrest	CDC20;MAD2L1	None	The checkpoint protein Mad2 inhibits the activity of the anaphase promoting complex by sequestering Cdc20 until all chromosomes are aligned at the metaphase plate.	None
Casein kinase II-HMG1 complex	P09429;P19784;P67870;P68400	3146;1459;1460;1457	"protein phosphorylation;negative regulation of DNA-templated transcription, elongation;enzyme regulator activity"	"modification by phosphorylation, dephosphorylation, autophosphorylation;enzymatic activity regulation / enzyme regulator"	HMGB1;CSNK2A2;CSNK2B;CSNK2A1	None	"CK2 is comprised of the subunits CK2alpha , CK2alpha ', and CK2beta , and the differences in FCP1 kinase activity among the elution fractions reflect a dose-dependent effect related to the amount of CK2 present but do not depend on the presence of HMG1.Phosphorylation of FCP1 by CK2 inhibits the transcription elongation activity of FCP1."	None
"Casein kinase II (beta-dimer, alpha, alpha')"	P19784;P67870;P68400	1459;1460;1457	"protein phosphorylation;enzyme regulator activity;negative regulation of DNA-templated transcription, elongation"	"modification by phosphorylation, dephosphorylation, autophosphorylation;enzymatic activity regulation / enzyme regulator"	CSNK2A2;CSNK2B;CSNK2A1	None	CK2 phosphorylates FCP1 and RAP74. Phosphorylation of FCP1 by CK2 inhibits the transcription elongation activity of FCP1.	None
HCF-1 complex	O15047;O15294;O75182;O75446;P07900;P08047;P11021;P11142;P34932;P51610;P61964;Q09028;Q13547;Q16576;Q92769;Q96ST3;Q9H7L9;Q9UBL3	9739;8473;23309;8819;3320;6667;3309;3312;3308;3054;11091;5928;3065;5931;3066;25942;64426;9070	"DNA topological change;cytokinesis;barrier septum assembly;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;cell morphogenesis;cell growth;chromosome organization;nucleus;histone deacetylation;histone methylation"	DNA conformation modification (e.g. chromatin);cytokinesis (cell division) /septum formation and hydrolysis;transcriptional control;cell growth / morphogenesis;organization of chromosome structure;nucleus	SETD1A;OGT;SIN3B;SAP30;HSP90AA1;SP1;HSPA5;HSPA8;HSPA4;HCFC1;WDR5;RBBP4;HDAC1;RBBP7;HDAC2;SIN3A;SUDS3;ASH2L	"Since the authors did not specify HSP90A, we used HSP90AA1."	"HCF-1 can regulate transcription, both positively and negatively, through selective modulation of chromatin structure."	None
"Ubiquitin E3 ligase (DDB1, CUL4A, RBX1)"	P62877;Q13619;Q16531	9978;8451;1642	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);DNA damage response"	RBX1;CUL4A;DDB1	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. The ubiquitin E3 ligase (DDB1, CUL4A and RBX1) perfoms targeted ubiquitination of CDT1 in response to DNA damage."	None
ATM-NBN complex	O60934;Q13315	4683;472	cell cycle checkpoint;protein phosphorylation;protein autophosphorylation;cellular response to DNA damage stimulus;response to radiation;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);modification by phosphorylation, dephosphorylation, autophosphorylation;DNA damage response;electromagnetic waves stress response (e.g. UV, X-ray);nucleus"	NBN;ATM	None	NBS1 (NBN) was co-immunoprecipitated by the ATM antibody from untreated cells and in increased quantities from cells treated with ionizing radiation. The results indicate that phosphorylation of Ser 278 and Ser 343 in NBS1 contributes to both cellular resistance to ionizing radiation and formation of foci that contain NBS1 in response to ionizing radiation.	None
"Ubiquitin E3 ligase (NFKBIA, BTRC, CUL1, SKP1A)"	P25963;P63208;Q13616;Q9Y297	4792;6500;8454;8945	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	NFKBIA;SKP1;CUL1;BTRC	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Ubiquitination-dependent destruction of NF-kappa-B inhibitor alpha is mediated by ubiquitin E3 ligases containing heterdimers and homodimers of beta-TrCP1 (BTRC) and beta-TrCP2 (FBXW11).	None
"Ubiquitin E3 ligase (NFKBIA, FBXW11, CUL1, SKP1A)"	P25963;P63208;Q13616;Q9UKB1	4792;6500;8454;23291	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cytoplasm;regulation of I-kappaB kinase/NF-kappaB signaling	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);cytoplasm"	NFKBIA;SKP1;CUL1;FBXW11	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Ubiquitination-dependent destruction of NF-kappa-B inhibitor alpha is mediated by ubiquitin E3 ligases containing heterdimers and homodimers of beta-TrCP1 (BTRC) and beta-TrCP2 (FBXW11).	None
PXN-ITGB5-PTK2 complex	P18084;P49023;Q05397	3693;5829;5747	integrin-mediated signaling pathway	integrin receptor signalling pathway	ITGB5;PXN;PTK2	None	"The changes in the expression of PAR1 in a cell affect its invasive capabilities. These changes come about through the specific recruitment of the alpha(v)-beta 5 integrin, through cytoskeletal reorganization, and through distinct signaling at FACs."	None
SRC-3 complex	O14920;O15111;P10155;Q15596;Q92793;Q9Y6K9;Q9Y6Q9	3551;1147;6738;10499;1387;8517;8202	"positive regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;I-kappaB kinase/NF-kappaB signaling;signaling;inflammatory response;nucleus"	"transcription activation;modification by acetylation, deacetylation;NIK-I-kappaB/NF-kappaB cascade;cellular signalling;inflammatory response;nucleus"	IKBKB;CHUK;TROVE2;NCOA2;CREBBP;IKBKG;NCOA3	None	SRC-3 enhances NF-kappaB-mediated gene expression in concert with IKK.	None
SRC-1 complex	P10155;Q15596;Q15788;Q92793	6738;10499;8648;1387	I-kappaB kinase/NF-kappaB signaling;signaling;nucleus	NIK-I-kappaB/NF-kappaB cascade;cellular signalling;nucleus	TROVE2;NCOA2;NCOA1;CREBBP	None	None	None
Set1B complex	P61964;Q15291;Q6UXN9;Q9P0U4;Q9UBL3;Q9UPS6	11091;5929;80335;30827;9070;23067	DNA topological change;regulation of gene expression by genetic imprinting;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus	"DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	WDR5;KDM6B;WDR82;CXXC1;ASH2L;SETD1B	None	The SET1B complex is a methyltransferase that produces trimethylated histone H3 at Lysine 4.	None
Set1A complex	O15047;P61964;Q15291;Q6UXN9;Q9P0U4;Q9UBL3	9739;11091;5929;80335;30827;9070	DNA topological change;regulation of gene expression by genetic imprinting;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus	"DNA conformation modification (e.g. chromatin);DNA imprinting and other epigenetic effects;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	SETD1A;WDR5;KDM6B;WDR82;CXXC1;ASH2L	None	The SET1A complex is a methyltransferase that produces mono-di- and trimethylated histone H3 at Lysine 4.	None
APH1A-PSEN1-NCSTN complex	P49768;Q92542;Q96BI3	5663;23385;51107	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;Notch signaling pathway;plasma membrane	proteasomal degradation (ubiquitin/proteasomal pathway);Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	PSEN1;NCSTN;APH1A	None	"Presenilin, nicastrin and mAPH1a are essential components of the gamma-secretase complex that is required for the intramembrane proteolysis of membrane proteins including the amyloid-beta precursor protein (APP) and Notch. The authors use the splice variant mAPH-1a-L for  experiments."	None
APH1A-PSEN2-NCSTN complex	P49810;Q92542;Q96BI3	5664;23385;51107	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;Notch signaling pathway	proteasomal degradation (ubiquitin/proteasomal pathway);Notch-receptor signalling pathway	PSEN2;NCSTN;APH1A	None	"Presenilin, nicastrin and mAPH1a are essential components of the gamma-secretase complex that is required for the intramembrane proteolysis of membrane proteins including the amyloid-beta precursor protein (APP) and Notch. The authors use the splice variant mAPH-1a-L for  experiments. In an additional pull down experiment the authors show the interaction of APH1B with presenilin 2."	None
TROY-NGR-LINGO1 complex	Q96FE5;Q9BZR6;Q9NS68	84894;65078;55504	neurogenesis;generation of neurons;neuron projection development	neurogenesis	LINGO1;RTN4R;TNFRSF19	None	"The authors additionally analyzed interactions between TAJ-NgR1 and TAJ-LINGO-1. The authors show that TAJ/TROY (an orphan receptor in the TNF family), broadly expressed in postnatal and adult neurons, binds to NgR1 and can replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA in the presence of myelin inhibitors."	None
BLM complex II	P15927;P27694;P35244;P54132;Q13472;Q9H9A7	6118;6117;6119;641;7156;80010	chromosome organization;DNA repair;cellular response to DNA damage stimulus;nucleus	organization of chromosome structure;DNA repair;DNA damage response;nucleus	RPA2;RPA1;RPA3;BLM;TOP3A;RMI1	"Another subunit of the complex was found in the analysis, which has not been further characterized: BLAPp100."	None	BLM complex II is involved in Bloom syndrome (BS).
FA complex (Fanconi anemia complex)	O15287;O15360;P27694;P54132;Q00597;Q13472;Q8NB91;Q9H9A7;Q9HB96;Q9NPI8;Q9NW38	2189;2175;6117;641;2176;7156;2187;80010;2178;2188;55120	protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	FANCG;FANCA;RPA1;BLM;FANCC;TOP3A;FANCB;RMI1;FANCE;FANCF;FANCL	None	"The FA complex contains several other proteins of unknown function, called FAAPs."	FA complex is involved in Fanconi anemia (FA) disease.
MSH2-MSH6 complex	P43246;P52701	4436;2956	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	MSH2;MSH6	None	"The mismatch DNA repair complex hMSH2-MSH6, regulates BLM helicase activity."	None
TRAF6-MALT1 complex	Q9UDY8;Q9Y4K3	10892;7189	positive regulation of catalytic activity;enzyme activator activity	enzyme activator	MALT1;TRAF6	None	The CARD domain protein BCL10 and paracaspase MALT1 are essential for the activation of IkappaB kinase (IKK) and NF-kappaB in response to T cell receptor (TCR) stimulation. TRAF6 ubiquitin ligase and TAK1 protein kinase mediate IKK activation by BCL10 and MALT1. MALT1 binds to TRAF6 through the C-terminal binding sites and induces the oligomerization of TRAF6 to activate IKK.	None
TRAF2-MALT1 complex	Q12933;Q9UDY8	7186;10892	positive regulation of catalytic activity;enzyme activator activity	enzyme activator	TRAF2;MALT1	None	None	None
"Ubiquitin E3 ligase (TRAF6, TAB2, MALT1, UEV1A, BCL10)"	O95999;Q13404;Q9NYJ8;Q9UDY8;Q9Y4K3	8915;None;23118;10892;7189	protein ubiquitination;positive regulation of catalytic activity;enzyme activator activity;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;enzyme activator;proteasomal degradation (ubiquitin/proteasomal pathway)"	BCL10;UBE2V1;TAB2;MALT1;TRAF6	None	"The TRAF6 ubiquitin ligase and TAK1 kinase mediate IkappaB kinase (IKK) activation by BCL10 and MALT1 in T lymphocytes. NF-kappaB is a ubiquitous transcription factor that plays a central role in many biological processes including innate and adaptive immunity. NF-kappaB is regulated primarily through its association with an inhibitory protein of the IkappaB family, which binds to and retains NF-kappaB in the cytoplasm."	None
SETDB1-containing HMTase complex	Q15047;Q6VMQ6	9869;55729	"DNA topological change;negative regulation of transcription, DNA-templated;RNA biosynthetic process;protein hydroxylation;protein methylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;RNA synthesis;posttranslational modification of amino acids (e.g. hydroxylation, methylation);organization of chromosome structure;nucleus"	SETDB1;ATF7IP	None	ATF7IP stimulates the HMTase activity of ESET (SETDB1) through facilitating the ESET-dependent conversion of dimethyl H3-K9 to the trimethyl state.	None
CARMA1-BCL10-MALT1 complex	O95999;Q9BXL7;Q9UDY8	8915;84433;10892	I-kappaB kinase/NF-kappaB signaling;plasma membrane	NIK-I-kappaB/NF-kappaB cascade;eukaryotic plasma membrane / membrane attached	BCL10;CARD11;MALT1	None	"The multiprotein complex consisting of the membrane-associated adapter protein CARMA1, the caspase-like protein MALT1, and the adapter protein BCL-10 is critical for TCR-dependent activation of the I{kappa}B kinase complex and subsequent NF-{kappa}B nuclear translocation."	None
FYB-CARMA1-BCL-10-MALT1 complex	O15117;O95999;Q9BXL7;Q9UDY8	2533;8915;84433;10892	I-kappaB kinase/NF-kappaB signaling;plasma membrane	NIK-I-kappaB/NF-kappaB cascade;eukaryotic plasma membrane / membrane attached	FYB;BCL10;CARD11;MALT1	None	"FYB (ADAP) was found to be an integral part of the multiprotein complex consisting of the membrane-associated adapter protein CARMA1, the caspase-like protein MALT1, and the adapter protein BCL-10, which is critical for TCR-dependent activation of the I{kappa}B kinase complex and subsequent NF-{kappa}B nuclear translocation."	None
JUND-FOSB-SMAD3-SMAD4 complex	P17535;P53539;P84022;Q13485	3727;2354;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;enzyme linked receptor protein signaling pathway;apoptotic process;nucleus"	transcriptional control;receptor enzyme mediated signalling;apoptosis (type I programmed cell death);nucleus	JUND;FOSB;SMAD3;SMAD4	None	"The authors found that only JunD and FosB, but not the other components of the AP-1 complex, are markedly induced during TGF-beta 1-dependent apoptosis. FosB enhanced Smad3\u00b7Smad4-dependent transcription, and its dominant-negative form blocked TGF-beta 1-dependent apoptosis but not growth inhibition. These results suggest that JunD\u00b7FosB activates transcription of a putative target gene for TGF-beta 1, which is responsible for apoptosis."	None
17S U2 snRNP	O15042;O43143;O75533;O75937;O75940;P08579;P09661;P10809;P14678;P26368;P62304;P62306;P62308;P62314;P62316;P62318;Q01081;Q07955;Q12874;Q12931;Q13435;Q15393;Q15427;Q15428;Q15459;Q7L014;Q7RTV0;Q8IWX8;Q96I25;Q9BWJ5;Q9P0W2;Q9UHX1;Q9Y3B4	23350;1665;23451;22826;10285;6629;6627;3329;6628;11338;6635;6636;6637;6632;6633;6634;7307;6426;10946;10131;10992;23450;10262;8175;10291;9879;84844;10523;84991;83443;10362;22827;51639	RNA splicing;nucleus	splicing;nucleus	U2SURP;DHX15;SF3B1;DNAJC8;SMNDC1;SNRPB2;SNRPA1;HSPD1;SNRPB;U2AF2;SNRPE;SNRPF;SNRPG;SNRPD1;SNRPD2;SNRPD3;U2AF1;SRSF1;SF3A3;TRAP1;SF3B2;SF3B3;SF3B4;SF3A2;SF3A1;DDX46;PHF5A;CHERP;RBM17;SF3B5;HMG20B;PUF60;SF3B6	None	"Spliceosome assembly is initiated by the interaction of the U1 snRNP with the 5' splice site, forming the E complex. The latter also contains the 17S U2 snRNP, which at this stage associates via a non-base pairing interaction. In a subsequent ATP-dependent step, the U2 snRNA base pairs with the branch site of the pre-mRNA leading to stable association of the U2 snRNP and formation of the so-called A complex or prespliceosome."	None
"Ubiquitin ligase (UBE2N, UBE2V2)"	P61088;Q15819	7334;7336	protein ubiquitination;cellular protein modification process;kinase activator activity;signaling	"modification by ubiquitination, deubiquitination;protein modification;kinase activator;cellular signalling"	UBE2N;UBE2V2	None	"TRAF6 is a signal transducer that activates IkappaB kinase (IKK) and Jun amino-terminal kinase (JNK) in response to pro-inflammatory mediators such as interleukin-1 (IL-1) and lipopolysaccharides (LPS). IKK activation by TRAF6 requires two intermediary factors, TRAF6-regulated IKK activator 1 (TRIKA1) and TRIKA2. TRIKA1 is a dimeric ubiquitin-conjugating enzyme complex composed of UBE2N and UBE2V1 or the functionally equivalent UBE2V2. This Ubiquitin-protein ligase complex, together with TRAF6, catalyses the formation of a Lys 63 (K63)-linked polyubiquitin chain that mediates IKK activation through a unique proteasome-independent mechanism."	None
"SMN complex, U7 snRNA specific"	P14678;P62304;P62306;P62308;P62318;P83369;Q969L4	6628;6635;6636;6637;6634;134353;84967	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	SNRPB;SNRPE;SNRPF;SNRPG;SNRPD3;LSM11;LSM10	None	The Lsm11 protein of the U7 snRNA specific SMN complex plays an important role in histone RNA 3' end processing.	Spinal muscular atrophy (SMA)
TAK1 complex	O43318;Q15750;Q9NYJ8	6885;10454;23118	protein phosphorylation;I-kappaB kinase/NF-kappaB signaling;JNK cascade	"modification by phosphorylation, dephosphorylation, autophosphorylation;NIK-I-kappaB/NF-kappaB cascade;JNK cascade"	MAP3K7;TAB1;TAB2	None	TAK1 complex stimulates IKK/NF-kappaB in the presence of UBC13-UEV1A complex and TRAF6.	None
MBD1-MCAF complex	Q6VMQ6;Q9UIS9	55729;4152	"DNA topological change;negative regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;organization of chromosome structure;nucleus	ATF7IP;MBD1	None	"MBD1 directly prevents transcription from methylated promoters in a histone deacetylation-independent manner, through interacting with MCAF. MBD1 competes with Sp1 for binding to MCAF. MBD1-MCAF complex blocks transcription through affecting Sp1 on methylated promoter regions."	None
SMAD3-SMAD4-FOXO3 complex	O43524;P84022;Q13485	2309;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	FOXO3;SMAD3;SMAD4	None	"Endogenous FoxO1, FoxO3, and FoxO4 bind to endogenous Smad2/3 and Smad4. Formation of these complexes was absolutely dependent on TGF-beta stimulation, as was the formation of a Smad2/3-Smad4 complex."	None
SMAD3-SMAD4-FOXO1 complex	P84022;Q12778;Q13485	4088;2308;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SMAD3;FOXO1;SMAD4	None	"Endogenous FoxO1, FoxO3, and FoxO4 bind to endogenous Smad2/3 and Smad4. Formation of these complexes was absolutely dependent on TGF-beta stimulation, as was the formation of a Smad2/3-Smad4 complex."	None
SMAD3-SMAD4-FOXO4 complex	P84022;P98177;Q13485	4088;4303;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SMAD3;FOXO4;SMAD4	None	"Endogenous FoxO1, FoxO3, and FoxO4 bind to endogenous Smad2/3 and Smad4. Formation of these complexes was absolutely dependent on TGF-beta stimulation, as was the formation of a Smad2/3-Smad4 complex."	None
MBD1-Suv39h1-HP1 complex	O43463;P45973;Q9UIS9	6839;23468;4152	"regulation of gene expression by genetic imprinting;negative regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;nucleus"	"DNA imprinting and other epigenetic effects;transcription repression;posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	SUV39H1;CBX5;MBD1	None	MBD1 tethers the Suv39h1-HP1 complex to methylated DNA regions. MBD1 interacts with Suv39h1-HP1 complex via MBD domain.	None
PRMT5 complex	O14744	10419	protein hydroxylation;protein methylation;cytoplasm	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);cytoplasm"	PRMT5	None	"PRMT5 (protein-arginine methyltransferase) formes distinct homo-oligomeric complexes, including a dimer and tetramer. Recombinant PRMT5 protein methylates myelin basic protein, histone, and the amino terminus of fibrillarin."	None
PRMT1 complex	Q99873	3276	protein hydroxylation;protein methylation;nucleus	"posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	PRMT1	None	"PRMT1 (protein-arginine methyltransferase) formes distinct homo-oligomeric complexes, including a dimer and tetramer."	None
TERF2-RAP1 complex	P12956;P13010;P49959;Q15554;Q92878;Q9BSI4;Q9NYB0	2547;7520;4361;7014;10111;26277;54386	DNA binding;cellular response to DNA damage stimulus;chromosome organization;nucleus	DNA binding;DNA damage response;organization of chromosome structure;nucleus	XRCC6;XRCC5;MRE11A;TERF2;RAD50;TINF2;TERF2IP	None	This complex is responsible for proper maintenance of telomere length and structure.	None
RAD50-MRE11-NBN-p200-p350 complex	O60934;P49959;Q92878	4683;4361;10111	DNA catabolic process;DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	NBN;MRE11A;RAD50	"Two other subunits of the complex were found in the analysis, which have not been further characterized: p350 and p200."	None	None
ITGA6-ITGB4-CD9 complex	P16144;P21926;P23229	3691;928;3655	movement of cell or subcellular component	cell motility	ITGB4;CD9;ITGA6	None	None	None
"Ubiquitin E3 ligase (CRY1, SKP1A, CUL1, FBXL3)"	P63208;Q13616;Q16526;Q9UKT7	6500;8454;1407;26224	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;ultradian rhythm;rhythmic process;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);rhythm (e.g. circadian, ultradian);nucleus"	SKP1;CUL1;CRY1;FBXL3	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Cry1 and Cry2, encode inhibitors of the Clock-Bmal1 complex that establish a negative-feedback loop. Cry1 and Cry2 proteins are ubiquitinated and degraded via the SCF(Fbxl3) ubiquitin ligase complex. This regulation by SCF(Fbxl3) is a prerequisite for the efficient and timely reactivation of Clock-Bmal1 and the consequent expression of Per1 and Per2, two regulators of the circadian clock that display tumor suppressor activity."	None
"Ubiquitin E3 ligase (CRY2, SKP1A, CUL1, FBXL3)"	P63208;Q13616;Q49AN0;Q9UKT7	6500;8454;1408;26224	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;ultradian rhythm;rhythmic process;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);rhythm (e.g. circadian, ultradian);nucleus"	SKP1;CUL1;CRY2;FBXL3	None	"Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Cry1 and Cry2, encode inhibitors of the Clock-Bmal1 complex that establish a negative-feedback loop. Cry1 and Cry2 proteins are ubiquitinated and degraded via the SCF(Fbxl3) ubiquitin ligase complex. This regulation by SCF(Fbxl3) is a prerequisite for the efficient and timely reactivation of Clock-Bmal1 and the consequent expression of Per1 and Per2, two regulators of the circadian clock that display tumor suppressor activity."	None
MDC1-H2AFX-TP53BP1 complex	P16104;Q12888;Q14676	3014;7158;9656	DNA repair;cell cycle checkpoint;DNA binding;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;DNA damage response;nucleus"	H2AFX;TP53BP1;MDC1	None	MDC1 forms complexes with phosporylated H2AFX.	None
MDC1-p53BP1-SMC1 complex	Q12888;Q14676;Q14683	7158;9656;8243	DNA repair;cell cycle checkpoint;DNA binding;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;nucleus"	TP53BP1;MDC1;SMC1A	None	Interaction of MDC1 with 53BP1 and SMC1 is unaffected by DNA damage.	None
RAD50-BRCA1 complex	P38398;Q92878	672;10111	DNA repair;nucleus	DNA repair;nucleus	BRCA1;RAD50	None	None	BRCA1 is involved in breast cancer.
BARD1-BRCA1-CSTF64 complex	P33240;P38398;Q99728	1478;672;580	RNA 3'-end processing;mRNA 3'-end processing;cellular response to DNA damage stimulus;nucleus	3'-end processing;DNA damage response;nucleus	CSTF2;BRCA1;BARD1	None	DNA damage increases formation of a CstF-BARD1-BRCA1 inhibitory complex. Complex formation represses polyadenylation of mRNA.	BRCA1 is involved in breast cancer.
BRCA1 A complex	P38398;Q6UWZ7;Q96RL1;Q99728	672;84142;51720;580	DNA repair;cell cycle checkpoint;response to radiation;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);electromagnetic waves stress response (e.g. UV, X-ray);nucleus"	BRCA1;FAM175A;UIMC1;BARD1	None	None	BRCA1 is involved in breast cancer.
BRCA1 C complex	P38398;Q96RL1;Q99708;Q99728	672;51720;5932;580	DNA recombination;cell cycle checkpoint;nucleus	"DNA recombination;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);nucleus"	BRCA1;UIMC1;RBBP8;BARD1	None	None	BRCA1 is involved in breast cancer.
BRCA1 B complex	O14867;P38398;Q99728	571;672;580	DNA recombination;nucleus	DNA recombination;nucleus	BACH1;BRCA1;BARD1	None	None	BRCA1 is involved in breast cancer.
ETS2-ERG complex	P11308;P15036	2078;2114	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	ERG;ETS2	None	The authors found that different domains of ETS2 make contacts with the Fos/Jun complex and with other members of the Ets family to form stable heterotrimeric ETS2/Fos/Jun and heterodimeric ETS2/ERG and ETS2/ETS1 complexes.	None
ETS2-ETS1 complex	P14921;P15036	2113;2114	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	ETS1;ETS2	None	The authors found that different domains of ETS2 make contacts with the Fos/Jun complex and with other members of the Ets family to form stable heterotrimeric ETS2/Fos/Jun and heterodimeric ETS2/ERG and ETS2/ETS1 complexes.	None
MCM4-MCM6-MCM7 complex	P33991;P33993;Q14566	4173;4176;4175	chromosome organization;DNA replication;ATP binding;nucleus	organization of chromosome structure;DNA synthesis and replication;ATP binding;nucleus	MCM4;MCM7;MCM6	None	This complex has DNA helicase activity.	None
MCM2-MCM4-MCM6-MCM7 complex	P33991;P33993;P49736;Q14566	4173;4176;4171;4175	chromosome organization;DNA replication;ATP binding;nucleus	organization of chromosome structure;DNA synthesis and replication;ATP binding;nucleus	MCM4;MCM7;MCM2;MCM6	None	This complex has DNA helicase activity.	None
PCNA-CHL12-RFC2-5 complex	P12004;P35249;P35250;P40937;P40938;Q8WVB6	5111;5984;5982;5985;5983;63922	DNA replication;nucleus	DNA synthesis and replication;nucleus	PCNA;RFC4;RFC2;RFC5;RFC3;CHTF18	None	CHL12-RFC2-5 functions as a novel clamp loader protein.	None
MMP-2-CLDN1 complex	O95832;P08253	9076;4313	metallopeptidase activity	None	CLDN1;MMP2	None	None	None
RFC complex	P35249;P35250;P35251;P40937;P40938	5984;5982;5981;5985;5983	DNA replication;DNA repair;cell cycle checkpoint;DNA binding;nucleus	"DNA synthesis and replication;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;nucleus"	RFC4;RFC2;RFC1;RFC5;RFC3	None	Assembly of RFC complex involves distinct subunit interations: RFC5 and RFC3 interact with the RFC4 subunit and RFC2 interacts with RFC5 and RFC4. RFC1 interacts primarily with RFC3 and RFC2. RFC complex functions as clamp loader. The complex is necessary for loading of PCNA onto dsDNA.	None
OCT4-SOX2 DNA-protein complex	P48431;Q01860	6657;5460	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;embryo development ending in birth or egg hatching;nucleus"	transcriptional control;DNA binding;early embryogenesis;nucleus	SOX2;POU5F1	None	"The authors analyzed the interaction of the two transcription factors Oct4 with Sox2 on the DNA enhancers of FGF4 (fibroblast growth factor 4) and UTF1 (undifferentiated transcription factor 1). The structural models revealed that the FGF4 and the UTF1  enhancers mediate the assembly of distinct POU/HMG-domain complexes, leading to different quaternary arrangements by swapping protein-protein interaction surfaces of Sox2."	None
OCT1-SOX2 DNA-protein complex	P14859;P48431	5451;6657	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;embryo development ending in birth or egg hatching;nucleus"	transcriptional control;DNA binding;early embryogenesis;nucleus	POU2F1;SOX2	None	"The authors analyzed the interaction of the two transcription factors Oct1 with Sox2 on the DNA enhancers of FGF4 (fibroblast growth factor 4) and UTF1 (undifferentiated transcription factor 1). The structural models revealed that the FGF4 and the UTF1  enhancers mediate the assembly of distinct POU/HMG-domain complexes, leading to different quaternary arrangements by swapping protein-protein interaction surfaces of Sox2."	None
PAX6-SOX2 DNA-protein complex	P26367;P48431	5080;6657	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;multicellular organism reproduction;eye development;nucleus"	transcriptional control;DNA binding;late embryogenesis ;eye;nucleus	PAX6;SOX2	None	"The authors analyzed the interaction of the two transcription factors Pax6 with Sox2 on the DNA enhancer of DC5. It was demonstrated that the same Sox2 interface (the C-terminal region of HMG) is required for heterodimer formation with Oct4 on FGF4 and with Pax6 on DC5, although these two Sox2 partners are members of different transcription factor families and, as such, both unrelated in sequence and structure."	None
CTF18-cohesion-RFC complex	P0CG13;P35249;P35250;P40937;P40938;Q8WVB6;Q9BVC3	54921;5984;5982;5985;5983;63922;79075	DNA replication;chromosome segregation;DNA binding;chromosome organization;nucleus	DNA synthesis and replication;chromosome segregation/division;DNA binding;organization of chromosome structure;nucleus	CHTF8;RFC4;RFC2;RFC5;RFC3;CHTF18;DSCC1	None	"CTF18-RFC complex interacts with PCNA homotrimer in the pressence of ATP and loads PCNA onto primed and gapped circular DNA, but not onto nicked or single-stranded circular DNA."	None
CTF8-DCC1 subcomplex	P0CG13;Q9BVC3	54921;79075	chromosome segregation;protein binding;chromosome organization;nucleus	chromosome segregation/division;protein binding;organization of chromosome structure;nucleus	CHTF8;DSCC1	None	None	None
CTF18-CTF8-DCC1 complex	P0CG13;Q8WVB6;Q9BVC3	54921;63922;79075	chromosome segregation;protein binding;chromosome organization;nucleus	chromosome segregation/division;protein binding;organization of chromosome structure;nucleus	CHTF8;CHTF18;DSCC1	None	None	None
9-1-1-APE1 complex	O60671;O60921;P27695;Q99638	5810;3364;328;5883	DNA catabolic process;RNA catabolic process;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA degradation;RNA degradation;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;APEX1;RAD9A	None	The 9-1-1 complex specifically stimulates the endonuclease activity of APEX1 for DNA repair.	None
9-1-1 complex	O60671;O60921;Q99638	5810;3364;5883	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	RAD1;HUS1;RAD9A	None	None	None
RAD17-RFC complex	O75943;P35249;P35250;P40937;P40938	5884;5984;5982;5985;5983	cell cycle checkpoint;DNA binding;ATP binding;cellular response to DNA damage stimulus;nucleus	"cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA binding;ATP binding;DNA damage response;nucleus"	RAD17;RFC4;RFC2;RFC5;RFC3	None	"The RSR complex works as a clamp loader, loading RHR onto DNA. RSR prefers DNA substrates posessing 5' recessed ends."	None
BRCA1-cABL complex	P00519;P38398	25;672	None	None	ABL1;BRCA1	None	BRCA1 controls c-Abl activity. Interaction occurs between th PXXP motif in the C-terminus of BRCA1 and the SH3 domain of c-Abl.	BRCA1 is involved in breast cancer.
RPAP1-RPB2-RPB3 complex	P19387;P30876;Q9BWH6	5432;5431;26015	"transcription, DNA-templated;nucleus"	TRANSCRIPTION;nucleus	POLR2C;POLR2B;RPAP1	None	None	None
BRCA1-SMAD3 complex	P38398;P84022	672;4088	"DNA repair;cell cycle;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;nucleus"	DNA repair;cell cycle;transcriptional control;TGF-beta-receptor signalling pathway;nucleus	BRCA1;SMAD3	None	Interaction is mediated by the MH1 domain of Smad3 and the C-terminal part of BRCA1.	BRCA1 is involved in breast cancer.
BRCA1-HDAC1-HDAC2 complex	P38398;Q13547;Q92769	672;3065;3066	DNA repair;protein deacetylation;nucleus	"DNA repair;modification by acetylation, deacetylation;nucleus"	BRCA1;HDAC1;HDAC2	None	"BRCA1 interacts with components of the histone deacetylase complex, and therefore may explain the involvement of BRCA1 in multiple processes such as transcription, DNA repair, and recombination. BRCA1 associates with HDAC1 and HDAC2 via the BRCT domain."	BRCA1 is involved in breast cancer.
BRCA1-BARD1-BACH1-DNA damage complex II	O14867;O60934;P38398;P49959;Q92547;Q92878;Q99708;Q99728	571;4683;672;4361;11073;10111;5932;580	DNA replication;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA synthesis and replication;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	BACH1;NBN;BRCA1;MRE11A;TOPBP1;RAD50;RBBP8;BARD1	None	This complex occurs after exposure to UV irradiation.	BRCA1 is involved in breast cancer.
ITGAV-ITGB3 complex	P05106;P06756	3690;3685	protein binding;cell migration;cell adhesion;cell growth	protein binding;cell migration;cell adhesion;cell growth / morphogenesis	ITGB3;ITGAV	None	Alpha(v)beta3 can differentially activate cell migration and intracellular signaling pathways in a ligand-specific manner (PMID:10835423).	None
BRCA1-BARD1-BACH1-DNA damage complex I	O14867;P38398;P40692;P52701;Q92547;Q99728	571;672;4292;2956;11073;580	DNA replication;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA synthesis and replication;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	BACH1;BRCA1;MLH1;MSH6;TOPBP1;BARD1	None	This complex occurs after exposure to UV irradiation. BRCA1-BARD1-BACH1 complex is required for post-damage interaction with TOPBP1.	BRCA1 is involved in breast cancer.
BRCA1-BARD1-BRCA2-DNA damage complex III	P38398;P51587;Q99728	672;675;580	DNA replication;DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA synthesis and replication;DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	BRCA1;BRCA2;BARD1	None	This complex occurs after exposure to UV irradiation.	BRCA1 is involved in breast cancer.
BRCA1-CtIP-CtBP complex	P38398;Q13363;Q99708	672;1487;5932	"DNA repair;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;nucleus"	DNA repair;transcriptional control;DNA damage response;nucleus	BRCA1;CTBP1;RBBP8	None	BRCA1 binds to CtBP through CtIP. Binding of BRCA1 to CtIP/CtBP is critical in mediating transcriptional regulation of p21 in response to DNA damage.	BRCA1 is involved in breast cancer.
BRCA1-VCP complex	P38398;P55072	672;7415	DNA repair;nucleus	DNA repair;nucleus	BRCA1;VCP	None	"VCP participates in the DNA damage-repair function as an ATP transporter, possibly facilitating the transcription-coupled repair."	BRCA1 is involved in breast cancer.
hSIR2-p53 complex	P04637;Q96EB6	7157;23411	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;cellular response to DNA damage stimulus;nucleus"	"transcriptional control;modification by acetylation, deacetylation;DNA damage response;nucleus"	TP53;SIRT1	None	The authors analyzed that hSir2 directly binds the human p53 protein in vivo and specifically deacetylates the K382 residue of p53.	None
"E3 ubiquitin ligase (BRCA1, BARD1) - UbcH5c complex"	P38398;P61077;Q99728	672;7323;580	protein ubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	BRCA1;UBE2D3;BARD1	None	UbcH5c binds to BRCA1 RING domain and not to the BARD1 RING.	BRCA1 is involved in breast cancer.
BRCA1-BARD1-UbcH7c complex	P38398;P68036;Q99728	672;7332;580	cellular response to DNA damage stimulus;nucleus	DNA damage response;nucleus	BRCA1;UBE2L3;BARD1	None	UbcH7c binds to BRCA1 RING domain and not to the BARD1 RING.	BRCA1 is involved in breast cancer.
BRCA1-RAD51 complex	P38398;Q06609	672;5888	DNA repair;DNA recombination;cell cycle checkpoint;nucleus	"DNA repair;DNA recombination;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);nucleus"	BRCA1;RAD51	None	BRCA1 and RAD51 mainly colocalize in S phase cells.	BRCA1 is involved in breast cancer.
BRCA1-RNA polymerase II complex	O15514;P13984;P18074;P19387;P19388;P19447;P20226;P24928;P29083;P29084;P30876;P32780;P35269;P36954;P38398;P52434;P52435;P53803;P61218;P62487;P62875;Q00403;Q13503;Q13888;Q13889;Q92759	5433;2963;2068;5432;5434;2071;6908;5430;2960;2961;5431;2965;2962;5438;672;5437;5439;5440;5435;5436;5441;2959;9412;2966;2967;2968	"transcription, DNA-templated;DNA binding;nucleus"	TRANSCRIPTION;DNA binding;nucleus	POLR2D;GTF2F2;ERCC2;POLR2C;POLR2E;ERCC3;TBP;POLR2A;GTF2E1;GTF2E2;POLR2B;GTF2H1;GTF2F1;POLR2I;BRCA1;POLR2H;POLR2J;POLR2K;POLR2F;POLR2G;POLR2L;GTF2B;MED21;GTF2H2;GTF2H3;GTF2H4	None	The Brca1 tumor supressor protein is associated with the transcription process.	BRCA1 is involved in breast cancer.
ITGB3-ITGAV-VTN complex	P04004;P05106;P06756	7448;3690;3685	cell migration	cell migration	VTN;ITGB3;ITGAV	None	"In beta(3)-LNCaP cells, alpha(v)beta(3) mediates cell migration and PI 3-kinase/AKT pathway activation on vitronectin, whereas adhesion to osteopontin does not support alpha(v)beta(3)-mediated cell migration and PI 3-kinase/AKT pathway activation."	None
RSmad complex	P51532;P84022;Q13485;Q15796;Q8NFD5;Q8TAQ2;Q92793;Q92922;Q9UPN9;Q9Y6Q9	6597;4088;4089;4087;57492;6601;1387;6599;51592;8202	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;TGF-beta-receptor signalling pathway;nucleus	SMARCA4;SMAD3;SMAD4;SMAD2;ARID1B;SMARCC2;CREBBP;SMARCC1;TRIM33;NCOA3	None	Affinity purification of proteins that selectively bind to activated RSmads.	None
TIF1gamma-SMAD2-SMAD3 complex	P84022;Q15796;Q9UPN9	4088;4087;51592	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;hemopoiesis;nucleus"	transcriptional control;TGF-beta-receptor signalling pathway;hemopoiesis;nucleus	SMAD3;SMAD2;TRIM33	None	Formation of complex is dependent on TGFbeta. TIF1gamma selectively binds receptor-posphorylated SMAD2 and SMAD3 in competition with SMAD4.	None
SRm160-SRm300 complex	Q8IYB3;Q9UQ35	10250;23524	RNA splicing;RNA binding;nuclear matrix	splicing;RNA binding;nuclear matrix	SRRM1;SRRM2	None	"The authors demonstrate that although SRm160/300 can promote splicing in the absence of U1 snRNP, under ""normal"" splicing reaction conditions containing endogenous levels of SR family proteins, SRm160/300 associates with pre-mRNA by a U1 snRNP-dependent pathway and its binding to pre-mRNA is further stabilized by U2 snRNP. SRm160/300 also associates preferentially with a subset of specific SR proteins comigrating with SRp40 and SRp75. The results indicate that SRm160/300 and SR family proteins have overlapping but nonreciprocal functions and that cooperative interactions between these factors is critical for the splicing of specific pre-mRNAs."	None
SMAD4-SMAD2-SMAD3 complex	P84022;Q13485;Q15796	4088;4089;4087	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;TGF-beta-receptor signalling pathway;nucleus	SMAD3;SMAD4;SMAD2	None	Formation of complex is dependent on TGFbeta. TIF1gamma selectively binds receptor-posphorylated SMAD2 and SMAD3 in competition with SMAD4.	None
Profilin 1 complex	P07737;P11142;P55072;P63261;Q00610;Q9BVA1	5216;3312;7415;71;1213;347733	protein complex assembly;endocytosis;actin cytoskeleton organization	assembly of protein complexes;endocytosis;actin cytoskeleton	PFN1;HSPA8;VCP;ACTG1;CLTC;TUBB2B	None	"In brain profilin I complex links the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains."	None
MEP50-PRMT5-ICLN complex	O14744;P54105;Q9BQA1	10419;1207;79084	"positive regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;prostate gland development;nucleus;steroid hormone mediated signaling pathway"	"transcription activation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;prostate gland;nucleus"	PRMT5;CLNS1A;WDR77	None	This complex enhances AR-driven transcription.	Overexpression of WDR77 (p44) correlates with prostate tumorigenesis.
ATRX-DAXX complex	P46100;Q9UER7	546;1616	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;organization of chromosome structure;nucleus	ATRX;DAXX	"Two other subunits of the complex were found in the analysis, which have not been further characterized: DAP50 and DAP60."	ATRX and DAXX colocalize in promyelocytic leukemia nuclear bodies. The level of this complex is significantly decreased in an ATRX patient cell line.	None
DAXX-Axin-p53-HIPK2 complex	O15169;P04637;Q9H2X6;Q9UER7	8312;7157;28996;1616	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein phosphorylation;response to radiation;apoptotic process;nucleus"	"transcriptional control;modification by phosphorylation, dephosphorylation, autophosphorylation;electromagnetic waves stress response (e.g. UV, X-ray);apoptosis (type I programmed cell death);nucleus"	AXIN1;TP53;HIPK2;DAXX	None	"Axin tethers DAXX to the tumor suppressor p53. UV induces colocalization of Axin, DAXX and HIPK2 in the nucleus."	None
ATRX-DAXX complex	P46100;Q9UER7	546;1616	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;organization of chromosome structure;nucleus	ATRX;DAXX	None	DAXX regulates ATRX activity by altering its cellular localization. DAXX targets ATRX to the promyelocytic leukemia protein nuclear bodies.	None
Axin-p53-HIPK2 complex	O15169;P04637;Q9H2X6	8312;7157;28996	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to radiation;apoptotic process;nucleus"	"transcriptional control;electromagnetic waves stress response (e.g. UV, X-ray);apoptosis (type I programmed cell death);nucleus"	AXIN1;TP53;HIPK2	None	"Axin stimulates the transcriptional activity of p53 selectively toward some of the p53 target genes, and induces p53-dependent cell death through facilitating HIPK2 phosphorylation of Ser(46)."	None
ITGAV-ITGB3-THBS1 complex	P05106;P06756;P07996	3690;3685;7057	protein binding	protein binding	ITGB3;ITGAV;THBS1	None	"The alpha(v)beta3 integrin on platelets, endothelial cells, and smooth muscle cells functions as an Arg-Gly-Asp (RGD)-dependent receptor for thrombospondin."	None
"ING4 complex (ING4, JADE2, KAT7, MEAF6)"	O95251;Q9HAF1;Q9NQC1;Q9UNL4	11143;64769;23338;51147	mitotic cell cycle;regulation of cell cycle;angiogenesis	mitotic cell cycle;mitotic cell cycle and cell cycle control;angiogenesis	KAT7;MEAF6;JADE2;ING4	None	ING4 associates with the HBO1 HAT required for normal progression through S phase and the majority of histone H4 acetylation in vivo. ING subunits are probably crucial for acetylation of chromatin substrates.	None
"ING4 complex (ING4, JADE3, KAT7, MEAF6)"	O95251;Q92613;Q9HAF1;Q9UNL4	11143;9767;64769;51147	mitotic cell cycle;regulation of cell cycle;angiogenesis	mitotic cell cycle;mitotic cell cycle and cell cycle control;angiogenesis	KAT7;JADE3;MEAF6;ING4	None	ING4 associates with the HBO1 HAT required for normal progression through S phase and the majority of histone H4 acetylation in vivo. ING subunits are probably crucial for acetylation of chromatin substrates.	None
ITGAV-ITGB3-NOV complex	P05106;P06756;P48745	3690;3685;4856	protein binding;cell adhesion	protein binding;cell adhesion	ITGB3;ITGAV;NOV	None	The C-terminal domain of NOV is involved in the interaction with integrins.	None
ITGA5-ITGB1-FN-1-NOV complex	P02751;P05556;P08648;P48745	2335;3688;3678;4856	protein binding;cell adhesion	protein binding;cell adhesion	FN1;ITGB1;ITGA5;NOV	None	The involvement of alpha5-beta1 in the process of endothelial cell adhesion to NOV was mediated by fibronectin.	None
ING2 complex	A0A024R3R1;O75446;P29374;Q09028;Q13547;Q16576;Q5PSV4;Q92769;Q96ST3;Q9H0E3;Q9H160;Q9H7L9;Q9HCU9	51742;8819;5926;5928;3065;5931;84312;3066;25942;79595;3622;64426;25855	DNA topological change;mitotic cell cycle;regulation of cell cycle;protein acetylation;protein deacetylation;apoptotic process;angiogenesis;chromosome organization;nucleus	"DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by acetylation, deacetylation;apoptosis (type I programmed cell death);angiogenesis;organization of chromosome structure;nucleus"	ARID4B;SAP30;ARID4A;RBBP4;HDAC1;RBBP7;BRMS1L;HDAC2;SIN3A;SAP130;ING2;SUDS3;BRMS1	None	ING2 is in an HDAC complex similar to ING1.ING subunits are probably crucial for acetylation of chromatin substrates.	None
Brg1-based SWI/SNF complex	O96019;Q12824;Q8TAQ2;Q92922	86;6598;6601;6599	"DNA topological change;mitotic cell cycle;regulation of cell cycle;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;transcriptional control	ACTL6A;SMARCB1;SMARCC2;SMARCC1	None	A subset of ING1-mSin3 HDAC complex was also shown to be associated with Brg1-based SWI/SNF chromatin remodelingcomplexes.	None
ITGA5-ITGB1-CAL4A3 complex	P05556;P08648;P39060	3688;3678;80781	negative regulation of protein kinase activity;kinase inhibitor activity	kinase inhibitior	ITGB1;ITGA5;COL18A1	None	"Endostatin binding to alpha5-beta1 integrin leads to the inhibition of focal adhesion kinase/c-Raf/MEK1/2/p38/ERK1 mitogen-activated protein kinase pathway, with no effect on phosphatidylinositol 3-kinase/Akt/mTOR/4E-BP1 and Cap-dependent translation."	None
NuA4/Tip60 HAT complex	O96019;Q92993;Q96L91;Q9H0E9;Q9H2F5;Q9NPF5;Q9NXR8;Q9UBU8;Q9Y265;Q9Y4A5	86;10524;57634;10902;80314;55929;54556;10933;8607;8295	chromosome organization;DNA repair;DNA topological change;mitotic cell cycle;regulation of cell cycle;DNA binding;apoptotic process;nucleus;histone acetylation	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;DNA binding;apoptosis (type I programmed cell death);nucleus	ACTL6A;KAT5;EP400;BRD8;EPC1;DMAP1;ING3;MORF4L1;RUVBL1;TRRAP	None	"The NuA4 histone acetyltransferase (HAT) multisubunit complex is responsible for acetylation of histone H4 and H2A N-terminal tails in yeast. The NuA4/Tip60 HAT complex is highly conserved in eukaryotes playing primary roles in transcription, cellular response to DNA damage, and cell cycle control. ING subunits are probably crucial for acetylation of chromatin substrates."	None
NuA4/Tip60 HAT complex	O95619;O96019;Q52LR7;Q92993;Q96L91;Q9H0E9;Q9H2F5;Q9HAF1;Q9NPF5;Q9NXR8;Q9UBU8;Q9Y230;Q9Y265;Q9Y4A5	8089;86;26122;10524;57634;10902;80314;64769;55929;54556;10933;10856;8607;8295	chromosome organization;DNA repair;DNA topological change;mitotic cell cycle;regulation of cell cycle;DNA binding;apoptotic process;nucleus;histone acetylation	organization of chromosome structure;DNA repair;DNA conformation modification (e.g. chromatin);mitotic cell cycle;mitotic cell cycle and cell cycle control;DNA binding;apoptosis (type I programmed cell death);nucleus	YEATS4;ACTL6A;EPC2;KAT5;EP400;BRD8;EPC1;MEAF6;DMAP1;ING3;MORF4L1;RUVBL2;RUVBL1;TRRAP	An actin component which was not exactly defined was also found.	"Human INGs could be divided in three groups, ING1/2, ING3, and ING4/5, suggesting three distinct types of association to protein complexes. The majority of ING3 is associated with the hNuA4/Tip60 HAT complex"	None
"ING5 complex (ING5, JADE1, KAT7, MEAF6)"	O95251;Q6IE81;Q8WYH8;Q9HAF1	11143;79960;84289;64769	mitotic cell cycle;regulation of cell cycle;apoptotic process	mitotic cell cycle;mitotic cell cycle and cell cycle control;apoptosis (type I programmed cell death)	KAT7;JADE1;ING5;MEAF6	None	"Members of the ING family of tumor suppressors regulatecell cycle progression, apoptosis, and DNA repair. HBO1-ING5 association is independent of MOZ/MORF and is responsible for the H4-specific HAT activity in purified ING5."	None
"ING5 (BRPF1, MOZ, MORF) complex"	P55201;Q8WYB5;Q8WYH8;Q92794;Q9HAF1	7862;23522;84289;7994;64769	mitotic cell cycle;regulation of cell cycle;apoptotic process	mitotic cell cycle;mitotic cell cycle and cell cycle control;apoptosis (type I programmed cell death)	BRPF1;KAT6B;ING5;KAT6A;MEAF6	None	ING5 HAT complexes interact with the MCM helicase and are essential for DNA replication to occur during S phase.ING subunits are probably crucial for acetylation of chromatin substrates. ING5 fractionates with two distinct complexes containing HBO1 or nucleosomal H3-specific MOZ/MORF HATs. Both MOZ/MORF-ING5 and HBO1-ING5 HAT complexes are important for DNA replication.	None
DSIF complex (DRB sensitivity-inducing factor complex)	O00267;P63272	6829;6827	"DNA-templated transcription, elongation;negative regulation of transcription, DNA-templated;nucleus;regulation of binding;protein binding"	transcription elongation;transcription repression;nucleus;regulation by binding / dissociation;protein binding	SUPT5H;SUPT4H1	None	"DSIF represses transcription in the presence of DRB (inhibitor of transcription elongation), thereby inducing DRB sensitivity. SPT5 forms a stable complex with SPT4 and interacts directly with the largest subunit of RNA-Polymerase II."	None
DSIF complex (DRB sensitivity-inducing factor complex)	O00267;P63272	6829;6827	"DNA-templated transcription, elongation;negative regulation of transcription, DNA-templated;regulation of binding;protein binding;nucleus"	transcription elongation;transcription repression;regulation by binding / dissociation;protein binding;nucleus	SUPT5H;SUPT4H1	None	"DSIF represses transcription in the presence of DRB (inhibitor of transcription elongation), thereby inducing DRB sensitivity."	None
"Serine-palmitoyltransferase (SPTLC1, SPTLC3) complex"	O15269;Q9NUV7	10558;55304	palmitoyltransferase complex;palmitoyltransferase activity;endoplasmic reticulum;sphingolipid biosynthetic process	endoplasmic reticulum	SPTLC1;SPTLC3	SPTLC3 overexpression increases SPT activity 2- to 3-fold. SPTLC3 can be considered as an isoform of SPTLC2.	Serine-palmitoyltransferase (SPT) catalyzes the rate-limiting step of the de novo synthesis of sphingolipids.	None
ITGA2b-ITGB3-CD9-GP1b-CD47 complex	P05106;P07359;P08514;P21926;Q08722	3690;2811;3674;928;961	cell adhesion;plasma membrane	cell adhesion;eukaryotic plasma membrane / membrane attached	ITGB3;GP1BA;ITGA2B;CD9;CD47	None	"The isolation of this complex was independent of platelet activation, although a twofold increase in the quantity of CD9 complex was seen after platelet activation by alpha-thrombin in the presence of CaCl2 compared with that present in EDTA."	None
P-TEFb-7SKRNA-HEXIM1 complex	O60563;O94992;P50750	904;10614;1025	"DNA-templated transcription, elongation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription elongation;transcriptional control;nucleus	CCNT1;HEXIM1;CDK9	None	7SK RNA is required for MAQ1 to associate with P-TEFb complex. P-TEFb is inactive when bound to MAQ1 and 7SK. The 7SK RNA/MAQ1 system appears to be a new kind of CDK regulator that may contribute to a feedback loop modulating the activity of RNAP II.	None
BRD4-P-TEFb complex	O60563;O60885;P50750	904;23476;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNT1;BRD4;CDK9	None	BRD4 interacts with p-TEFb through its bromodomain. Recruitment of P-TEFb to a promoter was dependent on Brd4 and was enhanced by an increase in chromatin acetylation.	None
BRD4-P-TEFb complex	O60563;O60885;P50750	904;23476;1025	"DNA-templated transcription, elongation;positive regulation of transcription, DNA-templated;nucleus;phosphorylation of RNA polymerase II C-terminal domain"	transcription elongation;transcription activation;nucleus	CCNT1;BRD4;CDK9	None	The data support the model that the Brd4-core P-TEFb (cyclinT1/Cdk9 heterodimer) binding is required to form the transcriptionally active P-TEFb.	None
P-TEFb-7SKRNA-HEXIM1 complex	O60563;O94992;P50750	904;10614;1025	"DNA-templated transcription, elongation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcription elongation;transcriptional control;nucleus	CCNT1;HEXIM1;CDK9	None	None	None
CD20-LCK-FYN-p75/80 complex	P06239;P06241;P11836	3932;2534;931	signaling	cellular signalling	LCK;FYN;MS4A1	"At the time of annotation, the identity of the additional member p75/80 of the protein complex was not known."	Lck accounted for most of the PTK activity in the CD20 complex.	None
"Ubiquitin E3 ligase (FBXW11, SKP1, CUL1)"	P63208;Q13616;Q9UKB1	6500;8454;23291	ubiquitin-dependent protein catabolic process;protein ubiquitination;protein phosphorylation;mitotic M phase	"proteasomal degradation (ubiquitin/proteasomal pathway);modification by ubiquitination, deubiquitination;modification by phosphorylation, dephosphorylation, autophosphorylation"	SKP1;CUL1;FBXW11	None	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Human somatic Wee1 (Wee1A) is down-regulated both by protein phosphorylation and degradation. The beta-transducin repeat-containing protein 1/2 (beta-TrCP1/2) F-box protein-containing SKP1/Cul1/F-box protein (SCF) complex (SCF(beta-TrCP1/2)) as an E3 ubiquitin ligase for Wee1A ubiquitination has been identified.	None
"Ubiquitin E3 ligase (BTRC, CUL1, RBX1, SKP1)"	P62877;P63208;Q13616;Q9Y297	9978;6500;8454;8945	protein ubiquitination;protein phosphorylation;ubiquitin-dependent protein catabolic process;mitotic M phase	"modification by ubiquitination, deubiquitination;modification by phosphorylation, dephosphorylation, autophosphorylation;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;SKP1;CUL1;BTRC	Hemagglutinin (HA-)tagged F-box proteins were also found in this study (not further specified).	Ubiquitin E3 ligases covalently attach ubiquitin to a lysine residue on a target protein. Polyubiquitination marks proteins for degradation by the proteasome. Human somatic Wee1 (Wee1A) is down-regulated both by protein phosphorylation and degradation. The beta-transducin repeat-containing protein 1/2 (beta-TrCP1/2) F-box protein-containing SKP1/Cul1/F-box protein (SCF) complex (SCF(beta-TrCP1/2)) as an E3 ubiquitin ligase for Wee1A ubiquitination has been identified.	None
ITGA5-ITGB3-COL6A3 complex	P05106;P08648;P12111	3690;3678;1293	protein binding;cell adhesion;plasma membrane;extracellular matrix	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached;extracellular matrix component	ITGB3;ITGA5;COL6A3	None	None	None
"Respiratory chain complex I (early intermediate NDUFAF1 assembly), mitochondrial"	O75251;O75489;O95139;P03886;P56556;Q16795;Q9Y375	374291;4722;4712;4535;4700;4704;51103	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS7;NDUFS3;NDUFB6;MT-ND1;NDUFA6;NDUFA9;NDUFAF1	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.NDUFAF1 is a crucial component in the early assembly of complex I but not of the mature holoenzyme.	"Complex I is involved e.g. in mitochondrial diseases, cardioencephalomyopathy (gene CIA30), or deficiency in fibroblasts."
ITGAV-ITGB1-SPP1 complex	P05556;P06756;P10451	3688;3685;6696	protein binding;cell adhesion;plasma membrane	protein binding;cell adhesion;eukaryotic plasma membrane / membrane attached	ITGB1;ITGAV;SPP1	None	None	None
"Respiratory chain complex I (incomplete intermediate ND1, ND2, ND3, CIA30 assembly), mitochondrial"	P03886;P03891;P03897;Q9Y375	4535;4536;4537;51103	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	MT-ND1;MT-ND2;MT-ND3;NDUFAF1	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
RBPJ-NOTCH1-MAML1 complex	P46531;Q06330;Q92585	4851;3516;9794	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;nucleus	NOTCH1;RBPJ;MAML1	None	"Complex formation is required for neoplastic transformation by Notch. MAML1 promotes association between NotchIC (intracellular domain of Notch) and RBPSUH (CSL). NotchIC binding to CSL displaces corepressors from CSL, leading to the binding of the transcriptional coactivator MAML1 to the complex."	Notch1 is involved in human cancer.
"Gamma-secretase complex (APH1A, PSEN1, PSENEN, NCSTN)"	P49768;Q92542;Q96BI3;Q9NZ42	5663;23385;51107;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN1;NCSTN;APH1A;PSENEN	None	"Proteolytic cleavage within the hydrophobic transmembrane domains of Notch and APP is intimately associated with a multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenillin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	Gamma-secretase is involved in Alzheimer's disease. In combination with Notch signaling pathway gamma secretase complex is also involved in lung cancer (PMID:17804716).
BCR-ABL (p185 fusion protein)-GRB2 complex	P62993;Q13745	2885;None	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	GRB2;N/A	None	It was shown that Grb2 binds to the Tyr177 autophosphorylation site on Bcr-Abl.	Chimeric bcr-abl oncogene is involved in Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL).
BCR-ABL (p210 fusion protein)-GRB2-SOS1 complex	A1Z199;P62993;Q07889	None;2885;6654	signaling;G-protein coupled receptor signaling pathway	cellular signalling;G-protein coupled receptor signalling pathway	BCR/ABL fu;GRB2;SOS1	None	It was shown that Grb2 binds to the Tyr177 autophosphorylation site on Bcr-Abl.	Chimeric bcr-abl oncogene is involved in Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL).
SHC-GRB2 complex	P29353;P62993	6464;2885	signaling	cellular signalling	SHC1;GRB2	None	"Bcr-Abl proteins induce the formation of a complex between tyrosine phosphorylated Shc and Grb2. Co-precipitation analysed in R1-p185, R1-p210 and in Ph(+) leucemic cell lines. No co-precipitation seen in parental R1 cells."	Chimeric bcr-abl oncogene is involved in Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (Ph+ ALL).
ITGA2b-ITGB3-CD47-FAK complex	P05106;P08514;Q05397;Q08722	3690;3674;5747;961	protein binding;cell adhesion	protein binding;cell adhesion	ITGB3;ITGA2B;PTK2;CD47	None	Activation of platelets with the agonist peptide 4N1K results in the association of FAK with the IAP-alpha-IIb-beta3 complex.	None
RBPJ-NOTCH1-MAML1 complex	P46531;Q06330;Q92585	4851;3516;9794	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;nucleus	NOTCH1;RBPJ;MAML1	None	"Complex formation is required for neoplastic transformation by Notch. MAML1 promotes association between NotchIC (intracellular domain of Notch) and RBPSUH (CSL). NotchIC binding to CSL displaces corepressors from CSL, leading to the binding of the transcriptional coactivator MAML1 to the complex."	Notch1 is involved in human cancer.
"Respiratory chain complex I (intermediate I/200kD and III/250kD), mitochondrial"	O75306;O75489;Q16795	4720;4722;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS2;NDUFS3;NDUFA9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.Intermediate I and III show the same components (therefore annotated as one entry only) but different molecular weights.	None
"Respiratory chain complex I (intermediate IV/310kD), mitochondrial"	O75306;O75489;P03886;Q16795	4720;4722;4535;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS2;NDUFS3;MT-ND1;NDUFA9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
"Respiratory chain complex I (intermediate V/380kD and VI/480kD), mitochondrial"	O43678;O75306;O75489;P03886;Q16795	4695;4720;4722;4535;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFA2;NDUFS2;NDUFS3;MT-ND1;NDUFA9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.Intermediate V and VI show the same components (therefore annotated as one entry only) but different molecular weights.	None
"Respiratory chain complex I (intermediate VII/650kD), mitochondrial"	O43181;O43678;O43920;O75251;O75306;O75489;P03886;P19404;P56556;Q16795	4724;4695;4725;374291;4720;4722;4535;4729;4700;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS4;NDUFA2;NDUFS5;NDUFS7;NDUFS2;NDUFS3;MT-ND1;NDUFV2;NDUFA6;NDUFA9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
"Respiratory chain complex I (intermediate), mitochondrial"	O43181;O43678;O43920;O75251;O75306;O75489;O95139;P03886;P19404;P56556;Q16795	4724;4695;4725;374291;4720;4722;4712;4535;4729;4700;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS4;NDUFA2;NDUFS5;NDUFS7;NDUFS2;NDUFS3;NDUFB6;MT-ND1;NDUFV2;NDUFA6;NDUFA9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
"Respiratory chain complex I (intermediate II/230kD), mitochondrial"	O43181;O75251;P19404	4724;374291;4729	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS4;NDUFS7;NDUFV2	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
RBP-Jkappa-Notch1 complex	P46531;Q06330	4851;3516	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;nucleus	NOTCH1;RBPJ	None	None	None
RBP-Jkappa-SHARP complex	Q06330;Q96T58	3516;23013	"negative regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription repression;DNA binding;Notch-receptor signalling pathway;nucleus	RBPJ;SPEN	None	None	None
PLC-gamma-2-Syk-LAT-FcR-gamma complex	O43561;P12314;P16885;P43405	27040;2209;5336;6850	transmembrane receptor protein tyrosine kinase signaling pathway;blood coagulation;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;blood coagulation	LAT;FCGR1A;PLCG2;SYK	None	Analyses done with different GST-PLC-gamma-2 fusion proteins from resting and CRP (collagen-related peptide) stimulated platelets.	None
PLC-gamma-2-Lyn-FcR-gamma complex	P07948;P12314;P16885	4067;2209;5336	transmembrane receptor protein tyrosine kinase signaling pathway;blood coagulation;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;blood coagulation	LYN;FCGR1A;PLCG2	None	Analyses done with different GST-PLC-gamma-2 fusion proteins from resting and CRP (collagen-related peptide) stimulated platelets. PLC-gamma-2 associates in vivo with Lyn and FcR gamma chain. The identity of Lyn was confirmed by sequential immunoprecipitation after the kinase assay.	None
SMRT-SKIP-CBF1 complex	Q06330;Q13573;Q9Y618	3516;22938;9612	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;intracellular protein transport;protein targeting;protein transport;Notch signaling pathway;nucleus"	"transcriptional control;protein targeting, sorting and translocation;protein transport;Notch-receptor signalling pathway;nucleus"	RBPJ;SNW1;NCOR2	None	CIR seems to tether SKIP to SMRT.	None
PLC-gamma-2-SLP-76 complex	P16885;Q13094	5336;3937	transmembrane receptor protein tyrosine kinase signaling pathway;blood coagulation;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;blood coagulation	PLCG2;LCP2	None	Analyses done with  GST-PLC-gamma-2SH2(C) fusion protein from resting and CRP (collagen-related peptide) stimulated platelets. PLC-gamma-2 associates directly with SLP-76 and LAT.	None
PLC-gamma-2-LAT complex	O43561;P16885	27040;5336	transmembrane receptor protein tyrosine kinase signaling pathway;blood coagulation;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;blood coagulation	LAT;PLCG2	None	Analyses done with  GST-PLC-gamma-2SH2(C) fusion protein from resting and CRP (collagen-related peptide) stimulated platelets. PLC-gamma-2 associates directly with SLP-76 and LAT.	None
Respiratory chain complex I (beta subunit) mitochondrial	O00483;O14561;O43674;O43676;O75438;O95139;O95168;O95169;O95178;O95298;O96000;P03905;P03915;P17568;Q9NX14;Q9Y6M9	4697;4706;4711;4709;4707;4712;4710;4714;4708;4718;4716;4538;4540;4713;54539;4715	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFA4;NDUFAB1;NDUFB5;NDUFB3;NDUFB1;NDUFB6;NDUFB4;NDUFB8;NDUFB2;NDUFC2;NDUFB10;MT-ND4;MT-ND5;NDUFB7;NDUFB11;NDUFB9	The authors assume an additional component (homolog to the bovine 10.6K protein).	"Complex I couples the transfer of two electrons from NADH to ubiquinone to the translocation of four protons across the mitochondrial inner membrane.Complex I  is an L-shaped molecule with one arm embedded in the mitochondrial inner membane and one arm protruding into the matrix, the peripheral arm.The assembly of complex I is a semi-sequential process in which different preassembled subcomplexes are joined to form the holoenzyme."	None
GRB2-SOS1 complex	P62993;Q07889	2885;6654	transmembrane receptor protein tyrosine kinase signaling pathway;immune response	transmembrane receptor protein tyrosine kinase signalling pathways;immune response	GRB2;SOS1	None	"In literature it has been shown that Grb2 binds to the guanine nucleotide exchange factor Sos, leading to activation of Ras."	None
Ku antigen-YY1-alphaMyHC promoter complex	P12956;P13010;P25490	2547;7520;7528	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	XRCC6;XRCC5;YY1	None	Ku complex binds to the human alphaMyHC promoter and represses alphaMyHC expression. Ku70 and YY1 protein levels are increased in patients with heart failure.	Human heart failure
Respiratory chain complex I (gamma subunit) mitochondrial	O15239;O43677;O43920;O95167;O95299;P03886;P03891;P03897;P03901;P03923;P51970;P56556;Q16795	4694;4717;4725;4696;4705;4535;4536;4537;4539;4541;4702;4700;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFA1;NDUFC1;NDUFS5;NDUFA3;NDUFA10;MT-ND1;MT-ND2;MT-ND3;MT-ND4L;MT-ND6;NDUFA8;NDUFA6;NDUFA9	None	"Complex I couples the transfer of two electrons from NADH to ubiquinone to the translocation of four protons across the mitochondrial inner membrane.Complex I  is an L-shaped molecule with one arm embedded in the mitochondrial inner membane and one arm protruding into the matrix, the peripheral arm.The assembly of complex I is a semi-sequential process in which different preassembled subcomplexes are joined to form the holoenzyme."	None
Respiratory chain complex I (lambda subunit) mitochondrial	O00217;O43181;O43678;O75251;O75306;O75380;O75489;O95182;P19404;P28331;P49821;P56181;Q16718;Q86Y39;Q9P0J0;Q9UI09	4728;4724;4695;374291;4720;4726;4722;4701;4729;4719;4723;4731;4698;126328;51079;55967	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS8;NDUFS4;NDUFA2;NDUFS7;NDUFS2;NDUFS6;NDUFS3;NDUFA7;NDUFV2;NDUFS1;NDUFV1;NDUFV3;NDUFA5;NDUFA11;NDUFA13;NDUFA12	None	"Complex I couples the transfer of two electrons from NADH to ubiquinone to the translocation of four protons across the mitochondrial inner membrane.Complex I  is an L-shaped molecule with one arm embedded in the mitochondrial inner membane and one arm protruding into the matrix, the peripheral arm.The assembly of complex I is a semi-sequential process in which different preassembled subcomplexes are joined to form the holoenzyme."	None
SHARP-CtBP complex	P56545;Q13363;Q96T58	1488;1487;23013	"negative regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription repression;DNA binding;Notch-receptor signalling pathway;nucleus	CTBP2;CTBP1;SPEN	None	CtBP augments SHARP-mediated repression.	None
"LAT-PLC-gamma-1-p85-GRB2-SOS signaling complex, C305 activated"	O43561;P19174;P27986;P62993;Q07889	27040;5335;5295;2885;6654	transmembrane receptor protein tyrosine kinase signaling pathway;response to stimulus;phosphatidylinositol-mediated signaling	transmembrane receptor protein tyrosine kinase signalling pathways;animal specific systemic sensing and response	LAT;PLCG1;PIK3R1;GRB2;SOS1	None	"The authors show that upon tyrosine phosphorylation, LAT binds Grb2, PLC-gamma1, the p85 subunit of PI3K, and other critical signaling molecules. They provide evidence that LAT plays an important role in linking the TCR to cellular activation."	None
SHARP-CtBP1-CtIP complex	Q13363;Q96T58;Q99708	1487;23013;5932	"negative regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription repression;DNA binding;Notch-receptor signalling pathway;nucleus	CTBP1;SPEN;RBBP8	None	CtIP and CtBP augment SHARP-mediated repression.	None
SHARP-CtIP-RBP-Jkappa complex	Q06330;Q96T58;Q99708	3516;23013;5932	"negative regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription repression;DNA binding;Notch-receptor signalling pathway;nucleus	RBPJ;SPEN;RBBP8	None	The ternary complex is formed only when both SHARP and CtIP are expressed.	None
SHARP-CtBP1-CtIP-RBP-Jkappa corepressor complex	Q06330;Q13363;Q96T58;Q99708	3516;1487;23013;5932	"negative regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription repression;DNA binding;Notch-receptor signalling pathway;nucleus	RBPJ;CTBP1;SPEN;RBBP8	None	The corepressor complex containing CtIP/CtBP probably facilitates RBP-Jkappa/SHARP-mediated repression of Notch target genes.	None
"Ecsit complex (ECSIT, MT-CO2, GAPDH, TRAF6, NDUFAF1)"	P00403;P04406;Q9BQ95;Q9Y375;Q9Y4K3	4513;2597;51295;51103;7189	protein complex assembly;mitochondrion	assembly of protein complexes;mitochondrion	MT-CO2;GAPDH;ECSIT;NDUFAF1;TRAF6	None	"Ecsit is a cytosolic adaptor protein essential for inflammatory response and embryonic development via the Toll-like and BMP (bone morphogenetic protein) signal transduction pathways, respectively. Here, a mitochondrial function for Ecsit (an evolutionary conserved signaling intermediate in Toll pathways) in the assembly of mitochondrial complex I (NADH:ubiquinone oxidoreductase) has also been demonstrated. Ecsit isoform 1 copurifies with tandem affinity-purified NDUFAF1."	None
PTF1-bHLH complex	Q7RTS3;Q99081	256297;6938	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;pancreas development;nucleus"	transcriptional control;DNA binding;pancreas;nucleus	PTF1A;TCF12	None	"PTF1, containing P48 and a form of HEB, can bind to and mediate the acinar activity of the A element of the ELA1 gene enhancer."	None
"Ecsit complex (ECSIT, NDUFS3, TOM20)"	O75489;Q15388;Q9BQ95	4722;9804;51295	protein complex assembly;mitochondrion	assembly of protein complexes;mitochondrion	NDUFS3;TOMM20;ECSIT	None	"Ecsit is a cytosolic adaptor protein essential for inflammatory response and embryonic development via the Toll-like and BMP (bone morphogenetic protein) signal transduction pathways, respectively. Here, a mitochondrial function for Ecsit (an evolutionary conserved signaling intermediate in Toll pathways) in the assembly of mitochondrial complex I (NADH:ubiquinone oxidoreductase) has also been demonstrated. Ecsit isoform 1 copurifies with tandem affinity-purified NDUFAF1."	None
"Ecsit complex (ECSIT, MT-CO2, NDUFA1, MT-ND1, TRAF6, NDUFAF1)"	O15239;P00403;P03886;Q9BQ95;Q9Y375;Q9Y4K3	4694;4513;4535;51295;51103;7189	protein complex assembly;mitochondrion	assembly of protein complexes;mitochondrion	NDUFA1;MT-CO2;MT-ND1;ECSIT;NDUFAF1;TRAF6	None	"Ecsit is a cytosolic adaptor protein essential for inflammatory response and embryonic development via the Toll-like and BMP (bone morphogenetic protein) signal transduction pathways, respectively. Here, a mitochondrial function for Ecsit (an evolutionary conserved signaling intermediate in Toll pathways) in the assembly of mitochondrial complex I (NADH:ubiquinone oxidoreductase) has also been demonstrated. Ecsit isoform 1 copurifies with tandem affinity-purified NDUFAF1."	None
"Ecsit complex (ECSIT, NDUFS3, NDUFAF1)"	O75489;Q9BQ95;Q9Y375	4722;51295;51103	protein complex assembly;mitochondrion	assembly of protein complexes;mitochondrion	NDUFS3;ECSIT;NDUFAF1	None	"Ecsit is a cytosolic adaptor protein essential for inflammatory response and embryonic development via the Toll-like and BMP (bone morphogenetic protein) signal transduction pathways, respectively. Here, a mitochondrial function for Ecsit (an evolutionary conserved signaling intermediate in Toll pathways) in the assembly of mitochondrial complex I (NADH:ubiquinone oxidoreductase) has also been demonstrated. Ecsit isoform 1 copurifies with tandem affinity-purified NDUFAF1."	None
"Respiratory chain complex I (incomplete NDUFAF1 assembly), mitochondrial"	P03886;Q9Y375	4535;51103	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	MT-ND1;NDUFAF1	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.NDUFAF1 is a crucial component in the early assembly/stability of complex I.	None
Notch1-p56lck-PI3K complex	P06239;P27986;P46531	3932;5295;4851	"positive regulation of transcription, DNA-templated;Notch signaling pathway;negative regulation of apoptotic process;T cell differentiation"	transcription activation;Notch-receptor signalling pathway;anti-apoptosis;T-cell	LCK;PIK3R1;NOTCH1	None	"Anti-apoptotic function may result from elevated expression of anti-apoptotic genes like IAP-2, Bcl-xl or FLIP."	None
RBP-Jkappa-RING1-KyoT2 complex	Q06330;Q06587;Q13642	3516;6015;2273	"negative regulation of transcription, DNA-templated;DNA binding;protein binding;Notch signaling pathway;nucleus"	transcription repression;DNA binding;protein binding;Notch-receptor signalling pathway;nucleus	RBPJ;RING1;FHL1	None	Overexpression of RING1 And KyoT2 inhibits transactivation of RBP-Jkappa by Notch.	None
YY1-Notch1-RBP-Jkappa complex	P25490;P46531;Q06330	7528;4851;3516	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;nucleus	YY1;NOTCH1;RBPJ	None	YY1 indirectly binds to CBF1-response element via association with the intracellular domain of Notch1 (N1IC). N1IC interacts directly with CBF1(RBP-Jkappa).	None
YY1-Notch1 complex	P25490;P46531	7528;4851	DNA binding;Notch signaling pathway;nucleus	DNA binding;Notch-receptor signalling pathway;nucleus	YY1;NOTCH1	None	Transcription factor Ying Yang 1 (YY1) is associated with exogenous N1IC in human K562 erythroleukemic cells. The ankyrin (ANK) domain of N1IC and zinc finger domains of YY1 are essential for the association of N1IC and YY1.	None
"Respiratory chain complex I (incomplete intermediate), mitochondrial"	O43181;O75251;O75306;O75380;O95169;O95299;P19404;P28331;P49821;P56181;Q16795	4724;374291;4720;4726;4714;4705;4729;4719;4723;4731;4704	protein complex assembly;hydrogen transport;respiratory electron transport chain;mitochondrial inner membrane;oxidative phosphorylation;aerobic respiration	assembly of protein complexes;electron transport;regulation of electron transport and membrane-associated energy conservation;mitochondrial inner membrane;aerobic respiration	NDUFS4;NDUFS7;NDUFS2;NDUFS6;NDUFB8;NDUFA10;NDUFV2;NDUFS1;NDUFV1;NDUFV3;NDUFA9	None	Complex I is the first multiprotein complex of the OXPHOS system and participates in the formation of a proton gradient across the inner mitochondrial membrane coupled to transfer of electrons from NADH to ubiquinone.	None
"LCK-SLP76-PLC-gamma-1-LAT complex, pervanadate-activated"	O43561;P06239;P19174;Q13094	27040;3932;5335;3937	transmembrane receptor protein tyrosine kinase signaling pathway;response to stimulus	transmembrane receptor protein tyrosine kinase signalling pathways;animal specific systemic sensing and response	LAT;LCK;PLCG1;LCP2	None	"The authors show that in pervanadate-treated Jurkat cells, but not in J.CaM1.6 cells, three tyrosine-phosphorylated proteins with molecular weights about 59, 76 and 150 Kd, corresponding to Lck, SLP76, PLC-gamma-1 were co-precipitated with LAT."	None
"PLC-gamma-1-LAT-c-CBL complex, OKT3 stimulated"	O43561;P19174;P22681	27040;5335;867	transmembrane receptor protein tyrosine kinase signaling pathway;response to stimulus	transmembrane receptor protein tyrosine kinase signalling pathways;animal specific systemic sensing and response	LAT;PLCG1;CBL	None	"The authors show that  upon OKT3 stimulation, an extensive phosphorylation of LAT was seen in J2.LAT cells, but the phosphorylation of LAT F171F191 was barely detectable."	None
"LAT-GRB2 complex, Fyn-mLck(KA) or Syk kinase activated"	O43561;P62993	27040;2885	transmembrane receptor protein tyrosine kinase signaling pathway;response to stimulus	transmembrane receptor protein tyrosine kinase signalling pathways;animal specific systemic sensing and response	LAT;GRB2	None	"The authors show that in the absence of a kinase, the association of LAT and Grb2 was not detected. Grb2 was co-precipitated with LAT, but not with LATF171F191, in the presence of Fyn, mLck(KA) or Syk kinases."	None
SMAD1-CBP complex	Q15797;Q92793	4086;1387	"DNA topological change;positive regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;transforming growth factor beta receptor signaling pathway;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription activation;modification by acetylation, deacetylation;TGF-beta-receptor signalling pathway;organization of chromosome structure;nucleus"	SMAD1;CREBBP	None	SMAD1 stimulates transcription cooperatively with CBP.	None
SMAD1-OAZ-HsN3 complex	P28070;P54368;Q15797	5692;4946;4086	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;proteasomal degradation (ubiquitin/proteasomal pathway);DNA binding;TGF-beta-receptor signalling pathway;nucleus	PSMB4;OAZ1;SMAD1	None	"The interaction of the subunits is enhanced upon BMP type I receptor activation and occur prior to the incorporation of HsN3 into the mature 20S proteasome. Furthermore, BMPs trigger the translocation of the complex to the nucleus."	None
"SLP-76-PLC-gamma-1-ITK complex, alpha-TCR stimulated"	P19174;Q08881;Q13094	5335;3702;3937	signaling;phosphatidylinositol-mediated signaling	cellular signalling	PLCG1;ITK;LCP2	None	The authors speculate that SLP-76 may activate PLC-gamma-1 by regulating the ITK-mediated phosphorylation of PLC-gamma-1 at Tyr783.	None
"SLP-76-PLC-gamma-1-VAV complex, alpha-TCR stimulated"	P15498;P19174;Q13094	7409;5335;3937	signaling;phosphatidylinositol-mediated signaling	cellular signalling	VAV1;PLCG1;LCP2	None	"SLP-76 inducibly associated with both Vav and catalytically active ITK, which efficiently phosphorylated a PLC-gamma1 fragment at Tyr783 in vitro."	None
CRK-BCAR1-DOCK1 complex	P46108;P56945;Q14185	1398;9564;1793	integrin-mediated signaling pathway;phagocytosis;regulation of programmed cell death	"integrin receptor signalling pathway;phagocyte response (e.g. macrophages, dendritic cells, granulocytes);regulation of apoptosis"	CRK;BCAR1;DOCK1	None	Alpha(v)beta5 integrin binds to the apoptotic cell for recruitment of this complex to the membrane.	None
"ITK-SLP-76 complex, anti-TCR stimulated"	Q08881;Q13094	3702;3937	signaling;response to stimulus;phosphatidylinositol-mediated signaling	cellular signalling;animal specific systemic sensing and response	ITK;LCP2	None	The authors show that catalytically active ITK is found primarily in complex with SLP-76. Further they demonstrate that a continued interaction with SLP-76 is required to maintain ITK in an active state.	None
NuMA-LGN-G-alpha-i-1 complex	P63096;P81274;Q14980	2770;29899;4926	mitotic cell cycle;regulation of cell cycle;spindle assembly;centrosome cycle	mitotic cell cycle;mitotic cell cycle and cell cycle control;spindle pole body/centrosome and microtubule cycle	GNAI1;GPSM2;NUMA1	None	"The authors propose that the trimeric NuMA-LGN-G-alpha complex regulates the interaction of aster MTs with the cell cortex. They analyzed with a FRET biosensor that LGN behaves as a conformational switch: in its closed state, the N and C termini interact, but NuMA or G-alpha-i can disrupt this association, allowing LGN to interact simultaneously with both proteins, resulting in their cortical localization."	None
Axin-SMAD3 complex	O15169;P84022	8312;4088	transforming growth factor beta receptor signaling pathway;cytoplasm	TGF-beta-receptor signalling pathway;cytoplasm	AXIN1;SMAD3	None	"Phosphorylation of SMAD3 by T(beta)R-I is faciliated in the presence of Axin. In the absence of ligand stimulation, Axin was colocalized with Smad3 in the cytoplasm in vivo. Upon receptor activation, Smad3 was strongly phosphorylated by TGF-beta type I receptor (TbetaR-I) in the presence of Axin, and dissociated from TbetaR-I and Axin."	None
mTORC2 complex	P42345;Q6R327;Q9BVC4	2475;253260;64223	cell morphogenesis;cell growth;actin cytoskeleton organization	cell growth / morphogenesis;actin cytoskeleton	MTOR;RICTOR;MLST8	None	mTORC1 and mTORC2 constitute a primordial signalling network conserved in eukaryotic evolution to control the fundamental process of cell growth.	None
mTORC1 complex	P42345;Q8N122;Q9BVC4	2475;57521;64223	cell morphogenesis;cell growth;regulation of protein serine/threonine kinase activity	cell growth / morphogenesis	MTOR;RPTOR;MLST8	None	mTORC1 and mTORC2 constitute a primordial signalling network conserved in eukaryotic evolution to control the fundamental process of cell growth.	None
ITGA9-ITGB1-VEGFC complex	P05556;P49767;Q13797	3688;7424;3680	cell migration;cell adhesion;cell differentiation	cell migration;cell adhesion;cell differentiation	ITGB1;VEGFC;ITGA9	None	Alpha9-beta1 directly binds to VEGF-C and -D and contributes to lymphangiogenesis.	None
ITGA9-ITGB1-VEGFA complex	P05556;P15692;Q13797	3688;7422;3680	angiogenesis	angiogenesis	ITGB1;VEGFA;ITGA9	None	Alpha9-beta1 integrin binds the VEGF121 isoform of VEGF-A.	None
SMAD3-E2F4/5-p107-DP1 complex	P28749;P84022;Q14186;Q15329;Q16254	5933;4088;7027;1875;1874	transforming growth factor beta receptor signaling pathway;cytoplasm	TGF-beta-receptor signalling pathway;cytoplasm	RBL1;SMAD3;TFDP1;E2F5;E2F4	None	"This complex preexists in the cytoplasm. In response to TGF-beta, this complex moves to the nucleus and associates with SMAD4."	None
"mTOR complex (MTOR, RAPTOR)"	P42345;Q8N122	2475;57521	cell morphogenesis;cell growth	cell growth / morphogenesis	MTOR;RPTOR	None	mTOR/RAFT1/FRAP is the target of the immunosuppressive drug rapamycin and the central component of a nutrient- and hormone-sensitive signaling pathway that regulates cell growth.	None
ITGA9-ITGB1-ADAM8 complex	P05556;P78325;Q13797	3688;101;3680	protein binding;cell adhesion;ossification;osteoclast differentiation	protein binding;cell adhesion;osteogenesis;bone	ITGB1;ADAM8;ITGA9	None	None	None
"mTOR complex (MTOR, RAPTOR, MLST8)"	P42345;Q8N122;Q9BVC4	2475;57521;64223	cell morphogenesis;cell growth;regulation of protein serine/threonine kinase activity	cell growth / morphogenesis	MTOR;RPTOR;MLST8	None	Raptor plays an important role in nutrient-sensitive signaling to S6K1 (ribosomal protein S6 kinase B1) and cell growth (PMID: 12150925).	None
"mTOR complex (MTOR, RAPTOR)"	P42345;Q8N122	2475;57521	cell morphogenesis;cell growth	cell growth / morphogenesis	MTOR;RPTOR	None	None	None
"Ubiquitin E3 ligase (SMAD7, SMURF2)"	O15105;Q9HAU4	4092;64750	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding;cytoplasm;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;cytoplasm;nucleus"	SMAD7;SMURF2	None	"SMURF is localized in the nucleus, but binding to SMAD7 induces export to the cytoplasm."	None
"Ubiquitin E3 ligase (SMAD7, SMURF1)"	O15105;Q9HCE7	4092;57154	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;protein binding;cytoplasm;nucleus	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);protein binding;cytoplasm;nucleus"	SMAD7;SMURF1	None	SMAD7 associates with SMURF1 in the nucleus and is exported to the cytoplasm.	None
Ubiquitin E3 ligase (SMAD7-SMURF1) - TGF(beta)	O15105;P36897;P37173;Q9HCE7	4092;7046;7048;57154	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;cytoplasm	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway);TGF-beta-receptor signalling pathway;cytoplasm"	SMAD7;TGFBR1;TGFBR2;SMURF1	None	SMAD7 enhances the interaction between SMURF1 and the TGF-beta receptor complex.	None
Axin-PP2A A-PP2A C-GSK3-beta-beta-catenin complex	O15169;P35222;P49841;Q15172	8312;1499;2932;5525	Wnt signaling pathway	Wnt signalling pathway	AXIN1;CTNNB1;GSK3B;PPP2R5A	"The authors describe as additional component of the complex ""protein phosphatase PP2A C"", that couldn't be identified."	The incubation of the lysates with casein kinase I isoform epsilon decreases the association of PP2A C and A with the beta-catenin degradation complex.	None
APC-AXIN1-CTNNB1 complex	O15169;P25054;P35222	8312;324;1499	Wnt signaling pathway	Wnt signalling pathway	AXIN1;APC;CTNNB1	None	None	None
60S APC containing complex	P23258;P25054;P46940;Q71U36	7283;324;8826;7846	actin cytoskeleton organization;cytoplasm	actin cytoskeleton;cytoplasm	TUBG1;APC;IQGAP1;TUBA1A	"Since the authors did not specify tubulin alpha as well as tubulin gamma, we used isoform tubulin alpha-1A chain  and isoform tubulin gamma-1 chain  , respectively."	The authors propose that 60S APC is a discrete high molecular weight complex with a novel function in cytoskeletal regulation in epithelial cells apart from its well established role in targeting catenin destruction or its proposed role in microtubule plus end stabilization.	None
TFIID complex	O00268;P20226;P21675;P49848;Q15542;Q15544;Q16514;Q16594;Q6P1X5	6874;6908;6872;6878;6877;6882;6883;6880;6873	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TBP;TAF1;TAF6;TAF5;TAF11;TAF12;TAF9;TAF2	None	The subunit stoichiometry is predicted by Sanders et al. (PMID:12138208).	None
TFIID subcomplex	O00268;P49848;Q15542;Q16514;Q16594	6874;6878;6877;6883;6880	"DNA-templated transcription, initiation;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription initiation;transcriptional control;DNA binding;nucleus	TAF4;TAF6;TAF5;TAF12;TAF9	None	The subunit stoichiometry is predicted by Sanders et al. (PMID:12138208).	None
APC-IQGAP1-Rac1 complex	P25054;P46940;P63000	324;8826;5879	cell migration;cytoskeleton organization;cytoskeleton	cell migration;cytoskeleton/structural proteins;cytoskeleton	APC;IQGAP1;RAC1	None	"When EGFP-APC-M1 (aa221-968) was immunoprecipitated from the cells expressing EGFP-APC-M1 and constitutively active Rac1 (Rac1V12), both Rac1V12 and IQGAP1 were coimmunoprecipitated. The authors showed that activated Rac1 and Cdc42 formed a tripartite complex with IQGAP1 and APC."	None
APC-IQGAP1-Cdc42 complex	P25054;P46940;P60953	324;8826;998	cell migration;cytoskeleton organization;cytoskeleton	cell migration;cytoskeleton/structural proteins;cytoskeleton	APC;IQGAP1;CDC42	None	"When EGFP-APC-M1 (aa221-968) was immunoprecipitated from the cells expressing EGFP-APC-M1 and constitutively active Cdc42 (Cdc42V12), both Cdc42V12 and IQGAP1 were coimmunoprecipitated. The authors showed that activated Rac1 and Cdc42 formed a tripartite complex with IQGAP1 and APC."	None
"p27-cyclinE-Cdk2 - Ubiquitin E3 ligase (SKP1A, SKP2, CUL1, CKS1B, RBX1) complex"	P24864;P24941;P46527;P61024;P62877;P63208;Q13309;Q13616	898;1017;1027;1163;9978;6500;6502;8454	mitotic cell cycle;protein phosphorylation;protein ubiquitination;ubiquitin-dependent protein catabolic process	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	CCNE1;CDK2;CDKN1B;CKS1B;RBX1;SKP1;SKP2;CUL1	None	"p27, an important cell cycle regulator, blocks the G1/S transition in cells by binding and inhibiting Cdk2/cyclin A and Cdk2/cyclin E complexes. Ubiquitination and subsequent degradation play a critical role in regulating the levels of p27 during cell cycle progression."	"Overexpression of p27 in certain cancer cells prevents DNA replication and tumor formation in nude mice, whereas the loss of p27 has been reported in many human cancers and predicts a poor prognosis in breast, prostate, colon, gastric, lung, and esophageal cancers. In several types of cancers, there is a strong correlation between the loss of p27 and induction of Skp2, a subunit of the SCFSkp2/Cks1 (Skp1, Cul1, Roc1, Skp2, Cks1 complex) ubiquitin E3 ligase that targets p27 for ubiquitination and degradation."
TGF-beta receptor II-TGF-beta3 complex	P10600;P37173	7043;7048	protein complex assembly;protein binding;transforming growth factor beta receptor signaling pathway;plasma membrane	assembly of protein complexes;protein binding;TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFB3;TGFBR2	None	TGF-beta 3 binds to TGF-beta receptor type II sequentially.	None
TGF-beta receptor II-TGF-beta1 complex	P01137;P37173	7040;7048	protein complex assembly;protein binding;transforming growth factor beta receptor signaling pathway;plasma membrane	assembly of protein complexes;protein binding;TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFB1;TGFBR2	None	TGF-beta 1 binds to TGF-beta receptor type II sequentially.	None
TGF-beta receptor II-TGF-beta receptor I-TGF-beta1 complex	P01137;P36897;P37173	7040;7046;7048	transforming growth factor beta receptor signaling pathway;plasma membrane	TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFB1;TGFBR1;TGFBR2	None	TGF-beta receptor I does not bind TGF-beta in the absence of TGF-beta receptor II.	None
TGF-beta receptor II-TGF-beta receptor I-TGF-beta3 complex	P10600;P36897;P37173	7043;7046;7048	transforming growth factor beta receptor signaling pathway;plasma membrane	TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFB3;TGFBR1;TGFBR2	None	TGF-beta receptor I does not bind TGF-beta in the absence of TGF-beta receptor II.	None
Microprocessor complex	P01137;P36897;P37173	7040;7046;7048	transforming growth factor beta receptor signaling pathway;plasma membrane	TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFB1;TGFBR1;TGFBR2	None	TGF-beta receptor I does not bind TGF-beta in the absence of TGF-beta receptor II.	None
"RNA-induced silencing complex, RISC"	P08238;Q15633;Q9UKV8;Q9UPY3	3326;6895;27161;23405	RNA biosynthetic process;RNA processing;RNA binding;cytoplasm	RNA synthesis;RNA processing;RNA binding;cytoplasm	HSP90AB1;TARBP2;AGO2;DICER1	None	None	None
PAC3-PAC4 complex	Q5JS54;Q9BT73	389362;84262	protein complex assembly	assembly of protein complexes	PSMG4;PSMG3	None	"20S proteasome assembly is orchestrated by two distinct pairs of chaperones in mammals, the PAC1-PAC2 complex and the PAC3-PAC4 complex."	None
PAC1-PAC2 complex	O95456;Q969U7	8624;56984	protein stabilization;protein folding;protein complex assembly	protein folding and stabilization;assembly of protein complexes	PSMG1;PSMG2	None	"20S proteasome assembly is orchestrated by two distinct pairs of chaperones in mammals, the PAC1-PAC2 complex and the PAC3-PAC4 complex."	None
LAT2-ITGB1 complex	P05556;Q9UHI5	3688;23428	single organismal cell-cell adhesion	cell-cell adhesion	ITGB1;SLC7A8	None	CD98-beta1 integrin association is required for focal adhesion kinase-dependent phosphoinositol 3-hydroxykinase activation and cellular transformation.	None
"Ubiquitin E3 ligase (SKP1A, SKP2, CUL1, CKS1B, RBX1)"	P61024;P62877;P63208;Q13309;Q13616	1163;9978;6500;6502;8454	mitotic cell cycle;regulation of cell cycle;protein ubiquitination;ubiquitin-dependent protein catabolic process	"mitotic cell cycle;mitotic cell cycle and cell cycle control;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	CKS1B;RBX1;SKP1;SKP2;CUL1	None	None	"Overexpression of p27 in certain cancer cells prevents DNA replication and tumor formation in nude mice, whereas the loss of p27 has been reported in many human cancers and predicts a poor prognosis in breast, prostate, colon, gastric, lung, and esophageal cancers. In several types of cancers, there is a strong correlation between the loss of p27 and induction of Skp2, a subunit of the SCFSkp2/Cks1 (Skp1, Cul1, Roc1, Skp2, Cks1 complex) ubiquitin E3 ligase that targets p27 for ubiquitination and degradation."
SMAD2-SMAD4-FAST1 complex	O75593;Q13485;Q15796	8928;4089;4087	"positive regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription activation;DNA binding;TGF-beta-receptor signalling pathway;nucleus	FOXH1;SMAD4;SMAD2	None	This complex is built only in the presence of TGF-beta signaling.	SMAD4 is involved in pancreatic carcinoma.
SMAD2-FAST1 complex	O75593;Q15796	8928;4087	DNA binding;transforming growth factor beta receptor signaling pathway;nucleus	DNA binding;TGF-beta-receptor signalling pathway;nucleus	FOXH1;SMAD2	None	TGF-beta induces formation of the SMAD2-FAST1 complex.	None
Multisynthetase complex	O43324;P07814;P14868;P41252;P47897;P54136;P56192;Q12904;Q13155;Q15046;Q9P2J5	9521;2058;1615;3376;5859;5917;4141;9255;7965;3735;51520	aminoacyl-tRNA ligase activity;cytoplasm;nucleus	aminoacyl-tRNA-synthetases;cytoplasm;nucleus	EEF1E1;EPRS;DARS;IARS;QARS;RARS;MARS;AIMP1;AIMP2;KARS;LARS	None	"The characteristic ""core"" complex of aminoacyl tRNAsynthetase in higher eukaryotes is composed of nine synthetase activities. These are specific for arginine, aspartate, glutamate, glutamine, isoleucine, leucine, lysine, methionine, and proline. There are also three auxiliary proteins in the multisynthetase complex: p43, p38, and p18. These are involved in protein-protein interactions within the particle and with other protein synthesis factors."	None
TGF-beta-receptor type II homodimer complex	P37173	7048	protein binding;transforming growth factor beta receptor signaling pathway;plasma membrane	protein binding;TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFBR2	None	TGF-beta receptor type II forms a homomeric complex in the absence of the ligand TGF-beta.	None
TGF-beta receptor II-TGF-beta1 complex	P01137;P37173	7040;7048	protein complex assembly;protein binding;transforming growth factor beta receptor signaling pathway;plasma membrane	assembly of protein complexes;protein binding;TGF-beta-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	TGFB1;TGFBR2	None	None	None
BMP2-BRIA complex	P12643;P12644;P36894	650;652;657	transforming growth factor beta receptor signaling pathway;cartilage development;ossification;osteoclast differentiation;BMP signaling pathway	TGF-beta-receptor signalling pathway;cartilage;osteogenesis;bone	BMP2;BMP4;BMPR1A	None	None	None
SKI-NCOR1-SIN3A-HDAC1 complex	O75376;P12755;Q13547;Q96ST3	9611;6497;3065;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;nucleus"	NCOR1;SKI;HDAC1;SIN3A	None	"The oncogenic form of Ski, v-Ski, which lacks the mSin3A binding domain, abrogates transcriptional repression."	None
hs4 enhancer complex (faster migrating complex)	P09086;P14859;P19838;P25490;Q04206	5452;5451;4790;7528;5970	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;I-kappaB kinase/NF-kappaB signaling;B cell differentiation;nucleus"	transcriptional control;DNA binding;NIK-I-kappaB/NF-kappaB cascade;B-cell;nucleus	POU2F2;POU2F1;NFKB1;YY1;RELA	None	This complex exists in healthy and malignant B-cell lines.	None
hs4 enhancer complex (slow migrating complex)	P25490;Q01201	7528;5971	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;I-kappaB kinase/NF-kappaB signaling;negative regulation of apoptotic process;B cell differentiation;nucleus"	transcriptional control;DNA binding;NIK-I-kappaB/NF-kappaB cascade;anti-apoptosis;B-cell;nucleus	YY1;RELB	None	None	This complex was observed only in patients with diffuse large B cell lymphoma (DLBCA).
mSin3A complex	Q09028;Q13547;Q16576;Q92769;Q96ST3	5928;3065;5931;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;nucleus"	RBBP4;HDAC1;RBBP7;HDAC2;SIN3A	"Three other subunits of the complex were found in the analysis, which have not been further characterized: p250, p180, p30."	None	None
MAD-MAX complex	P61244;Q05195	4149;4084	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	MAX;MXD1	None	Cell differentiation is accompanied by a change from MYC-MAX complexes (undifferentiated cells) to MAD-MAX complexes (differentiated cells). The ability of MAD to compete with MYC for binding to MAX and to repress MYC transcriptional activation suggests that MAD opposes the function of MYC.	None
MYC-MAX complex	P01106;P61244	4609;4149	"positive regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription activation;DNA binding;nucleus	MYC;MAX	None	Cell differentiation is accompanied by a change from MYC-MAX complexes (undifferentiated cells) to MAD-MAX complexes (differentiated cells). The ability of MAD to compete with MYC for binding to MAX and to repress MYC transcriptional activation suggests that MAD opposes the function of MYC.	None
mSin3A-HDAC1-HDAC2 complex	Q13547;Q92769;Q96ST3	3065;3066;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	HDAC1;HDAC2;SIN3A	None	None	None
MAD1-mSin3A-HDAC2 complex	Q05195;Q92769;Q96ST3	4084;3066;25942	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	MXD1;HDAC2;SIN3A	None	MAD-MAX complex functions as transcriptional repressor by recruiting the mSin3A-HDAC complex.	None
Nop56p-associated pre-rRNA complex	O00567;O76021;P05141;P05386;P05387;P05388;P06748;P08708;P09651;P11387;P13639;P15880;P16402;P18077;P18124;P18621;P19338;P22087;P25398;P26368;P26373;P27635;P30050;P32969;P35268;P36578;P37108;P39023;P40429;P42766;P46776;P46777;P46778;P46779;P46781;P47914;P49411;P50914;P52272;P55209;P55769;P61247;P61254;P61313;P61353;P61513;P62081;P62241;P62244;P62249;P62263;P62266;P62269;P62273;P62277;P62280;P62424;P62736;P62750;P62753;P62829;P62841;P62847;P62888;P62891;P62899;P62906;P62910;P62913;P62917;P63267;P67809;P68104;P83731;P83881;P84098;Q00839;Q01081;Q02543;Q02878;Q07020;Q08211;Q12905;Q12906;Q13428;Q13610;Q14978;Q6P3W7;Q71U36;Q8TDN6;Q92522;Q96SB4;Q99848;Q99879;Q9BQG0;Q9BVP2;Q9H4B7;Q9NR30;Q9NW13;Q9NX58;Q9NZI8;Q9Y2X3;Q9Y383;Q9Y3U8	10528;26156;292;6176;6181;6175;4869;6218;3178;7150;1938;6187;3007;6165;6129;6139;4691;2091;6206;11338;6137;6134;6136;6133;6146;6124;6727;6122;23521;11224;6157;6125;6144;6158;6203;6159;7284;9045;4670;4673;4809;6189;6154;6138;6155;6168;6201;6202;6210;6217;6208;6228;6222;6235;6207;6205;6130;59;6147;6194;9349;6209;6229;6156;6170;6160;4736;6161;6135;6132;72;4904;1915;6152;6173;6143;3192;7307;6142;6128;6141;1660;3608;3609;6949;11137;9221;55681;7846;55299;8971;6732;10969;8342;10514;26354;81027;9188;55131;55646;10642;51602;51631;25873	ribosome biogenesis;nucleus	ribosome biogenesis;nucleus	NOP56;RSL1D1;SLC25A5;RPLP1;RPLP2;RPLP0;NPM1;RPS17;HNRNPA1;TOP1;EEF2;RPS2;HIST1H1D;RPL35A;RPL7;RPL17;NCL;FBL;RPS12;U2AF2;RPL13;RPL10;RPL12;RPL9; RPL9;RPL22;RPL4;SRP14;RPL3;RPL13A;RPL35;RPL27A;RPL5;RPL21;RPL28;RPS9;RPL29;TUFM;RPL14;HNRNPM;NAP1L1;SNU13;RPS3A;RPL26;RPL15;RPL27;RPL37A;RPS7;RPS8;RPS15A;RPS16;RPS14;RPS23;RPS18;RPS29;RPS13;RPS11;RPL7A;ACTA2;RPL23A;RPS6;RPL23;RPS15;RPS24;RPL30;RPL39;RPL31;RPL10A;RPL32;RPL11;RPL8;ACTG2;YBX1;EEF1A1;RPL24;RPL36A;RPL19;HNRNPU;U2AF1;RPL18A;RPL6;RPL18;DHX9;ILF2;ILF3;TCOF1;PWP1;NOLC1;SCYL2;TUBA1A;BRIX1;H1FX;SRPK1;EBNA1BP2;HIST1H2BM;MYBBP1A;GNL3;TUBB1;DDX21;RBM28;LYAR;IGF2BP1;NOP58;LUC7L2;RPL36	None	"Identification of pre-rRNA species within hNop56p-associated pre-ribosomal ribonucleoprotein complexes, coupled with the known functions of yeast orthologs of the probable trans-acting factors identified in man, demonstrated that hNop56p functions in the early to middle stages of 60 S subunit synthesis."	None
Microprocessor complex	Q8WYQ5;Q9NRR4	54487;29102	RNA processing;RNA binding;nucleus	RNA processing;RNA binding;nucleus	DGCR8;DROSHA	None	This complex is responsible for pre-miRNA processing.	DGCR8 is deleted in DiGeorge syndrome.
ITGA10-ITGB1 complex	O75578;P05556	8515;3688	anisotropic cell growth	directional cell growth (morphogenesis)	ITGA10;ITGB1	None	None	None
ITGA11-ITGB1 complex	P05556;Q9UKX5	3688;22801	protein binding;cell migration	protein binding;cell migration	ITGB1;ITGA11	None	None	None
ITGA11-ITGB1-COL1A1 complex	P02452;P05556;Q9UKX5	1277;3688;22801	integrin-mediated signaling pathway	integrin receptor signalling pathway	COL1A1;ITGB1;ITGA11	None	None	None
"RNA polymerase II complex (RPB1, RAP74, CDK8, CYCC, SRB7, BAF190, BAF47), chromatin structure modifying"	P24863;P24928;P35269;P49336;P51531;Q12824;Q13503	892;5430;2962;1024;6595;6598;9412	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	CCNC;POLR2A;GTF2F1;CDK8;SMARCA2;SMARCB1;MED21	"Since the authors did not specify SNF2 (= SMARCA), we used isoform SNF2A (=SMARCA2)."	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity. Notably, the general transcription factors are absent from this complex."	None
"RNA polymerase II complex (CBP, PCAF, RPB1, BAF47, CYCC, CDK8), chromatin structure modifying"	P24863;P24928;P49336;Q12824;Q92793;Q92831	892;5430;1024;6598;1387;8850	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	CCNC;POLR2A;CDK8;SMARCB1;CREBBP;KAT2B	None	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity. Notably, the general transcription factors are absent from this complex."	None
"RNA polymerase II complex, (CBP, RPBI, PCAF, BAF47), chromatin structure modifying"	P24928;Q12824;Q92793;Q92831	5430;6598;1387;8850	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	POLR2A;SMARCB1;CREBBP;KAT2B	None	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity.Notably, the general transcription factors are absent from this complex."	None
Brg1-associated complex II	O14497;O14744;O96019;P51532;Q12824;Q8TAQ2;Q92922	8289;10419;86;6597;6598;6601;6599	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;DNA binding;organization of chromosome structure;nucleus	ARID1A;PRMT5;ACTL6A;SMARCA4;SMARCB1;SMARCC2;SMARCC1	In a following paper (PMID:14559996) p66 has been identified as PRMT5.	None	None
"RNA polymerase II complex, chromatin structure modifying"	P20226;P24863;P24928;P29083;P32780;P35269;P49336;P51531;Q00403;Q12824;Q13503;Q14919;Q6UW60;Q8TAQ2;Q92922;Q96GM5	6908;892;5430;2960;2965;2962;1024;6595;2959;6598;9412;10589;54760;6601;6599;6602	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	TBP;CCNC;POLR2A;GTF2E1;GTF2H1;GTF2F1;CDK8;SMARCA2;GTF2B;SMARCB1;MED21;DRAP1;PCSK4;SMARCC2;SMARCC1;SMARCD1	"Since the authors did not specify SNF2 (= SMARCA) and BAF60 (=SMARCD), we used isoform SNF2A (=SMARCA2) and BAF60A (=SMARCD1)."	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity.Notably, the general transcription factors are absent from this complex."	None
"RNA polymerase II complex, chromatin structure modifying"	O96019;P24863;P49336;Q12824;Q13503;Q8TAQ2;Q92922;Q969G3;Q96GM5	86;892;1024;6598;9412;6601;6599;6605;6602	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	ACTL6A;CCNC;CDK8;SMARCB1;MED21;SMARCC2;SMARCC1;SMARCE1;SMARCD1	"Since the authors did not specify BAF60, we used isoform BAF60A."	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity. Notably, the general transcription factors are absent from this complex."	None
"RNA polymerase II complex, chromatin structure modifying"	P19447;P24863;P24928;P35269;P49336;P51531;P51532;Q00403;Q12824;Q13503;Q13889;Q92793;Q92831	2071;892;5430;2962;1024;6595;6597;2959;6598;9412;2967;1387;8850	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	ERCC3;CCNC;POLR2A;GTF2F1;CDK8;SMARCA2;SMARCA4;GTF2B;SMARCB1;MED21;GTF2H3;CREBBP;KAT2B	None	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity. Notably, the general transcription factors are absent from this complex."	None
"RNA polymerase II complex, (CDK8 complex), chromatin structure modifying"	P24863;P35269;P49336;P51946;Q12824;Q13503;Q8TAQ2;Q92922	892;2962;1024;902;6598;9412;6601;6599	"DNA topological change;transcription, DNA-templated;DNA binding;nucleus"	DNA conformation modification (e.g. chromatin);TRANSCRIPTION;DNA binding;nucleus	CCNC;GTF2F1;CDK8;CCNH;SMARCB1;MED21;SMARCC2;SMARCC1	None	"RNA polymerase II complex contains chromatin structure remodeling activity and histone acetyltransferase activity.Notably, the general transcription factors are absent from this complex."	None
CTF18-cohesion-RFC-POLH complex	P0CG13;P35249;P35250;P40937;P40938;Q8WVB6;Q9BVC3;Q9Y253	54921;5984;5982;5985;5983;63922;79075;5429	DNA replication;DNA recombination;DNA repair;DNA binding;nucleus	DNA synthesis and replication;DNA recombination;DNA repair;DNA binding;nucleus	CHTF8;RFC4;RFC2;RFC5;RFC3;CHTF18;DSCC1;POLH	None	"The interaction of CTF18-cohesion-RFC complex  with  DNA-polymerase eta allows DNA replication fork to overcome interference by various template structures, including damaged DNA and DNA-protein complexes that maintain chromosome cohesion."	None
CTLH complex	Q7L5Y9;Q8IUR7;Q96S59;Q9H871;Q9UL63	10296;25852;10048;64795;4289	chromosome segregation;cell migration;microtubule cytoskeleton organization;cytoplasm;nucleus	chromosome segregation/division;cell migration;microtubule cytoskeleton;cytoplasm;nucleus	MAEA;ARMC8;RANBP9;RMND5A;MKLN1	None	"This complex might be involved in the regulation of microtubule dynamics, cell migration , nucleokinesis and chromosome segregation. CTHL complex contains alpha and beta splice variants of ARMC8."	None
UTX-MLL2/3 complex	O14686;O15550;P61964;Q14686;Q15291;Q5H9R7;Q6ZW49;Q86UW6;Q86XN7;Q8NEZ4;Q9UBL3;Q9Y2X9	8085;7403;11091;23054;5929;55291;22976;55728;80209;58508;9070;23528	"positive regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;cellular protein modification process;nucleus"	"transcription activation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);protein modification;nucleus"	KMT2D;KDM6A;WDR5;NCOA6;KDM6B;PPP6R3;PAXIP1;N4BP2;PROSER1;KMT2C;ASH2L;ZNF281	None	"Methylation of histone H3 lysine 27 (H3K27) is a post-translational modification highly correlated with genomic silencing. UTX, a member of JmjC-family proteins, is a di- and trimethyl H3K27 demethylase. Results uncover a concerted mechanism for transcriptional activation in which cycles of H3K4 methylation by MLL2/3 are linked with demethylation of H3K27 through UTX."	None
DGCR8-NCL complex	P19338;Q8WYQ5	4691;54487	RNA processing;RNA binding;nucleolus	RNA processing;RNA binding;nucleolus	NCL;DGCR8	None	"The authors demonstrated that certain RNA may be involved in the interaction between DGCR8 and Nucleolin, and removal of RNA induces dissociation of these two proteins. The results suggest that DGCR8 may be involved in maturation of miRNA at the nucleolus and nucleoplasm with Nucleolin."	None
DGCR8-ILF3 complex	Q12906;Q8WYQ5	3609;54487	RNA processing;RNA binding;nucleolus	RNA processing;RNA binding;nucleolus	ILF3;DGCR8	None	"The authors found that ILF3 is associated with both DGCR8 and Exportin5 (XPO5), although DGCR8 is not associated with XPO5."	None
ILF3-XPO5 complex	Q12906;Q9HAV4	3609;57510	RNA processing;RNA binding;RNA transport;RNA transmembrane transporter activity;nucleus	RNA processing;RNA binding;RNA transport;nucleus	ILF3;XPO5	None	"The authors found that ILF3 is associated with both DGCR8 and Exportin5 (XPO5), although DGCR8 is not associated with XPO5."	None
Microprocessor complex	Q8WYQ5;Q9NRR4	54487;29102	RNA processing;RNA binding;nucleolus	RNA processing;RNA binding;nucleolus	DGCR8;DROSHA	None	"The authors speculate that DGCR8 might play a significant role in the pri-miRNA recognition before interacting with DROSHA. In the coimmunoprecipitation assay DROSHA is seen as three isoforms (DROSHA-a, -b, -c)."	DGCR8 is deleted in DiGeorge syndrome.
DGCR8 multiprotein complex	O43390;P11021;P17844;P19338;P31943;P35637;Q00839;Q08211;Q12906;Q8WYQ5;Q92841	10236;3309;1655;4691;3187;2521;3192;1660;3609;54487;10521	RNA processing;nucleus	RNA processing;nucleus	HNRNPR;HSPA5;DDX5;NCL;HNRNPH1;FUS;HNRNPU;DHX9;ILF3;DGCR8;DDX17	None	None	None
FA core complex 1 (Fanconi anemia core complex 1)	O15287;O15360;Q00597;Q9HB96;Q9NPI8	2189;2175;2176;2178;2188	cellular response to DNA damage stimulus;nucleus	DNA damage response;nucleus	FANCG;FANCA;FANCC;FANCE;FANCF	None	None	None
CCND1-CDK4 complex	P11802;P24385	1019;595	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CDK4;CCND1	None	"Endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb onlypartially, a process that is likely to be completed by cyclin E-cdk2 complexes."	None
CCND2-CDK4 complex	P11802;P30279	1019;894	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CDK4;CCND2	None	"Endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb onlypartially, a process that is likely to be completed by cyclin E-cdk2 complexes."	None
CCND3-CDK4 complex	P11802;P30281	1019;896	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CDK4;CCND3	None	"Endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb onlypartially, a process that is likely to be completed by cyclin E-cdk2 complexes."	None
CCND1-CDK6 complex	P24385;Q00534	595;1021	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CCND1;CDK6	None	"Endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb onlypartially, a process that is likely to be completed by cyclin E-cdk2 complexes."	None
CCND2-CDK6 complex	P30279;Q00534	894;1021	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CCND2;CDK6	None	"Endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb onlypartially, a process that is likely to be completed by cyclin E-cdk2 complexes."	None
CCND3-CDK6 complex	P30281;Q00534	896;1021	mitotic cell cycle;protein phosphorylation;nucleus	"mitotic cell cycle;modification by phosphorylation, dephosphorylation, autophosphorylation;nucleus"	CCND3;CDK6	None	"Endogenous D-type cyclins, acting with cdk4/6, are able to phosphorylate pRb onlypartially, a process that is likely to be completed by cyclin E-cdk2 complexes."	None
APP-TOM40 complex	O96008;P05067	10452;351	intracellular protein transport;protein targeting;protein transport;mitochondrion	"protein targeting, sorting and translocation;protein transport;mitochondrion"	TOMM40;APP	None	Mitochondrial accumulation of APP is associated with decreased cytochrome c oxidase activity and increased levels of H2O2 in mitochondria. Reduced mitochondrial cytochrome c oxidase activity and increased oxidative stress have been associated with the pathogenesis of AD.	None
APP-TIM23 complex	O14925;P05067	100287932;351	intracellular protein transport;protein targeting;protein transport;mitochondrion	"protein targeting, sorting and translocation;protein transport;mitochondrion"	TIMM23;APP	None	Mitochondrial accumulation of APP is associated with decreased cytochrome coxidase activity and increased levels of H2O2 in mitochondria. Reduced mitochondrial cytochrome c oxidase activity and increased oxidative stress have been associated with the pathogenesis of AD.	APP is involved in Alzheimer disease.
ITGA6-ITGB4-SHC1-GRB2 complex	P16144;P23229;P29353;P62993	3691;3655;6464;2885	signaling;cytoskeleton organization	cellular signalling;cytoskeleton/structural proteins	ITGB4;ITGA6;SHC1;GRB2	None	The signal transduction by the alpha6beta4 integrin is mediated by an associated tyrosine kinase and that phosphorylation of distinct sites in the beta 4 tail mediates assembly of the hemidesmosomal cytoskeleton and recruitment of Shc/Grb2.	None
TIM17A-TIM23 complex	O14925;Q99595	100287932;10440	intracellular protein transport;protein targeting;protein transport;mitochondrial inner membrane	"protein targeting, sorting and translocation;protein transport;mitochondrial inner membrane"	TIMM23;TIMM17A	None	"The Tim17 proteins of distinct organisms were indistinguishable, indicating a high evolutionary conservation."	None
TIM50-SMN1 complex	Q16637;Q3ZCQ8	None;92609	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;RNA transport;RNA transmembrane transporter activity;nuclear transport;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;RNA transport;nuclear transport;nucleus	SMN1; SMN2;TIMM50	None	"There are two isoforms of TIM50:The nuclear isoform, TIM50a, participates in the release of snRNPs and SMN from the Cajal body (this complex), the mitochondrial isoform is an essential component of the TIM23 complex and regulates mitochondrial integrity and cell death.TIM50a is 103 aa longer (N-terminal) than TIM50."	Spinal muscular atrophy
TIM50-COIL complex	P38432;Q3ZCQ8	8161;92609	None	None	COIL;TIMM50	None	"There are two isoforms of TIM50:The nuclear isoform, TIM50a, participates in the release of snRNPs and SMN from the Cajal body (this complex), the mitochondrial isoform is an essential component of the TIM23 complex and regulates mitochondrial integrity and cell death.TIM50a is 103 aa longer (N-terminal) than TIM50."	Spinal muscular atrophy
DHX9-ADAR-vigilin-DNA-PK-Ku antigen complex	P12956;P13010;P55265;P78527;Q00341;Q08211	2547;7520;103;5591;3069;1660	DNA topological change;chromosome segregation;mRNA modification;RNA binding;chromosome organization;nucleus	DNA conformation modification (e.g. chromatin);chromosome segregation/division;mRNA modification;RNA binding;organization of chromosome structure;nucleus	XRCC6;XRCC5;ADAR;PRKDC;HDLBP;DHX9	None	Vigilin and DDP1 bind specifically to Inosine-containing RNAs.	None
ITGAV-ITGB3-SLC3A2 complex	P05106;P06756;P08195	3690;3685;6520	movement of cell or subcellular component;cell adhesion;plasma membrane	cell motility;cell adhesion;eukaryotic plasma membrane / membrane attached	ITGB3;ITGAV;SLC3A2	None	None	None
ITGB1-NRP1 complex	O14786;P05556	8829;3688	cell adhesion;plasma membrane	cell adhesion;eukaryotic plasma membrane / membrane attached	NRP1;ITGB1	None	NP-1 interacts with integrin beta1 to coordinate signaling events that promote cell adherence and invasiveness.	None
ITGAV-P2RY2-GNA12 complex	P06756;P41231;Q03113	3685;5029;2768	cell migration;plasma membrane	cell migration;eukaryotic plasma membrane / membrane attached	ITGAV;P2RY2;GNA12	None	"Alpha(v) integrin complexes provide the P2Y2R with access to G12, thereby allowing activation of this heterotrimeric G protein that controls actin cytoskeletal rearrangements required for chemotaxis."	None
ITGA9-ITGB1-SPP1 complex	P05556;P10451;Q13797	3688;6696;3680	protein binding;cell adhesion	protein binding;cell adhesion	ITGB1;SPP1;ITGA9	None	None	None
ITGA5-ITGB1-SPP1 complex	P05556;P08648;P10451	3688;3678;6696	protein binding;cell adhesion	protein binding;cell adhesion	ITGB1;ITGA5;SPP1	None	None	None
RBPJ-NOTCH1-MAML1 complex	P46531;Q06330;Q92585	4851;3516;9794	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;nucleus	NOTCH1;RBPJ;MAML1	None	RBPJ and the Ankyrin domain of Notch1 create a groove to bind MAML-1.	None
ITGA2B-ITGB3-ICAM4 complex	P05106;P08514;Q14773	3690;3674;3386	cell adhesion	cell adhesion	ITGB3;ITGA2B;ICAM4	None	None	None
ITGB5-ITGAV-VTN complex	P04004;P06756;P18084	7448;3685;3693	protein binding;cell adhesion	protein binding;cell adhesion	VTN;ITGAV;ITGB5	None	"In purified form, alpha(v)-beta5 preferentially binds to vitronectin."	None
SMN1-SIP1-SNRP complex	O14893;P14678;P62304;P62314;P62316;P62318;Q16637	8487;6628;6635;6632;6633;6634;None	cytoplasm;nucleus	cytoplasm;nucleus	GEMIN2;SNRPB;SNRPE;SNRPD1;SNRPD2;SNRPD3;SMN1; SMN2	None	SMN (Survival of Motor Neurons) and its associated protein SIP1 are in  a complex with spliceosomal snRNP proteins. The SMN/SIP1 complex is very stable.	Spinal muscular atrophy (SMA)
OCT1-OBF1-DNA-TLE1 complex	P14859;Q04724;Q16633	5451;7088;5450	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	POU2F1;TLE1;POU2AF1	None	Transcription activation by Oct1 in conjunction with OBF1 can be prevented by TLE1.	None
OCT2-TLE4 complex	P09086;Q04727	5452;7091	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	POU2F2;TLE4	None	None	None
OCT1-OBF1-DNA complex	P14859;Q16633	5451;5450	"positive regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription activation;DNA binding;nucleus	POU2F1;POU2AF1	None	None	None
TLE2 homodimer complex	Q04725	7089	"negative regulation of transcription, DNA-templated;protein binding;nucleus"	transcription repression;protein binding;nucleus	TLE2	None	TLE2 dimer has no DNA-binding ability but can be recuited to specific DNA sites through interaction with DNA-binding proteins.	None
TLE1-TLE2 complex	Q04724;Q04725	7088;7089	"negative regulation of transcription, DNA-templated;protein binding;nucleus"	transcription repression;protein binding;nucleus	TLE1;TLE2	None	TLE1/2 heterodimer has no DNA-binding ability but can be recuited to specific DNA sites through interaction with DNA-binding proteins.	None
TLE1 homodimer complex	Q04724	7088	"negative regulation of transcription, DNA-templated;protein binding;regulation of binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription repression;protein binding;regulation by binding / dissociation;regulator of transcription factor;nucleus	TLE1	None	TLE1 dimer has no DNA-binding ability but can be recuited to specific DNA sites through interaction with DNA-binding proteins.	None
TLE-Histone H3 complex	P68431;Q04724	None;7088	"DNA topological change;negative regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;organization of chromosome structure;nucleus	HIST1H3A;;TLE1	"Since the authors did not specify histone H3 and TLE, we used HIST1H3A and TLE1."	The authors postulate that TLEs regulate gene expression by interacting with nucleosomes through associations with the N-terminus of H3 proteins.	None
"Gamma-secretase complex (APH1B, PSEN1, PSENEN, NCSTN)"	P49768;Q8WW43;Q92542;Q9NZ42	5663;83464;23385;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;signaling;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;cellular signalling;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	PSEN1;APH1B;NCSTN;PSENEN	None	"A multimeric gamma-secretase complex that contains the presenilin-1 or presenilin-2 and the membrane glycoprotein nicastrin processes a number of type I transmembrane proteins such as the beta-amyloid precursor protein and the cell surface receptor notch-1. Three variants of APH1 (APH1A short, APH1A long and APH1B) as well as two presenillin variants (PSEN1 and PSEN2) allow the formation of six different gamma-secretase complexes."	None
STAT6-p100-RHA complex	P42226;Q08211;Q7KZF4	6778;1660;27044	"chromosome organization;DNA topological change;positive regulation of transcription, DNA-templated;DNA binding;nucleus"	organization of chromosome structure;DNA conformation modification (e.g. chromatin);transcription activation;DNA binding;nucleus	STAT6;DHX9;SND1	None	Experiments show that p100 protein mediates the assembly of the ternary complex  STAT6-p100-RHA. Chromatin immunoprecipitation studies show that RHA together with p100 enhance the binding of STAT6 on the human Ig-epsilon promoter after IL-4 stimulation. The authors propose that the ternary protein complex may facilitate the unwinding of the chromatin structure and accessibility of the promoter.	None
OCT1-OBF1-DNA complex	P14859;Q16633	5451;5450	"positive regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription activation;DNA binding;nucleus	POU2F1;POU2AF1	None	The OCT1 dimer is a better substrate for OBF1 than the monomer. OBF1 stabilizes the OCT1 dimer DNA complex by reducing its dissociation rate.	None
"Phosphatidylinositol 3-kinase (PIK3CA, PIK3R1)"	P27986;P42336	5295;5290	ATP binding;plasma membrane;phosphatidylinositol phosphorylation;phosphatidylinositol-mediated signaling	ATP binding;eukaryotic plasma membrane / membrane attached	PIK3R1;PIK3CA	None	"Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that phosphorylate phosphatidylinositol 4,5-bisphosphate at the 3-position of the inositol ring, and thus generate phosphatidylinositol 3,4,5-trisphosphate (PIP3 ), which, in turn, initiates a vast array of signaling events. PI3Ks are heterodimers, composed of catalytic and regulatory subunits, that are activated by growth factor-receptor tyrosine kinases."	In different types of cancer PIK3CA was found to be mutated. Defects in the phosphatidylinositol 3-kinase pathway contribute to type II diabetes.
TLE1 corepressor complex (MASH1 promoter-corepressor complex)	P06748;P09874;P19338;P34932;Q02880;Q04724;Q15233;Q92878	4869;142;4691;3308;7155;7088;4841;10111	"negative regulation of transcription, DNA-templated;protein binding;DNA binding;neuron differentiation;nucleus"	transcription repression;protein binding;DNA binding;neuron;nucleus	NPM1;PARP1;NCL;HSPA4;TOP2B;TLE1;NONO;RAD50	None	"The TLE1 complex is required for HES1-mediated transcription repression. PARP1 is inactive in the TLE1 complex. After Ca(2+) induction, kinase CaMKII-delta activates PARP1 leading to dismissal of the TLE1 corepresspor complex from HES1."	None
MASH1 promoter-coactivator complex	P09874;P12931;P24928;P62805;P68431;Q14469;Q15233;Q92793;Q92831	142;6714;5430;None;None;3280;4841;1387;8850	"positive regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;neuron differentiation;nucleus"	transcription activation;DNA binding;Notch-receptor signalling pathway;neuron;nucleus	PARP1;SRC;POLR2A;HIST1H4A;;HIST1H3A;;HES1;NONO;CREBBP;KAT2B	"Since the authors did not specify histone H3, we used HIST1H3A."	Poly(ADP-ribosyl)ation activity of PARP1 is required for dismissal of the TLE1-corepressor complex.	None
POSH-AKT2 complex	P31751;Q7Z6J0	208;57630	JNK cascade	JNK cascade	AKT2;SH3RF1	None	A POSH mutant unable to bind to Akt2 exhibits increased binding to MLK3. This increased binding of MLK3 to POSH is accompanied by increased activation of the JNK signaling pathway. The results suggest that Akt2 negatively regulates the POSH/JNK signaling complex by phosphorylating MLK3 and promoting the disassembly of the JNK signaling complex.	None
CRLR-RAMP2 complex	O60895;Q16602	10266;10203	G-protein coupled receptor signaling pathway;plasma membrane	G-protein coupled receptor signalling pathway;eukaryotic plasma membrane / membrane attached	RAMP2;CALCRL	None	"The results demonstrate that RAMP2 and RAMP3 and not only RAMP1 can promote the full maturation of CRLR, leading to its terminal glycosylation, and only the fully processed receptors were found to bind AM (adrenomedullin) and CGRP (calcitonin gene-related peptide)."	None
CRLR-RAMP3 complex	O60896;Q16602	10268;10203	G-protein coupled receptor signaling pathway;plasma membrane	G-protein coupled receptor signalling pathway;eukaryotic plasma membrane / membrane attached	RAMP3;CALCRL	None	"The results demonstrate that RAMP2 and RAMP3 and not only RAMP1 can promote the full maturation of CRLR, leading to its terminal glycosylation, and only the fully processed receptors were found to bind AM (adrenomedullin) and CGRP (calcitonin gene-related peptide)."	None
CAMK2-delta-MASH1 promoter-coactivator complex	P09874;P12931;P24928;Q13557;Q14469;Q15233;Q92793;Q92831	142;6714;5430;817;3280;4841;1387;8850	"positive regulation of transcription, DNA-templated;protein binding;DNA binding;Notch signaling pathway;neuron differentiation;nucleus"	transcription activation;protein binding;DNA binding;Notch-receptor signalling pathway;neuron;nucleus	PARP1;SRC;POLR2A;CAMK2D;HES1;NONO;CREBBP;KAT2B	None	HES1 is phosphorylated by CAMKII-delta during neural stem cell differentiation. This phosphorylation is linked to recruitment of coactivator complexes on the MASH1 promoter.	None
GRB2-SOS1 complex	P62993;Q07889	2885;6654	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways	GRB2;SOS1	None	"The authors describe the formation of either a Sos-1-Grb2 (S/G) or a Sos-1-E3b1-Eps8 (S/E/E8) complex, endowed with Ras- and Rac-specific GEF activities, respectively. Sos-1-Grb2 complex is disrupted upon RTKs (receptor tyrosine kinases) activation, whereas the S/E/E8 complex is not."	None
NK-3-Groucho-HIPK2-SIN3A-RbpA48-HDAC1 complex	Q04724;Q09028;Q13547;Q96ST3;Q99801;Q9H2X6	7088;5928;3065;25942;4824;28996	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	TLE1;RBBP4;HDAC1;SIN3A;NKX3-1;HIPK2	"Since the authors did not specify NKX3 and TLE, we used NKX3-1 and TLE1."	"The authors postulate that the Nk-3 homeodomain protein recruits a corepressor complex containing Groucho protein, HIPK2 and a histone deacetylase complex to repress transcription."	None
NK-3-Groucho complex	Q04724;Q99801	7088;4824	"negative regulation of transcription, DNA-templated;nucleus"	transcription repression;nucleus	TLE1;NKX3-1	"Since the authors did not specify NKX3 and TLE, we used NKX3-1 and TLE1."	NK-3 homeodomain protein can associate wih the human Groucho homolog TLE in the absence of DNA. This interaction translocates Groucho proteins from the cytoplasm into the nucleus.	None
Sulphiredoxin-peroxiredoxin complex	Q06830;Q9BYN0	5052;140809	ATP binding;signal transduction;cytoplasm	ATP binding;CELLULAR COMMUNICATION/SIGNAL TRANSDUCTION MECHANISM;cytoplasm	PRDX1;SRXN1	None	"Typical 2-Cys peroxiredoxins (Prxs) have an important role in regulating hydrogen peroxide-mediated cell signalling. In this process, Prxs can become inactivated through the hyperoxidation of an active site Cys residue to Cys sulphinic acid. The unique repair of this moiety by sulphiredoxin (Srx) restores peroxidase activity and terminates the signal."	None
GNAQ-GEFT-RHOA complex	P50148;P61586;Q86VW2	2776;387;115557	GTP binding	GTP binding	GNAQ;RHOA;ARHGEF25	None	It is assumed that the complex is involved in signal transduction.	None
Notch2(N-TM)-Notch2(N-EC)-Delta complex	O00548;Q04721	28514;4853	Notch signaling pathway;plasma membrane	Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached	DLL1;NOTCH2	"Since the authors did not specify DLL, we used DLL1."	In the trans-Golgi-network Notch2 is cleaved into the transmembrane Notch2(N-TM) subunit and into the extracellular Notch2(N-EC) subunit. Both subunits form a heterodimeric complex. The ligand Delta binds only to the heterodimeric form of Notch.	None
TFC4-CTNNB1 complex	P35222;Q9NQB0	1499;6934	"transcription, DNA-templated;Wnt signaling pathway"	TRANSCRIPTION;Wnt signalling pathway	CTNNB1;TCF7L2	None	"As a consequence of engaging the canonical Wnt pathway, a beta-catenin-T-cell factor (TCF) transcriptional complex is generated, which has been postulated to trigger the epithelial-mesenchymal transition (EMT) that characterizes the tissue-invasive phenotype of breast cancer."	None
CBF1-HDAC1-SMRT complex	Q06330;Q13547;Q9Y618	3516;3065;9612	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	RBPJ;HDAC1;NCOR2	None	CBF1 interacts with a corepressor complex containing HDAC1 and SMRT. Activation of Notch disrupts the formation of the repressor complex by competing of SMRT and Notch for binding with CBF1.	None
PR -PRLR complex	P01236;P16471	5617;5618	signaling	cellular signalling	PRL;PRLR	None	H1:R2 complex consists of one prolactin molecule and one receptor dimer. The process of receptor dimerization can be either constitutive or ligand dependent.	None
RIAM-Rap1-GTP-profilin complex	P07737;P62834;Q7Z5R6	5216;5906;54518	cell adhesion;actin cytoskeleton organization	cell adhesion;actin cytoskeleton	PFN1;RAP1A;APBB1IP	None	The results indicate that RIAM can function as a link between Rap1-GTP and the actin regulator Profilin either by direct RIAM binding to Profilin or by RIAM recruitment of Ena/VASP-Profilin complexes.	None
RIAM-profilin complex	P07737;Q7Z5R6	5216;54518	cell adhesion;actin cytoskeleton organization	cell adhesion;actin cytoskeleton	PFN1;APBB1IP	None	"RIAM  interacts with Profilin and Ena/VASP proteins, molecules that regulate actin dynamics."	None
RIAM-VASP complex	P50552;Q7Z5R6	7408;54518	cell adhesion;actin cytoskeleton organization	cell adhesion;actin cytoskeleton	VASP;APBB1IP	None	"RIAM  interacts with Profilin and Ena/VASP proteins, molecules that regulate actin dynamics."	None
PRLR homodimer complex	P16471	5618	signaling	cellular signalling	PRLR	None	"The process of receptor dimerization can be either constitutive or ligand dependent. The receptor dimer appears in variant (alternatively spliced) forms: As heterodimer long form (LF) - short form (SF) S1a/S1b and homodimers LF - LF, SF - SF."	None
TF-FVIIa-FXa-TFPI complex	P00742;P08709;P10646;P13726	2159;2155;7035;2152	blood coagulation	blood coagulation	F10;F7;TFPI;F3	None	The authors describe that the FXa-dependent inhibition of TF-FVIIa activity by TFPI leads to formation of the quaternary complex TF-FVIIa-FXa-TFPI.	None
HESX1-TLE1 complex	Q04724;Q9UBX0	7088;8820	"negative regulation of transcription, DNA-templated;DNA binding;Notch signaling pathway;nucleus;pituitary gland development"	transcription repression;DNA binding;Notch-receptor signalling pathway;nucleus	TLE1;HESX1	None	HESX1 recruits the TLE1 corepressor to specific promoters during pituitary organogenesis. This complex completely abolishes transcriptional activation mediated by PROP1.	None
AXIN1-APC-CTNNB1-GSK3B complex	O15169;P25054;P35222;P49841	8312;324;1499;2932	protein phosphorylation;Wnt signaling pathway;beta-catenin destruction complex	"modification by phosphorylation, dephosphorylation, autophosphorylation;Wnt signalling pathway"	AXIN1;APC;CTNNB1;GSK3B	"Since the authors did not specify Axin, we used isoform Axin1."	"The RGS domains of Axin and conductin interact directly with the region containing the third to seventh 20-aa repeats of APC. The interaction of APC with Axin is important for regulating the stability of beta-catenin. APC promotes a GSK-3b-dependent phosphorylation of beta-catenin by interacting with Axin, thereby down-regulating beta-catenin. APC binds not to GSK-3b but forms a complex with GSK-3b when Axin is present."	Adenomatous polyposis coli gene product (APC) functions as a tumor suppressor and its mutations in familial adenomatous polyposis and colorectal cancers lead to the accumulation of cytoplasmic beta-catenin.
NCOR-SIN3-HDAC-HESX1 complex	O75182;Q13547;Q92769;Q96ST3;Q9UBX0;Q9Y618	23309;3065;3066;25942;8820;9612	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;Notch signaling pathway;chromosome organization;nucleus;pituitary gland development"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;Notch-receptor signalling pathway;organization of chromosome structure;nucleus"	SIN3B;HDAC1;HDAC2;SIN3A;HESX1;NCOR2	None	HESX1 recruits the N-Cor-SIN3-HDAC complex to specific promoters during pituitary organogenesis.	None
DAXX-AXIN complex	O15169;Q9UER7	8312;1616	protein binding;kinase activator activity;regulation of sequence-specific DNA binding transcription factor activity;response to radiation;apoptotic process	"protein binding;kinase activator;regulator of transcription factor;electromagnetic waves stress response (e.g. UV, X-ray);apoptosis (type I programmed cell death)"	AXIN1;DAXX	None	The Daxx-Axin complex formation is enhanced by UV-irradiation.	None
Daxx-Axin-p53 complex	O15169;P04637;Q9UER7	8312;7157;1616	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to radiation;apoptotic process;nucleus"	"transcriptional control;electromagnetic waves stress response (e.g. UV, X-ray);apoptosis (type I programmed cell death);nucleus"	AXIN1;TP53;DAXX	None	"Axin enhances the interaction between DAXX and p53 in a dose-dependent manner. DAXX does not directly interact with p53, but through a bridge by Axin. DAXX-Axin-p53 complex promotes HIPK2 phosphorylation of p53 at Ser(46)."	None
NUMB-TP53-MDM2 complex	P04637;P49757;Q00987	7157;8650;4193	protein binding;Notch signaling pathway;signaling	protein binding;Notch-receptor signalling pathway;cellular signalling	TP53;NUMB;MDM2	None	"NUMB enters in a tricomplex with p53 and the E3 ubiquitin ligase MDM2, thereby preventing ubiquitination and degradation of p53. This results in increased p53 protein levels and activity, and in regulation of p53-dependent phenotypes."	"In breast cancers, loss of NUMB expression causes increased activity of the receptor NOTCH. Thus, in these cancers, a single event-loss of NUMB expression determines activation of an oncogene (NOTCH) and attenuation of the p53 tumour suppressor pathway."
CIN85 homotetramer complex	Q96B97	30011	cell-cell signaling	None	SH3KBP1	None	"CIN85 interacted with itself via its coiledcoilregion, regardless of EGF stimulation."	None
CIN85-BLNK complex	Q8WV28;Q96B97	29760;30011	B cell receptor signaling pathway	None	BLNK;SH3KBP1	None	The authors suggest a novel mechanism in regulation ofthe B cell signaling events in which CIN85 plays aspecific role by association with BLNK or c-Cbl.	None
CIN85-CBL complex	P22681;Q96B97	867;30011	cytoplasm;B cell receptor signaling pathway	cytoplasm	CBL;SH3KBP1	None	The authors suggest a novel mechanism in regulation of the B cell signaling events in which CIN85 plays a specific role by association with BLNK or c-Cbl.	None
USP1-UAF1 complex	O94782;Q8TAF3	7398;57599	protein deubiquitination;cellular response to DNA damage stimulus;nucleus	"modification by ubiquitination, deubiquitination;DNA damage response;nucleus"	USP1;WDR48	None	The active USP1-UAF1 complex deubiquitinates FANCD2 both as a dimeric complex and a ternary complex containing autocleaved USP1.	This complex regulates the Fanconi anemia (OMIM:227646) pathway by deubiquitinating FANCD2.
GNA14-p115RhoGEF complex	O95837;Q92888	9630;9138	cell morphogenesis;cell growth	cell growth / morphogenesis	GNA14;ARHGEF1	None	The G-protein alpha subunit a13 regulates cell growth and differentiation.	None
LMO4-CREB complex	P16220;P61968	1385;8543	"positive regulation of transcription, DNA-templated;calcium-mediated signaling;neurogenesis;generation of neurons"	transcription activation;Ca2+ mediated signal transduction;neurogenesis	CREB1;LMO4	None	Most probably homodimerization of LMO4 and interaction with CREB is necessary for full Ca(2+)-dependent transcription activation. This complex plays a key role in patterning thalamocortical connections during development.	None
FHL2 homodimer complex	Q14192	2274	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding"	transcriptional control;protein binding	FHL2	None	FHL2 protein forms homodimer complexes.	None
"PDGFRA-SHP-2 complex, PDGF stimulated"	P16234;Q06124	5156;5781	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	PDGFRA;PTPN11	None	The data demonstrate that SHP-2 does not need to be tyrosine phosphorylated in order to bind to the phosphorylated PDGFRA and are consistent with the idea that SHP-2 binds to the PDGFRA directly.	None
FHL3 homodimer complex	Q13643	2275	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding"	transcriptional control;protein binding	FHL3	None	FHL3 protein forms homodimer complexes.	None
ACT homodimer complex	Q5TD97	9457	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding"	transcriptional control;protein binding	FHL5	None	ACT protein forms homodimer complexes.	None
"GRB2-SHP-2 complex, PDGF stimulated"	P62993;Q06124	2885;5781	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	GRB2;PTPN11	None	"In summary, the data demonstrate that activation of the PDGFRA leads to phosphorylation of SHP-2 at Y580, which appears to trigger the formation of a complex between Grb2 and SHP-2. In addition, SHP-2 binds the activated PDGFRA directly, whereas Grb2 binds indirectly, via SHP-2."	None
FHL2-FHL3 complex	Q13643;Q14192	2275;2274	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding"	transcriptional control;protein binding	FHL3;FHL2	None	None	None
FHL2-ACT complex	Q14192;Q5TD97	2274;9457	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding"	transcriptional control;protein binding	FHL2;FHL5	None	None	None
FHL2-CREB complex	P16220;Q14192	1385;2274	"positive regulation of transcription, DNA-templated;DNA binding;protein binding"	transcription activation;DNA binding;protein binding	CREB1;FHL2	None	FHL proteins differentially modulate CRE-dependent transcription in mammalian cells.	None
FHL3-CREB complex	P16220;Q13643	1385;2275	"positive regulation of transcription, DNA-templated;DNA binding;protein binding"	transcription activation;DNA binding;protein binding	CREB1;FHL3	None	FHL proteins differentially modulate CRE-dependent transcription in mammalian cells.	None
ACT-CREB complex	P16220;Q5TD97	1385;9457	"positive regulation of transcription, DNA-templated;DNA binding;protein binding"	transcription activation;DNA binding;protein binding	CREB1;FHL5	None	FHL proteins differentially modulate CRE-dependent transcription in mammalian cells.	None
FHL4/STX11-ACT complex	O75558;Q5TD97	8676;9457	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein binding"	transcriptional control;protein binding	STX11;FHL5	None	None	None
SMAD4-SNO-SKI complex	P12755;P12757;Q13485	6497;6498;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcriptional control;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SKI;SKIL;SMAD4	None	Ski and Sno associate predominantly with the MH2 domain of SMAD4.	None
SKI-SMAD2 complex	P12755;Q15796	6497;4087	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SKI;SMAD2	None	Smad proteins are the DNA-binding partners of Ski. Ski represses TGF(beta)-induced and SMAD-dependent transcriptional activation.	None
SKI-SMAD3 complex	P12755;P84022	6497;4088	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SKI;SMAD3	None	Smad proteins are the DNA-binding partners of Ski. Ski represses TGF(beta)-induced and SMAD-dependent transcriptional activation.	None
SMAD4-SKI complex	P12755;Q13485	6497;4089	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	SKI;SMAD4	None	Smad proteins are the DNA-binding partners of Ski. Ski represses TGF(beta)-induced and SMAD-dependent transcriptional activation.	None
SMAD2-SKI-NCOR complex	O75376;P12755;Q15796	9611;6497;4087	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	NCOR1;SKI;SMAD2	None	Ski recruits the corepressor N-Cor to the SMAD proteins.	None
SMAD3-SKI-NCOR complex	O75376;P12755;P84022	9611;6497;4088	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	NCOR1;SKI;SMAD3	None	Ski recruits the corepressor N-Cor to the SMAD proteins.	None
SMAD4-SKI-NCOR complex	O75376;P12755;Q13485	9611;6497;4089	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	NCOR1;SKI;SMAD4	None	Ski recruits the corepressor N-Cor to the SMAD proteins.	None
LIN2-LIN7-SAP97-MINT1 complex	O14910;O14936;Q02410;Q12959	8825;8573;320;1739	intracellular protein transport;protein targeting;protein transport;anisotropic cell growth;axis specification;epithelial cell differentiation;morphogenesis of an epithelium	"protein targeting, sorting and translocation;protein transport;directional cell growth (morphogenesis);asymmetries and axis determination;epithelium"	LIN7A;CASK;APBA1;DLG1	None	None	None
LIN2-LIN7 complex	O14910;O14936	8825;8573	intracellular protein transport;protein targeting;protein transport;anisotropic cell growth;axis specification;epithelial cell differentiation;morphogenesis of an epithelium	"protein targeting, sorting and translocation;protein transport;directional cell growth (morphogenesis);asymmetries and axis determination;epithelium"	LIN7A;CASK	None	It was earlier described that LIN-2/CASK and LIN-7 form a complex and localize to the basolateral surfaces of renal epithelia and MDCK (Madin-Darby canine kidney) cells (PMID:10710551).	None
LIN2-SAP97 complex	O14936;Q12959	8573;1739	intracellular protein transport;protein transport;anisotropic cell growth;axis specification;epithelial cell differentiation	"protein targeting, sorting and translocation;protein transport;directional cell growth (morphogenesis);asymmetries and axis determination;epithelium"	CASK;DLG1	None	Association of SAP97 with LIN-2/CASK is crucial for lateral localization of SAP97 in MDCK cells.	None
ULBP1-KLRK1-HCST complex	P26718;Q9BZM6;Q9UBK5	22914;80329;10870	immune response	immune response	KLRK1;ULBP1;HCST	None	The ULBPs and the MICs share the property of binding to the NKG2D/DAP10 receptor and provide a positive signal for NK cell activation and cytotoxicity that can override the negative signal mediated by MHC class I/KIR engagement.	None
CDK9-IL6ST complex	P40189;P50750	3572;1025	signaling;cytoplasm	cellular signalling;cytoplasm	IL6ST;CDK9	None	"The pleiotropic activities of the gp130-utilizing cytokinespoint to an extensive role for Cdk9 as aregulator of immune response, inflammation and celldifferentiation."	None
Eps15-stonin2 complex	P42566;Q8WXE9	2060;85439	intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.)"	EPS15;STON2	None	Eps15 and stonin2 have both been shown to directly associate with the clathrin adaptor complex AP-2 and to localize to clathrin-coated pits (CCPs).	None
"SMAD2-SMAD4-FAST1-TGIF complex, TGF(beta) induced"	O75593;Q13485;Q15583;Q15796	8928;4089;7050;4087	"negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;DNA binding;TGF-beta-receptor signalling pathway;nucleus	FOXH1;SMAD4;TGIF1;SMAD2	The orthologous human proteins are used.	This complex is only present in TGF(beta)-treated cells.	None
"SMAD2-SMAD4-FAST1-TGIF-HDAC1 complex, TGF(beta) induced"	O75593;Q13485;Q13547;Q15583;Q15796	8928;4089;3065;7050;4087	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;transforming growth factor beta receptor signaling pathway;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;TGF-beta-receptor signalling pathway;organization of chromosome structure;nucleus	FOXH1;SMAD4;HDAC1;TGIF1;SMAD2	The orthologous human proteins are used.	This complex is only present in TGF(beta)-treated cells. Interaction of TGIF with HDAC1 is necessary for silencing of TGF(beta) transcriptional responses.	None
SCAMP1-SCAMP2-SCAMP3 complex	O14828;O15126;O15127	10067;9522;10066	protein transport;protein transporter activity;post-Golgi vesicle-mediated transport	protein transport;post Golgi transport	SCAMP3;SCAMP1;SCAMP2	None	None	None
HERP1/HEY2-NCOR-SIN3A complex	Q13547;Q96ST3;Q9UBP5;Q9Y618	3065;25942;23493;9612	"DNA topological change;negative regulation of transcription, DNA-templated;DNA binding;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcription repression;DNA binding;organization of chromosome structure;nucleus	HDAC1;SIN3A;HEY2;NCOR2	"The authors state that SIN3A is part of the SIN3A complex, described in PMID:11784859."	HERP1/HEY2 associates with the SIN3A complex.	None
RB1-HDAC1-BRG1 complex	P06400;P51532;Q13547	5925;6597;3065	"DNA topological change;cell cycle arrest;negative regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);cell cycle arrest;transcription repression;organization of chromosome structure;nucleus	RB1;SMARCA4;HDAC1	None	"Rb forms a repressor containing histone deacetylase (HDAC) and the hSWI/SNF nucleosome remodeling complex, which inhibits transcription of genes for cyclins E and A and arrests cells in the G1 phase of the cell cycle."	None
Delta1 homodimer complex	O00548	28514	Notch signaling pathway	Notch-receptor signalling pathway	DLL1	None	None	None
Gamma-secretase-Delta1 complex	O00548;P49768;Q92542;Q96BI3;Q9NZ42	28514;5663;23385;51107;55851	Notch signaling pathway	Notch-receptor signalling pathway	DLL1;PSEN1;NCSTN;APH1A;PSENEN	None	None	None
"SMN complex (GEMIN2, GEMIN3, GEMIN4, GEMIN5, SMN)"	O14893;P57678;Q16637;Q8TEQ6;Q9UHI6	8487;50628;None;25929;11218	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;ion transport;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;ion transport;cytoplasm;nucleus	GEMIN2;GEMIN4;SMN1; SMN2;GEMIN5;DDX20	None	"The survival of motor neurons (SMN) protein is the product of the disease gene of spinal muscular atrophy and is found both in the cytoplasm and the nucleus, where it is concentrated in gems. SMN is part of a multiprotein complex that includes Gemin2, Gemin3, and Gemin4. The SMN complex plays an important role in the cytoplasmic assembly of small nuclear ribonucleoproteins (snRNPs) and likely other RNPs in pre-mRNA splicing and in the assembly of transcriptosomes. Here, we report the identification of an additional component of the SMN complex, a novel WD repeat protein termed Gemin5. Gemin5 binds SMN directly and is a component of the SMN complex."	Spinal muscular atrophy
"SMN complex (GEMIN5,4,3), SMN-independent intermediate"	P57678;Q8TEQ6;Q9UHI6	50628;25929;11218	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN4;GEMIN5;DDX20	None	The survival of motor neurons (SMN) complex is essential for the biogenesis of small nuclear ribonucleoprotein (snRNP) complexes in eukaryotic cells.	"Reduced levels of SMN cause the motor neuron degenerative disease, spinal muscular atrophy."
"SMN complex (GEMIN6,7, UNRIP), SMN-independent intermediate"	Q8WXD5;Q9H840;Q9Y3F4	79833;79760;11171	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN6;GEMIN7;STRAP	None	The survival of motor neurons (SMN) complex is essential for the biogenesis of small nuclear ribonucleoprotein (snRNP) complexes in eukaryotic cells.	"Reduced levels of SMN cause the motor neuron degenerative disease, spinal muscular atrophy."
"SMN complex (GEMIN2,5, SMN)"	O14893;Q16637;Q8TEQ6	8487;None;25929	RNA splicing;RNA biosynthetic process;protein complex assembly;RNA binding;cytoplasm;nucleus	splicing;RNA synthesis;assembly of protein complexes;RNA binding;cytoplasm;nucleus	GEMIN2;SMN1; SMN2;GEMIN5	None	The survival of motor neurons (SMN) complex is essential for the biogenesis of small nuclear ribonucleoprotein (snRNP) complexes in eukaryotic cells.	"Reduced levels of SMN cause the motor neuron degenerative disease, spinal muscular atrophy."
NIAP homotetramer complex	Q13075	4671	regulation of programmed cell death	regulation of apoptosis	NAIP	None	The expression of NAIP in macrophagesand the structural organization of the NAIP raise the possibilitythat the protein function may be activated by pathogen-associatedmolecular patterns concomitant with proinflammatorycaspases.The authors propose therefore that a key role of NAIP may therefore beto allow caspase-1 activation while suppressing unintentionalactivation of caspase-3/7 and -9.	None
BAX homo-oligomer complex	Q07812	581	apoptotic process;mitochondrion	apoptosis (type I programmed cell death);mitochondrion	BAX	None	In unstimulated cells BAX normally exists as monomer. After apoptotic stimulation Bax is oligomerized.	None
COG complex	P83436;Q14746;Q8WTW3;Q96JB2;Q96MW5;Q9H9E3;Q9UP83;Q9Y2V7	91949;22796;9382;83548;84342;25839;10466;57511	Golgi organization;Golgi apparatus	Golgi;Golgi	COG7;COG2;COG1;COG3;COG8;COG4;COG5;COG6	None	The COG complex plays important roles in Golgi structure and function.	None
Tetrameric COG subcomplex	P83436;Q96MW5;Q9UP83;Q9Y2V7	91949;84342;10466;57511	vesicle-mediated transport;Golgi organization;cytoplasm	"vesicular transport (Golgi network, etc.);Golgi;cytoplasm"	COG7;COG8;COG5;COG6	None	The COG complex plays important roles in Golgi structure and function.	None
COG5-COG6-COG7 subcomplex	P83436;Q9UP83;Q9Y2V7	91949;10466;57511	vesicle-mediated transport;Golgi organization;Golgi apparatus	"vesicular transport (Golgi network, etc.);Golgi;Golgi"	COG7;COG5;COG6	None	"The COG complex plays important roles in Golgi structure and function.COG6 interacts with a binary COG5-COG7 subcomplex. Similarly, it was shown that COG8 interacts with a ternary COG5-COG6-COG7subcomplex."	None
Binary COG subcomplex	P83436;Q9UP83	91949;10466	vesicle-mediated transport;Golgi organization;Golgi apparatus	"vesicular transport (Golgi network, etc.);Golgi;Golgi"	COG7;COG5	None	"The COG complex plays important roles in Golgi structure and function. COG6 interacts with a binary COG5-COG7 subcomplex.  Similarly, it was shown that COG8 interacts with a ternary COG5-COG6-COG7 subcomplex."	None
COG1-COG8 subcomplex	Q8WTW3;Q96MW5	9382;84342	"protein transport;protein transporter activity;retrograde transport, vesicle recycling within Golgi;Golgi organization"	protein transport;retrograde transport;Golgi	COG1;COG8	None	COG1-COG8 subcomplex constitutes a bridge linking COG2-COG3-COG4 subcomplex to COG5-COG6-COG7 subcomplex. For defining the complex composition the authors combined in vitro co-translation assay with co-immunoprecipitation.	None
COG2-COG3-COG4 subcomplex	Q14746;Q96JB2;Q9H9E3	22796;83548;25839	"protein transport;protein transporter activity;retrograde transport, vesicle recycling within Golgi;Golgi organization"	protein transport;retrograde transport;Golgi	COG2;COG3;COG4	None	For defining the complex composition the authors combined in vitro co-translation assay with co-immunoprecipitation.	None
COG5-COG6-COG7 subcomplex	P83436;Q9UP83;Q9Y2V7	91949;10466;57511	"protein transport;protein transporter activity;retrograde transport, vesicle recycling within Golgi;Golgi organization"	protein transport;retrograde transport;Golgi	COG7;COG5;COG6	None	For defining the complex composition the authors combined in vitro co-translation assay with co-immunoprecipitation.	None
COG1-COG8-COG2-COG3-COG4 subcomplex	Q14746;Q8WTW3;Q96JB2;Q96MW5;Q9H9E3	22796;9382;83548;84342;25839	"protein transport;protein transporter activity;retrograde transport, vesicle recycling within Golgi;Golgi organization"	protein transport;retrograde transport;Golgi	COG2;COG1;COG3;COG8;COG4	None	COG1 mediates the interaction between COG1-COG8 and COG2-COG3-COG4. For defining the complex composition the authors combined in vitro co-translation assay with co-immunoprecipitation.	None
COG1-COG8-COG5-COG6-COG7 subcomplex	P83436;Q8WTW3;Q96MW5;Q9UP83;Q9Y2V7	91949;9382;84342;10466;57511	"protein transport;protein transporter activity;retrograde transport, vesicle recycling within Golgi;Golgi organization"	protein transport;retrograde transport;Golgi	COG7;COG1;COG8;COG5;COG6	None	COG8 mediates interaction between COG1-COG8 subcomplex and COG5-COG6-COG7 subcomplex. For defining the complex composition the authors combined in vitro co-translation assay with co-immunoprecipitation.	None
COG complex	P83436;Q14746;Q8WTW3;Q96JB2;Q96MW5;Q9H9E3;Q9UP83;Q9Y2V7	91949;22796;9382;83548;84342;25839;10466;57511	"Golgi organization;protein glycosylation;retrograde vesicle-mediated transport, Golgi to ER"	"Golgi;modification with sugar residues (e.g. glycosylation, deglycosylation)"	COG7;COG2;COG1;COG3;COG8;COG4;COG5;COG6	None	COG1 mediates the interaction between COG1-COG8 and COG2-COG3-COG4.For defining the complex composition the authors combined in vitro co-translation assay with co-immunoprecipitation.	None
GammaH2AFX-NDHII-Ku70-DNA complex	P12956;P16104;Q08211	2547;3014;1660	DNA repair;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA damage response;nucleus	XRCC6;H2AFX;DHX9	None	"NDH II directly bound to gammaH2AX, whereas association of Ku70 with gammaH2AX was mediated by chromosomal DNA."	None
NR3C2-UBC9-SRC-1 complex	P08235;P63279;Q15788	4306;7329;8648	"positive regulation of transcription, DNA-templated;nucleus"	transcription activation;nucleus	NR3C2;UBE2I;NCOA1	None	"The results support a physiological role of Ubc9 as a transcriptional MR coactivator, beyond the known SUMO E2-conjugating enzyme."	None
RIN1-STAM2-HRS complex	O14964;O75886;Q13671	9146;10254;9610	intracellular protein transport;protein targeting;protein transport;endosome	"protein targeting, sorting and translocation;protein transport;endosome"	HGS;STAM2;RIN1	None	None	None
"RIN1-STAM2-EGFR complex, EGF stimulated"	O75886;P00533;Q13671	10254;1956;9610	intracellular protein transport;protein targeting;protein transport;endocytosis;epidermal growth factor receptor signaling pathway;endosome	"protein targeting, sorting and translocation;protein transport;endocytosis;EGF-receptor signalling pathway;endosome"	STAM2;EGFR;RIN1	None	"It seems that Rin1 plays dual roles, one facilitating cytoskeletal-dependent cellular movement and a second facilitating vesicle trafficking and receptor degradation."	None
CHL2-BMP2 complex	P12643;Q6WN34	650;25884	transmembrane receptor protein serine/threonine kinase signaling pathway;ossification;osteoclast differentiation	transmembrane receptor protein serine/threonine kinase signalling pathways;osteogenesis;bone	BMP2;CHRDL2	None	None	None
CHL2-BMP2-TSG complex	P12643;Q6WN34;Q9GZX9	650;25884;57045	transmembrane receptor protein serine/threonine kinase signaling pathway;ossification;osteoclast differentiation	transmembrane receptor protein serine/threonine kinase signalling pathways;osteogenesis;bone	BMP2;CHRDL2;TWSG1	None	None	None
Pericentrin-GCP complex	O95613;Q96CW5;Q9BSJ2	5116;10426;10844	"mitotic cell cycle;spindle assembly;centrosome;gamma-tubulin ring complex, centrosomal"	mitotic cell cycle;spindle pole body/centrosome and microtubule cycle;centrosome	PCNT;TUBGCP3;TUBGCP2	None	The authors show that the centrosomal coiled-coil protein pericentrin anchors gamma TuRCsat spindle poles through an interaction with gamma tubulin complex proteins 2 and 3 (GCP2/3).	None
SKI-SMAD2 complex	P12755;Q15796	6497;4087	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SKI;SMAD2	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
SKI-SMAD3 complex	P12755;P84022	6497;4088	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SKI;SMAD3	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
SKI-SMAD2-SMAD4  pentameric complex	P12755;Q13485;Q15796	6497;4089;4087	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SKI;SMAD4;SMAD2	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
SKI-SMAD3-SMAD4 complex	P12755;P84022;Q13485	6497;4088;4089	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SKI;SMAD3;SMAD4	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
CREBBP-SMAD2 hexameric complex	Q15796;Q92793	4087;1387	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SMAD2;CREBBP	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
CREBBP-SMAD3 hexameric complex	P84022;Q92793	4088;1387	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SMAD3;CREBBP	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
CREBBP-SMAD2-SMAD4 pentameric complex	Q13485;Q15796;Q92793	4089;4087;1387	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SMAD4;SMAD2;CREBBP	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
CREBBP-SMAD3-SMAD4 pentameric complex	P84022;Q13485;Q92793	4088;4089;1387	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway"	transcriptional control;TGF-beta-receptor signalling pathway	SMAD3;SMAD4;CREBBP	None	The results suggest that Ski negatively regulates TGF-beta signaling by replacing CBP in R-Smad complexes.	None
DRIP78-PHLP complex	Q13371;Q6Y2X3	5082;85406	intracellular protein transport;protein targeting;protein transport;heterotrimeric G-protein complex assembly	"protein targeting, sorting and translocation;protein transport"	PDCL;DNAJC14	None	The authors suggest that the DRiP78\u00b7PhLP complex is important in selective formation of different G-beta-gamma pairs.	None
ADRB2 homodimer complex	P07550	154	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	ADRB2	None	None	None
TCL1(trimer)-AKT1 complex	P31749;P56279	207;8115	kinase activator activity	kinase activator	AKT1;TCL1A	None	TCL1 forms trimers which associate with AKT1 and binds to AKT PH domain.TCL1 increases Akt kinase activity and as a consequence enhances substrate phosphorylation.It stabilizes the mitochondrial transmembrane potential and enhances cell proliferation and survival.	None
TCL1(trimer)-AKT2 complex	P31751;P56279	208;8115	kinase activator activity	kinase activator	AKT2;TCL1A	None	TCL1 forms trimers which associate with AKT1 and binds to AKT PH domain.TCL1 increases Akt kinase activity and as a consequence enhances substrate phosphorylation.It stabilizes the mitochondrial transmembrane potential and enhances cell proliferation and survival.	None
TCL1 homotrimer complex	P56279	8115	kinase activator activity	kinase activator	TCL1A	None	TCL1 forms trimers which associate with AKT1 and binds to AKT PH domain.TCL1 increases Akt kinase activity and as a consequence enhances substrate phosphorylation.It stabilizes the mitochondrial transmembrane potential and enhances cell proliferation and survival.	None
Rb-HDAC1 complex	P06400;Q13547	5925;3065	"DNA topological change;G1/S transition of mitotic cell cycle;negative regulation of transcription, DNA-templated;protein deacetylation;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);G1/S transition of mitotic cell cycle;transcription repression;modification by acetylation, deacetylation;organization of chromosome structure;nucleus"	RB1;HDAC1	None	None	None
GABP(gamma)1-E2F1-DP1 complex	Q01094;Q14186;Q8TAK5	1869;7027;126626	"G1/S transition of mitotic cell cycle;positive regulation of transcription, DNA-templated;DNA binding;apoptotic process;nucleus"	G1/S transition of mitotic cell cycle;transcription activation;DNA binding;apoptosis (type I programmed cell death);nucleus	E2F1;TFDP1;GABPB2	None	None	None
"Ternary complex (GATA4, SRF, MYOCD)"	P11831;P43694;Q8IZQ8	6722;2626;93649	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	SRF;GATA4;MYOCD	None	None	None
RAB11FIP1-RAB11A complex	P62491;Q6WKZ4	8766;80223	intracellular protein transport;protein targeting;protein transport;receptor regulator activity	"protein targeting, sorting and translocation;protein transport;regulator of receptor activity"	RAB11A;RAB11FIP1	None	The RCP-Rab11 complex regulates the sorting of transferrin receptors from the degradative to the recycling pathway.	None
"SKI-SMAD3-SMAD4 complex, TGF(beta)-dependent"	P12755;P84022;Q13485	6497;4088;4089	"negative regulation of transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;nucleus"	transcription repression;TGF-beta-receptor signalling pathway;nucleus	SKI;SMAD3;SMAD4	None	c-SKI interacts with SMAD in a TGF(beta)-dependent manner.	None
SMAD3-cSKI-SIN3A-HDAC1 complex	P12755;P84022;Q13547;Q96ST3	6497;4088;3065;25942	"DNA topological change;negative regulation of transcription, DNA-templated;protein deacetylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcription repression;modification by acetylation, deacetylation;DNA binding;organization of chromosome structure;nucleus"	SKI;SMAD3;HDAC1;SIN3A	None	None	None
"Ubiquitin E3 ligase (SMURF2, SMAD3) - SnoN complex, TGF(beta)-dependent"	P12757;P84022;Q9HAU4	6498;4088;64750	"negative regulation of transcription, DNA-templated;protein ubiquitination;transforming growth factor beta receptor signaling pathway;nucleus;ubiquitin-dependent protein catabolic process"	"transcription repression;modification by ubiquitination, deubiquitination;TGF-beta-receptor signalling pathway;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	SKIL;SMAD3;SMURF2	None	This complex allows SMURF2 to target SnoN for ubiquitin-mediated degradation.	None
mTORC2 complex	P42345;Q6R327;Q9BPZ7;Q9BVC4	2475;253260;79109;64223	cell morphogenesis;cell growth;actin cytoskeleton organization;regulation of protein kinase B signaling	cell growth / morphogenesis;actin cytoskeleton	MTOR;RICTOR;MAPKAP1;MLST8	None	"The authors showed that hSin1, similar to Rictor, is selectively required for the phosphorylation and activation of the TORC2 substrate Akt, but not the TORC1 substrate S6K and that it plays an important role in the regulation of Akt activity and the phosphorylation of Akt substrates in vivo. They mentioned LST8 as a conserved component of the complex but did not show it in the experiments."	None
"mTOR complex (MTOR, RAPTOR, MLST8)"	P42345;Q8N122;Q9BVC4	2475;57521;64223	cell morphogenesis;cell growth	cell growth / morphogenesis	MTOR;RPTOR;MLST8	None	The raptor-mTOR complex regulates by phosphorylating the ribosomal S6 Kinase (S6K) in a  rapamycin-sensitive manner.	None
"ClpP complex, heptameric"	Q16740	8192	protein binding;mitochondrion	protein binding;mitochondrion	CLPP	None	ClpP occurs as a stable heptamer in solution. Heptameric hClpP has no proteolytic activity and very low peptidase activity.	None
"ClpX complex, hexameric"	O76031	10845	protein binding;mitochondrion	protein binding;mitochondrion	CLPX	None	None	None
ClpXP complex	O76031;Q16740	10845;8192	protein catabolic process;protein binding;mitochondrion	protein/peptide degradation;protein binding;mitochondrion	CLPX;CLPP	None	"In the presence of ATP, ClpX promotes interaction between two ClpP rings, forming a proteolytic active ClpXP complex: two rings of ClpP heptamers bind to two ClpX hexamers."	None
ACTN1-PARVB complex	P12814;Q9HBI1	87;29780	integrin-mediated signaling pathway;actin cytoskeleton	integrin receptor signalling pathway;actin cytoskeleton	ACTN1;PARVB	None	Affixin interacts with alpha-actinin and mediates integrin signaling for reorganization of F-actin induced by initial cell\u2013substrate interaction.	None
PAR4-BACE1 complex	P56817;Q96IZ0	23621;5074	protein catabolic process	protein/peptide degradation	BACE1;PAWR	None	The C-terminal domain of PAR-4 is necessary for forming a complex with the cytosolic tail of BACE1. PAR-4 may be directly involved in regulating the APP cleavage activity of BACE1.	This complex is involved in the pathogenesis of Alzheimer disease.
NEMO-HIF2(alpha)-ARNT complex	P27540;Q99814;Q9Y6K9	405;2034;8517	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling"	transcriptional control;NIK-I-kappaB/NF-kappaB cascade	ARNT;EPAS1;IKBKG	None	During hypoxia HIF(alpha) proteins migrate into the nucleus and heterodimerize with the aryl hydrocarbon nuclear translocator ARNT (also called HIF-1(beta)).	None
"Ubiquitin E3 ligase (CUL1, RBX1, SKP1)"	P62877;P63208;Q13616	9978;6500;8454	chromosome organization;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"organization of chromosome structure;modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;SKP1;CUL1	None	SCFhFBH1 (=SKP1/CUL1/ROC1 - human F-box DNA helicase) can act as helicase and E3 ubiquitin ligase.	None
Ku antigen complex	P12956;P13010	2547;7520	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	XRCC6;XRCC5	None	Ku complex interacts with and stimulates the Werner protein.	None
XRCC6-XRCC5-WRN complex	P12956;P13010;Q14191	2547;7520;7486	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	XRCC6;XRCC5;WRN	None	Ku complex interacts with and stimulates the Werner protein.	Werner syndrome (=is the hallmark premature agingdisorder in which affected humans appear older thantheir chronological age).
SMAD6-HOXC8 complex	O43541;P31273	4091;3224	"negative regulation of transcription, DNA-templated;DNA binding"	transcription repression;DNA binding	SMAD6;HOXC8	None	The Smad6-Hoxc8 complex inhibits interaction of Smad1 with Hoxc-8- and Smad1-induced transcription activity.	None
SMAD6-HOXA9 complex	O43541;P31269	4091;3205	DNA binding	DNA binding	SMAD6;HOXA9	None	None	None
CTNNAL1-CTNNB1 complex	P35222;Q9UBT7	1499;8727	signaling;cell adhesion	cellular signalling;cell adhesion	CTNNB1;CTNNAL1	None	None	None
CTNNA1-CTNNB1 complex	P35221;P35222	1495;1499	signaling;cell adhesion	cellular signalling;cell adhesion	CTNNA1;CTNNB1	None	None	None
"TSC (TSC1, TSC2, AXIN, GSK3) complex"	O15169;P49815;P49841;Q92574	8312;7249;2932;7248	TSC1-TSC2 complex;regulation of Wnt signaling pathway;mRNA transcription;beta-catenin destruction complex binding	mRNA synthesis	AXIN1;TSC2;GSK3B;TSC1	"Since the authors did not specify GSK3, we used isoform GSK3B."	TSC1/TSC2 complex associated with GSK3 and Axin promotes beta-catenin degradation to inhibit Wnt-stimulated TCF/LEF-dependent transcription. Beta-catenin signaling plays a role in TSC pathogenesis in vivo and suggest a novel role of GSK3 in modulating the TSC1/TSC2 complex through TSC1 phosphorylation.	"angiomyolipomas (AML), lymphangioleiomyomatosis (LAM)"
HSP90-FKBP38-CAM-Ca(2+) complex	P07900;P62158;Q14318	3320;None;23770	regulation of programmed cell death	regulation of apoptosis	HSP90AA1;CALM1; CAL;FKBP8	"Since the authors did not specify HSP90, we used isoform HSP90A."	"The authors show that the TPR domain of FKBP38 interacts with the C-terminal domain of Hsp90, but only if the FKBP38-CaM-Ca(2+) complex is preformed. The resulting ternary complex is enzymatically inactive, and the association of Bcl-2 and the PPIase site of FKBP38 is prevented."	None
DNM1L-FIS1 complex	O00429;Q9Y3D6	10059;51024	mitochondrion organization;mitochondrial fission	mitochondrion	DNM1L;FIS1	None	The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1.	None
HNRNPU-NR3C1 complex	P04150;Q00839	2908;3192	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	NR3C1;HNRNPU	None	"The glucocorticoid receptor (GR) is a ligand-dependent transcription factor that is able to modulate gene activity by binding to its response element, interactingwith other transcription factors (here = GRIP120 = hnRNP U), and contacting several accessory proteins such as coactivators."	None
"EIF3 core complex (EIF3A, EIF3B, EIF3G, EIF3I)"	O75821;P55884;Q13347;Q14152	8666;8662;8668;8661	translational initiation	translation initiation	EIF3G;EIF3B;EIF3I;EIF3A	None	EIF3b appears to be a central scaffolding subunit.	None
"EIF3 complex (EIF3A, EIF3B, EIF3G, EIF3I, EIF3C)"	O75821;P55884;Q13347;Q14152;Q99613	8666;8662;8668;8661;8663	translational initiation	translation initiation	EIF3G;EIF3B;EIF3I;EIF3A;EIF3C	None	"EIF3b appears to be a central scaffolding subunit. EIF3c is able to associate with the four-subunit eIF3 subcomplex, but does so only weakly under these expression and purification conditions."	None
"EIF3 complex (EIF3B, EIF3G, EIF3I)"	O75821;P55884;Q13347	8666;8662;8668	translational initiation	translation initiation	EIF3G;EIF3B;EIF3I	None	None	None
"EIF3 complex (EIF3B, EIF3J, EIF3I)"	O75822;P55884;Q13347	8669;8662;8668	translational initiation	translation initiation	EIF3J;EIF3B;EIF3I	None	None	None
"EIF3 complex (EIF3A, EIF3B, EIF3G, EIF3I, EIF3J)"	O75821;O75822;P55884;Q13347;Q14152	8666;8669;8662;8668;8661	translational initiation	translation initiation	EIF3G;EIF3J;EIF3B;EIF3I;EIF3A	None	EIF3b appears to be a central scaffolding subunit. The authors conclude that EIF3J promotes the stable association of EIF3 subcomplexes to the 40S ribosomal subunit.	None
CBF-DNA complex	P23511;P25208;Q13952	4800;4801;4802	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding;nucleus"	transcriptional control;DNA binding;nucleus	NFYA;NFYB;NFYC	None	None	None
p32-CBF-DNA complex	P23511;P25208;Q07021;Q13952	4800;4801;708;4802	"negative regulation of transcription, DNA-templated;DNA binding;nucleus"	transcription repression;DNA binding;nucleus	NFYA;NFYB;C1QBP;NFYC	None	p32 interacts specifically with CBF-B subunit and also associates with CBF-DNA complex.	None
beta(1)-AR receptosome (ADRB1-SAP97-AKAP79-PRKAR2A)	P08588;P13861;P24588;Q12959	153;5576;9495;1739	protein targeting;protein phosphorylation;G-protein coupled receptor signaling pathway;receptor recycling	"protein targeting, sorting and translocation;modification by phosphorylation, dephosphorylation, autophosphorylation;G-protein coupled receptor signalling pathway"	ADRB1;PRKAR2A;AKAP5;DLG1	None	SAP97 siRNA abolished the ability of the beta(1)-AR to co-immunoprecipitate AKAP79 and SAP97. This indicates that SAP97 probably serves as a bridging molecule between the beta1-AR and the AKAP79-PKA complex.	None
SVIP-VCP-DERL1 complex	P55072;Q8NHG7;Q9BUN8	7415;258010;79139	endoplasmic reticulum unfolded protein response;endoplasmic reticulum	unfolded protein response (e.g. ER quality control);endoplasmic reticulum	VCP;SVIP;DERL1	None	"The authors identified SVIP as the first endogenous inhibitor of ERAD (ER-associated degradation) that uses a novel mechanism through inhibiting the assembly of the gp78-p97/VCP-Derlin1 complex. The data suggest that p97/VCP and Derlin1 can form a complex with either gp78 or SVIP. The gp78 complex facilitates ERAD, whereas the SVIP complex inhibits ERAD."	None
gp78-VCP-DERL1 complex	P55072;Q9BUN8;Q9UKV5	7415;79139;267	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;endoplasmic reticulum unfolded protein response;endoplasmic reticulum	proteasomal degradation (ubiquitin/proteasomal pathway);unfolded protein response (e.g. ER quality control);endoplasmic reticulum	VCP;DERL1;AMFR	None	"The authors identified SVIP as the first endogenous inhibitor of ERAD (ER-associated degradation) that uses a novel mechanism through inhibiting the assembly of the gp78-p97/VCP-Derlin1 complex. The data suggest that p97/VCP and Derlin1 can form a complex with either gp78 or SVIP. The gp78 complex facilitates ERAD, whereas the SVIP complex inhibits ERAD."	None
VCP-VIMP-DERL1 complex	P55072;Q9BQE4;Q9BUN8	7415;55829;79139	None	None	VCP;VIMP;DERL1	None	None	None
VCP-VIMP-DERL2 complex	P55072;Q9BQE4;Q9GZP9	7415;55829;51009	endoplasmic reticulum unfolded protein response;endoplasmic reticulum;ERAD pathway	unfolded protein response (e.g. ER quality control);endoplasmic reticulum	VCP;VIMP;DERL2	None	None	None
VCP-VIMP-DERL1-DERL2-HRD1-SEL1L complex	P55072;Q86TM6;Q9BQE4;Q9BUN8;Q9GZP9;Q9UBV2	7415;84447;55829;79139;51009;6400	endoplasmic reticulum unfolded protein response;endoplasmic reticulum;ERAD pathway	unfolded protein response (e.g. ER quality control);endoplasmic reticulum	VCP;SYVN1;VIMP;DERL1;DERL2;SEL1L	None	Cell lin: U373.	None
RB1(hypophosphorylated)-E2F4 complex	P06400;Q16254	5925;1874	"G1/S transition of mitotic cell cycle;negative regulation of transcription, DNA-templated"	G1/S transition of mitotic cell cycle;transcription repression	RB1;E2F4	None	"Hypo-phosphorylated Rb interacts with E2F4 in the early G1 phase of the cell cyclus. Inactivation of Rb by hyper-phosphorylation in late G1 phase causes release of E2F, allowing transcription of genes important for DNA synthesis."	None
CyclinD3-CDK4-CDK6 complex	P11802;P30281;Q00534	1019;896;1021	mitotic cell cycle;G1/S transition of mitotic cell cycle;intracellular signal transduction;skeletal muscle tissue development	mitotic cell cycle;G1/S transition of mitotic cell cycle;cellular signalling;myogenesis	CDK4;CCND3;CDK6	None	Upon myocyte differentiation subunit composition of the CDK4/6 complex is altered. Interaction with cyclinD1 is reduced but interaction with cyclinD3 and p21 is enhanced thus inhibiting the kinase activity of CDK4/6.	None
CyclinD3-CDK4-CDK6-p21 complex	P11802;P30281;P38936;Q00534	1019;896;1026;1021	mitotic cell cycle;G1/S transition of mitotic cell cycle;intracellular signal transduction;skeletal muscle tissue development	mitotic cell cycle;G1/S transition of mitotic cell cycle;cellular signalling;myogenesis	CDK4;CCND3;CDKN1A;CDK6	None	Upon myocyte differentiation subunit composition of the CDK4/6 complex is altered. Interaction with cyclinD1 is reduced but interaction with cyclinD3 and p21 is enhanced thus inhibiting the kinase activity of CDK4/6.	None
p34(SEI-1)-CDK4-CyclinD2 complex	P11802;P30279;Q9UHV2	1019;894;29950	DNA replication;intracellular signal transduction	DNA synthesis and replication;cellular signalling	CDK4;CCND2;SERTAD1	None	p34(SEI1) binds to the CDK4-CyclinD2 complex.	None
"RBL2 complex (DNMT1, E2F4, E2F5, HDAC1, SUV39H1, RBL2)"	O43463;P26358;Q08999;Q13547;Q15329;Q16254	6839;1786;5934;3065;1875;1874	"transcription, DNA-templated"	TRANSCRIPTION	SUV39H1;DNMT1;RBL2;HDAC1;E2F5;E2F4	None	pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.	breast cancer
"RBL2 complex (E2F4, E2F5, HDAC1, SUV39H1, P300, RBL2)"	O43463;Q08999;Q09472;Q13547;Q15329;Q16254	6839;5934;2033;3065;1875;1874	"transcription, DNA-templated"	TRANSCRIPTION	SUV39H1;RBL2;EP300;HDAC1;E2F5;E2F4	None	pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.	breast cancer
RB-E2F1 complex	P06400;Q01094	5925;1869	"mitotic G1 phase;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	G1 phase of mitotic cell cycle;transcriptional control	RB1;E2F1	None	Rb forms a complex with E2F1 in the G1 phase of the cell cycle.	None
E2F1-p107-cyclinA complex	P20248;P28749;Q01094	890;5933;1869	"mitotic S phase;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	S phase of mitotic cell cycle;transcriptional control	CCNA2;RBL1;E2F1	None	p107 forms a complex with E2F1 and cyclin A in the S phase of the cell cycle.	None
RB1-TFAP2A complex	P05549;P06400	7020;5925	"positive regulation of transcription, DNA-templated"	transcription activation	TFAP2A;RB1	None	None	None
CTFC-TAF1 complex	P49711;Q01105	10664;6418	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	CTCF;SET	None	None	None
CTCF-nucleophosmin complex	P06748;P49711	4869;10664	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	NPM1;CTCF	None	CTCF and nucleophosmin work together as insularors blocking enhancer activity.	None
E2F4-p107-cyclinE complex	P24864;P28749;Q16254	898;5933;1874	G1/S transition of mitotic cell cycle;nucleus	G1/S transition of mitotic cell cycle;nucleus	CCNE1;RBL1;E2F4	None	In proliferating MCF-7 cells the complex contains mostly cyclin A. After overexpression of cyclin E most of the complexes contain cyclin E.	None
E2F4-p130 complex	Q08999;Q16254	5934;1874	G1/S transition of mitotic cell cycle;nucleus	G1/S transition of mitotic cell cycle;nucleus	RBL2;E2F4	None	After tamoxifen treatment p107 is replaced by p130.	None
ELK1-SRF-ELK3 complex	P11831;P19419;P41970	6722;2002;2004	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	SRF;ELK1;ELK3	None	None	None
AP1G1-PACS1-FURIN complex	O43747;P09958;Q6VY07	164;5045;55690	intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.)"	AP1G1;FURIN;PACS1	None	The data suggest that PACS-1 functions in a connector capacity by linking acidic cluster motifs to adaptor complexes and their associated vesicle-generating machinery.	None
SH3KBP1-CBLB-EGFR complex	P00533;Q13191;Q96B97	1956;868;30011	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways	EGFR;CBLB;SH3KBP1	None	"Growth factor stimulation led to a complex formation between endogenous SH3KBP1, Cbl-b and EGF or PDGF receptors in several cell lines. The results suggested that SH3KBP1 binding to Cbl-b is important for EGF receptor internalization, although it has no effect on Cbl-b-induced receptor ubiquitination."	None
MGC1-DNA-PKcs-Ku complex	P12956;P13010;P78527;Q14676	2547;7520;5591;9656	DNA repair;cell cycle checkpoint;cellular response to DNA damage stimulus;nucleus	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);DNA damage response;nucleus"	XRCC6;XRCC5;PRKDC;MDC1	None	MDC1 directly interacts with the DNA-PKc-Ku complex and this interaction is required for efficient DNA-PK autophosphorylation and DNA damage repair.	None
"Polycystin-1 multiprotein complex (ACTN1, CDH1, SRC, JUP, VCL, CTNNB1, PXN, BCAR1, PKD1, PTK2, TLN1)"	P12814;P12830;P12931;P14923;P18206;P35222;P49023;P56945;P98161;Q05397;Q9Y490	87;999;6714;3728;7414;1499;5829;9564;5310;5747;7094	cell adhesion;epithelial cell differentiation;morphogenesis of an epithelium;kidney development	cell adhesion;epithelium;kidney	ACTN1;CDH1;SRC;JUP;VCL;CTNNB1;PXN;BCAR1;PKD1;PTK2;TLN1	None	The results suggest that polycystin-1 complexes are present in focal adhesions in subconfluent cells  and in both focal adhesions and cell\u2013cell adherens complexes in confluent cells.	PKD1 is involved in autosomal dominant polycystic kidney disease (ADPKD).
JAK2-PAFR-TYK2 complex	O60674;P25105;P29597	3717;5724;7297	JAK-STAT cascade	JAK-STAT cascade	JAK2;PTAFR;TYK2	None	None	None
NCOA6-DNA-PK-Ku-PARP1 complex	P09874;P12956;P13010;P78527;Q14686	142;2547;7520;5591;23054	DNA repair;nucleus	DNA repair;nucleus	PARP1;XRCC6;XRCC5;PRKDC;NCOA6	None	TRBP (NCOA6) stimulates DNA-PK kinase activity in the absence of DNA.	None
DNA-PK-Ku complex	P12956;P13010;P78527	2547;7520;5591	DNA repair;protein phosphorylation;protein autophosphorylation;DNA binding;nucleus;mRNA transcription	"DNA repair;modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding;nucleus;mRNA synthesis"	XRCC6;XRCC5;PRKDC	None	For assembly of the DNA-PK-Ku70-Ku80 complex presence of DNA is necessary.	None
DNA-PK-Ku-eIF2-NF90-NF45 complex	P05198;P12956;P13010;P20042;P41091;P78527;Q12905;Q12906	1965;2547;7520;8894;1968;5591;3608;3609	DNA repair;protein phosphorylation;protein autophosphorylation;DNA binding;nucleus	"DNA repair;modification by phosphorylation, dephosphorylation, autophosphorylation;DNA binding;nucleus"	EIF2S1;XRCC6;XRCC5;EIF2S2;EIF2S3;PRKDC;ILF2;ILF3	None	"NF90, in complex with NF45, interacts with DNA-PKcs and Ku and promotes formation of a complex on DNA."	None
SWI/SNF-related chromatin-remodeling complex	P51531;P51608;Q13547;Q969G3;Q96ST3	6595;4204;3065;6605;25942	"negative regulation of transcription, DNA-templated;chromatin remodeling"	transcription repression	SMARCA2;MECP2;HDAC1;SMARCE1;SIN3A	None	"Human Brahma (Brm), a catalytic component of the SWI/SNF-related chromatin-remodeling complex, associates with MeCP2 in vivo and is functionally linked with repression. Brm-containing MeCP2 corepressor complex includes HDAC1 and Sin3aon soluble chromatin. MeCP2, Brm and BAF57 coimmunoprecipitate. BAF57 was associated with the FMR1 promoter on the repressed gene in FRAXA cells."	Brm and MeCP2 assembly on chromatin occurs on methylated genes in cancer and the gene FMR1 in fragile X syndrome.
YWHAQ-CALM1-CABIN1 complex	P27348;P62158;Q9Y6J0	10971;None;23523	signaling	cellular signalling	YWHAQ;CALM1; CAL;CABIN1	None	None	None
TIAM1-EFNB1-EPHA2 complex	P29317;P98172;Q13009	1969;1947;7074	neurogenesis;neuron projection development	neurogenesis	EPHA2;EFNB1;TIAM1	None	Tiam1 is required for neurite outgrowth induced by both ephrin-B1-mediated reverse signaling and EphA2-mediated forward signaling.	None
"TNF-alpha/NF-kappa B signaling complex (CHUK, KPNA3, NFKB2, NFKBIB, REL, IKBKG,  NFKB1, NFKBIE, RELB,  NFKBIA, RELA, TNIP2)"	O00221;O00505;O15111;P19838;P25963;Q00653;Q01201;Q04206;Q04864;Q15653;Q8NFZ5;Q9Y6K9	4794;None;1147;4790;4792;4791;5971;5970;5966;4793;79155;8517	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	NFKBIE;KPNA3;CHUK;NFKB1;NFKBIA;NFKB2;RELB;RELA;REL;NFKBIB;TNIP2;IKBKG	None	None	None
"TNF-alpha/NF-kappa B signaling complex (SEC16A, CHUK, IKBKB, NFKB2, REL, IKBKG, MAP3K14, RELA, FBXW7, USP2)"	O14920;O15027;O15111;O75604;Q00653;Q04206;Q04864;Q969H0;Q99558;Q9Y6K9	3551;9919;1147;9099;4791;5970;5966;55294;9020;8517	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	IKBKB;SEC16A;CHUK;USP2;NFKB2;RELA;REL;FBXW7;MAP3K14;IKBKG	None	None	None
PTIP-HMT complex	O15550;P61964;Q14686;Q15291;Q6ZW49;Q8NEZ4;Q9BTK6;Q9C005;Q9UBL3;Q9UMN6	7403;11091;23054;5929;22976;58508;79447;84661;9070;None	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;DNA binding;chromosome organization;nucleus"	"DNA conformation modification (e.g. chromatin);transcriptional control;posttranslational modification of amino acids (e.g. hydroxylation, methylation);DNA binding;organization of chromosome structure;nucleus"	KDM6A;WDR5;NCOA6;KDM6B;PAXIP1;KMT2C;PAGR1;DPY30;ASH2L;KMT2B	None	In cells without DNA damage PTIP associates with proteins involved in regulation of gene expression.	None
"TNF-alpha/NF-kappa B signaling complex (CHUK, BTRC, NFKB2, PPP6C, REL, CUL1, IKBKE, SAPS2, SAPS1, ANKRD28, RELA, SKP1)"	O00743;O15084;O15111;O75170;P63208;Q00653;Q04206;Q04864;Q13616;Q14164;Q9UPN7;Q9Y297	5537;23243;1147;9701;6500;4791;5970;5966;8454;9641;22870;8945	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	PPP6C;ANKRD28;CHUK;PPP6R2;SKP1;NFKB2;RELA;REL;CUL1;IKBKE;PPP6R1;BTRC	None	None	None
PTIP-DNA damage response complex	O60934;P49959;P54132;Q12888;Q6ZW49;Q92878	4683;4361;641;7158;22976;10111	DNA repair;DNA binding;cellular response to DNA damage stimulus;nucleus	DNA repair;DNA binding;DNA damage response;nucleus	NBN;MRE11A;BLM;TP53BP1;PAXIP1;RAD50	None	"In cells treated with DNA damage agents, PTIP associates with proteins involved in DNA damage response and DNA repair."	None
"CBP-RARA-RXRA-DNA complex, ligand stimulated"	P10276;P19793;Q92793	5914;6256;1387	"positive regulation of transcription, DNA-templated;signaling;nucleus"	transcription activation;cellular signalling;nucleus	RARA;RXRA;CREBBP	None	The authors suggest that CBP/p300 serves as an integrator of multiple signal transduction pathways within the nucleus.	None
Kinase maturation complex 1	P07900;P08238;P27348;P31946;P34932;P61981;P62258;P63104;Q04917;Q13163;Q16543;Q6Q0C0;Q7KZI7;Q99759;Q9NUG6;Q9UHV9	3320;3326;10971;7529;3308;7532;7531;7534;7533;5607;11140;84231;2011;4215;81572;5202	intracellular signal transduction	cellular signalling	HSP90AA1;HSP90AB1;YWHAQ;YWHAB;HSPA4;YWHAG;YWHAE;YWHAZ;YWHAH;MAP2K5;CDC37;TRAF7;MARK2;MAP3K3;PDRG1;PFDN2	None	None	None
Ubiquilin-proteasome complex	P25786;P25787;P60900;Q05086;Q9UHD9;Q9UMX0	5682;5683;5687;7337;29978;29979	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	PSMA1;PSMA2;PSMA6;UBE3A;UBQLN2;UBQLN1	None	None	None
TANK-TRAF2-TRAF3 complex	Q12933;Q13114;Q92844	7186;7187;10010	signaling	cellular signalling	TRAF2;TRAF3;TANK	None	None	None
RAF1-PPP2-PIN1 complex	P04049;P30153;P62714;P63151;Q13526	5894;5518;5516;5520;5300	transmembrane receptor protein serine/threonine kinase signaling pathway	transmembrane receptor protein serine/threonine kinase signalling pathways	RAF1;PPP2R1A;PPP2CB;PPP2R2A;PIN1	None	"The Raf-1 kinase is an important signaling molecule,functioning in the Ras pathway to transmit mitogenic,differentiative, and oncogenic signals to the downstream kinases MEK and ERK."	None
Kinase maturation complex 2	A7MCY6;P07900;P08238;Q12933;Q16543;Q92844;Q9H6S1;Q9UHD2	9755;3320;3326;7186;11140;10010;64343;29110	intracellular signal transduction	cellular signalling	TBKBP1;HSP90AA1;HSP90AB1;TRAF2;CDC37;TANK;AZI2;TBK1	None	None	None
Pex26-Pex6-Pex1 complex	O43933;Q13608;Q7Z412	5189;5190;55670	peroxisome organization;peroxisome	peroxisome;peroxisome	PEX1;PEX6;PEX26	None	The results indicate that Pex26 anchors Pex6 and Pex1 through Pex26-Pex6 and Pex6-Pex1 interactions.	"The complex is involved in peroxisome biogenesis disorders (PBDs), such as Zellweger syndrome and neonatal adrenoleukodystrophy."
CS-MAP3K7IP1-MAP3K7IP2 complex	O75390;Q15750;Q9NYJ8	1431;10454;23118	intracellular signal transduction	cellular signalling	CS;TAB1;TAB2	None	None	None
Calreticulin homo-oligomer complex	P27797	811	response to heat	heat shock response	CALR	The protein complex consists of several identical subunits (oligomerization).	"Heat shock, calcium depletion, or deletion of the C-terminal acidic domain enhance binding of purified calreticulin to polypeptide substrates and enhance calreticulin's chaperone activity. These conditions also enhance calreticulin oligomerization. In cells, calreticulin binds to deglycosylated major histocompatibility complex class I heavy chains when significant levels of calreticulin oligomerization intermediates are induced."	None
CHUK-IQGAP2-AKAP8L-RELA-TNIP2 complex	O15111;Q04206;Q13576;Q8NFZ5;Q9ULX6	1147;5970;10788;79155;26993	intracellular signal transduction	cellular signalling	CHUK;RELA;IQGAP2;TNIP2;AKAP8L	None	None	None
p14-Mp1-MEK1 complex	Q02750;Q9UHA4;Q9Y2Q5	5604;8649;28956	MAPK cascade	MAPKKK cascade	MAP2K1;LAMTOR3;LAMTOR2	None	None	None
"Casein kinase II (beta-dimer, alpha'-dimer)"	P19784;P67870	1459;1460	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	CSNK2A2;CSNK2B	None	None	None
"Casein kinase II (beta-dimer, alpha, alpha')"	P19784;P67870;P68400	1459;1460;1457	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	CSNK2A2;CSNK2B;CSNK2A1	None	None	None
"Casein kinase II (beta-dimer, alpha-dimer)"	P67870;P68400	1460;1457	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	CSNK2B;CSNK2A1	None	None	None
p14-Mp1-ERK2 complex	P28482;Q9UHA4;Q9Y2Q5	5594;8649;28956	MAPK cascade	MAPKKK cascade	MAPK1;LAMTOR3;LAMTOR2	None	None	None
REL-MAP3K8-RELA-TNIP2-PAPOLA complex	P41279;P51003;Q04206;Q04864;Q8NFZ5	1326;10914;5970;5966;79155	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	MAP3K8;PAPOLA;RELA;REL;TNIP2	None	None	None
RPA complex	P15927;P27694;P35244	6118;6117;6119	DNA replication;DNA binding	DNA synthesis and replication;DNA binding	RPA2;RPA1;RPA3	None	RPA facilitates unwinding of dsDNA.	None
CHUK-NFKB2-REL-IKBKG-SPAG9-NFKB1-NFKBIE-COPB2-TNIP1-NFKBIA-RELA-TNIP2 complex	O00221;O15111;O60271;P19838;P25963;P35606;Q00653;Q04206;Q04864;Q15025;Q8NFZ5;Q9Y6K9	4794;1147;9043;4790;4792;9276;4791;5970;5966;10318;79155;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	NFKBIE;CHUK;SPAG9;NFKB1;NFKBIA;COPB2;NFKB2;RELA;REL;TNIP1;TNIP2;IKBKG	None	None	None
53BP1-containing complex	P12956;P13010;P15927;P27694;Q12888	2547;7520;6118;6117;7158	DNA repair;DNA binding;cellular response to DNA damage stimulus	DNA repair;DNA binding;DNA damage response	XRCC6;XRCC5;RPA2;RPA1;TP53BP1	None	53BP1 is involved in DNA damage-induced RPA2 phosphorylation.	None
"TNF-alpha/Nf-kappa B signaling complex (RPL6, RPL30, RPS13, CHUK, DDX3X, NFKB2, NFKBIB, REL, IKBKG, NFKB1, MAP3K8, RELB, GLG1, NFKBIA, RELA, TNIP2,  GTF2I)"	O00571;O15111;P19838;P25963;P41279;P62277;P62888;P78347;Q00653;Q01201;Q02878;Q04206;Q04864;Q15653;Q8NFZ5;Q92896;Q9Y6K9	1654;1147;4790;4792;1326;6207;6156;2969;4791;5971;6128;5970;5966;4793;79155;2734;8517	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	DDX3X;CHUK;NFKB1;NFKBIA;MAP3K8;RPS13;RPL30;GTF2I;NFKB2;RELB;RPL6;RELA;REL;NFKBIB;TNIP2;GLG1;IKBKG	None	None	None
TNF-alpha/NF-kappa B signaling complex 5	O14920;O15111;O15446;O95602;P19838;P23508;P42704;P46199;P52292;P52434;P62875;P63208;Q00653;Q04206;Q04864;Q13576;Q13616;Q15653;Q16342;Q9GZS1;Q9H9Y6;Q9UJF2;Q9UKB1;Q9Y2S0;Q9Y6K9	3551;1147;10849;25885;4790;4163;10128;4528;3838;5437;5441;6500;4791;5970;5966;10788;8454;4793;5134;64425;84172;9462;23291;51082;8517	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	IKBKB;CHUK;CD3EAP;POLR1A;NFKB1;MCC;LRPPRC;MTIF2;KPNA2;POLR2H;POLR2L;SKP1;NFKB2;RELA;REL;IQGAP2;CUL1;NFKBIB;PDCD2;POLR1E;POLR1B;RASAL2;FBXW11;POLR1D;IKBKG	None	None	None
IKBKB-CDC37-KIAA1967-HSP90AB1-HSP90AA1 complex	O14920;P07900;P08238;Q16543;Q8N163	3551;3320;3326;11140;57805	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKB;HSP90AA1;HSP90AB1;CDC37;CCAR2	None	None	None
WRN-Ku70-Ku80-PARP1 complex	P09874;P12956;P13010;Q14191	142;2547;7520;7486	DNA binding;cellular response to DNA damage stimulus;nucleus	DNA binding;DNA damage response;nucleus	PARP1;XRCC6;XRCC5;WRN	None	PARP1 regulates the exonucleolytic activity of WRN.	None
CAP(C)-CAP(E) complex	O95347;Q9NTJ3	10592;10051	M phase;mitotic nuclear division;chromosome condensation;nucleus	M phase;chromosome condensation;nucleus	SMC2;SMC4	None	CAP(C)-CAP(E) complex is required for mitotic chromosome condensation.	None
SMC1-SMC3 complex	Q14683;Q9UQE7	8243;9126	M phase;mitotic nuclear division;nucleus	M phase;nucleus	SMC1A;SMC3	None	SMC1-SMC3 complex is required for metaphase progression in mitotic cells.	None
XRCC1-LIG3-PNK-TDP1 complex	P18887;P49916;Q96T60;Q9NUW8	7515;3980;11284;55775	DNA repair	DNA repair	XRCC1;LIG3;PNKP;TDP1	None	None	TDP1 is involved in Spinocerebellar ataxia with axonal neuropathy (SCAN1).
Dolichol-phosphate mannose (DPM) synthase	O60762;O94777;Q9P2X0	8813;8818;54344	protein glycosylation;protein galactosylation;endoplasmic reticulum	"modification with sugar residues (e.g. glycosylation, deglycosylation);endoplasmic reticulum"	DPM1;DPM2;DPM3	None	The results indicate that DPM2 stabilizes DPM3 and DPM3 stabilizes DPM1.	None
Ku-ORC complex	O43929;P12956;P13010;Q13416;Q9UBD5;Q9Y5N6	5000;2547;7520;4999;23595;23594	pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication origin binding;DNA binding;ATP binding;chromosome	ori recognition and priming complex formation;DNA binding;ATP binding;chromosome	ORC4;XRCC6;XRCC5;ORC2;ORC3;ORC6	None	"Ku associates specifically with DNA replication origins in vivo in a cell cycle dependent manner, its association being maximal in late G1 phase and decreasing as cells enter S phase (PMID:11694575)."	None
MNK1-eIF4F complex	P06730;P60842;Q04637;Q9BUB5	1977;1973;1981;8569	translational initiation;RNA binding	translation initiation;RNA binding	EIF4E;EIF4A1;EIF4G1;MKNK1	None	Mnk1 is associated with the eIF4F complex.	None
TCF4-CTNNB1-SUMO1-EP300-HADAC6 complex	P15884;P35222;P63165;Q09472;Q9UBN7	6925;1499;7341;2033;10013	"transcription, DNA-templated"	TRANSCRIPTION	TCF4;CTNNB1;SUMO1;EP300;HDAC6	None	None	None
TCF4-CTNNB1-EP300 complex	P15884;P35222;Q09472	6925;1499;2033	"transcription, DNA-templated"	TRANSCRIPTION	TCF4;CTNNB1;EP300	None	None	None
TCF4-CTNNB1 complex	P15884;P35222	6925;1499	"transcription, DNA-templated"	TRANSCRIPTION	TCF4;CTNNB1	None	None	None
TCF4-CTNNB1-CREBBP complex	P15884;P35222;Q92793	6925;1499;1387	"transcription, DNA-templated"	TRANSCRIPTION	TCF4;CTNNB1;CREBBP	None	None	None
TNF-alpha/NF-kappa B signaling complex 6	O14920;O15111;P07900;P08238;P22087;P36578;P62277;P62280;P62888;P62917;Q02878;Q16543;Q99558;Q9Y6K9	3551;1147;3320;3326;2091;6124;6207;6205;6156;6132;6128;11140;9020;8517	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	IKBKB;CHUK;HSP90AA1;HSP90AB1;FBL;RPL4;RPS13;RPS11;RPL30;RPL8;RPL6;CDC37;MAP3K14;IKBKG	None	None	None
VHL-VDU1-TCEB1-TCEB2 complex	P40337;Q15369;Q15370;Q8TEY7	7428;6921;6923;23032	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	VHL;TCEB1;TCEB2;USP33	None	"Only in the presence of VHL, VDU1 could be precipitated along with VHL, Elongin B and Elongin C."	None
TNF-alpha/NF-kappa B signaling complex 7	O43318;P07900;P08238;Q13451;Q15750;Q16543;Q8N5C8;Q9NYJ8	6885;3320;3326;2289;10454;11140;257397;23118	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	MAP3K7;HSP90AA1;HSP90AB1;FKBP5;TAB1;CDC37;TAB3;TAB2	None	None	None
TNF-alpha/NF-kappa B signaling complex 8	P07900;P08238;Q13451;Q14164;Q16543;Q86UP2	3320;3326;2289;9641;11140;3895	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	HSP90AA1;HSP90AB1;FKBP5;IKBKE;CDC37;KTN1	None	None	None
VHL-TCEB1-TCEB2 complex	P40337;Q15369;Q15370	7428;6921;6923	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	VHL;TCEB1;TCEB2	None	None	None
VHL-TBP1-HIF1A complex	P17980;P40337;Q16665	5702;7428;3091	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;response to reactive oxygen species;response to oxidative stress	proteasomal degradation (ubiquitin/proteasomal pathway);oxidative stress response	PSMC3;VHL;HIF1A	None	TBP-1 associates with the beta-domain of VHL and complexes with VHL and Hif1-alpha in vivo. The ability of VHL to degrade Hif1-alpha depends in part on its interaction with TBP-1 and suggests a new mechanism for Hif1-alpha stabilization in some VHL-deficient tumors.	None
Cell-cell junction complex (ARHGAP10-CTNNA1)	A1A4S6;P35221	79658;1495	cell-cell junction assembly	intercellular junction (gap junction/adherens junction)	ARHGAP10;CTNNA1	None	ARHGAP10 is a new component of cell-cell junctions that controls alpha-catenin recruitment and has a key role during L. monocytogenes uptake.	None
HIF1A-OS9-EGLN1 complex	Q13438;Q16665;Q9GZT9	10956;3091;54583	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress"	transcriptional control;oxidative stress response	OS9;HIF1A;EGLN1	None	"The results indicate that OS-9 and PHD2 bind to different regions of HIF-1-alpha, and therefore may bind simultaneously. The results show enhanced binding of PHD2 to V5-OS-9  in the presence of HIF-1-alpha."	None
HIF1A-OS9-EGLN3 complex	Q13438;Q16665;Q9H6Z9	10956;3091;112399	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress"	transcriptional control;oxidative stress response	OS9;HIF1A;EGLN3	None	"Similar to its effect on PHD2, OS-9 stimulates the binding of PHD3 to HIF-1-alpha and cooperates with PHD3 to inhibit HIF-1 transcriptional activity."	None
RAB9-TIP47-MPRI complex	O60664;P11717;P51151	10226;3482;9367	intracellular protein transport;protein targeting;protein transport;vesicle-mediated transport	"protein targeting, sorting and translocation;protein transport;vesicular transport (Golgi network, etc.)"	PLIN3;IGF2R;RAB9A	None	Rab9 bound to immobilized CI-MPR only in the presence of TIP47 in a concentration-dependent manner. Thus TIP47 formed a ternary complex linking the CI-MPR and Rab9.	None
Cell-cell junction complex (CDH1-CTNNB1)	P12830;P35222	999;1499	cell-cell junction assembly	intercellular junction (gap junction/adherens junction)	CDH1;CTNNB1	None	None	None
CAS-SRC-FAK complex	P12931;P56945;Q05397	6714;9564;5747	transmembrane receptor protein tyrosine kinase signaling pathway	transmembrane receptor protein tyrosine kinase signalling pathways	SRC;BCAR1;PTK2	None	None	None
tRNA splicing endonuclease	Q7Z6J9;Q8NCE0;Q8WW01;Q92989;Q9BSV6	283989;80746;116461;10978;79042	"tRNA processing;mRNA splicing, via spliceosome;mRNA processing;nucleus"	"tRNA processing;mRNA processing (splicing, 5'-, 3'-end processing);nucleus"	TSEN54;TSEN2;TSEN15;CLP1;TSEN34	None	None	None
"RNA endonuclease (SEN2deltaEx8, SEN54, CLP1)"	Q7Z6J9;Q8NCE0;Q92989	283989;80746;10978	RNA processing	RNA processing	TSEN54;TSEN2;CLP1	None	"TSEN2 is an alternatively spliced gene. SEN2deltaEx8 is the variant lacking exon 8. The complex formed with variant SEN2deltaEx8 does not properly cleave pre-tRNAs, although it does retain endonucleolytic activity. It is likely that the SEN2deltaEx8-containing complex is not a tRNA splicing endonuclease but is responsible for processing as yet unknown RNA substrates."	None
TNF-alpha/NF-kappa B signaling complex 9	O15111;P08238;Q13451;Q15653;Q16543	1147;3326;2289;4793;11140	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	CHUK;HSP90AB1;FKBP5;NFKBIB;CDC37	None	None	None
TNF-alpha/NF-kappa B signaling complex 10	O15111;P07900;P08238;P40222;Q15653;Q16543;Q676U5;Q8IX12;Q9UHD2;Q9Y6K9	1147;3320;3326;200081;4793;11140;55054;None;29110;8517	I-kappaB kinase/NF-kappaB signaling;cytokine activity	"NIK-I-kappaB/NF-kappaB cascade;cytokines (interleukines, colony stimulating factors, etc.)"	CHUK;HSP90AA1;HSP90AB1;TXLNA;NFKBIB;CDC37;ATG16L1;CCAR1;TBK1;IKBKG	None	None	None
CCND1-CDK4 complex	P11802;P24385	1019;595	G1/S transition of mitotic cell cycle	G1/S transition of mitotic cell cycle	CDK4;CCND1	None	None	None
P53-BARD1-KU70 complex	P04637;P12956;Q99728	7157;2547;580	apoptotic process;regulation of phosphorylation	apoptosis (type I programmed cell death)	TP53;XRCC6;BARD1	None	"The authors suggest that BARD1 facilitates the phosphorylation of p53 by binding to p53 and Ku-70, the subunit of DNA-PK, and that this is suf?cient and required for apoptosis induction."	None
ETS2-SMARCA4-INI1 complex	P15036;P51532;Q12824	2114;6597;6598	"negative regulation of transcription, DNA-templated;nucleus"	transcription repression;nucleus	ETS2;SMARCA4;SMARCB1	None	"Brg-1 and Ini1 could be detected in complex with ets-2 after tetracycline removal, but not in cells maintained in tetracycline."	None
LATS1-HTRA2-BIRC4 complex	O43464;O95835;P98170	27429;9113;331	cell death	cell death	HTRA2;LATS1;XIAP	None	WARTS forms a complex with XIAP while interacting with Omi and is potentially involved in the cell death through the inhibition of XIAP.	None
DDEF1-CTTN-PXN complex	P49023;Q14247;Q9ULH1	5829;2017;50807	cytoskeleton organization	cytoskeleton/structural proteins	PXN;CTTN;ASAP1	None	"This co-precipitation was only detected in highly invasive cells, such as MDA-MB-231 and 4T1/luc, but was undetectable in weak or noninvasive cells, such as MDA-MB-468 and MCF7, as well as in normal mammary epithelial cells. The authors describe that AMAP1 bridges cortactin and paxillin in highly invasive cells."	None
CDH1-CKS1B complex	P12830;P61024	999;1163	mitotic cell cycle	mitotic cell cycle	CDH1;CKS1B	None	None	None
CDH1-SKP2 complex	P12830;Q13309	999;6502	mitotic cell cycle	mitotic cell cycle	CDH1;SKP2	None	None	None
YY1-MDM2-p53 complex	P04637;P25490;Q00987	7157;7528;4193	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	TP53;YY1;MDM2	None	"YY1 is a potential cofactor for MDM2 in the regulation of p53 homeostasis. The physical interaction of YY1 with MDM2 appears to be important for efficient MDM2-p53 interaction in vivo, which in turn is necessary for p53 ubiquitination."	None
ELMO1-DOCK1 complex	Q14185;Q92556	1793;9844	protein binding;G-protein coupled receptor signaling pathway;cell migration	protein binding;G-protein coupled receptor signalling pathway;cell migration	DOCK1;ELMO1	None	Dock-ELMO complex functions as an unconventional two-part exchange factor for Rac.	None
ELMO1-DOCK2 complex	Q92556;Q92608	9844;1794	protein binding;G-protein coupled receptor signaling pathway;cell migration	protein binding;G-protein coupled receptor signalling pathway;cell migration	ELMO1;DOCK2	None	Dock-ELMO complex functions as an unconventional two-part exchange factor for Rac.	None
ELMO1-DOCK1-RAC1 complex	P63000;Q14185;Q92556	5879;1793;9844	protein binding;G-protein coupled receptor signaling pathway;cell migration	protein binding;G-protein coupled receptor signalling pathway;cell migration	RAC1;DOCK1;ELMO1	None	Dock-ELMO complex functions as an unconventional two-part exchange factor for Rac.	None
ELMO1-DOCK1-CRKII complex	P46108;Q14185;Q92556	1398;1793;9844	protein binding;G-protein coupled receptor signaling pathway;cell migration	protein binding;G-protein coupled receptor signalling pathway;cell migration	CRK;DOCK1;ELMO1	None	None	None
AGO2-FXR1-TNF(alpha)ARE-RNP complex	P51114;Q9UKV8	8087;27161	regulation of translation;RNA binding;cytoplasm	translational control;RNA binding;cytoplasm	FXR1;AGO2	None	AGO2 functions as translational activator under serum-starved conditions.	None
"Cell division cycle complex (CDC27, CDC16, ANAPC7)"	P30260;Q13042;Q9UJX3	996;8881;51434	mitotic cell cycle	mitotic cell cycle	CDC27;CDC16;ANAPC7	None	None	None
"Actin-ribonucleoprotein complex (POLR2A, GTF2F1, HNRNPU)"	P24928;P35269;Q00839	5430;2962;3192	"transcription, DNA-templated"	TRANSCRIPTION	POLR2A;GTF2F1;HNRNPU	None	None	None
THRB-RXRB complex	P10828;P28702	7068;6257	hormone-mediated signaling pathway	hormone mediated signal transduction	THRB;RXRB	None	None	None
ATM homodimer complex	Q13315	472	DNA repair	DNA repair	ATM	None	None	None
ERAP1-ERAP2 complex	Q6P179;Q9NZ08	64167;51752	antigen processing and presentation	antigen presentation / processing	ERAP2;ERAP1	None	None	None
Grancalcin-sorcin complex	P28676;P30626	25801;6717	calcium ion binding	calcium binding	GCA;SRI	None	None	None
Sorcin homodimer complex	P30626	6717	protein binding;calcium ion binding	protein binding;calcium binding	SRI	None	"The penta-EF hand (PEF) family of calcium binding proteins includes grancalcin, peflin, sorcin, calpain large and small subunits as well as ALG-2. Heterodimerization, in addition to differential interactions with target proteins, might be a way to regulate and fine tune processes mediated by calcium binding proteins of the penta-EF hand type. The interaction of grancalcin with sorcin is approximately 17 times stronger than sorcin homodimerization."	None
"Chromatin remodeling complex (TACC2, TACC3, PCAF)"	O95359;Q92831;Q9Y6A5	10579;8850;10460	DNA topological change	DNA conformation modification (e.g. chromatin)	TACC2;KAT2B;TACC3	None	None	None
EGR-EP300 complex	P18146;Q09472	1958;2033	"transcription, DNA-templated"	TRANSCRIPTION	EGR1;EP300	None	The results show that the interactions between p300/CBPand Egr1 can lead to complex feedback loops and toinhibition of Egr1 activities under specific conditions.	None
"RNA-induced silencing complex, RISC"	Q15633;Q9UKV8;Q9UPY3	6895;27161;23405	RNA biosynthetic process;RNA processing;RNA binding	RNA synthesis;RNA processing;RNA binding	TARBP2;AGO2;DICER1	None	The authors describe this complex as minimal Dicer-TRBP-AGO2 complex.	None
"TRBP containing complex (DICER, TRBP, AGO2, RPL7A, EIF6, MOV10)"	P56537;P62424;Q15633;Q9HCE1;Q9UKV8;Q9UPY3	3692;6130;6895;4343;27161;23405	RNA biosynthetic process;RNA processing;RNA binding	RNA synthesis;RNA processing;RNA binding	EIF6;RPL7A;TARBP2;MOV10;AGO2;DICER1	None	The authors show that depletion of eIF6 in human cells specifically abrogates miRNA-mediated regulation of target protein and mRNA levels.	None
"TRBP containing complex (DICER, RPL7A, EIF6, MOV10 and subunits of the 60S ribosomal particle)"	P05386;P05387;P18077;P18124;P26373;P30050;P46778;P46779;P49207;P50914;P56537;P61313;P61353;P61513;P62424;P62888;P62906;P62910;P62913;P84098;Q02543;Q9HCE1;Q9UHA3;Q9UPY3;Q9Y3U8	6176;6181;6165;6129;6137;6136;6144;6158;6164;9045;3692;6138;6155;6168;6130;6156;4736;6161;6135;6143;6142;4343;51187;23405;25873	RNA biosynthetic process;regulation of translation;RNA binding	RNA synthesis;translational control;RNA binding	RPLP1;RPLP2;RPL35A;RPL7;RPL13;RPL12;RPL21;RPL28;RPL34;RPL14;EIF6;RPL15;RPL27;RPL37A;RPL7A;RPL30;RPL10A;RPL32;RPL11;RPL19;RPL18A;MOV10;RSL24D1;DICER1;RPL36	None	"In mass spectrometric sequencing analyses the authors showed that in addition to RISC subunits they obtained protein sequences corresponding to nearly all subunits of the large (60S) ribosomal particle. The ability of eIF6 to inhibit joining of the 60S and 40S subunits of the ribosome and, thus, to prevent formation of a translationally competent complex, raises the possibility that eIF6 may repress translation by blocking initiation or ribosome recycling."	None
"RNA-induced silencing complex, RISC"	Q15633;Q9UKV8;Q9UPY3	6895;27161;23405	RNA biosynthetic process;RNA processing;RNA binding;cytoplasm	RNA synthesis;RNA processing;RNA binding;cytoplasm	TARBP2;AGO2;DICER1	None	The authors demonstrated that this complex can cleave target RNA using precursor microRNA (pre-miRNA) hairpin as the source of siRNA.	None
ARNT-HIF1A complex	P27540;Q16665	405;3091	"positive regulation of transcription, DNA-templated;nucleus"	transcription activation;nucleus	ARNT;HIF1A	None	None	None
TRIB3-DDIT3 complex	P35638;Q96RU7	1649;57761	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	DDIT3;TRIB3	None	None	None
RAG1-RAG2 tetramer complex	P15918;P55895	5896;5897	DNA recombination	DNA recombination	RAG1;RAG2	None	None	None
GAIT complex	O60506;P04406;P07814;P40429	10492;2597;2058;23521	regulation of translation	translational control	SYNCRIP;GAPDH;EPRS;RPL13A	None	None	None
MLL1-WDR5 complex	O00268;O43451;O75461;P21675;P34932;P49848;P51610;P61964;Q03164;Q15291;Q15545;Q16594;Q6PI98;Q7Z3B3;Q8IXM2;Q8IZL8;Q8WWY3;Q96EZ8;Q99496;Q9BVI0;Q9H4L4;Q9H7Z6;Q9HCK8;Q9NXF1;Q9UBL3;Q9Y265;Q9Y4W2	6874;8972;1876;6872;3308;6878;3054;11091;4297;5929;6879;6880;125476;284058;124944;27043;26121;10445;6045;51230;26168;84148;57680;54881;9070;8607;81887	"DNA topological change;positive regulation of transcription, DNA-templated;protein hydroxylation;protein methylation;nucleus"	"DNA conformation modification (e.g. chromatin);transcription activation;posttranslational modification of amino acids (e.g. hydroxylation, methylation);nucleus"	TAF4;MGAM;E2F6;TAF1;HSPA4;TAF6;HCFC1;WDR5;KMT2A;KDM6B;TAF7;TAF9;INO80C;KANSL1;BAP18;PELP1;PRPF31;MCRS1;RNF2;PHF20;SENP3;KAT8;CHD8;TEX10;ASH2L;RUVBL1;LAS1L	The apparent size of the MOF-containing MLL1-WDR5 complex is around 1.5 MDa.	"The MLL1-WDR5 complex has a robust MLL1-mediated histone methyltransferase activity that can effect mono-, di-, and trimethylation of H3 K4 and a MOF-mediated histone acetyltransferase activity that is specific for H4 K16. Both activities are required for optimal transcription activation on a chromatin template in vitro and on an endogenous MLL1 target gene, Hox a9, in vivo."	"The MLL1 subunit is the product of a protooncogene that was first detected through chromosomal translocations directly associated with aggressive lymphoid and myeloid acute leukemias, especially among infants."
SERPINA1-ELA2 complex	P01009;P08246	5265;1991	protein processing	protein processing (proteolytic)	SERPINA1;ELANE	None	None	None
SERPINA3-CTSG complex	P01011;P08311	12;1511	protein processing	protein processing (proteolytic)	SERPINA3;CTSG	None	None	None
SERPINA1-CTSG complex	P01009;P08311	5265;1511	protein processing	protein processing (proteolytic)	SERPINA1;CTSG	None	None	None
BRCC complex	P38398;P46736;P51587;Q06609;Q9NXR7	672;79184;675;5888;9577	DNA repair;cell cycle checkpoint;protein ubiquitination;cellular response to DNA damage stimulus;nucleus;ubiquitin-dependent protein catabolic process	"DNA repair;cell cycle checkpoints (checkpoints of morphogenesis, DNA-damage,-replication, mitotic phase and spindle);modification by ubiquitination, deubiquitination;DNA damage response;nucleus;proteasomal degradation (ubiquitin/proteasomal pathway)"	BRCA1;BRCC3;BRCA2;RAD51;BRE	None	"BRCC may not play a direct role in DNA repair, but through its E3 ubiquitin ligase activity BRCC can regulate factors involved in DNA repair. BRE and BRCC36 are regulatory subunits modulating the ligase activity of the BRCC complex."	BRCA1 or BRCA2 genes and their deleterious alleles are involved in breast cancer and ovarian cancer.
PLEKHM2-KIF5B complex	P33176;Q8IWE5	3799;23207	movement of cell or subcellular component	cell motility	KIF5B;PLEKHM2	None	"During Salmonella typhimurium infection SKIP acts as an essential mediator of SifA (a S. thyphimurium protein, required for the formation of Salmonella-induced filaments). A dynamic process of kinesin recruitment in Salmonella-infected cells is mediated by the secretion of unidentified SPI-2 TTSS effectors and is down-regulated by the SifA-mediated recruitment of SKIP on membranes. The authors suggest that S. typhimurium is able to fine-tune the SCV-associated kinesin motor activity by regulating the secretion of its own effector proteins."	None
NGF-TrkA complex	P01138;P04629	4803;4914	transmembrane receptor protein tyrosine kinase signaling pathway;neurogenesis;generation of neurons;nervous system development	transmembrane receptor protein tyrosine kinase signalling pathways;neurogenesis;nervous system	NGF;NTRK1	None	None	None
Neurotrophin-3-p75 complex	P08138;P20783	4804;4908	transmembrane receptor protein tyrosine kinase signaling pathway;neurogenesis;generation of neurons;nervous system development	transmembrane receptor protein tyrosine kinase signalling pathways;neurogenesis;nervous system	NGFR;NTF3	None	None	None
TIAM1-GRIN1 complex	Q05586;Q13009	2902;7074	cell morphogenesis;cell growth;neuron differentiation	cell growth / morphogenesis;neuron	GRIN1;TIAM1	None	None	None
HTR1D-S1PR1 complex	P21453;P28221	1901;3352	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	S1PR1;HTR1D	None	None	None
HTR1D  homodimer complex	P28221	3352	protein binding	protein binding	HTR1D	None	None	None
HTR1A-HTR1D complex	P08908;P28221	3350;3352	protein binding	protein binding	HTR1A;HTR1D	None	None	None
HTR1B homodimer complex	P28222	3351	protein binding	protein binding	HTR1B	None	None	None
HTR1A-HTR1B complex	P08908;P28222	3350;3351	protein binding	protein binding	HTR1A;HTR1B	None	None	None
HTR1D-HTR1B complex	P28221;P28222	3352;3351	protein binding	protein binding	HTR1D;HTR1B	None	None	None
GABBR2-HTR1A complex	O75899;P08908	9568;3350	protein binding	protein binding	GABBR2;HTR1A	None	None	None
HTR1A-GPR26 complex	P08908;Q8NDV2	3350;2849	protein binding	protein binding	HTR1A;GPR26	None	None	None
HTR1A-EDG3 complex	P08908;Q99500	3350;1903	protein binding	protein binding	HTR1A;S1PR3	None	None	None
HTR1A homodimer complex	P08908	3350	protein binding	protein binding	HTR1A	None	None	None
HTR1A-S1PR1 complex	P08908;P21453	3350;1901	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	HTR1A;S1PR1	None	None	None
HSP70-BAG5-PARK2 complex	O60260;P0DMV8;P34932;Q9UL15	5071;3303;3308;9529	protein stabilization;protein folding;enzyme regulator activity;regulation of catalytic activity	protein folding and stabilization;enzymatic activity regulation / enzyme regulator	PARK2;HSPA1A;HSPA4;BAG5	"Since the authors did not specify HSP70, we used isoform HSPA1A (HSP70-1A)."	"The authors show that within this complex, BAG5 inhibits both parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins."	None
NGF-p75 complex	P01138;P08138	4803;4804	transmembrane receptor protein tyrosine kinase signaling pathway;neurogenesis;generation of neurons;nervous system development	transmembrane receptor protein tyrosine kinase signalling pathways;neurogenesis;nervous system	NGF;NGFR	None	The complex is composed of an NGF homodimer asymmetrically bound to a single p75.	None
ANCO1-HDAC3  complex	O15379;Q6UB99	8841;29123	"negative regulation of transcription, DNA-templated"	transcription repression	HDAC3;ANKRD11	None	None	None
Sororin-cohesin complex	O60216;Q14683;Q29RF7;Q96FF9;Q9NTI5;Q9UQE7	5885;8243;23244;113130;23047;9126	mitotic cell cycle;chromosome segregation;nucleus	mitotic cell cycle;chromosome segregation/division;nucleus	RAD21;SMC1A;PDS5A;CDCA5;PDS5B;SMC3	None	Sororin interacts with the cohesin complex. It regulates the ability of the cohesin complex to mediate sister chromatid cohesion.	None
NRG1-IKZF4 complex	Q02297;Q9H2S9	3084;64375	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	NRG1;IKZF4	None	The Nrg-ICD-Eos complex induces endogenous PSD-95 expression in vivo through a signaling pathway that is mostly independent of gamma-secretase regulation. This upregulation of PSD-95 expression by the Nrg-ICD-Eos complex provides a molecular basis for activity-dependent synaptic plasticity.	None
EPOR receptor complex	P19235	2057	protein binding	protein binding	EPOR	None	None	None
CRKII-C3G complex	P46108;Q13905	1398;2889	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	CRK;RAPGEF1	None	None	None
EPO-EPOR complex	P01588;P19235	2056;2057	signaling	cellular signalling	EPO;EPOR	None	None	None
Splicing-associated factors complex	P35659;Q15287;Q86V81;Q8IYB3;Q9Y5S9	7913;10921;10189;10250;9939	RNA splicing;RNA binding;nucleus	splicing;RNA binding;nucleus	DEK;RNPS1;ALYREF;SRRM1;RBM8A	None	None	None
Mediator complex	A0JLT2;O43513;O60244;O60313;O75448;O75586;O95402;Q13503;Q15528;Q15648;Q6P2C8;Q71F56;Q71SY5;Q96G25;Q96HR3;Q96RN5;Q9BTT4;Q9BUE0;Q9H944;Q9NPJ6;Q9NVC6;Q9NX70;Q9P086;Q9UHV7;Q9ULK4;Q9Y2X0;Q9Y3C7	219541;9443;9282;4976;9862;10001;9441;9412;6837;5469;9442;23389;81857;112950;90390;51586;84246;54797;9477;29079;9440;55588;400569;9969;9439;10025;51003	"positive regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription activation;protein binding;regulator of transcription factor;nucleus	MED19;MED7;MED14;OPA1;MED24;MED6;MED26;MED21;MED22;MED1;MED27;MED13L;MED25;MED8;MED30;MED15;MED10;MED18;MED20;MED4;MED17;MED29;MED11;MED13;MED23;MED16;MED31	None	None	None
MED18-MED20-MED29 mediator subcomplex	Q9BUE0;Q9H944;Q9NX70	54797;9477;55588	"positive regulation of transcription, DNA-templated;protein binding;regulation of sequence-specific DNA binding transcription factor activity;nucleus"	transcription activation;protein binding;regulator of transcription factor;nucleus	MED18;MED20;MED29	None	None	None
p50-p65 NF(kappa)B complex	P19838;Q04206	4790;5970	"positive regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling"	transcription activation;NIK-I-kappaB/NF-kappaB cascade	NFKB1;RELA	None	None	None
p50-p65 NF(kappa)B-SRC1 complex	P19838;Q04206;Q15788	4790;5970;8648	"positive regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling"	transcription activation;NIK-I-kappaB/NF-kappaB cascade	NFKB1;RELA;NCOA1	None	SRC-1 potentiates NF(kappa)B transactivation.	None
IKBA-p50-p65 Nf(kappa)B complex	P19838;P25963;Q04206	4790;4792;5970	I-kappaB kinase/NF-kappaB signaling;signaling;cytoplasm	NIK-I-kappaB/NF-kappaB cascade;cellular signalling;cytoplasm	NFKB1;NFKBIA;RELA	None	I(kappa)B(alpha) inhibits DNA binding activity of NF(kappa)B heterodimer.	None
IKB(epsilon)-RELA-cREL complex	O00221;Q04206;Q04864	4794;5970;5966	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling;cytoplasm"	transcriptional control;NIK-I-kappaB/NF-kappaB cascade;cytoplasm	NFKBIE;RELA;REL	None	IKB(epsilon) is able to inhibit NF(kappa)B-directed transactivation via cytoplasmic retention of rel proteins.	None
IKB(beta)-RELA-cREL complex	Q04206;Q04864;Q15653	5970;5966;4793	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling;cytoplasm"	transcriptional control;NIK-I-kappaB/NF-kappaB cascade;cytoplasm	RELA;REL;NFKBIB	None	None	None
IKB(alpha)-RELA-cREL complex	P25963;Q04206;Q04864	4792;5970;5966	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;I-kappaB kinase/NF-kappaB signaling;signaling;cytoplasm"	transcriptional control;NIK-I-kappaB/NF-kappaB cascade;cellular signalling;cytoplasm	NFKBIA;RELA;REL	None	None	None
"DISC complex (FAS, FADD, CASP8)"	P25445;Q13158;Q14790	355;8772;841	apoptotic process;extrinsic apoptotic signaling pathway	apoptosis (type I programmed cell death)	FAS;FADD;CASP8	None	None	None
MURR1-NF(kappa)Bp65-IKBA complex	P25963;Q04206;Q8N668	4792;5970;150684	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	NFKBIA;RELA;COMMD1	None	"Murr1, a gene product known previously for its involvement in copper regulation, inhibits HIV-1 growth in unstimulated CD4+ T cells. This inhibition was mediated in part through its ability to inhibit basal and cytokine-stimulated nuclear factor NF(kappa)B activity."	None
IKBA-p50-p65 Nf(kappa)B complex	P19838;P25963;Q04206	4790;4792;5970	I-kappaB kinase/NF-kappaB signaling;signaling;cytoplasm	NIK-I-kappaB/NF-kappaB cascade;cellular signalling;cytoplasm	NFKB1;NFKBIA;RELA	None	None	None
"CIA targeting (MIP18, CIAO1, MMS19) complex"	O76071;Q96T76;Q9Y3D0	9391;64210;51647	iron-sulfur cluster assembly	None	CIAO1;MMS19;FAM96B	None	"The cytoplasmic iron-sulfur assembly (CIA) targeting complex is required for the transfer of an iron-sulfur (Fe-S) cluster to cytoplasmic and nuclear proteins. The complex members MIP18 and CIAO1 associate with the C terminus of MMS19. By doing so, they form a docking site for Fe-S proteins that is disrupted in the absence of either MMS19 or MIP18. The Fe-S helicase XPD seems to be the only exception, since it can interact with MMS19 independently of MIP18 and CIAO1. The direct interaction between MMS19 and MIP18 is required to protect MIP18 from proteasomal degradation."	None
ILK-PARVB-ARHGEF6 complex	Q13418;Q15052;Q9HBI1	3611;9459;29780	small GTPase mediated signal transduction;actin cytoskeleton organization	small GTPase mediated signal transduction;actin cytoskeleton	ILK;ARHGEF6;PARVB	None	"The results suggest that activation of alpha-PIX is dependent on ILK binding to beta-parvin, an event that depends upon ILK activity."	None
PARVB-ARHGEF6 complex	Q15052;Q9HBI1	9459;29780	actin cytoskeleton organization	actin cytoskeleton	ARHGEF6;PARVB	None	The complex between beta-parvin and alpha-PIX is constitutively formed and is not regulated by either the presence or absence of ILK or its kinase activity. This suggests that ILK may modulate the activity of alpha-PIX indirectly through its binding to and phosphorylation of beta-parvin.	None
EED-EZH-YY1 polycomb complex	O75530;P25490;Q15910	8726;7528;2146	"negative regulation of transcription, DNA-templated;RNA biosynthetic process;DNA binding;nucleus"	transcription repression;RNA synthesis;DNA binding;nucleus	EED;YY1;EZH2	None	None	None
RING1-Polycomb repressive complex	O00257;P35226;P78364;Q06587	8535;648;1911;6015	"negative regulation of transcription, DNA-templated;nucleus"	transcription repression;nucleus	CBX4;BMI1;PHC1;RING1	None	None	None
BMI1-HPH1-HPH2 complex	P35226;P78364;Q8IXK0	648;1911;1912	"negative regulation of transcription, DNA-templated;RNA biosynthetic process;DNA binding;nucleus"	transcription repression;RNA synthesis;DNA binding;nucleus	BMI1;PHC1;PHC2	None	None	None
EED-EZH polycomb complex	O75530;Q15910	8726;2146	"negative regulation of transcription, DNA-templated;RNA biosynthetic process;DNA binding;nucleus"	transcription repression;RNA synthesis;DNA binding;nucleus	EED;EZH2	None	None	None
CALM1-FKBP38-BCL2 complex	P10415;P62158;Q14318	596;None;23770	calcium ion binding;enzyme regulator activity;regulation of catalytic activity;regulation of programmed cell death	calcium binding;enzymatic activity regulation / enzyme regulator;regulation of apoptosis	BCL2;CALM1; CAL;FKBP8	None	None	None
TRAF2-cIAP1/BIRC2 complex	Q12933;Q13490	7186;329	protein ubiquitination;apoptotic process	"modification by ubiquitination, deubiquitination;apoptosis (type I programmed cell death)"	TRAF2;BIRC2	None	None	None
LTBR homodimer complex	P36941	4055	signaling	cellular signalling	LTBR	None	"The viral HCV (hepatitis) core protein can associate with the dimeric oroligomeric form of LT-bR, and this protein-protein interaction has a modulatory effect on the signaling pathway of LT-bR in certain cell types."	None
Tumor necrosis factor receptor 1 signaling complex	P19438;Q12933;Q13490;Q15628	7132;7186;329;8717	signaling;apoptotic process	cellular signalling;apoptosis (type I programmed cell death)	TNFRSF1A;TRAF2;BIRC2;TRADD	None	None	None
PLCB1-PARD3-PARD6A complex	Q8TEW0;Q9NPB6;Q9NQ66	56288;50855;23236	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signaling;second-messenger-mediated signaling;anisotropic cell growth;axis specification"	transcriptional control;cellular signalling;second messenger mediated signal transduction;directional cell growth (morphogenesis);asymmetries and axis determination	PARD3;PARD6A;PLCB1	None	The results suggest that the interaction of PLC-beta with cell polarity Par proteins may serve as a nexus to transduce extracellular signals to transcriptional regulation through G-protein-mediated signaling pathway in cell polarity and cell asymmetric division.	None
PLCB3-PARD3-PARD6A complex	Q01970;Q8TEW0;Q9NPB6	5331;56288;50855	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;signaling;second-messenger-mediated signaling;anisotropic cell growth;axis specification"	transcriptional control;cellular signalling;second messenger mediated signal transduction;directional cell growth (morphogenesis);asymmetries and axis determination	PLCB3;PARD3;PARD6A	None	The results suggest that the interaction of PLC-beta with cell polarity Par proteins may serve as a nexus to transduce extracellular signals to transcriptional regulation through G-protein-mediated signaling pathway in cell polarity and cell asymmetric division.	None
TRAF2-TRADD complex	Q12933;Q15628	7186;8717	apoptotic process	apoptosis (type I programmed cell death)	TRAF2;TRADD	None	TRADD and TRAF2 form a ternary complex  with the viral protein NS5A.	None
"Ternary complex (TRAF2, FADD, TRADD)"	Q12933;Q13158;Q15628	7186;8772;8717	apoptotic process	apoptosis (type I programmed cell death)	TRAF2;FADD;TRADD	None	None	None
CCNB2-CDC2 complex	O95067;P06493	9133;983	cell cycle	cell cycle	CCNB2;CDK1	None	None	None
CCNB1-CDC2 complex	P06493;P14635	983;891	cell cycle	cell cycle	CDK1;CCNB1	None	None	None
CDC2-PCNA-CCNB1-GADD45A complex	P06493;P12004;P14635;P24522	983;5111;891;1647	cell cycle	cell cycle	CDK1;PCNA;CCNB1;GADD45A	None	None	None
CDC2-PCNA-CCNB1-GADD45B complex	O75293;P06493;P12004;P14635	4616;983;5111;891	cell cycle	cell cycle	GADD45B;CDK1;PCNA;CCNB1	None	None	None
CDC2-PCNA-CCNB1-GADD45G complex	O95257;P06493;P12004;P14635	10912;983;5111;891	cell cycle	cell cycle	GADD45G;CDK1;PCNA;CCNB1	None	None	None
IL12A-IL12B complex	P29459;P29460	3592;3593	T cell differentiation	T-cell	IL12A;IL12B	None	"The authors demonstrated that when p40 is associated with a p35 subunit, the heterodimer acts as an agonist mediating biologic activity, and when p40 associates with another p40, the homodimer behaves as an antagonist in vitro."	None
IL12B homodimer complex	P29460	3593	T cell differentiation	T-cell	IL12B	None	"The authors demonstrated that when p40 (IL12B) is associated with a p35 (IL12A) subunit, the heterodimer acts as an agonist mediating biologic activity, and when p40 associates with another p40, the homodimer behaves as an antagonist in vitro."	None
CDK1-CCNB1-CCNF complex	P06493;P14635;P41002	983;891;899	cell cycle	cell cycle	CDK1;CCNB1;CCNF	None	"Cdc2, cyclin B1 and cyclin F form  a complex that exhibits histone  H1 kinase activity."	None
CDC2-CCNB1-PTCH1 complex	P06493;P14635;Q13635	983;891;5727	cell cycle	cell cycle	CDK1;CCNB1;PTCH1	None	None	None
CDK2-CCNA2 complex	P20248;P24941	890;1017	cell cycle	cell cycle	CCNA2;CDK2	None	None	None
CDC2-CCNA2 complex	P06493;P20248	983;890	cell cycle	cell cycle	CDK1;CCNA2	None	None	None
PAR6-CDC42 complex	P60953;Q9BYG5	998;84612	None	None	CDC42;PARD6B	None	None	None
CDC2-CCNA2-CDK2 complex	P06493;P20248;P24941	983;890;1017	cell cycle	cell cycle	CDK1;CCNA2;CDK2	None	None	None
CDK2-CCNE1 complex	P24864;P24941	898;1017	cell cycle	cell cycle	CCNE1;CDK2	None	None	None
LMO4-gp130 complex	O14543;P23458;P40189;P61968;Q06124	9021;3716;3572;8543;5781	"positive regulation of transcription, DNA-templated;signaling"	transcription activation;cellular signalling	SOCS3;JAK1;IL6ST;LMO4;PTPN11	None	LMO4 associates with the gp130 complex and IL-6 may enhance its association.	None
Stat1-alpha-dimer-CBP DNA-protein complex	P42224;Q92793	6772;1387	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	STAT1;CREBBP	None	"The results demonstrate that both phosphorylated homodimeric and unphosphorylated monomeric Stat1-alpha can interact with CBP/p300, and their interactions occur at two different regions of both Stat1-alpha and CBP/p300."	None
SHP-NR5A2 complex	O00482;Q15466	2494;8431	"negative regulation of transcription, DNA-templated"	transcription repression	NR5A2;NR0B2	None	None	None
CNTF-CNTFR-gp130-LIFR complex	P26441;P26992;P40189;P42702	1270;1271;3572;3977	signaling;nervous system development	cellular signalling;nervous system	CNTF;CNTFR;IL6ST;LIFR	None	None	None
LIFR-LIF-gp130 complex	P15018;P40189;P42702	3976;3572;3977	signaling;nervous system development	cellular signalling;nervous system	LIF;IL6ST;LIFR	None	None	None
"LINC complex, S-phase"	P10244;P28749;Q09028;Q52LA3;Q5TKA1;Q6MZP7;Q96GY3	4605;5933;5928;91750;286826;132660;55957	"G2/M transition of mitotic cell cycle;positive regulation of transcription, DNA-templated;nucleus"	G2/M transition of mitotic cell cycle;transcription activation;nucleus	MYBL2;RBL1;RBBP4;LIN52;LIN9;LIN54;LIN37	None	During S-phase B-MYB and p107 become incorporated into the LINC complex.	None
LINC core complex	Q09028;Q52LA3;Q5TKA1;Q6MZP7;Q96GY3	5928;91750;286826;132660;55957	"G2/M transition of mitotic cell cycle;positive regulation of transcription, DNA-templated;nucleus"	G2/M transition of mitotic cell cycle;transcription activation;nucleus	RBBP4;LIN52;LIN9;LIN54;LIN37	None	LINC selectively binds to the promoters of G2/M genes whose products are required for mitosis and plays an important role in their cell cycle dependent activation.	None
"LINC complex, quiescent cells"	Q08999;Q09028;Q16254;Q52LA3;Q5TKA1;Q6MZP7;Q96GY3	5934;5928;1874;91750;286826;132660;55957	"G2/M transition of mitotic cell cycle;positive regulation of transcription, DNA-templated;nucleus"	G2/M transition of mitotic cell cycle;transcription activation;nucleus	RBL2;RBBP4;E2F4;LIN52;LIN9;LIN54;LIN37	None	In quiescent cells LINC selectively interacts with p130 and E2F4. This association is lost during S-phase.	None
Emerin complex 1	P35579;P50402;P60709;Q12965;Q13813;Q15417;Q8WWI1;Q9BRV8	4627;2010;60;4643;6709;1266;4008;80143	nucleus	nucleus	MYH9;EMD;ACTB;MYO1E;SPTAN1;CNN3;LMO7;SIKE1	None	None	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin-actin-NMI-(alphaII)spectrin complex	P50402;P60709;Q13287;Q13813	2010;60;9111;6709	nucleus	nucleus	EMD;ACTB;NMI;SPTAN1	None	None	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin-actin-NMI complex	P50402;P60709;Q13287	2010;60;9111	nucleus	nucleus	EMD;ACTB;NMI	None	None	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin architectural complex	P02545;P20700;P50402;P60709;Q13287;Q13813	4000;4001;2010;60;9111;6709	nucleus organization;nucleus	nucleus;nucleus	LMNA;LMNB1;EMD;ACTB;NMI;SPTAN1	None	None	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin regulatory complex	O15379;O75531;P28749;P50402;P60709;P68431;Q02539;Q13547;Q8WWI1	8841;8815;5933;2010;60;None;3024;3065;4008	"DNA topological change;regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;chromosome organization;nucleus"	DNA conformation modification (e.g. chromatin);transcriptional control;organization of chromosome structure;nucleus	HDAC3;BANF1;RBL1;EMD;ACTB;HIST1H3A;;HIST1H1A;HDAC1;LMO7	None	None	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin complex 24	P02545;P06400;P20700;P33991;P49736;P50402;P68431;Q00839;Q02539;Q07021;Q08999;Q13287;Q14566;Q9H0E3;Q9H503	4000;5925;4001;4173;4171;2010;None;3192;3024;708;5934;9111;4175;79595;140836	DNA replication;RNA processing;nucleus	DNA synthesis and replication;RNA processing;nucleus	LMNA;RB1;LMNB1;MCM4;MCM2;EMD;HIST1H3A;;HNRNPU;HIST1H1A;C1QBP;RBL2;NMI;MCM6;SAP130;BANF2	None	Complexes are named on the basis of their S300 elution fraction number. Subunits 9-15 were identified via LCMS/MS analysis.	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin complex 25	O75531;O95218;O95777;P05455;P20700;P31946;P50402;P60709;P61978;P62258;P62314;Q13283;Q16543;Q9H0E3;Q9P287;Q9Y333	8815;9406;51691;6741;4001;7529;2010;60;3190;7531;6632;10146;11140;79595;56647;57819	RNA processing;intracellular signal transduction;nucleus	RNA processing;cellular signalling;nucleus	BANF1;ZRANB2;LSM8;SSB;LMNB1;YWHAB;EMD;ACTB;HNRNPK;YWHAE;SNRPD1;G3BP1;CDC37;SAP130;BCCIP;LSM2	None	Complexes are named on the basis of their S300 elution fraction number. Subunits 5-16 were identified via LCMS/MS analysis.	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin complex 32	O00422;O15379;P20700;P28749;P50402;P60709;P68431;Q08999;Q12824;Q13263;Q13287;Q13547;Q13813;Q14839;Q8TAQ2;Q92922;Q9BQ87;Q9BZK7;Q9C005;Q9H503;Q9NPJ6;Q9UKL0	10284;8841;4001;5933;2010;60;None;5934;6598;10155;9111;3065;6709;1108;6601;6599;90665;79718;84661;140836;29079;23186	DNA topological change;chromosome organization;nucleus	DNA conformation modification (e.g. chromatin);organization of chromosome structure;nucleus	SAP18;HDAC3;LMNB1;RBL1;EMD;ACTB;HIST1H3A;;RBL2;SMARCB1;TRIM28;NMI;HDAC1;SPTAN1;CHD4;SMARCC2;SMARCC1;TBL1Y;TBL1XR1;DPY30;BANF2;MED4;RCOR1	None	Complexes are named on the basis of their S300 elution fraction number. Subunits 9-22 were identified via LCMS/MS analysis.	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
Emerin complex 52	O00148;O95777;P10827;P12277;P14866;P20700;P27348;P46940;P50402;P51858;P60709;P61978;P62258;P62314;Q00839;Q02539;Q07021;Q08999;Q12906;Q13287;Q53EL6;Q9BZZ5;Q9Y2U8	10212;51691;7067;1152;3191;4001;10971;8826;2010;3068;60;3190;7531;6632;3192;3024;708;5934;3609;9111;27250;8539;23592	RNA processing;intracellular signal transduction;nucleus	RNA processing;cellular signalling;nucleus	DDX39A;LSM8;THRA;CKB;HNRNPL;LMNB1;YWHAQ;IQGAP1;EMD;HDGF;ACTB;HNRNPK;YWHAE;SNRPD1;HNRNPU;HIST1H1A;C1QBP;RBL2;ILF3;NMI;PDCD4;API5;LEMD3	None	Complexes are named on the basis of their S300 elution fraction number. Subunits 8-23 were identified via LCMS/MS analysis.	Emerin is involved in Emery-Dreifuss muscular dystrophy (EDMD).
HSP90-CIP1-FKBPL complex	P07900;P38936;Q9UIM3	3320;1026;63943	protein stabilization;protein folding;cellular response to DNA damage stimulus	protein folding and stabilization;DNA damage response	HSP90AA1;CDKN1A;FKBPL	None	The results show that the ability of WISp39 to stabilize p21 is dependent on its ability to bind and recruit Hsp90.	None
PSD95-FYN-NR2A complex	P06241;P78352;Q12879	2534;1742;2903	signaling;plasma membrane	cellular signalling;eukaryotic plasma membrane / membrane attached	FYN;DLG4;GRIN2A	None	"NR2A was coimmunoprecipitated with Fyn only in the presence of PSD-95. So it was shown that PSD-95 induced formation of a ternary complex of NR2A, PSD-95, and Fyn."	None
Securin-separase complex	O95997;Q14674	9232;9700	nuclear division;chromosome segregation	nuclear division;chromosome segregation/division	PTTG1;ESPL1	None	None	None
ESPL1-CDC2 complex	P06493;Q14674	983;9700	nuclear division;chromosome segregation	nuclear division;chromosome segregation/division	CDK1;ESPL1	None	None	None
FARP2-NRP1-PlexinA1 complex	O14786;O94887;Q9UIW2	8829;9855;5361	signaling;nervous system development	cellular signalling;nervous system	NRP1;FARP2;PLXNA1	None	Interaction of FARP2 with PlexinA1 is substantially reduced in the absence of neuropilin1.	None
FARP2-NRP1-PlexinA2 complex	O14786;O75051;O94887	8829;5362;9855	signaling;nervous system development	cellular signalling;nervous system	NRP1;PLXNA2;FARP2	None	None	None
FARP2-NRP1-PlexinA3 complex	O14786;O94887;P51805	8829;9855;55558	signaling;nervous system development	cellular signalling;nervous system	NRP1;FARP2;PLXNA3	None	None	None
FARP2-NRP1-PlexinA4 complex	O14786;O94887;Q9HCM2	8829;9855;91584	signaling;nervous system development	cellular signalling;nervous system	NRP1;FARP2;PLXNA4	None	None	None
SEMA4A-PlexinD1 complex	Q9H3S1;Q9Y4D7	64218;23129	angiogenesis;blood vessel development;vasculature development	angiogenesis;vessels	SEMA4A;PLXND1	None	SEMA4A-PlexinD1 signaling negatively regulates angiogenesis.	None
"Ternary complex (LRRC7, CAMK2a, ACTN4)"	O43707;Q96NW7;Q9UQM7	81;57554;815	cell adhesion	cell adhesion	ACTN4;LRRC7;CAMK2A	None	None	None
CEBPE-E2F1-RB1 complex	P06400;Q01094;Q15744	5925;1869;1053	granulocyte differentiation	granulocyte	RB1;E2F1;CEBPE	None	None	None
Nrp1-PlexinD1 complex	O14786;Q9Y4D7	8829;23129	angiogenesis;cardiac muscle tissue development;heart development;blood vessel development;vasculature development	angiogenesis;heart muscle;vessels	NRP1;PLXND1	None	PlexinD1-Npn1 form a functional receptor for Sema3C.	None
SEMA3C-PlexinD1-Nrp1 complex	O14786;Q99985;Q9Y4D7	8829;10512;23129	angiogenesis;cardiac muscle tissue development;heart development;blood vessel development;vasculature development	angiogenesis;heart muscle;vessels	NRP1;SEMA3C;PLXND1	None	None	None
PlexinC1-SEMA7A complex	O60486;O75326	10154;8482	signaling;neuron projection development	cellular signalling	PLXNC1;SEMA7A	Human is used as reference organism.	None	None
PlexinC1-SEMA7A complex	O43157;Q92854	5364;10507	signaling;neuron projection development	cellular signalling	PLXNB1;SEMA4D	None	None	None
TRIM27-RB1 complex	P06400;P14373	5925;5987	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated"	transcriptional control	RB1;TRIM27	None	None	None
PlexinA1-NRP1 complex	O14786;Q9UIW2	8829;5361	nervous system development;neuron projection development	nervous system	NRP1;PLXNA1	None	None	None
PlexinA3-Nrp1 complex	O14786;P51805	8829;55558	nervous system development;neuron projection development	nervous system	NRP1;PLXNA3	None	None	None
PlexinB1-Nrp1 complex	O14786;O43157	8829;5364	nervous system development	nervous system	NRP1;PLXNB1	None	None	None
PlexinA1-Nrp2 complex	O60462;Q9UIW2	8828;5361	nervous system development;neuron projection development	nervous system	NRP2;PLXNA1	None	None	None
hRAD51C-hXRCC3 complex	O43543;Q06609	7516;5888	DNA repair	DNA repair	XRCC2;RAD51	None	None	None
VCP-VIMP-DERL1 complex	P55072;Q9BQE4;Q9BUN8	7415;55829;79139	"retrograde protein transport, ER to cytosol;ERAD pathway"	None	VCP;VIMP;DERL1	None	None	None
"Membrane protein complex (VCP, UFD1L, SEC61B)"	P55072;P60468;Q92890	7415;10952;7353	"retrograde protein transport, ER to cytosol"	None	VCP;SEC61B;UFD1L	None	None	None
SEMA6D-PlexinA1-NRP1 complex	O14786;Q8NFY4;Q9UIW2	8829;80031;5361	cardiac muscle tissue development;heart development;nervous system development;embryonic heart tube morphogenesis	heart muscle;nervous system	NRP1;SEMA6D;PLXNA1	None	None	None
TALL1 homo-oligomer complex	Q9Y275	10673	B cell differentiation	B-cell	TNFSF13B	Oligomer	None	None
Nucleolar remodeling complex (NoRC complex)	O60264;Q9UIF9	8467;11176	DNA topological change;rRNA transcription;chromosome organization	DNA conformation modification (e.g. chromatin);rRNA synthesis;organization of chromosome structure	SMARCA5;BAZ2A	None	None	None
TIP5-DNMT-HDAC1 complex	P26358;Q13547;Q9UBC3;Q9UIF9	1786;3065;1789;11176	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;protein acetylation;protein deacetylation;DNA binding"	"transcriptional control;modification by acetylation, deacetylation;DNA binding"	DNMT1;HDAC1;DNMT3B;BAZ2A	None	None	None
ArgBP2a-CBL-PTK2B complex	O94875;P22681;Q14289	8470;867;2185	intracellular protein transport;protein targeting;protein transport;actin cytoskeleton organization;neuron differentiation	"protein targeting, sorting and translocation;protein transport;actin cytoskeleton;neuron"	SORBS2;CBL;PTK2B	None	None	None
PRMT2 homo-oligomer complex	P55345	3275	receptor regulator activity	regulator of receptor activity	PRMT2	Oligomer	None	None
"FAK-beta5 integrin complex, VEGF induced"	P18084;Q05397	3693;5747	transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;cell-substrate junction assembly	transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;cell-substrate adherens junction	ITGB5;PTK2	None	VEGF induces the formation of FAK-beta5 integrin complex.	None
SH3P2/OSTF1-CBL-SRC complex	P12931;P22681;Q92882	6714;867;26578	cell adhesion;actin cytoskeleton	cell adhesion;actin cytoskeleton	SRC;CBL;OSTF1	None	None	None
NOS3-CAV1 complex	P29474;Q03135	4846;857	regulation of nitrogen utilization;regulation of nitrogen compound metabolic process;nitric oxide mediated signal transduction	regulation of nitrogen metabolism;NO mediated signal transduction	NOS3;CAV1	None	None	None
"NOS3-HSP90 complex, VEGF induced"	P07900;P29474	3320;4846	nitric oxide biosynthetic process;regulation of nitrogen utilization;regulation of nitrogen compound metabolic process;nitric oxide mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis	nitric oxide biosynthesis;regulation of nitrogen metabolism;NO mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis	HSP90AA1;NOS3	None	VEGF stimulation promotes dissociation of eNOS and Caveolin and association of eNOS with HSP90.	None
"NOS3-HSP90-AKT complex, VEGF induced"	P07900;P29474;P31749	3320;4846;207	nitric oxide biosynthetic process;regulation of nitrogen utilization;regulation of nitrogen compound metabolic process;nitric oxide mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis	nitric oxide biosynthesis;regulation of nitrogen metabolism;NO mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis	HSP90AA1;NOS3;AKT1	None	VEGF stimulation promotes association of eNOS with HSP90 and AKT.	None
CIN85-CBL complex	P22681;Q96B97	867;30011	membrane budding;vesicle organization;endocytosis	vesicle formation;endocytosis	CBL;SH3KBP1	None	None	None
CIN85-CBL-SH3GL2 complex	P22681;Q96B97;Q99962	867;30011;6456	membrane budding;vesicle organization;endocytosis	vesicle formation;endocytosis	CBL;SH3KBP1;SH3GL2	None	"Endogenous or overexpressed Cbl co-precipitated with endophilin A1 only in the presence of CIN85, indicating that CIN85 acts as a linker between Cbl and endophilins."	None
CIN85-SH3GL3-CBL complex	P22681;Q96B97;Q99963	867;30011;6457	membrane budding;vesicle organization;endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway	vesicle formation;endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways	CBL;SH3KBP1;SH3GL3	None	None	None
TBP-TAF complex	P20226;Q15572;Q15573;Q53T94	6908;9013;9015;9014	"transcription, DNA-templated;DNA binding"	TRANSCRIPTION;DNA binding	TBP;TAF1C;TAF1A;TAF1B	None	None	None
IKBKG homotrimer complex	Q9Y6K9	8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKG	None	None	None
"NRP1-VEGFC complex, heparin dependent"	O14786;P49767	8829;7424	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;transport vesicle	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;intracellular transport vesicles	NRP1;VEGFC	None	None	None
NRP2-VEGFC complex	O60462;P49767	8828;7424	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;transport vesicle	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;intracellular transport vesicles	NRP2;VEGFC	None	VEGFC colocalizes with NRP2 in endocytotic vesicles.	None
"NRP2-VEGFD complex, heparin dependent"	O43915;O60462	2277;8828	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;transport vesicle	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;intracellular transport vesicles	VEGFD;NRP2	None	VEGFD colocalizes with NRP2 in endocytotic vesicles.	None
"NRP1-VEGFD complex, heparin dependent"	O14786;O43915	8829;2277	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;transport vesicle	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;intracellular transport vesicles	NRP1;VEGFD	None	None	None
TGF-beta receptor-SMAD3 complex	P36897;P37173;P84022	7046;7048;4088	transforming growth factor beta receptor signaling pathway;growth factor activity	TGF-beta-receptor signalling pathway;growth factors	TGFBR1;TGFBR2;SMAD3	None	None	None
Pre-initiation complex (PIC)	P20226;P24928;P60709	6908;5430;60	"DNA-templated transcription, initiation;nucleic acid binding"	transcription initiation;nucleic acid binding	TBP;POLR2A;ACTB	None	Actin is required for the initiation of transcription (for the formation of pre-initiation complexes).	None
NRP2-VEGFR3 complex	O60462;P35916	8828;2324	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;transport vesicle	receptor-mediated endocytosis;transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;intracellular transport vesicles	NRP2;FLT4	None	None	None
PlexinA1-NRP1 complex	O14786;Q9UIW2	8829;5361	signaling;nervous system development;neuron projection development	cellular signalling;nervous system	NRP1;PLXNA1	None	None	None
PlexinA1-NRP1-SEMA3A complex	O14786;Q14563;Q9UIW2	8829;10371;5361	signaling;nervous system development;neuron projection development	cellular signalling;nervous system	NRP1;SEMA3A;PLXNA1	None	Plexin A increases Neuropilin 1 affinity for SEMA3A.	None
2AR-mGluR2 complex	P08913;P42262	150;2891	G-protein coupled receptor signaling pathway;response to antipsychotic drug	G-protein coupled receptor signalling pathway	ADRA2A;GRIA2	None	"The results are consistent with the hypothesis that the 2AR-mGluR2 complex integrates serotonin and glutamate signaling to regulate the sensory gating functions of the cortex, a process that is disrupted in psychosis."	2AR-mGluR2 complex is involved in psychosis.
2AR-mGluR2 complex	P08913;P42262	150;2891	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	ADRA2A;GRIA2	None	"The results are consistent with the hypothesis that the 2AR-mGluR2 complex integrates serotonin and glutamate signalling to regulate the sensory gating functions of the cortex, a process that is disrupted in psychosis."	2AR-mGluR2 complex is involved in psychosis.
MRIT complex	O15519;Q07817;Q14790	8837;598;841	activation of cysteine-type endopeptidase activity involved in apoptotic process	caspase activation	CFLAR;BCL2L1;CASP8	None	None	None
SUMO1-SUA1-UBA2 complex	P63165;Q9UBE0;Q9UBT2	7341;10055;10054	protein sumoylation;protein desumoylation;Smt3-protein conjugation	modification by ubiquitin-related proteins	SUMO1;SAE1;UBA2	None	"Sua1p and hUba2p form a complex, and the complexed hUba2p binds SUMO-1."	None
SUA1-UBA2 complex	Q9UBE0;Q9UBT2	10055;10054	protein sumoylation	modification by ubiquitin-related proteins	SAE1;UBA2	None	Human Uba2 bound SUMO-1 and this complex had the activity of the SUMO-1 activating enzyme.	None
PLXNA1-RANBPM complex	Q96S59;Q9UIW2	10048;5361	"retrograde transport, vesicle recycling within Golgi;signaling;neuron projection development"	retrograde transport;cellular signalling	RANBP9;PLXNA1	None	RanBPM has the potential to link Plexin-A receptors to retrograde transport and microtubule function in axonal guidance.	None
PLXNA2-RANBPM complex	O75051;Q96S59	5362;10048	"retrograde transport, vesicle recycling within Golgi;signaling;neuron projection development"	retrograde transport;cellular signalling	PLXNA2;RANBP9	None	RanBPM has the potential to link Plexin-A receptors to retrograde transport and microtubule function in axonal guidance.	None
PLXNA3-RANBPM complex	P51805;Q96S59	55558;10048	"retrograde transport, vesicle recycling within Golgi;signaling;neuron projection development"	retrograde transport;cellular signalling	PLXNA3;RANBP9	None	RanBPM has the potential to link Plexin-A receptors to retrograde transport and microtubule function in axonal guidance.	None
PLXNA4-RANBPM complex	Q96S59;Q9HCM2	10048;91584	"retrograde transport, vesicle recycling within Golgi;signaling;neuron projection development"	retrograde transport;cellular signalling	RANBP9;PLXNA4	None	RanBPM has the potential to link Plexin-A receptors to retrograde transport and microtubule function in axonal guidance.	None
"CRMP-MICAL-PlexinA1 complex, induced by SEMA3A"	Q14194;Q8TDZ2;Q9UIW2	1400;64780;5361	signaling;nervous system development;neuron projection development	cellular signalling;nervous system	CRMP1;MICAL1;PLXNA1	None	MIDCAL1 forms a SEMA3A-modulated complex with CRMP and PlexA proteins.	None
RUNX1-CBF-beta-DNA complex	Q01196;Q13951	861;865	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	RUNX1;CBFB	None	The heterodimeric complex between AML1 and CBF beta has an essential role in the ontogeny of definitive hematopoiesis and is the most frequent target for chromosomal rearrangements in human acute leukemias.	The complex is involved in acute leukemias.
ZO1-(beta)cadherin-(VE)cadherin-VEGFR2 complex	P33151;P35222;P35968;Q07157	1003;1499;3791;7082	transmembrane receptor protein tyrosine kinase signaling pathway;angiogenesis;cell-cell junction assembly;blood vessel development;vasculature development	transmembrane receptor protein tyrosine kinase signalling pathways;angiogenesis;intercellular junction (gap junction/adherens junction);vessels	CDH5;CTNNB1;KDR;TJP1	None	None	None
"Death induced signaling complex II (FADD, CASP8, CFLAR), cytosolic, CD95L induced"	O15519;Q13158;Q14790	8837;8772;841	apoptotic signaling pathway	induction of apoptosis by extracellular signals	CFLAR;FADD;CASP8	None	"In contrast to the caspase activation at the CD95 DISC reported to occur within seconds after stimulation, caspase activation in the cytosol took place hours after stimulation. This complex was found in all investigated cell lines:  SKW6.4, BJAB, Raji, HUT78 and J16."	None
"DISC complex (FAS, FADD, CASP8, CFLAR), membrane-associated, CD95L induced"	O15519;P25445;Q13158;Q14790	8837;355;8772;841	apoptotic signaling pathway	induction of apoptosis by extracellular signals	CFLAR;FAS;FADD;CASP8	None	"The CD95 DISC is formed within seconds after CD95 stimulation, followed by caspase-8 activation at the DISC complex."	None
"DISC complex (FAS, FADD, CASP8)"	P25445;Q13158;Q14790	355;8772;841	apoptotic process;plasma membrane;extrinsic apoptotic signaling pathway	apoptosis (type I programmed cell death);eukaryotic plasma membrane / membrane attached	FAS;FADD;CASP8	None	"The authors compared the formation of the DISC between typeI (SKW6.5, H9) and type II  (JUrkat, CEM) cells. In type I cells, induction of apoptosis was accompanied by activation of large amounts of caspase-8 by the death-inducing signaling complex (DISC), whereas in type II cells DISC formation was strongly reduced and activation of caspase-8 and caspase-3 occurred following the loss of mitochondrial transmembrane potential."	None
PGAM5-KEAP1-NRF2 complex	Q14145;Q16236;Q96HS1	9817;4780;192111	"regulation of RNA biosynthetic process;regulation of transcription, DNA-templated;response to reactive oxygen species;response to oxidative stress;mitochondrial outer membrane"	transcriptional control;oxidative stress response;mitochondrial outer membrane	KEAP1;NFE2L2;PGAM5	None	"The authors describe that PGAM5, by anchoring the Keap1-Nrf2 complex to outer membrane of mitochondria, may facilitate coordination between mitochondrial function and regulation of Nrf2-dependent anti-oxidant gene expression."	None
"DISC complex (CD95, FADD, CASP8)"	Q13158;Q14790;Q8IUB6	8772;841;355	apoptotic signaling pathway	induction of apoptosis by extracellular signals	FADD;CASP8;CD95	None	This complex formation was induced by 5-FU.	None
"GABA-A receptor (GABRA1, GABRB2, GABRG2)"	P14867;P18507;P47870	2554;2566;2561	chloride transport;ion channel activity	chloride transport;ion channels	GABRA1;GABRG2;GABRB2	None	None	"Epilepsy, juvenile mioclonic."
p53-BCL2 complex	P04637;P10415	7157;596	apoptotic process;mitochondrion	apoptosis (type I programmed cell death);mitochondrion	TP53;BCL2	None	None	None
p53-BCL2 complex	P04637;Q07817	7157;598	apoptotic process;mitochondrion	apoptosis (type I programmed cell death);mitochondrion	TP53;BCL2L1	None	None	None
Apoptosome-procaspase 9 complex	O14727;P55211;P99999	317;842;54205	apoptotic process;cytoplasm	apoptosis (type I programmed cell death);cytoplasm	APAF1;CASP9;CYCS	None	None	None
MCL1-BAK1 complex	Q07820;Q16611	4170;578	regulation of programmed cell death;mitochondrial outer membrane	regulation of apoptosis;mitochondrial outer membrane	MCL1;BAK1	None	None	None
IKBKG homotetramer complex	Q9Y6K9	8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKG	None	Cross link agent EGS appears to cross-link preferentially the IKK-gamma subunits in the IKK-alpha-IKK-beta-IKK-gamma holocomplex.	None
IKBKG-IKBKB  complex	O14920;Q9Y6K9	3551;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKB;IKBKG	None	The tetrameric oligomerization is not required for binding of IKK-gamma to IKK-alpha or IKK-beta.	None
IKBKG-CHUK complex	O15111;Q9Y6K9	1147;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	CHUK;IKBKG	None	The tetrameric oligomerization is not required for binding of IKK-gamma to IKK-alpha or IKK-beta.	None
"DJ-1-SNCA complex, high molecular weight complex"	P37840;Q99497	6622;11315	None	None	SNCA;PARK7	None	None	None
PINK1-MIRO2-Milton complex	Q8IXI1;Q9BXM7;Q9UPV9	89941;65018;22906	vesicle-mediated transport;mitochondrial outer membrane	"vesicular transport (Golgi network, etc.);mitochondrial outer membrane"	RHOT2;PINK1;TRAK1	None	This complex is involved in anterograde axonal transport of mitochondria.	None
MIRO2-Milton complex	Q8IXI1;Q9UPV9	89941;22906	vesicle-mediated transport;mitochondrial outer membrane	"vesicular transport (Golgi network, etc.);mitochondrial outer membrane"	RHOT2;TRAK1	None	This complex is involved in anterograde axonal transport of mitochondria.	None
PPD complex	O60260;Q99497;Q9BXM7	5071;11315;65018	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process;cytoplasm	proteasomal degradation (ubiquitin/proteasomal pathway);cytoplasm	PARK2;PARK7;PINK1	None	"PPD complex plays an important role in degradation of un- or misfolded Parkin substrates, like Parkin itself or Synphilin-1. Usually the PPD complex is found in the cytoplasm, but a small ammount was also detected in the mitochondrial fraction."	None
AIF-CYPA-DNA complex	O95831;P62937	9131;5478	apoptotic process;nucleus	apoptosis (type I programmed cell death);nucleus	AIFM1;PPIA	None	"After apoptotic stimulus, AIF translocates to the nucleus, interacts with DNA and tethers CypA to chromatin."	None
I-kappa-B kinase complex	O14920;O15111;Q9Y6K9	3551;1147;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKB;CHUK;IKBKG	None	"The authors conclude that while IKK gamma is a stoichiometric component of the IKK complex, obligatory for NF-kappa B signaling, IKAP is not associated with IKKs and plays no specific role in cytokine-induced NF-kappa B activation."	None
HSP90-CDC37-LRRK2 complex	P08238;Q16543;Q5S007	3326;11140;120892	intracellular signal transduction	cellular signalling	HSP90AB1;CDC37;LRRK2	None	HSP90 and CDC37 do not serve as substrate for LRRK2 kinase but associates as chaperones participating in maintenance of proper folding of the kinase.	None
AK2-FADD-caspase-10 (AFAC10) complex	P54819;Q13158;Q92851	204;8772;843	intrinsic apoptotic signaling pathway	induction of apoptosis by intracellular signals	AK2;FADD;CASP10	None	AFAC10 complexes are detected in cells undergoing intrinsic cell death and AK2 promotes the association of caspase-10 with FADD. AK2 mediates a novel intrinsic apoptotic pathway that may be involved in tumorigenesis.	None
FAS-FADD-CASP8-CASP10 complex	P25445;Q13158;Q14790;Q92851	355;8772;841;843	apoptotic process	apoptosis (type I programmed cell death)	FAS;FADD;CASP8;CASP10	None	"Stimulation of Fas was induced by anti-Fas or by FasL. The FRET-results suggest that caspase-8 and -10 can be recruited likely within 50 \u00c5, which would constitute the same Fas signaling complex. Caspase-10 is recruited into the Fas signaling complex and becomes activated like caspase-8 with slightly faster kinetics under these conditions. FRET signals showed pairs of of caspase-8 and -10 DEDs (death effector domains) with themselves and with each other, indicating a natural propensity of these domains to cause homotypic and heterotypic complexes."	None
"DISC complex (FAS, FADD, CASP8)"	P25445;Q13158;Q14790	355;8772;841	apoptotic process	apoptosis (type I programmed cell death)	FAS;FADD;CASP8	None	"Stimulation of Fas was induced by anti-Fas or by FasL. FRET signals showed pairs of of caspase-8 and -10 DEDs (death effector domains) with themselves and with each other, indicating a natural propensity of these domains to cause homotypic and heterotypic complexes."	None
FAS-FADD-CASP10 complex	P25445;Q13158;Q92851	355;8772;843	apoptotic process	apoptosis (type I programmed cell death)	FAS;FADD;CASP10	None	"Stimulation of Fas was induced by anti-Fas or by FasL.  FRET signals showed pairs of of caspase-8 and -10 DEDs (death effector domains) with themselves and with each other, indicating a natural propensity of these domains to cause homotypic and heterotypic complexes."	None
CAV1-VDAC1-ESR1 complex	P03372;P21796;Q03135	2099;7416;857	ion channel activity;plasma membrane	ion channels;eukaryotic plasma membrane / membrane attached	ESR1;VDAC1;CAV1	None	None	Disease: CAV1-VDAC1-ESR1 complex is involved in Alzheimer's disease.
APBB1-TSHZ3-HDAC1 complex	O00213;Q13547;Q63HK5	322;3065;57616	"negative regulation of transcription, DNA-templated;nucleus"	transcription repression;nucleus	APBB1;HDAC1;TSHZ3	None	CASP4 appears to be one target for the repressor complex centering on FE65.	Disease: TSHZ3 is involved in Alzheimer disease.
BRAF-MAP2K1-MAP2K2-YWHAE complex	P15056;P36507;P62258;Q02750	673;5605;7531;5604	signaling	cellular signalling	BRAF;MAP2K2;YWHAE;MAP2K1	None	None	None
RAF1-MAP2K1-YWHAE complex	P04049;P62258;Q02750	5894;7531;5604	signaling	cellular signalling	RAF1;YWHAE;MAP2K1	None	None	None
PPP2R1A-PPP2R1B-PPP2CA-PPME1-EIF4A1 complex	P30153;P30154;P60842;P67775;Q9Y570	5518;5519;1973;5515;51400	protein dephosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	PPP2R1A;PPP2R1B;EIF4A1;PPP2CA;PPME1	None	None	None
MAP2K1-BRAF-RAF1-YWHAE-KSR1 complex	P04049;P15056;P62258;Q02750;Q8IVT5	5894;673;7531;5604;8844	signaling	cellular signalling	RAF1;BRAF;YWHAE;MAP2K1;KSR1	None	None	None
KSR1 homo-oligomer complex	Q8IVT5	8844	MAPK cascade	MAPKKK cascade	KSR1	None	The authors found that KSR1 homo-oligomerization is required to couple distinct KSR\u00b7MEK and KSR\u00b7B-Raf complexes to allow MEK activation.IMP (the Ras effector and ubiquitin-protein isopeptide ligase family member) association blocks KSR1 homo-oligomerization.	None
BRAF-RAF1-14-3-3 complex	P04049;P15056;P63104	5894;673;7534	MAPK cascade	MAPKKK cascade	RAF1;BRAF;YWHAZ	None	"Expression of IMP (Ras effector and ubiquitin-protein isopeptide ligase family member)  blocked BRAF-RAF1 complex formation.Although 14-3-3 association has been implicated as a prerequisite for B-Raf\u00b7c-Raf complex formation, IMP impaired Raf hetero-oligomerization without affecting the relative amounts of 14-3-3 coprecipitating with B-Raf."	None
KSR1-RAF1-MEK complex	P04049;Q02750;Q8IVT5	5894;5604;8844	MAPK cascade	MAPKKK cascade	RAF1;MAP2K1;KSR1	"Since the authors did not specify Mek, we used isoform Mek1."	IMP (Ras effector and ubiquitin-protein isopeptide ligase family member)  significantly inhibited the association of c-Raf with KSR1. This is in stark contrast to the insensitivity of KSR1\u00b7B-Raf complexes to IMP expression.	None
KSR1-BRAF-MEK complex	P15056;Q02750;Q8IVT5	673;5604;8844	MAPK cascade	MAPKKK cascade	BRAF;MAP2K1;KSR1	"Since the authors did not specify Mek, we used isoform Mek1."	IMP (Ras effector and ubiquitin-protein isopeptide ligase family member)  significantly inhibited the association of c-Raf with KSR1. This is in stark contrast to the insensitivity of KSR1\u00b7B-Raf complexes to IMP expression.	None
"RAF1-RAS complex, EGF induced"	P01112;P04049	3265;5894	signaling;plasma membrane	cellular signalling;eukaryotic plasma membrane / membrane attached	HRAS;RAF1	None	"The authors showed that whereas EGF induces complex formation between RAS and C-RAF, and (G12V)RAS binds directly to C-RAF, a RAS:C-RAF complex is not induced by the impaired activity mutants of B-RAF or by (V600E)B-RAF."	None
"RAF1-BRAF complex, RAS stimulated"	P04049;P15056	5894;673	signaling	cellular signalling	RAF1;BRAF	None	"The authors found that C-RAF binds to B-RAF only under activating conditions, whereas mutant B-RAF binds to C-RAF constitutively. Additionally they showed that wild-type B-RAF can also activate C-RAF, but that C-RAF does not activate B-RAF."	None
"RAF1-CNK1 complex, RAS stimulated"	P04049;Q969H4	5894;10256	signaling	cellular signalling	RAF1;CNKSR1	None	"The authors described that the interaction between the wild-type proteins of Raf and CNK was detectable but weak. Further they showed that coexpression of activated RasV12 enhanced the association between the two proteins, indicating that Raf-1 preactivated by RasV12 undergoes a conformational change that improves its binding to CNK1."	None
"BRAF-CNK1 complex, not RAS stimulated"	P15056;Q969H4	673;10256	signaling	cellular signalling	BRAF;CNKSR1	None	"The authors showed that in contrast to Raf-1, B-Raf bound to CNK1 without the coexpression of activated Ras."	None
CNK1 homodimer complex	Q969H4	10256	signaling	cellular signalling	CNKSR1	None	The authors showed that coexpression of activators of the MAP kinase pathway such as RasV12 or the constitutively active MEK mutant MEK-Glu-217/Glu-221  strongly induced dimerization of the CNK proteins.	None
CNK1-SRC-RAF1 complex	P04049;P12931;Q969H4	5894;6714;10256	signaling	cellular signalling	RAF1;SRC;CNKSR1	None	"The results indicated that CNK1 regulates the Src-dependent activation of Raf-1 only under optimized conditions. Too low or too high amounts of CNK1 prevented the formation of the trimeric complex and promoted dimerization between CNK1 and Src or Raf-1, thereby preventing activation of Raf-1 by Src. The authors describe that CNK1 acts as a scaffold protein that assembles and coordinates two kinases of a single signaling pathway."	None
"Gamma-secretase complex (APH1A, PSENEN, PSEN1, NCSTN, TMP21)"	P49755;P49768;Q92542;Q96BI3;Q9NZ42	10972;5663;23385;51107;55851	protein processing;regulation of sequence-specific DNA binding transcription factor activity;signaling;Notch signaling pathway;plasma membrane;Golgi apparatus	protein processing (proteolytic);regulator of transcription factor;cellular signalling;Notch-receptor signalling pathway;eukaryotic plasma membrane / membrane attached;Golgi	TMED10;PSEN1;NCSTN;APH1A;PSENEN	None	None	None
LRRK2-CHIP-HSP90 complex	P08238;Q5S007;Q9UNE7	3326;120892;10273	proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	HSP90AB1;LRRK2;STUB1	None	None	LRRK2 is involved in Parkinson disease.
LRRK2-FADD-CASP8 complex	Q13158;Q14790;Q5S007	8772;841;120892	apoptotic process	apoptosis (type I programmed cell death)	FADD;CASP8;LRRK2	None	None	None
Calcineurin	P63098;Q08209	5534;5530	calcium-mediated signaling;calcineurin complex;calmodulin binding;phosphatase activity	Ca2+ mediated signal transduction	PPP3R1;PPP3CA	None	"Calcineurin (CaN) is a calcium- and calmodulin-dependent protein serine/threonine phosphatase which is critical for several important cellular processes, including T-cell activation. CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cytoplasmic binding proteins (cyclophilin and FKBP12, respectively). CaN is a heterodimer composed of a catalytic A unit and a regulatory B unit."	None
Ubiquitin-conjugating enzyme E2 (UBC13-UEV1A)	P61088;Q13404	7334;7335	protein ubiquitination;protein K63-linked ubiquitination;I-kappaB kinase/NF-kappaB signaling	"modification by ubiquitination, deubiquitination;NIK-I-kappaB/NF-kappaB cascade"	UBE2N;UBE2V1	None	This complex supports the activation of the I-kappa-B kinase complex by TRAF6. It catalyzes the formation of a Lys 63 (K63)-linked polyubiquitin chain.	None
PARK2-EPS15-EGFR complex	O60260;P00533;P42566	None;None;None	vacuolar transport;epidermal growth factor receptor signaling pathway	vacuolar/lysosomal transport;EGF-receptor signalling pathway	PARK2;EGFR;EPS15	None	None	None
CHIP-HSC70-TAU-UBCH5B complex	P10636;P11142;P62837;Q9UNE7	4137;3312;7322;10273	protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	MAPT;HSPA8;UBE2D2;STUB1	None	"CHIP-HSC70 complex ubiquitinates phosphorylated Tau and enhances cell survival by decreasing the toxicity of hyperphosphorylated tau, a important factor in the neurofibrillary pathology of Alzheimer disease, via proteasomal degradation. It is shown that Alzheimer tau binds to Hsc70, and its phosphorylation is a recognition requirement for the addition of ubiquitin (Ub) by the E3 Ub ligase CHIP (carboxyl terminus of the Hsc70-interacting protein) and the E2 conjugating enzyme UbcH5B."	Alzheimer disease
Dynein complex	O14576;P63167;Q14204;Q9Y6G9	None;None;None;None	cytoskeleton-dependent intracellular transport	cytoskeleton-dependent transport	DYNC1I1;DYNLL1;DYNC1H1;DYNC1LI1	None	None	None
Dynein-dynactin complex	O14576;P63167;Q14203;Q14204;Q9Y6G9	None;None;None;None;None	cytoskeleton-dependent intracellular transport	cytoskeleton-dependent transport	DYNC1I1;DYNLL1;DCTN1;DYNC1H1;DYNC1LI1	None	None	None
DISC1-FEZ1 complex	Q99689;Q9NRI5	None;27185	cell morphogenesis;cell growth	cell growth / morphogenesis	FEZ1;DISC1	None	None	OMIM: 181500 Schizophrenia
DISC-FEZ1-F-actin complex	Q6PJ43;Q99689;Q9NRI5	None;None;27185	cell morphogenesis;cell growth	cell growth / morphogenesis	ACTG1;FEZ1;DISC1	None	None	OMIM: 181500 Schizophrenia
PDE4B-DISC1 complex	Q07343;Q9NRI5	5142;27185	regulation of cAMP catabolic process	None	PDE4B;DISC1	None	None	"OMIM:181500 Schizophrenia, OMIM:608516.Major depression disorder (PMID:17823207)."
BAG3-HSC70-HSPB8-CHIP complex	O95817;P11142;Q9UJY1;Q9UNE7	9531;3312;26353;10273	protein stabilization;protein folding;response to stress	protein folding and stabilization;stress response	BAG3;HSPA8;HSPB8;STUB1	None	"The BAG3-HSC70-HSPB8-CHIP complex facilitates the degradation of damaged components, such as filamin, through chaperone-assisted selective autophagy (CASA)."	None
LKB1-STRAD-MO25 complex	Q15831;Q7RTN6;Q9Y376	6794;92335;51719	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	STK11;STRADA;CAB39	None	"LKB1 activity is regulated by the pseudokinase STRAD-alpha and the scaffolding protein MO25-alpha, through an unknown, phosphorylation-independent, mechanism. The core heterotrimeric LKB1-STRAD-alpha-MO25-alpha complex, reveals an unusual allosteric mechanism of LKB1 activation."	"Loss-of-function mutations in the tumor suppressor LKB1 cause the rare inherited disease Peutz-Jeghers syndrome (PJS) in humans and are associated with various sporadic cancers, in particular non\u2013small cell lung cancer."
APP-TNFRSF21 complex	O75509;P05067	27242;351	neuron remodeling;neuron death	None	TNFRSF21;APP	None	APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.	None
DISC1-ZNF365 complex	Q70YC5;Q9NRI5	22891;27185	neurogenesis;generation of neurons	neurogenesis	ZNF365;DISC1	None	None	None
Xanthine oxidase	P47989	7498	purine nucleotide catabolic process;molybdenum ion binding;hypoxanthine oxidation;xanthine oxidation;NAD+ binding	purine nucleotide /nucleoside/nucleobase catabolism	XDH	None	"Xanthine oxidase is a molybdoenzyme that catalyses the oxidation of hypoxanthine to xanthine and of xanthine to uric acid. In mammalian systems, it occurs as partially interconvertible Type D (dehydrogenase) and Type O (oxidase) forms, reducing, respectively, NAD+ or oxygen. In such systems, the term 'xanthine oxidase' commonly refers to both Type D and Type O forms."	None
ESR1-SP1 complex	P03372;P08047	2099;6667	None	None	ESR1;SP1	None	None	None
ESR1-CEBPB complex	P03372;P17676	2099;1051	None	None	ESR1;CEBPB	None	None	None
ESR1-GRIP1 complex	P03372;Q9Y3R0	2099;23426	None	None	ESR1;GRIP1	None	None	None
TRA2B1-SRSF9-SRSF6 complex	P62995;Q13242;Q13247	None;None;None	"regulation of RNA splicing;regulation of mRNA splicing, via spliceosome"	regulation of splicing	TRA2B;SRSF9;SRSF6	TRA2B1 variant was used.	"Tau (Mapt) exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c-SRp55 complex that either recruits or antagonizes htra2beta1. SRp30c is also known as SRSF9, and SRp55 as SRSF6. To confirm the three factors acting as a complex, co-immunoprecipitations of the three proteins were done. It could be shown that htra2beta1 (a variant of TRA2B) interacts with SRp55 and SRp30c interacts with both SRp55 and htra2beta1."	"TAU-mutations that affect exon 10 splicing cause frontotemporal dementia (FTDP). TAU-exon 2 is significantly reduced in myotonic dystrophy type 1, whose symptoms include dementia."
SRSF9-SRSF6 complex	Q13242;Q13247	None;None	"regulation of RNA splicing;regulation of mRNA splicing, via spliceosome"	regulation of splicing	SRSF9;SRSF6	None	"Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c-SRp55 complex that either recruits or antagonizes htra2beta1 (a variant of TRA2B)."	"TAU-mutations that affect exon 10 splicing cause frontotemporal dementia (FTDP). TAU-exon 2 is significantly reduced in myotonic dystrophy type 1, whose symptoms include dementia."
CST complex	Q2NKJ3;Q86WV5;Q9H668	80169;100134934;79991	single-stranded DNA binding;telomere maintenance	None	CTC1;TEN1;OBFC1	None	None	None
c-Abl-cortactin-nmMLCK complex	P00519;Q14247;Q15746	25;2017;4638	cytoskeleton organization;establishment of endothelial barrier	cytoskeleton/structural proteins	ABL1;CTTN;MYLK	"MYLK has been defined as non-muscle isoform, nmMYLK."	"The association of c-Abl, nmMLCK (nonmuscle), and cortactin is increased in ECs (endothelial cells) during S1P (sphingosine 1-phosphate) ,induced barrier enhancement."	"nmMLCK plays a role in inflammatory processes, several polymorphisms in the nmMLCK gene (MYLK) are highly associated with susceptibility to acute inflammatory states such as acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and asthma."
HSPA2-ACR-PDIA6 complex	P12821;P54652;Q15084	1636;3306;10130	regulation of acrosome reaction	None	ACE;HSPA2;PDIA6	None	None	None
BAG6-HSPA2 complex	P46379;P54652	7917;3306	spermatogenesis;regulation of protein folding	None	BAG6;HSPA2	None	None	None
ACAP1-CHC-Glut4 complex	P14672;Q00610;Q15027	6517;1213;9744	endocytic recycling	None	SLC2A4;CLTC;ACAP1	None	The results suggested that ACAP1 acted like AP adaptors in bridging an interaction between cargo tails and clathrin triskelion.	None
CART complex	O14964;O43707;O75382;Q9ULV0	9146;81;10612;4645	transferrin receptor activity;receptor recycling;endocytic recycling	None	HGS;ACTN4;TRIM3;MYO5B	None	"The CART complex is necessary for efficient recycling of the transferrin (Tf) receptor to the plasma membrane, but not movement to lysosomes and degradation of the EGFR.The CART complex, composed of hrs, actinin-4, BERP, and myosin V, seemed to require BERP to link myosin V to hrs-actinin-4."	None
AFF4 super elongation complex (SEC)	O00472;O60563;O60583;P42568;P50750;P51825;P55199;Q03111;Q96JC9;Q9HB65;Q9UHB7	22936;904;905;4300;1025;4299;8178;4298;85403;80237;27125	"DNA-templated transcription, elongation"	transcription elongation	ELL2;CCNT1;CCNT2;MLLT3;CDK9;AFF1;ELL;MLLT1;EAF1;ELL3;AFF4	Complex subunit Cyclin-T2  is described as isoform Cyclin-T2a or Cyclin-T2b.	"AFF4 is a central factor required for the assembly and integrity of the ELL/P-TEFb (consisting of Cdk9 with cyclin T1, T2a orT2b)/MLL partner elongation complex."	The authors propose that the AFF4 super elongation complex (SEC) could be a key regulator in the pathogenesis of leukemia through many of the MLL (Mixed Lineage Leukemia) partners are found in hematological malignancies.
MCPIP1-MCPIP4 complex	A2A288;Q5D1E8	340152;80149	inflammatory response	inflammatory response	ZC3H12D;ZC3H12A	None	None	None
ERbeta-AR complex	P10275;Q92731	367;2100	"regulation of transcription, DNA-templated"	transcriptional control	AR;ESR2	None	17beta-estradiol (E2) up-regulates SOX4 expression in the absence of androgen through the formation of a protein complex between ERbeta (estrogen beta receptor) and AR (androgen receptor). Knockdown of AR or ERbeta blocks the E2-induced SOX4 expression. ChIP assays confirmed that both ERbeta and AR bind to the SOX4 promoter in response to E2. E2 could promote proliferation of PCa cells through the up-regulation of SOX4 under androgen-depleted environment (PMID:26015225).	OMIM:176807 Prostate cancer
Seipin-AGPAT2 complex	O15120;Q96G97	10555;26580	regulation of adipose tissue development;lipid biosynthetic process	"lipid, fatty acid and isoprenoid metabolism"	AGPAT2;BSCL2	None	The seipin can bind AGPAT2 during adipogenesis and this interaction during adipogenesis can increase the nuclear accumulation of PPARgamma (PMID:25737955).	"OMIM:608594 Lipodystrophy, congenital generalized, type 1"
Seipin-AGPAT2-lipin1 complex	O15120;Q14693;Q96G97	10555;23175;26580	regulation of adipose tissue development;lipid biosynthetic process	"lipid, fatty acid and isoprenoid metabolism"	AGPAT2;LPIN1;BSCL2	None	None	"OMIM:269700 LipoLdystrophy, congenital generalized, type 2OMIM:608594  LipoLdystrophy, congenital generalized, type 1"
Seipin-lipin1 complex	Q14693;Q96G97	23175;26580	None	None	LPIN1;BSCL2	None	None	"OMIM:269700 Lipodystrophy, congenital generalized, type 2"
NF-YA-LaminA complex	P02545;P23511	4000;4800	cell cycle;cell proliferation	cell cycle	LMNA;NFYA	None	None	None
c-Jun-ATF3 complex	P05412;P18847	3725;467	"regulation of transcription, DNA-templated"	transcriptional control	JUN;ATF3	None	None	OMIM:114480 Breast cancer
PLEKHA7-PDZD11 complex	Q5EBL8;Q6IQ23	51248;144100	adherens junction	None	PDZD11;PLEKHA7	None	None	None
alphaB-crystallin-Nav1.5 complex	P02511;Q14524	1410;6331	regulation of voltage-gated sodium channel activity;regulation of protein ubiquitination	None	CRYAB;SCN5A	None	None	None
MEF2-NR2F2 complex	P24468;Q02078	7026;4205	regulation of steroid metabolic process	None	NR2F2;MEF2A	None	None	None
ZP3-MFGE8 protein	P48830;Q95114	280964;281913	acrosome reaction;regulation of hydrolase activity;acrosomal matrix	None	ZP3;MFGE8	None	None	None
ZP3-SPACA3 complex	A6QQ77;P48830	617955;280964	acrosome reaction;regulation of hydrolase activity;acrosomal matrix	None	SPACA3;ZP3	None	None	None
ZP3-IZUMO1 complex	P21754;Q8IYV9	7784;284359	regulation of acrosome reaction	None	ZP3;IZUMO1	None	None	None
proMBP-angiotensinogen complex	P01019;P13727	183;5553	regulation of blood pressure;female pregnancy	None	AGT;PRG2	proMBP (MBP) is derived from a preproprotein of 222 amino acids.	None	The authors suggest that this complex may be involved in the pathophysiology of pregnancies associated with hypertension.
PAPP-A-proMBP complex	P13727;Q13219	5553;5069	female pregnancy	None	PRG2;PAPPA	proMBP (MBP) is derived from a preproprotein of 222 amino acids.	"The serum levels of proMBP exceeds that of PAPP-A by several fold on a molar basis, and consequently, only a fraction of circulating proMBP is bound to PAPP-A."	None
proMBP-angiotensinogen-c3dg complex	P01019;P01024;P13727	183;718;5553	regulation of blood pressure;female pregnancy	None	AGT;C3;PRG2	None	None	The authors suggest that this complex may be involved in the pathophysiology of pregnancies associated with hypertension.
STIM1-TRPV4 complex	Q13586;Q9HBA0	6786;59341	regulation of calcium ion transport	None	STIM1;TRPV4	None	None	None
FHF complex	Q86VS8;Q8N612;Q96ED9;Q9H8T0;Q9UJC3	84376;84067;29911;64400;51361	vesicle-mediated transport;vesicle fusion;endosomal transport	"vesicular transport (Golgi network, etc.);vesicle fusion"	HOOK3;FAM160A2;HOOK2;AKTIP;HOOK1	None	Hook proteins as well as FTS interact with members of both the class B and class C components of the homotypic vesicular protein sorting (HOPS) complex.	None
protein phosphatase 2A C-subunit-synapsin complex	P17600;P67775	6853;5515	modulation of synaptic transmission	None	SYN1;PPP2CA	None	None	None
DGAT2-MGAT2 complex	Q10469;Q96PD7	4247;84649	triglyceride biosynthetic process	None	MGAT2;DGAT2	None	None	None
BAG1-HSC70 complex	P11142;Q99933	3312;573	protein folding	protein folding and stabilization	HSPA8;BAG1	None	None	None
BAG1-HSP70 complex	P0DMV8;Q99933	3303;573	protein folding	protein folding and stabilization	HSPA1A;BAG1	"Since the authors did not specify HSP70, we used isoform HSPA1A."	None	None
Hook1-Vps16 complex	Q9H269;Q9UJC3	64601;51361	endosomal transport	None	VPS16;HOOK1	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook1-Vps18 complex	Q9P253;Q9UJC3	57617;51361	endosomal transport	None	VPS18;HOOK1	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook1-Vps39 complex	Q96JC1;Q9UJC3	23339;51361	endosomal transport	None	VPS39;HOOK1	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook1-Vps41 complex	P49754;Q9UJC3	27072;51361	endosomal transport	None	VPS41;HOOK1	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook2-Vps16 complex	Q96ED9;Q9H269	29911;64601	endosomal transport	None	HOOK2;VPS16	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook2-Vps41 complex	P49754;Q96ED9	27072;29911	endosomal transport	None	VPS41;HOOK2	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook3-Vps16 complex	Q86VS8;Q9H269	84376;64601	endosomal transport	None	HOOK3;VPS16	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
Hook3-Vps41 complex	P49754;Q86VS8	27072;84376	endosomal transport	None	VPS41;HOOK3	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
FTS-Vps16 complex	Q9H269;Q9H8T0	64601;64400	endosomal transport	None	VPS16;AKTIP	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
FTS-Vps18 complex	Q9H8T0;Q9P253	64400;57617	endosomal transport	None	AKTIP;VPS18	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
FTS-Vps41 complex	P49754;Q9H8T0	27072;64400	endosomal transport	None	VPS41;AKTIP	None	FTS and Hook proteins associate with class B and class C components of the HOPS complex.	None
DAXX-MDM2-USP7 complex	Q00987;Q93009;Q9UER7	4193;7874;1616	"DNA damage response, detection of DNA damage;regulation of proteasomal protein catabolic process;nucleoplasm"	DNA damage response	MDM2;USP7;DAXX	None	None	None
CBP80/20- dependent translation complex	O43310;P38919;P52298;P55884;Q09161;Q9BZI7	9811;9775;22916;8662;4686;65109	None	None	CTIF;EIF4A3;NCBP2;EIF3B;NCBP1;UPF3B	None	"CTIF interacts directly via its MIF4G domain with CBP80, is part of the CBP80/20-dependent translation initiation complex, and is complexed with eIF3 and eIF4AIII. Endogenous CBP80, eIF3b, and NMD factor Upf3X copurified with endogenous CTIF. Depletion of endogenous CTIF from an in vitro translation system selectively blocks the translation of CBP80-bound mRNAs, while addition of purified CTIF restores it."	None
SELK multiprotein complex	P04843;P04844;P27824;P39656;P46977;P55072;Q9BQE4;Q9BUN8;Q9GZP9;Q9Y6D0	6184;6185;821;1650;3703;7415;55829;79139;51009;58515	endoplasmic reticulum unfolded protein response;ERAD pathway	unfolded protein response (e.g. ER quality control)	RPN1;RPN2;CANX;DDOST;STT3A;VCP;VIMP;DERL1;DERL2;SELK	None	None	None
MINOS complex	Q16891;Q5TGZ0;Q9NX63	10989;440574;54927	inner mitochondrial membrane organization	None	IMMT;MINOS1;CHCHD3	None	None	None
RFX5-RFXANK-RFXAP complex	O00287;O14593;P48382	5994;8625;5993	"transcription factor activity, sequence-specific DNA binding"	None	RFXAP;RFXANK;RFX5	None	None	"OMIM:209920 Bare lymphocyte syndrome, type II (PMID:10417269)"
Rs1 homooctamer complex	O15537	6247	visual perception;retina layer formation;adaptation of rhodopsin mediated signaling;cell adhesion	visual transduction;cell adhesion	RS1	None	None	OMIM:312700 Retinoschisis (PMID:15644328).
Ferritin complex	P02792;P02794	2512;2495	cellular iron ion homeostasis;immune response;iron ion transport	immune response	FTL;FTH1	"OMIM:615604  L-ferritin deficiency, OMIM:615517 Hemochromatosis, type 5 (PMID:8695634),"	None	None
USP7-MAGEL2-TRIM27 complex	P14373;Q93009;Q9UJ55	5987;7874;54551	endosomal transport	None	TRIM27;USP7;MAGEL2	OMIM:209850 Autism (PMID:26365382).	None	None
GM-CSF receptor complex	P04141;P15509;P32927	1437;1438;1439	granulocyte colony-stimulating factor signaling pathway;cytokine receptor activity	None	CSF2;CSF2RA;CSF2RB	None	"Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine that controls the production and function of blood cells. It is deregulated in clinical conditions such as rheumatoid arthritis and leukemia. Its receptors are heterodimers consisting of a ligand-specific alpha subunit and a beta subunit that is shared with the interleukin (IL)-3 and IL-5 receptors. JAK2 activation is a feature of GM-CSF receptor activation and plays a critical  role in GM-CSF signaling. The structure of the GM-CSF receptor complex reveals a hexameric 2:2:2 assembly, consisting of two beta chains, two GMR alpha chains, and two GM-CSF molecules. The crystal lattice generates an unexpected dodecamer complex, an assembly consisting of two hexameric complexes related by a crystallographic two-fold axis. The dodecamer assembles in a head-to-head orientation. Functional studies reveal that dodecamer formation is required for receptor activation and signaling. This differs from the 2:1:1 stoichiometry  (2 betac,1 GMRalpha,1 GM-CSF) (McClure et al., 2003). This is likely to be a result of differences in the total protein concentration at which the complex is formed as we observe a protein concentration-dependent shift in molecular  weight and hence stoichiometry of GM-CSF receptor complex. The 2:1:1 complex probably represents a relatively stable intermediate in the assembly of higher-order 2:2:2 GM-CSFreceptor complexes."	"Abnormalities in GM-CSF production or receptor function have been implicated in multiple pathologies such as rheumatoid arthritis (Cook et al., 2001), juvenile myelomonocytic leukemia (Birnbaum et al., 2000), chronic myelomonocytic leukemia (Ramshaw et al., 2002), and alveolar proteinosis (Dirksen et al., 1998). Furthermore, the GM-CSF receptor may also be important in the pathogenesis of chronic myeloid leukemia and myeloproliferative diseases by propagating survival and proliferation signalspromoted by the abnormal expression of Bcr-Abl and JAK2 mutations, respectively (PMID:18692472)."
Cdt1-Geminin complex	O75496;Q9H211	51053;81620	regulation of DNA replication	None	GMNN;CDT1	None	None	None
Importin alpha-CAS-RanGTP complex	P52292;P55060;P62826	3838;1434;5901	nucleocytoplasmic transport;nucleus;protein transport;cytoplasm;protein export from nucleus;transmembrane transport	nucleus;protein transport;cytoplasm	KPNA2;CSE1L;RAN	None	"NLS proteins are transported into the nucleus by the importin alpha/beta heterodimer. Importin alpha binds the NLS, while importin beta mediates translocation through the nuclear pore complex. After translocation, RanGTP, whose predicted concentration is high in the nucleus and low in the cytoplasm, binds importin beta and displaces importin alpha. Importin alpha must then be returned to the cytoplasm, leaving the NLS protein behind. CAS protein mediates importin alpha re-export. CAS binds strongly to importin alpha only in the presence of RanGTP, forming an importin alpha/CAS/RanGTP complex. Importin alpha is released from this complex in the cytoplasm by the combined action of RanBP1 and RanGAP1. CAS binds preferentially to NLS-free importin alpha, hereby leaving import substrates back in the nucleus. CAS binding to importin alpha depends on RanGTP. It was shown that without further addition or with addition of wild-type RanGDP, importin beta bound efficiently to importin alpha, but CAS only weakly. The opposite pattern was observed when the permanently GTP-bound Ran mutants were added: importin beta binding was completely abolished, whereas the CAS binding to importin alpha was greatly enhanced. This suggested that the CAS/RanGTP complex is the high affinity form for importin alpha binding."	None
KPNA2-KPNB1 complex	P52292;Q14974	3838;3837	"nucleocytoplasmic transport;nucleus;cytoplasm;protein transport;protein import into nucleus, translocation;transmembrane transport"	nucleus;cytoplasm;protein transport	KPNA2;KPNB1	None	"NLS proteins are transported into the nucleus by the importin alpha/beta heterodimer. Importin alpha binds the NLS, while importin beta mediates translocation through the nuclear pore complex. It was shown that without further addition or with addition of wild-type RanGDP, importin beta bound efficiently to importin alpha."	None
KPNB1-RAN complex	P62826;Q14974	5901;3837	nucleocytoplasmic transport;protein export from nucleus;nucleus;cytoplasm;transmembrane transport	nucleus;cytoplasm	RAN;KPNB1	None	"NLS proteins are transported into the nucleus by the importin alpha/beta heterodimer. Importin alpha binds the NLS, while importin beta mediates translocation through the nuclear pore complex. After translocation, RanGTP, whose predicted concentration is high in the nucleus and low in the cytoplasm, binds importin beta disassembling the importin alpha/beta heterodimer."	None
CENP-T-W complex	Q5EE01;Q96BT3	387103;80152	chromosome segregation;DNA binding;kinetochore assembly	chromosome segregation/division;DNA binding;centromere/kinetochore complex maturation	CENPW;CENPT	None	None	None
CENP-S-X complex	A8MT69;Q8N2Z9	201254;378708	chromosome segregation;DNA binding;kinetochore assembly	chromosome segregation/division;DNA binding;centromere/kinetochore complex maturation	STRA13;APITD1	None	None	None
CENP-T-W-S-X heterotetramer complex	A8MT69;Q5EE01;Q8N2Z9;Q96BT3	201254;387103;378708;80152	kinetochore assembly;DNA binding;chromosome segregation	centromere/kinetochore complex maturation;DNA binding;chromosome segregation/division	STRA13;CENPW;APITD1;CENPT	None	None	None
BAFL-BAF-LAP2beta complex	O75531;P42167;Q9H503	8815;7112;140836	None	None	BANF1;TMPO;BANF2	None	BAF-L forms ternary complexes in vitro with BAF and LAP2beta through heterodimerization with BAF.	None
BAFL-BAF complex	O75531;Q9H503	8815;140836	None	None	BANF1;BANF2	None	BAF-L regulates BAF function via heterodimerization and might thereby influence tissue-specific roles of BAF.	None
"Codanin-1-Asf1\u2013histone H3.1-histone H4\u2013importin-4 complex,  cytosolic"	P62805;P68431;Q8IWY9;Q8TEX9;Q9Y294	None;None;146059;79711;25842	chromatin assembly;DNA replication	DNA synthesis and replication	HIST1H4A;;HIST1H3A;;CDAN1;IPO4;ASF1A	Codanin-1 seems to guard a limiting step in chromatin replication.	None	"Mutations in Codanin-1 can cause congenital dyserythropoietic anaemia type I (CDAI), characterized by chromatin abnormalities in bone marrow erythroblasts."
IKBKG-CHUK complex	O15111;Q9Y6K9	1147;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	CHUK;IKBKG	None	The complex can be activated by MEKK1.	None
PRKAA2-PRKAB2-PRKAG3 complex	O43741;P54646;Q9UGI9	5565;5563;53632	AMP-activated protein kinase activity;skeletal muscle adaptation	None	PRKAB2;PRKAA2;PRKAG3	None	None	None
PRKAA1-PRKAB2-PRKAG1 complex	O43741;P54619;Q13131	5565;5571;5562	AMP-activated protein kinase activity	None	PRKAB2;PRKAG1;PRKAA1	None	None	None
PRKAA2-PRKAB2-PRKAG1 complex	O43741;P54619;P54646	5565;5571;5563	AMP-activated protein kinase activity;skeletal muscle adaptation	None	PRKAB2;PRKAG1;PRKAA2	None	None	None
TRIAL-DR5 complex	O14763;P50591	8795;8743	apoptotic process	apoptosis (type I programmed cell death)	TNFRSF10B;TNFSF10	None	None	OMIM: 114480 Breast cancer
LPP-PPP2CA-PPP2R3A complex	P67775;Q93052;Q9Z176	5515;4026;None	focal adhesion	None	PPP2CA;LPP;Ppp2r3d	None	None	None
hTREX84 complex	Q13769;Q6I9Y2;Q86W42;Q8NI27;Q96FV9;Q96J01	8563;80145;79228;57187;9984;84321	mRNA export from nucleus	None	THOC5;THOC7;THOC6;THOC2;THOC1;THOC3	The 40K protein has been described as hTREX40. hTREX40 is described as isoform 2 of THOC6 (Q86W42).	None	hTREX84 is highly expressed in aggressive forms of breast cancer.
BBSome	A8MTZ0;Q3SYG4;Q8IWZ6;Q8N3I7;Q8NFJ9;Q8TAM2;Q96RK4;Q9BXC9	92482;27241;55212;129880;582;123016;585;583	cilium organization;intraciliary transport;cilium	None	BBIP1;BBS9;BBS7;BBS5;BBS1;TTC8;BBS4;BBS2	None	None	"All the BBS proteins were identified by mutations of their respective genes in patients with Bardet\u2013Biedl syndrome (BBS), a genetically heterogeneous disease (ciliopathy) characterized by a wide spectrum of clinical features, including rod\u2013cone dystrophy, morbid obesity, polydactyly, genital anomalies, learning difficulties, and renal anomalies."
ACK1 signaling complex	P46108;P56945;P60953;Q07912	1398;9564;998;10188	signaling	cellular signalling	CRK;BCAR1;CDC42;TNK2	None	"CDC42, ACK1, p130Cas, and CRK form a collagen-regulated signaling complex. The interaction of Ack1 and p130Cas relies on SH3 and Proline-rich domains. ACK1 not only associated with p130Casbut also induced its phosphorylation."	None
BBSome core complex	Q3SYG4;Q8IWZ6;Q8NFJ9;Q9BXC9	27241;55212;582;583	cilium	None	BBS9;BBS7;BBS1;BBS2	None	None	None
BBSome linker complex	A8MTZ0;Q8TAM2;Q96RK4	92482;123016;585	cilium	None	BBIP1;TTC8;BBS4	None	None	None
Exocyst complex	O00471;O60645;Q8IYI6;Q8TAG9;Q96A65;Q96KP1;Q9NV70;Q9UPT5	10640;11336;149371;54536;60412;55770;55763;23265	vesicle tethering;exocytosis	exocytosis	EXOC5;EXOC3;EXOC8;EXOC6;EXOC4;EXOC2;EXOC1;EXOC7	None	"The exocyst complex regulates tethering of transferrin-receptor-containing recycling vesicles to the plasma membrane, downstream of the Rab11 small GTPase."	None
Exocyst EXOC5-EXOC6 subcomplex	O00471;Q8TAG9	10640;54536	None	None	EXOC5;EXOC6	None	None	None
Exocyst EXOC5-EXOC6-EXOC7 subcomplex	O00471;Q8TAG9;Q9UPT5	10640;54536;23265	None	None	EXOC5;EXOC6;EXOC7	None	None	None
Angiogenin-PRI complex	P03950;P13489	283;6050	regulation of angiogenesis	None	ANG;RNH1	None	None	None
Intraflagellar transport complex B	A0AVF1;Q13099;Q8IY31;Q8N4P2;Q8R3P7;Q8TDR0;Q8WYA0;Q96LB3;Q9BW83;Q9H7X7;Q9NQC8;Q9NWB7;Q9P2H3;Q9UG01;Q9Y366;Q9Y547	79989;8100;90410;150737;76779;26146;28981;80173;11020;64792;56912;55081;57560;26160;51098;51668	intraciliary transport;cilium	None	TTC26;IFT88;IFT20;TTC30B;Cluap1;TRAF3IP1;IFT81;IFT74;IFT27;IFT22;IFT46;IFT57;IFT80;IFT172;IFT52;HSPB11	"All but one of the subunits we examined were of human origin, except mouse Cluap1."	None	None
Intraflagellar transport complex B core complex	A0AVF1;Q13099;Q8N4P2;Q8WYA0;Q96LB3;Q9BW83;Q9H7X7;Q9NQC8;Q9Y366;Q9Y547	79989;8100;150737;28981;80173;11020;64792;56912;51098;51668	cilium;intraciliary transport	None	TTC26;IFT88;TTC30B;IFT81;IFT74;IFT27;IFT22;IFT46;IFT52;HSPB11	None	None	None
Intraflagellar transport complex B peripheral subcomplex	Q8IY31;Q8R3P7;Q8TDR0;Q9NWB7;Q9P2H3;Q9UG01	90410;76779;26146;55081;57560;26160	cilium	None	IFT20;Cluap1;TRAF3IP1;IFT57;IFT80;IFT172	"All but one of the subunits we examined were of human origin, except mouse Cluap1."	None	None
Caspase-10-SUMO-FADD/Drp1 complex	O00429;Q13158;Q92851	10059;8772;843	necroptotic process;mitochondrion	mitochondrion	DNM1L;FADD;CASP10	None	None	Disease: ischemic injury
CDCP1-Src-EGFR complex	P00533;P12931;Q9H5V8	1956;6714;64866	epidermal growth factor receptor signaling pathway	EGF-receptor signalling pathway	EGFR;SRC;CDCP1	None	None	None
LUBAC complex	Q96EP0;Q9BYM8;Q9H0F6	55072;10616;81858	protein K63-linked ubiquitination;I-kappaB kinase/NF-kappaB signaling;innate immune response	NIK-I-kappaB/NF-kappaB cascade;innate immune response (invertebrates and vertebrates)	RNF31;RBCK1;SHARPIN	None	"LUBAC complex binds to NEMO (IKBKG ) in the IKK complex, and assembles linear polyubiquitin chains on NEMO. The activated IKK complex subsequently induces the degradation of NFKBIA resulting in activation of NF-kappaB complex.LUBAC catalyzes the formation of M1-linked ubiquitin chains (PMID:26670046)."	Null mutations in the Sharpin gene are responsible for chronic proliferative dermatitis in mice.
PPP2R1A-PPP2R3B complex	P30153;Q9Y5P8	5518;28227	protein dephosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	PPP2R1A;PPP2R3B	None	None	None
PP2A A/C-striatin complex	O43815;P30153;P67775	6801;5518;5515	protein dephosphorylation;calcium-mediated signaling	"modification by phosphorylation, dephosphorylation, autophosphorylation;Ca2+ mediated signal transduction"	STRN;PPP2R1A;PPP2CA	Since the authors did not specify serine/threonine-protein phosphatase 2A catalytic subunit we used the alpha isoform. Since the authors did not specify serine/threonine-protein phosphatase 2A regulartory subunit we used the alpha isoform.	None	None
PP2A A/C-SG2NA complex	P30153;P67775;Q13033	5518;5515;29966	protein dephosphorylation;calcium-mediated signaling	"modification by phosphorylation, dephosphorylation, autophosphorylation;Ca2+ mediated signal transduction"	PPP2R1A;PPP2CA;STRN3	Since the authors did not specify serine/threonine-protein phosphatase 2A catalytic subunit we used the alpha isoform. Since the authors did not specify serine/threonine-protein phosphatase 2A regulartory subunit we used the alpha isoform.	None	None
AuroraB-AuroraC-INCENP complex	O14965;Q96GD4;Q9NQS7	6790;9212;3619	protein stabilization	protein folding and stabilization	AURKA;AURKB;INCENP	None	None	Prostate cancer
SAPCD2-Galphai-LGN complex	P63096;P81274;Q86UD0	2770;29899;89958	establishment of mitotic spindle orientation;asymmetric cell division	None	GNAI1;GPSM2;SAPCD2	None	None	None
ArPIKfyve-Sac3-Sph1 complex	Q92562;Q9Y2I7;Q9Y6H5	9896;200576;9627	protein stabilization	protein folding and stabilization	FIG4;PIKFYVE;SNCAIP	None	None	None
STIP-USP7-Mdm2 complex	Q00987;Q93009;Q9UBB9	4193;7874;None	protein stabilization	protein folding and stabilization	MDM2;USP7;TFIP11	None	None	None
STIP-USP7-p53 complex	P04637;Q93009;Q9UBB9	7157;7874;None	protein stabilization;nucleoplasm	protein folding and stabilization	TP53;USP7;TFIP11	None	None	None
ArgRS-GlnRS-AIMP1 complex	P47897;P54136;Q12904	5859;5917;9255	tRNA aminoacylation for protein translation;aminoacyl-tRNA synthetase multienzyme complex	None	QARS;RARS;AIMP1	None	None	None
p38gamma-Hsp90-K-Ras complex	P01116;P08238;P53778	3845;3326;6300	regulation of cell growth	None	KRAS;HSP90AB1;MAPK12	None	None	K-Ras-dependent colon cancer
IGF2-IGFBP2 complex	P01344;P18065	3481;3485	regulation of osteoblast differentiation;heparin binding	None	IGF2;IGFBP2	None	None	None
CHDH-SQSTM1-MAP1LC3 complex	Q13501;Q8NE62;Q9H492	8878;55349;84557	positive regulation of mitophagy in response to mitochondrial depolarization	None	SQSTM1;CHDH;MAP1LC3A	None	None	None
ADAM12-alphaVbeta3-integrin-MMP-14 complex	O43184;P05106;P06756;P50281	8038;3690;3685;4323	regulation of apoptotic process	None	ADAM12;ITGB3;ITGAV;MMP14	None	None	None
B-WICH complex	O00159;O60264;O75533;P35659;Q03468;Q9BQG0;Q9NR30;Q9UIG0	4641;8467;23451;7913;2074;10514;9188;9031	chromatin binding;transcription from RNA polymerase III type 3 promoter;nucleus	nucleus	MYO1C;SMARCA5;SF3B1;DEK;ERCC6;MYBBP1A;DDX21;BAZ1B	None	"The 45 S rRNA, the 5 S rRNA, and the 7SL RNA are parts of the B-WICH complex."	None
Stargazin-AP-2-AP-3a complex	O14617;O95782;Q9Y698	8943;160;10369	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	None	AP3D1;AP2A1;CACNG2	None	None	None
Stargazin-Glu1-mu2 complex	P42261;Q96CW1;Q9Y698	2890;1173;10369	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	None	GRIA1;AP2M1;CACNG2	None	None	None
Stargazin-Glu1-mu3 complex	P42261;P53677;Q9Y698	2890;10947;10369	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	None	GRIA1;AP3M2;CACNG2	None	None	None
Stargazin-Glu2A-mu2 complex	P42262;Q96CW1;Q9Y698	2891;1173;10369	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	None	GRIA2;AP2M1;CACNG2	None	None	None
Stargazin-Glu2A-mu3 complex	P42262;P53677;Q9Y698	2891;10947;10369	regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity	None	GRIA2;AP3M2;CACNG2	None	None	None
TFAP2C-Myc-KDM5B complex	P01106;Q92754;Q9UGL1	4609;7022;10765	regulation of cell cycle process	None	MYC;TFAP2C;KDM5B	None	None	None
ICAT-AR-beta-catenin complex	P10275;P35222;Q9NSA3	367;1499;56998	regulation of Wnt signaling pathway;regulation of androgen receptor activity	None	AR;CTNNB1;CTNNBIP1	None	None	None
PNP homotrimer complex	P00491	4860	purine nucleoside metabolic process;purine-nucleoside phosphorylase activity	None	PNP	None	None	None
MT1-G(i)-RGS20 complex	O76081;P48039;P63096	8601;4543;2770	"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	None	RGS20;MTNR1A;GNAI1	None	None	None
MT1-MT2 complex	P48039;P49286	4543;4544	"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger"	None	MTNR1A;MTNR1B	None	None	None
RSG20-MT1-MT2 complex	O76081;P48039;P49286	8601;4543;4544	regulation of inward rectifier potassium channel activity	None	RGS20;MTNR1A;MTNR1B	None	None	None
GM130-GRASP65 complex	Q08379;Q9BQQ3	2801;64689	None	None	GOLGA2;GORASP1	None	None	None
DOCK8-WIP-WASp complex	O43516;P42768;Q8NF50	7456;7454;81704	actin cytoskeleton;T cell receptor binding;cytokinesis;immunological synapse formation;T cell migration	actin cytoskeleton;cytokinesis (cell division) /septum formation and hydrolysis	WIPF1;WAS;DOCK8	None	"DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton. The WASp-interacting protein (WIP) bridges DOCK8 to WASp and actin in T cells. The guanine nucleotide exchange factor activity of DOCK8 is essential for the integrity of the subcortical actin cytoskeleton as well as for TCR-driven WASp activation, F-actin assembly, immune synapse formation, actin foci formation, mechanotransduction, T cell transendothelial migration, and homing to lymph nodes, all of which also depend on WASp. The results indicate that DOCK8 and WASp are in the same signaling pathway that links TCRs to the actin cytoskeleton in TCR-driven actin assembly. DOCK8 binds to and colocalizes constitutively with WIP and WASp in T cells. WIP bridges DOCK8 to actin. DOCK8 GEF activity mediates TCR-driven WASp activation. DOCK8 is essential for TCR-driven actin foci formation and mechanotransduction."	"Wiskott-Aldrich syndrome (WAS) is associated with mutations in the WAS protein (WASp), which plays a critical role in the initiation of T cell receptor-driven (TCR-driven) actin polymerization. The clinical phenotype of WAS includes susceptibility to infection, allergy, autoimmunity, and malignancy and overlaps with the symptoms of dedicator of cytokinesis 8 (DOCK8) deficiency, suggesting that the 2 syndromes share common pathogenic mechanisms."
GATOR1 complex	O75140;Q12980;Q8WTW4	9681;8131;10641	regulation of cellular response to amino acid starvation;negative regulation of TORC1 signaling;GTPase activator activity	GTPase activator (GAP)	DEPDC5;NPRL3;NPRL2	None	The loss of GATOR1 proteins prevented the inactivation of mTORC1 and dTORC1 normally caused by amino acid deprivation.	"GATOR1 components are present in low single-digit percentages of glioblastomas and ovarian cancers,"
GATOR2 complex	P55735;Q6PJI9;Q96EE3;Q96S15;Q9NXC5	6396;79726;81929;84219;54468	regulation of TORC1 signaling	None	SEC13;WDR59;SEH1L;WDR24;MIOS	None	Inhibition of GATOR2 subunits suppresses mTORC1 signaling. GATOR2 is an inhibitor of an inhibitor (GATOR1) of the amino acid\u2013sensing branch of the TORC1 pathway.	None
GATOR complex	O75140;P55735;Q12980;Q6PJI9;Q8WTW4;Q96EE3;Q96S15;Q9NXC5	9681;6396;8131;79726;10641;81929;84219;54468	regulation of TORC1 signaling;regulation of cellular response to amino acid starvation	None	DEPDC5;SEC13;NPRL3;WDR59;NPRL2;SEH1L;WDR24;MIOS	None	GATOR as a complex that is composed of the two subcomplexes GATOR1 complexand GATOR2 complex. GATOR as a complex that interacts with and negatively regulates the Rag guanosine triphosphatases (GTPases) which promote mTORC1 translocation to the lysosomal surface.	Inactivating mutations in GATOR1 components were found in glioblastomas and ovarian cancers.
POL2R-SYMPK-SSU72 complex	P24928;Q92797;Q9NP77	5430;8189;29101	regulation of mRNA polyadenylation	None	POLR2A;SYMPK;SSU72	None	None	None
DGKZ-RASGRP1-HRAS complex	O95267;P01112;Q13574	10125;3265;8525	Ras protein signal transduction	None	RASGRP1;HRAS;DGKZ	None	None	None
HDAC10-PAX3-KAP1 complex	P23760;Q13263;Q969S8	5077;10155;83933	"regulation of melanin biosynthetic process;transcription factor activity, sequence-specific DNA binding"	None	PAX3;TRIM28;HDAC10	None	None	None
KRIT1-CCM2-ICAP1 complex	O00522;O14713;Q9BSQ5	889;9270;83605	cell adhesion	cell adhesion	KRIT1;ITGB1BP1;CCM2	None	None	None
KRIT1-CCM2-MEKK3 complex	O00522;Q99759;Q9BSQ5	889;4215;83605	regulation of p38MAPK cascade	None	KRIT1;MAP3K3;CCM2	None	None	None
Rab11a-FIP3-DLIC-1 complex	P62491;Q9Y6G9;Q9Y6K9	8766;51143;8517	endosomal transport	None	RAB11A;DYNC1LI1;IKBKG	None	None	None
ULK1-ATG13-RB1CC1  complex	O75143;O75385;Q8TDY2	9776;8408;9821	autophagosome organization;autophagy	None	ATG13;ULK1;RB1CC1	None	None	None
ULK2-ATG13-RB1CC1 complex	O75143;Q8IYT8;Q8TDY2	9776;9706;9821	autophagy;autophagosome organization	None	ATG13;ULK2;RB1CC1	None	None	None
ULK1-ATG13-RB1CC1-ATG101 complex	O75143;O75385;Q8TDY2;Q9BSB4	9776;8408;9821;60673	autophagy	None	ATG13;ULK1;RB1CC1;ATG101	None	None	None
"Ubiquitin E3 ligase (CUL3, KLHL3, WNK1)"	Q13618;Q9H4A3;Q9UH77	8452;65125;26249	ubiquitin-dependent protein catabolic process;cullin-RING ubiquitin ligase complex	proteasomal degradation (ubiquitin/proteasomal pathway)	CUL3;WNK1;KLHL3	None	"CUL3 assembles with BTB proteins (e.g. KLHL3) to form Cullin-RING E3 ubiquitin ligase complexes. The CUL3-KLHL3 E3 ligase complex regulates blood pressure via its ability to interact with and ubiquitylate WNK isoforms. The recombinant wild-type CUL3-KLHL3 E3 ligase complex, but not a disease-causing CUL3-KLHL3[R528H] mutant complex, ubiquitylated WNK1 in vitro. siRNA (small interfering RNA)-mediated knockdown of CUL3 increased WNK1 protein levels and kinase activity in HeLa cells. The KLHL3 interaction site in WNK1 could be mapped to a non-catalytic region (residues 479-667)."	The CUL3-KLHL3 E3 ligase complex is mutated in Gordon hypertension syndrome (= Pseudohypoaldosteronismtype II = PHAII).
TGF-betaR2-TGF-beta3 complex	P10600;P37173	7043;7048	transmembrane receptor protein serine/threonine kinase signaling pathway	transmembrane receptor protein serine/threonine kinase signalling pathways	TGFB3;TGFBR2	None	None	None
c-Fos-c-Jun-SAF-1 complex	P01100;P05412;P56270	2353;3725;4150	"regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	FOS;JUN;MAZ	None	None	None
"Dynein-2 complex, cytoplasmic"	P51808;P63167;P63172;Q8IVD9;Q8NCM8;Q8TCX1;Q8TF09;Q8WVS4;Q8WW35;Q96EX3;Q96FJ2;Q9NP97	6990;8655;6993;23386;79659;51626;83657;55112;255758;89891;140735;83658	intraciliary retrograde transport;cilium;smoothened signaling pathway	hedgehog-dependent signalling pathway	DYNLT3;DYNLL1;DYNLT1;NUDCD3;DYNC2H1;DYNC2LI1;DYNLRB2;WDR60;TCTEX1D2;WDR34;DYNLL2;DYNLRB1	None	None	"Defects in the function of primary cilia lead to a cohort of human diseases known as the ciliopathies; among these, mutations in components of the dynein-2 complex cause Jeune syndrome, short rib polydactyly type III and asphyxiating thoracic dystrophy."
AJUBA-GFI1-HDAC1 complex	Q13547;Q96IF1;Q99684	3065;84962;2672	"negative regulation of transcription, DNA-templated"	transcription repression	HDAC1;AJUBA;GFI1	None	"The majority of Gfi1 repression activity is dependent upon HDAC function. However, a residual repression activity is present in inhibitor-treated samples suggesting Gfi1 and Ajuba utilize as yet unidentified non-HDAC-dependent repression mechanism(s)."	"It has been demonstrated that SCN (severe congenital neutropenia)-associated mutations in GFI1 generate dominant-negative-acting proteins (GFI1N382S), which selectively deprepress GFI1 target genes such as CSF1. A SNAG domain mutant protein (Gfi1P2A) also functioned in a dominant negative manner;however, a protein with both mutations (Gfi1P2A\u0002N382S) lacked dominant negative activity."
DHDDS-NUS1 complex	Q86SQ9;Q96E22	79947;116150	dolichyl monophosphate biosynthetic process;protein glycosylation;endoplasmic reticulum;cholesterol homeostasis	"modification with sugar residues (e.g. glycosylation, deglycosylation);endoplasmic reticulum;cholesterol homeostasis"	DHDDS;NUS1	None	Dolichol monophosphate (Dol-P) functions as an obligate glycosyl carrier lipid in protein glycosylation reactions. Nogo-B receptor (NUS1)as an essential component of the Dol-P biosynthetic machinery.	"A Mutation on NgBR Causes Congenital Scoliosis, Severe Neurological Impairment, Refractory Epilepsy, Hearing Deficit, and Visual Impairment."
14-3-3q-SGK1-tau complex	O00141;P10636;P27348	6446;4137;10971	regulation of protein phosphorylation	None	SGK1;MAPT;YWHAQ	None	None	None
AJUBA-GFI1-HDAC2 complex	Q92769;Q96IF1;Q99684	3066;84962;2672	"negative regulation of transcription, DNA-templated"	transcription repression	HDAC2;AJUBA;GFI1	None	"The majority of Gfi1 repression activity is dependent upon HDAC function. However, a residual repression activity is present in inhibitor-treated samples suggesting Gfi1 and Ajuba utilize as yet unidentified non-HDAC-dependent repression mechanism(s)."	"It has been demonstrated that SCN (severe congenital neutropenia)-associated mutations in GFI1 generate dominant-negative-acting proteins (GFI1N382S), which selectively deprepress GFI1 target genes such as CSF1. A SNAG domain mutant protein (Gfi1P2A) also functioned in a dominant negative manner;however, a protein with both mutations (Gfi1P2A\u0002N382S) lacked dominant negative activity."
AJUBA-GFI1-HDAC3 complex	O15379;Q96IF1;Q99684	8841;84962;2672	"negative regulation of transcription, DNA-templated"	transcription repression	HDAC3;AJUBA;GFI1	None	"The majority of Gfi1 repression activity is dependent upon HDAC function. However, a residual repression activity is present in inhibitor-treated samples suggesting Gfi1 and Ajuba utilize as yet unidentified non-HDAC-dependent repression mechanism(s)."	"It has been demonstrated that SCN (severe congenital neutropenia)-associated mutations in GFI1 generate dominant-negative-acting proteins (GFI1N382S), which selectively deprepress GFI1 target genes such as CSF1. A SNAG domain mutant protein (Gfi1P2A) also functioned in a dominant negative manner;however, a protein with both mutations (Gfi1P2A\u0002N382S) lacked dominant negative activity."
Telomerase holoenzyme	O14746;O60832;Q86US8;Q9BUR4;Q9NPE3;Q9NX24;Q9NY12	7015;1736;23293;55135;55505;55651;54433	telomerase activity;telomerase holoenzyme complex	None	TERT;DKC1;SMG6;WRAP53;NOP10;NHP2;GAR1	None	.	"Telomerase is associated with various diseases such as cancer, dyskeratosis congenita, bone marrow failure and idiopathic pulmonary fibrosis"
BBS4 centriolar satellite complex	Q15154;Q96RK4;Q9UPN4	5108;585;22994	cilium;intraciliary transport	None	PCM1;BBS4;CEP131	None	None	"Bardet-Biedl syndrome (BBS) is a well-known ciliopathy with mutations reported in 18 different genes. Most of the proteinproducts of the BBS genes localize at or near the primary cilium and the centrosome. Near the centrosome, BBS proteinsinteract with centriolar satellite proteins, and the BBSome (a complex of seven BBS proteins) is believed to play a role intransporting ciliary membrane proteins."
BBS-chaperonin complex	P17987;P48643;P49368;P50990;P50991;P78371;Q6ZW61;Q8IWZ6;Q8TAM1;Q9NPJ1	6950;22948;7203;10694;10575;10576;166379;55212;79738;8195	cilium;chaperone-mediated protein complex assembly;intraciliary transport	None	TCP1;CCT5;CCT3;CCT8;CCT4;CCT2;BBS12;BBS7;BBS10;MKKS	None	None	"Bardet-Biedl syndrome (BBS) is a human genetic disorder resultingin obesity, retinal degeneration, polydactyly, and nephropathy.Recent studies indicate that trafficking defects to the ciliary membraneare involved in this syndrome."
FBXW7-CSF3R-GSK3B complex	P49841;Q969H0;Q99062	2932;55294;1441	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;granulocyte differentiation;granulocyte colony-stimulating factor signaling pathway	granulocyte	GSK3B;FBXW7;CSF3R	None	Fbw7 in cooperation with GSK3B negatively modulates G-CSFR protein steady state levels by promoting its degradation and thus regulates granulocytic differentiation.	Fbw7 also interacts with and degrades G-CSFR-T718 (a truncated mutant of G-CSFR found in severe congenital neutropenia/acute myeloid leukemia (SCN/AML patients)) though at a quite slower rate compared to G-CSFR.
MIB complex	O75431;Q13505;Q16891;Q5TGZ0;Q5XKP0;Q6UXV4;Q9BRQ6;Q9BUR5;Q9NVH1;Q9NX63;Q9Y512	10651;4580;10989;440574;125988;139322;84303;79135;55735;54927;25813	mitochondrial crista junction;cristae formation	None	MTX2;MTX1;IMMT;MINOS1;MIC13;APOOL;CHCHD6;APOO;DNAJC11;CHCHD3;SAMM50	None	None	None
LPA(2)-NHERF2-PLC-beta3 complex	Q01970;Q15599;Q9HBW0	5331;9351;9170	regulation of lipid metabolic process	"regulation of lipid, fatty acid and isoprenoid metabolism"	PLCB3;SLC9A3R2;LPAR2	None	None	None
Shc-ERalpha-IGF-1R complex	P03372;P08069;P29353	2099;3480;6464	regulation of MAP kinase activity	None	ESR1;IGF1R;SHC1	None	None	None
myosin-Vb-Rab11-FIP2-Rab11a complex	P62491;Q7L804;Q9ULV0	8766;22841;4645	vesicle-mediated transport	"vesicular transport (Golgi network, etc.)"	RAB11A;RAB11FIP2;MYO5B	None	None	None
GPC-4.1R-p55 complex	P04921;P11171;Q00013	2995;2035;4354	None	None	GYPC;EPB41;MPP1	None	None	None
MICOS complex	Q16891;Q5TGZ0;Q5XKP0;Q6UXV4;Q9BRQ6;Q9BUR5;Q9NX63	10989;440574;125988;139322;84303;79135;54927	MICOS complex;cristae formation	None	IMMT;MINOS1;MIC13;APOOL;CHCHD6;APOO;CHCHD3	None	The mitochondrial contact site and cristae junction (CJ) organizing system (MICOS) dynamically regulate mitochondrial membrane architecture.	"Several mitochondrial disorders in humans areoften accompanied by alterations of mitochondrial ultrastructure including MERRF syndrome (Myoclonic epilepsy with ragged red fibers), BTHS (Barth syndrome), fatal neonatal lactic acidosis, mtDNA defects and hypertrophic cardiomyopathy and loss of CJs with the formation of concentric stacks of cristae membrane are some of the hallmarks observed in mitochondria from such patients."
GM-CSF-receptor complex	P04141;P15509;P32927	1437;1438;1439	None	None	CSF2;CSF2RA;CSF2RB	None	"The used recombinant proteins display the soluble part of the GM-CSF receptor subunits CSF2RA (1-320),CSF2RB (1-438)."	None
ANKS6-NEK8-INVS-NPHP3 complex	Q68DC2;Q7Z494;Q86SG6;Q9Y283	203286;27031;284086;27130	cilium;kidney development	kidney	ANKS6;NPHP3;NEK8;INVS	None	None	"Nephronophthisis is the most frequent genetic cause of renal failure in children, presenting  with cystic kidney disease combined with extrarenal manifestations, such as retinitis pigmentosa (Senior-L\u00f8ken syndrome), liver fibrosis, cerebellar vermis hypoplasia (Joubert syndrome), situs inversus or cardiac malformations. Because most NPHP gene products  localize to the cilium or its associated structures, nephronophthisis and related syndromes, such as Joubert syndrome and Meckel-Gruber syndrome (MKS), have been termed ciliopathies."
USH2 complex	O75445;Q8WXG9;Q9H5P4;Q9P202	7399;84059;79955;25861	None	None	USH2A;GPR98;PDZD7;WHRN	"It was shown  that multiple domains of the four USH proteins interact among one another. Importantly, both WHRN and PDZD7 are required for the complex formation with USH2A and GPR98. In this USH2 quaternary complex, WHRN prefers to bind to USH2A, whereas PDZD7 prefers to bind to GPR98. Interaction between WHRN and PDZD7 is the bridge between USH2A and GPR98. Additionally, the USH2 quaternary complex has a variable stoichiometry. (PMID: 25406310)"	None	"OMIM:276901 Usher syndrome, type 2A, (PMID:25406310)."
MPP7-DLG1-LIN7A complex	O14910;Q12959;Q5T2T1	8825;1739;143098	MPP7-DLG1-LIN7 complex;cell junction	cell junction	LIN7A;DLG1;MPP7	None	None	None
Histone-2-Histone-4-ASF1-MCM2 complex	P49736;P62805;P68431;Q07955	4171;None;None;6426	chromatin assembly	None	MCM2;HIST1H4A;;HIST1H3A;;SRSF1	None	None	None
MPP7-DLG1-LIN7C complex	Q12959;Q5T2T1;Q9NUP9	1739;143098;55327	MPP7-DLG1-LIN7 complex	None	DLG1;MPP7;LIN7C	None	None	None
DLG5-SORBS3-CTNNB1 complex	O60504;P35222;Q8TDM6	10174;1499;9231	cell-cell junction	intercellular junction (gap junction/adherens junction)	SORBS3;CTNNB1;DLG5	None	None	None
"Ubiquitin E3 ligase (CUL3, KLHL3, WNK4)"	Q13618;Q96J92;Q9UH77	8452;65266;26249	ligase activity;protein ubiquitination;ion homeostasis;ubiquitin ligase complex;ubiquitin-dependent protein catabolic process;cullin-RING ubiquitin ligase complex	"modification by ubiquitination, deubiquitination;homeostasis;proteasomal degradation (ubiquitin/proteasomal pathway)"	CUL3;WNK4;KLHL3	None	"CUL3 assembles with BTB proteins (e.g. KLHL3) to form Cullin-RING E3 ubiquitin ligase complexes. The CUL3-KLHL3 E3 ligase complex regulates blood pressure via its ability to interact with and ubiquitylate WNK isoforms. Immunoprecipitation studies confirmed that the wild-type WNK4 robustly bound to KLHL3, but interaction with either disease-causing WNK4 mutant tested was strikingly impaired."	The CUL3-KLHL3 E3 ligase complex is mutated in Gordon hypertension syndrome (= Pseudohypoaldosteronismtype II = PHAII).
"Ubiquitin E3 ligase (CUL3, KLHL3)"	Q13618;Q9UH77	8452;26249	ligase activity;protein ubiquitination;ion homeostasis;ubiquitin ligase complex;ubiquitin-dependent protein catabolic process;cullin-RING ubiquitin ligase complex	"modification by ubiquitination, deubiquitination;homeostasis;proteasomal degradation (ubiquitin/proteasomal pathway)"	CUL3;KLHL3	None	CUL3 assembles with BTB proteins (e.g. KLHL3) to form Cullin-RING E3 ubiquitin ligase complexes. The CUL3-KLHL3 E3 ligase complex regulates blood pressure via its ability to interact with and ubiquitylate WNK isoforms.	The CUL3-KLHL3 E3 ligase complex is mutated in Gordon hypertension syndrome (= Pseudohypoaldosteronismtype II = PHAII).
Cullin-RING E3 ubiquitin ligase complex	Q15369;Q15370;Q93034;Q96DX5	6921;6923;8065;140462	None	None	TCEB1;TCEB2;CUL5;ASB9	None	"Cullin RING E3 ubiquitin ligase (CRL) complexes catalyze the specific polyubiquitination of cellular proteins to target them for degradation by the proteasome. ASB9 is unstable alone but forms a stable ternary complex with EloBC that binds with high affinity to the Cullin 5 N-terminal domain (Cul5NTD) but not to Cul2NTD. The application of several biophysical techniques are described including differential scanning fluorimetry, isothermal titration calorimetry (ITC), nanoelectrospray ionization, and ion-mobility mass spectrometry (IM-MS) to provide structural and thermodynamic information for the quaternary ASB CRL complex."	None
DLL1-CTNNB1-CDH2 complex	O00548;P19022;P35222	28514;1000;1499	adherens junction;protein localization to adherens junction	None	DLL1;CDH2;CTNNB1	None	Experimental results suggest that Dll1 is presented on the surface of adherens junctions formed at the apical termini of processes through interaction with MAGI1 to activate Notch on neighboring cells in the developing central nervous system.	None
DMTN-SYNE1- complex	Q08495;Q8NF91	2039;23345	None	None	DMTN;SYNE1	None	None	None
HEXA-HEXB complex	P06865;P07686	3073;3074	"beta-N-acetylhexosaminidase activity;carbohydrate metabolic process;glycosphingolipid metabolic process;glycosaminoglycan metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds"	C-compound and carbohydrate metabolism	HEXA;HEXB	None	None	OMIM:272800 Tay-Sachs disease (PMID::2141777).
HEXB homodimer complex	P07686	3074	"beta-N-acetylhexosaminidase activity;carbohydrate metabolic process;glycosphingolipid metabolic process;glycosaminoglycan metabolic process;hydrolase activity, hydrolyzing O-glycosyl compounds"	C-compound and carbohydrate metabolism	HEXB	None	None	OMIM:268800 Sandhoff disease (PMID: 2147027).
Factor-Xa-TFPI-factor-VIIa-tissue factor complex	P00742;P08709;P10646;P13726	2159;2155;7035;2152	regulation of blood coagulation	None	F10;F7;TFPI;F3	None	None	None
Rev1-Rev3-Rev7-Polkappa complex	O60673;Q9UBT6;Q9UBZ9;Q9UI95	5980;51426;51455;10459	regulation of error-prone translesion synthesis	None	REV3L;POLK;REV1;MAD2L2	None	None	None
NUB1L-UFD1-NPL4-NEDD8 complex	Q15843;Q8TAT6;Q92890;Q9Y5A7	4738;55666;7353;51667	regulation of protein neddylation	None	NEDD8;NPLOC4;UFD1L;NUB1	None	None	None
G alpha-13-Hax-1-cortactin-Rac complex	O00165;P31749;Q14247;Q14344	10456;207;2017;10672	cell migration	cell migration	HAX1;AKT1;CTTN;GNA13	None	"By tethering G alpha-\u000113 to cortactin in a complex containing Rac, Hax-1 provides a signaling nexus that facilitates the dynamic and uninterrupted transmission of signals from G alpha-\u000113 to cortactin through Rac to promote cell protrusion and migration."	None
SIVA1-XIAP-TAK1 complex	O15304;O43318;P98170	10572;6885;331	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	SIVA1;MAP3K7;XIAP	SIVA1 is a proapoptotic protein involved in T-cell apoptosis through a caspase-dependent mitochondrial pathway.XIAP functions as ubiquitin-E3-ligase and belongs to a family of apoptosis inhibitors. (PMID:19584092)TAK1 is a subunit of the TAK1 complex (Corum-ID 2758) known to regulate NF-kappaB activity.	"XIAP, SIVA1 and TAK1 form a ternary complex in Jurkat T cells. Complex formation increases after PMA/Iono stimulation."	None
SLC2A1-DMTN-ADD2 complex	P11166;P35612;Q08495	6513;119;2039	actin binding;membrane part;spectrin binding	None	SLC2A1;ADD2;DMTN	None	The authors proposed model predicts a major role of GLUT1 interactions with dematin and adducin in stabilizing the vertical linkage of the junctional complex.	None
"prohibitin 2 complex, mitochondrial"	O00165;P05141;P35232;P45880;Q99623	10456;292;5245;7417;11331	apoptotic process;apoptotic mitochondrial changes	apoptosis (type I programmed cell death);apoptotic mitochondrial changes	HAX1;SLC25A5;PHB;VDAC2;PHB2	None	"Human PHB2 has pleiotropic functions in the mitochondria, including inhibition of apoptosis via the PHB2-\u0001Hax-1 complex and regulation of the mitochondrial morphology."	None
"Ubiquitin E3 ligase (DDB1, DYRK2, EDD, VPRBP)"	O95071;Q16531;Q92630;Q9Y4B6	51366;1642;8445;9730	mitotic cell cycle phase transition;protein phosphorylation involved in cellular protein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	UBR5;DDB1;DYRK2;VPRBP	None	EDVP\u2013DYRK2 complex regulates katanin p60 ubiquitylation. EDVP\u2013DYRK2 complex controls mitotic transition through the modulation of katanin protein levels.	None
"Ubiquitin E3 ligase (DDIT4, DDB1, BTRC, CUL4A)"	Q13619;Q16531;Q9NX09;Q9Y297	8451;1642;54541;8945	regulation of TOR signaling;ubiquitin-dependent protein catabolic process;protein phosphorylation;response to hypoxia	"proteasomal degradation (ubiquitin/proteasomal pathway);modification by phosphorylation, dephosphorylation, autophosphorylation"	CUL4A;DDB1;DDIT4;BTRC	None	The CUL4A\u2013DDB1\u2013ROC1\u2013b-TRCP ubiquitin ligase complex acts to regulate mTOR signalling by modulating the stability of REDD1. REDD1 is a recently described component of the stress response. REDD1 was first identified as a gene induced by hypoxia and DNA damage.	Decreased REDD1 mRNA expression hasbeen observed in primary breast tumours.
HAX-1-XIAP complex	O00165;P98170	10456;331	apoptotic process;negative regulation of protein polyubiquitination	apoptosis (type I programmed cell death)	HAX1;XIAP	None	The formation of the HAX-1\u2013XIAP complex inhibits apoptosis by enhancing the stability of XIAP against proteosomal degradation.	None
DDN-MAGI2-SH3KBP1 complex	O94850;Q86UL8;Q96B97	23109;9863;30011	dendritic spine	None	DDN;MAGI2;SH3KBP1	None	None	None
DDR1-PRKCZ-WWC1 complex	Q05513;Q08345;Q8IX03	5590;780;23286	None	None	PRKCZ;DDR1;WWC1	None	"DDR1, PRKCZ and WWC1 interact in atripartite complex, but predominantly in the absence of collagen."	None
CR2-CD19 complex	P15391;P20023	930;1380	immune response	immune response	CD19;CR2	None	None	None
SPATA2-CYLD complex	Q9NQC7;Q9UM82	1540;9825	protein K63-linked deubiquitination;innate immune response;I-kappaB kinase/NF-kappaB signaling	innate immune response (invertebrates and vertebrates);NIK-I-kappaB/NF-kappaB cascade	CYLD;SPATA2	None	The SPATA2 PUB domain (aa 1\u2013241) formes a 2:2 complex with dimeric CYLD USP domain of 136 kDa in SEC-MALS.	None
vWF-GPIb complex	P04275;P07359	7450;2811	regulation of blood coagulation	None	VWF;GP1BA	None	None	None
ELK1-SAP1a-EWS-FLI-FLI complex	P19419;P28324;Q01543;Q16198	2002;2005;2313;None	"regulation of transcription, DNA-templated"	transcriptional control	ELK1;ELK4;FLI1;EWS-Fli1	None	None	None
CDKN1A-TP53-CDK1-PCNA complex	P04637;P06493;P38936	7157;983;1026	None	None	TP53;CDK1;CDKN1A	None	None	None
tRNA Splicing Ligase Complex	Q52LJ0;Q92499;Q9BVC5;Q9Y224;Q9Y3I0	283742;1653;79074;51637;51493	"tRNA-splicing ligase complex;RNA splicing, via endonucleolytic cleavage and ligation"	None	FAM98B;DDX1;C2orf49;C14orf166;RTCB	None	None	None
B-WICH complex	O00159;O60264;O75533;P35659;Q03468;Q9BQG0;Q9C093;Q9NR30;Q9UIG0	4641;8467;23451;7913;2074;10514;79925;9188;9031	"transcription, DNA-templated;ATP-dependent chromatin remodeling;nucleus"	TRANSCRIPTION;nucleus	MYO1C;SMARCA5;SF3B1;DEK;ERCC6;MYBBP1A;SPEF2;DDX21;BAZ1B	Interactions in the B-WICH Depend on RNA and active transcription. U1 small nuclear ribonucleoprotein 1SNRP homolog protein was nor available at the time of annotation	None	None
DDX11-RAD21-SMC1A-SMC3 complex	O60216;Q14683;Q96FC9;Q9UQE7	5885;8243;1663;9126	sister chromatid cohesion	None	RAD21;SMC1A;DDX11;SMC3	None	None	None
DDX11-Ctf18-RFC complex	O75717;P12004;Q5FWF5;Q8WVB6;Q96FC9;Q9BVC3	11169;5111;114799;63922;1663;79075	helicase activity;sister chromatid cohesion	None	WDHD1;PCNA;ESCO1;CHTF18;DDX11;DSCC1	None	None	None
DDX27-PeBoW complex	O00541;Q14137;Q96GQ7;Q9GZL7	23481;23246;55661;55759	rRNA processing;nucleolus	rRNA processing;nucleolus	PES1;BOP1;DDX27;WDR12	None	Knockdown of DDX27 impairs processing of 47S rRNA.	None
RAB27A-SLP3-KLC1 transport complex	P51159;Q07866;Q4VX76	5873;3831;94120	cytotoxic T cell degranulation	None	RAB27A;KLC1;SYTL3	None	Inhibition of the Rab27a/Slp3/kinesin-1 transport compleximpairs lytic granule secretion. This multiprotein complex enables lytic granules to reach the plasma membrane and is thus essential for their release into the IS (immune synapse).	"Rab27a deficiency is associated with impaired cytotoxic activity, unbalanced expansion, and activation of CD8 T lymphocytes and the uncontrolled macrophage activation that characterizes Griscelli syndrome type 2."
protein complex (DDX28; DHX30; GRSF1; FASTKD2; FASTKD5)	Q12849;Q7L2E3;Q7L8L6;Q9NUL7;Q9NYY8	2926;22907;60493;55794;22868	None	None	GRSF1;DHX30;FASTKD5;DDX28;FASTKD2	None	None	None
DEAF1- complex	O75398;P12956;P13010	10522;2547;7520	nucleus	nucleus	DEAF1;XRCC6;XRCC5	None	None	None
AATF-NGDN-NOL10 complex	Q8NEJ9;Q9BSC4;Q9NY61	25983;79954;26574	regulation of ribosome biogenesis	None	NGDN;NOL10;AATF	None	None	None
MSP58-RINT1 complex	Q6NUQ1;Q96EZ8	60561;10445	regulation of ribosome biogenesis	None	RINT1;MCRS1	None	None	None
NLRP1 inflammasome	P29466;P51878;Q9C000;Q9ULZ3	834;838;22861;29108	interleukin-1-mediated signaling pathway	None	CASP1;CASP5;NLRP1;PYCARD	None	"PYCARD recruits CASP1 and the C-terminal CARD domain of NALP1 recruits, and activates CASP5. (PMID:15030775)"	None
DLG4-DLGAP1-SHANK3 complex	O14490;P78352;Q9BYB0	9229;1742;85358	None	None	DLGAP1;DLG4;SHANK3	None	None	None
NLRP3 inflammasome	P29466;Q96P20;Q9ULZ3;Q9Y2G2	834;114548;29108;22900	interleukin-1-mediated signaling pathway	None	CASP1;NLRP3;PYCARD;CARD8	None	None	None
NLRP2 inflammasome	P29466;Q9NX02;Q9ULZ3;Q9Y2G2	834;55655;29108;22900	interleukin-1-mediated signaling pathway	None	CASP1;NLRP2;PYCARD;CARD8	None	None	None
"Elongator complex (ELP1, ELP2, ELP3, ELP4, ELP5, ELP6)"	O95163;Q0PNE2;Q6IA86;Q8TE02;Q96EB1;Q9H9T3	8518;54859;55250;23587;26610;55140	regulation of transcription from RNA polymerase II promoter	None	IKBKAP;ELP6;ELP2;ELP5;ELP4;ELP3	None	None	OMIM:117100  Centrotemporal epilepsy (PMID:19172991).
Nav1.2-beta2 complex	O60939;Q99250	6327;6326	None	None	SCN2B;SCN2A	None	None	None
Afadin-beta-catenin complex	P35222;P55196	1499;4301	cell-cell adhesion;adherens junction organization	None	CTNNB1;AFDN	None	None	"Mesangial proliferative nephritis, glomerulonephritis (PMID:26568295)."
CTNNB1-DNMT1 complex	P26358;P35222	1786;1499	regulation of Wnt signaling pathway;DNA methylation	DNA methylation	DNMT1;CTNNB1	None	None	Colorectal cancer (PMID:25753001).
Amot-cadherin-11-beta-catenin-p120 complex	O60716;P35222;P55287;Q4VCS5	1500;1499;1009;154796	regulation of cell migration	None	CTNND1;CTNNB1;CDH11;AMOT	None	None	None
beta-catenin-B-cell lymphoma 9 protein  complex	O00512;P35222	607;1499	regulation of Wnt signaling pathway	None	BCL9;CTNNB1	None	None	None
PITX2-MLL4-ASH2L-RBBP5-PTIP complex	O14686;Q15291;Q6ZW49;Q99697;Q9UBL3	8085;5929;22976;5308;9070	regulation of cell differentiation	None	KMT2D;KDM6B;PAXIP1;PITX2;ASH2L	None	None	None
GIT1-ARHGEF7-PAK1-PXN complex	P49023;Q13153;Q14155;Q9Y2X7	5829;5058;8874;28964	None	None	PXN;PAK1;ARHGEF7;GIT1	None	None	None
Jade-1-NPHP4 complex	O75161;Q6IE81	261734;79960	negative regulation of Wnt signaling pathway	None	NPHP4;JADE1	None	None	OMIM:606966 Nephronophthisis 4 (PMID:11920287).
SETD7-YAP-AXIN1-beta-catenin complex	O15169;P35222;P46937;Q8WTS6	8312;1499;10413;80854	regulation of Wnt signaling pathway;regulation of hippo signaling	None	AXIN1;CTNNB1;YAP1;SETD7	None	None	None
TNF-R1-associated signaling complex	O14920;O15111;O43318;P01375;P19438;Q12933;Q13489;Q13546;Q15025;Q15628;Q15750;Q96EP0;Q9BYM8;Q9NYJ8;Q9Y6K9	3551;1147;6885;7124;7132;7186;330;8737;10318;8717;10454;55072;10616;23118;8517	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	IKBKB;CHUK;MAP3K7;TNF;TNFRSF1A;TRAF2;BIRC3;RIPK1;TNIP1;TRADD;TAB1;RNF31;RBCK1;TAB2;IKBKG	None	"After binding of TNF to its receptor TNFR1 BIRC3 (cIAP) is recruited to the TNF-R1 complex via TRADD and TRAF2. BIRC3 together with BIRC2, ubiquitylates RIPK1 allowing the recruitment of LUBAC complex. LUBAC adds linear polyUb chains to NEMO (IKKBKG) and possibly other substrates in the complex."	None
ZNF304-corepressor complex	P26358;Q13263;Q15047;Q9HCX3	1786;10155;9869;57343	DNA methylation;DNA binding;nucleus;positive regulation of methylation-dependent chromatin silencing	DNA methylation;DNA binding;nucleus	DNMT1;TRIM28;SETDB1;ZNF304	None	"Promoter-bound ZNF304 recruits a corepressor complex that includes the DNA methyltransferase DNMT1, resulting in DNAhypermethylation and transcriptional silencing."	"The ZNF304-corepressor complex is involved in colorectal cancer. ZNF304 is a protein that binds to stretches of DNA, including regions of DNA at the start of several tumor suppressor genes, and it recruits the enzymes that add the chemical marks that switch off these genes."
TNF-R1 signaling complex	P01375;P19438;Q12933;Q13546;Q15628	7124;7132;7186;8737;8717	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	TNF;TNFRSF1A;TRAF2;RIPK1;TRADD	None	"TNF binds to its receptor TNFR1. TRADD recruits TRAF2 and RIPK1 simultaneously to TNFR1 via its N-terminal TRAF-interacting domain and C-terminal death domain, respectively."	None
PKP1-ZO-1 complex	Q07157;Q13835	7082;5317	cell adhesion;regulation of odontogenesis;ameloblast differentiation	cell adhesion	TJP1;PKP1	None	None	None
FoxM1-Axin-GSK3beta complex	O15169;P49841;Q08050	8312;2932;2305	None	None	AXIN1;GSK3B;FOXM1	None	None	None
beta-Catenin destruction complex	O15169;P25054;P35222;P49841	8312;324;1499;2932	beta-catenin destruction complex	None	AXIN1;APC;CTNNB1;GSK3B	None	None	"OMIM:114500 Colorectal cancer, OMIM:175100 Adenomatous polyposis of the colon (PMID:27462886)."
Sox4-beta-catenin-p300 complex	P35222;Q06945;Q09472	1499;6659;2033	positive regulation of sequence-specific DNA binding transcription factor activity	None	CTNNB1;SOX4;EP300	None	None	Uterine carcinosarcoma (PMID:26841870).
"Glutamate receptor 1 complex, metabotropic"	Q13255	2911	glutamate receptor activity	None	GRM1	None	None	None
"Glutamate receptor 2 complex, metabotropic"	Q14416	2912	glutamate receptor activity	None	GRM2	None	None	None
"Glutamate receptor 4 complex, metabotropic"	Q14833	2914	glutamate receptor activity	None	GRM4	None	None	None
"Glutamate receptor 7 complex, metabotropic"	Q14831	2917	glutamate receptor activity	None	GRM7	None	None	None
RHAMM-beta-catenin complex	O75330;P35222	3161;1499	regulation of cell proliferation	None	HMMR;CTNNB1	None	None	Fibrosarcoma (PMID:26825774).
"Glutamate receptor 8 complex, metabotropic"	O00222	2918	glutamate receptor activity	None	GRM8	None	None	None
PDLIM1-E-cadherin-beta-catenin complex	O00151;P12830;P35222	9124;999;1499	regulation of protein complex stability	None	PDLIM1;CDH1;CTNNB1	None	None	Colorectal cancer (PMID:26701804).
mGluR2-mGluR4 complex	Q14416;Q14833	2912;2914	glutamate receptor activity	None	GRM2;GRM4	None	None	None
OVOL2-beta-catenin-TCF4 complex	P15884;P35222;Q9BRP0	6925;1499;58495	regulation of canonical Wnt signaling pathway	None	TCF4;CTNNB1;OVOL2	None	None	Colorectal cancer (PMID:26619963).
Synexin-sorcin complex	P20073;P30626	310;6717	chromaffin granule;chromaffin granule membrane	None	ANXA7;SRI	None	"Synexin (annexin VII) forms a complex with sorcin and recruits this protein to chromaffin granule membranes in a Ca2+-dependent manner. Sorcin is able to inhibit synexin-mediated chromaffin granule aggregation in a manner saturable with increasing sorcin concentrations, but does not influence the Ca2+ sensitivity of synexin-mediated granule aggregation. Therefore, the interaction between sorcin and synexin may serve to regulate the functions of these proteins on membrane surfaces in a Ca2+-dependent manner. Overlay assays using deletion constructs of the synexin N-terminal domain mapped the sorcin binding site to the N-terminal 31 amino acids of the synexin protein. Affinity chromatography identified sorcin as a Ca2+-dependent synexin-binding protein."	None
mGluR2-mGluR7 complex	Q14416;Q14831	2912;2917	glutamate receptor activity	None	GRM2;GRM7	None	None	None
mGluR2-mGluR8 complex	O00222;Q14416	2918;2912	glutamate receptor activity	None	GRM8;GRM2	None	None	None
mGluR3-mGluR4 complex	Q14832;Q14833	2913;2914	glutamate receptor activity	None	GRM3;GRM4	None	None	None
mGluR3-mGluR7 complex	Q14831;Q14832	2917;2913	glutamate receptor activity	None	GRM7;GRM3	None	None	None
mGluR3-mGluR8 complex	O00222;Q14832	2918;2913	glutamate receptor activity	None	GRM8;GRM3	None	None	None
MiDAC complex	Q13547;Q6PJG2;Q92769;Q9H147	3065;91748;3066;116092	None	None	HDAC1;ELMSAN1;HDAC2;DNTTIP1	None	None	None
Calcineurin-FKBP12 complex	P62942;P63098;Q08209	2280;5534;5530	calcium-mediated signaling;calcineurin complex;calmodulin binding;phosphatase activity	Ca2+ mediated signal transduction	FKBP1A;PPP3R1;PPP3CA	None	"Calcineurin (CaN) is a calcium- and calmodulin-dependent protein serine/threonine phosphatase which is critical for several important cellular processes, including T-cell activation. CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cytoplasmic binding proteins (cyclophilin and FKBP12, respectively). In the native CaN structure, an auto-inhibitory element binds at the Zn/Fe-containing active site. The metal-site geometry and active-site water structure suggest a catalytic mechanism involving nucleophilic attack on the substrate phosphate by a metal-activated water molecule. In the FKBP12-FK506-CaN complex, the auto-inhibitory element is displaced from the active site. The site of binding of FKBP12-FK506 appears to be shared by other non-competitive inhibitors of calcineurin, including a natural anchoring protein. CaN is a heterodimer composed of a catalytic A unit and a regulatory B unit."	None
PEF1-ALG2 complex	O75340;Q9UBV8	10016;553115	response to calcium ion;cytoplasm	cytoplasm	PDCD6;PEF1	None	"Peflin dissociated from ALG-2 in the presence of Ca(2+). Peflin and ALG-2 co-localized in the cytoplasm, but ALG-2 was also detected in the nuclei as revealed by immunofluorescent staining and subcellular fractionation. Peflin was recovered in the cytosolic fraction in the absence of Ca(2+) but in the membrane/cytoskeletal fraction in the presence of Ca(2+). These results suggest that peflin has features common to those of other PEF proteins (dimerization and translocation to membranes) and may modulate the function of ALG-2 in Ca(2+) signaling. Peflin, a Ca(2+)-binding protein, belongs to the penta-EF-hand (PEF) protein family, which includes the calpain small subunit, sorcin, grancalcin, and ALG-2 (apoptosis-linked gene 2)."	None
NPHP1-NPHP4-BCAR1 complex	O15259;O75161;P56945	4867;261734;9564	cell-cell adhesion;cell-matrix adhesion;cell division	cell-matrix adhesion	NPHP1;NPHP4;BCAR1	None	None	"Nephrocystin and nephrocystin-4 are proteins involved in familial juvenile nephronophthisis, an autosomal recessive nephropathy characterized by cyst formation and renal fibrosis (PMID:15661758)."
CORVET complex	Q8N3P4;Q8WUH2;Q96AX1;Q9H269;Q9H270;Q9P253	23355;9392;65082;64601;55823;57617	CORVET complex;vesicle tethering;endosomal vesicle fusion	None	VPS8;TGFBRAP1;VPS33A;VPS16;VPS11;VPS18	None	None	Missense mutations in the gene VPS11 are associated with  hypomyelination and developmental delay (PMID:26307567).
HOPS complex	P49754;Q96AX1;Q96JC1;Q9H269;Q9H270;Q9P253	27072;65082;23339;64601;55823;57617	HOPS complex;vesicle tethering;endosomal vesicle fusion	None	VPS41;VPS33A;VPS39;VPS16;VPS11;VPS18	None	The mammalian HOPS complex is recruited to membranes by binding to the RAB7 effector RILP.	Missense mutations in the gene VPS11 are associated with hypomyelination and developmental delay (PMID:26307567).
Endosomal targeting complex (VIPAS39-VPS33B)	Q9H267;Q9H9C1	26276;63894	endosomal vesicle fusion;vesicle tethering	None	VPS33B;VIPAS39	None	None	Autosomal recessive mutations in VPS33B or VIPAS39 cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome.
KCTD12-GNB1-GNG2 complex	P59768;P62873;Q96CX2	54331;2782;115207	desensitization of G-protein coupled receptor protein signaling pathway	None	GNG2;GNB1;KCTD12	None	None	None
KCTD8-GNB1-GNG2 complex	P59768;P62873;Q6ZWB6	54331;2782;386617	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	GNG2;GNB1;KCTD8	None	None	None
KCTD16-GNB1-GNG2 complex	P59768;P62873;Q68DU8	54331;2782;57528	G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	GNG2;GNB1;KCTD16	None	None	None
CNOT1-CNOT2-CNOT3 complex	A5YKK6;O75175;Q9NZN8	23019;4849;4848	"regulation of transcription, DNA-templated;gene silencing by miRNA;regulation of post-translational protein modification"	transcriptional control	CNOT1;CNOT3;CNOT2	None	None	None
4E-T-DDX6-CNOT1 complex	A5YKK6;P26196;Q9NRA8	23019;1656;56478	negative regulation of translation;regulation of deadenylation-independent decapping of nuclear-transcribed mRNA	None	CNOT1;DDX6;EIF4ENIF1	None	None	None
DNJC3-DNAJB1-HSPA8 complex	P11142;P25685;Q13217	3312;3337;5611	PKR signal transduction	None	HSPA8;DNAJB1;DNAJC3	None	None	None
DNAJC7-HSPA8-HSP90AA1 complex	P07900;P11142;Q99615	3320;3312;7266	ATP-independent chaperone mediated protein folding;response to heat	heat shock response	HSP90AA1;HSPA8;DNAJC7	"Since HSP70 and HSP90 from rabbit were not available in the UniProt database at the time of annotation, the orthologous proteins from homo sapiens were used."	None	None
NMNAT2-HSP90 complex	P07900;Q9BZQ4	3320;23057	chaperone-mediated protein folding;protein refolding	None	HSP90AA1;NMNAT2	None	"Elevating NMNAT2 levels in rTg4510 mice (aFrontotemporal Dementia and Parkinsonism-17 (FTDP-17) tauopathy model) ameliorates their neurodegenerative phenotype. These finding suggest a role for NMNAT2 in neuronal maintenance in the brain, but the mechanism underlying neuroprotection remains to be elucidated."	"Brain NMNAT2 mRNA levels correlate positively with global cognitive function and negatively with Alzheimer disease pathology. In Alzheimer disease brains, NMNAT2 mRNA and protein levels are reduced."
MST1-SAV1 complex	Q13043;Q9H4B6	6789;60485	cilium assembly	None	STK4;SAV1	None	"The effect of Mst2 on Sav phosphorylation and stability was almost always greater than that of Mst1, suggesting that Sav is a preferred partner-substrate of Mst2 compared to Mst1. Sav is phosphorylated by Mst and the phosphorylation is likely to be direct."	None
MST2-SAV1 complex	Q13188;Q9H4B6	6788;60485	cilium assembly	None	STK3;SAV1	None	"The effect of Mst2 on Sav phosphorylation and stability was almost always greater than that of Mst1, suggesting that Sav is a preferred partner-substrate of Mst2 compared to Mst1. Sav is phosphorylated by Mst and the phosphorylation is likely to be direct."	None
MITRAC12-SURF1-COX1 complex	P00395;Q15526;Q9Y2R0	4512;6834;28958	mitochondrion;mitochondrial inner membrane;translation	mitochondrion;mitochondrial inner membrane;translation	MT-CO1;SURF1;COA3	None	Copurification of MITRAC12 with COX1 and SURF1 suggested a role in early steps of cytochrome c oxidase biogenesis. MITRAC12 is a cytochrome c oxidase assembly factor and required for efficient COX1 translation. Mitochondria from MITRAC12-depleted cells displayed reduced cytochrome c oxidase activity.	None
MITRAC7-COX1 complex	P00395;Q8N5G0	4512;389203	mitochondrion;cytochrome c biosynthetic process	mitochondrion	MT-CO1;SMIM20	None	"Cytochrome c oxidase, the terminal enzyme of the respiratory chain, is assembled from mitochondria- and nuclear-encoded subunits. The MITRAC complex represents the central assembly intermediate during this process as it receives imported subunits and regulates mitochondrial translation of COX1 mRNA. MITRAC7 is a COX1-specific chaperone that binds newly synthesized COX1 to stabilize the molecule during assembly. Although a lack of MITRAC7 causes turnover of newly synthesized COX1, overabundance of MITRAC7 traps COX1 in the MITRAC assembly intermediate. Hence, MITRAC7 reveals a checkpoint of the cytochrome c oxidase assembly process."	None
TRIM31-MAGEA1-NSE4 complex	P43355;Q9BZY9;Q9NXX6	4100;11074;54780	"regulation of transcription, DNA-templated"	transcriptional control	MAGEA1;TRIM31;NSMCE4A	None	None	Melanoma (PMID:25590999).
AURKA-HDAC6 cilia-disassembly complex	O14965;Q9UBN7	6790;10013	cilium disassembly	None	AURKA;HDAC6	None	"Upon receiving a cell-cycle re-entry cue, Aurora kinase A (AURKA) is activated and in turn enhances the activity of HDAC6, an enzyme that deacetylates ciliary tubulin, promoting cilia disassembly."	None
PDGFB-PDGFRB complex	P01127;P09619	5155;5159	platelet-derived growth factor receptor-beta signaling pathway	None	PDGFB;PDGFRB	None	None	"OMIM:606190 Meningioma, radiation-induced (PMID:8057146).OMIM:607907 Dermatofibrosarcoma protuberans (PMID:12202658).OMIM:615007 Basal ganglia calcification (PMID: 23255827).OMIM:228550 Myofibromatosis (PMID: 23731537).OMIM:616592 Kosaki overgrowth syndrome (PMID:25454926).OMIM:601812 Premature aging syndrome(PMID:9056558)."
RIPK1-FADD-caspase-8 complex	Q13158;Q13546;Q14790	8772;8737;841	ripoptosome;regulation of extrinsic apoptotic signaling pathway;regulation of necroptotic process	None	FADD;RIPK1;CASP8	None	None	Cancer (PMID:20038679).
pallidin-Cappuccino-BLOS1 complex	P78537;Q9NUP1;Q9UL45	2647;55330;26258	None	None	BLOC1S1;BLOC1S4;BLOC1S6	None	None	None
dysbindin-Snapin-BLOS2 complex	O95295;Q6QNY1;Q96EV8	23557;282991;84062	None	None	SNAPIN;BLOC1S2;DTNBP1	None	None	None
Fibrinogen complex	P02671;P02675;P02679	2243;2244;2266	platelet activation	None	FGA;FGB;FGG	None	None	Congenital fibrinogen disorders (PMID:).27492693
C1q complex	P02745;P02746;P02747	712;713;714	"immune system process;immune response;complement activation;complement activation, classical pathway;innate immune response"	immune response;complement response;innate immune response (invertebrates and vertebrates)	C1QA;C1QB;C1QC	None	None	"OMIM:613652 C1q deficiency (PMID:884029, PMID:2894352, PMID:8630118)."
DNTTIP1-ZNF541-HDAC1-HDAC2 complex	Q13547;Q92769;Q9H0D2;Q9H147	3065;3066;84215;116092	histone deacetylase complex;histone deacetylase activity	None	HDAC1;HDAC2;ZNF541;DNTTIP1	None	None	None
SETDB1-DNMT3A complex	Q15047;Q9Y6K1	9869;1788	"transcriptional repressor complex;regulation of transcription, DNA-templated"	transcriptional control	SETDB1;DNMT3A	None	None	None
SETDB1-DNMT3B complex	Q15047;Q9UBC3	9869;1789	None	None	SETDB1;DNMT3B	None	None	None
ATF4-CREB1 complex	P16220;P18848	1385;468	"regulation of transcription, DNA-templated"	transcriptional control	CREB1;ATF4	None	None	None
ATL1 homo-oligomer complex	Q8WXF7	51062	membrane protein complex	None	ATL1	None	"Yeast two-hybrid analyses and co-immunoprecipitation studies demonstrated that atlastin-1 can self-associate, and gel-exclusion chromatography and chemical cross-linking studies indicated that atlastin-1 exists as an oligomer in vivo, most likely a tetramer. Membrane fractionation and protease protection assays revealed that atlastin-1 is an integral membrane protein with two predicted transmembrane domains; both the N-terminal GTP-binding and C-terminal domains are exposed to the cytoplasm. Together, these findings indicate that the SPG3A protein atlastin-1 is a multimeric integral membrane GTPase that may be involved in Golgi membrane dynamics or vesicle trafficking."	None
SPG3A-SPG4-SPG31 complex	Q8WXF7;Q9H902;Q9UBP0	51062;65055;6683	microtubule binding;endoplasmic reticulum organization	endoplasmic reticulum	ATL1;REEP1;SPAST	None	"REEP1 interacts with the HSP proteins atlastin-1 and spastin through intramembrane hairpin domains. REEP proteins were required for ER network formation in vitro, and REEP1 also bound microtubules and promoted ER alignment along the microtubule cytoskeleton (PMID:20200447)."	"Hereditary spastic paraplegias (HSPs; SPG1\u201345) are inherited neurological disorders characterized by lower extremity spastic weakness. More than half of HSP cases result from autosomal dominant mutations in atlastin-1 (also known as SPG3A), receptor expression enhancing protein 1 (REEP1; SPG31), or spastin (SPG4). The atlastin-1 GTPase interacts with spastin, a microtubule-severing ATPase, as well as with the DP1/Yop1p and reticulon families of ER-shaping proteins, and SPG3A caused by atlastin-1 mutations has been linked pathogenically to abnormal ER morphology. Defects in tubular ER shaping and network interactions with the microtubule cytoskeleton seem to be the predominant pathogenic mechanism of HSP."
ATL2-SPG31 complex	Q8NHH9;Q9H902	64225;65055	endoplasmic reticulum organization;microtubule binding	endoplasmic reticulum	ATL2;REEP1	None	"REEP1 coimmunoprecipitated with the human atlastin family members, atlastin-1, atlastin-2 and atlastin-3. ATL2 and ATL3 are highly similar to ATL1 in the membrane-spanning regions but divergent in the cytoplasmic C terminus."	"Mutations in the receptor expression enhancing protein 1 (REEP1) gene have been reported to be associated with an autosomal dominant HSP phenotype (SPG31) (PMID:19034539). REEP proteins were required for ER network formation, and REEP1 also bound microtubules and promoted ER alignment along the microtubule cytoskeleton (PMID:20200447)."
ATL3-SPG31 complex	Q6DD88;Q9H902	25923;65055	endoplasmic reticulum organization;microtubule binding	endoplasmic reticulum	ATL3;REEP1	None	"REEP1 coimmunoprecipitated with the human atlastin family members, atlastin-1, atlastin-2 and atlastin-3. ATL2 and ATL3 are highly similar to ATL1 in the membrane-spanning regions but divergent in the cytoplasmic C terminus."	"REEP proteins were required for ER network formation, and REEP1 also bound microtubules and promoted ER alignment along the microtubule cytoskeleton (PMID:20200447)."
TTN-TCAP complex	O15273;Q8WZ42	8557;7273	sarcomere organization;cardiac muscle fiber development;cardiac myofibril assembly;muscle filament sliding	None	TCAP;TTN	None	None	None
MIS18 complex	O43482;Q6P0N0;Q9NYP9	11339;55320;54069	centromere complex assembly;regulation of CENP-A containing nucleosome assembly	None	OIP5;MIS18BP1;MIS18A	None	None	None
HAUS augmin-like complex	O94927;Q68CZ6;Q7Z4H7;Q8BFT2;Q96CS2;Q99871;Q9BT25;Q9NVX0	23354;79441;54801;219072;115106;55559;93323;55142	mitotic nuclear division;spindle assembly;centrosome organization;G2/M transition of mitotic cell cycle	M phase;spindle pole body/centrosome and microtubule cycle;centrosome;G2/M transition of mitotic cell cycle	HAUS5;HAUS3;HAUS6;Haus4;HAUS1;HAUS7;HAUS8;HAUS2	None	None	OMIM:601626 Acute myeloid leukemia (PMID:27036161). Congenital glioblastoma multiforme (PMID:27121553).Clear cell renal cell carcinoma (PMID:26061684).
ATP4A-ATP4B complex	P20648;P51164	495;496	potassium ion transmembrane transport	None	ATP4A;ATP4B	None	None	Familial gastric neuroendocrine tumors (PMID:27491072).
GABBR1-GABBR2 complex	O75899;Q9UBS5	9568;2550	"gamma-aminobutyric acid signaling pathway;synaptic transmission, GABAergic"	gamma-aminobutyric acid signalling pathway	GABBR2;GABBR1	None	None	None
SCNN1A-SCNN1B-SCNN1G complex	P37088;P51168;P51170	6337;6338;6340	sodium ion transport	None	SCNN1A;SCNN1B;SCNN1G	None	None	"OMIM:264350 Pseudohypoaldosteronism, type I (PMID:10404817). OMIM:177200 Liddle syndrome (PMID:7550319, PMID:7954808). OMIM:219700 Cystic fibrosis (PMID:19060118)."
SCNN1B-SCNN1G-SCNN1D complex	P51168;P51170;P51172	6338;6340;6339	sodium ion transport	None	SCNN1B;SCNN1G;SCNN1D	None	None	None
CHRNA2-CHRNB4 complex	P30926;Q15822	1143;1135	"synaptic transmission, cholinergic;response to nicotine;neuromuscular synaptic transmission"	None	CHRNB4;CHRNA2	None	None	None
KIAA0753-FOR20-OFD1 complex	O75665;Q2KHM9;Q96NB1	8481;9851;123811	cilium assembly;centriolar satellite;ciliary basal body organization	None	OFD1;KIAA0753;FOPNL	The central region of KIAA0753 (OFIP) stabilizes MTs.	"Depletion of individual proteins of the complex affectscentrosomes, PSs (pericentriolar satellites) and ciliogenesis."	The OFIP-OFD1-FOR20 complex is defective in a patient with oral-facial-digital (OFD) syndromes. Heterozygous mutations of KIAA0753/OFIP in a patientwith an OFD VI syndrome have been analyzed.. The patient cells showed a strong reduction of FOR20 and OFD1 at the centrosome and PSs (pericentriolar satellites).
"Cytochrome c oxidase, mitochondrial"	P00395;P00403;P00414;P09669;P13073;P20674;Q15526;Q7KZN9;Q7Z7K0;Q96I36;Q9BVV7;Q9GZY4;Q9P0S2;Q9Y2R0	4512;4513;4514;1345;1327;9377;6834;1355;152100;84987;29090;55744;51241;28958	None	None	MT-CO1;MT-CO2;MT-CO3;COX6C;COX4I1;COX5A;SURF1;COX15;CMC1;COX14;TIMM21;COA1;COX16;COA3	None	"During complex IV (= cytochrome C oxidase) assembly, imported subunits engage with mitochondria-encoded COX1 in assembly intermediates. The majority of imported complex IV subunits present N-terminal presequences and are transported by the presequence translocase. Progression of complex IV assembly requires nuclear-encoded subunits to utilize this import pathway: human TIM21 associates with the presequence translocase as well as MITRAC complexes in a dynamic manner. MITRAC12 associates with SURF1 and COX1 assembly intermediates and is required for efficient COX1 translation. Assembly of the early cytochrome c oxidase subunit COX4-1 requires TIM21, whereas it is dispensable forlate-assembling subunits. The finding that TIM21 also interacts with complex I intermediates points to a more general role of TIM21 in respiratory-chain assembly. Furthermore, TIM21 appears to be tightly connected to MITRAC15, which, in contrast to TIM23 and MITRAC12, coimmunoprecipitates with TIM21 under all tested conditions. MITRAC15 associates with MITRAC and is required for complex IV but also complex I assembly."	"Mutations in SURF1 are the most frequent cause of Leigh Syndrome with cytochrome c oxidase deficiency. Mutations in C12orf62, a factor that couples COX I synthesis with cytochrome c oxidase assembly, cause fatal neonatal lactic acidosis."
SMAR1-HDAC1-SIN3A-SIN3B repressor complex	O75182;Q13547;Q8N9N5;Q96ST3	23309;3065;54971;25942	"regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	SIN3B;HDAC1;BANP;SIN3A	None	The authors demonstrate that SMAR1 represses cyclin D1gene expression by acting as a transcriptional repressor.	"Amplification and dysregulation of cyclin D1 is predominantly observed in breast carcinomas. In the majority of the breast cancer cell lines used, elevated levels of cyclin D1 were correlated with drastically reduced levels of SMAR1."
SMAR1-HDAC1-SIN3A-SIN3B-p107-p130 repressor complex	O75182;P28749;Q08999;Q13547;Q8N9N5;Q96ST3	23309;5933;5934;3065;54971;25942	"regulation of transcription, DNA-templated;nucleus"	transcriptional control;nucleus	SIN3B;RBL1;RBL2;HDAC1;BANP;SIN3A	"Although the authors observed the interaction of pocket Rb proteins (RBL1, RBL2) in the SMAR1-associated complex, Western analysis data from an Rb-None cell line (MDA-MB-468) and Rb-inactive cell lines (293 and HBL-100) suggest that the Rb is dispensable for SMAR1-mediated cyclin D1 repression."	The authors demonstrate that SMAR1 represses cyclin D1 gene expression by acting as a transcriptional repressor.	"Amplification and dysregulation of cyclin D1 is predominantly observed in breast carcinomas. In the majority of the breast cancer cell lines used, elevated levels of cyclin D1 were correlated with drastically reduced levels of SMAR1."
"TIM50-TIM23 complex, mitochondrial"	O14925;Q3ZCQ8	100287932;92609	None	None	TIMM23;TIMM50	None	"Translocation of nuclear-encoded mitochondrial preproteins is mediated by translocases in the outer (TOM) and inner (TIM) membranes.Tim50, a component of the mitochondrial translocator, regulates mitochondrial integrity and cell death. It is demonstrated that human Tim50 possesses phosphatase activity and is present in a complex with human Tim23. Down-regulation of human Tim50 expression by RNA interference increases the sensitivity of human cell lines to death stimuli by accelerating the release of cytochrome c from the mitochondria. The loss of Tim50 in vertebrates causes mitochondrial membrane permeabilization and dysfunction followed by cytoplasmic release of cytochrome c along with other mitochondrial inducers of cell death. Thus Tim50 is important for both mitochondrial function and early neuronal development."	"TIM50 is an essential component of TIM23 complex and involved in protein translocating into the inner mitochondrial membrane. It was found that the loss of TIM50 suppresses proliferation and induces apoptosis in breast cancer (PMID:26289846).Injection of Tim50-specific morpholino antisense oligonucleotides during early zebrafish embryonic development causes neurodegeneration, dysmorphic hearts, and reduced motility as a result of increased cell death (PMID:15044455)."
TIM23-TOM22-TIM50-HSD3B2 complex	O14925;P26439;Q3ZCQ8;Q9NS69	100287932;3284;92609;56993	regulation of steroid biosynthetic process;mitochondrial inner membrane	mitochondrial inner membrane	TIMM23;HSD3B2;TIMM50;TOMM22	None	"Inner mitochondrial translocase Tim50 interacts with 3beta-hydroxysteroid dehydrogenase type 2 to regulate adrenal and gonadal steroidogenesis. Through mass spectrometry and Western blotting of mitochondrial complexes and density gradient ultracentrifugation, it was shown that that 3betaHSD2 formed a transient association with the translocases Tim50 and Tom22 and with Tim23. This association occurred primarily through the interaction of Tim50 with the N terminus of 3betaHSD2 and contributed to enzymatic activity. Tim50 knockdown inhibited catalysis of dehydroepiandrostenedione to androstenedione and pregnenolone to progesterone."	"In the adrenals, testes, and ovaries, 3beta-hydroxysteroid dehydrogenase type 2 (3betaHSD2) catalyzes the conversion of pregnenolone to progesterone and dehydroepiandrostenedione to androstenedione. Alterations in this pathway can have deleterious effects, including sexual development impairment, spontaneous abortion, and breast cancer."
DJ-1-DJBP-AR complex	P10275;Q5THR3;Q99497	367;64800;11315	"regulation of androgen receptor signaling pathway;regulation of transcription, DNA-templated"	transcriptional control	AR;EFCAB6;PARK7	None	"DJBP directly binds to both DJ-1 and AR in a testosterone-dependent manner and  DJ-1 associates with AR via DJBP in a ternary complex. DJBP was found to inhibit AR transcription activity by recruiting histone-deacetylase complexes, including HDAC1 and mSin3, and DJ-1 was found to restore the repressed activity of the AR."	None
MAK-ACTR-AR complex	P10275;P20794;Q9Y6Q9	367;4117;8202	"regulation of androgen receptor signaling pathway;regulation of transcription, DNA-templated"	transcriptional control	AR;MAK;NCOA3	None	MAK and ACTR seem to be in proximity and synergize with each other in the transactivation of AR.	None
TIMM8A-TIMM13 complex	O60220;Q9Y5L4	1678;26517	mitochondrial intermembrane space;protein transport	mitochondrial intermembrane space;protein transport	TIMM8A;TIMM13	"The 70-kDa complex appears to be composed of three molecules of DDP1 and three molecules of hTim13. However, it cannot be decided whether this stoichiometry is fixed or determined by the relative expression levels of the components."	"The DDP1-Tim13 complex acts in the intermembrane space and specifically assists the import of the Tim23 precursors into the mitochondrial inner membrane thereby forming a hetero-oligomeric complex of 70 kDa. It is suggested that an impaired mitochondrial preprotein import is the pathogenetic basis of the Mohr-Tranebjaerg syndrome. Antibodies against DDP1 and hTim13 did not precipitate hTim9,hTim10a, or hTim10b."	"Mutations in the DDP1 cause the Mohr-Tranebjaerg syndrome, a progressive neurodegenerative disorder characterized by sensorineural hearing loss, dystonia, mental retardation, and blindness."
ARL2-TBCD complex	P36404;Q9BTW9	402;6904	microtubule cytoskeleton organization	microtubule cytoskeleton	ARL2;TBCD	None	Arl2 has a role in modulating the interaction of tubulin-folding cofactors with native tubulin in vivo.	None
"TIM17A-TIM23 complex, mitochondrial"	O14925;Q99595	100287932;10440	mitochondrion;inner mitochondrial membrane protein complex;protein import into mitochondrial inner membrane;response to stress	mitochondrion;stress response	TIMM23;TIMM17A	None	"TIM17A and TIM17B are expressed ubiquitously in mammals, however they demonstrate tissue-specific expression profiles with TIM17A enriched in the brain and TIM17B enriched in skeletal muscle. No functional differences between Tim17A and Tim17B are currently known, TIM17A is a transcriptional target of the mammalian UPRmt, suggesting that these two Tim17 homologs are differentially regulated during stress. Tim17A and Tim17B co-immunopurify with Tim23 in mitochondria. Tim17A is a stress-regulated subunit of the translocase of the inner membrane 23 (TIM23) mitochondrial protein import complex. It is indicated that Tim17A degradation is a stress-responsive mechanism by which cells adapt mitochondrial protein import efficiency and promote mitochondrial proteostasis in response to the numerous pathologic insults that induce stress-regulated translation attenuation."	None
MLL1 core complex	P61964;Q03164;Q15291;Q9UBL3	11091;4297;5929;9070	histone H3-K4 methylation	None	WDR5;KMT2A;KDM6B;ASH2L	None	"Whereas wild-type MLL1 co-immunoprecipitates theWDR5, RbBP5, and Ash2L subcomplex, co-immunoprecipitation is abolished when Arg-3765 of MLL1 is replaced with alanine."	None
"TIM17B-TIM23 complex, mitochondrial"	O14925;O60830	100287932;10245	inner mitochondrial membrane protein complex;mitochondrion;protein import into mitochondrial inner membrane;response to stress	mitochondrion;stress response	TIMM23;TIMM17B	None	"TIM17A and TIM17B are expressed ubiquitously in mammals, however they demonstrate tissue-specific expression profiles with TIM17A enriched in the brain and TIM17B enriched in skeletal muscle. No functional differences between Tim17A and Tim17B are currently known. Tim17A and Tim17B co-immunopurify with Tim23 in mitochondria."	None
EARP complex	Q5VIR6;Q8N1B4;Q96JG6;Q9UID3	55275;6293;55610;738	None	None	VPS53;VPS52;VPS50;VPS51	None	None	None
MLL2 complex	O00255;O14686;O15294;O75475;P51610;P61964;Q15291;Q9C005;Q9UBL3;Q9Y5Z7	4221;8085;8473;11168;3054;11091;5929;84661;9070;29915	"histone H3-K4 methylation;regulation of transcription, DNA-templated;nucleus;chromatin organization"	transcriptional control;nucleus	MEN1;KMT2D;OGT;PSIP1;HCFC1;WDR5;KDM6B;DPY30;ASH2L;HCFC2	"Corresponding to protein Menin, the authors refer to isoform 2 of Uniprot: O00255 (O00255-2).The authors did not specify the proteins HCFC1 and HCFC2. Both proteins are shown alternatively."	None	None
MLL3 complex	O15550;P61964;Q14686;Q15291;Q6ZW49;Q8NEZ4;Q9BTK6;Q9C005;Q9UBL3	7403;11091;23054;5929;22976;58508;79447;84661;9070	"histone H3-K4 methylation;nucleus;regulation of transcription, DNA-templated;chromatin organization"	nucleus;transcriptional control	KDM6A;WDR5;NCOA6;KDM6B;PAXIP1;KMT2C;PAGR1;DPY30;ASH2L	"Corresponding to protein MLL3, the authors refer to isoform 3 of Uniprot: Q8NEZ4 (Q8NEZ4-3)."	None	None
MLL1 complex	O00255;O15294;P51610;P61964;Q03164;Q15291;Q9C005;Q9UBL3	4221;8473;3054;11091;4297;5929;84661;9070	"histone H3-K4 methylation;regulation of transcription, DNA-templated;nucleus;chromatin organization"	transcriptional control;nucleus	MEN1;OGT;HCFC1;WDR5;KMT2A;KDM6B;DPY30;ASH2L	"Corresponding to protein Menin, the authors refer to isoform 2 of Uniprot: O00255 (O00255-2). Since the authors did not specify host cell factor, we used HCFC1"	None	None
GARP complex	Q5VIR6;Q8N1B4;Q9P1Q0;Q9UID3	55275;6293;51542;738	"retrograde transport, endosome to Golgi;trans-Golgi network;GARP complex"	None	VPS53;VPS52;VPS54;VPS51	None	"GARP deficiency results in accumulation of sphingolipid synthesis intermediates and lysosomal dysfunction, indicating that GARP is necessary for sphingolipid homeostasis (PMID:26357016)."	"People with mutations in VPS53, a subunit of the GARP complex, suffer from a severe neurodegenerative disease known as \u2018progressive cerebello-cerebral atrophy type 2\u2019 (PCCA2)."
NINJ1 homo-oligomer complex	Q92982	4814	cell adhesion	cell adhesion	NINJ1	None	None	None
MLL4 complex	O14686;O15550;P61964;Q14686;Q15291;Q6ZW49;Q9BTK6;Q9C005;Q9UBL3	8085;7403;11091;23054;5929;22976;79447;84661;9070	"histone H3-K4 methylation;nucleus;regulation of transcription, DNA-templated;chromatin organization"	nucleus;transcriptional control	KMT2D;KDM6A;WDR5;NCOA6;KDM6B;PAXIP1;PAGR1;DPY30;ASH2L	"Corresponding to protein MLL4, the authors refer to isoform 3 of Uniprot: O14686 (O14686-3)."	None	None
TRAPP complex	O43617;O75865;P0DI81;P48553;Q5T215;Q7Z392;Q86SZ2;Q8IUR0;Q8WVT3;Q96Q05;Q9UL33;Q9Y296;Q9Y2L5;Q9Y5R8	27095;79090;6399;7109;100128327;60684;122553;126003;51112;83696;51693;51399;22878;58485	ER to Golgi vesicle-mediated transport;vesicle-mediated transport;COPI-coated vesicle	"ER to Golgi transport;vesicular transport (Golgi network, etc.)"	TRAPPC3;TRAPPC6A;TRAPPC2;TRAPPC10;TRAPPC3L;TRAPPC11;TRAPPC6B;TRAPPC5;TRAPPC12;TRAPPC9;TRAPPC2L;TRAPPC4;TRAPPC8;TRAPPC1	None	None	None
Set1A complex	O15047;O15294;P51610;P61964;Q15291;Q6UXN9;Q9C005;Q9P0U4;Q9UBL3;Q9Y5Z7	9739;8473;3054;11091;5929;80335;84661;30827;9070;29915	"histone H3-K4 methylation;nucleus;regulation of transcription, DNA-templated;chromatin organization"	nucleus;transcriptional control	SETD1A;OGT;HCFC1;WDR5;KDM6B;WDR82;DPY30;CXXC1;ASH2L;HCFC2	"Corresponding to protein CXXC1 (CFP1) , the authors refer to isoform 2 of Uniprot: Q9P0U4 (Q9P0U4-2).The authors did not specify the proteins HCFC1 and HCFC2. Both proteins are shown alternatively."	None	None
Set1B complex	O15294;P51610;P61964;Q15291;Q6UXN9;Q8NFC6;Q96IK1;Q9C005;Q9P0U4;Q9UBL3;Q9UPS6;Q9Y5Z7	8473;3054;11091;5929;80335;259282;91272;84661;30827;9070;23067;29915	"histone H3-K4 methylation;nucleus;regulation of transcription, DNA-templated;chromatin organization"	nucleus;transcriptional control	OGT;HCFC1;WDR5;KDM6B;WDR82;BOD1L1;BOD1;DPY30;CXXC1;ASH2L;SETD1B;HCFC2	"Corresponding to protein CXXC1 (CFP1) , the authors refer to isoform 2 of Uniprot: Q9P0U4 (Q9P0U4-2).The authors did not specify the proteins HCFC1 and HCFC2. Both proteins are shown alternatively."	None	None
Bcl-2-Beclin1-UVRAG-PI(3)KC3 complex	P10415;Q14457;Q8NEB9;Q99570;Q9P2Y5	596;8678;5289;30849;7405	autophagosome assembly	None	BCL2;BECN1;PIK3C3;PIK3R4;UVRAG	None	"Beclin1 functions as a platform to form a Bcl-2\u2013UVRAG\u2013PI(3)KC3 multiprotein complex in which binding of each constituent requires a different region of Beclin1. Bcl-2\u2013Beclin1 interaction declines during starvation, whereas the UVRAG\u2013Beclin1 interaction remains intact. This indicates that UVRAG and Bcl-2 function as activator and repressor, respectively. Under stressed conditions, Bcl-2 only weakly associates with the Beclin\u2013PI(3)KC3 complex, whereas UVRAG remains in the complex, resulting in continuously activating signal transduction and thus unbalanced, amplified autophagy. (PMID:16799551)"	None
mitochondrial calcium uniporter complex	Q8IYU8;Q8NE86;Q9BPX6;Q9H4I9;Q9NWR8	221154;90550;10367;91689;55013	mitochondrial calcium ion transport;mitochondrion;mitochondrial calcium ion homeostasis	mitochondrion	MICU2;MCU;MICU1;SMDT1;MCUB	None	Subunit EMRE (SMDT1) is essential for in vivo uniporter current and additionally bridges the calcium-sensing role of MICU1 and MICU2 with the calcium conducting role of MCU.	"Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling (OMIM:615673, PMID:24336167)."
Cubam complex	O60494;Q9BXJ7	8029;81693	endocytosis;cobalamin transport	endocytosis	CUBN;AMN	None	None	"Imerslund-Gr\u00e4sbeck syndrome (I-GS; megaloblastic anemia 1, OMIM:261100), is caused by genetic defects in either the cubilin or AMN genes. IG-S is characterized by selective malabsorption of cobalamin (vitamin B(12)) despite normal production and function of intrinsic factor GIF."
erlin1/2-RNF170 complex	O75477;O94905;Q96K19	10613;11160;81790	endoplasmic reticulum membrane;receptor recycling	None	ERLIN1;ERLIN2;RNF170	None	RNF170 interacts constitutively with the erlin1/2 complex and depletion of the erlin1/2 complex inhibits RNF170 association with activated IP3 receptors but not vice-versa. It appears that RNF170 is recruited to activated IP3 receptors by the erlin1/2 complex.	"A  point mutation Arg-to-Cys in human RNF170 is the cause of autosomaldominant sensory ataxia, a rare, progressive ataxia caused bydegeneration of the posterior columns of the spinal cord (OMIM:608984)"
ZEB2-KDM1A complex	O60315;O60341	9839;23028	None	None	ZEB2;KDM1A	None	None	"OMIM:613065 Leukemia, acute lymphoblastic; ALL"
Cubilin-intrinsic factor-cobalamin complex	O60494;P27352	8029;2694	cobalamin transport	None	CUBN;GIF	None	Cobalamin (vitamin B12 is bound to the intrinsic factor GIF.	None
WASH complex	A8K0Z3;Q12768;Q2M389;Q9Y3C0;Q9Y4E1	100287171;9897;23325;51019;253725	None	None	WASH1;KIAA0196;KIAA1033;CCDC53;FAM21C	None	None	Strumpellin is mutated in the human disease hereditary spastic paraplegia (OMIM:603563). WASH is a member of the Wiskott-Aldrich syndrome protein family (WASP).
CUL4B-DDB1-DTL-CSN complex	P61201;Q13098;Q13620;Q16531;Q9NZJ0	9318;2873;8450;1642;51514	None	None	COPS2;GPS1;CUL4B;DDB1;DTL	None	"CUL4/DDB1 E3 ligase complex plays a critical role in regulating the cell cycle progression, replication and DNA damage."	None
CAPZalpha-CAPZbeta complex	P47756;P52907	832;829	actin filament capping	None	CAPZB;CAPZA1	"Since the authors did not specify F-actin-capping protein, we used isoform CAPZA1."	CAPZalpha-CAPZbeta complex is weakly associated with the WASH complex.	None
WASH-CAPZalpa/beta complex	A8K0Z3;P47756;P52907;Q12768;Q2M389;Q9Y3C0;Q9Y4E1	100287171;832;829;9897;23325;51019;253725	actin filament capping;early endosome;Arp2/3 complex-mediated actin nucleation;endosomal transport	None	WASH1;CAPZB;CAPZA1;KIAA0196;KIAA1033;CCDC53;FAM21C	"Since the authors did not specify F-actin-capping protein, we used isoform CAPZA1."	"CAPZalpha/beta heterodimer complex also copurified with WASH complex, but only weakly, suggesting that CAPZ is a peripheral component. FAM21 interacts directly with CAPZ and inhibits its actin-capping activity."	Strumpellin is mutated in the human disease hereditary spastic paraplegia (OMIM:603563). WASH is a member of the Wiskott-Aldrich syndrome protein family (WASP).
HIF1alpha-VHL-ElonginB-ElonginC complex	P40337;Q15369;Q15370;Q16665	7428;6921;6923;3091	oxygen homeostasis	None	VHL;TCEB1;TCEB2;HIF1A	None	VHL is responsible for the ubiquitination of  HIF1alpha.	Mutations in the VHL protein are associated with von Hippel\u2013Lindau cancer predisposition syndrome (OMIM:193300).
CUL4A-DDB1-DTL complex	Q13619;Q16531;Q9NZJ0	8451;1642;51514	cellular protein catabolic process;cellular response to DNA damage stimulus	cytoplasmic and nuclear protein degradation;DNA damage response	CUL4A;DDB1;DTL	None	"CUL4/DDB1 E3 ligase complex plays a critical role in regulating the cell cycle progression, replication and DNA damage.DTL is a protein that associates with CUL4 and DDB1 and is required for CDT1 degradation in response to DNA damage in both Drosophila and human cells."	None
CUL4B-DDB1-TLE2 complex	Q04725;Q13620;Q16531	7089;8450;1642	proteasomal protein catabolic process	None	TLE2;CUL4B;DDB1	None	None	None
CUL4A-DDB1-EED complex	O75530;Q13619;Q16531	8726;8451;1642	proteasomal protein catabolic process;regulation of histone methylation	None	EED;CUL4A;DDB1	None	None	None
CUL4A-DDB1-WDR5 complex	P61964;Q13619;Q16531	11091;8451;1642	regulation of histone methylation;proteasomal protein catabolic process	None	WDR5;CUL4A;DDB1	None	"WDR5, DDB1 and CUL4A can interact with the H3 N-terminal peptide containing methylated K4, but not its unmodified form in cell lysates, suggesting that these interactions are specific for methylated histone H3."	None
CUL4B-DDB1-WDR26 complex	Q13620;Q16531;Q9H7D7	8450;1642;80232	None	None	CUL4B;DDB1;WDR26	None	None	None
CUL4A-DDB1-RBBP5 complex	Q13619;Q15291;Q16531	8451;5929;1642	None	None	CUL4A;KDM6B;DDB1	None	None	None
CUL4A-DDB1-WDR5B complex	Q13619;Q16531;Q86VZ2	8451;1642;54554	None	None	CUL4A;DDB1;WDR5B	None	None	None
CUL4A-DDB1-WDR57 complex	Q13619;Q16531;Q96DI7	8451;1642;9410	None	None	CUL4A;DDB1;SNRNP40	None	None	None
CUL4A-DDB1-WDR61 complex	Q13619;Q16531;Q9GZS3	8451;1642;80349	None	None	CUL4A;DDB1;WDR61	None	None	None
CUL4B-DDB1-GRWD1 complex	Q13620;Q16531;Q9BQ67	8450;1642;83743	None	None	CUL4B;DDB1;GRWD1	None	None	None
TOM20-TOM22-pOTC complex	P00480;Q15388;Q9NS69	5009;9804;56993	mitochondrial outer membrane translocase complex;mitochondrion;mitochondrial transport	mitochondrion;mitochondrial transport	OTC;TOMM20;TOMM22	None	Tom22 functions as an import receptor for preproteins. It forms a receptor complex with human Tom20. The internal segment of the human Tom22 cytosolic domain is important for the complex formation. The N-terminal domain of Tom22 is important for binding to the mature portion of pre-ornithine transcarbamylase (pOTC).	None
"TOM complex (TOM5, TOM6, TOM7, TOM20, TOM22, TOM40, TOM70), mitochondrial"	O94826;O96008;Q15388;Q8N4H5;Q96B49;Q9NS69;Q9P0U1	9868;10452;9804;401505;100188893;56993;54543	protein import into mitochondrial outer membrane;mitochondrion;mitochondrial outer membrane;mitochondrial outer membrane translocase complex;mitochondrial outer membrane translocase complex assembly	mitochondrion;mitochondrial outer membrane	TOMM70;TOMM40;TOMM20;TOMM5;TOMM6;TOMM22;TOMM7	None	"In the present study, the TOM complex was immuno-isolated from HeLa cells and hTom5 and hTom6 were newly identified as components of the complex together with hTom70, hTom20, hTom22, hTom40, and hTom7. Knockdown of Tom7, but not Tom5 and Tom6, strongly compromised stability of the TOM complex. Conversely, knockdown of hTom40 decreased the level of all small Tom proteins. Matrix import of preprotein was affected by double knockdown of any combinationof small Tom proteins. These results indicate that human small Tom proteins maintain the structural integrity of the TOM complex."	None
"TOM7 120K intermediate assembly complex (TOM7, TOM22, TOM40), mitochondrial"	O96008;Q9NS69;Q9P0U1	10452;56993;54543	mitochondrial outer membrane;outer mitochondrial membrane protein complex;mitochondrion;protein import into mitochondrial outer membrane	mitochondrial outer membrane;mitochondrion	TOMM40;TOMM22;TOMM7	None	Tom7 is a component of the translocase of the outermitochondrial membrane (TOM) and assembles into ageneral import pore complex that translocates preproteinsinto mitochondria. Tom7 does not require ATP for its import and assembly.	None
SOS1-ABI1-EPS8 complex	Q07889;Q12929;Q8IZP0	6654;2059;10006	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;actin cytoskeleton reorganization	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways	SOS1;EPS8;ABI1	None	"Similarly to eps8, eps8Ls interact with Abi1 and Sos-1; however, only eps8L1 and eps8L2 activate the Rac-GEF activity of Sos-1, and bind to actin in vivo."	None
SOS1-ABI1-EPS8L1 complex	Q07889;Q8IZP0;Q8TE68	6654;10006;54869	actin cytoskeleton reorganization;small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways	SOS1;ABI1;EPS8L1	None	"Similarly to eps8, eps8Ls interact with Abi1 and Sos-1; however, only eps8L1 and eps8L2 activate the Rac-GEF activity of Sos-1, and bind to actin in vivo."	None
"Estrogen receptor complex (ESR1, EP300, NCOA1)"	P03372;Q09472;Q15788	2099;2033;8648	regulation of estrogen receptor binding	None	ESR1;EP300;NCOA1	None	ERAP160 directly interacts with ER and associates with p300 in vivo in rabbit reticulocyte lysates.	None
SOS1-ABI1-EPS8L2 complex	Q07889;Q8IZP0;Q9H6S3	6654;10006;64787	actin cytoskeleton reorganization;small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway	small GTPase mediated signal transduction;transmembrane receptor protein tyrosine kinase signalling pathways	SOS1;ABI1;EPS8L2	None	"Similarly to eps8, eps8Ls interact with Abi1 and Sos-1; however, only eps8L1 and eps8L2 activate the Rac-GEF activity of Sos-1, and bind to actin in vivo."	None
SOS1-ABI1-EPS8L3 complex	Q07889;Q8IZP0;Q8TE67	6654;10006;79574	None	None	SOS1;ABI1;EPS8L3	None	"The lack of Rac-GEF activity in eps8L3-containing complexes indicated that some additional molecular characteristics, shared by eps8, eps8L1, and eps8L2, are not present in eps8L3. Eps8, eps8L1, and L2, but not eps8L3 could directly associate to F-actin."	None
ERBB3-SPG1 complex	P21860;P32004	2065;3897	ErbB-3 class receptor binding;ERBB3 signaling pathway;regulation of ERBB signaling pathway;neuregulin receptor activity	None	ERBB3;L1CAM	None	During nervous system development different cell-to-cell communication mechanisms operate in parallel guiding migrating neurons and growing axons to generate complex arrays of neural circuits. Cross-regulatory interactions between different signalling pathways and redundancy between them can increase precision and fidelity of guidance systems. Immunoglobulin superfamily proteins of the NCAM and L1 families couple specific substrate recognition and cell adhesion with the activation of receptor tyrosine kinases. It has been shown that L1CAM binds physically erbB receptors. Different Ig-like domains located in the extracellular part of L1CAM can support this interaction. Binding of L1CAM to erbB enhances its response to neuregulins. L1CAM was able to physically interact with erbB3 in HEK293 cells.	"Mutations in the human L1-CAM gene are responsible for a complex neurodevelopmental condition, generally referred to as L1 syndrome. Several pathogenic L1-CAM mutations have been identified in humans that cause L1 syndrome in affected individuals without affecting the level of L1-CAM-mediated homophilic cell adhesion when tested in vitro (PMID:19617634)."
ERBB2-SPG1 complex	P04626;P32004	2064;3897	neuregulin receptor activity;regulation of ERBB signaling pathway;ERBB2 signaling pathway;ErbB-2 class receptor binding	None	ERBB2;L1CAM	None	"During nervous system development different cell-to-cell communication mechanisms operate in parallel guiding migrating neurons and growing axons to generate complex arrays of neural circuits. Cross-regulatory interactions between different signalling pathways and redundancy between them can increase precision and fidelity of guidance systems. Immunoglobulin superfamily proteins of the NCAM and L1 families couple specific substrate recognition and cell adhesion with the activation of receptor tyrosine kinases. It has been shown that L1CAM binds physically erbB receptors. Different Ig-like domains located in the extracellular part of L1CAM can support this interaction. Binding of L1CAM to erbB enhances its response to neuregulins. Immunoprecipitation oferbB2 pulled down L1CAM, showing that L1CAM and erbB2receptor are physically bound when expressed in HEK293 cells."	"Mutations in the human L1-CAM gene are responsible for a complex neurodevelopmental condition, generally referred to as L1 syndrome. Several pathogenic L1-CAM mutations have been identified in humans that cause L1 syndrome in affected individuals without affecting the level of L1-CAM-mediated homophilic cell adhesion when tested in vitro (PMID:19617634)."
SERCA-PLN complex	P16615;P26678	488;5350	calcium ion transport;regulation of relaxation of cardiac muscle;single-stranded DNA binding;miRNA binding	None	ATP2A2;PLN	None	None	"OMIM:609909 Cardiomyopathy, dilated, 1P (PMID:25563649)."
pERK-vimentin-KPNA2 complex	P08670;P27361;P52292	7431;5595;3838	cytoplasm;response to tumor cell;cell migration	cytoplasm;cell migration	VIM;MAPK3;KPNA2	None	Vimentin binds to phosphorylated ERK1 or ERK2 (PMID:15748847).	pERK-vimentin-KPNA2 complex levels are positively associated with cancer invasiveness. The complex level is higher in advanced stage lung adenocarcinoma compared with that in early-stage cancer tissues.
ILK-SERCA2A-PLN complex	P16615;P26678;Q13418	488;5350;3611	regulation of relaxation of cardiac muscle;Z disc	None	ATP2A2;PLN;ILK	None	None	"OMIM:609909 Cardiomyopathy, dilated, 1P."
ILK-HSP90-CDC37 complex	P07900;Q13418;Q16543	3320;3611;11140	None	None	HSP90AA1;ILK;CDC37	None	None	None
MAN1-SMAD2 complex	Q15796;Q9Y2U8	4087;23592	transforming growth factor beta receptor signaling pathway	TGF-beta-receptor signalling pathway	SMAD2;LEMD3	None	MAN1 competes with transcription factors for binding to Smad2.	None
SLN-ATP2A1 complex	O00631;O14983	6588;487	regulation of calcium ion transport	None	SLN;ATP2A1	None	None	None
SLN-PLN-SERCA1A complex	O00631;O14983;P26678	6588;487;5350	regulation of calcium-transporting ATPase activity	None	SLN;ATP2A1;PLN	None	None	None
SLN-PLN-SERCA2A complex	O00631;P16615;P26678	6588;488;5350	regulation of calcium-transporting ATPase activity	None	SLN;ATP2A2;PLN	None	None	None
SERCA2a-alphaKAP-CaM-CaMKII complex	P16615;P52294;P62158;Q9UQM7	488;3836;801;815	None	None	ATP2A2;KPNA1;CALM1; CAL;CAMK2A	None	None	None
CEP164-TTBK2 complex	Q6IQ55;Q9UPV0	146057;22897	cellular response to DNA damage stimulus;cilium assembly;centriole	DNA damage response	TTBK2;CEP164	None	None	CEP164 is involved in Nephronophthisis 15 (PMID:22863007).
CCDC92-CEP164 complex	Q53HC0;Q9UPV0	80212;22897	cellular response to DNA damage stimulus	DNA damage response	CCDC92;CEP164	None	None	CEP164 is involved in Nephronophthisis 15 (PMID:22863007).
Harmonin-SANS complex	Q495M9;Q9Y6N9	124590;10083	ear development;sensory perception of sound	ear;hearing	USH1G;USH1C	None	None	Hearing impairment mutations of harmonin and Sans in Usher syndrome (OMIM:276904) patients are found to disrupt the formation of the harmonin/Sans complex.
Akt-PHLPP1-PHLPP2-FANCI-FANCD2-USP1-UAF1 complex	O60346;O94782;P31749;Q6ZVD8;Q8TAF3;Q9BXW9;Q9NVI1	23239;7398;207;23035;57599;2177;55215	None	None	PHLPP1;USP1;AKT1;PHLPP2;WDR48;FANCD2;FANCI	None	None	"FANCI and FANCD2 are involved in Fanconi anemia, complementation group I."
Harmonin-CAD23 complex	Q9H251;Q9Y6N9	64072;10083	ear development;sensory perception of sound	ear;hearing	CDH23;USH1C	None	None	Hereditary hearing-vision loss disease Usher syndrome (USH) (OMIM:276904) is caused by defects in USH1C gene.
Ubiquilin-VCP-erasin complex	P55072;Q92575;Q9UMX0	7415;23190;29979	ERAD pathway;response to endoplasmic reticulum stress	None	VCP;UBXN4;UBQLN1	"For GST-pull down assays recombinant full-length mouse VCP(p97), human erasin and  human hHR23A was used."	None	Disturbances in the ER-associated protein degradation (ERAD) pathway are involved in human diseases.
DZIP1-GLI3 complex	P10071;Q86YF9	2737;22873	cilium assembly;smoothened signaling pathway	hedgehog-dependent signalling pathway	GLI3;DZIP1	None	None	None
SPG3A-SPG33 complex	Q5T4F4;Q8WXF7	118813;51062	endoplasmic reticulum;vesicle-mediated transport;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	ZFYVE27;ATL1	None	"Protrudin is an integral membrane protein that regulates polarized vesicular trafficking in neurons. It possesses a hairpin domain and interacts with HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, andreticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. Protrudin facilitates the interaction of Kif5 with Rab11, VAP family proteins, Surf4, and reticulon proteins, suggesting that it serves as an adaptor protein and that the protrudin-Kif5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP."
SPG10-SPG33 complex	Q12840;Q5T4F4	3798;118813	vesicle-mediated transport;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;endoplasmic reticulum	"vesicular transport (Golgi network, etc.);endoplasmic reticulum"	KIF5A;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
FLRT3-LPHN3-UNC5B complex	Q8IZJ1;Q9HAR2;Q9NZU0	219699;23284;23767	cell-cell adhesion;synapse assembly;neuron migration	synaptogenesis	UNC5B;ADGRL3;FLRT3	None	"FLRT3 binds the other two proteins simultaneously and bridges them, although LPHN3 and UNC5 do not directly interact with each other."	None
FLRT3-LPHN3-UNC5D complex	Q6UXZ4;Q9HAR2;Q9NZU0	137970;23284;23767	cell-cell adhesion;neuron migration;synapse assembly	synaptogenesis	UNC5D;ADGRL3;FLRT3	"The authors mention mouse Unc5D, but describe the Uniprot entry: Q6UXZ4 (human). So the human protein was used."	"FLRT3 binds the other two proteins simultaneously and bridges them, although LPHN3 and UNC5 do not directly interact with each other."	None
FLRT3-LPHN3 complex	Q9HAR2;Q9NZU0	23284;23767	synapse assembly;cell-cell adhesion	synaptogenesis	ADGRL3;FLRT3	None	None	None
MYO7A-PDZD7 complex	Q13402;Q9H5P4	4647;79955	sensory perception of sound;stereocilium membrane	hearing	MYO7A;PDZD7	None	None	Mutations in MYO7A affect the development and function of the mechanically sensitive stereocilia of hair cells and are therefore associated with deafness.
CEP164-DZIP1 complex	Q86YF9;Q9UPV0	22873;22897	intraciliary transport;smoothened signaling pathway	hedgehog-dependent signalling pathway	DZIP1;CEP164	None	None	CEP164 is involved in Nephronophthisis 15 (PMID:22863007).
TSC2-HERC1 complex	P49815;Q15751	7249;8925	TOR signaling	None	TSC2;HERC1	TSC2 pull-down experiments were performed in mouse brain tissue.	TSC1 inhibits the interaction of TSC2 and HERC1 ubiquitin ligase by binding to TSC2.	"Mutations in TSC2 are associated with tuberous sclerosis (OMIM:613254).In healthy subjects, interaction of TSC1 with TSC2 excludes TSC2 from interacting with HERC1. Disease mutations in TSC2 allow binding to HERC1 also in the presence of TSC1."
DZIP1-IFT88 complex	Q13099;Q86YF9	8100;22873	intraciliary anterograde transport;cilium assembly;centriole	None	IFT88;DZIP1	None	None	None
SPG31-SPG33 omplex	Q5T4F4;Q9H902	118813;65055	endoplasmic reticulum;vesicle-mediated transport;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	ZFYVE27;REEP1	None	"Protrudin is an integral membrane protein that regulates polarized vesicular trafficking in neurons. It possesses a hairpin domain and interacts with HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, andreticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. Protrudin facilitates the interaction of Kif5 with Rab11, VAP family proteins, Surf4, and reticulon proteins, suggesting that it serves as an adaptor protein and that the protrudin-Kif5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP."
REEP5-SPG33 complex	Q00765;Q5T4F4	7905;118813	endoplasmic reticulum;vesicle-mediated transport;endoplasmic reticulum tubular network maintenance;endoplasmic reticulum tubular network assembly	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	REEP5;ZFYVE27	None	"Protrudin is an integral membrane protein that regulates polarized vesicular trafficking in neurons. It possesses a hairpin domain and interacts with HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, andreticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. Protrudin facilitates the interaction of Kif5 with Rab11, VAP family proteins, Surf4, and reticulon proteins, suggesting that it serves as an adaptor protein and that the protrudin-Kif5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP."
SPG33-VAPA complex	Q5T4F4;Q9P0L0	118813;9218	endoplasmic reticulum;vesicle-mediated transport;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	ZFYVE27;VAPA	None	"Protrudin is an integral membrane protein that regulates polarized vesicular trafficking in neurons. It possesses a hairpin domain and interacts with HSP-related proteins including myelin proteolipid protein 1 (SPG2), atlastin-1 (SPG3A), REEP1 (SPG31), REEP5 (similar to REEP1), Kif5A (SPG10), Kif5B, Kif5C, andreticulon 1, 3, and 4 (similar to reticulon 2, SPG12). Membrane topology analysis indicated that one of three hydrophobic segments of protrudin forms a hydrophobic hairpin domain similar to those of other SPG proteins. Protrudin was found to localize predominantly to the tubular endoplasmic reticulum (ER), and forced expression of protrudin promoted the formation and stabilization of the tubular ER network. Protrudin facilitates the interaction of Kif5 with Rab11, VAP family proteins, Surf4, and reticulon proteins, suggesting that it serves as an adaptor protein and that the protrudin-Kif5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP."
GPX1-SBP1 complex	P07203;Q13228	2876;8991	cell redox homeostasis	None	GPX1;SELENBP1	None	None	The level of SBP1 is reduced in several cancer types. GPX1 is associated with cancer risk and development.
DCDC2-MAPK8IP1 complex	Q9UHG0;Q9UQF2	51473;9479	JNK cascade	JNK cascade	DCDC2;MAPK8IP1	None	None	DCDC2 is involved in Nephronophthisis 19.
CUL4B-DDB1-TLE1 complex	Q04724;Q13619;Q16531	7088;8451;1642	proteasomal protein catabolic process	None	TLE1;CUL4A;DDB1	None	None	None
KIF5B-SPG33 complex	P33176;Q5T4F4	3799;118813	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	KIF5B;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
CUL4B-DDB1-TLE3 complex	Q04726;Q13620;Q16531	7090;8450;1642	proteasomal protein catabolic process	None	TLE3;CUL4B;DDB1	None	None	None
KIF5C-SPG33 complex	O60282;Q5T4F4	3800;118813	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	KIF5C;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
RAB11B-SPG10-SPG33 complex	Q12840;Q15907;Q5T4F4	3798;9230;118813	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	KIF5A;RAB11B;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons.Protrudin, KIF5, and Rab11b form a membrane-associated complex, consistent with the fact that protrudin has two putative transmembrane domains."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814).Mutations of protrudin or KIF5 are a cause of human hereditary spastic paraplegia (HSP)."
RAB11A-SPG33 complex	P62491;Q5T4F4	8766;118813	endoplasmic reticulum;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	RAB11A;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons.  Coimmunoprecipitation experiments in HeLa revealed that protrudin also associated with GDP-Rab11a and GDP-Rab11b to similar extents."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
RAB11B-SPG33 complex	Q15907;Q5T4F4	9230;118813	endoplasmic reticulum;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	RAB11B;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons. Coimmunoprecipitation experiments in HeLa revealed that protrudin also associated with GDP-Rab11a and GDP-Rab11b to similar extents."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
SPG33-SURF4 complex	O15260;Q5T4F4	6836;118813	endoplasmic reticulum;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	SURF4;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons. The binding of Surf4 and protrudin was also confirmed in a coimmunoprecipitation assay."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
RTN3-SPG33 complex	O95197;Q5T4F4	10313;118813	endoplasmic reticulum;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	RTN3;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons.Coimmunoprecipitation experiments also revealed that protrudin interacted directly with RTN3 and promoted the binding of the latter to KIF5A."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
SPG33-VAPB complex	O95292;Q5T4F4	9217;118813	endoplasmic reticulum;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	VAPB;ZFYVE27	None	"Protrudin is a membrane protein that regulates polarized vesicular trafficking in neurons (PMID:24668814). It serves as an adaptor molecule that connects KIF5 and its cargoes in vesicular transport during process formation. Protrudin facilitated the interaction of KIF5 with Rab11, VAP-A and -B, Surf4, and RTN3, suggesting that protrudin serves as an adaptor protein and that the protrudin-KIF5 complex contributes to the transport of these proteins in neurons. A pulldown assay revealed also the direct interaction of protrudin with VAP-B."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
SWELL1-containing complex	Q6NSJ5;Q6P9F7;Q7L1W4;Q8IWT6;Q8TDW0	80131;23507;55144;56262;84230	volume-sensitive anion channel activity;cell volume homeostasis	None	LRRC8E;LRRC8B;LRRC8D;LRRC8A;LRRC8C	None	"For full channel activity LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E) is necessary. LRRC8C-E subunits associated with SWELL1 (LRRC8A) contribute to ion selectivity."	None
3M core complex	O75147;Q14999;Q9H0W5	23363;9820;83987	microtubule cytoskeleton organization;centrosome;cytoplasm	microtubule cytoskeleton;centrosome;cytoplasm	OBSL1;CUL7;CCDC8	None	None	"Besides CUL7, two additional genes, OBSL1 and CCDC8, have been foundto be mutated in 3M syndrome. These three genes are mutated in a mutually exclusive manner, with CUL7 being the most frequently mutated (~65%), followed by OBSL1 (~30%) and CCDC8 (~5%)."
SPG4-SPG33 complex	Q5T4F4;Q9UBP0	118813;6683	None	None	ZFYVE27;SPAST	None	"ZFYVE27, a novel member of the FYVE-finger family of proteins, is a specific spastin-binding protein."	"Mutated protrudin (SPG33) shows an aberrant intracellular pattern in its tubular structure. Its interaction with spastin (SPG4) is severely affected. It is postulated that this specific mutation in protrudin affects neuronal intracellular trafficking in the corticospinal tract, which is consistent with the pathology of Hereditary Spastic Paraplegia (HSP (PMID:16826525)."
KCNE1-KCNH2 complex	P15382;Q12809	3753;3757	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	None	KCNE1;KCNH2	None	None	None
3M complex	O75147;P04637;P62877;Q14999;Q8IWT3;Q8N3Y1;Q9H0W5	23363;7157;9978;9820;23113;26259;83987	microtubule cytoskeleton organization	microtubule cytoskeleton	OBSL1;TP53;RBX1;CUL7;CUL9;FBXW8;CCDC8	None	None	"Besides CUL7, two additional genes, OBSL1 and CCDC8, have been foundto be mutated in 3M syndrome. These three genes are mutated in a mutually exclusive manner, with CUL7 being the most frequently mutated (~65%), followed by OBSL1 (~30%) and CCDC8 (~5%)."
KCNE2-KCNH2 complex	Q12809;Q9Y6J6	3757;9992	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	None	KCNH2;KCNE2	None	None	None
USF1-USF2 complex	P22415;Q15853	7391;7392	"regulation of transcription from RNA polymerase II promoter;RNA polymerase II transcription factor activity, sequence-specific DNA binding"	None	USF1;USF2	None	None	Varicella-zoster virus infection.
LRRC8A-LRRC8C complex	Q8IWT6;Q8TDW0	56262;84230	cell volume homeostasis;volume-sensitive anion channel activity	None	LRRC8A;LRRC8C	None	"For full channel activity LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E) is necessary. LRRC8C-E subunits associated with SWELL1 (LRRC8A) contribute to ion selectivity."	None
LRRC8A-LRRC8D complex	Q7L1W4;Q8IWT6	55144;56262	cell volume homeostasis;volume-sensitive anion channel activity	None	LRRC8D;LRRC8A	None	"For full channel activity LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E) is necessary. LRRC8C-E subunits associated with SWELL1 (LRRC8A) contribute to ion selectivity."	None
LRRC8A-LRRC8E complex	Q6NSJ5;Q8IWT6	80131;56262	cell volume homeostasis;volume-sensitive anion channel activity	None	LRRC8E;LRRC8A	None	"For full channel activity LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E) is necessary. LRRC8C-E subunits associated with SWELL1 (LRRC8A) contribute to ion selectivity."	None
CHRNA9-CHRNA10 complex	Q9GZZ6;Q9UGM1	57053;55584	acetylcholine-gated cation channel activity;response to auditory stimulus	None	CHRNA10;CHRNA9	None	None	None
Intraflagellar transport complex A	Q7Z4L5;Q8NEZ3;Q96RY7;Q9HBG6;Q9P2L0	79809;57728;9742;55764;57539	cilium;intraciliary retrograde transport;smoothened signaling pathway	hedgehog-dependent signalling pathway	TTC21B;WDR19;IFT140;IFT122;WDR35	None	None	WDR19 is involved in Nephronophthisis 13 (PMID:22819833). WDR19 is involved in Senior-Loken syndrome 8 (PMID:23683095). IFT140 is involved in Short-rib thoracic dysplasia 9 with or without polydactyly (PMID:23418020). IFT122 is involved in Cranioectodermal dysplasia 1 (PMID:20493458). TTC21B is involved in Nephronophthisis 12 (PMID:25635582). WDR35 is involved in Cranioectodermal dysplasia 2 (PMID:20817137). WDR35 is involved in Short-rib thoracic dysplasia 7 with or without polydactyly (PMID:21473986).
VEcad-VEGFR complex	P33151;P35916;P35968	1003;2324;3791	regulation of vascular endothelial growth factor signaling pathway;cellular response to oscillatory fluid shear stress	None	CDH5;FLT4;KDR	None	None	None
CAP-cbl-flotilin complex	O75955;P22681;Q9BX66	10211;867;10580	regulation of glucose import	None	FLOT1;CBL;SORBS1	None	None	None
E2F-1-DP-1 complex	Q01094;Q14186	1869;7027	None	None	E2F1;TFDP1	None	None	None
E2F-1-DP-1-cyclinA-CDK2 complex	P24941;P78396;Q01094;Q14186	1017;8900;1869;7027	"DNA binding;regulation of transcription, DNA-templated"	DNA binding;transcriptional control	CDK2;CCNA1;E2F1;TFDP1	None	None	None
FOXO3-CBP complex	O43524;Q92793	2309;1387	transcription coactivator activity	None	FOXO3;CREBBP	None	None	None
Hsp90-p23 complex	P07900;Q15185	3320;10728	None	None	HSP90AA1;PTGES3	None	None	None
c-Abl-CAS-Abi1 complex	P00519;P56945;Q8IZP0	25;9564;10006	regulation of smooth muscle contraction	None	ABL1;BCAR1;ABI1	None	None	None
CCP110-CEP290 complex	O15078;O43303	80184;9738	cilium assembly	None	CEP290;CCP110	None	None	None
CEP290-IQCB1 complex	O15078;Q15051	80184;9657	cilium assembly;centrosome	centrosome	CEP290;IQCB1	None	None	None
CC2D2A-CEP290 complex	O15078;Q9P2K1	80184;57545	ciliary basal body	None	CEP290;CC2D2A	None	None	None
CTNND1-GLIS2 complex	O60716;Q9BZE0	1500;84662	nucleus	nucleus	CTNND1;GLIS2	None	None	None
NPHP1-PKD1 complex	O15259;P98161	4867;5310	apoptotic process	apoptosis (type I programmed cell death)	NPHP1;PKD1	None	None	None
BBS1-BBS4-BBS5-PKD1-TTC8 complex	P98161;Q8N3I7;Q8NFJ9;Q8TAM2;Q96RK4	5310;129880;582;123016;585	cilium;intraciliary transport	None	PKD1;BBS5;BBS1;TTC8;BBS4	None	None	None
AP5-SPG11-SPG15 complex	O43299;Q2VPB7;Q68DK2;Q96JI7;Q9H0R1;Q9NUS5	9907;91056;23503;80208;55745;55317	endosome;lysosome;AP-5 adaptor complex;Golgi apparatus;intracellular protein transport;protein targeting;transport vesicle	"endosome;vacuole or lysosome;Golgi;protein targeting, sorting and translocation;intracellular transport vesicles"	AP5Z1;AP5B1;ZFYVE26;SPG11;AP5M1;AP5S1	"The four AP-5 subunits can be coimmunoprecipitated with SPG11 andSPG15, both from cytosol and from detergent-extracted membranes, with a stoichiometry of 1:1:1:1:1:1."	"AP-5 complex (constisting of  AP5Z1, AP5B1, AP5M1, and AP5S1) is a recently identified but evolutionarily ancient member oft he family of heterotetrameric adaptor proteins (AP complexes). It is associated with the two proteins SPG11 and SPG15. AP-5, SPG11, and SPG15 colocalize on a late endosomal/lysosomal compartment. Both SPG11 and SPG15 have predicted secondary structures containing alpha-solenoids related to those of clathrin heavy chain and COPI subunits. SPG11 also has an N-terminal, beta-propeller\u2013like domain, which interacts in vitro with AP-5. It is proposed that AP-5, SPG15, and SPG11 form a coat-like complex, with AP-5 involved in protein sorting, SPG15 facilitating the docking of the coat onto membranes by interacting with PI3P via its FYVE domain, and SPG11 (possibly together with SPG15) forming a scaffold."	SPG11 (ALS5) and SPG15 (ZFYVE26) are mutated in patients with hereditary spastic paraplegia (HSP).
ANKRA2-CCDC8-OBSL1-CUL7 complex	O75147;Q14999;Q9H0W5;Q9H9E1	23363;9820;83987;57763	None	None	OBSL1;CUL7;CCDC8;ANKRA2	ANKRA2 inhibits CUL7 interaction with HDAC4/5.	"These results indicate that OBSL1 serves as a scaffold to bridge interaction ofCUL7 with CCDC8, which in turn associates with ANKRA2."	"The CCDC8, CUL7, and OBSL1 genes are mutated in patients with 3M syndrome. The unexpected identification of CCDC8 as a major partner of ANKRA2 suggests an important role of ANKRA2 in 3M syndrome."
ATL2-SPG33 complex	Q5T4F4;Q8NHH9	118813;64225	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	ZFYVE27;ATL2	None	"Protrudin binds all three human atlastins (atlastin-1, atlastin-2, and atlastin-3) and endoplasmic reticulum-shaping proteins and regulates network formation. The interaction with atlastins required protrudin residues 1-205."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
PDZD11-nectin1 complex	Q15223;Q5EBL8	5818;51248	calcium ion homeostasis	None	NECTIN1;PDZD11	None	None	None
PDZD11-nectin3 complex	Q5EBL8;Q9NQS3	51248;25945	calcium ion homeostasis	None	PDZD11;NECTIN3	None	None	None
ATL3-SPG33 complex	Q5T4F4;Q6DD88	118813;25923	endoplasmic reticulum;endoplasmic reticulum tubular network assembly;endoplasmic reticulum tubular network maintenance;vesicle-mediated transport	"endoplasmic reticulum;vesicular transport (Golgi network, etc.)"	ZFYVE27;ATL3	None	"Protrudin binds all three human atlastins (atlastin-1, atlastin-2, and atlastin-3) and endoplasmic reticulum-shaping proteins and regulates network formation. The interaction with atlastins required protrudin residues 1-205."	"The protrudin gene (ZFYVE27) is mutated in a subset of individuals with hereditary spastic paraplegia (HSP), and protrudin is therefore also referred to as spastic paraplegia 33 (SPG33). It is suggested that protrudin contributes to the regulation of ER morphology and function, and that its deregulation by mutation is a causative defect in HSP (PMID:24668814)."
SPG4-SPG12 complex	O75298;Q9UBP0	6253;6683	None	None	RTN2;SPAST	None	It is shown that the RTN2 protein interacts with spastin and that this interaction requires sequences of the spastin protein that contain the predicted hairpin membrane domain.	Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12 (SPG12).
CADM1-4.1B-MPP3 complex	Q13368;Q9BY67;Q9Y2J2	4356;23705;23136	None	None	MPP3;CADM1;EPB41L3	None	None	None
NF2-WWC1 complex	P35240;Q8IX03	4771;23286	hippo signaling	None	NF2;WWC1	None	None	None
RhBG-kAE1-ankyrin-G complex	P02730;Q12955;Q9H310	6521;288;57127	None	None	SLC4A1;ANK3;RHBG	None	None	None
MGAT1-NGT complex	P26572;Q9Y2D2	4245;23443	UDP-N-acetylglucosamine transport;Golgi membrane	None	MGAT1;SLC35A3	None	None	None
NEK2A-SAV1-STK3 complex	P51955;Q13188;Q9H4B6	4751;6788;60485	centrosome organization;spindle assembly	centrosome;spindle pole body/centrosome and microtubule cycle	NEK2;STK3;SAV1	None	None	None
MGAT2-SLC35A3 complex	Q10469;Q9Y2D2	4247;23443	UDP-N-acetylglucosamine transport;Golgi membrane	None	MGAT2;SLC35A3	None	None	None
MGAT4B-SLC35A3 complex	Q9UQ53;Q9Y2D2	11282;23443	UDP-N-acetylglucosamine transport;Golgi membrane	None	MGAT4B;SLC35A3	None	None	None
MGAT4B-SLC35A2(splice variant 1) complex	P78381;Q9UQ53	7355;11282	UDP-galactose transport;Golgi membrane	None	SLC35A2;MGAT4B	One of the subunits in this complex is a splice varient 1 of SLC35A2 protein.	None	None
AP5 adaptor complex	O43299;Q2VPB7;Q9H0R1;Q9NUS5	9907;91056;55745;55317	AP-5 adaptor complex;endosome;lysosome;Golgi apparatus;intracellular protein transport;transport vesicle;protein targeting;protein transport	"endosome;vacuole or lysosome;Golgi;protein targeting, sorting and translocation;intracellular transport vesicles;protein transport"	AP5Z1;AP5B1;AP5M1;AP5S1	None	"Adaptor protein (AP) complexes (AP1-5) facilitate the trafficking of cargo from one membrane compartment of the cell to another by recruiting other proteins to particular types of vesicles. All of the AP complexes are involved in post-Golgi trafficking pathways. AP-5 is an evolutionarily ancient complex, which is involved in endosomal sorting."	"Mutations in AP5Z1,a gene playing a role in intracellular membrane trafficking, have been reported to be associated with spastic paraplegia type 48 (SPG48) (PMID:25333062)."
MAGT5-SLC35A3 complex	Q09328;Q9Y2D2	4249;23443	UDP-N-acetylglucosamine transport;Golgi membrane	None	MGAT5;SLC35A3	None	None	None
WDR20-USP12-UAF1 complex	O75317;Q8TAF3;Q8TBZ3	219333;57599;91833	protein deubiquitination	"modification by ubiquitination, deubiquitination"	USP12;WDR48;WDR20	None	WDR20 has a stimulatory activity to the USP12\u00b7UAF1 complex. It is speculated that WDR20 serves as a specific adaptor subunit for recruiting specific substrates. This complex is not involved in the Fanconi anemia  DNA repair pathway.	None
WDR20-USP46-UAF1 complex	P62068;Q8TAF3;Q8TBZ3	64854;57599;91833	protein deubiquitination	"modification by ubiquitination, deubiquitination"	USP46;WDR48;WDR20	None	This complex is not involved in the Fanconi anemia DNA repair pathway.	None
USP12-UAF1 complex	O75317;Q8TAF3	219333;57599	nucleus;protein deubiquitination	"nucleus;modification by ubiquitination, deubiquitination"	USP12;WDR48	None	The complex is not involved in the regulation of the Fanconi anemia pathway.	None
USP46-UAF1 complex	P62068;Q8TAF3	64854;57599	protein deubiquitination;nucleus	"modification by ubiquitination, deubiquitination;nucleus"	USP46;WDR48	None	This complex is not involved in the regulation of the Fanconi anemia pathway.	None
USP1-UAF1 complex	O94782;Q8TAF3	7398;57599	nucleus;protein deubiquitination	"nucleus;modification by ubiquitination, deubiquitination"	USP1;WDR48	None	None	This complex regulates the Fanconi anemia (OMIM:227646) pathway by deubiquitinating FANCD2.
"CCC-Wash (WASH1, FAM21C) complex"	A8K0Z3;O60826;Q567U6;Q7Z3J2;Q7Z4G1;Q86VX2;Q86X83;Q8N668;Q9GZQ3;Q9H0A8;Q9NX08;Q9P000;Q9UBI1;Q9Y4E1;Q9Y6G5	100287171;28952;54520;57020;170622;149951;51122;150684;28991;54939;54951;29099;23412;253725;51397	filamentous actin;cargo loading into vesicle;WASH complex;copper ion homeostasis	None	WASH1;CCDC22;CCDC93;C16orf62;COMMD6;COMMD7;COMMD2;COMMD1;COMMD5;COMMD4;COMMD8;COMMD9;COMMD3;FAM21C;COMMD10	None	"All 10 human COMMD family members coprecipitated endogenous CCDC93. The interaction experiments validated the notion that these factors form a multiprotein complex. COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62. This COMMD/CCDC22/CCDC93 (CCC) complex interacts with the multisubunit WASH complex, an evolutionarily conserved system, which is required for endosomal deposition of F-actin and cargo trafficking in conjunction with the retromer. Interactions between the WASH complex subunit FAM21, and the carboxyl-terminal ends of CCDC22 and CCDC93 are responsible for CCC complex recruitment to endosomes. In the absence of the CCC complex or its recruitment to endosomes, ATP7A is mislocalized and does not traffic in response to copper availability, resulting in altered copper handling."	"Depletion of CCC complex components leads to lack of copper-dependent movement of the copper transporter ATP7A from endosomes, resulting in intracellular copper accumulation and modest alterations in copper homeostasis in humans with CCDC22 mutations."
Phosphorylase kinase complex	P46020;P62158;Q16816;Q93100	5255;801;5260;5257	glycogen metabolic process	glycogen metabolism	PHKA1;CALM1; CAL;PHKG1;PHKB	None	None	None
USP22-SAGA complex	O75528;Q12962;Q14CW9;Q86TJ2;Q92830;Q9HBM6;Q9UPT9;Q9Y4A5	10474;6881;56970;93624;2648;51616;23326;8295	nucleus;histone acetyltransferase activity;H4 histone acetyltransferase complex;histone deubiquitination;regulation of cell cycle process;mRNA transcription	nucleus;mRNA synthesis	TADA3;TAF10;ATXN7L3;TADA2B;KAT2A;TAF9B;USP22;TRRAP	"The authors did not specify ADA2, but according to PMID:26468280 the subunit of the SAGA complex is ADA2B."	None	USP22 is a cancer stem cell marker and is required for the biological activity of the MYC oncoprotein.
ODC-OAZ1-CCND1 complex	P11926;P24385;P54368	4953;595;4946	protein catabolic process	protein/peptide degradation	ODC1;CCND1;OAZ1	None	The authors found that the ODC-AZ-CCND1 ternary complex may exist in equilibrium and that the AZ-mediated degradation of ODC and CCND1 is inhibited by ternary complex formation.	None
"SAGA complex, GCN5-linked"	O75486;O75528;O75529;O94864;P00813;Q12962;Q14CW9;Q16514;Q16594;Q5T6C5;Q86TJ2;Q8NEM7;Q92830;Q96ES7;Q9HBM6;Q9ULK2;Q9UPT9;Q9Y4A5;Q9Y6J9	8464;10474;27097;9913;100;6881;56970;6883;6880;127002;93624;55578;2648;112869;51616;222255;23326;8295;10629	histone acetylation;nucleus;histone H3-K14 acetylation	nucleus	SUPT3H;TADA3;TAF5L;SUPT7L;ADA;TAF10;ATXN7L3;TAF12;TAF9;ATXN7L2;TADA2B;SUPT20H;KAT2A;SGF29;TAF9B;ATXN7L1;USP22;TRRAP;TAF6L	It is not clear whether ATXN7 (O15265) is also a subunit of the complex.	None	None
CCDC22-COMMD1-CUL2 complex	O60826;Q13617;Q8N668	28952;8453;150684	protein ubiquitination	"modification by ubiquitination, deubiquitination"	CCDC22;CUL2;COMMD1	None	"It is demonstrated that all COMMD proteins bind to CCDC22. COMMD1 binds preferentially to Cul2, whereas COMMD8 binds better to Cul1 and Cul3. These data suggested that despite the ability of COMMDs, CCDC22, and Cullin to form a triple complex, none of them seems to play a scaffold role. The high level of CCDC22 expression observed in the immune system, particularly in myeloid and T cells, suggests an important immunological role, in keeping with the NFkappaB regulatory function. The involvement of CCDC22 and COMMD8 in the ubiquitination of IkappaB represents a novel aspect in the regulation of this critical pathway that might be amenable to therapeutic manipulation."	CCDC22 is a factor recently implicated in X-linked intellectual disability (XLID). COMMD1 deficiency results in defective copper homeostasis (PMID:25355947).
CCC complex	O60826;Q567U6;Q7Z3J2;Q7Z4G1;Q86VX2;Q86X83;Q8N668;Q9GZQ3;Q9H0A8;Q9NX08;Q9P000;Q9UBI1;Q9Y6G5	28952;54520;57020;170622;149951;51122;150684;28991;54939;54951;29099;23412;51397	early endosome;copper ion homeostasis	None	CCDC22;CCDC93;C16orf62;COMMD6;COMMD7;COMMD2;COMMD1;COMMD5;COMMD4;COMMD8;COMMD9;COMMD3;COMMD10	None	"All 10 human COMMD family members coprecipitated endogenous CCDC93. The interaction experiments validated the notion that these factors form a multiprotein complex. COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62. In the absence of the CCC complex or its recruitment to endosomes, ATP7A is mislocalized and does not traffic in response to copper availability, resulting in altered copper handling."	"Depletion of CCC complex components leads to lack of copper-dependent movement of the copper transporter ATP7A from endosomes, resulting in intracellular copper accumulation and modest alterations in copper homeostasis in humans with CCDC22 mutations."
SMAD2-SMAD4-WWTR1 complex	Q13485;Q15796;Q9GZV5	4089;4087;25937	"transcription, DNA-templated"	TRANSCRIPTION	SMAD4;SMAD2;WWTR1	None	None	None
MED15-WWTR1 complex	Q96RN5;Q9GZV5	51586;25937	"transcription, DNA-templated"	TRANSCRIPTION	MED15;WWTR1	None	None	None
SMAD3-SMAD4-WWTR1 complex	P84022;Q13485;Q9GZV5	4088;4089;25937	"transcription, DNA-templated"	TRANSCRIPTION	SMAD3;SMAD4;WWTR1	None	None	None
KCND3-KCNIP4 complex	Q6PIL6;Q9UK17	80333;3752	regulation of potassium ion transmembrane transport	None	KCNIP4;KCND3	None	None	None
WWTR1-YAP1 complex	P46937;Q9GZV5	10413;25937	"transcription, DNA-templated"	TRANSCRIPTION	YAP1;WWTR1	None	None	None
WWTR1 homodimer	Q9GZV5	25937	"transcription, DNA-templated"	TRANSCRIPTION	WWTR1	None	None	None
EP300-KAT2B-TBX5-WWTR1 complex	Q09472;Q92831;Q99593;Q9GZV5	2033;8850;6910;25937	"transcription, DNA-templated"	TRANSCRIPTION	EP300;KAT2B;TBX5;WWTR1	None	None	None
KCNJ11-ABCC9 complex	O60706;Q14654	10060;3767	regulation of potassium ion transmembrane transport	None	ABCC9;KCNJ11	None	None	None
CTNNB1-TBX5-YAP1 complex	P35222;P46937;Q99593	1499;10413;6910	"transcription, DNA-templated"	TRANSCRIPTION	CTNNB1;YAP1;TBX5	None	None	None
"ATAC complex, GCN5-linked"	O75478;O75528;P61964;Q01658;Q8IYH5;Q92830;Q96ES7;Q9H8E8;Q9NS73;Q9ULM3	6871;10474;11091;1810;26009;2648;112869;57325;51562;55689	None	None	TADA2A;TADA3;WDR5;DR1;ZZZ3;KAT2A;SGF29;KAT14;MBIP;YEATS2	None	None	None
CCDC22-COMMD8-CUL1 complex	O60826;Q13616;Q9NX08	28952;8454;54951	IkappaB kinase activity;protein ubiquitination	"modification by ubiquitination, deubiquitination"	CCDC22;CUL1;COMMD8	None	"It is demonstrated that all COMMD proteins bind to CCDC22. COMMD1 binds preferentially to Cul2, whereas COMMD8 binds better to Cul1 and Cul3. These data suggested that despite the ability of COMMDs, CCDC22, and Cullin to form a triple complex, none of them seems to play a scaffold role. The high level of CCDC22 expression observed in the immune system, particularly in myeloid and T cells, suggests an important immunological role, in keeping with the NFkappaB regulatory function. The involvement of CCDC22 and COMMD8 in the ubiquitination of IkappaB represents a novel aspect in the regulation of this critical pathway that might be amenable to therapeutic manipulation."	CCDC22 is a factor recently implicated in X-linked intellectual disability (XLID).
"Ubiquitin E3 ligase (CCDC22, COMMD8, CUL3)"	O60826;Q13618;Q9NX08	28952;8452;54951	protein ubiquitination;cullin-RING ubiquitin ligase complex	"modification by ubiquitination, deubiquitination"	CCDC22;CUL3;COMMD8	None	"It is demonstrated that all COMMD proteins bind to CCDC22. COMMD1 binds preferentially to Cul2, whereas COMMD8 binds better to Cul1 and Cul3. These data suggested that despite the ability of COMMDs, CCDC22, and Cullin to form a triple complex, none of them seems to play a scaffold role. The high level of CCDC22 expression observed in the immune system, particularly in myeloid and T cells, suggests an important immunological role, in keeping with the NFkappaB regulatory function. The involvement of CCDC22 and COMMD8 in the ubiquitination of IkappaB represents a novel aspect in the regulation of this critical pathway that might be amenable to therapeutic manipulation."	CCDC22 is a factor recently implicated in X-linked intellectual disability (XLID).
LATS1-NPHP4 complex	O75161;O95835	261734;9113	hippo signaling	None	NPHP4;LATS1	None	None	None
NEK8-WWTR1 complex	Q86SG6;Q9GZV5	284086;25937	nucleus;hippo signaling	nucleus	NEK8;WWTR1	None	None	None
"STAGA complex, SPT3-linked"	O15265;O75486;O75528;O75529;O94864;Q12962;Q14CW9;Q16514;Q16594;Q86TJ2;Q8NEM7;Q92830;Q96BN2;Q96ES7;Q9H0E3;Q9NPA8;Q9UPT9;Q9Y4A5;Q9Y6J9	6314;8464;10474;27097;9913;6881;56970;6883;6880;93624;55578;2648;117143;112869;79595;56943;23326;8295;10629	histone acetylation;nucleus	nucleus	ATXN7;SUPT3H;TADA3;TAF5L;SUPT7L;TAF10;ATXN7L3;TAF12;TAF9;TADA2B;SUPT20H;KAT2A;TADA1;SGF29;SAP130;ENY2;USP22;TRRAP;TAF6L	"The authors indicate that the interaction of USP22 to ATAC complex is only weak, but is observed under physiological salt concentrations."	None	None
"ATAC complex, YEATS2-linked"	O43318;O75478;O75528;P61964;Q01658;Q14157;Q8IYH5;Q92830;Q96ES7;Q9H8E8;Q9NR33;Q9NRF9;Q9NS73;Q9ULM3	6885;6871;10474;11091;1810;9898;26009;2648;112869;57325;56655;54107;51562;55689	nucleus;histone acetylation	nucleus	MAP3K7;TADA2A;TADA3;WDR5;DR1;UBAP2L;ZZZ3;KAT2A;SGF29;KAT14;POLE4;POLE3;MBIP;YEATS2	"The authors indicate that the interaction of UBAP2L to ATAC complex is only weak, but is observed under physiological salt concentrations."	None	None
GLIS3-SUFU complex	Q8NEA6;Q9UMX1	169792;51684	"transcription, DNA-templated;nucleus"	TRANSCRIPTION;nucleus	GLIS3;SUFU	None	None	None
PI4K2A-WASH complex	O00203;P46934;P47756;P50570;P52907;Q00610;Q12768;Q2M389;Q5T1M5;Q641Q2;Q92888;Q92974;Q96N67;Q9BTU6	8546;4734;832;1785;829;1213;9897;23325;23307;387680;9138;9181;85440;55361	early endosome	None	AP3B1;NEDD4;CAPZB;DNM2;CAPZA1;CLTC;KIAA0196;KIAA1033;FKBP15;FAM21A;ARHGEF1;ARHGEF2;DOCK7;PI4K2A	None	"Two complexes, the WASH complex (an endosomal Arp2/3 activator) and the biogenesis of lysosome-related organelles complex-1 (BLOC-1), interact with and are regulated by the lipid kinase phosphatidylinositol-4-kinase type IIalpha (PI4K2A). (Novel) regulators of these complexes that copurify with PI4K2A are additionally displayed."	None
PI4K2A-PRDX1 complex	Q06830;Q9BTU6	5052;55361	None	None	PRDX1;PI4K2A	None	"Two complexes, the WASH complex (an endosomal Arp2/3 activator) and the biogenesis of lysosome-related organelles complex-1 (BLOC-1), interact with and are regulated by the lipid kinase phosphatidylinositol-4-kinase type IIalpha (PI4K2A). It was also found that PI4KIIA interacts with the antioxidant enzyme peroxiredoxin-1 (Prdx-1)."	None
WWTR1-YWHAQ complex	P27348;Q9GZV5	10971;25937	"hippo signaling;transcription, DNA-templated"	TRANSCRIPTION	YWHAQ;WWTR1	The authors did not mention which 14-3-3 protein was used.	None	None
CTNNB1-GLIS2 complex	P35222;Q9BZE0	1499;84662	canonical Wnt signaling pathway	None	CTNNB1;GLIS2	None	None	None
DVL2-INVS-NPHP4-RPGRIP1L complex	O14641;O75161;Q68CZ1;Q9Y283	1856;261734;23322;27130	None	None	DVL2;NPHP4;RPGRIP1L;INVS	None	None	None
MKS1-TMEM67 complex	Q5HYA8;Q9NXB0	91147;54903	cilium assembly	None	TMEM67;MKS1	None	None	None
SYNE2-TMEM67 complex	Q5HYA8;Q8WXH0	91147;23224	cilium assembly;actin cytoskeleton reorganization	None	TMEM67;SYNE2	None	None	None
TNFR2 signaling complex	P01375;P20333;Q9NQH7	7124;7133;63929	tumor necrosis factor receptor superfamily complex;tumor necrosis factor-mediated signaling pathway	None	TNF;TNFRSF1B;XPNPEP3	The mitochondrial 57 kDa isoform of XPNPEP3 (APP3m) was found in the complex.	None	None
IL13RA1-TRAF3IP1 complex	P78552;Q8TDR0	3597;26146	interleukin-13 binding;signal transduction	CELLULAR COMMUNICATION/SIGNAL TRANSDUCTION MECHANISM	IL13RA1;TRAF3IP1	None	None	None
GLIS2-TRIM32 complex	Q13049;Q9BZE0	22954;84662	"nucleus;transcription, DNA-templated"	nucleus;TRANSCRIPTION	TRIM32;GLIS2	None	None	None
DTNBP1-TRIM32 complex	Q13049;Q96EV8	22954;84062	protein ubiquitination	"modification by ubiquitination, deubiquitination"	TRIM32;DTNBP1	None	None	None
NEDD4-PI4K2A complex	P46934;Q9BTU6	4734;55361	None	None	NEDD4;PI4K2A	None	"Two complexes, the WASH complex (an endosomal Arp2/3 activator) and the biogenesis of lysosome-related organelles complex-1 (BLOC-1), interact with and are regulated by the lipid kinase phosphatidylinositol-4-kinase type IIalpha (PI4K2A). It was also found that PI4KIIA interacts with the ubiquitin ligase Nedd4-1."	None
CLTC-PI4K2A complex	Q00610;Q9BTU6	1213;55361	transport vesicle	intracellular transport vesicles	CLTC;PI4K2A	None	"Two complexes, the WASH complex (an endosomal Arp2/3 activator) and the biogenesis of lysosome-related organelles complex-1 (BLOC-1), interact with and are regulated by the lipid kinase phosphatidylinositol-4-kinase type IIalpha (PI4K2A). It was also found that PI4KIIA interacts with vesicle-mediated transport proteins such as clathrin heavy chain."	None
PI4K2A-PLDN complex	Q9BTU6;Q9UL45	55361;26258	None	None	PI4K2A;BLOC1S6	None	"Two complexes, the WASH complex (an endosomal Arp2/3 activator) and the biogenesis of lysosome-related organelles complex-1 (BLOC-1), interact with and are regulated by the lipid kinase phosphatidylinositol-4-kinase type IIalpha (PI4K2A). It was also found that PI4KIIA interacts with the pallidin subunit of BLOC-1."	None
DVL1-PI4K2A complex	O14640;Q9BTU6	1855;55361	None	None	DVL1;PI4K2A	None	Dvl directly interacts with and activates PI4KII alpha by increasing its V(max) for ATP and PtdIns.	None
MKKS-BBS12 complex	Q6ZW61;Q9NPJ1	166379;8195	cilium;cilium assembly	None	BBS12;MKKS	None	None	None
ARL2-TBCD complex	P36404;Q9BTW9	402;6904	microtubule cytoskeleton organization	microtubule cytoskeleton	ARL2;TBCD	None	None	None
KCNQ1 homotetramer	P51787	3784	potassium ion transmembrane transport;voltage-gated potassium channel activity	None	KCNQ1	None	None	None
DVL1-PIP5K1B-PI4K2A complex	O14640;O14986;Q9BTU6	1855;8395;55361	None	None	DVL1;PIP5K1B;PI4K2A	None	"In a coimmunoprecipitation experiment PI4K2A, PIP5K1B proteins were pulled down with Dvl in HEK293T cells. Wnt promotes the formation of this Dvl, PI4K2A, and PIP5K1B  \u0001complex as Wnt3a is able to induce the binding of Dvl to the PIP5K1B and PI4K2A complex, leading to a more stable interaction between PIP5K1B and PI4K2A."	None
CXCR2-NHERF1-PLC-beta-3 complex	O14745;P25025;Q01970	9368;3579;5331	cell proliferation;chemokine-mediated signaling pathway	None	SLC9A3R1;CXCR2;PLCB3	None	"The authors observed significantly reduced cell proliferation in Colo357 and HPAC cells, stimulated by CXCL5 and CXCL8."	"Disrupting the CXCR2 complex significantly inhibited the malignant cellular functions (i.e., proliferation and invasion) in vitro and pancreatic tumor growth in vivo."
TBCD-tubulin(alpha)-tubulin(beta) complex	P07437;Q71U36;Q9BTW9	203068;7846;6904	microtubule cytoskeleton organization	microtubule cytoskeleton	TUBB;TUBA1A;TBCD	"Since the authors did not specify tubulin-alpha and tubulin-beta, we used Tubulin alpha-1A chain (Q71U36) and Tubulin beta chain (P07437)."	None	None
KCNQ1-KCNE2 complex	P51787;Q9Y6J6	3784;9992	potassium ion transmembrane transport;voltage-gated potassium channel activity	None	KCNQ1;KCNE2	None	None	None
KCNQ1-KCNE3 complex	P51787;Q9Y6H6	3784;10008	regulation of ion transmembrane transport;voltage-gated potassium channel activity	None	KCNQ1;KCNE3	None	None	None
CAPN1-HSP90AB1 complex	P07384;P08238	823;3326	proteolysis	None	CAPN1;HSP90AB1	None	None	None
PIP5K1B-PI4K2A complex	O14986;Q9BTU6	8395;55361	None	None	PIP5K1B;PI4K2A	None	"Wnt3a is able to induce the binding of Dvl to the PIP5K1B and PI4K2A complex, leading to a more stable interaction between PIP5K1B and PI4K2A."	None
KCNQ1-KCNE4 complex	P51787;Q8WWG9	3784;23704	potassium ion transmembrane transport;voltage-gated potassium channel activity	None	KCNQ1;KCNE4	None	None	None
KCNQ1-KCNE5 complex	P51787;Q9UJ90	3784;23630	potassium ion transmembrane transport;voltage-gated potassium channel activity	None	KCNQ1;KCNE5	None	None	None
Calpain 1	P04632;P07384	826;823	proteolysis	None	CAPNS1;CAPN1	None	None	None
KCNQ2-KCNQ3 complex	O43525;O43526	3786;3785	None	None	KCNQ3;KCNQ2	None	None	None
TBCD-ARL2-tubulin(beta) complex	P07437;P36404;Q9BTW9	203068;402;6904	microtubule cytoskeleton organization;microtubule polymerization	microtubule cytoskeleton	TUBB;ARL2;TBCD	The authors state that it was impossible to specify the isoform of tubulin-beta. We used Tubulin beta chain (P07437).	None	None
TBCE-TBCB-tubulin(alpha) complex	Q15813;Q71U36;Q99426	6905;7846;1155	microtubule cytoskeleton organization	microtubule cytoskeleton	TBCE;TUBA1A;TBCB	"Since the authors did not specify tubulin-alpha, we used Tubulin alpha-1A chain (Q71U36)."	None	None
TBCD-ARL2-tubulin(beta)-TBCE complex	P07437;P36404;Q15813;Q9BTW9	203068;402;6905;6904	microtubule cytoskeleton organization	microtubule cytoskeleton	TUBB;ARL2;TBCE;TBCD	"Since the authors did not specify tubulin-beta, we used Tubulin beta chain (P07437)."	None	None
DLG5-MST1-MST2 complex	Q13043;Q13188;Q8TDM6	6789;6788;9231	establishment of cell polarity;regulation of hippo signaling	None	STK4;STK3;DLG5	None	None	None
KCNQ3-KCNQ5 complex	O43525;Q9NR82	3786;56479	potassium ion transmembrane transport;voltage-gated potassium channel activity;synaptic transmission	synaptic transmission	KCNQ3;KCNQ5	None	None	None
CALM1-KCNQ4(splice variant 1) complex	P56696;P62158	9132;801	regulation of potassium ion transport	None	KCNQ4;CALM1; CAL	None	None	None
FILIP1-FLNA complex	P21333;Q7Z7B0	2316;27145	None	None	FLNA;FILIP1	None	FILIP1 is a RhoD/Rif effector and an FLNa-binding protein.	None
FILIP1-RhoD complex	O00212;Q7Z7B0	29984;27145	filopodium assembly;actin filament bundle assembly	None	RHOD;FILIP1	None	RhoD induces the formation of filopodia and actin bundles and binds FILIP1 in a GTP-dependent manner.	None
WHAMM-RhoD complex	O00212;Q8TF30	29984;123720	actin cytoskeleton reorganization	None	RHOD;WHAMM	None	WHAMM is required for RhoD-dependent actin reorganization. RhoD binds WHAMM in a GTP-dependent manner.	None
ARP3-WHAMM complex	P61158;Q8TF30	10096;123720	actin cytoskeleton reorganization	None	ACTR3;WHAMM	None	WHAMM is required for RhoD-dependent actin reorganization and binds to the Arp2/3 complex. The presence of the Arp2/3 complex in the immunoprecipitates was revealed using antibodies against Arp3A.	None
GRASP1-GRIP1 complex	Q4V328;Q9Y3R0	56850;23426	Ras guanyl-nucleotide exchange factor activity	None	GRIPAP1;GRIP1	None	None	None
9-1-1-RHINO complex	O60671;O60921;Q99638;Q9BSD3	5810;3364;5883;83695	DNA damage checkpoint;DNA repair;chromatin;nucleus	DNA repair;nucleus	RAD1;HUS1;RAD9A;RHNO1	None	None	None
IQGAP1-CXCR2 complex	P25025;P46940	3579;8826	chemokine-mediated signaling pathway	None	CXCR2;IQGAP1	None	The signaling scaffolding protein IQGAP1 was consistently identified with both the unstimulated and activated receptor immunoprecipitations. CXCR2 colocalizes with IQGAP1 at the leading edge of polarized human neutrophils.	None
"14-3-3 gamma-CXCR2 complex, unstimulated"	P25025;P61981	3579;7532	None	None	CXCR2;YWHAG	None	The interaction of CXCR2 with 14-3-3 gamma represents a potential novel link to signaling pathways through its function as an adaptor molecule that is a known regulator of G-protein signaling (RGS) proteins.	None
"VASP-CXCR2 complex, CXCL8 stimulated"	P25025;P50552	3579;7408	actin cytoskeleton organization	actin cytoskeleton	CXCR2;VASP	None	The actin regulating protein VASP may provide a link betweenthe activated chemokine receptor and the acting cytoskeleton.	None
RHINO-TopBP1 complex	Q92547;Q9BSD3	11073;83695	DNA repair;DNA damage checkpoint;chromatin;nucleus	DNA repair;nucleus	TOPBP1;RHNO1	None	None	None
9b-1-1 complex	O60671;O60921;Q6WBX8	5810;3364;144715	DNA repair;DNA damage checkpoint;nucleus	DNA repair;nucleus	RAD1;HUS1;RAD9B	None	None	None
9b-1b-1 complex	O60671;Q6WBX8;Q8NHY5	5810;144715;135458	nucleus;DNA damage checkpoint;DNA repair	nucleus;DNA repair	RAD1;RAD9B;HUS1B	None	None	None
SIGMAR1-KCNH2 complex	Q12809;Q99720	3757;10280	regulation of potassium ion transmembrane transport	None	KCNH2;SIGMAR1	None	None	None
PRAME-Cullin2 ubiquitin ligase complex	P78395;Q13617	23532;8453	nucleus;chromatin binding;protein ubiquitination	"nucleus;modification by ubiquitination, deubiquitination"	PRAME;CUL2	None	None	None
H2A-H2B-TDIF2-PCNA complex	P12004;Q16777;Q16778;Q5QJE6	5111;8338;8349;30836	chromatin remodeling;nucleus;DNA binding	nucleus;DNA binding	PCNA;HIST2H2AC;HIST2H2BE;DNTTIP2	None	"TdIF2 takes H2A/H2B away from the core histone in the presence of PCNA to form aH2A-H2B-TdIF2-PCNA complex, indicating that TdIF2 functions as a chromatin remodeling protein."	None
PRAME-ElonginBC ubiquitin ligase	P78395;Q15369;Q15370	23532;6921;6923	chromatin binding;nucleus;protein ubiquitination	"nucleus;modification by ubiquitination, deubiquitination"	PRAME;TCEB1;TCEB2	None	None	None
AURKA-INPP5E complex	O14965;Q9NRR6	6790;56623	cilium;phosphatidylinositol-mediated signaling;cilium disassembly	None	AURKA;INPP5E	None	None	None
INPP5E-PDE6D-RPGR complex	O43924;Q92834;Q9NRR6	5147;6103;56623	protein localization to cilium	None	PDE6D;RPGR;INPP5E	None	None	None
SMG1-UPF2-Y14-MAGOH-UPF3B-EIF4A3 complex	P38919;P61326;Q96Q15;Q9BZI7;Q9HAU5;Q9Y5S9	9775;4116;23049;65109;26019;9939	"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay"	None	EIF4A3;MAGOH;SMG1;UPF3B;UPF2;RBM8A	None	"SMG-1 associates with the known EJC components Upf2, Y14, Magoh, Upf3b, and eIF4A3 through the CD region in the absence of RNA."	None
AHI1-NPHP1 heterodimer	O15259;Q8N157	4867;54806	cilium assembly	None	NPHP1;AHI1	None	None	None
AHI1-HAP1 complex	P54257;Q8N157	9001;54806	brain development	brain	HAP1;AHI1	None	None	None
AQP1 homotetramer	P29972	358	water transport;water transmembrane transporter activity	None	AQP1	None	None	None
KCNMA1-LRRC26 complex	Q12791;Q2I0M4	3778;389816	None	None	KCNMA1;LRRC26	None	None	None
AHI1-NPHP1 heterotetramer	O15259;Q8N157	4867;54806	cilium assembly	None	NPHP1;AHI1	None	None	None
SOG complex	P55735;Q12980;Q5T011;Q6PJI9;Q8WTW4;Q96EE3;Q96S15;Q9NXC5	6396;8131;23334;79726;10641;81929;84219;54468	lysosome localization;negative regulation of TORC1 signaling	None	SEC13;NPRL3;SZT2;WDR59;NPRL2;SEH1L;WDR24;MIOS	None	The SOG complex has a molecular weight of around 1.06 MDa.	"Mutations in the metazoan-specific SZT2 gene cause epilepsy, a disease frequently associated with mTORC1 hyperactivation.SZT2 deficiency results in constitutive mTORC1 signalling in cells under nutrient-deprived conditions and neonatal lethality in mice, which was associated with failure to inactivate mTORC1 during fasting."
KICSTOR complex	Q5T011;Q969R8;Q96MD2;Q9Y664	23334;55846;144577;11133	lysosome localization;negative regulation of TORC1 signaling;regulation of autophagy	None	SZT2;ITFG2;C12orf66;KPTN	None	"KICSTOR localizes to lysosomes; binds andrecruits GATOR1, but not GATOR2, to the lysosomal surface; and is necessary for the interaction of GATOR1 with its substrates, the Rag GTPases, and with GATOR2.HEK293T cells that lack any of the KICSTOR subunits, amino acid deprivation did not inhibit mTORC1 signalling, or induce autophagy."	None
RasGAP-AURKB-survivin complex	O15392;P20936;Q96GD4	332;5921;9212	G-protein coupled receptor signaling pathway;mitotic cell cycle;regulation of cell cycle	G-protein coupled receptor signalling pathway;mitotic cell cycle;mitotic cell cycle and cell cycle control	BIRC5;RASA1;AURKB	None	The authors define this ternary complex by several protein-protein interactions. RasGAP binds to the kinase domain of Aurora and this interaction inhibits the kinase activity of AURKA and AURKB.	None
IL10 receptor	Q08334;Q13651	3588;3587	negative regulation of inflammatory response;B cell proliferation;mast cell proliferation	None	IL10RB;IL10RA	None	None	None
CCR4-NOT complex	A5YKK6;O75175;Q92600;Q96LI5;Q9H9A5;Q9NZN8;Q9UIV1;Q9UKZ1;Q9ULM6	23019;4849;9125;246175;25904;4848;29883;55571;57472	"CCR4-NOT complex;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;RNA binding;regulation of transcription, DNA-templated"	RNA binding;transcriptional control	CNOT1;CNOT3;RQCD1;CNOT6L;CNOT10;CNOT2;CNOT7;CNOT11;CNOT6	None	"In eukaryotes, degradation of functional mRNAs is most often initiated by progressive shortening of their poly(A) tails. This step is predominantly catalyzed by two interacting deadenylases called CCR4 and CAF1."	None
TBX20-TBX18 repressor complex	O95935;Q9UMR3	9096;57057	"negative regulation of transcription, DNA-templated"	transcription repression	TBX18;TBX20	None	None	None
TBX20-TLE1 repressor complex	Q04724;Q9UMR3	7088;57057	"negative regulation of transcription, DNA-templated;heart development"	transcription repression;heart muscle	TLE1;TBX20	None	None	None
TBX20-TLE3 repressor complex	Q04726;Q9UMR3	7090;57057	"heart development;negative regulation of transcription, DNA-templated"	heart muscle;transcription repression	TLE3;TBX20	None	None	None
TBX20-HDAC2 repressor complex	Q92769;Q9UMR3	3066;57057	"negative regulation of transcription, DNA-templated"	transcription repression	HDAC2;TBX20	None	None	None
SCRIB-NOS1AP-VANGL1 complex	O75052;Q14160;Q8TAA9	9722;23513;81839	establishment or maintenance of cell polarity;cell migration;lamellipodium	cell migration	NOS1AP;SCRIB;VANGL1	None	"NOS1AP colocalizes with both SCRIB and VANGL1 along cellular protrusions in metastatic breast cancer cells, but does not colocalize with either SCRIB or VANGL1 at cell junctions in normal breast cells. SCRIB, NOS1AP and VANGL1 regulate the migration of human breast cancer cells."	The data point to the relevance of NOS1AP and SCRIB protein complexes in breast cancer.
SCRIB-GIT1-ARHGEF7-PAK1 complex	Q13153;Q14155;Q14160;Q9Y2X7	5058;8874;23513;28964	establishment or maintenance of cell polarity;cell migration	cell migration	PAK1;ARHGEF7;SCRIB;GIT1	None	SCRIB associates independently with ARHGEF\u2013PAK\u2013GIT protein complexes and with NOS1AP\u2013VANGL protein complexes.	None
SCRIB-GIT1-ARHGEF7-PAK1 complex	Q13153;Q14155;Q14160;Q9Y2X7	5058;8874;23513;28964	cell migration;cell leading edge;establishment or maintenance of cell polarity	cell migration	PAK1;ARHGEF7;SCRIB;GIT1	"Since the authors did not specify PAK, we used isoform PAK1."	"The data demonstrate that the HRG (heregulin b1, a growth factor triggering cell motility)-dependent migration of T47D cells is controlled by the ability of Scrib to interact with the beta-PIX-PAK complex.Scrib interacts with the beta-PIX-PAK protein complex and is required for the retention of the protein complex at the leading edge of migratory cells."	None
RAD6A-KCMF1-UBR4 complex	P49459;Q5T4S7;Q9P0J7	7319;23352;56888	lysosomal protein catabolic process	None	UBE2A;UBR4;KCMF1	None	None	Two different RAD6A point mutants (R7W and R11Q) found inX-linked intellectual disability (XLID) patients specifically losethe interactions with KCMF1 and UBR4.
mitochondrial permeability  transition pore (PTP) complex (PPIF-SPG7-VDAC1)	P21796;P30405;Q9UQ90	7416;10105;6687	mitochondrial depolarization;mitochondrial inner membrane;mitochondrial outer membrane	mitochondrial inner membrane;mitochondrial outer membrane	VDAC1;PPIF;SPG7	None	SPG7 is a core component of the PTP (permeability  transition pore) which not only interacts with matrix protein CypD (PPIF) but also with the OMM channel VDAC1 at OMM/IMM (outer mitochondrial membrane/inner mitochondrial membrane) contact sites. Silencing or disruption of SPG7-CypD binding prevented Ca2+ and ROS-induced mitochondrial membrane potential depolarization and cell death.	None
CLIC5A-EZR-PODXL complex	O00592;P15311;Q9NZA1	5420;7430;53405	podocyte foot;actin cytoskeleton reorganization	None	PODXL;EZR;CLIC5	None	"Ezrin and podocalyxin colocalize with CLIC5A in glomeruli, and podocalyxin coimmunoprecipitates with CLIC5A from glomerular lysates."	"The authors postulate that the interaction between podocalyxin and subjacentfilamentous actin, which requires ezrin, is compromised in podocytes of CLIC5A-deficient mice, leading to dysfunction under unfavorable genetic or environmental conditions."
SCHIP1-EZR-NHERF2 complex	P15311;Q15599;Q9P0W5	7430;9351;100505385	podocyte foot;actin cytoskeleton reorganization	None	EZR;SLC9A3R2;SCHIP1	None	The authors propose that Schip1 is an adaptor protein in complex with ezrin-Nherf2 that links actin cytoskeleton to the podocyte foot process plasma membrane and mediates its dynamics in response to PDGF-beta.	None
"NHE3-NHERF2-ACTN4, Ca(2+) induced"	O43707;P48764;Q15599	81;6550;9351	regulation of sodium ion transport;regulation of pH	None	ACTN4;SLC9A3;SLC9A3R2	None	"E3KARP (NHERF2) is specifically involved in the inhibition of NHE3 activity by elevation of Ca(2+) through an interaction with ACTN4. Elevation of Ca(2+) induces NHE3 oligomerization and endocytosis of NHE3 with formation of a protein complex containing NHE3, E3KARP (NHERF2), and ACTN4."	Inhibition of Na(+)/H(+) exchange induced by elevation of Ca(2+) is involved in normal intestinal physiology and in the pathophysiology of diarrheal disease (PMID: 2873653).
SLC9A3R1-ACTN4 complex	O14745;O43707	9368;81	actin cytoskeleton organization	actin cytoskeleton	SLC9A3R1;ACTN4	None	"The NHERF1/a-actinin-4 interaction increased a-actinin-4 ubiquitination and decreased its expression levels, resulting in actin cytoskeleton disassembly."	The results indicate that NHERF1 may regulate tumor cell invasion and metastasis through modulation of a-actinin-4 protein expression levels.
PTEN-NHERF1-EGFR complex	O14745;P00533;P60484	9368;1956;5728	negative regulation of protein kinase B signaling	None	SLC9A3R1;EGFR;PTEN	None	The PTEN-EBP50-EGFR complex attenuated EGF-induced AKT signaling. The disruption of this complex led to an increase of EGF-induced AKT activation level.	None
NHERF1-PRKCZ complex	O14745;Q05513	9368;5590	I-kappaB kinase/NF-kappaB signaling	NIK-I-kappaB/NF-kappaB cascade	SLC9A3R1;PRKCZ	None	Inflammatory stimuli promote the formation of an EBP50-PKC-Zeta complex at the cell membrane that induces NF-kappaB signaling.	None
NHERF1-NPT2A-EZR complex	O14745;P15311;Q06495	9368;7430;6569	phosphate ion transport;cellular response to parathyroid hormone stimulus	phosphate transport	SLC9A3R1;EZR;SLC34A1	None	"The NHERF1 ternary complex is required for PTH (parathyroid hormone)-sensitive Pi (phosphate) transport. Mutations in Npt2a, NHERF1, or ezrin that interfere with theformation of the ternary complex or its phosphorylation impedes the normal function and regulatory influence of PTH."	The failure to assemble and regulate the Npt2a-NHERF1-ezrin ternary complex is responsible for the loss of function of the NHERF1 mutants and defines a novel molecular mechanism of PTH (parathyroid hormone) resistance and hyperphosphaturia.
PDZK1-NHERF1-EZR complex	O14745;P15311;Q5T2W1	9368;7430;5174	microvillus organization	None	SLC9A3R1;EZR;PDZK1	None	"PDZK1 shuttles from the nucleus in low con?uence cells to microvilli in high con?uence cells, and this regulates the formation of the PDZK1/EBP50/ezrin complex in vivo."	None
"LPAR2-TRIP6-NHERF2 complex, LPA stimulated"	Q15599;Q15654;Q9HBW0	9351;7205;9170	negative regulation of apoptotic process	anti-apoptosis	SLC9A3R2;TRIP6;LPAR2	None	"LPA2-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA2-mediated full activation of antiapoptotic signaling. LPA2, TRIP6, and NHERF2 colocalize in cells as shown in LPA1/2 DKO MEFs (LPA1/2 double knock-out  mouse embryonic fibroblasts) by fluorescence microscopy."	"The LPA2-mediated antiapoptotic effect was abolished only when both CXXC- and PDZ-binding motifs were disrupted, indicating that the supramolecular complexes formed via the C-terminal tail of LPA2 are required for the full antiapoptotic function of LPA2, and thus play a critical role in the chemoprotective action of LPA in can-cer cells."
LPAR2-SIVA1 complex	O15304;Q9HBW0	10572;9170	regulation of apoptotic process	None	SIVA1;LPAR2	None	Siva-1 colocalized with LPA2 and S1P4 but not S1P1 in the cytosol in LPA1/2 DKO MEFs (double knock-out mouse embryonic fibroblasts).	None
SIVA1-S1PR4 complex	O15304;O95977	10572;8698	None	None	SIVA1;S1PR4	None	Siva-1 colocalized with LPA2 and S1P4 but not S1P1 in the cytosol in LPA1/2 DKO MEFs (double knock-out mouse embryonic fibroblasts).	None
LPAR2-SIVA1 complex	O15304;Q9HBW0	10572;9170	regulation of apoptotic process	None	SIVA1;LPAR2	None	Endogenous Siva-1 was found to co-immunoprecipitate with the LPA2receptor in DKO-LPA2 MEFs (LPA1/2 double knock-out mouse embryonic fibroblasts).Prolonged LPA stimulation promotes the association of Siva-1 with the LPA2receptor and targets both proteins for ubiquitination and degradation.Siva-1 is predominantly present in the nucleus but co-localizes with the LPA2receptor in the cytosol or on the plasma membrane	None
"S1PR1-c-Met-ITGB4 complex, HGF- or S1P-induced"	P08581;P16144;P21453	4233;3691;1901	establishment of endothelial barrier;membrane raft	None	MET;ITGB4;S1PR1	None	The c-Met-S1PR1-ITGB4 complex is dynamically regulated within the lipid rafts in response to HGF.	None
VEGFR2-S1PR1-ERK1/2-PKC-alpha complex	P17252;P21453;P27361;P28482;P35968	5578;1901;5595;5594;3791	cell migration;ERK1 and ERK2 cascade	cell migration	PRKCA;S1PR1;MAPK3;MAPK1;KDR	None	"S1P receptors form complexes with VEGFR-2 and the S1P1/VEGFR-2 complex associates with protein kinase C (PKC)-alpha and ERK1/2.The authors hypothesize that VEGFR-2 forms a signaling complex with S1P1, evoking bidirectional signaling regulating both ERK1/2 phosphorylation and haptotaxis of ML-1 cells."	None
VEGFR2-S1PR2-ERK1/2-PKC-alpha complex	O95136;P17252;P27361;P28482;P35968	9294;5578;5595;5594;3791	cell migration;ERK1 and ERK2 cascade	cell migration	S1PR2;PRKCA;MAPK3;MAPK1;KDR	None	S1P receptors form complexes with VEGFR-2 and the S1P2/VEGFR-2 complex associates with protein kinase C (PKC)-alpha and ERK1/2.	None
VEGFR2-S1PR3-ERK1/2-PKC-alpha complex	P17252;P27361;P28482;P35968;Q99500	5578;5595;5594;3791;1903	cell migration;ERK1 and ERK2 cascade	cell migration	PRKCA;MAPK3;MAPK1;KDR;S1PR3	None	S1P receptors form complexes with VEGFR-2 and the S1P3/VEGFR-2 complex associates with protein kinase C (PKC)-alpha and ERK1/2.	None
VEGFR2-S1PR5-ERK1/2-PKC-alpha complex	P17252;P27361;P28482;P35968;Q9H228	5578;5595;5594;3791;53637	cell migration;ERK1 and ERK2 cascade	cell migration	PRKCA;MAPK3;MAPK1;KDR;S1PR5	None	S1P receptors form complexes with VEGFR-2 and the S1P5/VEGFR-2 complex associates with protein kinase C (PKC)-alpha and ERK1/2.	None
"S1PR1\u2013beta-arrestin 2 complex, ApoM(+)HDL-S1P stimulated"	P21453;P32121	1901;409	negative regulation of inflammatory response;negative regulation of I-kappaB kinase/NF-kappaB signaling	None	S1PR1;ARRB2	None	"Exposure of HUVECs to ApoM(+)HDL-S1P, but not to albumin-S1P, promoted the formation of a cell surface S1P1\u2013beta-arrestin 2 complex and attenuated the ability of the proinflammatory cytokine TNF? to activate NF-kappaB and increase ICAM-1 abundance."	Mouse endothelial S1P1 acted as an anti-inflammatory and anti-atherosclerotic GPCR (G protein-coupled receptor) in vivo.
IGF1R-CXCR4-GNAI2-GNB1 complex	P04899;P08069;P61073;P62873	2771;3480;7852;2782	cell migration	cell migration	GNAI2;IGF1R;CXCR4;GNB1	None	"The results show the existence of a constitutive complex between IGF-1R, CXCR4, Gialpha2, and Gbeta.Both Gialpha2 and Gbeta are associated with the complex in both cell lines; however, activation of the complex, as determined by release of Gialpha2 and Gbeta from CXCR4, only occurs in MDA-MB-231 cells."	CXCR4 seems to play an important role for in cancer.
ADRA1A-CXCR4 complex	P35348;P61073	148;7852	regulation of blood pressure	None	ADRA1A;CXCR4	None	Disruption of alpha-1A/B-adrenergic receptor-CXCR4 heteromeric complexes inhibits alpha1-AR\u2013mediated functions in vascular smooth muscle cells and treatment with CXCR4 agonists enhances the potency of the alpha-1-AR agonist phenylephrine to increase blood pressure.	Compounds targeting the alpha-1A/B-adrenergic receptor-CXCR4 heteromeric complexes could provide an alternative pharmacological approach tomodulating blood pressure.
ADRB1-CXCR4 complex	P08588;P61073	153;7852	regulation of blood pressure	None	ADRB1;CXCR4	None	Disruption of alpha-1A/B-adrenergic receptor-CXCR4 heteromeric complexes inhibits alpha1-AR\u2013mediated functions in vascular smooth muscle cells and treatment with CXCR4 agonists enhances the potency of the alpha-1-AR agonist phenylephrine to increase blood pressure.	Compounds targeting the alpha-1A/B-adrenergic receptor-CXCR4 heteromeric complexes could provide an alternative pharmacological approach to modulating blood pressure.
DRD4-KLHL12-CUL3 complex	P21917;Q13618;Q53G59	1815;8452;59349	regulation of protein ubiquitination	None	DRD4;CUL3;KLHL12	None	The D4 receptor does not directly interact with Cul3 but is recruited to the E3 ligase via KLHL12 as an adaptor. This complex formation specifically targets the D4receptor for ubiquitination. The experiments indicate that the D4-KLHL12 association could be human (primate)-specific.	None
ULK1-ATG13-ATG14-PIK3C3 complex	O75143;O75385;Q6ZNE5;Q8NEB9	9776;8408;22863;5289	autophagosome assembly;regulation of autophagy	None	ATG13;ULK1;ATG14;PIK3C3	None	"ATG13, a binding partner of ULK1, mediates the interaction of ULK1 with the ATG14-containing PIK3C3/VPS34 complex, the key machinery for initiation of autophagosome formation. ULK1 binds ATG14 via ATG13 and phosphorylates ATG14 Ser29 when cells are starved of nutrients or treated with MTOR inhibitors."	None
"Ubiquitin E3 ligase (FBXO18, SKP1A, CUL1, RBX1)"	P62877;P63208;Q13616;Q8NFZ0	9978;6500;8454;84893	protein ubiquitination;DNA duplex unwinding;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process	"modification by ubiquitination, deubiquitination;proteasomal degradation (ubiquitin/proteasomal pathway)"	RBX1;SKP1;CUL1;FBXO18	None	The SCF-hFBH1 complex can act as a DNA helicase and E3 ubiquitin ligase simultaneously.	None
"APOL1 complex A (APOL1, APOA1, HPR, C3)"	O14791;P00739;P01024;P02647	8542;3250;718;335	regulation of plasma lipoprotein particle levels	None	APOL1;HPR;C3;APOA1	None	"APOL1 complex A is larger than typical HDL particles (8\u201312 nm), with similar distributions noted across APOL1 G0/G0, G1/G1, and G2/G2  genotypes. Based on the results from three fractionation procedures, APOL1-containing complexes do not appear to reside in typical se-rum HDL particles, as de?ned by density, charge, and size."	None
"APOL1 complex B (APOL1, APOA1, HPR, FN1, IGHM)"	O14791;P00739;P01871;P02647;P02751	8542;3250;3507;335;2335	regulation of plasma lipoprotein particle levels	None	APOL1;HPR;IGHM;APOA1;FN1	None	"Based on the results from three fractionation procedures, APOL1-containing complexes do not appear to reside in typical serum HDL particles, as defined by density, charge, and size."	None
TTR-RBP complex	P02753;P02766	5950;7276	vitamin A transport;vitamin A metabolic process;retinal binding	None	RBP4;TTR	None	The removal o f retinol from holoRBP leads to a six-fold weaker affinity for TTR.  Retinoic acid-RBP possesses a four-fold weaker affinity for TTR. compared with retinol- RBP.	None
ZAG-PIP complex	P12273;P25311	5304;563	arachidonic acid binding	None	PIP;AZGP1	None	"Fluorescence analysis reveals that complexes have similar binding affinities as native ZAG, for their proposed ligands like arachidonic acid, polyethylene glycol and synthetic peptide."	Both proteins are reported to be androgen regulated and considered as a prognostic marker for prostate and breast carcinomas.
CP\u2013LF\u2013MPO complex	P00450;P02788;P05164	1356;4057;4353	defense response;response to oxidative stress	oxidative stress response	CP;LTF;MPO	None	The fact that CP provides the incorporation of oxidized iron into LF also suggests the participation of the triple CP\u2013LF\u2013MPO complex  in protective reactions in the organism.	None
CP-LF complex	P00450;P02788	1356;4057	iron ion homeostasis	None	CP;LTF	None	None	None
CP-MPO complex	P00450;P05164	1356;4353	defense response	None	CP;MPO	None	None	None
Calprotectin heterotetramer	P05109;P06702	6279;6280	inflammatory response;innate immune response;calcium ion binding	inflammatory response;innate immune response (invertebrates and vertebrates);calcium binding	S100A8;S100A9	None	None	"Increased serum levels of calprotectin are observed in rheumatoid arthritis, various autoimmune diseases, cystic fibrosis, chronical bronchitis, acute allograft rejection, gut inflammation as well as inflammatory dermatoses and abscesses."
iNOS-S100A8/A9 complex	P05109;P06702;P35228	6279;6280;4843	peptidyl-cysteine S-nitrosylation;calcium ion binding	calcium binding	S100A8;S100A9;NOS2	None	"IFN-gamma and LDL(ox) synergistically induce iNOS expression, and initiate the assembly of a S-nitrosylase complex consisting of iNOS and S100A8/A9. iNOS-S100A8/A9 directs selective S-nitrosylation of multiple targets, including GAPDH."	None
FGF21-FGFR1c-KLB complex	P11362;Q86Z14;Q9NSA1	2260;152831;26291	fibroblast growth factor receptor signaling pathway	FGF-receptor signalling pathway	FGFR1;KLB;FGF21	None	The D1-linker region of FGFR1c negatively regulates the formation of the FGF21/FGFR1c/beta-Klotho ternary complex. The D1-linker region of FGFR1c prevents direct FGF21 binding to FGFR1c so that no receptor activation occurs in the absence of beta-Klotho.	None
"FGF19-FGFR4-KLB complex, heparin induced"	O95750;P22455;Q86Z14	9965;2264;152831	positive regulation of ERK1 and ERK2 cascade;fibroblast growth factor receptor signaling pathway;positive regulation of protein phosphorylation	FGF-receptor signalling pathway	FGF19;FGFR4;KLB	None	"The results show that KLB is required for FGF19 binding to the cell surface FGFR4 and that heparin promotes this interaction.FGF19 requires KLB for binding to FGFR4, intracellular signaling, and downstreamgene modulation. The requirement for KLB restricts the endocrine activity of FGF19 to tissues that express both FGFR4 and KLB. The liver-specific activity of FGF19 is supported by this molecular mechanism."	None
FGFR4-KLB complex	P22455;Q86Z14	2264;152831	fibroblast growth factor receptor signaling pathway	FGF-receptor signalling pathway	FGFR4;KLB	None	KLB and FGFR4 form a constitutive heparin- and ligand-independent complex.	None
FGF21-FGFR1c-KLB complex	P11362;Q86Z14;Q9NSA1	2260;152831;26291	fibroblast growth factor receptor signaling pathway;positive regulation of ERK1 and ERK2 cascade	FGF-receptor signalling pathway	FGFR1;KLB;FGF21	None	Beta-Klotho\u2013FGFR1c and beta-Klotho\u2013FGFR4 complexes were able to pull down FGF21 more efficiently than FGFRs alone and the other beta-Klotho\u2013FGFR combinations.	None
FGF21-FGFR4-KLB complex	P22455;Q86Z14;Q9NSA1	2264;152831;26291	fibroblast growth factor receptor signaling pathway;positive regulation of ERK1 and ERK2 cascade	FGF-receptor signalling pathway	FGFR4;KLB;FGF21	None	Beta-Klotho\u2013FGFR1c and beta-Klotho\u2013FGFR4 complexes were able to pull down FGF21 more efficiently than FGFRs alone and the other beta-Klotho\u2013FGFR combinations.	None
FGFR1c-KLB complex	P11362;Q86Z14	2260;152831	fibroblast growth factor receptor signaling pathway	FGF-receptor signalling pathway	FGFR1;KLB	None	None	None
FGFR4-KLB complex	P22455;Q86Z14	2264;152831	fibroblast growth factor receptor signaling pathway	FGF-receptor signalling pathway	FGFR4;KLB	None	None	None
IGF2BP1 complex	O60506;O95793;P61254;P62753;P67809;Q00839;Q08211;Q15717;Q9NZI8	10492;6780;6154;6194;4904;3192;1660;1994;10642	mRNA stabilization;cytoplasm	cytoplasm	SYNCRIP;STAU1;RPL26;RPS6;YBX1;HNRNPU;DHX9;ELAVL1;IGF2BP1	None	The IGF2BP1 complex stabilizes the c-myc RNA by associating with the Coding Region instability Determinant (CRD).	None
EphA1 receptor signaling complex	P06239;P21709;P27986;Q14289	3932;2041;5295;2185	T cell migration;signaling	cellular signalling	LCK;EPHA1;PIK3R1;PTK2B	None	None	None
NIF-1-DBC1-EMSY complex	Q7Z589;Q8N163;Q9H4Z2	56946;57805;63925	"retinoic acid receptor signaling pathway;transcription, DNA-templated"	TRANSCRIPTION	EMSY;CCAR2;ZNF335	None	"The results imply that DBC-1 and EMSY, as components of a NIF-1 complex, play an important role in the RA-mediated stimulation of Sox9 and HoxA1 by RAR-alpha."	None
NIF1-ASH2L-RBBP5-WDR5 complex	P61964;Q15291;Q9H4Z2;Q9UBL3	11091;5929;63925;9070	histone methylation	None	WDR5;KDM6B;ZNF335;ASH2L	None	The isolated NIF-1 complex contains a H3 methyltransferase activity that methylates one or more residues other than H3-Lys-4 (H3K4).	None
DBC1-SIRT1 complex	Q8N163;Q96EB6	57805;23411	regulation of protein deacetylation;positive regulation of apoptotic process	None	CCAR2;SIRT1	None	DBC1 inhibits SIRT1-mediated deacetylation of p53. DBC1-mediated inhibitory effects specifically act on SIRT1 deacetylase activity. DBC1 promotes p53-mediated apoptosis through specific inhibition of SIRT1.	None
DBIRD complex	Q5BKZ1;Q8N163	284695;57805	"regulation of alternative mRNA splicing, via spliceosome;transcription elongation from RNA polymerase II promoter"	None	ZNF326;CCAR2	None	"DBC1 and ZIRD form a stable complex that binds RNAPII (RNA polymerase II). DBIRD complex acts at the interface between mRNP (messengerribonucleoprotein particle) particles and RNAPII, integratingtranscript elongation with the regulation of alternative splicing."	None
IRF2BP2-IRF2BP1-IRF2BPL complex	Q7Z5L9;Q8IU81;Q9H1B7	359948;26145;64207	"negative regulation of transcription, DNA-templated;regulation of apoptotic process"	transcription repression	IRF2BP2;IRF2BP1;IRF2BPL	None	The authors identified FASTKD2 (Fas-activated serine-threonine kinase domain 2) as a target gene of the DIF-1 complex in breast cancer cells. The DIF-1-BP1-EAP1 complex binds to and selectively represses the FASTKD2 gene in breast cancer cells. FASTKD2 is proapoptotic.All the breast cancer cell lines that have been studied (whether estrogen receptor positive or negative) undergo apoptosis when DIF-1 is knocked down or inactivated bythe binding of NRIF3/DD1.	None
"WRAD  complex (WDR5, RBBP5, ASH2L, DPY30)"	P61964;Q15291;Q9C005;Q9UBL3	11091;5929;84661;9070	histone H3-K4 monomethylation	None	WDR5;KDM6B;DPY30;ASH2L	None	"Histone H3 is the preferred substrate for isolated human WRAD, which, in the absence of MLL1, preferentially monomethylates lysine 4. WDR5, RbBP5, and Ash2L form the minimal complex (WRA complex) required for methylation of histone H3 and that DPY-30 (WRAD complex) functions to enhance complex stability and enzymatic activity."	None
"WRA complex (WDR5, RBBP5, ASH2L)"	P61964;Q15291;Q9UBL3	11091;5929;9070	histone H3-K4 monomethylation	None	WDR5;KDM6B;ASH2L	None	"WDR5, RbBP5, and Ash2L form the minimal complex required for methylation of histone H3 and that DPY-30 (WRAD complex) functions to enhance complex stability and enzymatic activity."	None
"MWRAD complex (MLL1, WDR5, RBBP5, ASH2L, DPY30)"	P61964;Q03164;Q15291;Q9C005;Q9UBL3	11091;4297;5929;84661;9070	histone H3-K4 monomethylation;histone H3-K4 dimethylation	None	WDR5;KMT2A;KDM6B;DPY30;ASH2L	None	Nucleosomal histone H3 methylation is observed only when the assays are conducted with a fully assembled MLL1 core complex containing a stoichiometric equivalent of MLL1 and WRAD that catalyzes H3K4 mono- and dimethylation under the applied assay conditions.	None
COPRS-PRMT5-RUNX1-CBFB complex	O14744;Q01196;Q13951;Q9NQ92	10419;861;865;55352	"transcription, DNA-templated;muscle cell differentiation"	TRANSCRIPTION	PRMT5;RUNX1;CBFB;COPRS	None	"The capacity of COPR5 to associate with CBFB was conirmed by ChIP experiments, suggesting that COPR5 could be targeted via the RUNX1 complex to promoters."	None
COPRS-PRMT5 complex	O14744;Q9NQ92	10419;55352	"histone H4-R3 methylation;nucleus;regulation of transcription, DNA-templated;covalent chromatin modification"	nucleus;transcriptional control	PRMT5;COPRS	None	COPR5 favours H4R3 PRMT5-dependent methylation. COPR5 seems to modulate the substrate specificity and/or activity of nuclear PRMT5-containingcomplexes towards histones. COPR5 depletion and overexpression affect CCNE1 promoter expression.	None
5FMC (Friends of Methylated Chtop) complex	Q8IZL8;Q9BV38;Q9H4L4;Q9NXF1;Q9Y4W2	27043;57418;26168;54881;81887	"protein desumoylation;transcription, DNA-templated"	modification by ubiquitin-related proteins;TRANSCRIPTION	PELP1;WDR18;SENP3;TEX10;LAS1L	None	"The interactions between Chtop and 5FMC are most likely transient and highly dynamic. The authors showed that Pelp1 is critical for the integrity of 5FMC and that Chtop and 5FMC are recruited by Zinc finger binding protein-89 (Zbp-89), thereby regulating both (de)sumoylation of, and transactivation by Zbp-89."	None
LAS1L-PELP1-TEX10-WDR18-NOL9-SENP3  complex	Q5SY16;Q8IZL8;Q9BV38;Q9H4L4;Q9NXF1;Q9Y4W2	79707;27043;57418;26168;54881;81887	ribosome biogenesis;nucleolus;rRNA processing	ribosome biogenesis;nucleolus;rRNA processing	NOL9;PELP1;WDR18;SENP3;TEX10;LAS1L	None	The authors demonstrate that all these proteins localize to the nucleolus and cosediment with the pre-60S ribosomal particle and that they are required for efficient processing of the 28S rRNA.	None
PeBoW complex	O00541;Q14137;Q9GZL7	23481;23246;55759	rRNA processing;ribosome biogenesis	rRNA processing;ribosome biogenesis	PES1;BOP1;WDR12	None	"Most likely, the PeBoW complex is a stable subcomponent of larger preribosomal particles."	None
PELP1-TEX10-WDR18 complex	Q8IZL8;Q9BV38;Q9NXF1	27043;57418;54881	ribosome biogenesis;rRNA processing	ribosome biogenesis;rRNA processing	PELP1;WDR18;TEX10	None	The SUMO system controls the spatial distribution of this complex and the associated factors MDN1 and LAS1L.	None
CHTOP-methylosome complex	O14744;P84090;Q99873;Q9BQA1;Q9Y3Y2	10419;2079;3276;79084;26097	"histone H4-R3 methylation;regulation of transcription, DNA-templated;cytosine binding"	transcriptional control	PRMT5;ERH;PRMT1;WDR77;CHTOP	None	The CHTOP-methylosome complex associated with 5hmC (5-hydroxymethylcytosine) methylates H4R3 and transactivates cancer-related genes.	"5hmC (5-hydroxymethylcytosine) serves as a recruitment signal for theCHTOP-methylosome complex, which in turn methylates H4R3and thereby activates the transcription of genes required for glioblastomagenesis."
HRD1 complex	O94905;P11021;P14625;P35613;Q13438;Q86TM6;Q96CS3;Q96DZ1;Q9GZP9;Q9UBU6;Q9UBV2;Q9Y385;Q9Y679	11160;3309;7184;682;10956;84447;23197;27248;51009;51439;6400;51465;550	response to endoplasmic reticulum stress;endoplasmic reticulum membrane	None	ERLIN2;HSPA5;HSP90B1;BSG;OS9;SYVN1;FAF2;ERLEC1;DERL2;FAM8A1;SEL1L;UBE2J1;AUP1	"Hrd1 forms heterogeneous high-molecular-mass complexes with distinct stoichiometries. Here, components from fraction 12 (see suppl. figure S3A) were annotated."	None	None
E6AP-HERC2-MAPK6-NEURL4 complex	O95714;Q05086;Q16659;Q96JN8	8924;7337;5597;84461	regulation of centrosome cycle	None	HERC2;UBE3A;MAPK6;NEURL4	None	"E6AP (UBE3) exists as part of several different protein complexes, including the proteasome and an independent high-molecular-weight complex containing HERC2, NEURL4, and MAPK6."	None
MMAA-MUT complex	P22033;Q8IVH4	4594;166785	methylmalonyl-CoA mutase activity	None	MUT;MMAA	None	MMAA has a GTPase activity that is modulated by MUT. Formation of a stable MMAA-MUT complex is nucleotide-selective for MMAA (GMPPNP over GDP) and adenosylcobalamin-dependent for MUT. (PMID: 20876572)	None
Bag6-Ubl4A-Trc35 Complex	P11441;P46379;Q7L5D6	8266;7917;51608	positive regulation of ERAD pathway	None	UBL4A;BAG6;GET4	None	None	None
CBX3-EHMT2-NR3C1 complex	P04150;Q13185;Q96KQ7	2908;11335;10919	"transcription, DNA-templated"	TRANSCRIPTION	NR3C1;CBX3;EHMT2	None	G9a methylation (K185) is required for HP1-gamma-G9a-GR complex formation. G9a phosphorylation (T186) by Aurora kinase B in cells prevents HP1-gamma  recognition.	None
CBX3-EHMT1-NR3C1 complex	P04150;Q13185;Q9H9B1	2908;11335;79813	"transcription, DNA-templated"	TRANSCRIPTION	NR3C1;CBX3;EHMT1	None	GLP methylation (K205) is required for HP1-gamma-GLP-GR complex formation. GLP phosphorylation (T206) by Aurora kinase B in cells prevents HP1-gamma recognition.	None
AMFR-ERLIN2-TMUB1 complex	O94905;Q9BVT8;Q9UKV5	11160;83590;267	ERAD pathway;endoplasmic reticulum	endoplasmic reticulum	ERLIN2;TMUB1;AMFR	None	None	None
"AMFR-STING-INSIG1 complex, herpes simplex virus 1 induced"	O15503;Q86WV6;Q9UKV5	3638;340061;267	ERAD pathway;innate immune response;protein ubiquitination	"innate immune response (invertebrates and vertebrates);modification by ubiquitination, deubiquitination"	INSIG1;TMEM173;AMFR	None	AMFR catalyzed the formation of the K27-linked polyubiquitin chains on STING. INSIG1 bridges AMFR and STING in the intracellular DNA-induced signaling.	None
BAG6-AMFR-FAF2 complex	P46379;Q96CS3;Q9UKV5	7917;23197;267	ER-associated misfolded protein catabolic process;ERAD pathway;endoplasmic reticulum membrane	None	BAG6;FAF2;AMFR	None	UbxD8 and gp78 were simultaneously present in a Bag6-containing complex. This observation would only be possible if Bag6 forms an oligomer that simultaneously interacts with these factors .	None
CRBN-DDB1-CUL4A-RBX1 E3 ubiquitin ligase	P62877;Q13619;Q16531;Q96SW2	9978;8451;1642;51185	ubiquitin protein ligase activity;ubiquitin ligase complex;system development	None	RBX1;CUL4A;DDB1;CRBN	None	"Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Cereblon (CRBN) was identified as a thalidomide-binding protein. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity."	None
EXT1-EXT2 complex	Q16394;Q93063	2131;2132	Golgi apparatus;heparan sulfate proteoglycan biosynthetic process	Golgi	EXT1;EXT2	None	"EXT1 and EXT2 possess GlcA-T and GlcNAc-T activities in vitro. Compared to ETX1 or EXT2 homodimers, the EXT1-EXT2 complex possesses enhanced glycosyltransferase activity."	Inherited mutations in either of the two EXT genes can result in hereditary multiple exostoses.
Fanconi anemia FAAP100 complex	O15287;O15360;Q00597;Q0VG06;Q8IYD8;Q8NB91;Q9BTP7;Q9HB96;Q9NPI8;Q9NW38	2189;2175;2176;80233;57697;2187;91442;2178;2188;55120	cellular response to DNA damage stimulus;nucleus;protein monoubiquitination	DNA damage response;nucleus	FANCG;FANCA;FANCC;FAAP100;FANCM;FANCB;FAAP24;FANCE;FANCF;FANCL	None	None	None
L-B-P100 subcomplex	Q0VG06;Q8NB91;Q9NW38	80233;2187;55120	nucleus;cytoplasm	nucleus;cytoplasm	FAAP100;FANCB;FANCL	None	"L-B-P100 subcomplex is part of the Fanconi anemia core complex. According to a model, the L-B-P100 complex is normally present in the cytosol, and moves to the nucleus when it is associated with FANCA and FANCM."	None
AUP1-OS9-SEL1L-UBC6e-UBXD8 complex	Q13438;Q96CS3;Q9UBV2;Q9Y385;Q9Y679	10956;23197;6400;51465;550	"retrograde protein transport, ER to cytosol;ERAD pathway;endoplasmic reticulum membrane"	None	OS9;FAF2;SEL1L;UBE2J1;AUP1	None	None	None
v-ATPase-Ragulator-AXIN/LKB1-AMPK complex	O15169;O43504;P21281;P27449;P38606;P54619;P61421;Q0VGL1;Q13131;Q15831;Q6IAA8;Q9UHA4;Q9Y2Q5;Q9Y478	8312;10542;526;527;523;5571;9114;389541;5562;6794;55004;8649;28956;5564	endosome;regulation of energy homeostasis	endosome	AXIN1;LAMTOR5;ATP6V1B2;ATP6V0C;ATP6V1A;PRKAG1;ATP6V0D1;LAMTOR4;PRKAA1;STK11;LAMTOR1;LAMTOR3;LAMTOR2;PRKAB1	"Since the authors did not specify AMPK, we used isoforms Prkaa1, Prkab1 and Prkag1."	"v-ATPase-Ragulator complex is an initiating sensor for energy stress and meanwhile serves as an endosomal docking site for LKB1-mediated AMPK activation by forming the v-ATPase-Ragulator-AXIN/LKB1-AMPK complex, thereby providing a switch between catabolism and anabolism."	None
TSC complex	P49815;Q92574;Q9P0N9	7249;7248;107080638	lysosome;detection of nutrient;positive regulation of TORC1 signaling;insulin receptor signaling pathway;phosphatidylinositol 3-kinase signaling	vacuole or lysosome;perception of nutrients and nutritional adaptation;insulin receptor signalling pathway	TSC2;TSC1;TBC1D7	None	Insulin activates mTORC1 by inducing dissociation of the TSC complex from the lysosome. Insulin and amino acids independently regulate localization of the TSC complex and mTORC1 to the lysosome and Rheb.	None
Phosphatidylinositol 4-kinase complex	P42356;Q86TV6;Q8IYD1;Q9BYI3	5297;145567;23708;84668	plasma membrane;myelination;phosphatidylinositol biosynthetic process	eukaryotic plasma membrane / membrane attached	PI4KA;TTC7B;GSPT2;FAM126A	"The phosphatidylinositol 4-kinase complex is composed of PI4KA, EFR3 (EFR3A or EFR3B), TTC7 (TTC7A or TTC7B) and FAM126 (FAM126A or FAM126B)."	None	Hypomyelination and congenital cataract (HCC) is caused by mutations in FAM126A.
HUSH complex	Q8NEY8;Q99549;Q9UK61	51535;54737;23272	nucleus;gene silencing;chromatin binding	nucleus	PPHLN1;MPHOSPH8;FAM208A	None	The HUSH complex mediates epigenetic regulation of both endogenous and viral genes at heterochromatic loci marked by H3K9me3.	None
Gamma-tubulin complex	P23258;Q96CW5;Q96RT7;Q96RT8;Q9BSJ2;Q9UGJ1	7283;10426;85378;114791;10844;27229	microtubule nucleation;centrosome	centrosome	TUBG1;TUBGCP3;TUBGCP6;TUBGCP5;TUBGCP2;TUBGCP4	None	None	None
MMXD complex	O76071;P05141;P18074;Q96T76;Q9Y3D0	9391;292;2068;64210;51647	mitotic spindle;spindle assembly;chromosome segregation	spindle pole body/centrosome and microtubule cycle;chromosome segregation/division	CIAO1;SLC25A5;ERCC2;MMS19;FAM96B	None	None	"Findings suggest that abnormalities in the function of the MMXD complex due to the XPD mutations lead to aneuploidy and/or cell death, contributing at least partly to the phenotypes such as a high incidence of skin tumors in XP6BE and XPCS-2 patients."
MMS19 complex	O76071;Q96T76;Q9H6Q4;Q9Y3D0	9391;64210;64428;51647	cytoplasm;DNA replication;DNA repair	cytoplasm;DNA synthesis and replication;DNA repair	CIAO1;MMS19;NARFL;FAM96B	None	None	None
CIA2B-CIA1-MMS19 complex	O76071;Q96T76;Q9Y3D0	9391;64210;51647	CIA complex;protein maturation;iron-sulfur cluster assembly	None	CIAO1;MMS19;FAM96B	None	"CIA1 and CIA2B assemble with MMS19, forming the so-called CIA targeting complex that is involved in the biogenesis of the majority of cytosolic and nuclear Fe/S proteins."	None
"Ubiquitin E3 ligase (CUL1, FBXO10, SKP1)"	P63208;Q13616;Q9UK96	6500;8454;26267	positive regulation of apoptotic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	SKP1;CUL1;FBXO10	None	FBXO10 is a component of a ubiquitin ligase that can target BCL2 protein for degradation.	None
"Ubiquitin E3 ligase (CUL1, FBXO6, RBX1, SKP1)"	P62877;P63208;Q13616;Q9NRD1	9978;6500;8454;26270	ERAD pathway;glycoprotein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;SKP1;CUL1;FBXO6	None	"A family of ubiquitin ligase subunits  (FBXO2, FBXO6, FBXO17, FBXO27, and FBXO44) target glycoproteins through their attached glycans. Each family member has differing specificity for glycosylated substrates."	None
"Ubiquitin E3 ligase (CUL1, FBXO17, RBX1, SKP1)"	P62877;P63208;Q13616;Q96EF6	9978;6500;8454;115290	ERAD pathway;glycoprotein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;SKP1;CUL1;FBXO17	None	"A family of ubiquitin ligase subunits  (FBXO2, FBXO6, FBXO17, FBXO27, and FBXO44) target glycoproteins through their attached glycans. Each family member has differing specificity for glycosylated substrates."	None
"Ubiquitin E3 ligase (CUL1, FBXO27, RBX1, SKP1)"	P62877;P63208;Q13616;Q8NI29	9978;6500;8454;126433	ERAD pathway;glycoprotein catabolic process;ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;SKP1;CUL1;FBXO27	None	"A family of ubiquitin ligase subunits  (FBXO2, FBXO6, FBXO17, FBXO27, and FBXO44) target glycoproteins through their attached glycans. Each family member has differing specificity for glycosylated substrates."	None
"Ubiquitin E3 ligase (CUL1, FBXO44, RBX1, SKP1)"	P62877;P63208;Q13616;Q9H4M3	9978;6500;8454;93611	ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;SKP1;CUL1;FBXO44	None	"A family of ubiquitin ligase subunits  (FBXO2, FBXO6, FBXO17, FBXO27, and FBXO44) target glycoproteins through their attached glycans. Each family member has differing specificity for glycosylated substrates. In contrast to other family members, FBXO44 showed no significant binding to any of the 200 glycans tested."	None
"PELI1-IRAK4-IRAK1-TRAF6 complex, IL-1-induced"	P51617;Q96FA3;Q9NWZ3;Q9Y4K3	3654;57162;51135;7189	interleukin-1-mediated signaling pathway	None	IRAK1;PELI1;IRAK4;TRAF6	None	"The PELI1-IRAK-IRAK4-TRAF6 signaling complex is likely to be intermediate, located between the IL-1 receptor complex and the TAK1 complex in the IL-1 pathway."	None
FBXW7-CDX2-GSK3B complex	P49841;Q969H0;Q99626	2932;55294;1045	protein ubiquitination involved in ubiquitin-dependent protein catabolic process;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	None	GSK3B;FBXW7;CDX2	None	"Fbw7 targets CDX2 for ubiquitin-mediated proteasome degradation in a GSK3-beta-dependent manner. GSK3-beta, a serine/threonine kinase, may phosphorylate CDX2 in its CPD (Cdc4-phosphodegron) motifs leading to its degradation by Fbw7."	The deregulated expression of CDX2 is often observed in colon cancers.
CTNNB1-FERMT2-TCF7L2 complex	P35222;Q96AC1;Q9NQB0	1499;10979;6934	nucleus;positive regulation of Wnt signaling pathway	nucleus	CTNNB1;FERMT2;TCF7L2	None	None	None
CTNNB1-FERMT2-YBX1 complex	P35222;P67809;Q96AC1	1499;4904;10979	"positive regulation of ERBB signaling pathway;regulation of transcription, DNA-templated;cytoplasm;nucleus"	transcriptional control;cytoplasm;nucleus	CTNNB1;YBX1;FERMT2	None	None	High Kindlin-2 (FERMT2) expression is correlated with high tumor grade and poor prognosis in glioma patients.
FGF1-FGFR1-ITGB3 complex	P05106;P05230;P11362	3690;2246;2260	positive regulation of ERK1 and ERK2 cascade;fibroblast growth factor receptor signaling pathway	FGF-receptor signalling pathway	ITGB3;FGF1;FGFR1	None	Results suggest that the simultaneous binding of FGFR1 and Integrin beta-3 to FGF1 occurs during FGF signaling.	None
EED-EZH2-PHF19 complex	O75530;Q15910;Q5T6S3	8726;2146;26147	nucleus	nucleus	EED;EZH2;PHF19	None	"hPCL3 (PHF19) encodes a long isoform, hPCL3L and a smaller isoform, hPCL3S. Both isoforms are widely co-expressed at high levels in medulloblastoma."	Both isoforms of hPCL3 (PHF19) are widely co-expressed at high levels in medulloblastoma.
ELN-FBLN2-FBN1 complex	P15502;P35555;P98095	2006;2200;2199	microfibril binding	None	ELN;FBN1;FBLN2	None	Fibulins 2 and Fibulin 5 can act as adaptors between Fibrillin-1 and (Tropo-) elastin.	None
ELN-FBLN5-FBN1 complex	P15502;P35555;Q9UBX5	2006;2200;10516	microfibril binding	None	ELN;FBN1;FBLN5	None	Fibulins 2 and Fibulin 5 can act as adaptors between Fibrillin-1 and (Tropo-) elastin.	None
CTTN-FER-PTK2 complex	P16591;Q05397;Q14247	2241;5747;2017	regulation of cell morphogenesis	None	FER;PTK2;CTTN	None	Results suggest that Fer-mediated phosphorylation of specific FAK tyrosine residues may lead to membrane protrusions even in non-adherent conditions.	None
ILK-LIMS1-PARVA complex	P48059;Q13418;Q9NVD7	3987;3611;55742	cell migration;apoptotic process;regulation of cell shape;cell-matrix adhesion	cell migration;apoptosis (type I programmed cell death);cell-matrix adhesion	LIMS1;ILK;PARVA	Experiments in mice (PMID: 18480182) have shown the existance of ILK-LIMS1-PARVA complex and ILK-LIMS2-PARVA complex.	"The PINCH-1- integrin-linked kinase (ILK)- -parvin (PIP) complex plays important roles in the regulation of glomerular cell behavior, including podocyte shape change, apoptosis, and mesangial fibronectin matrix deposition.DEX partially stimulates hMSC migration by the expression of beta1-integrin through formation of a ILK-LIMS1/2-PARVA complex."	None
ILK-LIMS2-PARVA complex	Q13418;Q7Z4I7;Q9NVD7	3611;55679;55742	cell migration;regulation of cell shape;cell-matrix adhesion	cell migration;cell-matrix adhesion	ILK;LIMS2;PARVA	Experiments in mice (PMID: 18480182) have shown the existance of ILK-LIMS1-PARVA complex and ILK-LIMS2-PARVA complex with different functions.	Overexpression of PINCH-2 in mesangial cells resulted in displacement of PINCH-1 from the PIP complex but impaired neither mesangial cell spreading nor fibronectin matrix deposition.DEX partially stimulates hMSC migration by the expression of beta1-integrin through formation of a ILK-LIMS1/2-PARVA complex.	None
FAK\u2013p130Cas\u2013MT1 complex	P50281;P56945;Q05397	4323;9564;5747	regulation of extracellular matrix disassembly	None	MMP14;BCAR1;PTK2	None	Invasive matrix degradation at focal adhesions occurs via protease recruitment by the FAK\u2013p130Cas\u2013MT1 complex	Disruption of the FAK\u2013p130Cas\u2013MT1 complex impairs tumor cell invasion in vitro
MAPK1-PTK2-PXN complex	P28482;P49023;Q05397	5594;5829;5747	cell migration;wound healing	cell migration	MAPK1;PXN;PTK2	None	The growth factor proepithelin promotes paxillin activation and the formation of the MAPK3-PTK2-PXN complex.	None
Robo4\u2013paxillin complex	P49023;Q8WZ75	5829;54538	regulation of vasculogenesis	None	PXN;ROBO4	None	Formation of a Robo4\u2013paxillin complex at the cell surface blocks activation of the small GTPase Arf6. Blocking Arf6 activity promotes vascular stability.	None
ARHGEF7-GIT2-PAK1 complex	Q13153;Q14155;Q14161	5058;8874;9815	regulation of T cell activation;T cell receptor signaling pathway	None	PAK1;ARHGEF7;GIT2	None	None	None
AKT1-FOXO1-WDFY2 complex	P31749;Q12778;Q96P53	207;2308;115825	positive regulation of adipose tissue development	None	AKT1;FOXO1;WDFY2	None	WDFY2 binds Akt1 and Foxo1 and facilitates Foxo1 Ser253 phosphorylation by insulin-stimulated Akt1.	None
PRKCZ-VAMP2-WDFY2 complex	P63027;Q05513;Q96P53	6844;5590;115825	synaptic vesicle recycling	vesicle recycling	VAMP2;PRKCZ;WDFY2	None	The complex may be involved in vesicle cycling in various secretory pathways.	None
FOXP3-TRIM28-ZFP90 complex	Q13263;Q8TF47;Q9BZS1	10155;146198;50943	"chromatin remodeling;negative regulation of transcription, DNA-templated"	transcription repression	TRIM28;ZFP90;FOXP3	None	"In human regulatory T cells, a specific splice form of ZFP90 couples FOXP3 to a repressive chromatin-remodeling complex that includes the adaptor TRIM28.There is no sequence homologous with the unique C-terminal sequence of ZFP90 from the FOXP3-TRIM28-ZFP90 complex in the mouse genome."	"FOXP3 mutations in humans with immune dysfunction, polyendocrinopathy, enteropathy, X-linked syndrome, leads to the rapid onset of fatal autoimmune lymphoproliferative disease."
AJUBA-PRMT5-SNAI1 complex	O14744;O95863;Q96IF1	10419;6615;84962	nuclear transcriptional repressor complex	None	PRMT5;SNAI1;AJUBA	The AJUBA protein functions as an adaptor to bridge SNAIL and PRMT5 proteins.	"When AJUBA, SNAIL, and PRMT5 are coexpressed, a significant amount of the PRMT5 protein is relocated to the nucleus and colocalizes with nuclear SNAIL and AJUBA.The AJUBA-PRMT5-SNAI1 complex binds to the endogenous promoter of E-cadherin and downregulates  E-cadherin gene expression."	None
PRKCZ-SQSTM-TRAF6 complex	Q05513;Q13501;Q9Y4K3	5590;8878;7189	regulation of NIK/NF-kappaB signaling	None	PRKCZ;SQSTM1;TRAF6	None	Results provide evidence indicating that Ajuba is a new cytosolic component of the IL-1 signaling pathway modulating IL-1-induced NFkappaB activation by influencing the assembly and activity of the PRKCZ-SQSTM-TRAF6 signaling complex.	None
MYC-TRRAP-KAT2A complex	P01106;Q92830;Q9Y4A5	4609;2648;8295	"chromatin remodeling;histone acetylation;transcription, DNA-templated"	TRANSCRIPTION	MYC;KAT2A;TRRAP	None	TRRAP and hGCN5 are contained in a complex which associates withthe c-Myc N terminus in vivo and after in vitro reconstitution.	None
KAT2A-TRRAP complex	Q92830;Q9Y4A5	2648;8295	"histone acetylation;transcription, DNA-templated"	TRANSCRIPTION	KAT2A;TRRAP	None	"hGCN5 (KAT2A) and TRRAP preexist in a complex in mammalian cells. Their interaction does not require c-Myc, and only a small fraction of the hGCN5-TRRAP complexcontains c-Myc."	None
ARHGEF2-MAPK1-MAPK3-PXN complex	P27361;P28482;P49023;Q92974	5595;5594;5829;9181	positive regulation of Rho protein signal transduction;regulation of vascular permeability	None	MAPK3;MAPK1;PXN;ARHGEF2	None	"Cyclic stretches in lung cells induce functional interactions between paxillin, p42/44 MAPK, and GEF-H1."	None
Norrin receptor complex	O75197;O95859;Q00604;Q9ULV1	4041;23554;4693;8322	cell surface receptor signaling pathway;plasma membrane	transmembrane signal transduction;eukaryotic plasma membrane / membrane attached	LRP5;TSPAN12;NDP;FZD4	None	Overexpressed TSPAN12 associates with the Norrin-receptor complex and significantly increases Norrin/beta-catenin but not Wnt/beta-catenin signaling.	None
LRP6-PTH-PTH1R complex	O75581;P01270;Q03431	4040;5741;5745	cell surface receptor signaling pathway involved in cell-cell signaling;plasma membrane	eukaryotic plasma membrane / membrane attached	LRP6;PTH;PTH1R	None	"The authors found that PTH activates  beta-catenin signaling in osteoblasts both in vitro and in vivo by sharing of a coreceptor with Wnt; however, PTH signal acts in a distinct manner from that of the canonical Wnt signaling pathway in that LRP6 forms a complex with PTH and PTH1R. The ternary complex promoted phosphorylation of LRP6, which recruits axin from the cytoplasma, and induces  beta-catenin stabilization."	None
FZD5-LGR5-LRP6 complex	O75473;O75581;Q13467	8549;4040;7855	positive regulation of Wnt signaling pathway;plasma membrane	eukaryotic plasma membrane / membrane attached	LGR5;LRP6;FZD5	None	None	None
BARD1\u2013BRCA1\u2013RAD51 complex	P38398;Q06609;Q99728	672;5888;580	DNA repair;strand invasion;reciprocal DNA recombination	DNA repair	BRCA1;RAD51;BARD1	None	Experiments establish the biological importance of the BRCA1\u2013BARD1\u2013RAD51 complex in DNA damage repair via homologous recombination and provide cellular evidence for a role of BRCA1\u2013BARD1 in the DNA strand invasion step of homologous recombination.	"One mutation (K140N) in BARD1, found in two patients with colorectal adenocarcinoma, attenuated the affinity of BRCA1\u2013BARD1 for RAD51 and also compromised the ability of the tumour suppressor complex to enhance D-loop formation and synaptic complex assembly."
"Isocitrate dehydrogenase [NADP], mitochondrial"	P48735	3418	mitochondrion;isocitrate metabolic process	mitochondrion	IDH2	None	"The results show that loss of SIRT3 increases acetylation of IDH2 at lysine 413 (IDH2-K413-Ac), thereby decreasing its enzymatic activity by reducing IDH2 dimer formation."	"Metabolically, expression of IDH2 (K413Q) alters cancer cell metabolism and results in accumulation of ROS."
"Isocitrate dehydrogenase [NAD], mitochondrial"	O43837;P50213;P51553	3420;3419;3421	isocitrate metabolic process;NAD binding;mitochondrion;metal ion binding;tricarboxylic acid cycle	"NAD/NADP binding;mitochondrion;metal binding;tricarboxylic-acid pathway (citrate cycle, Krebs cycle, TCA cycle)"	IDH3B;IDH3A;IDH3G	None	"The allosteric regulation of the alpha-2-beta-gamma heterotetramer is through the gamma subunit not the beta subunit.The gamma subunit plays the regulatory role to activate the holoenzyme, and the beta subunit the structural role to facilitate the assembly of the holoenzyme."	None
NG2-galectin-3-alpha3beta1-integrin complex	P05556;P17931;P26006;Q6UVK1	3688;3958;3675;1464	regulation of angiogenesis	None	ITGB1;LGALS3;ITGA3;CSPG4	None	None	None
ARTN-GFRA3-RET comples	O60609;P07949;Q5T4W7	2676;5979;9048	nervous system development	nervous system	GFRA3;RET;ARTN	None	None	None
Idas-Geminin-Cdt1 complex	D6RGH6;O75496;Q9H211	345643;51053;81620	regulation of DNA replication	None	MCIDAS;GMNN;CDT1	None	None	None
REP-RGGT-Rab complex	P20336;P24386;Q92696	5864;1121;5875	regulation of protein geranylgeranylation	None	RAB3A;CHM;RABGGTA	None	None	None
C2ORF3-Prp43-TFIP11 complex	O43143;P16383;Q9UBB9	1665;6936;None	"regulation of alternative mRNA splicing, via spliceosome"	None	DHX15;GCFC2;TFIP11	None	None	None
BOLA2-GLRX3 complex	O76003;Q9H3K6	10539;107984053	iron ion homeostasis	None	GLRX3;BOLA2	None	Results suggest that the BOLA2-GLRX3 complex is conserved in higher eukaryotes and may play a role in signaling cellular iron status in humans.	None
GATB-GATC-QRSL1 complex	O43716;O75879;Q9H0R6	283459;5188;55278	glutamyl-tRNA aminoacylation;mitochondrion;glutaminyl-tRNAGln biosynthesis via transamidation	mitochondrion	GATC;GATB;QRSL1	None	None	None
BICD2-dynein-dynactin complex	O14576;Q14203;Q8TD16	1780;1639;23299	regulation of mitotic spindle organization	None	DYNC1I1;DCTN1;BICD2	Disease-related point mutations in BICD2 increase binding to dynein/dynactin and motility (PMID: 28883039).	None	"OMIM:615290 Spinal muscular atrophy, lower extremity-predominant, 2; SMALED2"
CTNNB1-GID8 complex	P35222;Q9NWU2	1499;54994	nucleus;canonical Wnt signaling pathway	nucleus	CTNNB1;GID8	None	GID8 (TWA1) is a regulator of the Wnt pathway promoting colorectal tumorigenesis by facilitating beta-catenin nuclear retention.	GID8 (TWA1) is significantly upregulated in human CRC tissues and correlates with a poor prognosis for CRC patients.
AXIN1-GID8-GSK3B complex	O15169;P49841;Q9NWU2	8312;2932;54994	canonical Wnt signaling pathway;cytoplasm	cytoplasm	AXIN1;GSK3B;GID8	None	"GID8 (TWA1) is a regulator of the Wnt pathway promoting colorectal tumorigenesis by facilitating beta-catenin nuclear retention.Data indicate that in the absence of Wnt signal, GID8 is targeted by the Axin complex for ubiquitination and degradation."	GID8 (TWA1) is significantly upregulated in human CRC tissues and correlates with a poor prognosis for CRC patients.
"Serine-palmitoyltransferase (SPTLC1, SPTLC2) complex"	O15269;O15270	10558;9517	None	None	SPTLC1;SPTLC2	None	Serine-palmitoyltransferase (SPT) catalyzes the rate-limiting step of the de novo synthesis of sphingolipids.	None
"Serine-palmitoyltransferase (SPTLC1, SPTLC2, SPTLC3) complex"	O15269;O15270;Q9NUV7	10558;9517;55304	endoplasmic reticulum;palmitoyltransferase activity;palmitoyltransferase complex;sphingolipid biosynthetic process	endoplasmic reticulum	SPTLC1;SPTLC2;SPTLC3	None	"SPT (serine palmitoyltransferase) catalyses the rate-limiting step for the de novo synthesis of sphingolipids. It is concluded that the functional SPT is not a dimer, but a higher organized complex, composed of three distinct subunits (SPTLC1, SPTLC2 and SPTLC3) with a molecular mass of 480 kDa. The stoichiometry of SPTLC2 and SPTLC3 seems not to be fixed and is probably changed dynamically in dependence of the tissue specific SPTLC2 and SPTLC3 expression levels. A model of an octameric SPT structure is proposed."	None
"Serine-palmitoyltransferase (SPTLC1, SPTLC3, ssSPTb) complex"	O15269;Q8NFR3;Q9NUV7	10558;165679;55304	endoplasmic reticulum;palmitoyltransferase activity;palmitoyltransferase complex;sphingolipid biosynthetic process	endoplasmic reticulum	SPTLC1;SPTSSB;SPTLC3	None	"Serine palmitoyltransferase (SPT) catalyzes the first committed step in sphingolipid biosynthesis. The two small subunit isoforms of SPT, ssSPTa and ssSPTb, share a conserved hydrophobic central domain predicted to reside in the membrane, and each interacts with both hLCB1 and hLCB2. The resulting four SPT isozymes have distinct Acyl-CoA preferences and synthesize different LCBs ( long-chain bases). The most active and selective isozyme was hLCB1-hLCB2a-ssSPTa showing a strong preference for C16-CoA . The hLCB1-hLCB2b-ssSPTa isozyme used C14-CoA as well. The hLCB1-hLCB2a-ssSPTb enzyme showed a clear preference for C18-CoA, whereas the hLCB1-hLCB2b-ssSPTb multimer displayed an ability to use a broader range of acyl-CoAs, without apparent preference. Isozymes containing the ssSPTb subunit preferred longer acyl-CoAs."	HSAN1 (Hereditary sensory autonomic neuropathy 1) is the result of dominant mutations in hLCB1.It has been presumed that these mutations lead to a 50%  decrease in SPT activity in all tissues.
"Serine-palmitoyltransferase (SPTLC1, SPTLC3, ssSPTa) complex"	O15269;Q969W0;Q9NUV7	10558;171546;55304	endoplasmic reticulum;palmitoyltransferase activity;palmitoyltransferase complex;sphingolipid biosynthetic process	endoplasmic reticulum	SPTLC1;SPTSSA;SPTLC3	None	"Serine palmitoyltransferase (SPT) catalyzes the first committed step in sphingolipid biosynthesis. The two small subunit isoforms of SPT, ssSPTa and ssSPTb, share a conserved hydrophobic central domain predicted to reside in the membrane, and each interacts with both hLCB1 and hLCB2. The resulting four SPT isozymes have distinct Acyl-CoA preferences and synthesize different LCBs ( long-chain bases). The most active and selective isozyme was hLCB1-hLCB2a-ssSPTa showing a strong preference for C16-CoA . The hLCB1-hLCB2b-ssSPTa isozyme used C14-CoA as well. The hLCB1-hLCB2a-ssSPTb enzyme showed a clear preference for C18-CoA, whereas the hLCB1-hLCB2b-ssSPTb multimer displayed an ability to use a broader range of acyl-CoAs, without apparent preference. Isozymes containing the ssSPTb subunit preferred longer acyl-CoAs."	HSAN1 (Hereditary sensory autonomic neuropathy 1) is the result of dominant mutations in hLCB1.It has been presumed that these mutations lead to a 50% decrease in SPT activity in all tissues.
"Serine-palmitoyltransferase (SPTLC1, SPTLC2, ssSPTb) complex"	O15269;O15270;Q8NFR3	10558;9517;165679	endoplasmic reticulum;palmitoyltransferase activity;palmitoyltransferase complex;sphingolipid biosynthetic process	endoplasmic reticulum	SPTLC1;SPTLC2;SPTSSB	None	"Serine palmitoyltransferase (SPT) catalyzes the first committed step in sphingolipid biosynthesis. The two small subunit isoforms of SPT, ssSPTa and ssSPTb, share a conserved hydrophobic central domain predicted to reside in the membrane, and each interacts with both hLCB1 and hLCB2. The resulting four SPT isozymes have distinct Acyl-CoA preferences and synthesize different LCBs ( long-chain bases). The most active and selective isozyme was hLCB1-hLCB2a-ssSPTa showing a strong preference for C16-CoA . The hLCB1-hLCB2b-ssSPTa isozyme used C14-CoA as well. The hLCB1-hLCB2a-ssSPTb enzyme showed a clear preference for C18-CoA, whereas the hLCB1-hLCB2b-ssSPTb multimer displayed an ability to use a broader range of acyl-CoAs, without apparent preference. Isozymes containing the ssSPTb subunit preferred longer acyl-CoAs."	HSAN1 (Hereditary sensory autonomic neuropathy 1) is the result of dominant mutations in hLCB1.It has been presumed that these mutations lead to a 50% decrease in SPT activity in all tissues.
"Serine-palmitoyltransferase (SPTLC1, SPTLC2, ssSPTa) complex"	O15269;O15270;Q969W0	10558;9517;171546	endoplasmic reticulum;palmitoyltransferase activity;palmitoyltransferase complex;sphingolipid biosynthetic process	endoplasmic reticulum	SPTLC1;SPTLC2;SPTSSA	None	"Serine palmitoyltransferase (SPT) catalyzes the first committed step in sphingolipid biosynthesis. The two small subunit isoforms of SPT, ssSPTa and ssSPTb, share a conserved hydrophobic central domain predicted to reside in the membrane, and each interacts with both hLCB1 and hLCB2. The resulting four SPT isozymes have distinct Acyl-CoA preferences and synthesize different LCBs ( long-chain bases). The most active and selective isozyme was hLCB1-hLCB2a-ssSPTa showing a strong preference for C16-CoA . The hLCB1-hLCB2b-ssSPTa isozyme used C14-CoA as well. The hLCB1-hLCB2a-ssSPTb enzyme showed a clear preference for C18-CoA, whereas the hLCB1-hLCB2b-ssSPTb multimer displayed an ability to use a broader range of acyl-CoAs, without apparent preference. Isozymes containing the ssSPTb subunit preferred longer acyl-CoAs."	HSAN1 (Hereditary sensory autonomic neuropathy 1)  is the result of dominant mutations in hLCB1.It has been presumed that these mutations lead to a 50% decrease in SPT activity in all tissues.
JUN-FBW7-PRR7 complex	P05412;Q8TB68;Q969H0	3725;80758;55294	regulation of JUN kinase activity	None	JUN;PRR7;FBXW7	None	PRR7 inhibits the ubiquitination of c-Jun by FBW7. This increases c-Jun-dependent transcriptional activity and promotes neuronal death.	None
ORMDL3-SPTLC1 complex	O15269;Q8N138	10558;94103	negative regulation of sphingolipid biosynthetic process	None	SPTLC1;ORMDL3	None	"Orm proteins as negative regulators of sphingolipid synthesis form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. Phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. The authors describe the SPOTS complex (= Serine-palmitoyltransferase LBC1/2)-(ORMDL1/2)-TSC3-SAC1 complex) in S.cerevisiae and conclude via analysis in human cells (mass spectrometry, immunoprecipitations) that the yeast functional complex between Orm proteins (= ORMDL in humans) and serine palmitoyltransferase is also conserved in human cells."	None
ProTalpha C2 complex	P06454;P49006;P60709;Q01105	5757;65108;60;6418	negative regulation of apoptotic process;cell proliferation	anti-apoptosis	PTMA;MARCKSL1;ACTB;SET	None	None	None
ProTalpha C5 complex	P06454;P25786;P39687;Q00325;Q07021	5757;5682;8125;5250;708	ethanolamine-phosphate cytidylyltransferase activity	None	PTMA;PSMA1;ANP32A;SLC25A3;C1QBP	None	None	None
ProTalpha C7 complex	P06454;P39687;Q92688	5757;8125;10541	negative regulation of apoptotic process;cell proliferation	anti-apoptosis	PTMA;ANP32A;ANP32B	None	None	None
ProTalpha C8 complex	P06454;P39687;P62491;Q92688	5757;8125;8766;10541	negative regulation of apoptotic process;cell proliferation	anti-apoptosis	PTMA;ANP32A;RAB11A;ANP32B	None	None	None
ProTalpha C9 complex	P06454;Q01105	5757;6418	negative regulation of apoptotic process;cell proliferation	anti-apoptosis	PTMA;SET	None	None	None
THSD1-FAK-talin-vinculin complex	P18206;Q05397;Q9NS62;Q9Y490	7414;5747;55901;7094	regulation of focal adhesion assembly	None	VCL;PTK2;THSD1;TLN1	None	None	The harmful variants in THSD1 (Thrombospondin type-1 domain-containing protein 1) likely cause intracranial aneurysm and subarachnoid hemorrhage in a subset of both familial and sporadic patients with supporting evidence from two vertebrate models (PMID:29069646).
ABI3-WAVE2-CYFIP1 complex	Q7L576;Q9P2A4;Q9Y6W5	23191;51225;10163	regulation of phosphatidylinositol 3-kinase signaling	None	CYFIP1;ABI3;WASF2	None	None	None
FGF1-ITGAV-ITGB3 complex	P05106;P05230;P06756	3690;2246;3685	fibroblast growth factor receptor signaling pathway	FGF-receptor signalling pathway	ITGB3;FGF1;ITGAV	None	"The direct binding of FGF1 to soluble and cell-surface integrin alphavbeta3 (= ITGAV-ITGB3) plays a role in FGF1 signaling. An FGF1 mutant (R50E) was identified that was defective in integrin binding but still bound to heparin and FGFR. R50E was defective in inducing DNA synthesis, cell proliferation, cell migration, and chemotaxis, suggesting that the direct integrin binding to FGF1 is critical for FGF signaling."	FGF1 and FGF2 are responsible for resistance to chemotherapeuticagents in cancer and are also pro-inflammatory growth factors that play a role in pathological angiogenesis in chronic inflammatory diseases.
JIP1-JIP2 complex	Q13387;Q9UQF2	23542;9479	regulation of anterograde axonal transport of mitochondrion	None	MAPK8IP2;MAPK8IP1	None	None	None
ADIPOQ-PLOD3-GLT25D1 complex	O60568;Q15848;Q8NBJ5	8985;9370;79709	regulation of lipid transport	None	PLOD3;ADIPOQ;COLGALT1	None	None	None
ST3GAL6-EGFR complex	P00533;Q9Y274	1956;10402	regulation of cell migration	None	EGFR;ST3GAL6	None	None	"OMIM:167000 Ovarian Cancer, Epithelial(PMID:28423672)."
SEPHS1-SEPHS2-SEPSECS-SECp43 complex	P49903;Q80VC6;Q99611;Q9HD40	22929;71787;22928;51091	selenocysteine incorporation;selenocysteine metabolic process	selenocystein biosynthesis and incorporation	SEPHS1;Trnau1ap;SEPHS2;SEPSECS	None	None	None
PLOD2-FKBP10 complex	O00469;Q96AY3	5352;60681	None	None	PLOD2;FKBP10	None	None	OMIM:259450 Bruck syndrome 1.OMIM:609220 Bruck syndrome 2 (PMID:28378777).
CAPZA3-CAPZB complex	P47756;Q96KX2	832;93661	spermatogenesis	None	CAPZB;CAPZA3	None	None	None
HTT-DISC1-PDE4B complex	P42858;Q07343;Q9NRI5	3064;5142;27185	None	None	HTT;PDE4B;DISC1	None	None	OMIM:143100 Huntington disease (PMID:28263187).
PP2A-NR3A complex	P30153;P63151;P67775;Q8TCU5	5518;5520;5515;116443	regulation of synaptic plasticity;regulation of phosphoprotein phosphatase activity	None	PPP2R1A;PPP2R2A;PPP2CA;GRIN3A	"Since the authors did not specify A and C subunit of the PP2A complex, we used isoform  PPP2R1A and PPP2CA."	None	None
FERMT3-RACK1 complex	P63244;Q86UX7	10399;83706	integrin alphaL-beta2 complex;scaffold protein binding;integrin-mediated signaling pathway	integrin receptor signalling pathway	RACK1;FERMT3	None	"Kindlin-3 (= FERMT3) is involved in integrin alphaLbeta2 outside-in signaling, induces integrin alphaLbeta2 clustering, and interacts with the scaffold protein, the receptor for activated-C kinase 1, RACK1. This interaction involves the pleckstrin homology domain of kindlin-3 and blades 5\u20137 of RACK1. It is show that integrin alphaLbeta2 engagement by its ligand ICAM-1 promotes the association of kindlin-3 with RACK1."	None
ITGB1-RACK1 complex	P05556;P63244	3688;10399	protein kinase C binding;regulation of integrin-mediated signaling pathway	None	ITGB1;RACK1	None	"The integrin beta subunit cytoplasmic domains are important for activation-dependent cell adhesion and adhesion-dependent signaling events. An interaction between integrin beta subunit cytoplasmic domain and Rack1, a Trp-Asp (WD) repeat protein that bind activated protein kinase C, has been shown. The Rack1-binding site on integrin beta 2 subunit resides within a conserved, membrane-proximal region. Rack1 co-immunoprecipitates with at least two different beta integrins, beta 1 integrins in 293T cells and beta 2 integrins in JY lymphoblastoid cells. The findings suggest that Rack1 may link protein kinase C directly to integrins and participate in the regulation of integrin functions."	None
ITGB2-RACK1 complex	P05107;P63244	3689;10399	protein kinase C binding;regulation of integrin-mediated signaling pathway	None	ITGB2;RACK1	None	"The integrin beta subunit cytoplasmic domains are important for activation-dependent cell adhesion and adhesion-dependent signaling events. An interaction between integrin beta subunit cytoplasmic domain and Rack1, a Trp-Asp (WD) repeat protein that bind activated protein kinase C, has been shown. The Rack1-binding site on integrin beta 2 subunit resides within a conserved, membrane-proximal region. Rack1 co-immunoprecipitates with at least two different beta integrins, beta 1 integrins in 293T cells and beta 2 integrins in JY lymphoblastoid cells. The findings suggest that Rack1 may link protein kinase C directly to integrins and participate in the regulation of integrin functions."	None
GNAI1-GNGT1-GNB1 complex	P62873;P63096;P63211	2782;2770;2792	None	None	GNB1;GNAI1;GNGT1	None	None	None
GNAI1-GNB2-GNGT1 complex	P62879;P63096;P63211	2783;2770;2792	None	None	GNB2;GNAI1;GNGT1	None	None	None
GNAI1-GNB3-GNGT1 complex	P16520;P63096;P63211	2784;2770;2792	None	None	GNB3;GNAI1;GNGT1	None	None	None
GNAI1-GNB4-GNGT1 complex	P63096;P63211;Q9HAV0	2770;2792;59345	None	None	GNAI1;GNGT1;GNB4	None	None	None
GNAI1-GNB5-GNGT1 complex	O14775;P63096;P63211	10681;2770;2792	None	None	GNB5;GNAI1;GNGT1	None	None	None
GNAI1-GNB1-GNG2 complex	P59768;P62873;P63096	54331;2782;2770	None	None	GNG2;GNB1;GNAI1	None	None	None
GNAI1-GNB2-GNG2 complex	P59768;P62879;P63096	54331;2783;2770	None	None	GNG2;GNB2;GNAI1	None	None	None
GNAI1-GNB3-GNG2 complex	P16520;P59768;P63096	2784;54331;2770	None	None	GNB3;GNG2;GNAI1	None	None	None
GNAI1-GNB4-GNG2 complex	P59768;P63096;Q9HAV0	54331;2770;59345	None	None	GNG2;GNAI1;GNB4	None	None	None
GNAI1-GNB5-GNG2 complex	O14775;P59768;P63096	10681;54331;2770	None	None	GNB5;GNG2;GNAI1	None	None	None
GNAI1-GNB1-GNG3 complex	P62873;P63096;P63215	2782;2770;2785	None	None	GNB1;GNAI1;GNG3	None	None	None
GNAI1-GNB2-GNG3 complex	P62879;P63096;P63215	2783;2770;2785	None	None	GNB2;GNAI1;GNG3	None	None	None
GNAI1-GNB3-GNG3 complex	P16520;P63096;P63215	2784;2770;2785	None	None	GNB3;GNAI1;GNG3	None	None	None
GNAI1-GNB4-GNG3 complex	P63096;P63215;Q9HAV0	2770;2785;59345	None	None	GNAI1;GNG3;GNB4	None	None	None
GNAI1-GNB5-GNG3 complex	O14775;P63096;P63215	10681;2770;2785	None	None	GNB5;GNAI1;GNG3	None	None	None
DCP1A-NR3C1-PNRC2-UPF1-complex	P04150;Q92900;Q9NPI6;Q9NPJ4	2908;5976;55802;55629	nuclear-transcribed mRNA catabolic process;regulation of monocyte chemotaxis	None	NR3C1;UPF1;DCP1A;PNRC2	None	Dexamethasone treatment triggers efficient formation of the DCP1A-NR3C1-PNRC2-UPF1-complex. The authors demonstrate that 'Glucocorticoid receptor-mediated mRNA decay' (GMD) targets a subset of cellular mRNAs. Results suggest that GMD plays an important role in the chemotaxis of monocytes via regulation of CCL2 mRNA stability.	None
GNAI1-GNB1-GNG4 complex	P50150;P62873;P63096	2786;2782;2770	None	None	GNG4;GNB1;GNAI1	None	None	None
GNAI1-GNB2-GNG4 complex	P50150;P62879;P63096	2786;2783;2770	None	None	GNG4;GNB2;GNAI1	None	None	None
GNAI1-GNB3-GNG4 complex	P16520;P50150;P63096	2784;2786;2770	None	None	GNB3;GNG4;GNAI1	None	None	None
GNAI1-GNB4-GNG4 complex	P50150;P63096;Q9HAV0	2786;2770;59345	None	None	GNG4;GNAI1;GNB4	None	None	None
GNAI1- GNB5-GNG4 complex	O14775;P50150;P63096	10681;2786;2770	None	None	GNB5;GNG4;GNAI1	None	None	None
GNAI1-GNB1-GNG5 complex	P62873;P63096;P63218	2782;2770;2787	None	None	GNB1;GNAI1;GNG5	None	None	None
GNAI1-GNB2-GNG5 complex	P62879;P63096;P63218	2783;2770;2787	None	None	GNB2;GNAI1;GNG5	None	None	None
BVR-PKCD-ERK2 complex	P28482;P53004;Q05655	5594;644;5580	regulation of ERK1 and ERK2 cascade;cell proliferation	None	MAPK1;BLVRA;PRKCD	None	"The BVR-PKCdelta-ERK2 ternary complex is essential for ERK2 signal transduction and activation of genes are linked to cell proliferation and cancer. MEK1/2 and the protein phosphatase PP2A were also present in the complex. hBVR and ERK2 were phosphorylated by PKCdelta. hBVR was required for the activation of PKCdelta and its interaction with ERK2. The C-terminal phenylalanine residues of PKCdelta (Phe(660), Phe(663), and Phe(665)) were necessary for binding to ERK2 but not for hBVR binding. Formation of the hBVR-PKCdelta-ERK2 complex required the hBVR docking site for ERK, FXFP (DEF, C-box) and D(delta)-box (ILXXLXL) motifs."	None
PDZK1-PLCB3-SSTR5 complex	P35346;Q01970;Q5T2W1	6755;5331;5174	somatostatin signaling pathway;type 5 somatostatin receptor binding;G-protein coupled receptor signaling pathway	G-protein coupled receptor signalling pathway	SSTR5;PLCB3;PDZK1	None	"Phospholipase C-beta (PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. The formation of complexes between somatostatin receptors (SSTRs 1-5), PDZK1 (PDZ domain-containing 1), and PLC-beta3 is essential for the specific activation of PLC-beta3 and the subsequent physiologic responses by somatostatin (SST). SSTR5 not only interacted with PDZK1 but also interacted with endogenous PLC-beta3, but not with PLC-beta1. It was also confirmed that other SSTR isotypes (SSTR1-4) interact with PDZK1 and form complexes with PLC-beta3."	None
PDZK1-PLCB3- SSTR1 complex	P30872;Q01970;Q5T2W1	6751;5331;5174	G-protein coupled receptor signaling pathway;somatostatin signaling pathway;type 1 somatostatin receptor binding	G-protein coupled receptor signalling pathway	SSTR1;PLCB3;PDZK1	None	"Phospholipase C-beta (PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. The formation of complexes between somatostatin receptors (SSTRs 1-5), PDZK1 (PDZ domain-containing 1), and PLC-beta3 is essential for the specific activation of PLC-beta3 and the subsequent physiologic responses by somatostatin (SST)."	None
PDZK1-PLCB3- SSTR2 complex	P30874;Q01970;Q5T2W1	6752;5331;5174	G-protein coupled receptor signaling pathway;somatostatin signaling pathway;type 2 somatostatin receptor binding	G-protein coupled receptor signalling pathway	SSTR2;PLCB3;PDZK1	None	"Phospholipase C-beta (PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. The formation of complexes between somatostatin receptors (SSTRs 1-5), PDZK1 (PDZ domain-containing 1), and PLC-beta3 is essential for the specific activation of PLC-beta3 and the subsequent physiologic responses by somatostatin (SST)."	None
PDZK1-PLCB3- SSTR3 complex	P32745;Q01970;Q5T2W1	6753;5331;5174	G-protein coupled receptor signaling pathway;somatostatin signaling pathway;type 3 somatostatin receptor binding	G-protein coupled receptor signalling pathway	SSTR3;PLCB3;PDZK1	None	"Phospholipase C-beta (PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. The formation of complexes between somatostatin receptors (SSTRs 1-5), PDZK1 (PDZ domain-containing 1), and PLC-beta3 is essential for the specific activation of PLC-beta3 and the subsequent physiologic responses by somatostatin (SST)."	None
PDZK1-PLCB3- SSTR4 complex	P31391;Q01970;Q5T2W1	6754;5331;5174	G-protein coupled receptor signaling pathway;somatostatin signaling pathway;type 4 somatostatin receptor binding	G-protein coupled receptor signalling pathway	SSTR4;PLCB3;PDZK1	None	"Phospholipase C-beta (PLC-beta) is a key molecule in G protein-coupled receptor (GPCR)-mediated signaling. The formation of complexes between somatostatin receptors (SSTRs 1-5), PDZK1 (PDZ domain-containing 1), and PLC-beta3 is essential for the specific activation of PLC-beta3 and the subsequent physiologic responses by somatostatin (SST)."	None
IFNAR1-IFNAR2-IFNW1 complex	P05000;P17181;P48551	3467;3454;3455	cytokine activity;cytokine receptor binding;type I interferon receptor binding	"cytokines (interleukines, colony stimulating factors, etc.)"	IFNW1;IFNAR1;IFNAR2	None	Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer.	None
IFNAR2-IFNA2 complex	P01563;P48551	3440;3455	cytokine activity;cytokine receptor binding;type I interferon receptor binding	"cytokines (interleukines, colony stimulating factors, etc.)"	IFNA2;IFNAR2	None	Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer.	None
IFNAR1-IFNAR2-IFNA2 complex	P01563;P17181;P48551	3440;3454;3455	cytokine activity;cytokine receptor binding;type I interferon receptor binding	"cytokines (interleukines, colony stimulating factors, etc.)"	IFNA2;IFNAR1;IFNAR2	None	Type I Interferons (IFNs) are important cytokines for innate immunity against viruses and cancer.	None
TLR1-TLR2 complex	O60603;Q15399	7097;7096	Toll-like receptor binding;immune response	immune response	TLR2;TLR1	None	"TLR2 in association with TLR1 or TLR6 plays an important role in the innate immune response by recognizing microbial lipoproteins and lipopeptides. Binding of the tri-acylated lipopeptide, Pam(3)CSK(4), induced the formation of an ""m"" shaped heterodimer of the TLR1 and TLR2 ectodomains whereas binding of the di-acylated lipopeptide, Pam(2)CSK(4), did not. The three lipid chains of Pam(3)CSK(4) mediate the heterodimerization of the receptor; the two ester-bound lipid chains are inserted into a pocket in TLR2, while the amide-bound lipid chain is inserted into a hydrophobic channel in TLR1. An extensive hydrogen-bonding network, as well as hydrophobic interactions, between TLR1 and TLR2 further stabilize the heterodimer."	None
TLR1-TLR2-lipoprotein complex	O60603;Q15399	7097;7096	immune response;Toll-like receptor binding	immune response	TLR2;TLR1	None	Human lipopolysaccharide-binding protein LBP and CD14 independently deliver triacylated lipoproteins to Toll-likereceptors TLR1 and TLR2 and enhance formation of the TLR1-TLR2-lipopeptide ternary complex but are not part of the stable ternary complex.	None
PIAS1-SUMO1-UBC9 complex	O75925;P63165;P63279	8554;7341;7329	SUMO binding;SUMO ligase activity;transcription corepressor activity	None	PIAS1;SUMO1;UBE2I	None	"UBC9 and PIAS1 are engaged both in a canonical E2\u00b7E3 interaction as well as assembled into a previously unidentified non-covalent ternary complex with SUMO as evidenced by bioluminescence resonance energy transfer, nuclear magnetic resonance spectroscopy, and isothermal titration calorimetry studies. In this ternary complex, SUMO functions as a bridge by forming non-overlapping interfaces with UBC9 and PIAS1. Data suggest that phosphorylation of serine residues adjacent to the PIAS1 SUMO-interacting motif favors formation of the non covalent PIAS1\u00b7SUMO\u00b7UBC9 ternary complex. The non-covalent ternary complex is required for the known transcriptional repression activities mediated by UBC9 and SUMO1."	None
OTUB1-UBC13-MMS2 complex	P61088;Q15819;Q96FW1	7334;7336;55611	ubiquitin protein ligase binding;protein deubiquitination;protein ubiquitination;regulation of DNA repair;double-strand break repair;protein polyubiquitination;ubiquitin-protein transferase activity	"modification by ubiquitination, deubiquitination"	UBE2N;UBE2V2;OTUB1	None	A deubiquitinating enzyme OTUB1 inhibits Lys-63-linked ubiquitination by binding to a ubiquitin-conjugating enzyme UBC13. The mechanism of human OTUB1-UBC13 interaction was revealed by human OTUB1-UBC13-MMS2 complex structure and structure-based mutagenesis. The atomic-level interactions presented by the OTUB1-UBC13-MMS2 complex structure are critical for Lys-63-linked ubiquitination inhibition.	None
Propionyl-CoA carboxylase	P05165;P05166	5095;5096	mitochondrion;biotin binding;propionyl-CoA carboxylase activity	mitochondrion;biotin binding	PCCA;PCCB	None	"The holoenzyme of Propionyl-coenzyme A carboxylase is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa. Biotin is an obligate co-factor."	Deficiencies in the biotin-dependent enzyme propionyl-coenzyme A carboxylase are linked to propionic acidemia. (PMID:29033250)
KRIT1-HEG1-RAP1B complex	O00522;P61224;Q9ULI3	889;5908;57493	GTPase activity;plasma membrane	eukaryotic plasma membrane / membrane attached	KRIT1;RAP1B;HEG1	None	"KRIT1 FERM domain can bind Rap1 GTPase and HEG1 cytoplasmic tail. The biological function of KRIT1 requires that its FERM (band 4.1, ezrin, radixin, moesin) domain physically interact with both the small GTPase Rap1 and the cytoplasmic tail of the Heart of glass (HEG1) membrane anchor."	"CCMs (Cerebral Cavernous Malformations ) occur in both sporadic and autosomal dominant inherited forms, and the latter are due to heterozygous mutations at three loci, CCM1 (KRIT1), CCM2 (OSM), and CCM3 (PDCD10)."
GNAI1-GNB3-GNG5 complex	P16520;P63096;P63218	2784;2770;2787	None	None	GNB3;GNAI1;GNG5	None	None	None
GNAI1-GNB4-GNG5 complex	P63096;P63218;Q9HAV0	2770;2787;59345	None	None	GNAI1;GNG5;GNB4	None	None	None
GNAI1-GNB5-GNG5 complex	O14775;P63096;P63218	10681;2770;2787	None	None	GNB5;GNAI1;GNG5	None	None	None
NFAT5-WWTR1 complex	O94916;Q9GZV5	10725;25937	response to osmotic stress	osmosensing  and response	NFAT5;WWTR1	None	None	None
C9orf72-SMCR8-WDR41 complex	Q8TEV9;Q96LT7;Q9HAD4	140775;203228;55255	autophagy;Golgi membrane	None	SMCR8;C9orf72;WDR41	None	"The ALS (amyotrophic lateral sclerosis) and FTLD (frontotemporal lobar degeneration) associated protein C9orf72 interacts with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. WDR41 is tightly associated with the Golgi complex. WDR41 interacts with the C9orf72/SMCR8 dimer to form ternary complex, which then interacts with the FIP200/Ulk1/ATG13/ATG101 complex."	Hexanucleotide repeat expansion in the C9orf72 gene has been shown to be the main cause of ALS (amyotrophic lateral sclerosis) / FTLD (frontotemporal lobar degeneration).
C9orf72-SMCR8 complex	Q8TEV9;Q96LT7	140775;203228	autophagy;Golgi membrane	None	SMCR8;C9orf72	None	"The ALS (amyotrophic lateral sclerosis) and FTLD (frontotemporal lobar degeneration) associated protein C9orf72 interacts with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. WDR41 is tightly associated with the Golgi complex. WDR41 interacts with the C9orf72/SMCR8 dimer to form ternary complex, which then interacts with the FIP200/Ulk1/ATG13/ATG101 complex."	Hexanucleotide repeat expansion in the C9orf72 gene has been shown to be the main cause of ALS (amyotrophic lateral sclerosis) / FTLD (frontotemporal lobar degeneration).
WDR41-(C9orf72-SMCR8)-(FIP200-ULK1-ATG13-ATG101) complex	O75143;O75385;Q8TDY2;Q8TEV9;Q96LT7;Q9BSB4;Q9HAD4	9776;8408;9821;140775;203228;60673;55255	autophagy;Golgi membrane	None	ATG13;ULK1;RB1CC1;SMCR8;C9orf72;ATG101;WDR41	None	"The ALS (amyotrophic lateral sclerosis) and FTLD (frontotemporal lobar degeneration) associated protein C9orf72 interacts with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. WDR41 is tightly associated with the Golgi complex. WDR41 interacts with the C9orf72/SMCR8 dimer to form ternary complex, which then interacts with the FIP200/Ulk1/ATG13/ATG101 complex."	Hexanucleotide repeat expansion in the C9orf72 gene has been shown to be the main cause of ALS (amyotrophic lateral sclerosis) / FTLD (frontotemporal lobar degeneration).
GNAI1-GNB1-GNG7 complex	O60262;P62873;P63096	2788;2782;2770	None	None	GNG7;GNB1;GNAI1	None	None	None
GNAI1-GNB2-GNG7 complex	O60262;P62879;P63096	2788;2783;2770	None	None	GNG7;GNB2;GNAI1	None	None	None
GNAI1-GNB3-GNG7 complex	O60262;P16520;P63096	2788;2784;2770	None	None	GNG7;GNB3;GNAI1	None	None	None
GNAI1-GNB4-GNG7 complex	O60262;P63096;Q9HAV0	2788;2770;59345	None	None	GNG7;GNAI1;GNB4	None	None	None
GNAI1-GNB5-GNG7 complex	O14775;O60262;P63096	10681;2788;2770	None	None	GNB5;GNG7;GNAI1	None	None	None
GNAI1-GNB1-GNG8 complex	P62873;P63096;Q9UK08	2782;2770;94235	None	None	GNB1;GNAI1;GNG8	None	None	None
GNAI1-GNB2-GNG8 complex	P62879;P63096;Q9UK08	2783;2770;94235	None	None	GNB2;GNAI1;GNG8	None	None	None
GNAI1-GNB3-GNG8 complex	P16520;P63096;Q9UK08	2784;2770;94235	None	None	GNB3;GNAI1;GNG8	None	None	None
GNAI1-GNB4-GNG8 complex	P63096;Q9HAV0;Q9UK08	2770;59345;94235	None	None	GNAI1;GNB4;GNG8	None	None	None
GNAI1-GNB5-GNG8 complex	O14775;P63096;Q9UK08	10681;2770;94235	None	None	GNB5;GNAI1;GNG8	None	None	None
GNAI1-GNB1-GNG10 complex	P50151;P62873;P63096	2790;2782;2770	None	None	GNG10;GNB1;GNAI1	None	None	None
GNAI1-GNB2-GNG10 complex	P50151;P62879;P63096	2790;2783;2770	None	None	GNG10;GNB2;GNAI1	None	None	None
GNAI1-GNB3-GNG10 complex	P16520;P50151;P63096	2784;2790;2770	None	None	GNB3;GNG10;GNAI1	None	None	None
GNAI1-GNB4-GNG10 complex	P50151;P63096;Q9HAV0	2790;2770;59345	None	None	GNG10;GNAI1;GNB4	None	None	None
GNAI1-GNB5-GNG10 complex	O14775;P50151;P63096	10681;2790;2770	None	None	GNB5;GNG10;GNAI1	None	None	None
GNAI1-GNB1-GNG11 complex	P61952;P62873;P63096	2791;2782;2770	None	None	GNG11;GNB1;GNAI1	None	None	None
GNAI1-GNB2-GNG11 complex	P61952;P62879;P63096	2791;2783;2770	None	None	GNG11;GNB2;GNAI1	None	None	None
GNAI1-GNB3-GNG11 complex	P16520;P61952;P63096	2784;2791;2770	None	None	GNB3;GNG11;GNAI1	None	None	None
GNAI1-GNB4-GNG11 complex	P61952;P63096;Q9HAV0	2791;2770;59345	None	None	GNG11;GNAI1;GNB4	None	None	None
GNAI1-GNB5-GNG11 complex	O14775;P61952;P63096	10681;2791;2770	None	None	GNB5;GNG11;GNAI1	None	None	None
GNAI1-GNB1-GNG12 complex	P62873;P63096	2782;2770	None	None	GNB1;GNAI1	None	None	None
GNAI1-GNB2-GNG12 complex	P62879;P63096;Q9UBI6	2783;2770;55970	None	None	GNB2;GNAI1;GNG12	None	None	None
GNAI1-GNB3-GNG12 complex	P16520;P63096;Q9UBI6	2784;2770;55970	None	None	GNB3;GNAI1;GNG12	None	None	None
GNAI1-GNB4-GNG12 complex	P63096;Q9HAV0;Q9UBI6	2770;59345;55970	None	None	GNAI1;GNB4;GNG12	None	None	None
GNAI1-GNB5-GNG12 complex	O14775;P63096;Q9UBI6	10681;2770;55970	None	None	GNB5;GNAI1;GNG12	None	None	None
FIP200-ULK1-ATG13-ATG101 complex	O75143;O75385;Q8TDY2;Q9BSB4	9776;8408;9821;60673	autophagy	None	ATG13;ULK1;RB1CC1;ATG101	None	"WDR41 interacts with the C9orf72/SMCR8 dimer to form ternary complex, which then interacts with the FIP200/Ulk1/ATG13/ATG101 complex, which is essential for autophagy initiation."	None
GNAI1-GNB1-GNG13 complex	P62873;P63096;Q9P2W3	2782;2770;51764	None	None	GNB1;GNAI1;GNG13	None	None	None
GNAI1-GNB2-GNG13 complex	P62879;P63096;Q9P2W3	2783;2770;51764	None	None	GNB2;GNAI1;GNG13	None	None	None
GNAI1-GNB3-GNG13 complex	P16520;P63096;Q9P2W3	2784;2770;51764	None	None	GNB3;GNAI1;GNG13	None	None	None
GNAI1-GNB4-GNG13 complex	P63096;Q9HAV0;Q9P2W3	2770;59345;51764	None	None	GNAI1;GNB4;GNG13	None	None	None
GNAI1-GNB5-GNG13 complex	O14775;P63096;Q9P2W3	10681;2770;51764	None	None	GNB5;GNAI1;GNG13	None	None	None
GNAS-L-GNB1-GNG1 complex	P62873;P63092;P63211	2782;2778;2792	None	None	GNB1;GNAS;GNGT1	None	None	None
ASAH1-NR5A1 complex	Q13285;Q13510	2516;427	"transcription coactivator activity;RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding"	None	NR5A1;ASAH1	None	The ability of the ASAH1 (acid ceramidase) to repress SF-1 (Steroidogenic Factor 1)-dependent gene transcription in H295R human adrenocortical cells requires a direct interaction with the receptor.	None
ASAH1-NR5A1-SAPD complex	P07602;Q13285;Q13510	5660;2516;427	"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding;transcription coactivator activity"	None	PSAP;NR5A1;ASAH1	"The saponsin precursor is proteolytically processed to generate four main cleavage products including saposins A, B, C, and D. As no UniProtId is given for SAP-D, the ID of prosaposin is used."	ASAH1 and its coactivator protein SAP-D are expressed in the nuclear envelope and nucleoplasmic fractions. Endogenous ASAH1 and SAP-D coimmunoprecipitate with SF-1.	None
DNAAF2-HEATR2-SPAG1 complex	Q07617;Q86Y56;Q9NVR5	6674;54919;55172	cilium movement;cilium assembly	None	SPAG1;DNAAF5;DNAAF2	"FRET analysis of HEAT domain deletions and human mutations showed that HEATR2 interacted with itself and SPAG1 at multiple HEAT domains, while DNAAF2 interacted with SPAG1 (PMID:29358401)."	None	"Human mutations in HEATR2 did not affect this interaction, but triggered the formation of p62/Sequestosome-1-positive aggregates containing the early preassembly proteins, suggesting that degradation of an early preassembly complex is responsible for disease and pointing to key regions required for HEATR2 scaffold stability. It was speculated that HEATR2 is an early scaffold for the initiation of dynein complex assembly in motile cilia (PMID:29358401).OMIM:614874 Ciliary dyskinesia, primary, 18"
AURKB-VRK1 complex	Q96GD4;Q99986	9212;7443	chromatin remodeling;histone serine kinase activity	None	AURKB;VRK1	None	VRK1 and\u00a0AURKB interaction inhibits phosphorylation of\u00a0histone H3 in\u00a0vivo (PMID:29340707).	None
SOX2-VRK1 complex	P48431;Q99986	6657;7443	"cell proliferation;transcription factor activity, sequence-specific DNA binding transcription factor recruiting"	None	SOX2;VRK1	None	Sox2 and VRK1 proteins synergistically cooperate in the activation of CCND1 gene expression and thus can contribute together to cell cycle progression and proliferation (PMID: 27334688).	None
NBS1-VRK1 complex	O60934;Q99986	4683;7443	"DNA damage response, detection of DNA damage"	DNA damage response	NBN;VRK1	None	The preassembled NBS1\u2013VRK1 complex that is activated by DNA damage and that contributes to the stability of NBS1 thus facilitating the sequential steps inn DNA damage response (PMID:26869104).	None
NBS1\u2013RNF8-VRK1 complex	O60934;O76064;Q99986	4683;9025;7443	None	None	NBN;RNF8;VRK1	None	None	None
PRRX1-UCHL1 complex	P09936;P54821	7345;5396	None	None	UCHL1;PRRX1	None	None	None
PRRX2-UCHL1 complex	P09936;Q99811	7345;51450	None	None	UCHL1;PRRX2	None	None	None
IGF2R-PLAUR-PLG complex	P00747;P11717;Q03405	5340;3482;5329	insulin-like growth factor receptor binding;urokinase plasminogen activator receptor activity;transforming growth factor beta1 activation;plasminogen activation	None	PLG;IGF2R;PLAUR	None	"Transforming growth factor- beta1 (TGF- beta1) is a critical cytokine for cell proliferation and differentiation. It is secreted by many cells in a latent pro-form (LTGF- beta1) from which biologically active TGF- beta1 is released. M6P/IGFII-R directly interacts with uPA-R and also binds Plg (plasminogen). Moreover, the M6P/IGFII-R - uPA-R complex can simultaneously recruit the ligands uPA, Plg and LTGF- beta1, and controls uPA-mediated activation of Plg to Plm for TGF-beta1 release. Plasmin generated from Plg in the complex mediates release of TGF-beta1 when M6P/IGFII-R is associated with uPA-R."	"TGF-beta1 None mice exhibit a disastrous phenotype including multiorgan inflammatory syndrome, lack of Langerhans cells, progressive growth retardation and death by 4 weeks of age."
IGF2R-PLAUR complex	P11717;Q03405	3482;5329	insulin-like growth factor receptor binding	None	IGF2R;PLAUR	None	A direct interaction between uPA-R and M6P/IGFII-R is demonstrated. This binding is independent of the GPI part of uPA-R. The binding of M6P/IGFII-R to uPA-R is neither mediated nor inhibited by uPA. Experiments indicate that neither ligationof M6P/IGFII-R nor ligation of uPA-R prevents their mutual interaction.	None
IGF2R-PLAUR-PLAU complex	P00749;P11717;Q03405	5328;3482;5329	insulin-like growth factor receptor binding;urokinase plasminogen activator receptor activity	None	PLAU;IGF2R;PLAUR	None	"It is shown that the mannose-6-phosphate/insulin-like growth factor II-receptor (M6P/IGFII-R), which binds LTGF- beta1, complexes with urokinase (plasminogen activator)-receptor (uPA-R) on the surface of human monocytes and directly binds plasminogen (Plg). Plasmin generated from Plg in the complex mediates release of TGF- beta1 when M6P/IGFII-R is associated with uPA-R. Thus, this interaction of M6P/IGFII-R and uPA-R suggests a potential mechanism for the generation of TGF- beta1 by cells. The M6P/IGFII-R-uPAR complex can simultaneously recruit the ligands uPA (Urokinase plasminogen activator), Plg (Plasminogen) and LTGF-beta1 (Latent transforming growth factor-beta1), and controls uPA-mediated activation of Plg to Plm for TGF-beta1 release."	"TGF-beta1 None mice exhibit a disastrous phenotype including multiorgan inflammatory syndrome, lack of Langerhans cells, progressive growth retardation and death by 4 weeks of age."
IGF2R-PLG-PLAU-PLAUR-LTGFbeta1 complex	P00747;P00749;P01137;P11717;Q03405	5340;5328;7040;3482;5329	insulin-like growth factor receptor binding;plasminogen activation;transforming growth factor beta1 activation;urokinase plasminogen activator receptor activity	None	PLG;PLAU;TGFB1;IGF2R;PLAUR	"As the inactive pro-form LTGF-beta1 (= TGF-beta1 + LAP) is not given in UniProt, the biologically active TGF-beta1 (= TGF-beta1 without LAP) is used for annotation. M6P/IGFII-R binds via a distinct site Plasminogen (PLG) and enables uPA-mediated conversion of PLG to Plasmin (PLM). PLM generated from PLG in the IGF2R-PLG-LTGF-beta1 complex mediates the release of active TGF- beta1 when M6P/IGFII-R is associated with uPAR (PLAUR) and its ligand uPA (PLAU)."	"It is shown in this study that M6P/IGFII-R (IGF2R) and uPAR (PLAUR) are associated at the surface of human monocytes, and that this complex can simultaneously bind LTGF-beta1,Plg (Plaminogen) and uPA (PLAU). It was found that the controlledgeneration of Plm (Plasmin) from Plg in this complex mediatesrelease of active TGF-beta1 from LTGF-beta1."	"TGF-beta1 None mice exhibit a disastrous phenotype including multiorgan inflammatory syndrome, lack of Langerhans cells, progressive growth retardation and death by 4 weeks of age."
NUFIP2-Roquin1 complex	Q5TC82;Q7Z417	149041;57532	T cell costimulation;mRNA catabolic process	None	RC3H1;NUFIP2	None	NUFIP2 increases the binding affinity of Roquin1 (RC3H1) in a ternary complex with ICOS 3'-UTR.	None
PLAUR-PLAU complex	P00749;Q03405	5328;5329	urokinase plasminogen activator receptor activity;plasminogen activation	None	PLAU;PLAUR	None	The natural ligand of uPAR is uPA. uPAR-bound uPA converts Plasminogen into Plasmin by proteolytic cleavage atamino acid Arg560-Val561.	None
ABRAXAS2-SHMT1 complex	P34896;Q15018	6470;23172	protein deubiquitination	"modification by ubiquitination, deubiquitination"	SHMT1;ABRAXAS2	None	None	None
ABRAXAS2-SHMT2 complex	P34897;Q15018	6472;23172	protein deubiquitination;cellular response to interferon-alpha	"modification by ubiquitination, deubiquitination"	SHMT2;ABRAXAS2	None	None	None
GRB7-PTK2 complex	Q05397;Q14451	5747;2886	cell migration	cell migration	PTK2;GRB7	None	"Focal adhesion kinase (FAK/Ptk2) is a cytoplasmic tyrosine kinase that has been shown to play a critical role in integrin-mediated signal transduction. Grb7 is a member of signaling proteins that include Grb7, Grb10, and Grb14. The family members have a highly conserved structure: the NH2-terminal region has proline-rich motifs, the central region has a pleckstrin homology (PH) domain, and the COOH-terminal region has an SH2 domain. Consistent with their domain structures, Grb7 family proteins have been shown to interact with a variety ofother proteins, including tyrosine kinase receptors and protooncogenes. These interactions are believed to play arole in the regulation of mitogenic signaling pathways. It is shown that the SH2 domain of Grb7 can directly interact with FAK through Tyr-397, a major autophosphorylation site invitro and in vivo. This interaction is cell adhesion-dependent,suggesting that the FAK-Grb7 complex is involved in integrin signaling. Overexpression of Grb7 enhanced cell migration toward fibronectin, whereas overexpression of its SH2 domain alone inhibited cell migration."	None
HSPA9-GRPEL1-GRPEL2 complex	P38646;Q8TAA5;Q9HAV7	3313;134266;80273	heat shock protein binding;protein import into mitochondrial matrix	None	HSPA9;GRPEL2;GRPEL1	None	"Most mitochondrial proteins are nuclearly encoded and are imported into the matrix compartment where they are properly folded. This process is facilitated by the mitochondrial heat shock protein 70 (mtHsp70), a chaperone contributing to mitochondrial protein quality control. Nucleotide exchange factors (NEFs) play a crucial role in exchanging ADP for ATP at mtHsp70's nucleotide-binding domain, thereby modulating mtHsp70's chaperone activity. Two putative NEF orthologs, GrpE-like 1 (GrpEL1) and GrpEL2, are reported that modulate mtHsp70's function in human cells. Both GrpEL1 and GrpEL2 associate with mtHsp70 as a hetero-oligomeric subcomplex and regulate mtHsp70 function. The formation of this subcomplex was critical for conferring stability to the NEFs, helped fine-tune mitochondrial protein quality control, and regulated crucial mtHsp70 functions, such as import of preproteins and biogenesis of Fe-S clusters."	None
GRPEL1-GRPEL2 complex	Q8TAA5;Q9HAV7	134266;80273	heat shock protein binding;protein import into mitochondrial matrix	None	GRPEL2;GRPEL1	None	"Most mitochondrial proteins are nuclearly encoded and are imported into the matrix compartment where they are properly folded. This process is facilitated by the mitochondrial heat shock protein 70 (mtHsp70), a chaperone contributing to mitochondrial protein quality control. Nucleotide exchange factors (NEFs) play a crucial role in exchanging ADP for ATP at mtHsp70's nucleotide-binding domain, thereby modulating mtHsp70's chaperone activity. Two putative NEF orthologs, GrpE-like 1 (GrpEL1) and GrpEL2, are reported that modulate mtHsp70's function in human cells. Both GrpEL1 and GrpEL2 associate with mtHsp70 as a hetero-oligomeric subcomplex and regulate mtHsp70 function. The formation of this subcomplex was critical for conferring stability to the NEFs, helped fine-tune mitochondrial protein quality control, and regulated crucial mtHsp70 functions, such as import of preproteins and biogenesis of Fe-S clusters. The direct interaction between EL1 and EL2 was determined by biolayer interferometry."	None
HSPA9-GRPEL1 complex	P38646;Q9HAV7	3313;80273	heat shock protein binding;protein import into mitochondrial matrix	None	HSPA9;GRPEL1	None	"Most mitochondrial proteins are nuclearly encoded and are imported into the matrix compartment where they are properly folded. This process is facilitated by the mitochondrial heat shock protein 70 (mtHsp70), a chaperone contributing to mitochondrial protein quality control. Nucleotide exchange factors (NEFs) play a crucial role in exchanging ADP for ATP at mtHsp70's nucleotide-binding domain, thereby modulating mtHsp70's chaperone activity. Two putative NEF orthologs, GrpE-like 1 (GrpEL1) and GrpEL2, are reported that modulate mtHsp70's function in human cells. Both GrpEL1 and GrpEL2 associate with mtHsp70 as a hetero-oligomeric subcomplex and regulate mtHsp70 function. The formation of this subcomplex was critical for conferring stability to the NEFs, helped fine-tune mitochondrial protein quality control, and regulated crucial mtHsp70 functions, such as import of preproteins and biogenesis of Fe-S clusters."	None
HSPA9-GRPEL2 complex	P38646;Q8TAA5	3313;134266	heat shock protein binding;protein import into mitochondrial matrix	None	HSPA9;GRPEL2	None	"Most mitochondrial proteins are nuclearly encoded and are imported into the matrix compartment where they are properly folded. This process is facilitated by the mitochondrial heat shock protein 70 (mtHsp70), a chaperone contributing to mitochondrial protein quality control. Nucleotide exchange factors (NEFs) play a crucial role in exchanging ADP for ATP at mtHsp70's nucleotide-binding domain, thereby modulating mtHsp70's chaperone activity. Two putative NEF orthologs, GrpE-like 1 (GrpEL1) and GrpEL2, are reported that modulate mtHsp70's function in human cells. Both GrpEL1 and GrpEL2 associate with mtHsp70 as a hetero-oligomeric subcomplex and regulate mtHsp70 function. The formation of this subcomplex was critical for conferring stability to the NEFs, helped fine-tune mitochondrial protein quality control, and regulated crucial mtHsp70 functions, such as import of preproteins and biogenesis of Fe-S clusters."	None
HSPA9-GRPEL1-GRPEL2-TIMM44 complex	O43615;P38646;Q8TAA5;Q9HAV7	10469;3313;134266;80273	heat shock protein binding;protein targeting to mitochondrion	None	TIMM44;HSPA9;GRPEL2;GRPEL1	None	"The mitochondrial import motor consists of chaperone mtHsp70 as the core component together with a heterodimerof cochaperones J-proteins/J-like proteins, NEF (Nucleotide exchange factors), and scaffold protein Tim44. Because interaction of NEF-mtHsp70-Tim44 complex is known to be ATP-sensitive in nature, the coIP was performed in the presence of 2mM ATP. Addition of ATP in the immunoprecipitatesresulted in the dissociation of mtHsp70 and Tim44, but the EL1-EL2 subcomplex remained stable, indicating thatin humans the NEF paralogs associate with the import motor asa hetero-subcomplex."	None
GSKIP-GSK3B-PRKAR2A complex	P13861;P49841;Q9P0R6	5576;2932;51527	Wnt signaling pathway;protein phosphorylation;catenin import into nucleus	"Wnt signalling pathway;modification by phosphorylation, dephosphorylation, autophosphorylation"	PRKAR2A;GSK3B;GSKIP	None	"A cytoplasmic destruction complex targets beta-catenin for degradation and thus prevents Wnt signaling. Wnt signals cause beta-catenin accumulation and translocation into the nucleus, where it induces Wnt target gene expression.GSKIP facilitates control of the beta-catenin stabilizing phosphorylation at Ser-675 by PKA.GSKIP directly binds GSK3beta and PKA. It controls the stability of beta-catenin and thus its transcriptional activity through facilitating its phosphorylation by the two kinases. GSK3beta phosphorylates Ser-33/Ser-37/Thr-41 in the cytoplasm and targets it for proteasomal degradation. The phosphorylation of Ser-675 by PKA stabilizes beta-catenin and enhances Wnt-induced signaling."	None
GSKIP-GSK3B-PRKAR2A complex	P13861;P49841;Q9P0R6	5576;2932;51527	protein phosphorylation;Wnt signaling pathway	"modification by phosphorylation, dephosphorylation, autophosphorylation;Wnt signalling pathway"	PRKAR2A;GSK3B;GSKIP	None	"A ternary complex consisting of GSKIP, RIIalpha of PKA, and GSK3B was identified. This complex facilitates PKA phosphorylation of GSK3B. The complex formation was detected only if GSKIP was present. GSK3B interacts indirectly with RIIalpha via GSKIP. GSKIP contains the domain of unknown function 727 (DUF727). DUF727 covers almost the entire sequence of human GSKIP (amino acids 32\u2013139) and confers the ability to interact with both RII (amino acids 28\u201352) and GSK3B (amino acids 115\u2013139). The PKA- and GSK3B-binding sites are located in different regions of GSKIP."	None
GSKIP-PRKAR2B complex	P31323;Q9P0R6	5577;51527	protein phosphorylation	"modification by phosphorylation, dephosphorylation, autophosphorylation"	PRKAR2B;GSKIP	None	GSKIP contains the domain of unknown function 727 (DUF727). DUF727 covers almost the entire sequence of human GSKIP (amino acids 32\u2013139) and confers the ability to interact with both RII (amino acids 28\u201352) and GSK3B (amino acids 115\u2013139). GSKIP binds RII subunits withnanomolar affinities in Biacore measurements (RIIalpha with KD = 5 nM and RIIbeta with KD = 43 nM). It is apparently an RII-specific AKAP because binding of RI subunits was not detectable in Biacore experiments.	None
PRKAR2A-GSKIP-GSK3B-DNM1L complex	O00429;P13861;P49841;Q9P0R6	10059;5576;2932;51527	mitochondrial translational elongation;response to oxidative stress;protein phosphorylation	"oxidative stress response;modification by phosphorylation, dephosphorylation, autophosphorylation"	DNM1L;PRKAR2A;GSK3B;GSKIP	"Since the authors did not specify the regulatory subunit of PKA RII (alpha or beta), we used isoform PRKAR2A (alpha)."	GSKIP and GSK3B play central roles in the cAMP/PKA/GSKIP/GSK/Drp1 axis signaling that causes mitochondrial elongation under oxidative stress GSKIP- and GSK3-mediated anchoring strengthens cAMP/PKA/Drp1 axis signaling in the regulation of mitochondrial elongation by forming a working complex comprising PKA/GSKIP/GSK3B/Drp1. Both GSKIP and GSK3B function as anchoring proteins in the cAMP/PKA/Drp1 signaling axis modulating Drp1 phosphorylation.	The PKA/GSKIP/GSK3/Drp1 axis and the PKA signaling pathways are involved in the pathogenesis of neurodegenerative diseases.
COMMD1-CCDC22-CCDC93-C16orf62 complex	O60826;Q567U6;Q7Z3J2;Q8N668	28952;54520;57020;150684	copper ion homeostasis;early endosome	None	CCDC22;CCDC93;C16orf62;COMMD1	None	"COMMD1 is directly linked to early endosomes through its interaction with a protein complex containing CCDC22, CCDC93, and C16orf62. CCDC22/CCDC93/COMMD1 interactions are not dependent on C16orf62."	COMMD1 deficiency results in defective copper homeostasis.
CCDC22-CCDC93-C16orf62 complex	O60826;Q567U6;Q7Z3J2	28952;54520;57020	endosome;copper ion homeostasis	endosome	CCDC22;CCDC93;C16orf62	None	"Coimmunoprecipitation of endogenous CCDC22, CCDC93, and C16orf62 in HEK293T cell lysates confirm their interactions.  The carboxyl-terminal ends of CCDC22 and CCDC93 are responsible for CCC complex recruitment to endosomes."	"Depletion of CCC complex components leads to lack of copper-dependent movement of the copper transporter ATP7A from endosomes, resulting in intracellular copper accumulation and modest alterations in copper homeostasis in humans with CCDC22 mutations."
CCDC93-COMMD1-COMMD6 complex	Q567U6;Q7Z4G1;Q8N668	54520;170622;150684	copper ion homeostasis;early endosome	None	CCDC93;COMMD6;COMMD1	None	COMMD1 is directly linked to early endosomes through its interaction with a protein complex. Immunoprecipitation of endogenous CCDC93 resulted in the coprecipitation of endogenous COMMD1 and COMMD6 but not IKK1 6 in HEK293T cell lysates.	COMMD1 deficiency results in defective copper homeostasis.
COMMD1-CCDC93-C16orf62 complex	Q567U6;Q7Z3J2;Q8N668	54520;57020;150684	copper ion homeostasis;early endosome	None	CCDC93;C16orf62;COMMD1	None	COMMD1 is directly linked to early endosomes through its interaction with a protein complex. Endogenous COMMD1 coimmunoprecipitates with C16orf62 and CCDC93 in HEK293 cell lysates.	COMMD1 deficiency results in defective copper homeostasis.
CCDC22-CCDC93-C16orf62-FAM21-WASH1 complex	A8K0Z3;O60826;Q567U6;Q7Z3J2;Q9Y4E1	100287171;28952;54520;57020;253725	endosome	endosome	WASH1;CCDC22;CCDC93;C16orf62;FAM21C	"Since the authors did not specify FAM21, we used isoform FAM21C."	"Interactions betweenthe WASH complex subunit FAM21, and the carboxyl-terminal ends of CCDC22 and CCDC93 are responsible for CCC complex recruitment to endosomes.  Coimmunoprecipitation of endogenous CCC subunits (CCDC22, CCDC93, and C16orf62) with the WASH components (FAM21 and WASH) was noted using HeLa cell lysates. The C-terminus of CCDC93 can make a direct and high-affinity interaction with the N-terminal tail region of FAM21."	None
VCP-SELK-DERL1 complex	P55072;Q9BUN8;Q9Y6D0	7415;79139;58515	None	None	VCP;DERL1;SELK	None	"SelK has higher affinity for Derlin-1, whereas SelS has higher affinity for Derlin-2. This suggests that the selenoproteins SelK and SelS could determine the nature of the substrate translocated through the Derlin channel."	None
SEC23-SEC24 adaptor complex	O95487;Q15436	10427;10484	COPII adaptor activity;COPII vesicle coating;endoplasmic reticulum	endoplasmic reticulum	SEC24B;SEC23A	"Since the authors did not specify SEC24 (a,b,c,or d), we used the longest isoform SEC24B."	"COPII coats are assembled from 3 components, ie, Sar1b, Sec23/24, and Sec13/31 complexes, necessary to capture cargo proteins and sculpt the ER membrane into vesicles. GTP loaded Sar1b recruits the cargo adaptor complex Sec23/Sec24 to ER exit domains."	None
SEC23-SEC24-SCAP-SREBP1c complex	O95487;P36956;Q12770;Q15436	10427;6720;22937;10484	COPII adaptor activity;COPII vesicle coating;nuclear transport;lipid metabolic process;endoplasmic reticulum	"nuclear transport;lipid, fatty acid and isoprenoid metabolism;endoplasmic reticulum"	SEC24B;SREBF1;SCAP;SEC23A	"Since the authors did not specify SEC24 (a,b,c,or d), we used the longest isoform SEC24B. Alternative promoter usage and splicing of gene SREBF1 result in several transcript variants, including SREBP-1c (mentioned in this paper)."	"Coimmunoprecipitation studies in microsomes isolated from Caco-2/15 cells with Sar1b overexpression documented a pronounced interaction of Sec23/Sec24 with sterol regulatory element binding protein (SREBP) cleavage-activating protein and SREBP-1c, thereby permitting the transfer of the transcription factor SREBP-1c to the nucleus for the activation of genes involved in lipid metabolism."	None
"Coat protein complex II (SAR1B, PREB, SEC23A , SEC24B, SEC23IP)"	O95487;Q15436;Q9HCU5;Q9Y6B6;Q9Y6Y8	10427;10484;10113;51128;11196	COPII adaptor activity;COPII vesicle coating;endoplasmic reticulum	endoplasmic reticulum	SEC24B;SEC23A;PREB;SAR1B;SEC23IP	"Since the authors did not specify SEC24 (a,b,c,or d), we used the longest isoform SEC24B."	"Sar1b plays a significant role in the assembly, organization, and function of the coat protein complex II (COPII), a critical complex for the transport of proteins from the endoplasmic reticulum to the Golgi. Along with the enhanced chylomicrons, microsomes were characterized by abundant Sec12, the guanine exchange factor that promotes the localization of Sar1b in the endoplasmic reticulum. Coimmunoprecipitation experiments revealed high levels of the complex components Sec23/Sec24 and p125, the Sec23-interacting protein."	"Although 2 isoforms characterize Sar1, only Sar1b hasbeen associated with the rare recessive disorder CRD,characterized by the selective retention of CM-like particleswithin the ER of enterocytes."
VCP-VIMP-DERL2 complex	P55072;Q9BQE4;Q9GZP9	7415;55829;51009	endoplasmic reticulum;ERAD pathway	endoplasmic reticulum	VCP;VIMP;DERL2	None	"SelK has higher affinity for Derlin-1, whereas SelS has higher affinity for Derlin-2. This suggests that the selenoproteins SelK and SelS could determine the nature of the substrate translocated through the Derlin channel."	None
GNAS-L-GNB2-GNG1 complex	P62879;P63092;P63211	2783;2778;2792	None	None	GNB2;GNAS;GNGT1	None	None	None
GNAS-L-GNB3-GNG1 complex	P16520;P63092;P63211	2784;2778;2792	None	None	GNB3;GNAS;GNGT1	None	None	None
GNAS-L-GNB4-GNG1 complex	P63092;P63211;Q9HAV0	2778;2792;59345	None	None	GNAS;GNGT1;GNB4	None	None	None
GNAS-L-GNB1-GNG1 complex	O14775;P63092;P63211	10681;2778;2792	None	None	GNB5;GNAS;GNGT1	None	None	None
GNAS-L-GNB1-GNG2 complex	P59768;P62873;P63092	54331;2782;2778	None	None	GNG2;GNB1;GNAS	None	None	None
GNAS-L-GNB2-GNG2 complex	P59768;P62879;P63092	54331;2783;2778	None	None	GNG2;GNB2;GNAS	None	None	None
GNAS-L-GNB3-GNG2 complex	P16520;P59768;P63092	2784;54331;2778	None	None	GNB3;GNG2;GNAS	None	None	None
GNAS-L-GNB4-GNG2 complex	P59768;P63092;Q9HAV0	54331;2778;59345	None	None	GNG2;GNAS;GNB4	None	None	None
GNAS-L-GNB4-GNG2 complex	O14775;P59768;P63092	10681;54331;2778	None	None	GNB5;GNG2;GNAS	None	None	None
GNAS-L-GNB1-GNG3 complex	P62873;P63092;P63215	2782;2778;2785	None	None	GNB1;GNAS;GNG3	None	None	None
GNAS-L-GNB2-GNG3 complex	P62879;P63092;P63215	2783;2778;2785	None	None	GNB2;GNAS;GNG3	None	None	None
GNAS-L-GNB1-GNG3 complex	P16520;P63092;P63215	2784;2778;2785	None	None	GNB3;GNAS;GNG3	None	None	None
GNAS-L-GNB4-GNG3 complex	P63092;P63215;Q9HAV0	2778;2785;59345	None	None	GNAS;GNG3;GNB4	None	None	None
GNAS-L-GNB5-GNG3 complex	O14775;P63092;P63215	10681;2778;2785	None	None	GNB5;GNAS;GNG3	None	None	None
TSC1-TSC2 complex	P49815;Q92574	7249;7248	beta-catenin destruction complex binding;TSC1-TSC2 complex;mRNA transcription;regulation of Wnt signaling pathway	mRNA synthesis	TSC2;TSC1	None	GSK3 phosphorylates TSC1 and mediates TSC1-TSC2 interaction. TSC1/TSC2 complex associated with GSK3 and Axin promotes beta-catenin degradation to inhibit Wnt-stimulated TCF/LEF-dependent transcription.	"angiomyolipomas (AML), lymphangioleiomyomatosis (LAM)"
TSC2-DVL complex	O14640;P49815	1855;7249	TSC1-TSC2 complex;regulation of Wnt signaling pathway	None	DVL1;TSC2	"Since the authors did not specify Dsh/DVL, we used isoform DVL1."	"Dsh associates with TSC2 but not TSC1. The interaction between TSC2 and TSC1 or Dsh appeared to be mutually exclusive. In the presence of all three proteins, TSC2 preferentially associated with TSC1."	None
TSC2-GSK3-AXIN-DVL complex	O14640;O15169;P49815;P49841	1855;8312;7249;2932	regulation of Wnt signaling pathway;TSC1-TSC2 complex	None	DVL1;AXIN1;TSC2;GSK3B	"Since the authors did not specify GSK3 and Dsh/DVL, we used isoforms GSK3B and DVL1, respectively."	"In the absence of Wnt, tuberin (TSC2) co-immunoprecipitated GSK3, Axin, and to a minimal extent, Dsh. On Wnt stimulation, significantly more tuberin was associated with Dsh but the amount of GSK3 or Axin associated with TSC2 decreased significantly. The inverse relationship of tuberin interaction between Dsh and GSK3/Axin is consistent with the putative role of Dsh in promoting the disassembly of the beta-catenin degradation complex and in doing so, associating with TSC2."	None
GNAS-L-GNB1-GNG4 complex	P50150;P62873;P63092	2786;2782;2778	None	None	GNG4;GNB1;GNAS	None	None	None
GNAS-L-GNB2-GNG4 complex	P50150;P62879;P63092	2786;2783;2778	None	None	GNG4;GNB2;GNAS	None	None	None
GNAS-L-GNB3-GNG4 complex	P16520;P50150;P63092	2784;2786;2778	None	None	GNB3;GNG4;GNAS	None	None	None
GNAS-L-GNB4-GNG4 complex	P50150;P63092;Q9HAV0	2786;2778;59345	None	None	GNG4;GNAS;GNB4	None	None	None
GNAS-L-GNB5-GNG4 complex	O14775;P50150;P63092	10681;2786;2778	None	None	GNB5;GNG4;GNAS	None	None	None
GNAS-L-GNB1-GNG5 complex	P62873;P63092;P63218	2782;2778;2787	None	None	GNB1;GNAS;GNG5	None	None	None
GNAS-L-GNB2-GNG5 complex	P62879;P63092;P63218	2783;2778;2787	None	None	GNB2;GNAS;GNG5	None	None	None
GNAS-L-GNB3-GNG5 complex	P16520;P63092;P63218	2784;2778;2787	None	None	GNB3;GNAS;GNG5	None	None	None
GNAS-L-GNB4-GNG5 complex	P63092;P63218;Q9HAV0	2778;2787;59345	None	None	GNAS;GNG5;GNB4	None	None	None
GNAS-L-GNB5-GNG5 complex	O14775;P63092;P63218	10681;2778;2787	None	None	GNB5;GNAS;GNG5	None	None	None
GNAS-L-GNB1-GNG7 complex	O60262;P62873;P63092	2788;2782;2778	None	None	GNG7;GNB1;GNAS	None	None	None
GNAS-L-GNB2-GNG7 complex	O60262;P62879;P63092	2788;2783;2778	None	None	GNG7;GNB2;GNAS	None	None	None
GNAS-L-GNB3-GNG7 complex	O60262;P16520;P63092	2788;2784;2778	None	None	GNG7;GNB3;GNAS	None	None	None
GNAS-L-GNB4-GNG7 complex	O60262;P63092;Q9HAV0	2788;2778;59345	None	None	GNG7;GNAS;GNB4	None	None	None
GNAS-L-GNB5-GNG7 complex	O14775;O60262;P63092	10681;2788;2778	None	None	GNB5;GNG7;GNAS	None	None	None
GNAS-L-GNB1-GNG8 complex	P62873;P63092;Q9UK08	2782;2778;94235	None	None	GNB1;GNAS;GNG8	None	None	None
GNAS-L-GNB2-GNG8 complex	P62879;P63092;Q9UK08	2783;2778;94235	None	None	GNB2;GNAS;GNG8	None	None	None
GNAS-L-GNB3-GNG8 complex	P16520;P63092;Q9UK08	2784;2778;94235	None	None	GNB3;GNAS;GNG8	None	None	None
GNAS-L-GNB4-GNG8 complex	P63092;Q9HAV0;Q9UK08	2778;59345;94235	None	None	GNAS;GNB4;GNG8	None	None	None
GNAS-L-GNB5-GNG8 complex	O14775;P63092;Q9UK08	10681;2778;94235	None	None	GNB5;GNAS;GNG8	None	None	None
p53-MDM2 complex	P04637;Q00987	7157;4193	regulation of ubiquitin protein ligase activity	None	TP53;MDM2	None	None	None
CCNB1-CCNF complex	P14635;P41002	891;899	cell cycle	cell cycle	CCNB1;CCNF	None	A novel interaction between cyclin B1 and cyclin F was identified. Data suggest that the NLS (nuclear localization signal) regions of cyclin F regulate cyclin B1 localization to the nucleus.	None
Glutamate-cysteine ligase	P48506;P48507	2729;2730	None	None	GCLC;GCLM	None	None	None
GNAS-L-GNB1-GNG10 complex	P50151;P62873;P63092	2790;2782;2778	None	None	GNG10;GNB1;GNAS	None	None	None
GNAS-L-GNB2-GNG10 complex	P50151;P62879;P63092	2790;2783;2778	None	None	GNG10;GNB2;GNAS	None	None	None
GNAS-L-GNB3-GNG10 complex	P16520;P50151;P63092	2784;2790;2778	None	None	GNB3;GNG10;GNAS	None	None	None
3-methylcrotonyl-CoA carboxylase	Q96RQ3;Q9HCC0	56922;64087	mitochondrion;methylcrotonoyl-CoA carboxylase activity;biotin binding	mitochondrion;biotin binding	MCCC1;MCCC2	None	None	Deficiencies in MCCC activity cause a rare autosomal recessive genetic disorder (17360195).
Methionine adenosyltransferase alpha2 beta-v1	P31153;Q9NZL9	4144;27430	None	None	MAT2A;MAT2B	None	None	None
CCR4-NOT-CNOT7-CNOT6 complex	A5YKK6;O75175;Q92600;Q9C0C2;Q9H9A5;Q9NZN8;Q9UIV1;Q9UKZ1;Q9ULM6	23019;4849;9125;85456;25904;4848;29883;55571;57472	"mRNA catabolic process;CCR4-NOT complex;regulation of transcription, DNA-templated"	transcriptional control	CNOT1;CNOT3;RQCD1;TNKS1BP1;CNOT10;CNOT2;CNOT7;CNOT11;CNOT6	None	"The core complex consists of 7 subunits (CNOT1, CNOT2, CNOT3, CNOT9, CNOT10, TAB182 and C2ORF29) and is associated with variable deadenylases (CNOT6, CNOT6L, CNOT7 and CNOT8) (19558367)."	None
GNAS-L-GNB4-GNG10 complex	P50151;P63092;Q9HAV0	2790;2778;59345	None	None	GNG10;GNAS;GNB4	None	None	None
GNAS-L-GNB5-GNG10 complex	O14775;P50151;P63092	10681;2790;2778	None	None	GNB5;GNG10;GNAS	None	None	None
GNAS-L-GNB1-GNG11 complex	P61952;P62873;P63092	2791;2782;2778	None	None	GNG11;GNB1;GNAS	None	None	None
Methionine adenosyltransferase alpha1 beta-v1	Q00266;Q9NZL9-	4143;27430	methionine adenosyltransferase activity;methionine adenosyltransferase complex;S-adenosylmethionine biosynthetic process	None	MAT1A;MAT2B	None	None	None
TIMM8A-TIMM13-TIMM23 complex	O14925;O60220;Q9Y5L4	100287932;1678;26517	mitochondrial intermembrane space;protein transport	mitochondrial intermembrane space;protein transport	TIMM23;TIMM8A;TIMM13	None	The hTim23 precursor interacts with the intact DDP1-hTim13 complex in the intermembrane space of mammalian mitochondria. The human DDP1-hTim13 complex facilitates the import of human Tim23 into mitochondria.	"Mutations in the DDP1 cause the Mohr-Tranebjaerg syndrome, a progressive neurodegenerative disorder characterized by sensorineural hearing loss, dystonia, mental retardation, and blindness."
GNAS-L-GNB2-GNG11 complex	P61952;P62879;P63092	2791;2783;2778	None	None	GNG11;GNB2;GNAS	None	None	None
GNAS-L-GNB3-GNG11 complex	P16520;P61952;P63092	2784;2791;2778	None	None	GNB3;GNG11;GNAS	None	None	None
GNAS-L-GNB4-GNG11 complex	P61952;P63092;Q9HAV0	2791;2778;59345	None	None	GNG11;GNAS;GNB4	None	None	None
GNAS-L-GNB5-GNG11 complex	O14775;P61952;P63092	10681;2791;2778	None	None	GNB5;GNG11;GNAS	None	None	None
GNAS-L-GNB1-GNG12 complex	P62873;P63092;Q9UBI6	2782;2778;55970	None	None	GNB1;GNAS;GNG12	None	None	None
GNAS-L-GNB2-GNG12 complex	P62879;P63092;Q9UBI6	2783;2778;55970	None	None	GNB2;GNAS;GNG12	None	None	None
GNAS-L-GNB3-GNG12 complex	P16520;P63092;Q9UBI6	2784;2778;55970	None	None	GNB3;GNAS;GNG12	None	None	None
GNAS-L-GNB4-GNG12 complex	P63092;Q9HAV0;Q9UBI6	2778;59345;55970	None	None	GNAS;GNB4;GNG12	None	None	None
GNAS-L-GNB5-GNG12 complex	O14775;P63092;Q9UBI6	10681;2778;55970	None	None	GNB5;GNAS;GNG12	None	None	None
GNAS-L-GNB1-GNG13 complex	P62873;P63092;Q9P2W3	2782;2778;51764	None	None	GNB1;GNAS;GNG13	None	None	None
GNAS-L-GNB2-GNG13 complex	P62879;P63092;Q9P2W3	2783;2778;51764	None	None	GNB2;GNAS;GNG13	None	None	None
GNAS-L-GNB3-GNG13 complex	P16520;P63092;Q9P2W3	2784;2778;51764	None	None	GNB3;GNAS;GNG13	None	None	None
GNAS-L-GNB4-GNG13 complex	P63092;Q9HAV0;Q9P2W3	2778;59345;51764	None	None	GNAS;GNB4;GNG13	None	None	None
GNAS-L-GNB5-GNG13 complex	O14775;P63092;Q9P2W3	10681;2778;51764	None	None	GNB5;GNAS;GNG13	None	None	None
CCR4-NOT-CNOT7-CNOT6L complex	A5YKK6;O75175;Q92600;Q96LI5;Q9C0C2;Q9H9A5;Q9NZN8;Q9UIV1;Q9UKZ1	23019;4849;9125;246175;85456;25904;4848;29883;55571	"CCR4-NOT complex;mRNA catabolic process;regulation of transcription, DNA-templated"	transcriptional control	CNOT1;CNOT3;RQCD1;CNOT6L;TNKS1BP1;CNOT10;CNOT2;CNOT7;CNOT11	None	"The core complex consists of 7 subunits (CNOT1, CNOT2, CNOT3, CNOT9, CNOT10, TAB182 and C2ORF29) and is associated with variable deadenylases (CNOT6, CNOT6L, CNOT7 and CNOT8) (19558367)."	None
CCR4-NOT-CNOT8-CNOT6 complex	A5YKK6;O75175;Q92600;Q9C0C2;Q9H9A5;Q9NZN8;Q9UFF9;Q9UKZ1;Q9ULM6	23019;4849;9125;85456;25904;4848;9337;55571;57472	"CCR4-NOT complex;mRNA catabolic process;regulation of transcription, DNA-templated"	transcriptional control	CNOT1;CNOT3;RQCD1;TNKS1BP1;CNOT10;CNOT2;CNOT8;CNOT11;CNOT6	None	"The core complex consists of 7 subunits (CNOT1, CNOT2, CNOT3, CNOT9, CNOT10, TAB182 and C2ORF29) and is associated with variable deadenylases (CNOT6, CNOT6L, CNOT7 and CNOT8) (19558367)."	None
CCR4-NOT-CNOT8-CNOT6L complex	A5YKK6;O75175;Q92600;Q96LI5;Q9C0C2;Q9H9A5;Q9NZN8;Q9UFF9;Q9UKZ1	23019;4849;9125;246175;85456;25904;4848;9337;55571	"CCR4-NOT complex;mRNA catabolic process;regulation of transcription, DNA-templated"	transcriptional control	CNOT1;CNOT3;RQCD1;CNOT6L;TNKS1BP1;CNOT10;CNOT2;CNOT8;CNOT11	None	"The core complex consists of 7 subunits (CNOT1, CNOT2, CNOT3, CNOT9, CNOT10, TAB182 and C2ORF29) and is associated with variable deadenylases (CNOT6, CNOT6L, CNOT7 and CNOT8) (19558367)."	None
Dysbindin 1-A-DNA-PK-complex	P12956;P13010;P78527;Q96EV8	2547;7520;5591;84062	"regulation of transcription, DNA-templated"	transcriptional control	XRCC6;XRCC5;PRKDC;DTNBP1	None	"The DNA-PK complex interacts only with splice isoforms A and B of Dysbindin 1, but not with C. It was found that isoforms A and B localized in nucleus, where the kinase complex exist, whereas the isoform C was found exclusively in cytosol. Furthermore, results of phosphorylation assay suggest that the DNA-PK complex phosphorylated dysbindin-1 isoforms A and B in cells. These observations suggest that DNA-PK regulates the dysbindin-1 isoforms A and B by phosphorylation in nucleus. Isoform C does not contain exons from 1 to 6.The DNA-PK complex interacts only with splice isoforms A and B of Dysbindin 1, but not with C. It was found that isoforms A and B localized in nucleus, where the kinase complex exist, whereas the isoform C was found exclusively in cytosol. Furthermore, results of phosphorylation assay suggest that the DNA-PK complex phosphorylated dysbindin-1 isoforms A and B in cells. These observations suggest that DNA-PK regulates the dysbindin-1 isoforms A and B by phosphorylation in nucleus. Isoform C does not contain exons from 1 to 6."	None
DHHC6-SELK complex	Q9H6R6;Q9Y6D0	64429;58515	endoplasmic reticulum;immune response;protein palmitoylation	endoplasmic reticulum;immune response	ZDHHC6;SELK	None	"DHHC6 and SELK interact through SH3 domain and SH3-binding domains, respectively, to form a complex in the ER membrane. DHHC6-SELK complex catalyzes the posttranslational palmitoylation of the IP3R Ca2+ channel to regulate immune cell activation. (PMID:25368151)."	None
MSL complex	Q68DK7;Q8N5Y2;Q9H7Z6;Q9HCI7	339287;10943;84148;55167	histone H4-K16 acetylation;histone H4-K5 acetylation	None	MSL1;MSL3;KAT8;MSL2	None	None	None
NSL complex	O15294;P51610;P61964;Q7Z3B3;Q96EZ8;Q9BVI0;Q9H7Z6;Q9H9L4;Q9P2N6	8473;3054;11091;284058;10445;51230;84148;54934;55683	histone H4-K16 acetylation;histone H4-K5 acetylation	None	OGT;HCFC1;WDR5;KANSL1;MCRS1;PHF20;KAT8;KANSL2;KANSL3	None	"MSL-associated MOF acetylates nucleosomal histone H4 almost exclusively on lysine 16, NSL-associated MOF exhibits a relaxed specificity and also acetylates nucleosomal histone H4 on lysines 5 and 8 (PMID:20018852)."	None
MMS19-XPD complex	P18074;Q96T76	2068;64210	iron-sulfur cluster assembly;helicase activity	None	ERCC2;MMS19	None	The Fe-S helicase XPD interacts independently and directlywith MMS19. Co-IP experiments with Flag-MMS19 and XPD showed a robust interaction between MMS19 and XPD that was independent of the co-expression of MIP18 and/orCIAO1.	"Mutations in the XPD gene result in xeroderma pigmentosum (XP) and trichothiodystrophy (TTD), the phenotypes of which are often intricate (PMID:12820975)."
MMS19-FAM96B complex	Q96T76;Q9Y3D0	64210;51647	protein catabolic process	protein/peptide degradation	MMS19;FAM96B	None	MMS19 binds to MIP18 and protects it from proteasomaldegradation.	None
HCF1-THAP11 complex	P51610;Q96EK4	3054;57215	regulation of cell growth;nucleus	nucleus	HCFC1;THAP11	None	"THAP11 is highly expressed in human colon cancers, both primary tumors and metastases (PMID:22371484)."	None
CDH4-HDAC2-MTA2-RBBP7-TWIST1 complex	O94776;Q14839;Q15672;Q16576;Q92769	9219;1108;7291;5931;3066	regulation of sequence-specific DNA binding transcription factor activity;regulation of cell migration	regulator of transcription factor	MTA2;CHD4;TWIST1;RBBP7;HDAC2	None	None	The components of TWIST complex are required for cancer metastasis in vivo (PMID:20714342).
DLC1-DLGAP1-MYO5A complex	O14490;Q96QB1;Q9Y4I1	9229;10395;4644	None	None	DLGAP1;DLC1;MYO5A	None	None	None
DLGAP1-DLG4-DYNLL2 complex	O14490;P78352;Q96FJ2	9229;1742;140735	None	None	DLGAP1;DLG4;DYNLL2	None	None	None
DISC1-DRD2 complex	P14416;Q9NRI5	1813;27185	None	None	DRD2;DISC1	None	DRD2 forms a protein complex with Disrupted in Schizophrenia1 (DISC1) that facilitates D2R-mediatedglycogen synthase kinase (GSK)-3 signaling and inhibits agonist-induced D2R internalization (PMID:25433637).	None
ARXN1-CIC complex	P54253;Q96RK0	6310;23152	None	None	ATXN1;CIC	None	None	None
CHRNA7-NMDAR1 complex	P36544;Q05586	1139;2902	None	None	CHRNA7;GRIN1	None	None	None
CHRNA7-GRIN2A complex	P36544;Q12879	1139;2903	None	None	CHRNA7;GRIN2A	None	None	None
SNCA-TUBB3 complex	P37840;Q13509	6622;10381	None	None	SNCA;TUBB3	None	None	None
RPGRIP1-SPATA7 complex	Q96KN7;Q9P0W8	57096;55812	regulation of protein transport	None	RPGRIP1;SPATA7	None	None	None
AURKA-HRAS-RAF1 complex	O14965;P01112;P04049	6790;3265;5894	regulation of MAP kinase activity	None	AURKA;HRAS;RAF1	None	None	None
ABCB1-ANXA2-RACK1-SRC complex	P07355;P08183;P12931;P63244	302;5243;6714;10399	None	None	ANXA2;ABCB1;SRC;RACK1	None	None	None
ERS1-MDM2 complex	P03372;Q00987	2099;4193	None	None	ESR1;MDM2	None	None	OMIM:114480 Breast cancer (PMID: 26909605).
ESR1-MDM4 complex	O15151;P03372	4194;2099	None	None	MDM4;ESR1	None	None	OMIM:615363 Breast cancer (PMID:26909605).
IGBP1-MID1-PPP2CA complex	O15344;P67775;P78318	4281;5515;3476	None	None	MID1;PPP2CA;IGBP1	None	Metformin disrupts the MID1 protein complex and reduces AR protein levels in prostate cancer cells identifying AR as an indirect metformin target (PMID:24484909).	OMIM:176807 prostate cancer
"ING5 (BRPF2, MOZ, MORF) complex"	O95696;Q8WYB5;Q8WYH8;Q92794;Q9HAF1	23774;23522;84289;7994;64769	apoptotic process;mitotic cell cycle;regulation of cell cycle	apoptosis (type I programmed cell death);mitotic cell cycle;mitotic cell cycle and cell cycle control	BRD1;KAT6B;ING5;KAT6A;MEAF6	None	ING5 HAT complexes interact with the MCM helicase and are essential for DNA replication to occur during S phase.ING subunits are probably crucial for acetylation of chromatin substrates. ING5 fractionates with two distinct complexes containing HBO1 or nucleosomal H3-specific MOZ/MORF HATs. Both MOZ/MORF-ING5 and HBO1-ING5 HAT complexes are important for DNA replication.	None
"ING5 (BRPF3, MOZ, MORF) complex"	Q8WYB5;Q8WYH8;Q92794;Q9HAF1;Q9ULD4	23522;84289;7994;64769;27154	apoptotic process;mitotic cell cycle;regulation of cell cycle	apoptosis (type I programmed cell death);mitotic cell cycle;mitotic cell cycle and cell cycle control	KAT6B;ING5;KAT6A;MEAF6;BRPF3	None	ING5 HAT complexes interact with the MCM helicase and are essential for DNA replication to occur during S phase.ING subunits are probably crucial for acetylation of chromatin substrates. ING5 fractionates with two distinct complexes containing HBO1 or nucleosomal H3-specific MOZ/MORF HATs. Both MOZ/MORF-ING5 and HBO1-ING5 HAT complexes are important for DNA replication.	None
"ING5 complex (ING5, JADE2, KAT7, MEAF6)"	O95251;Q8WYH8;Q9HAF1;Q9NQC1	11143;84289;64769;23338	apoptotic process;mitotic cell cycle;regulation of cell cycle	apoptosis (type I programmed cell death);mitotic cell cycle;mitotic cell cycle and cell cycle control	KAT7;ING5;MEAF6;JADE2	None	"Members of the ING family of tumor suppressors regulatecell cycle progression, apoptosis, and DNA repair. HBO1-ING5 association is independent of MOZ/MORF and is responsible for the H4-specific HAT activity in purified ING5."	None
"ING5 complex (ING5, JADE3, KAT7, MEAF6)"	O95251;Q8WYH8;Q92613;Q9HAF1	11143;84289;9767;64769	apoptotic process;mitotic cell cycle;regulation of cell cycle	apoptosis (type I programmed cell death);mitotic cell cycle;mitotic cell cycle and cell cycle control	KAT7;ING5;JADE3;MEAF6	None	"Members of the ING family of tumor suppressors regulatecell cycle progression, apoptosis, and DNA repair. HBO1-ING5 association is independent of MOZ/MORF and is responsible for the H4-specific HAT activity in purified ING5."	None
ABCB1-PPP2R3C-TFPI2 complex	P08183;P48307;Q969Q6	5243;7980;55012	regulation of protein phosphorylation	None	ABCB1;TFPI2;PPP2R3C	None	None	None
HCFC1-THAP11-ZNF143 complex	P51610;P52747;Q96EK4	3054;7702;57215	"regulation of transcription, DNA-templated;DNA binding"	transcriptional control;DNA binding	HCFC1;ZNF143;THAP11	None	None	None
HCFC1-THAP11 subcomplex	P51610;Q96EK4	3054;57215	DNA binding	DNA binding	HCFC1;THAP11	None	None	None
3-Hydroxyacyl CoA dehydrogenase	P40939;P55084	3030;3032	fatty acid beta-oxidation;mitochondrion	mitochondrion	HADHA;HADHB	None	None	None
ABCG5-ABCG8 complex	Q9H221;Q9H222	64241;64240	sterol transport	None	ABCG8;ABCG5	None	None	None
"MLC1-Na,K-ATPase-Kir4.1-AQP4-TRPV4-syntrophin complex"	P05026;P55087;P78508;Q15049;Q9HBA0;Q9NSN8	481;361;3766;None;59341;54212	None	None	ATP1B1;AQP4;KCNJ10;MLC1;TRPV4;SNTG1	"Since the authors did not specify sntrophin, we used isoform SNTG1."	None	"Mutations in MCL1 are the causative factor for megalencephalic leukoencephalopathy with subcortical cysts. Mutations in MCL1 impair the functional interaction of MCL1 with the macromolecular protein complex that includes Na,K-ATPase, Kir4.1, AQP-4, TRPV4 and syntrophin."
AKT1-NQO2 complex	P16083;P31749	4835;207	inflammatory response;cell proliferation;protein kinase B signaling	inflammatory response	NQO2;AKT1	None	None	None
KAT2A-Oxoglutarate dehydrogenase complex	P09622;P36957;Q02218;Q92830	1738;1743;4967;2648	nucleus	nucleus	DLD;DLST;OGDH;KAT2A	None	None	None
"HEPACAM-MLC1-Na,K-ATPase-Kir4.1-AQP4-TRPV4 complex"	P05026;P55087;P78508;Q14CZ8;Q15049;Q9HBA0	481;361;3766;220296;None;59341	None	None	ATP1B1;AQP4;KCNJ10;HEPACAM;MLC1;TRPV4	None	None	None
p532-Clathrin-HSP70 complex	P0DMV8;Q00610;Q15751	3303;1213;8925	transmembrane transport;cytoplasm	cytoplasm	HSPA1A;CLTC;HERC1	None	Cytosolic  p532 (HERC1) is complexed with clathrin and  HSP70  whereas membrane-associated p532 co-localizes with ARF1.	None
ARNTL-NPAS2 complex	O00327;Q99743	406;4862	mRNA transcription	mRNA synthesis	ARNTL;NPAS2	None	None	None
Core clock complex	O00327;O15516	406;9575	mRNA transcription	mRNA synthesis	ARNTL;CLOCK	None	None	None
ARNTL-HIF1A complex	O00327;Q16665	406;3091	DNA binding	DNA binding	ARNTL;HIF1A	None	None	None
ARNTL-EPAS1 complex	O00327;Q99814	406;2034	DNA binding	DNA binding	ARNTL;EPAS1	None	None	None
BCL2-CISD2 complex	P10415;Q8N5K1	596;493856	autophagy;endoplasmic reticulum	endoplasmic reticulum	BCL2;CISD2	None	None	None
Carboxypeptidase N	P15169;P22792	1369;1370	bradykinin catabolic process;carboxypeptidase activity	None	CPN1;CPN2	None	None	None
BIN1-EHBP1-RAB8A complex	O00499;P61006;Q8NDI1	274;4218;23301	regulation of protein transport	None	BIN1;RAB8A;EHBP1	None	"Rab8, EHBP1L1, and Bin1 play a role in apical protein transport and that Rab8 may play an additional role in basolateral transport in small intestine polarized epithelial cells (PMID:26833786)."	None
FEN1-WRN complex	P39748;Q14191	2237;7486	telomere maintenance via semi-conservative replication	None	FEN1;WRN	None	"Mutation FEN1 E359K from person with a history of family breast cancer disrupts FEN1/WRN interaction and gap dependent endonuclease activity, which impairs the cell\u2019s ability to counteract replication stresses. which impairs the cell\u2019s ability to counteract replication stresses (PMID:24608430)"	None
ETS1-PRX1 complex	P14921;P54821	2113;5396	"regulation of transcription, DNA-templated;response to nicotine"	transcriptional control	ETS1;PRRX1	None	"In oral precancerous lesion cells, Ets1 directly regulates Prx1 expression and nicotine might promote the development of oral precancerous lesion by magnifying the positive feedback signal pathway between Ets1 and Prx1 (PMID:29275566)"	OMIM:188890 Tobacco addiction(PMID:29275566)
GSK3B-HSP90AA1-PKM2 complex	P07900;P14618;P49841	3320;5315;2932	regulation of protein phosphorylation	None	HSP90AA1;PKM;GSK3B	None	HSP90 led to PKM2 phosphorylation at Thr-328 induced by HSP90 was dependent on GSK-3beta(PMID:29262861)	None
HEXIM1-DNA-PK-paraspeckle components-ribonucleoprotein complex	O94992;P12956;P13010;P23246;P43243;P78527;Q15233;Q8WXF1;Q96PK6	10614;2547;7520;6421;9782;5591;4841;55269;100526737	regulation of innate immune response;nucleus	nucleus	HEXIM1;XRCC6;XRCC5;SFPQ;MATR3;PRKDC;NONO;PSPC1;RBM14	None	HEXIM1 interacts with the long non-coding RNA NEAT1 to create the necessary platform for the assembly of the HDP-RNP (PMID:28712728).	None
AIP4-DTX3L complex	Q8TDB6;Q96J02	151636;83737	endosomal transport;early endosome;protein ubiquitination	"modification by ubiquitination, deubiquitination"	DTX3L;ITCH	None	DTX3L interacts directly with AIP4 (ITCH) upon CXCR4 activation on early endosomes (PMID:24790097).	None
SIMPLE-HRS-STAM1 complex	O14964;Q92783;Q99732	9146;8027;9516	endosome to lysosome transport;early endosome;ERK1 and ERK2 cascade	None	HGS;STAM;LITAF	None	None	"Mutations in SIMPLE (small integral membrane protein of lysosome/late endosome) cause Charcot-Marie-Tooth disease (CMT), type 1C. These loss of function mutations impair endosomal trafficking and lead to prolonged ERK1/2 signaling downstream of ErbB activation."
ANGPTL4-LRP6-SDC1 complex	O75581;P18827;Q9BY76	4040;6382;51129	regulation of canonical Wnt signaling pathway	None	LRP6;SDC1;ANGPTL4	None	"ANGPTL4 as a Wnt signaling antagonist  binds to syndecans and forms a ternary complex with the Wnt co-receptor Lipoprotein receptor-related protein 6 (LRP6). This protein complex is internalized via clathrin-mediated endocytosis and degraded in lysosomes, leading to attenuation of Wnt/?-catenin signaling (PMID:29017031)."	None
ANGPTL4-LRP6-SDC2 complex	O75581;P34741;Q9BY76	4040;6383;51129	regulation of canonical Wnt signaling pathway	None	LRP6;SDC2;ANGPTL4	None	"ANGPTL4 as a Wnt signaling antagonist binds to syndecans and forms a ternary complex with the Wnt co-receptor Lipoprotein receptor-related protein 6 (LRP6). This protein complex is internalized via clathrin-mediated endocytosis and degraded in lysosomes, leading to attenuation of Wnt/?-catenin signaling (PMID:29017031)."	None
ANGPTL4-LRP6-SDC4 complex	O75581;P31431;Q9BY76	4040;6385;51129	regulation of canonical Wnt signaling pathway	None	LRP6;SDC4;ANGPTL4	None	None	None
EIF2B2-EIF2B3-EIF2B4-EIF2B5 complex	P49770;Q13144;Q9NR50;Q9UI10	8892;8893;8891;8890	translation initiation factor activity;regulation of translational initiation	None	EIF2B2;EIF2B5;EIF2B3;EIF2B4	None	None	None
EIF2B1-EIF2B2-EIF2B3-EIF2B4-EIF2B5 complex	P49770;Q13144;Q14232;Q9NR50;Q9UI10	8892;8893;1967;8891;8890	regulation of translational initiation;translation initiation factor activity	None	EIF2B2;EIF2B5;EIF2B1;EIF2B3;EIF2B4	None	None	None
JUND-TAP1 complex	P17535;Q03518	3727;6890	transcription coactivator activity	None	JUND;TAP1	"Since Jund and Tap1 from gibbon were not available in the UniProt database at the time of annotation, the orthologous proteins from human were used."	None	None
ERCC1-RPA1-XPA complex	P07992;P23025;P27694	2067;7507;6117	regulation of DNA repair	None	ERCC1;XPA;RPA1	None	None	None
PRT1-RGP1 complex	P55884;Q92546	8662;9827	regulation of translation	translational control	EIF3B;RGP1	None	None	None
ACTB-ANP32A-C1QBP-PSMA1-PTMA-PSMA1 complex	P06454;P25786;P39687;P60709;Q00325;Q07021	5757;5682;8125;60;5250;708	cell proliferation;negative regulation of apoptotic process;regulation of mitochondrial membrane permeability	anti-apoptosis	PTMA;PSMA1;ANP32A;ACTB;SLC25A3;C1QBP	None	None	None
ANP32A-ANP32B-PSMA3-PTMA-SLC25A5 complex	P05141;P06454;P25788;P39687;Q92688	292;5757;5684;8125;10541	cell proliferation;negative regulation of apoptotic process;regulation of mitochondrial membrane permeability	anti-apoptosis	SLC25A5;PTMA;PSMA3;ANP32A;ANP32B	None	None	None
PARD3B-PARD6A-PRKCI complex	P41743;Q8TEW8;Q9NPB6	5584;117583;50855	apical junction assembly	None	PRKCI;PARD3B;PARD6A	None	None	None
HIC1-PCL3L-PCR2 complex	O75530;Q14526;Q15022;Q15910;Q5T6S3	8726;3090;23512;2146;26147	"histone methylation;negative regulation of transcription, DNA-templated"	transcription repression	EED;HIC1;SUZ12;EZH2;PHF19	None	None	None
ADA-DPP4 complex	P00813;P27487	100;1803	adenosine deaminase activity	None	ADA;DPP4	None	None	None
END1-ENDRA complex	P05305;P25101	1906;1909	endothelin receptor activity	None	EDN1;EDNRA	None	None	None
IL10-IL10RA complex	P22301;Q13651	3586;3587	cytokine-mediated signaling pathway	None	IL10;IL10RA	None	None	None
CRY1-Core clock complex	O00327;O15516;Q16526	406;9575;1407	circadian rhythm	None	ARNTL;CLOCK;CRY1	None	None	None
CTNNB1-ESR1 complex	P03372;P35222	2099;1499	mRNA transcription;fat cell proliferation	mRNA synthesis	ESR1;CTNNB1	None	None	None
ESYT1-ESYT2 complex	A0FGR8;Q9BSJ8	57488;23344	endoplasmic reticulum	endoplasmic reticulum	ESYT2;ESYT1	None	None	None
ESYT1-ESYT3 complex	A0FGR9;Q9BSJ8	83850;23344	endoplasmic reticulum	endoplasmic reticulum	ESYT3;ESYT1	None	None	None
NFKB1-STAT3 complex	P19838;P40763	4790;6774	"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding"	None	NFKB1;STAT3	None	None	None
RELA-STAT3 complex	P40763;Q04206	6774;5970	"regulation of cytokine activity;transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding"	None	STAT3;RELA	None	"STAT3, via direct interactions with NF-kappaB p65, serves as a dominant-negative inhibitor of NF-kappaB activity to suppress indirectly cytokine induction of the iNOS promoter in mesangial cells(PMID:12057007)"	None
CTNNB1-DDX5-HDGF complex	P17844;P35222;P51858	1655;1499;3068	regulation of cell growth;regulation of response to drug	None	DDX5;CTNNB1;HDGF	None	"miR-296-3p-PRKCA-FAK-Ras-c-Myc feedback loop modulated by HDGF/DDX5/?-catenin complex attenuates cell growth, metastasis, and chemoresistance in LADC (PMID:28751441)"	OMIM:211980 Lung cancer(PMID:28751441)
CLEC4E-FCER1G complex	P30273;Q9ULY5	2207;26253	regulation of immune response;Fc-gamma receptor signaling pathway	None	FCER1G;CLEC4E	None	None	None
CLEC4E-MS4A2 complex	Q01362;Q9ULY5	2206;26253	regulation of immune response	None	MS4A2;CLEC4E	None	None	None
HINT1-TIP60 complex	P49773;Q92993	3094;10524	"positive regulation of transcription, DNA-templated;regulation of apoptotic process"	transcription activation	HINT1;KAT5	None	Hint1 forms a complex with Tip60 and is associated with the Bax promoter (PMID:16835243).	None
HINT1-UBC3-RBX1 complex	P49427;P49773;P62877	997;3094;9978	None	None	CDC34;HINT1;RBX1	None	HINT1 inhibits the ubiquitylation of p27 by binding to the SCF (SKP2) ubiquitin ligase complex and interfering with recruitment of the E2 enzyme CDC34/Ubc3 by Rbx1/Roc1 (PMID:19112177).	None
HINT1-SP1 complex	P08047;P49773	6667;3094	"regulation of transcription, DNA-templated"	transcriptional control	SP1;HINT1	None	HINT1 forms a complex with Sp1 on the Src promoter and inhibits the expression of Src (PMID:19112177).	None
AML1-HIPK2-p300 complex	Q01196;Q09472;Q9H2X6	861;2033;28996	"regulation of transcription, DNA-templated"	transcriptional control	RUNX1;EP300;HIPK2	None	None	None
RAC1-RHOA-VANGL2 complex	P61586;P63000;Q9ULK5	387;5879;57216	None	None	RHOA;RAC1;VANGL2	None	None	None
MICALL1-RAB13 complex	P51153;Q8N3F8	5872;85377	endosomal transport	None	RAB13;MICALL1	None	MICAL-L1/Rab protein complex can regulate EGFR trafficking at late endocytic pathways (PMID:21795389)	None
AUF1(p45)-ZFP36 complex	P26651;Q14103	7538;3184	regulation of RNA binding	None	ZFP36;HNRNPD	None	"AUF1p45, but not AUF1p37, increased TTP binding affinity for RNA ?5-fold. These data suggest that certain isoforms of AUF1 can serve as \u201cco-activators\u201d of TTP family protein binding to RNA (PMID:22203679)"	None
HNRNPD(p45)-ZFP36L1 complex	Q07352;Q14103	677;3184	None	None	ZFP36L1;HNRNPD	None	None	None
HNRNPD(p45)-ZFP36L2 complex	P47974;Q14103	678;3184	None	None	ZFP36L2;HNRNPD	None	None	None
CTNNAL1-DNTA complex	Q9UBT7;Q9Y4J8	8727;1837	None	None	CTNNAL1;DTNA	None	None	None
NLGN1-NRXN1 complex	Q8N2Q7;Q9ULB1	22871;9378	None	None	NLGN1;NRXN1	None	"NX/NL synaptic complex is intrinsically involved in the regulation of DISC1 function, thus contributing to a better understanding of the pathology of schizophrenia (PMID:26078884)"	None
DISC1-TRAK1 complex	Q9NRI5;Q9UPV9	27185;22906	mitochondrion localization	None	DISC1;TRAK1	None	It is likely that DISC1 directly influences directional mitochondrial movement by complexing with TRAK1 and Miro1 in neurons (PMID:24092329).	None
DISC1-RHOT1 complex	Q8IXI2;Q9NRI5	55288;27185	mitochondrion localization	None	RHOT1;DISC1	None	It is likely that DISC1 directly influences directional mitochondrial movement by complexing with TRAK1 and Miro1 in neurons(PMID:24092329).	None
MTR4-RBM7-ZCCHC8 complex	P42285;Q6NZY4;Q9Y580	23517;55596;10179	None	None	MTREX;ZCCHC8;RBM7	None	NEXT complex targets promoter upstream transcripts for exosomal degradation (PMID:21855801).	None
GDF15-ERBB2 complex	P04626;Q99988	2064;9518	regulation of MAPK cascade;regulation of ERK1 and ERK2 cascade;cell proliferation	None	ERBB2;GDF15	None	GDF15 promoted the proliferation of cervical cancer cells via the up-regulation of CyclinD1 and CyclinE1 and the down-regulation of p21 through both the PI3K/AKT and MAPK/ERK signaling pathways in a complex with ErbB2 (PMID:29636108)	OMIM:603956 Cervical cancer(PMID:29636108)
PARP1-LIG3 complex	P09874;P49916	142;3980	None	None	PARP1;LIG3	None	None	None
ASXL1-HCFC1-OGT complex	O15294;P51610;Q8IXJ9	8473;3054;171023	"histone H3-K4 methylation;positive regulation of transcription, DNA-templated"	transcription activation	OGT;HCFC1;ASXL1	None	None	None
IL-15-lactadherin complex	P40933;Q08431	3600;4240	None	None	IL15;MFGE8	None	None	None
TRIM25-G3BP2 complex	Q14258;Q9UN86	7706;9908	None	None	TRIM25;G3BP2	None	The overexpression of TRIM25 promoted prostate cancer cell proliferation and cell survival by modulating p53 nuclear export mechanism with G3BP2 interaction (PMID:29379164)	OMIM:176807 Prostate cancer  (PMID:29379164).
NDFIP1-NEDD4L-SLC11A2 complex	P49281;Q96PU5;Q9BT67	4891;23327;80762	protein ubiquitination;response to iron ion;response to cobalt ion;metal ion transport	"modification by ubiquitination, deubiquitination"	SLC11A2;NEDD4L;NDFIP1	None	None	None
TF-TFRC complex	P02786;P02787	7037;7018	ferric iron binding;iron ion transmembrane transport;endocytosis	endocytosis	TFRC;TF	None	None	None
ARAF-PIK3R1 complex	P10398;P27986	369;5295	None	None	ARAF;PIK3R1	None	None	None
EYA1-SIX1 complex	Q15475;Q99502	6495;2138	nephron development;regulation of neuron differentiation	None	SIX1;EYA1	None	Eya-Six may form a complex to regulate nephron progenitor cell development before metanephric specification and are critical mesenchymal factors for inducing nephric duct development (PMID:25903664)	OMIM:602588 Branchiootic syndrome 1 (PMID:11734542)
EYA1-SIX2 complex	Q99502;Q9NPC8	2138;10736	nephron development;regulation of neuron differentiation	None	EYA1;SIX2	None	Eya-Six may form a complex to regulate nephron progenitor cell development before metanephric specification and are critical mesenchymal factors for inducing nephric duct development (PMID:25903664)	OMIM:602588 Branchiootic syndrome 1 (PMID:11734542)
KATNA1-KATNAL1-KATNB1-KATNBL1 complex	O75449;Q9BVA0;Q9BW62;Q9H079	11104;10300;84056;79768	regulation of organelle organization	None	KATNA1;KATNB1;KATNAL1;KATNBL1	None	None	None
ASH2L-KDM6B-KDM6B-WDR5 complex	O15054;P61964;Q15291;Q9UBL3	23135;11091;5929;9070	None	None	KDM6B;WDR5;KDM6B;ASH2L	None	None	None
"Ubiquitin E3 ligase (CUL3, KEAP1, RBX1)"	P62877;Q13618;Q14145	9978;8452;9817	cullin-RING ubiquitin ligase complex	None	RBX1;CUL3;KEAP1	None	None	None
CUL3-KCTD11 complex	Q13618;Q693B1	8452;147040	None	None	CUL3;KCTD11	None	None	None
CUL3-KCTD6 complex	Q13618;Q8NC69	8452;200845	None	None	CUL3;KCTD6	None	None	None
BRD7-SWI\u2013SNF complex	O14497;O14744;O96019;P51531;P51532;Q8TAQ2;Q8WUB8;Q92922;Q969G3;Q96GM5;Q9NPI1	8289;10419;86;6595;6597;6601;55274;6599;6605;6602;29117	"negative regulation of transcription, DNA-templated"	transcription repression	ARID1A;PRMT5;ACTL6A;SMARCA2;SMARCA4;SMARCC2;PHF10;SMARCC1;SMARCE1;SMARCD1;BRD7	None	None	None
BRD7-SWI\u2013SNF-SUZ12 complex	P51531;P51532;Q15022;Q9NPI1;Q9NVM4	6595;6597;23512;29117;54496	None	None	SMARCA2;SMARCA4;SUZ12;BRD7;PRMT7	None	None	None
BRD7-BAF60A-MEP50 complex	Q96GM5;Q9BQA1;Q9NPI1	6602;79084;29117	None	None	SMARCD1;WDR77;BRD7	None	None	None
BRD7-EZH2-SUZ12 complex	Q15022;Q15910;Q9NPI1	23512;2146;29117	None	None	SUZ12;EZH2;BRD7	None	None	None
BRD7-CBP-SWI\u2013SNF complex	O14744;P51531;P51532;Q8WUB8;Q969G3;Q9NPI1;Q9NWQ8	10419;6595;6597;55274;6605;29117;55824	None	None	PRMT5;SMARCA2;SMARCA4;PHF10;SMARCE1;BRD7;PAG1	None	None	None
KDM8-RCCD1 complex	A6NED2;Q8N371	91433;79831	None	None	RCCD1;KDM8	None	KDM8-RCCD1 complex has a role in chromosome stability and division fidelity (PMID:24981860).	None
KHDC3L-NLRP5-OOEP-TLE6 complex	A6NGQ2;P59047;Q587J8;Q9H808	441161;126206;154288;79816	embryo development	None	OOEP;NLRP5;KHDC3L;TLE6	None	None	None
FYN-KHDRBS1-PLCG1 complex	P06241;P19174;Q07666	2534;5335;10657	regulation of RNA metabolic process	None	FYN;PLCG1;KHDRBS1	None	"tr-kit (truncated form of the tyrosine kinase receptorc-kit) promotes the formation of a multimolecular complex composed of Fyn, PLCgamma1 and Sam68, which allows phosphorylation of PLCgamma1 by Fyn, and may modulate RNA metabolism (PMID:14647465)"	None
DCS complex	P26599;P31943;Q92945;Q9UKA9	5725;3187;8570;58155	"mRNA splicing, via endonucleolytic cleavage and ligation;nucleus"	nucleus	PTBP1;HNRNPH1;KHSRP;PTBP2	None	None	None
Prohibitin-HIRA complex	P35232;P54198;Q9NPG3;Q9Y6J0	5245;7290;29855;23523	nucleosome assembly	None	PHB;HIRA;UBN1;CABIN1	None	PHB interacts with the HIRA complex (a histone H3.3 chaperone) and stabilizes the protein levels of HIRA complex components.	None
OGT-HIRA complex	O15294;P54198;Q9NPG3;Q9Y6J0	8473;7290;29855;23523	None	None	OGT;HIRA;UBN1;CABIN1	None	"OGT interacts with UBN1, modifies HIRA, and promotes nucleosome assembly of H3.3."	None
DTX3L-PARP9 complex	Q8IXQ6;Q8TDB6	83666;151636	protein ubiquitination;defense response to virus	"modification by ubiquitination, deubiquitination"	PARP9;DTX3L	None	mediates ubiquitination of both host histones and viral proteases to enhance IFN-dependent immunity and thereby control viral infection.	None
DTX3L-PARP9-STAT1 complex	P42224;Q8IXQ6;Q8TDB6	6772;83666;151636	"defense response to virus;protein ubiquitination;regulation of transcription, DNA-templated"	"modification by ubiquitination, deubiquitination;transcriptional control"	STAT1;PARP9;DTX3L	None	None	None
HIVEP3-RUNX2-WWP1 complex	Q13950;Q5T1R4;Q9H0M0	860;59269;11059	bone maturation	None	RUNX2;HIVEP3;WWP1	None	Shn3 (HIVEP3) interacts with WWP1 to enhance the ubiquitination of Runx2 (PMID:16728642).	None
RSF complex	O60264;Q96T23	8467;51773	chromatin organization	None	SMARCA5;RSF1	None	The RSF complex physically associates with CENP-A chromatin at the mononucleosome level (PMID:19398759).	None
CENP-A nucleosomal complex	P07199;P33778;P49450;P62805;Q03188;Q08945;Q8N0S6;Q8NCD3;Q92674;Q96BT3;Q96H22;Q96QV6;Q96T23;Q9H3R5;Q9Y5B9	1059;3018;1058;None;1060;6749;91687;55355;2491;80152;55839;221613;51773;64946;11198	nucleus;chromosome organization	nucleus;organization of chromosome structure	CENPB;HIST1H2BB;CENPA;HIST1H4A;;CENPC;SSRP1;CENPL;HJURP;CENPI;CENPT;CENPN;HIST1H2AA;RSF1;CENPH;SUPT16H	None	None	None
"Potassium channel complex (KCNA1, KCNA2, KCNAB2)"	P16389;Q09470;Q13303	3737;3736;8514	potassium channel activity;potassium ion transmembrane transport;potassium channel complex;voltage-gated potassium channel complex	None	KCNA2;KCNA1;KCNAB2	None	"Axonal K1 channels involved in normal spinal cord function are candidate targets for therapeutics, which improve sensorimotor function in spinal cord injury. Kv1.1, Kv1.2, and Kvb2 form heteromultimeric complexes at juxtaparanodal zones in myelinated fibers. The same complexes are also present in paranodal regions of some spinal cord axons, and staining with antibodies against Caspr, a component of the paranodal axoglial junction, overlaps with these paranodal K1 channels. This latter observation suggests a unique role for these channels in normal spinal cord function and may provide an explanation for the sensitivity of spinal cord to K1 channel blockers."	None
CENP-H-I complex	Q13352;Q6IPU0;Q71F23;Q7L2Z9;Q8N0S6;Q92674;Q96H22;Q9BS16;Q9BU64;Q9H3R5;Q9NSP4	23421;401541;79682;55166;91687;2491;55839;64105;79172;64946;79019	chromosome organization;nucleosome assembly;chromosome segregation;kinetochore assembly;cell cycle	organization of chromosome structure;chromosome segregation/division;centromere/kinetochore complex maturation;cell cycle	ITGB3BP;CENPP;CENPU;CENPQ;CENPL;CENPI;CENPN;CENPK;CENPO;CENPH;CENPM	None	"The CENP-H-I complex is required for the incorporation of newly synthesized CENP-A into centromeres.CENP-L and CENP-M were only isolated in chicken cells, although both proteins were identified in proteomic analysis of human CENP-A nucleosomes, suggesting that they function at human centromeres."	None
ADAM22-LGI1 complex	O95970;Q9P0K1	9211;53616	"synaptic transmission, glutamatergic"	None	LGI1;ADAM22	None	"Epilepsy-related ligand-receptor complex, LGI1-ADAM22, regulates synaptic transmission and has emerged as a determinant of brain excitability, as their mutations and acquired LGI1 autoantibodies cause epileptic disorders in human. The crystal structure of human LGI1-ADAM22 complex, revealing a 2:2 heterotetrameric assembly, is reported. The hydrophobic pocket of the C-terminal epitempin-repeat (EPTP) domain of LGI1 binds to the metalloprotease-like domain of ADAM22. The N-terminal leucine-rich repeat and EPTP domains of LGI1 mediate the intermolecular LGI1-LGI1 interaction. The LGI1-ADAM22ligand\u2013receptor interaction plays an essential role in AMPA type glutamate receptor-mediated synaptic transmission via PSD-95."	Mutations of LGI1 cause autosomal dominant lateral temporal lobe epilepsy (ADLTE; also known as autosomal dominant partial epilepsy with auditory features (ADPEAF)).
SREBP-1a-PKM2 complex	P14618;P36956	5315;6720	regulation of lipid biosynthetic process;cell proliferation	None	PKM;SREBF1	None	"In mammalian cells, there are three SREBP isoforms (SREBP-1a, -1c, and -2) encoded by two different genes, Srebf1 and Srebf2 . Two distinct promoters generate SREBP-1a and SREBP-1c isoforms from the Srebf1 gene . Srebf1a is expressed at higher levels in cancer cells as compared with normal tissues, whereas Srebf1c is the predominant product of Srebf1 in normal tissues. PKM2 directly interacts with the nuclear form of SREBP-1a, but not with SREBP-1c, and SREBP-2  isoforms in hepatocellular carcinoma cells (PMID:29514980)."	OMIM:114550 Hepatocellular carcinoma (PMID:29514980)
TMEM173-TBK1 complex	Q86WV6;Q9UHD2	340061;29110	cardioblast migration	None	TMEM173;TBK1	None	None	None
"AKT1-APPL1-HDAC3 complex, induced by IGF-1"	O15379;P31749;Q9UKG1	8841;207;26060	None	None	HDAC3;AKT1;APPL1	None	None	None
TOP3B-c complex	O95985;Q9H7E2	8940;81550	None	None	TOP3B;TDRD3	None	None	None
"ARRB1-ARHGEF18-ENAH complex, induce by EDN-1"	P49407;Q6ZSZ5;Q8N8S7	408;23370;55740	None	None	ARRB1;ARHGEF18;ENAH	None	None	None
CAPG-PRMT5 complex	O14744;P40121	10419;822	"regulation of transcription, DNA-templated"	transcriptional control	PRMT5;CAPG	None	"CAPG suppressed PRMT5 binding to the STC-1 gene promoter, which decreased PRMT5-dependent histone H4R3 methylation and subsequent decrease of CpG DNA methylation, resulting in enhanced STC-1 transcription . Therefore, CAPG and PRMT5 expression may be a promising biomarker to determine prognosis in breast cancer (PMID:29721098)."	OMIM:114480 Breast cancer PRMT5 interacts with CAPG and predicts a favorable prognosis in breast cancer (PMID:29721098).
CENP-A-histone H4 heterodimer- HJURP complex	P49450;P62805;Q8NCD3	1058;None;55355	chromatin organization;nucleosome assembly	None	CENPA;HIST1H4A;;HJURP	None	HJURP binds to the CENPA-histone H4 heterodimer and prevents tetramer formation of CENPA and histone H4.	None
GJB2-PTK2-NANOG complex	P29033;Q05397;Q9H9S0	2706;5747;79923	regulation of stem cell division	None	GJB2;PTK2;NANOG	None	"Cx26 promotes cancer stem cells (CSC) self-renewal by forming a signaling complex with the pluripotency transcription factor NANOG and focal adhesion kinase (FAK), resulting in NANOG stabilization and FAK activation. The unique signaling complex may be amenable for targeting and compromising  triple-negative breast cancer CSC maintenance (PMID:29422613)."	OMIM:114480 Breast cancer  (PMID:29422613).
CFTR-GOPC-STX6 complex	O43752;P13569;Q9HD26	10228;1080;57120	regulation of late endosome to lysosome transport	None	STX6;CFTR;GOPC	None	The functional requirement of CAL suggested a model that the CAL/STX6/CFTR complex directs CFTR trafficking to the lysosome (PMID:20130090).	None
HK1-VDAC1 complex	P19367;P21796	3098;7416	cellular response to stress	None	HK1;VDAC1	None	"Genotoxic stress enables ATF2 nuclear export and localization at the mitochondria, where it perturbs the HK1-VDAC1 complex."	None
TP53-TSPY1-USP7 complex	P04637;Q01534;Q93009	7157;100289087;7874	spermatogenesis	None	TP53;TSPY1;USP7	None	None	None
TSPY1-TSPYL5-USP7 complex	Q01534;Q86VY4;Q93009	100289087;85453;7874	regulation of cell cycle;regulation of apoptotic process	mitotic cell cycle and cell cycle control	TSPY1;TSPYL5;USP7	None	None	None
PPP1R13L-CEP55 complex	Q53EZ4;Q8WUF5	55165;10848	None	None	CEP55;PPP1R13L	None	None	None
PPP1CA-PPP1R13L complex	P62136;Q8WUF5	5499;10848	dephosphorylation	None	PPP1CA;PPP1R13L	None	iASPP\u2013PP1 complex dephosphorylates mitotic CEP55 at Ser436(PMID:29743530).	None
ISLR2-ROCK1 complex	Q13464;Q6UXK2	6093;57611	None	None	ROCK1;ISLR2	None	"Linx/Rho-kinase complex could be at least relevant to the regulation of cell body size and neurite extension, which may have a role in the development of brain architecture and neuronal connectivity (PMID:29739947)."	None
KIAA1468-OSBP-RAB11A complex	P22059;P62491;Q9P260	5007;8766;57614	regulation of sterol transport	None	OSBP;RAB11A;KIAA1468	None	None	None
ATF2-HK1-VDAC1 complex	P15336;P19367;P21796	1386;3098;7416	"regulation of transcription, DNA-templated;cellular response to stress"	transcriptional control	ATF2;HK1;VDAC1	None	"Following genotoxic stress, cytosolic ATF2 is transportet into mitochondria where it binds to HK1-VDAC1 complex resulting in disruption of the complex. This sensitizes cells to stress and impaires mitochondrial membrane integrity."	None
mtRNase P	O15091;Q7L0Y3;Q99714	9692;54931;None	mitochondrial ribonuclease P complex	None	KIAA0391;TRMT10C;HSD17B10	Human mtRNase P is composed of three proteins but no RNA.	tRNAs are synthesized as immature precursors. Extra nucleotides at their 5' termini are removed by an endonuclease called ribonuclease P (RNase P).	None
HSD17B10-TRMT10C complex	Q7L0Y3;Q99714	54931;None	tRNA processing;mitochondrial protein complex;tRNA binding	tRNA processing	TRMT10C;HSD17B10	None	"The MRPP1-MRPP2 complex is not only responsible for mitochondrial RNase P-based 5?-leader removal, but  it also remains attached to the tRNA substrate to enable further downstream processing steps including 3? -tail removal by ELAC2 and 3?-CCA addition by the CCA adding enzyme."	None
FLCN-FNIP2 complex	Q8NFG4;Q9P278	201163;57600	TOR signaling	None	FLCN;FNIP2	None	FLCN-FNIP2 is a Rag-interacting complex and is necessary for mTORC1 activation by amino acids.	None
KAT2B-KIF11-MYSM1 complex	P52732;Q5VVJ2;Q92831	3832;114803;8850	"monoubiquitinated histone H2A deubiquitination;histone acetylation;DNA-templated transcription, initiation;DNA-templated transcription, elongation"	transcription initiation;transcription elongation	KIF11;MYSM1;KAT2B	None	"ChIP data indicate that the 2A-DUB complex, with the consequent alteration of uH2A status, participates in the initiation and likely the elongation steps of androgen/AR-induced gene activation."	None
ECT2-KIF23-RACGAP1 complex	Q02241;Q9H0H5;Q9H8V3	9493;29127;1894	actomyosin contractile ring assembly;spindle midzone	None	KIF23;RACGAP1;ECT2	None	Active Rho is required for contractile ring formation and ECT2-KIF23-RACGAP1 complex regulates translocation of Rho to the equatorial region.	None
KIF23-RACGAP1 complex	Q02241;Q9H0H5	9493;29127	spindle midzone;microtubule bundle formation;cytokinesis	cytokinesis (cell division) /septum formation and hydrolysis	KIF23;RACGAP1	None	"Centralspindlin, but not its individual components, strongly promotes microtubule bundling in vitro."	None
HOOK1-SHP2 complex	Q06124;Q9UJC3	5781;51361	negative regulation of epithelial to mesenchymal transition	None	PTPN11;HOOK1	None	SHP2-Hook1 complex may play an important role in tumor metastases by regulating epithelial-mesenchymal transition in cancer cells.	None
HOOK2-PCM1-RAB8A complex	P61006;Q15154;Q96ED9	4218;5108;29911	protein localization to centrosome;cilium assembly	None	RAB8A;PCM1;HOOK2	None	None	None
Exosome	Q01780;Q06265;Q13868;Q15024;Q5RKV6;Q8TF46;Q96B26;Q99547;Q9NPD3;Q9NQT4;Q9NQT5;Q9Y3B2	5394;5393;23404;23016;118460;115752;11340;10200;54512;56915;51010;51013	exoribonuclease activity;RNA catabolic process;cytoplasm	RNA degradation;cytoplasm	EXOSC10;EXOSC9;EXOSC2;EXOSC7;EXOSC6;DIS3L;EXOSC8;MPHOSPH6;EXOSC4;EXOSC5;EXOSC3;EXOSC1	None	None	None
HOOK2-PAR3-Par6alpha-PKCiota complex	P41743;Q8TEW0;Q96ED9;Q9NPB6	5584;56288;29911;50855	epithelial cell migration;centrosome localization	None	PRKCI;PARD3;HOOK2;PARD6A	None	Hook2 acts as an adaptor to recruit the PAR complex to the centrosome.	None
HOOK2-KCL3-LRGUK1-RIMBP3 complex	Q6P597;Q96ED9;Q96M69;Q9UFD9	147700;29911;136332;85376	manchette assembly;spermatid development	None	KLC3;HOOK2;LRGUK;RIMBP3	None	None	None
"Glycine receptor (GLRA11, GLRB)"	P23415;P48167	2741;2743	extracellular-glycine-gated chloride channel activity	None	GLRA1;GLRB	"Functional GlyRs are formed from a total of five subunits (alpha1-alpha4, beta). Although alpha subunits efficiently form homomeric GlyRs in recombinant expression systems, homomeric alpha1, alpha3 and alpha4 GlyRs are weakly expressed in adult neurons. In contrast, alpha2 homomeric GlyRs are abundantly expressed in embryonic neurons, although their numbers decline sharply by adulthood. Numerous lines of biochemical, biophysical, pharmacological and genetic evidence suggest the majority of glycinergic neurotransmission in adults is mediated by heteromeric alpha1beta GlyRs. Immunocytochemical co-localisation experiments suggest the presence of alpha2beta, alpha3beta and alpha4beta GlyRs at synapses in the adult mouse retina. Immunocytochemical and electrophysiological evidence also implicates alpha3beta GlyRs as important mediators of glycinergic inhibitory neurotransmission in nociceptive sensory neuronal circuits in peripheral laminae of the spinal cord dorsal horn (PMID:18721822)."	"The glycine receptor chloride channel (GlyR), a member of the pentameric Cys-loop ion channel receptor family, mediates inhibitory neurotransmission in the spinal cord, brainstem and retina. They are also found presynaptically, where they modulate neurotransmitter release (PMID:18721822)."	None
"GABA-A receptor (GABRA1, GABRB2, GABRG2)"	P14867;P18507;P47870	2554;2566;2561	GABA-A receptor activity	None	GABRA1;GABRG2;GABRB2	None	None	None
"GABA-A receptor (GABRA1, GABRB2, GABRD)"	O14764;P14867;P47870	2563;2554;2561	GABA-A receptor activity	None	GABRD;GABRA1;GABRB2	None	None	None
AP1B1-AP1G2-AP1M-1AP1S1 complex	O75843;P61966;Q10567;Q9BXS5	8906;1174;162;8907	vesicle-mediated transport	"vesicular transport (Golgi network, etc.)"	AP1G2;AP1S1;AP1B1;AP1M1	None	None	None
TANGO1L-cTAGE5-SEC12 complex	O15320;Q5JRA6;Q9HCU5	4253;375056;10113	ER to Golgi vesicle-mediated transport	ER to Golgi transport	CTAGE5;MIA3;PREB	None	"TANGO1 (L) is an integral membrane protein that binds to collagen and the coatomer of vesicles and is necessary for collagen secretion from the ER. The short isoform of TANGO1 (TANGO1S), lacking the collagen-binding domain, was found that it was independently required for collagen export from the ER. Each of the TANGO1 isoforms forms a stable protein complex with factors involved in collagen secretion: TANGO1L/cTAGE5/Sec12 (900 kDa) and TANGO1S/cTAGE5/Sec12 (700 kDa). TANGO1S and TANGO1L seemed to be interchangeable in exporting collagen from the ER. It was suggested that mammalian ER exit sites possess two different-sized membrane-bound macromolecular complexes that specifically function in large-cargo export from the ER (PMID:27413011)."	None
Astrin-kinastrin complex	P53350;P63167;Q562F6;Q96R06;Q9Y448	5347;8655;151246;10615;90417	regulation of attachment of spindle microtubules to kinetochore	None	PLK1;DYNLL1;SGO2;SPAG5;KNSTRN	None	None	None
HDAC3-H1.3-SMRT-N-Cor complex	O15379;O75376;P16402;Q9Y618	8841;9611;3007;9612	None	None	HDAC3;NCOR1;HIST1H1D;NCOR2	None	HDAC3-H1.3 complex containing silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and nuclear receptor corepressor 1 (N-CoR) was accumulated in synchronized HeLa cells in late G2 phase and mitosis (PMID:26663086).	None
LAP1-TOR1A complex	O14656;Q5JTV8	1861;26092	regulation of ATPase activity	None	TOR1A;TOR1AIP1	None	None	None
ARF1-ARL1-PKD2-ARFIP2 complex	P40616;P53365;P84077;Q13563	400;23647;375;5311	regulation of protein transport;vesicle-mediated transport	"vesicular transport (Golgi network, etc.)"	ARL1;ARFIP2;ARF1;PKD2	None	"At the TGN (trans-Golgi network), where PKD2 interacts with active ARF1, PKD2, and ARL1 are required for the assembly of a complex comprising of ARF1 and Arfaptin2 leading to secretion of matrix metalloproteinase-2 and -7. In conclusion, our data indicate that PKD2 is a core factor in the formation of this multiprotein complex at the TGN that controls constitutive secretion of matrix metalloproteinase cargo (PMID:26507660)."	None
HAS1-HAS2 complex	Q92819;Q92839	3037;3036	hyaluronan synthase activity	None	HAS2;HAS1	None	None	None
HAS2-HAS3	O00219;Q92819	3038;3037	hyaluronan synthase activity	None	HAS3;HAS2	None	None	None
DTNBP1(1A)-HDAC3 complex	O15379;Q96EV8	8841;84062	None	None	HDAC3;DTNBP1	"Dysbindin-1 formed a protein complex with HDAC3 in human neuroblastoma cells and in mouse brain. The interaction between dysbindin-1 and HDAC3 occurred in an isoform-specific manner: HDAC3 coupled with dysbindin-1A and -1B, but not -1C (PMID:25196196)."	None	None
EglN2-NRF1-PGC1alpha complex	Q14494;Q96KS0;Q9UBK2	4779;112398;10891	transcription coactivator activity	None	NFE2L1;EGLN2;PPARGC1A	None	"By forming an activator complex with PGC1alpha and NRF1 on chromatin, EglN2 promotes the transcription of ferridoxin reductase (FDXR) and maintains mitochondrial function. In addition, FDXR, as one of effectors for EglN2, contributes to breast tumorigenesis in vitro and in vivo. These findings suggest that EglN2 regulates mitochondrial function in ERalpha-positive breast cancer (PMID:26492917)."	None
CD44-ERK1-ERK2-RHAMM complex	O75330;P16070;P27361;P28482	3161;960;5595;5594	ERK1 and ERK2 cascade;cell motility	None	HMMR;CD44;MAPK3;MAPK1	None	None	"Rhamm and CD44 act together in a hyaluronan-dependent mechanism to coordinate sustained signaling through ERK1,2, leading to high basal motility of invasive breast cancer cells."
"Potassium channel complex (KCNB1, KCNE2)"	Q14721;Q9Y6J6	3745;9992	potassium channel activity;potassium channel complex;voltage-gated potassium channel complex	None	KCNB1;KCNE2	None	"Kv2.1 is a voltage-gated potassium (Kv) channel alpha-subunit expressed in mammalian heart and brain. MinK-related peptides (MiRPs), encoded by KCNE genes, are single-transmembrane domain ancillary subunits that form complexes with Kv channel alpha-subunits to modify their function. Human MinK slowed Kv2.1 activation 25%, while human MiRP1 slowed Kv2.1 activation and deactivation twofold. Inherited mutations in human MinK and MiRP1, previously associated with LQTS, were also evaluated. D76N-MinK and S74L-MinK reduced Kv2.1 current density (threefold and 40%, respectively) and slowed deactivation (60% and 80%, respectively). Compared to wild-type human MiRP1-Kv2.1 complexes, channels formed with M54T- or I57T-MiRP1 showed greatly slowed activation (tenfold and fivefold, respectively)."	Mutations in human MinK (KCNE1) and MiRP1 (KCNE2) are associated with inherited and acquired forms of long QT syndrome (LQTS).
"Potassium channel complex (KCNB1, KCNE1)"	P15382;Q14721	3753;3745	potassium channel activity;potassium channel complex;voltage-gated potassium channel complex	None	KCNE1;KCNB1	None	"Kv2.1 is a voltage-gated potassium (Kv) channel alpha-subunit expressed in mammalian heart and brain. MinK-related peptides (MiRPs), encoded by KCNE genes, are single-transmembrane domain ancillary subunits that form complexes with Kv channel alpha-subunits to modify their function. Human MinK slowed Kv2.1 activation 25%, while human MiRP1 slowed Kv2.1 activation and deactivation twofold. Inherited mutations in human MinK and MiRP1, previously associated with LQTS, were also evaluated. D76N-MinK and S74L-MinK reduced Kv2.1 current density (threefold and 40%, respectively) and slowed deactivation (60% and 80%, respectively). Compared to wild-type human MiRP1-Kv2.1 complexes, channels formed with M54T- or I57T-MiRP1 showed greatly slowed activation (tenfold and fivefold, respectively)."	Mutations in human MinK (KCNE1) and MiRP1 (KCNE2) are associated with inherited and acquired forms of long QT syndrome (LQTS).
IL1RAP-IL1RL1-KIT complex	P10721;Q01638;Q9NPH3	3815;9173;3556	Toll signaling pathway	None	KIT;IL1RL1;IL1RAP	None	Kit and IL1RAP (IL-1RAcP) interact constitutively and IL1RL1 (IL-33R) joins this complex upon ligand binding.  Association of IL1RL1 with KIT depends on cholesterol-rich membrane microdomains.	None
IL1RAP-KIT complex	P10721;Q9NPH3	3815;3556	Toll signaling pathway	None	KIT;IL1RAP	None	IL1RAP (c-Kit) interacts constitutively with IL-1RAcP and not ligand-dependent.	None
PAQR3-SCAP-SREBF2 complex	Q12770;Q12772;Q6TCH7	22937;6721;152559	cholesterol homeostasis;Golgi apparatus	cholesterol homeostasis;Golgi	SCAP;SREBF2;PAQR3	None	"PAQR3 interacts with Scap/SREBP and promotes localization of Scap/SREBP in the Golgi, resulting in enhanced SREBP processing and cellular cholesterol level. PAQR3 interacts with SREBP-2 and Scap via distinct structural motifs. Endogenous PAQR3 was able to interact with endogenous Scap or endogenous SREBP-2 by the co-immunoprecipitation assays. PAQR3 could dose-dependently promote the complex formation between Scap and SREBP-2."	None
SCAP-SREBF2 complex	Q12770;Q12772	22937;6721	cholesterol homeostasis;Golgi apparatus	cholesterol homeostasis;Golgi	SCAP;SREBF2	None	"PAQR3 interacts with Scap/SREBP and promotes localization of Scap/SREBP in the Golgi, resulting in enhanced SREBP processing and cellular cholesterol level. PAQR3 interacts with SREBP-2 and Scap via distinct structural motifs. PAQR3 could dose-dependently promote the complex formation between Scap and SREBP-2."	None
PAQR3-SCAP-complex	Q12770;Q6TCH7	22937;152559	cholesterol homeostasis;Golgi apparatus	cholesterol homeostasis;Golgi	SCAP;PAQR3	None	"PAQR3 interacts with Scap/SREBP and promotes localization of Scap/SREBP in the Golgi, resulting in enhanced SREBP processing and cellular cholesterol level. PAQR3 interacts with SREBP-2 and Scap via distinct structural motifs. Endogenous PAQR3 was able to interact with endogenous Scap or endogenous SREBP-2 by the co-immunoprecipitation assays."	None
PAQR3-SREBF2 complex	Q12772;Q6TCH7	6721;152559	cholesterol homeostasis;Golgi apparatus	cholesterol homeostasis;Golgi	SREBF2;PAQR3	None	"PAQR3 interacts with Scap/SREBP and promotes localization of Scap/SREBP in the Golgi, resulting in enhanced SREBP processing and cellular cholesterol level. PAQR3 interacts with SREBP-2 and Scap via distinct structural motifs. Endogenous PAQR3 was able to interact with endogenous Scap or endogenous SREBP-2 by the co-immunoprecipitation assays."	None
"Ubiquitin E3 ligase (CUL3, KLHL7, RBX1)"	P62877;Q13618;Q8IXQ5	9978;8452;55975	cullin-RING ubiquitin ligase complex;proteasome-mediated ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;CUL3;KLHL7	None	None	Ala-153 mutations in KLHL7 that attenuate its interaction and co-localization with Cul3 cause autosomal dominant retinitis pigmentosa.
"Ubiquitin E3 ligase (CUL3, KLHL8)"	Q13618;Q9P2G9	8452;57563	cullin-RING ubiquitin ligase complex;proteasome-mediated ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	CUL3;KLHL8	None	"Rapsyn, a postsynaptic protein required for clustering of nicotinic acetylcholine receptors (nAChRs) at the neuromuscular junction is polyubiquitinated by a KLHL8-containing E3 ligase."	None
INSIG1-SCAP complex	O15503;Q12770	3638;22937	sterol metabolic process;endoplasmic reticulum	endoplasmic reticulum	INSIG1;SCAP	None	"Under cholesterol sufficient condition, Insigs act as anchor proteins to retain Scap/SREBP in the ER. Immunoprecipitation of PAQR3 could only bring down Scap but not Insig-1. Likewise, immunoprecipitation of Insig-1 could only bring down Scap but not PAQR3. Overexpression of PAQR3 was able to reduce Insig/Scap interaction in a dose-dependent manner. The results indicated that PAQR3 and Insig can mutually exclusively compete for Scap interaction, leading to either activation of SREBP by anchoring it to the GA (via PAQR3) or inactivation of SREBP by anchoring it to the ER (via Insig).  The mutually exclusive interaction between Scap and PAQR3 or Insig-1 is regulated by cholesterol level."	None
INSIG1-PAQR3 complex	O15503;Q6TCH7	3638;152559	endoplasmic reticulum;sterol metabolic process	endoplasmic reticulum	INSIG1;PAQR3	None	"Under cholesterol sufficient condition, Insigs act as anchor proteins to retain Scap/SREBP in the ER. Immunoprecipitation of PAQR3 could only bring down Scap but not Insig-1. Likewise, immunoprecipitation of Insig-1 could only bring down Scap but not PAQR3. Overexpression of PAQR3 was able to reduce Insig/Scap interaction in a dose-dependent manner. The results indicated that PAQR3 and Insig can mutually exclusively compete for Scap interaction, leading to either activation of SREBP by anchoring it to the GA (via PAQR3) or inactivation of SREBP by anchoring it to the ER (via Insig). The mutually exclusive interaction between Scap and PAQR3 or Insig-1 is regulated by cholesterol level."	None
"Ubiquitin E3 ligase (CUL3, KLHL12, PEF1, PDCD6)"	O75340;Q13618;Q53G59;Q9UBV8	10016;8452;59349;553115	cullin-RING ubiquitin ligase complex;COPII vesicle coat;response to calcium ion;proteasome-mediated ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	PDCD6;CUL3;KLHL12;PEF1	None	"CUL3 and its adaptor KLHL12 require two calcium-binding proteins, PEF1 and PDCD6 (ALG2), for recognition of their substrate SEC31. PEF1 and ALG2 form a target-specific co-adaptor that translates a transient rise in cytosolic calcium levels into more persistent SEC31 ubiquitylation, which in turn triggers formation of large COPII coats and promotes collagen secretion."	None
"Ubiquitin E3 ligase (CUL3, KLHL9, KLHL13, RBX1)"	P62877;Q13618;Q9P2J3;Q9P2N7	9978;8452;55958;90293	cullin-RING ubiquitin ligase complex;mitotic cytokinetic process;proteasome-mediated ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;CUL3;KLHL9;KLHL13	None	"Ubiquitin E3 ligase (CUL3, KLHL9, KLHL13, RBX1) is essential for mitotic division. In complex with the substrate-specific adaptors KLHL9 and KLHL13, CUL3 is required for correct chromosome alignment in metaphase, proper midzone and midbody formation, and completion of cytokinesis. The complex regulates Aurora B localization on mitotic chromosomes possibly by inhibiting its efficient removal from chromosome arms."	None
"Ubiquitin E3 ligase (CUL3, KLHL20, RBX1)"	P62877;Q13618;Q9Y2M5	9978;8452;27252	cullin-RING ubiquitin ligase complex;negative regulation of autophagic cell death;proteasome-mediated ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;CUL3;KLHL20	None	"Death-associated protein kinase (DAPK) is a mediator of interferon-induced cell death. The Ubiquitin E3 ligase (CUL3, KLHL20, RBX1) complex promotes DAPK polyubiquitination, thereby inducing the proteasomal degradation of DAPK and attenuation of autophagy. In interferon-treated cells, the enrichment and sequestration of KLHL20 in PML nuclear bodies disrupts KLHL20\u2013DAPK complex, thus impairing DAPK ubiquitination by KLHL20."	None
"Ubiquitin E3 ligase (CUL3, KLHL24, RBX1)"	P62877;Q13618;Q6TFL4	9978;8452;54800	cullin-RING ubiquitin ligase complex;proteasome-mediated ubiquitin-dependent protein catabolic process	proteasomal degradation (ubiquitin/proteasomal pathway)	RBX1;CUL3;KLHL24	None	None	"Defects in keratin 14 causes skin fragility, epitomized by epidermolysis bullosa (EB), a life-threatening disorder. Stabilizing mutations of Ubiquitin E3 ligase (CUL3, KLHL24, RBX1) causes loss of keratin 14 and human skin fragility."
"Ubiquitin E3 ligase (CUL3, KLHL25)"	Q13618;Q9H0H3	8452;64410	cullin-RING ubiquitin ligase complex;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of translation	proteasomal degradation (ubiquitin/proteasomal pathway);translational control	CUL3;KLHL25	None	"Translation via eIF4E activity is controlled by a family of repressor proteins, termed 4E-binding proteins (E4-BPs). Ubiquitin E3 ligase (CUL3, KLHL25) complex plays a key role in ubiquitination and subsequent degradation of the hypophosphorylated 4E-BP1."	None
APP-Abeta42-VDAC1 complex	P05067;P21796	351;7416	mitochondrion;membrane raft;voltage-gated anion channel activity;cell death	mitochondrion;cell death	APP;VDAC1	"VDAC1 associates with APP (100 kDa full-length APP) and Abeta (1-42 fragment of APP, oligomeric)."	"Voltage-dependent anion channel (VDAC) is a mitochondrial protein abundantly found in neuronal lipid rafts. In these membrane domains, VDAC is associated with a complex of signaling proteins that trigger neuroprotective responses. It is demonstrated that VDAC1 associates with APP (100 kDa full-length APP) and Abeta (1-42 fragment, oligomeric) in lipid rafts of neurons. Interaction of VDAC1 with APP was observed in lipid rafts from the frontal and entorhinal cortex of human brains affected by AD at early stages (I-IV/0-B of Braak and Braak). Furthermore, Abeta exposure enhanced the dephosphorylation of VDAC1 that correlated with cell death. Both effects were reverted in the presence of tyrosine phosphatase inhibitors."	None
"Ubiquitin E3 ligase (CUL3, KLHL42)"	Q13618;Q9P2K6	8452;57542	cullin-RING ubiquitin ligase complex;regulation of mitotic cell cycle phase transition	None	CUL3;KLHL42	None	"Overexpression of KLHL42 results in an increased microtubule density, cytoplasmic bridges between cells, and bi-nucleated cells. In contrast, knockdown of KLHL42 protein levels by double strand RNA results in a dramatic reduction in the cellular microtubule framework. Thus, Ubiquitin E3 ligase (CUL3, KLHL42) is required for normal mitosis in mammalian cells."	None
CTNNB1-EPCAM-FHL2-LEF1 complex	P16422;P35222;Q14192;Q9UJU2	4072;1499;2274;51176	"nucleus;regulation of transcription, DNA-templated;signal transduction"	nucleus;transcriptional control;CELLULAR COMMUNICATION/SIGNAL TRANSDUCTION MECHANISM	EPCAM;CTNNB1;FHL2;LEF1	None	EpCAM as a mitogenic signal transducer  involves shedding of its ectodomain EpEX and nuclear translocation of its intracellular domain EpICD. Endogenous EpICD was detected in the nuclear CTNNB1-EPCAM-FHL2-LEF1 complex with a native molecular size of 650 K.	"In patients, EpICD was found in nuclei of colon carcinoma but not of normal tissue."
CD44-LRP1 complex	P16070;Q07954	960;4035	receptor-mediated endocytosis;membrane raft;cell adhesion	receptor-mediated endocytosis;cell adhesion	CD44;LRP1	None	CD44 is routed through early endosomes toward lysosomes in a LRP1-dependent pathway. LRP1-mediated internalization of CD44 proceeds mostly via clathrin-coated pits.	LRP1-mediated endocytosis of CD44 controls tumor cell attachment.
KMT2E-OGT-USP7 complex	O15294;Q8IZD2;Q93009	8473;55904;7874	"nucleus;cell cycle;hemopoiesis;regulation of transcription, DNA-templated"	nucleus;cell cycle;hemopoiesis;transcriptional control	OGT;KMT2E;USP7	None	The MLL5 protein stability is cooperatively regulated by O-GlcNAc transferase (OGT) and ubiquitin-specific protease 7 (USP7).	MLL5 protein levels are correlated with expression of OGT and USP7 in primary cervical adenocarcinomas.
KNTC1-ZW10-ZWILCH complex	O43264;P50748;Q9H900	9183;9735;55055	mitotic cell cycle checkpoint	None	ZW10;KNTC1;ZWILCH	None	The KNTC1-ZW10-ZWILCH complex is essential for the mitotic checkpoint.	None
KNL1-MIS12-NDC80-SPC24-ZWINT complex	O14777;O95229;Q8NBT2;Q8NG31;Q9H081	10403;11130;147841;57082;79003	mitotic cell cycle checkpoint	None	NDC80;ZWINT;SPC24;KNL1;MIS12	None	ZWINT has a crucial role in the recruitment of ZW10 to unattached kinetochores.	None
KPNB1-SMN-SPN complex	P16150;Q14974;Q16637	6693;3837;None	cytoplasm	cytoplasm	SPN;KPNB1;SMN1; SMN2	None	"Applying gel filtration, Importin beta (KPNB1), SMN and SPN comigrate in the 400-500 kDa region."	None
DKK1-KREMEN1-LRP6 complex	O75581;O94907;Q96MU8	4040;22943;83999	None	None	LRP6;DKK1;KREMEN1	None	DKK1-KREMEN1-LRP6 complex is also characterized in PMID 12050670.	None
BORC complex	O95295;P78537;Q6QNY1;Q969J3;Q96B45;Q96FH0;Q96GS4;Q9BQD3	23557;2647;282991;118426;119032;729991;54785;79036	BORC complex	None	SNAPIN;BLOC1S1;BLOC1S2;BORCS5;BORCS7;BORCS8;BORCS6;KXD1	None	"BORC complex associates peripherally with the lysosomal membrane, where it functions to recruit the small GTPase Arl8. This initiates a chain of interactions that promotes the kinesin-dependent movement of lysosomes toward the plus ends of microtubules in the peripheral cytoplasm."	None
MAPK6-MAPKAPK5-SEPT7 complex	Q16181;Q16659;Q8IW41	989;5597;8550	None	None	SEPT7;MAPK6;MAPKAPK5	None	None	None
KEOPS complex	Q14657;Q96S44;Q9NPF4;Q9Y3C4	8270;112858;55644;51002	translation;telomere maintenance	translation	LAGE3;TP53RK;OSGEP;TPRKB	None	None	"Mutations in KEOPS-complex genes cause Galloway\u2013Mowat syndrome (GAMOS), an autosomal- recessive disease characterized by the combination of early-onset nephrotic syndrome (SRNS) and microcephaly with brain anomalies (PMID:28805828)."
PRAME complex	P62877;P78395;Q13617;Q14657;Q15369;Q15370;Q9NPF4	9978;23532;8453;8270;6921;6923;55644	None	None	RBX1;PRAME;CUL2;LAGE3;TCEB1;TCEB2;OSGEP	None	None	None
LGR4-RSPO supercomplex	O00401;O14641;O60610;P36507;P46940;P49023;Q02750;Q05397;Q9BXB1;Q9BXY4	8976;1856;1729;5605;8826;5829;5604;5747;55366;84870	focal adhesion assembly;Wnt signaling pathway	Wnt signalling pathway	WASL;DVL2;DIAPH1;MAP2K2;IQGAP1;PXN;MAP2K1;PTK2;LGR4;RSPO3	None	None	None
INSC-LGN-PAR3 complex	P81274;Q1MX18;Q8TEW0	29899;387755;56288	establishment of cell polarity	None	GPSM2;INSC;PARD3	None	None	None
NCKAP1-WASF3 complex	Q9UPY6;Q9Y2A7	10810;10787	actin cytoskeleton reorganization	None	WASF3;NCKAP1	None	None	"Destabilization of the complex lowers the invasive capacity of breast, prostate, and colon cancer cells."
NCKAP1-WASF3-RAC1 complex	P63000;Q9UPY6;Q9Y2A7	5879;10810;10787	actin cytoskeleton reorganization	None	RAC1;WASF3;NCKAP1	None	None	RAC1 binding to the WASF3-NCKAP1 complex is required for the invasive signaling axis in breast cancer cells
LARP1-PABPC1-RYDEN complex	P11940;Q6PKG0;Q9NUL5	26986;23367;55337	defense response to virus	None	PABPC1;LARP1;RYDEN	None	None	RYDEN is a interferon-stimulated cellular inhibitor against replication of dengue virus and other viruses. This inhibition is achieved by forming a protein complex with LARP1 and PABPC1.
LGR5-RNF43-RSPO1 complex	O75473;Q2MKA7;Q68DV7	8549;284654;54894	Wnt signaling pathway	Wnt signalling pathway	LGR5;RSPO1;RNF43	None	None	None
7SK RNP complex	O60563;O94992;P50750;Q4G0J3	904;10614;1025;51574	"negative regulation of transcription, DNA-templated"	transcription repression	CCNT1;HEXIM1;CDK9;LARP7	None	The CDK9-CCNT1-HEXIM1-LARP7 complex regulates not only viral but also cellular POLII class genes through the 7SK P-TEFb system.	None
SUMO1-SYT7 complex	O43581;P63165	9066;7341	negative regulation of exocytosis;negative regulation of insulin secretion	None	SYT7;SUMO1	None	None	None
LATS2-SIAH2-ZYX complex	O43255;Q15942;Q9NRM7	6478;7791;26524	regulation of hippo signaling;transforming growth factor beta receptor signaling pathway	TGF-beta-receptor signalling pathway	SIAH2;ZYX;LATS2	None	"Zyxin forms a functional ternary complex with Siah2 and Lats2, thus enhances their binding and promotes Siah2-induced Lats2 degradation."	None
APP-PSEN1 complex	P05067;P49768	351;5663	beta-amyloid formation;amyloid precursor protein catabolic process	None	APP;PSEN1	APP or presenilin proteins carrying familial AD-linked missense mutations still can form complexes.	"Mutations in the presenilin 1 (PS1) and presenilin 2 (PS2) genes increase the production of the highly amyloidogenic 42-residue form of amyloid beta-protein (Abeta42) in a variety of cell lines and transgenic mice. APP-PS complexes were recovered from human 293 and HS683 cells. APP was consistently found to coimmunoprecipitate with PS1 or PS2 proteins. Full maturation of APP was not required for the interaction; most APP molecules complexed with PS were solely N-glycosylated. Such complexes exist under physiological conditions. Treatment of cells with brefeldin A or incubation at 20 degrees C did not block complex formation, suggesting that the association between APP and PS occurs in part in the endoplasmic reticulum. Complex formation was detected for both wt and mutant PS and APP proteins. Deletion of the APP C-terminal domain did not abrogate complex formation, suggesting that the interaction does not occur in the cytoplasmic domains of the proteins."	Alzheimer
APP-PSEN2 complex	P05067;P49810	351;5664	amyloid precursor protein catabolic process;beta-amyloid formation	None	APP;PSEN2	APP or presenilin proteins carrying familial AD-linked missense mutations still can form complexes.	"Mutations in the presenilin 1 (PS1) and presenilin 2 (PS2) genes increase the production of the highly amyloidogenic 42-residue form of amyloid beta-protein (Abeta42) in a variety of cell lines and transgenic mice. APP-PS complexes were recovered from human 293 and HS683 cells. APP was consistently found to coimmunoprecipitate with PS1 or PS2 proteins. Full maturation of APP was not required for the interaction; most APP molecules complexed with PS were solely N-glycosylated. Such complexes exist under physiological conditions. Treatment of cells with brefeldin A or incubation at 20 degrees C did not block complex formation, suggesting that the association between APP and PS occurs in part in the endoplasmic reticulum. Complex formation was detected for both wt and mutant PS and APP proteins. Deletion of the APP C-terminal domain did not abrogate complex formation, suggesting that the interaction does not occur in the cytoplasmic domains of the proteins."	Alzheimer
VHL-ElonginB-ElonginC complex	P40337;Q15369;Q15370	7428;6921;6923	protein ubiquitination	"modification by ubiquitination, deubiquitination"	VHL;TCEB1;TCEB2	None	None	None
APP-APBB1-KAT5 complex	O00213;P05067;Q92993	322;351;10524	histone acetylation;transcription cofactor binding;mRNA transcription;DNA binding	mRNA synthesis;DNA binding	APBB1;APP;KAT5	None	"The cytoplasmic tail of APP forms a multimeric complex with the nuclear adaptor protein Fe65 and the histone acetyltransferase Tip60. This complex potently stimulates transcription via heterologous Gal4- or LexA-DNA binding domains, suggesting that release of the cytoplasmic tail of APP by gamma-cleavage may function in gene expression."	None
Shieldin complex	Q6ZNX1;Q86V20;Q8IYI0;Q9UI95	None;54537;149840;10459	double-strand break repair	None	SHLD3;SHLD2;SHLD1;MAD2L2	None	The authors propose a model in which the shieldin complex is the ultimate mediator of 53BP1-dependent DNA repair by binding ssDNA and occluding access to resection nucleases.	None
APP(AICD)-MED12 complex	P05067;Q93074	351;9968	mediator complex binding;mRNA transcription;RNA polymerase II activity;gene expression	mRNA synthesis	APP;MED12	AICD is a small APP intracellular domain.	"Regulated intramembrane proteolysis of the amyloid precursor-protein (APP) produces both a characterstic amyloid-beta peptide that contributes to neuritic plaque formation and neurodegeneration in Alzheimer disease and a small APP intracellular domain (AICD) that transcriptionally activates genes implicated in Alzheimer disease pathology. It is shown that the AICD activates transcription by targeting MED12, an RNA polymerase II transcriptional Mediator subunit that is implicated in human cognitive development. AICD binds to MED12/Mediator in vitro and in vivo. Disruption of the AICD/MED12 interaction inhibits AICD transactivation potential and expression of AICD target genes."	Alzheimer
MAP2K4-MAP3K3-NBR1 complex	P45985;Q14596;Q99759	6416;4077;4215	inflammatory response;regulation of JNK cascade	inflammatory response	MAP2K4;NBR1;MAP3K3	None	None	None
ESR1-TRAP/Mediator coactivator-complex	O43513;O60244;O75448;O75586;P03372;P24863;P49336;Q09472;Q13503;Q15648;Q15788;Q93074;Q9BTT4;Q9H944;Q9NVC6;Q9UHV7;Q9ULK4;Q9Y2X0	9443;9282;9862;10001;2099;892;1024;2033;9412;5469;8648;9968;84246;9477;9440;9969;9439;10025	"mRNA transcription;nucleus;regulation of transcription, DNA-templated;mediator complex"	mRNA synthesis;nucleus;transcriptional control	MED7;MED14;MED24;MED6;ESR1;CCNC;CDK8;EP300;MED21;MED1;NCOA1;MED12;MED10;MED20;MED17;MED13;MED23;MED16	None	The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. All TRAP/Mediator components examined (with exception of TRAP150) were found to associate with ERalpha and ERbeta LBDs (C-terminal ligand binding domains) in an E2-dependent manner. The assays also show ligand-dependent interactions of SRC-1 and p300 with ER LBDs. These interactions are stronger for ERalpha than for ERbeta. No interactions of general transcription factors TFIIE (IIEalpha) and TFIIF (RAP30) were observed.	None
ESR2-TRAP/Mediator coactivator complex	O43513;O60244;O75448;O75586;P24863;P49336;Q09472;Q13503;Q15648;Q15788;Q92731;Q93074;Q9BTT4;Q9H944;Q9NVC6;Q9UHV7;Q9ULK4;Q9Y2X0	9443;9282;9862;10001;892;1024;2033;9412;5469;8648;2100;9968;84246;9477;9440;9969;9439;10025	"mediator complex;mRNA transcription;nucleus;regulation of transcription, DNA-templated"	mRNA synthesis;nucleus;transcriptional control	MED7;MED14;MED24;MED6;CCNC;CDK8;EP300;MED21;MED1;NCOA1;ESR2;MED12;MED10;MED20;MED17;MED13;MED23;MED16	None	The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. All TRAP/Mediator components examined (with exception of TRAP150) were found to associate with ERalpha and ERbeta LBDs (C-terminal ligand binding domains) in an E2-dependent manner. The assays also show ligand-dependent interactions of SRC-1 and p300 with ER LBDs. These interactions are stronger for ERalpha than for ERbeta. No interactions of general transcription factors TFIIE (IIEalpha) and TFIIF (RAP30) were observed.	None
"CDK8 subcomplex (CCNC, CDK8, MED12, MED13)"	P24863;P49336;Q93074;Q9UHV7	892;1024;9968;9969	histone kinase activity	None	CCNC;CDK8;MED12;MED13	1:1:1:1 stoichiometry was established for the CDK8 subcomplex based upon densitometry measurements	"The human CDK8 subcomplex consisting of four proteins (CDK8, Cyclin C, Med12, and Med13) is a histone kinase that requires Med12 for activity and can function independently of Mediator. Med12, but not Med13, is essential for activating the CDK8 kinase."	None
"CDK8 subcomplex (CCNC, CDK8, MED12)"	P24863;P49336;Q93074	892;1024;9968	histone kinase activity	None	CCNC;CDK8;MED12	1:1:1 stoichiometry was established for the CDK8 subcomplex based upon densitometry measurements	"The human CDK8 subcomplex consisting of four proteins (CDK8, Cyclin C, Med12, and Med13) is a histone kinase that requires Med12 for activity and can function independently of Mediator. Med12, but not Med13, is essential for activating the CDK8 kinase. Med12 and Med13 each also independently interact with the CDK8/Cyclin-C pair."	None
"CDK8 subcomplex (CCNC, CDK8, MED13)"	P24863;P49336;Q9UHV7	892;1024;9969	histone kinase activity	None	CCNC;CDK8;MED13	1:1:1 stoichiometry was established for the CDK8 subcomplex based upon densitometry measurements	"The human CDK8 subcomplex consisting of four proteins (CDK8, Cyclin C, Med12, and Med13) is a histone kinase that requires Med12 for activity and can function independently of Mediator. Med12, but not Med13, is essential for activating the CDK8 kinase. Med12 and Med13 each also independently interact with the CDK8/Cyclin-C pair."	None
FOXO1-ESR1 complex	P03372;Q12778	2099;2308	nuclear hormone receptor binding;estrogen receptor binding	None	ESR1;FOXO1	None	FKHR interacts with ERalpha in an E2-dependent fashion and represses ER-mediated transactivation.	None
APP(AICD)-FOXO3 complex	O43524;P05067	2309;351	cytoplasm;cell death;response to oxidative stress;nucleus;apoptotic process	cytoplasm;cell death;oxidative stress response;nucleus;apoptosis (type I programmed cell death)	FOXO3;APP	AICD is a small APP intracellular domain.	"In human cells, AICD physically interacts with FoxO1, FoxO3a, or FoxO4 in HEK 293T cells in the cytoplasm, translocates with Foxo3a into the nucleus upon oxidative stress, and promotes FoxO-induced transcription of pro-apoptotic gene Bim. Data demonstrate that APP modulates FoxO-mediated cell death through AICD, which acts as a transcriptional co-activator of FoxO."	None
APP(AICD)-FOXO1 complex	P05067;Q12778	351;2308	cell death;cytoplasm;apoptotic process	cell death;cytoplasm;apoptosis (type I programmed cell death)	APP;FOXO1	AICD is a small APP intracellular domain.	"In human cells, AICD physically interacts with FoxO1, FoxO3a, or FoxO4 in HEK 293T cells in the cytoplasm, translocates with Foxo3a into the nucleus upon oxidative stress, and promotes FoxO-induced transcription of pro-apoptotic gene Bim. Data demonstrate that APP modulates FoxO-mediated cell death through AICD, which acts as a transcriptional co-activator of FoxO."	None
APP(AICD)-FOXO4 complex	P05067;P98177	351;4303	cell death;cytoplasm;apoptotic process	cell death;cytoplasm;apoptosis (type I programmed cell death)	APP;FOXO4	AICD is a small APP intracellular domain.	"In human cells, AICD physically interacts with FoxO1, FoxO3a, or FoxO4 in HEK 293T cells in the cytoplasm, translocates with Foxo3a into the nucleus upon oxidative stress, and promotes FoxO-induced transcription of pro-apoptotic gene Bim. Data demonstrate that APP modulates FoxO-mediated cell death through AICD, which acts as a transcriptional co-activator of FoxO."	None
AKAP13-MAP2K3-MAP3K20-MAPK14-PKN1 complex	P46734;Q12802;Q16512;Q16539;Q9NYL2	5606;11214;5585;1432;51776	MAPK cascade	MAPKKK cascade	MAP2K3;AKAP13;PKN1;MAPK14;MAP3K20	None	Silencing of AKAP13 expression  specifically reduces alpha1-adrenergic-receptor-mediated MAPK14 (p38alpha) activation without affecting receptor-mediated activation of other MAPK pathways.	None